You are on page 1of 354

FINAL

PROGRAMME
ECR 2015 will be a green meeting designed
to meet environmental sustainability criteria set
by the Österreichisches Umweltzeichen
(Austria’s national eco-friendly certificate).

Coordination
ESR Office, Neutorgasse 9, 1010 Vienna, Austria
Phone: (+ 43 1) 533 40 64-0
E-mail: communications@myESR.org
www.myESR.org
Managing Editor: Julia Patuzzi
Art Direction: Petra Mühlmann, Andreasz Diesenreiter
Layout: Barbara Biegl
Photo Credits: Unless otherwise indicated all pictures
© ESR – European Society of Radiology
All data as per date of publication: February 2015
ESR accepts no responsibility for errors or misprints.
WILLKOMMEN
IN WIEN

1
Timetable

08:30 9:00 09:30 10:00 10:30 11:00 11:30 12:00 12:15 13:00 13:30 14:00
Wednesday, March 4

E³ - ECR Academy E³ - ECR Academy E³ - The Beauty of Basic Knowledge


E³ 121 E³ 221 E³ 24A, E³ 25A
Special Focus Sessions
SF 1a, SF 1b, SF 1c Scientific Sessions (200) Siemens Healthcare and Bayer HealthCare
Joint Symposium - Breast Care Day
Refresher Courses (100) Siemens Healthcare and Bayer HealthCare Bayer HealthCare Symposium
Joint Symposium - Breast Care Day SuperSonic Imagine Symposium
HIMSS Symposium

E³ - ECR Academies
1 E³ - ECR Academies
2 Late-Breaking Clinical Trials

Josef Lissner
E³ 518, E³ 519, E³ 520, E³ 521 E³ 620, E³ 621 Honorary Lecture
E³ - Rising Stars Programme E³ - Rising Stars Programme James A. Brink; US
Basic Session 1 Basic Session 2
Thursday, March 5

State of the Art Symposium E³ - The Beauty of Basic Knowledge


SA 5 Scientific Sessions (600) E³ 24B, E³ 25B
Special Focus Session Multimedia Classroom MM 6 Bayer HealthCare Symposium
SF 5 Bracco Symposium
Professional Challenges Sessions Joint Course: ESR/RSNA GE Healthcare Symposium
PC 5a, PC 5b MC 628 Siemens Healthcare Symposia
Refresher Courses (500) Toshiba Medical Systems Symposium
Joint Course: ESR/RSNA RTF Quiz

5 6
MC 528
Joint Session: ESR/EFSUMB

E³ - ECR Academies ESR meets Germany Wilhelm Conrad Röntgen


E³ 918, E³ 919, E³ 921, E³ 920 Honorary Lecture
E³ - ECR Master Classes E³ - ECR Academies Gerald Antoch; DE
E³ 926a, E³ 926b, E³ 926c E³ 1020, E³ 1021
E³ - Rising Stars Programme E³ - Rising Stars Programme E³ - The Beauty of Basic Knowledge
Student Session 3 Student Session 4 E³ 24C, E³ 25C
Friday, March 6

New Horizon Session Scientific Sessions (1000) MIR @ ECR


NH 9
Special Focus Sessions Multimedia Classroom MM 10 Bayer HealthCare and Siemens Healthcare
SF 9a, SF 9b Joint Symposium
EIBIR Session Bracco Symposium
Professional Challenges Session
PC 9 Joint Session: ESR/EFOMP GE Healthcare Symposium
Multidisciplinary Session Guerbet Symposium
MS 9 Philips Symposium
Samsung Symposium
Refresher Courses (900) Toshiba Medical Systems Symposia
ESR Research and
Training Working Group Session
Joint Session: ESR/EFOMP

E³ - ECR Academies
9 10
ESR meets the Republic of Korea Nikola Tesla
E³ 1318, E³ 1321, E³ 1322 Honorary Lecture
E³ - EDiR Prep Session E³ - ECR Academies Anne G. Osborn; US
E³ 1422
Saturday, March 7

E³ 1323
E³ - ECR Master Class E³ - EDiR Prep Session Junior Image
E³ 1326 E³ 1423 Interpretation Quiz
E³ - Rising Stars Programme E³ - Rising Stars Programme
Basic Session 5 E³ - The Beauty of Basic Knowledge
Basic Session 4 E³ 24D, E³ 25D
Refresher Courses (1300) Scientific Sessions (1400)
Bracco Symposium
Joint Session: ESR/EORTC Multimedia Classroom MM 14 GE Healthcare Symposium
Philips Symposia
ESR Patient

E³ - ECR Academies
13 Advisory Group Session
RTF Highlighted Lectures

ESR meets Turkey


14 E³ - The Beauty of Basic Knowledge
E³ 1721, E³ 1722 E³ 24E, E³ 25E
E³ - ECR Master Class E³ - ECR Academies
E³ 1726 E³ 1821 E³ - Rising Stars Programme
Sunday, March 8

E³ - Rising Stars Programme E³ - EDiR Prep Session Case-Based Diagnosis Training


Basic Session 6 E³ 1823
New Horizon Session Scientific Sessions (1800)
NH 17
Special Focus Sessions ESR Patient Advisory Group Session
SF 17a, SF 17b, SF 17c
Refresher Courses (1700)
EDiR Session
Joint Session: ESR/ERS
17 18
2 ECR 2015 | Final Programme www.myESR.org
Timetable

14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 17:45 18:00 18:30 19:00

Wednesday, March 4
Scientific Sessions (300) E³ - ECR Academy Opening Ceremony
E³ 418
Siemens Healthcare Special Focus Session Presentation of Honorary Members:
Symposium - Breast Care Day SF 4 N. Reed Dunnick; US
Professional Challenges Sessions Tae-Hwan Lim; KR
PC 4a, PC 4b Anne G. Osborn; US
Refresher Courses (400)

E³ - ECR Academies
3 Siemens Healthcare
Symposium - Breast Care Day

E³ - ECR Academies
4
E³ 720, E³ 721 E³ 818, E³ 819, E³ 820, E³ 821
E³ - Rising Stars Programme E³ - ECR Master Class
Student Session 1 E³ 826

Thursday, March 5
E³ - Rising Stars Programme
Scientific Sessions (700) Student Session 2
Multimedia Classroom MM 7 Special Focus Sessions
SF 8a, SF 8b, SF 8c
ESOR Session Professional Challenges Sessions
EuroSafe Imaging Session PC 8a, PC 8b
EIBIR Session Pros & Cons Session PS 827
Joint Course: ESR/RSNA Multidisciplinary Session MS 8
MC 728 Refresher Courses (800)

EFRS meets Germany


7 Multimedia Classroom MM 8
Joint Course: ESR/RSNA
MC 828

ESR meets EAU


8
Image Interpretation Quiz E³ - ECR Academies
E³ 1218, E³ 1219, E³ 1221, E³ 1222
Multimedia Classroom MM 11 E³ - ECR Master Classes
EuroSafe Imaging Session E³ 1226a, E³ 1226b, E³ 1226c, E³ 1226d

Friday, March 6
EIBIR Session E³ - Rising Stars Programme
Basic Session 3
Joint Session: ESR/ESMRMB State of the Art Symposium
MIR @ ECR SA 12
Special Focus Session
GE Healthcare Russia Symposium SF 12
Hologic Symposium Professional Challenges Sessions
HIMSS Symposium PC 12a, PC 12b
Refresher Courses (1200)

E³ - ECR Academies
11 Multimedia Classroom MM 12
MIR @ ECR

E³ - ECR Academies
12
E³ 1518, E³ 1521, E³ 1522 E³ 1618, E³ 1621, E³ 1622
E³ - EDiR Prep Session E³ - EDiR Prep Session

Saturday, March 7
E³ 1523 E³ 1623
E³ - ECR Master Class E³ - ECR Master Classes
E³ 1526 E³ 1626a, E³ 1626b, E³ 1626c
E³ - Rising Stars Programme State of the Art Symposium
Student Final Session SA 16
New Horizon Session Special Focus Session
NH 15 SF 16
Special Focus Session Multidisciplinary Session
SF 15 MS 16
Refresher Courses (1500)
Multimedia Classroom MM 15
EuroSafe Imaging Session
Joint Session: ESR/ESTRO

E³ - EDiR Prep Session


15 Refresher Courses (1600)
EuroSafe Imaging Session
Joint Session: ESR/ESTRO 16
E³ 1923
E³ - Rising Stars Programme
Sunday, March 8

Case-Based Diagnosis Training


Scientific Sessions (1900)

19
www.myESR.org Final Programme | ECR 2015 3
Information

27th European Congress of Radiology


CONGRESS VENUE CONGRESS LANGUAGE
Austria Center Vienna English
Bruno Kreisky Platz 1
1220 Vienna, Austria

ONSITE OPENING HOURS


Registration Technical Exhibition
Tuesday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 First Level (Gallery)
Wednesday, March 4 . . . . . . . . . . . . . . . . . . . . . . 07:00–18:00 Wednesday, March 4 . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00
Thursday, March 5 to Sunday, March 8 . . . . . . 07:30–18:00 Thursday, March 5 to Sunday, March 8 . . . . . . 10:00–17:00

Preview Centre Travel Service


Tuesday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Tuesday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
Wednesday, March 4 to Sunday, March 8 . . . . 07:30–18:00 Wednesday, March 4 to Saturday, March 7 . . 07:30–18:00
Sunday, March 8 . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
EPOS™ – Scientific Exhibition
Wednesday, March 4 to Sunday, March 8 . . . . 08:00–18:00 Press Office & Business Centre
Wednesday, March 4 to Sunday, March 8 . . . . 08:00–18:00
Technical Exhibition
EXPO Halls and EXPO Foyer D
Thursday, March 5 to Saturday, March 7 . . . . 10:00–17:00
Sunday, March 8 . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00

SESSIONS IN JOINT SPONSORSHIP WITH


CIRSE Cardiovascular and Interventional Radiological Society of Europe
EFOMP European Federation of Organisations for Medical Physics
EFRS European Federation of Radiographer Societies
ESCR European Society of Cardiac Radiology
ESER European Society of Emergency Radiology
ESGAR European Society of Gastrointestinal and Abdominal Radiology
ESHNR European Society of Head and Neck Radiology
ESMOFIR European Society of Molecular and Functional Imaging in Radiology
ESNR European Society of Neuroradiology
ESOI European Society of Oncologic Imaging
ESPR European Society of Paediatric Radiology
ESSR European Society of Musculoskeletal Radiology
ESTI European Society of Thoracic Imaging
ESUR European Society of Urogenital Radiology
EUSOBI European Society of Breast Imaging
EuSoMII European Society of Medical Imaging Informatics
ISRRT International Society of Radiographers and Radiological Technologists

4 ECR 2015 | Final Programme www.myESR.org


Programme by Session Type

Title Title

Table of
Contents
Welcome Scientific Programme
by the ESR President . . . . . . . . . . . . . . . . . . . . . . . . . 6 ESR/EFRS meets Sessions . . . . . . . . . . . . . . . . . . . 85
by the ECR 2015 Congress President . . . . . . . . . . . 8 New Horizons Sessions . . . . . . . . . . . . . . . . . . . . . . 89
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . 91
General Information Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . 93
Information from A to Z . . . . . . . . . . . . . . . . . . . . . . 12 Professional Challenges Sessions . . . . . . . . . . . . . 97
CME at ECR 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Multidisciplinary Sessions . . . . . . . . . . . . . . . . . . . 101
Headline Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 European Excellence in Education (E3) . . . . . . . . 103
(Junior) Image Interpretation Quizzes . . . . . . . . . 26 Rising Stars Programme . . . . . . . . . . . . . . . . 105
MIR @ ECR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 European Diploma Prep Sessions . . . . . . . . 111
EPOS™ – Scientific Exhibition . . . . . . . . . . . . . . . . . 28 The Beauty of Basic Knowledge . . . . . . . . . 113
Social Media Guide . . . . . . . . . . . . . . . . . . . . . . . . . . 31 ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . 115
Free Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . 123
Green Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
ECR 2015 welcomes its industry partners . . . . . . 35 Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . 129
Invest in the Youth . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Multimedia Classroom . . . . . . . . . . . . . . . . . . . . . . 131
ESR Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Refresher Courses / Scientific Sessions . . . . . . . 133
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 Abdominal and Gastrointestinal . . . . . . . . . . 134
Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
Floor Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Chest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Dignitaries Computer Applications. . . . . . . . . . . . . . . . . . 142
Honorary Member N. Reed Dunnick . . . . . . . . . . . 54 Molecular Imaging . . . . . . . . . . . . . . . . . . . . . 143
Honorary Member Tae-Hwan Lim . . . . . . . . . . . . . 55 Genitourinary . . . . . . . . . . . . . . . . . . . . . . . . . . 144
Honorary Member & Honorary Lecturer Head and Neck . . . . . . . . . . . . . . . . . . . . . . . . 146
Anne G. Osborn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 Interventional Radiology . . . . . . . . . . . . . . . . 147
Gold Medallist Claus D. Claussen . . . . . . . . . . . . . . 57 Musculoskeletal . . . . . . . . . . . . . . . . . . . . . . . 149
Gold Medallist Yves Menu . . . . . . . . . . . . . . . . . . . . 58 Neuro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Gold Medallist András Palkó . . . . . . . . . . . . . . . . . . 59 Paediatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
Honorary Lecturer Gerald Antoch . . . . . . . . . . . . . . 60 Physics in Radiology . . . . . . . . . . . . . . . . . . . . 154
Honorary Lecturer James A. Brink . . . . . . . . . . . . . 61 Radiographers . . . . . . . . . . . . . . . . . . . . . . . . . 155
Vascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Committees Oncologic Imaging . . . . . . . . . . . . . . . . . . . . . 158
ESR Executive Council . . . . . . . . . . . . . . . . . . . . . . . 64 Emergency Radiology. . . . . . . . . . . . . . . . . . . 159
Congress Committee. . . . . . . . . . . . . . . . . . . . . . . . . 65 Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
Programme Planning Committee . . . . . . . . . . . . . . 65
Scientific Subcommittees . . . . . . . . . . . . . . . . . . . . 66 Educational & Scientific Programme
Topic Coordinators. . . . . . . . . . . . . . . . . . . . . . . . . . . 69 Postgraduate Educational Programme . . . . . . . . 169
Scientific Sessions and
Programme Overviews Late-Breaking Clinical Trials . . . . . . . . . . . . . . . . . 241
Wednesday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . 72 List of Authors and Co-Authors. . . . . . . . . . . . . . . 315
Thursday, March 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . 74 List of Moderators . . . . . . . . . . . . . . . . . . . . . . . . . . 347
Friday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Saturday, March 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Sunday, March 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80

www.myESR.org Final Programme | ECR 2015 5


Forewords

Foreword by the ESR President

Dear Colleagues and Friends,

As president of the European Society of Radiology (ESR) it is my great This has been a year of big numbers. The ESR has hit a record high in the
privilege to welcome you to our annual meeting, the European Congress number of Institutional Member Societies (44), our flagship journal, Euro-
of Radiology (ECR). pean Radiology, has achieved its highest Impact Factor ever (4.338) and,
most significantly, the number of individual ESR members has climbed
The ECR is an annual event that the whole international radiological com- to 62,793, consolidating our status as the largest radiological society in
munity looks forward to, whether they are attending for the first time the world. The third International Day of Radiology (IDOR) celebrated on
or returning aer the positive experience of previous years. The interna- November 8, in collaboration with RSNA and ACR, has also set a new
tional radiological community considers the ECR to be the event that can record of 128 participating Societies from 68 countries. Another high
truly meet their requirements in terms of being brought up to date with figure this year was the 3,474 people who were able to enjoy ECR 2014
radiological science and technology. thanks to the expansion of our online streaming service, ECR Live. At ECR
2015, nearly every lecture will be broadcast live and made available to
The ECR is always a wonderful event but, as I wrote in the ECR 2015 watch on demand aerwards. I very much hope that many of you will
preliminary programme, it is made extra-special this year by marking the make good use of that opportunity and factor some post-congress view-
10th anniversary of the European Society of Radiology. ing into your ECR schedule.

Every year the ECR programme is different than the previous one and it is The ESR has always considered education to be one of its main activi-
enriched with new initiatives carried out thanks to the valuable support ties. Year aer year we have developed new educational activities and
of the men and women from the Congress Committee, the Programme consolidated existing ones. The European School of Radiology (ESOR )
Planning Committee, the Scientific Committee and Subcommittees, and in its eighth year of activity, has continued to grow and now offers an
the ESR Office staff. This year, numerous initiatives have deeply modified even more diverse range of educational opportunities than ever before,
the congress programme while of course leaving intact its high scien- not only in Europe, but also in Asia, the Middle East and Latin America.
tific standards. Sincere thanks go to Professor Bernd Hamm, the ECR Following the success of the ESR Learning Centre established in Barce-
2015 Congress President, and to those who worked with him throughout lona in 2013, we are taking steps to expand this project further, with
almost two years of preparation for the congress. additional centres being opened in Vienna and Bogotá. The opening of
a learning centre in Colombia in particular will help us to reach out to
The ECR also represents the handover point from one ESR President to more than 12,000 individual ESR members living in Latin America. A new
the next. So, for me, it is the conclusion of a year lived with great enthu- multifunctional educational ‘e-learning platform’ will be launched at ECR
siasm, a year during which I received more than I gave. In this time, the 2015, with educational materials structured according to the European
constant and fruitful collaboration with the Board of Directors and the Training Curriculum (ETC).
Executive Council, efficiently supported by the extraordinary ESR staff,
has enabled the achievement of projects that were started in previous The ETC is a living document and an updated version will be released
years, the consolidation of initiatives that were begun last year; and the next March. The European Diploma in Radiology (EDiR) established as a
launching of new activities that I hope will be continued in future years. complement to national qualification processes is also gaining in signif-
icance, as shown by over 130 candidates at the next EDiR examination
during ECR 2015.

6 ECR 2015 | Final Programme www.myESR.org


Forewords

Foreword by the ESR President

On November 4, at the European Parliament in Brussels, the ESR offi-


cially launched a call for a European action plan for medical imaging, to
improve quality of care and patient safety, targeting harmonisation in
regard to quality and safety, education and training, as well as research
and technology. This will significantly improve European healthcare sys-
tems and will ensure better quality and safety for patients in Europe. The
quality of the imaging equipment available in Europe is a key aspect of
this. Updating and upgrading existing equipment will increase access to
better healthcare. Raising awareness of radiation protection, as well as
promoting best practice in keeping radiation doses as low as possible Prof. Lorenzo Bonomo is chairman of the Department
while maintaining image quality, will benefit patients by directly improv- of Radiological Sciences and Bioimaging at the Catholic
ing the quality and safety of imaging practice. For this reason, we recently University of Rome, A. Gemelli Hospital, Italy.
published a paper entitled Renewal of radiological equipment; an impor-
tant subject well appreciated by many European national societies.

Advances in Information Technology (IT) have revolutionised healthcare in Another initiative in favour of the less affluent European countries is ‘ESR
general and within radiology in particular, but have also created new chal- Support’, with which we aim to improve access to radiological training
lenges regarding data volume, standardisation, data protection, etc., which and educational resources for aspiring physicians and scientists, and to
require harmonisation efforts on a European scale. The ESR has called ensure better healthcare for future generations by providing better train-
upon the EU institutions to endorse the development of Clinical Decision ing opportunities in radiology in less affluent regions.
Support (CDS) systems to improve clinical workflow, appropriateness cri-
teria, and training for referrers, to support the harmonisation of coding and Finally I would like to give you a very warm welcome to ECR 2015. I hope
terminology and to revise the legal framework for teleradiology. you will all return home having spent your days updating your professional
and scientific knowledge, exploring technological innovations and enjoy-
One of the goals I set myself at the beginning of my presidency was to ing the wonderful atmosphere of the city of Vienna in good company.
draw the national societies closer by intensifying dialogue with them. For
this reason, the ESR approached its European national societies regard-
ing holding ‘National Society meets ESR’ sessions at their national con-
gresses, based on the model of the traditional ‘ESR meets’ sessions held
at the ECR since 2005, in order to further strengthen and improve the
relationship between national societies and the ESR.
Lorenzo Bonomo
ESR President

www.myESR.org Final Programme | ECR 2015 7


Forewords

Foreword by the ECR President

Dear Friends of the ECR,

It is a great honour for me to welcome you to the European Congress of The ESR marks its tenth anniversary at ECR 2015, and I am delighted that
Radiology (ECR) 2015, the annual meeting of the European Society of we will be celebrating this decade of remarkable achievements together.
Radiology (ESR). As an attendee of every ECR over the last 25 years, I The internal borders of Europe have been re-drawn many times over the
have seen the meeting evolve significantly. I have watched the crowds in centuries, and as a resident of Berlin, the location of one of the most
the entrance hall and the audiences in the lecture rooms swell to a point infamous boundaries in the world, I am very much aware of the negative
where the ECR now regularly attracts more than 20,000 participants. I am effect such divisions can have. It is one of the strongest virtues of the ESR
confident that this year will be no exception, because the ECR’s deserved that we work hard to overcome barriers and to ensure that everyone can
reputation is not only for high scientific quality but also for constant be afforded the same opportunities as each other.
innovation in science, education, interactivity, and networking. The 2,935
abstracts we received for this year’s event – the highest number in ECR One aspect of the ECR that encapsulates this idea of providing opportu-
history – is a great example of that reputation. This very encouraging nities is the long-running and very popular Invest in the Youth initiative.
show of enthusiasm from the radiological community underlines the This year, I am pleased to say that the ESR has decided to put even more
meeting’s position as one of the best and most popular medical events into this project than usual and we have therefore been able to invite
in the world. twice the number of applicants who were invited last year. This is not
only excellent news for the participants, but for us as a specialty. The
If you have seen the ECR 2015 poster, then you will know that the motto ECR can have a fantastic impact on young people, reinforcing their con-
for this year’s congress is ‘radiology without borders’. Today, more than nection to radiology and stimulating their careers. The more chances like
ever before, our specialty transcends the boundaries between countries. this we can provide, the better it is for us as a community, for progress
Wherever we are in the world, we have always been united by our profes- in radiological research, and ultimately for the patients who we are all
sion and the effort we all make to drive our field forward, but now we are working to serve.
increasingly working together in a practical sense too; sharing informa-
tion, learning directly from each other and literally helping each other. I An important innovative development this year is the restructuring of the
think the ECR is the perfect reflection of this spirit. At the congress there session formats. With the exception of Refresher Courses, most of the
are no boundaries; we are all united by our passion for the specialty. educational sessions at the ECR are now grouped under the heading of E³
– European Excellence in Education, and they are now arranged accord-
You may also have noticed that the ECR 2015 poster includes a map of ing to the different levels defined by the European Training Curriculum for
Europe. It is true that in recent years the ECR has become a global event, Radiology. The E³ programme is divided into five branches – Rising Stars,
attracting attendees from far and wide, and really benefitting from the European Diploma Prep Sessions, The Beauty of Basic Knowledge, ECR
huge range of different experience that is brought together under one Academies, and ECR Master Classes – which reflect the different levels
roof. But it is worth remembering that this is the annual meeting of the of education in radiology, as well as the different stages of an individual’s
European Society of Radiology and this is where our heart is. professional career.

8 ECR 2015 | Final Programme www.myESR.org


Forewords

Foreword by the ECR President

The Rising Stars programme is aimed at residents, medical students, and


radiographers in training, while the European Diploma Prep Sessions aim
to provide preparatory sessions for future European Diploma in Radiology
(EDiR) candidates. The content of these programmes reflects level I and
II of the European Training Curriculum and the EDiR courses have been
put together in close cooperation with the European Board of Radiol-
ogy. The Beauty of Basic Knowledge programme focuses on knowledge
essential to the daily practice of radiology and is best suited to residents
and board-certified radiologists. The ECR Academies consist of a series
of sessions relevant to a particular area of radiology, suited to general Bernd Hamm is professor of radiology and chairman of
and subspecialised radiologists, with the content mostly corresponding all three merged departments of radiology at the Charité,
to level III of the European Training Curriculum. Finally, the ECR Mas- Humboldt-Universität zu Berlin and Freie Universität
ter Classes are designed for participants and subspecialists seeking cut- (Campus Mitte, Campus Virchow-Klinikum, and Campus
ting-edge information in specific fields of interest, with one ECR Master Benjamin Franklin). He is also clinical director of four
Class offered for each subspecialty in radiology (level III and beyond). outpatient service facilities in nuclear medicine and
radiology at the Charité, as well as scientific and clinical
This new structure is the result of intense exchange and excellent coop- chairman of three imaging centres in Berlin.
eration between the Congress Programme Planning Committee mem-
bers and I am very much looking forward to seeing all this hard work
and preparation come to fruition. I have no doubt that this will enhance I offer you a very warm welcome to Vienna and I hope you will enjoy the
the clarity of the ECR programme (for both participants and speakers) congress, the many social events, and the rich cultural opportunities the
and make for a smoother experience, especially for the many delegates city has to offer. Most of all, I hope you will leave having gained new
visiting the congress for the first time. knowledge, some wonderful experiences and a real sense of ‘radiology
without borders’.
The ECR never fails to inspire and innovate, so I would like to thank every-
one who has been involved in the creation of ECR 2015, for ensuring that
it will live up to this particular tradition. Thanks to the fantastic efforts of
the Congress Programme Planning Committee, the Chairs and members
of the Scientific Committee, the Subspecialty Societies and, of course,
the dedicated support of ESR office staff.
Bernd Hamm
ECR 2015 Congress President

www.myESR.org Final Programme | ECR 2015 9


Programme by Session Type

TEN YEARS OF ESR


Title Title

TAKE THE ESR WALK OF FAME


WITH US AT ECR 2015
PICK UP YOUR OWN STAR AT
THE MEMBERSHIP DESK
10 ECR 2015 | Final Programme www.myESR.org
General Information

Information from A–Z

General
Information

www.myESR.org Final Programme | ECR 2015 11


General Information

Information from A–Z

ARTS & CULTURE BOOKSTORE


Delegates are encouraged to visit the Arts & Culture Desk in the This year, for the second time, the ECR is offering delegates an outstanding
entrance hall for information on Vienna’s cultural events such as exclusive service. The Viennese bookstore Buchkontor will open a special ECR
opera performances, delightful concerts, and the fascinating exhibitions bookstore in the entrance hall of the congress venue. Browse through a
in Vienna’s most important and remarkable museums. Pick up your per- wide range of books, from guidebooks on Vienna’s best sights to cookbooks
sonal Arts & Culture Brochure at this counter to find descriptions of full of delicious Austrian recipes. For the more discerning reader, there will
all cultural places. also be a range of Austrian literature so you can take some of the country’s
history and culture home with you. The Buchkontor staff look forward to
BADGES & WRISTBANDS welcoming you and helping you find that page-turner.
For organisational and security reasons, badges and wristbands must be Buchkontor’s ECR Bookstore, entrance hall.
worn at the congress venue. Access to the different areas will only be
granted upon presentation of an appropriate badge and wristband. BROADCAST ZONES/ROOMS
The ECR features specific Broadcast Zones/Rooms, where you can listen
Lost or Forgotten Badges to sessions and view the corresponding presentation material in a relaxed
A replacement badge will only be provided if you are wearing your event atmosphere when the actual lecture rooms are overcrowded. Broadcast
wristband. Zones/Rooms are located next to Room B and C (2nd level), Rooms M
and N (1st level), Rooms E1 and F2 (entrance level) and Rooms G and K
Lost or Forgotten Wristbands (lower level).
A replacement wristband will only be provided on full payment of the See Floor Plans on pages 43–52.
applicable onsite registration fee.
BUSINESS CENTRE
BOOK OF ABSTRACTS The Press Office & Business Centre, located on the entrance level, offers
In keeping with the ESR’s commitment to environmental sustainability, copy facilities for a small charge.
and due to demand from its members, the Book of Abstracts is only Opening hours:
available online. Wednesday, March 4 to Sunday, March 8 . . . . . . . . . . . . . . . . . 08:00–18:00
All abstracts can be accessed at www.i3-journal.org/articles.
You can also create your own personal Book of Abstracts with the help CAFÉS & RESTAURANTS
of the popular ECR Interactive Programme Planner (ipp.myESR.org). If you are looking for an ideal meeting point, or if you just want to take a
Abstracts of EPOS™ presentations no longer appear in the Book of short break, try one of the various foyer cafés and restaurants. They are
Abstracts. Each full EPOS™ presentation can instead be cited by a situated throughout the whole congress venue and on all levels of the
Digital Object Identifier (DOI), which appears with the presentation at building, offering a variety of tasty hot and cold snacks.
www.myESR.org/epos. Please see the ‘coffee-cup’ signs on the Floor Plans on pages 43–52 of
this programme to locate the various foyer cafés.

CASEBASED DIAGNOSIS TRAINING


Please refer to the E3 Rising Stars Programme and see page 109.

12 ECR 2015 | Final Programme www.myESR.org


General Information

Information from A–Z

CASES OF THE DAY CHURCHES AND RELIGIOUS COMMUNITIES IN VIENNA


From Wednesday to Saturday, five Cases of the Day covering different Vienna is a multi-denominational, multi-cultural city. We will be pleased
sections of radiology are shown on computer stations in the ECR Live & to provide you with information on local religious communities and places
EPOS™ Lounge on the 1st level. Participants are invited to submit their of worship at the Travel Service Desk.
diagnoses. The winners will be announced on the ESR website.
We would like to acknowledge the contribution of the following authors CME ACCREDITATION SYSTEM
to the Cases of the Day: The ESR is happy to introduce our new fully digital CME acquisition
system for ECR 2015. Please note that we no longer provide printed
Wednesday: CME stickers.
Case 1: R.M. Kwee, F.M.H.M. Vanhoenacker, Evaluation and CME acquisition will be possible via
M.E.A.P.M. Adriaensen van Roij; Netherlands/Belgium
Case 2: M.D. Monedero Picazo, S. Alandete Germán, F. Delgado Cordón, • The official ECR app, ECR 2015, available via the App Store (iOS) and
A. Meseguer Ripollés, M. Graells Ferrer, D. Uceda Navarro; Spain Google play (Android)
Case 3: M. Bertolotto; Italy • More than 160 laptops in the ECR Live & EPOS Lounge located on
Case 4: R. Oca Pernas, C. Delgado Sánchez-Gracián, C. Trinidad; Spain the 1st level
Case 5: J.A. Aguilar, E. Blanc, R. Medina; Spain • The registration counters on the entrance level from Friday, March 6,
13:00 onwards
Thursday: • The CME & Evaluation terminals located on the 1st level
Case 1: P. Thamm, J.-P. Kühn, N. Hosten; Germany
Case 2: M. Notohamiprodjo, P. Krumm, A. Baur-Melnyk, Please note that evaluation of the sessions is only possible
K. Nikolaou; Germany March 4–9, 2015.
Case 3: A. Meseguer, G. Martín, D. Uceda Navarro, E. de la Vía,
S. Alandete; Spain CME credits will only be awarded if
Case 4: O. Nikolić, D. Popović, M. Basta-Nikolić, D. Kozić, K. Petrović, • You are logged into www.webges.com/cslide/ecr2015/myevaluations/
S. Stojanović; Serbia login with your username and Personal ID (printed on your badge)
Case 5: I. Carbonell Casañ, J. Vizuete del Rio; Spain • You have fully completed the electronic questionnaire for each session

Friday: See pages 22–23.


Case 1: S. Robinson; Austria
Case 2: J.R. Ayuso; Spain COAT CHECK
Case 3: K. Van Looveren, C. Venstermans, F. De Belder, H. Dotremont, The coat check services are located on the entrance level, in Foyers E and
P.M. Parizel; Belgium F, as well as on the lower level next to Room D1.
Case 4: D. Bajramovic, M. Reijnierse; Netherlands
Case 5: P. Franchi, M.G. Mantini, V. Valentini, L. Bonomo, A.R. Larici; Italy COMMUNICATION AREAS
If you are looking for the perfect place to meet and talk with friends or just
Saturday: to relax and browse through ECR Today, ECR 2015 offers areas perfectly
Case 1: S.C. Shelmerdine, C.M. Owens; United Kingdom equipped for communication and recreation; the ESR Welcome Lounge
Case 2: S. Nicolay, C. Venstermans; Belgium right in the middle of the entrance hall, and the Rising Stars Lounge on the
Case 3: P. Calvillo Batllés, J. Carreres Polo; Spain 2nd level, which welcomes all students, residents and trainees.
Case 4: D. Ramos Andrade, P. Donato, F. Caseiro-Alves; Portugal
Case 5: U. Aydingoz; Turkey CONFIRMATION OF PAYMENT AND ATTENDANCE
Congress-related confirmation will be available during and aer the con-
gress from the ESR website (www.myESR.org) via the MyUserArea (login
with your last name and your Personal ID as printed on your badge).

www.myESR.org Final Programme | ECR 2015 13


General Information

Information from A–Z

CONGRESS LANGUAGE ‘EFRS MEETS’ SESSION


English Aer the enormous success at ECR 2013 and 2014, which reflected the
good relations between the ESR and the European Federation of Radiog-
CONGRESS VENUE rapher Societies (EFRS), the EFRS is again hosting a dedicated session.
Austria Center Vienna ‘EFRS meets Germany’ underlines the essential role of radiographers in
Bruno Kreisky Platz 1 medical imaging. Please refer to page 86 for the programme of the session.
1220 Vienna, Austria
Phone: (+43 1) 533 40 64–0 EIBIR BOOTH
To reach the ACV by public transport from the city centre (Stephansplatz) Visit the EIBIR Booth in the entrance hall for the most recent news on the
take the U1 underground line (red line, direction Leopoldau). Get off European Institute for Biomedical Imaging Research.
at Kaisermühlen/Vienna International Centre and take the exit marked
Donau-City-Straße. EMERGENCY INFORMATION/FIRST AID
Travelling time: approximately eight minutes. For fire, medical or police assistance, please contact ACV Information or
the nearest available ECR or ACV staff member. A medical specialist trained
‘ECR LIVE’ in emergency medicine will be present for the duration of the congress.
Aer last year’s success, the ESR is once again providing a live streaming See Red Cross sign on the Floor Plan page 45.
service for ECR 2015, under the name ECR Live, in an effort to bring the
ECR to everyone. All ECR sessions are being broadcast live via the ESR EPOS™  SCIENTIFIC EXHIBITION
website, with Facebook and Twitter options integrated into the web The ECR 2015 electronic scientific exhibition is open Wednesday to Sunday
interface to provide a fully interactive experience. from 08:00 to 18:00. EPOS™ can be accessed via the 160 workstations in
ECR Live is kindly supported by Siemens and Bayer. the ECR Live & EPOS™ Lounge, which is located on the 1st level.
Link: live.myESR.org See pages 28–29.

ECR LIVE & EPOS™ LOUNGE ‘ESR MEETS’ SESSIONS


The ECR Live & EPOS™ Lounge has 160 computer terminals where dele- The purpose of ‘ESR meets’ is to forge closer ties between the ESR and its
gates can watch ECR sessions either live or on demand. Enjoy the Lounge’s guest societies. The three guest nations of this year’s ECR are the Republic
relaxing atmosphere while you catch up with the congress sessions. of Korea, Turkey and the Congress President’s home country, Germany.
There are dedicated sessions for the radiological communities of these
ECR TODAY nations to demonstrate the excellence of radiology in their countries.
ECR Today, the popular daily newspaper of the congress, is published from In addition, ECR 2015 again features special activities focusing on a partner
Wednesday to Sunday and distributed in the entrance hall of the congress discipline, providing a platform to establish closer ties. This year’s guest in
venue and in the entrance area of the Technical Exhibition. In addition, all the series will be the European Association of Urology.
issues are available online at www.myESR.org Places at these sessions are allocated on a first-come, first-served basis.
Please refer to pages 86–87 for the programme of the sessions.
ECR 2015 SMARTPHONE APP
The ECR 2015 App gives iPhone, iPad and Android users a new ESR WELCOME LOUNGE
way to experience the congress. The app is packed with features, Visit the ESR Welcome Lounge in the entrance hall! Whether you are
including general congress information, scientific and educational looking for an ideal meeting point or just want to take a short break – the
programme details, top news stories from ECR Today, full abstracts, ESR Welcome Lounge will suit your needs. Free wireless LAN is provided
and even floor plans of the Austria Center. Please make sure you for your convenience.
have Bluetooth enabled, as the app supports iBeacons™ technology. Watch out for artistic performances from the ‘ESR meets’ countries during
You can download the ECR 2015 App from iTunes/Google Play. the lunch breaks.

EFOMP (European Federation of Organisations for Medical Physics) EUROPEAN BOARD OF RADIOLOGY EBR
WORKSHOP Visit the EBR Booth in the entrance hall to learn all about the European
This workshop is the 17th in the series of EFOMP Workshops on ‘New Diploma in Radiology (EDiR), how to apply, and where and when the next
Technology in Diagnostic Radiology’. This year’s workshop is entitled ‘Mul- exams will take place.
ti-energy imaging: from physics to diagnosis’. It has been organised by www.myEBR.org
EFOMP in collaboration with the ESR to address the current and future
technological requirements for radiology imaging equipment (please refer
to pages 163–164).

14 ECR 2015 | Final Programme www.myESR.org


General Information

Information from A–Z

EUROPEAN DIPLOMA IN RADIOLOGY EDiR The programmes will be concluded with a self-assessment test, published
An examination for the European Diploma in Radiology is being held at in the new platform ‘ESR Education on demand’. ECR delegates can access
ECR 2015. The electronic-based written examination takes place on Tues- the platform and the self-assessment tests through the work stations in
day, March 3, in the ECR Live & EPOS™ Lounge on the 1st level, whereas the ECR Live & EPOS™ Lounge (1st level).
the case-based oral examinations take place Wednesday, March 4 to
Friday, March 6, in various rooms on the entrance level in the M Building The ECR Academies consist of a series of four to six sessions relevant
(See Floor Plan M Building on page 50). to a particular area of radiology. This may be a classic organ-based field
Success in the examination certifies a standard of radiological knowledge or a technically oriented area of another field related to radiology, such as
deemed appropriate by the ESR for independent practise in general management. Each ECR Academy spans several days, in which the different
radiology. facets of the area in question are covered by experts in the field. An ECR
www.myEBR.org Academy is a coherent course in which the different sessions complement
one another in order to reflect the entirety of the field.
EUROPEAN EXCELLENCE IN EDUCATION E3 The ECR Academies are particularly suited to general radiologists or radi-
The E3 programme emphasises the importance of lifelong learning. It ologists with a subspecialisation.
covers the entire range of educational issues, from undergraduate medical All programmes (apart from Interactive Teaching Sessions) will be con-
education to subspecialised continuing professional development. cluded with a self-assessment test, published in the new platform ‘ESR
The E3 programme consists of the following five branches, which reflect Education on demand’. ECR delegates can access the platform and the
the different levels of education in radiology, as well as the different stages self-assessment tests through the work stations in the ECR Live & EPOS™
of an individual’s professional career: Lounge (1st level).
Rising Stars Programme, European Diploma Prep Sessions, The Beauty of
Basic Knowledge, ECR Academies, ECR Master Classes. The ECR Master Classes focus on continuous professional develop-
ment and lifelong learning. The classes are designed for subspecialised
The European Diploma Prep Sessions aim to prepare prospective radiologists seeking cutting-edge information in their particular fields of
candidates for the European Diploma in Radiology (EDiR). interest. They are held by experts in the field and reflect state-of-the-art
They are also suitable for residents who want an overview of the various knowledge, as well as emerging trends.
topics relevant to imaging and for those preparing for their national board During the ECR, one ECR Master Class is offered for each subspecialty in
examinations. radiology (CIRSE [one on vascular and one on interventional radiology],
The content of the programme reflects Level I and Level II European ESCR, ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI,
Training Curriculum for Radiology (ETC) learning objectives across a two- ESUR, EUSOBI).
year cycle. The sessions are held in close cooperation with the European
Board of Radiology (EBR). ‘EUROPEAN RADIOLOGY’
Each of the six sessions is led by three lecturers and moderated by one European Radiology is Europe’s number one journal in general radiology.
chairman. See page 39.

The Beauty of Basic Knowledge programmes focus on knowledge EUROPEAN SCHOOL OF RADIOLOGY ESOR BOOTH
essential to the daily practice of radiology. The format of these sessions Visit the ESOR Booth in the entrance hall for the latest news on the
reflects the tradition of conventional teaching sessions, in which an experi- European School of Radiology. In addition, there is an ESOR Info Desk in
enced teacher shares his or her insights into a topic of particular relevance the Rising Stars Lounge.
with a group of attendees.
A Beauty of Basic Knowledge session typically consists of a 45-minute EUROSAFE IMAGING
lecture held by one speaker (plus 15 minutes for conclusions and discus- EuroSafe Imaging is the ESR’s latest initiative in radiation protection. It aims
sion). The teaching format is usually case based with some interaction to promote the safe and appropriate use of medical imaging in Europe and
with the attendees. around the world. Please visit the EuroSafe Imaging Poster Exhibition
The content of the sessions is mostly tied to the Level I and Level II in the ECR Live & EPOS™ Lounge on the 1st level, with submissions from all
European Training Curriculum for Radiology (ETC) learning objectives. The over Europe. And stop by the EuroSafe Imaging Booth in the entrance
Beauty of Basic Knowledge sessions are suited to residents and board-cer- hall to learn all about this important initiative.
tified radiologists who want to refresh their knowledge in basic topics of
imaging and image-guided therapy.

www.myESR.org Final Programme | ECR 2015 15


General Information

Information from A–Z

OPENING CEREMONY
Wednesday, March 4
17:45–19:00, Room A
Red Bull Flying Bach © Erwin Polanc / Red Bull Content Pool

16 ECR 2015 | Final Programme www.myESR.org


General Information

Information from A–Z

EXPO HALLS & EXPO FOYER D JUNIOR IMAGE INTERPRETATION QUIZ


Opening hours: The Image Interpretation Quizzes are two traditional highlights of every
Thursday, March 5 to Saturday, March 7: . . . . . . . . . . . . . . . . . 10:00–17:00 ECR. This year’s themes are ‘Couples for Europe’ and ‘Battle for the
Sunday, March 8: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 audience’ (see page 26).

Visit the additional technical exhibition area LIABILITY


on the 1st level of the congress venue: The ESR and the Austria Center Vienna are free from all liabilities that
First Level (Gallery) may arise from the delegates’ and presenters’ participation in ECR 2015
Opening hours: and its activities.
Wednesday, March 4: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00
Thursday, March 5 to Sunday, March 8: . . . . . . . . . . . . . . . . . . 10:00–17:00 LOST AND FOUND
Lost and found articles may be picked up or handed in at the ACV Infor-
FREE PUBLICATIONS mation Desk located in the entrance area.
The ESR again presents the ‘Free Publications’ Booth on the 1st level,
integrated into the ECR Live & EPOS™ Lounge. Pick up free copies of MEDITATION & PRAYER ZONE
radiology journals and magazines and get free access to online radiology The Meditation & Prayer Zone is located on the lower level next to Room K.
journals (see page 33). You will find it marked on the Floor Plan page 49.

FUTURE MEETINGS DESK MEETING ROOMS


This area – located in the ECR Live & EPOS™ Lounge on the 1st level – Meeting rooms at ECR 2015 are to be found here:
offers you an overview of future meetings in the field of radiology and
related disciplines, from all over the world. Feel free to contribute flyers In the Austria Center Vienna
and posters to promote your own meetings and courses. 1st level: Meeting Rooms 1.85, 1.86
2nd level: Meeting Rooms 2.11, 2.12, 2.13, 2.14, 2.17,
HEADLINE SESSIONS 2.34, 2.61, 2.82, 2.83, 2.95
rd
For details on the Honorary Lectures by Gerald Antoch, James A. Brink and 3 level: Meeting Rooms 3.32, 3.33, 3.34
Anne G. Osborn see page 25.
In the adjoining M Building
‘INSIGHTS INTO IMAGING’ (only available from Wednesday, March 4, to Friday, March 6)
Insights into Imaging is the ESR’s online journal for education and guide- Entrance level: Meeting Rooms M4, M5, M6, MOE 03, MOE 05, MOE 07,
lines. It is open access and PubMed indexed. See page 39. MOE 27, MOE 58, MOE 59, MOE 60, MOE 61, MOE 68, MOE 69, MOE 75,
MOE 79, MOE 100.
INDUSTRY WORKSHOPS
At ECR 2015 there are various Industry Workshops scheduled, organised by You will find them marked on the Floor Plans (see pages 43–52).
Bayer HealthCare, Fujifilm Europe, GE Healthcare, Hologic, I.M.S. – Internazi- Please contact the Info Service Desk at the entrance to the M Building for
onale Medico Scientifica, Siemens Healthcare and Toshiba Medical Systems. onsite booking of meeting rooms; from Saturday onwards please contact
Please note that Industry Workshops are no longer CME-accredited. the Meeting Room Service Desk at the right end of the registration desks.
See separate booklet for details.
MEMBERSHIP
INTERACTIVE PROGRAMME PLANNER For membership application and renewal, please go to the membership
The ESR is again proud to present this popular interactive tool for ECR 2015. desk in the entrance hall.
The IPP provides a convenient way to explore and customise the congress
programme online, in both traditional browser and mobile device versions. MINI COURSE
Featuring various search and browse functions for sessions as well as ECR 2015 features again the joint course of the ESR and RSNA (Radiological
posters, the IPP also includes a ‘basket’ option, which enables users to Society of North America), which will this year focus again on ‘Emergency
collate items from the programme to create their own personal calendar Radiology’.
and even print a personalised Book of Abstracts. The sessions will be interactive with electronic voting/self assessment.
Link: ipp.myESR.org Places for all courses are allocated on a first-come, first-served basis. Please
Mobile link for smartphones: m.myESR.org refer to pages 127–128 for the course’s programme.

www.myESR.org Final Programme | ECR 2015 17


General Information

Information from A–Z

MIR @ ECR PRESS


Aer last year’s success, the ESR Subcommittee on Management in The ECR 2015 Opening Press Conference takes place on Wednesday,
Radiology has again organised a special session at the ECR on core March 4, at 09:30 at the Austria Center Vienna, Room 2.95, 2nd level.
managerial issues and supportive methods and techniques. It takes place For press accreditation, please contact the Press Office & Business
on Friday, March 6, 13:00–17:30 in Room D2. Centre on the entrance level. To obtain a press badge, you must present an
See page 27. international press ID or a confirmation letter from the relevant medium.
Delegates and exhibitors may display their press kits in the Press Office
MULTIDISCIPLINARY SESSIONS & Business Centre. There are also several publicly available computer
The concept of these sessions is to promote a multidisciplinary approach terminals as well as workspace and plug points for you to work with your
to detection and treatment, integrating radiologists and other clinicians personal laptop.
to share their expertise. Opening hours:
The topics that are covered this year are: critical limb ischaemia, manage- Wednesday, March 4 to Sunday, March 8: . . . . . . . . . . . . . . . . 08:00–18:00
ment of rectal cancer and diffuse interstitial lung disease.
Please refer to pages 101–102 for the programme of the sessions. PREVIEW CENTRE
Speakers are reminded to check in at the cSlide Preview Centre’s welcome
MULTIMEDIA CLASSROOM SESSIONS desk at least three hours prior to their scheduled presentation, even if they
These sessions represent the latest progress in computer applications at have already uploaded their presentation prior to the conference. Three
the congress. In this dedicated classroom, participants get a chance to speaker registration workstations will be at the speakers’ disposal, and an
solve cases on workstations, kindly supplied by several different companies. additional workstation for last-minute changes and uploads is available.
The aim is to provide direct (doctor-to-doctor) training on the workstation Onsite presentation upload procedure:
for the interpretation of cases in CT angiography, MDCT in emergencies, » Check in at the cSlide Preview Centre Welcome Desk to receive your
cardiac CT and oncologic imaging. login details and the title of your presentation
Onsite registration is necessary. Please refer to pages 131–132 for the » Log into an available computer and upload your presentation
programme of the sessions. » Presentations can be checked in presenter mode and edited onsite

NEW HORIZONS SESSIONS The Preview Centre is located on the 1st level, next to the ECR Live &
The aim of the New Horizons Sessions is to provide practitioners with EPOS™ Lounge.
an overview of the new developments in a specific area of practice e.g. Opening hours:
specialty, technique, or disease. These developments may become routine Tuesday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
within a few years, or may indicate a new direction for research and clinical Wednesday, March 4 to Sunday, March 8: . . . . . . . . . . . . . . . . 07:30–18:00
application. There are three New Horizons Sessions at ECR 2015, entitled
‘Image-guided interventions of the prostate’, ‘Optical molecular imaging: a Please note that only digital material will be accepted for oral presentations.
new dimension for radiology’ and ‘Comprehensive personalised imaging of Presenters may submit their presentation material, with their login details,
cardiothoracic diseases’. Session places are allocated on a first-come, first- prior to the congress. All material must be in English and be provided on
served basis. Please refer to page 90 for the programme of the sessions. CD-ROM, DVD or USB devices. All presentations will be transferred to the
session rooms electronically.
OPENING CEREMONY The material remains the property of the speakers.
The ECR 2015 Opening Ceremony will take place Wednesday, March 4,
17:45–19:00 in Room A. ESR Honorary Membership will be awarded to PROFESSIONAL CHALLENGES SESSIONS
N. Reed Dunnick, Tae-Hwan Lim and Anne G. Osborn. These sessions are intended to communicate and exchange issues on
radiological training and education, research networking, radiological man-
agement and professional developments. This year’s topics are ‘Radiol-
ogist: imager or doctor?’, ‘What are the concrete benefits of structured
reporting?’, ‘Looking into the future of radiology’, ‘Imaging biobanks: from
genomic to radiomic in the era of personalised medicine’, ‘Integration
of imaging biomarker activities on a European level’, ‘Imaging in popu-
lation-based studies’, ‘Personalised medicine in radiology’, ‘Harmonised
approach for imaging in Europe: myth or reality?’ and ‘Medicolegal aspects
in daily practice’.
Places are allocated on a first-come, first-served basis.
Please refer to pages 97–99 for the sessions’ programme.

18 ECR 2015 | Final Programme www.myESR.org


General Information

Information from A–Z

PUBLIC TRANSPORT REGISTRATION OPENING HOURS


Tickets for public transportation are available online at shop.wienerlinien.at Tuesday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
or at any underground station. Wednesday, March 4: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:00–18:00
Underground map: see page 41. Thursday, March 5: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
Friday, March 6: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
PUBLISHERS ROW 1ST LEVEL & Saturday, March 7: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
PARTNER PUBLISHERS ENTRANCE LEVEL Sunday, March 8: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
Opening hours:
Wednesday, March 4: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00 RESTAURANT RESERVATIONS
Thursday, March 5 to Sunday, March 8: . . . . . . . . . . . . . . . . . . 10:00–17:00 Our staff at the Dining & Shopping Desk in the entrance hall will be
Browse through a wide range of scientific publications displayed by the pleased to recommend places to eat close to your hotel or near a certain
most important publishers in the field of medicine. theatre, and will be happy to reserve a table for you.

RADIOLOGY TRAINEES FORUM RTF RISING STARS LOUNGE / RESIDENTS & STUDENTS LOUNGE
The RTF promotes and coordinates the efforts of radiology trainees at a The Rising Stars Lounge for residents and students is located on the 2nd
European level in order to improve the progress of radiology and related level. In the lounge you will find information on the European School of
sciences. One of the RTF’s most important goals is to provide an equal level Radiology, the European Diploma of Radiology and the Radiology Trainees
of radiological knowledge and skills for radiology trainees all over Europe. Forum.
Highlighted Lectures organised by the RTF will be given on Saturday, Don’t miss the Meet & Greet Sessions with ESR President Lorenzo
March 7, 10:30–12:00 in Room M (see page 109). Bonomo (Friday, March 6, 13:20–13:40) and ECR 2015 Congress President
The RTF General Assembly takes place on Friday, March 6, 10:15–12:45, Bernd Hamm (Thursday, March 5, 09:30–10:00).
in Meeting Room 1.85 (1st level). For more detailed information please
visit the RTF Meeting Point in the Rising Stars & RTF Lounge on RISING STARS PROGRAMME
the 2nd level. See pages 105–109.
Don’t miss the Meet & Greet Sessions with ESR President Lorenzo
Bonomo (Friday, March 6, 13:20–13:40) and ECR 2015 Congress Presi- SATELLITE SYMPOSIA
dent Bernd Hamm (Thursday, March 5, 09:30–10:00) in the Rising Stars Industrial Satellite Symposia are presented by international companies.
& RTF Lounge. Please note that Satellite Symposia are no longer CME-accredited. Places
And join us at the RTF Quiz with Quizmaster Prof. José Cáceres on Thursday, are allocated on a first-come, first-served basis.
March 5, 13:30–14:30 in the Rising Stars & RTF Lounge. See separate booklet for details.

RECORDING / PHOTOGRAPHY SCIENTIFIC PRESENTATION AWARDS


Video or audio recording of presentations is not allowed without the The authors of the best scientific papers and scientific/educational exhibits
speaker’s/exhibitor’s and ECR’s prior permission. Flash photography is not will be presented with a certificate and given free ECR 2016 registration.
permitted during presentations. Interviews must take place outside the Scientific Papers: The award will be assigned to the best paper presentation
lecture room. For queries, please contact the ESR Press Office. of each topic based on the evaluation by session moderators, subcommit-
tee members and session participants. Selection criteria comprise quality of
REFRESHER COURSES presentation, scientific content and overall impression of the performance.
72 Refresher Courses have been organised by the various scientific The award winners will be informed aer the congress and will be published
subcommittees for ECR 2015. Based on the topic of the session, some on the ESR website.
refresher courses are presented in an ‘integrated’ format with an organised Scientific/educational exhibits: See page 29 (Scientific Exhibition
panel discussion, similar to Special Focus Sessions. Awards).
Places are allocated on a first-come, first-served basis. For the first time at ECR 2015, at the end of each scientific session, attend-
Please refer to pages 133–159 for the programme of the sessions. ees will be asked to vote, via smartphones or tablets, for their favourite
paper. The presenter of the most popular paper will be awarded a
certificate by the session moderators.

www.myESR.org Final Programme | ECR 2015 19


General Information

Information from A–Z

European Board of Radiology

Take the
European Diploma in Radiology

EDiR
YOUR PASSPORT
TO A BETTER CAREER
Next Exams:
Warsaw, Poland: April 16–17
(exclusive for Members of the Polish Medical Society of Radiology)
ESR Learning Centre Barcelona, Spain: June
(International edition, open to all countries)
Malmö, Sweden: September, 8–9
(exclusive for members of the Societies of Radiology in Nordic Countries)
JFR, Paris, France: October
(exclusive for members of the French Society of Radiology)
TURKRAD, Antalya, Turkey: November
(exclusive for members of the Turkish Society or Radiology)

www.myEBR.org
diploma@myEBR.org
20 ECR 2015 | Final Programme www.myESR.org
General Information

Information from A–Z

SECURITY / SAFETY STUDENTS’ SESSIONS


The safety of all congress attendees is of utmost importance to the Euro- At ECR 2015, students have again the chance to present their own abstracts
pean Society of Radiology. The Austria Center Vienna and the ESR have in front of a huge audience. The submitters of the best 20 abstracts have
taken security precautions to ensure the maximum possible safety for all been invited to Vienna to present their work in dedicated sessions.
ECR participants. Please inform our staff, especially our room attendants, See page 108.
immediately if security problems occur.
The ESR reserves the right to check your identification upon admission TAXI
to the congress centre and/or inside the building. You may be asked at There is a taxi stand outside the main entrance.
any time to present adequate proof of identity by showing your passport,
driver’s licence, national or military identification, or student ID, all with TECHNICAL EXHIBITION
photograph and signature. Opening hours:
EXPO Halls and EXPO Foyer D
SMOKING Thursday, March 5 to Saturday, March 7: . . . . . . . . . . . . . . . . 10:00–17:00
Smoking is not permitted inside the Austria Center Vienna. The ECR is a Sunday, March 8: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00
non-smoking congress. Outside the building, we kindly ask you to use
the ashtrays provided. Please note that smoking is prohibited in front of First Level (Gallery)
the main entrance. Wednesday, March 4: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00
Thursday, March 5 to Sunday, March 8: . . . . . . . . . . . . . . . . . . 10:00–17:00
SOCIAL MEDIA
The official congress hashtag for Twitter and Instagram is #ECR2015. Detailed information on the Technical Exhibition can be found in the
‘On-Show exhibition guide – Exhibitor Directory and Product Information’,
SOCIETY BOOTHS which is distributed together with the congress bags.
More than 50 national and international radiological societies present
their meetings and societies in the society booths area, which is located TRAVEL SERVICE
on the entrance level, next to the registration desks and the coat checks. The ESR and ECR are proud to offer their delegates services that should
facilitate their travel arrangements and make their stay in Vienna as pleas-
SPECIAL ASSISTANCE ant as possible. The ESR’s Travel Service Desk is located in the entrance
Delegates with special needs may park on the lower level with direct hall of the Austria Center Vienna. Next to it you can find the ECR’s official
elevator access to the ACV. All lecture rooms are accessible by wheelchair. travel agency Mondial.
Opening hours:
SPECIAL FOCUS SESSIONS Tuesday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
Special Focus Sessions deal with a topic at the cutting edge of develop- Wednesday, March 4 to Saturday, March 7: . . . . . . . . . . . . . . 07:30–18:00
ment and clinical application. The topics of these sessions are presented Sunday, March 8: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
so as to promote debate and to give an in-depth analysis. The chair-
man introduces each aspect of the topic and the panellists then discuss Air Travel
their different perspectives and opinions. The audience is also given the The Austrian Airlines desk in the entrance area offers services for Austrian
opportunity to discuss their ideas with the lecturers. Places are allocated Airlines and Star Alliance flights.
on a first-come, first-served basis. Please refer to pages 93–96 for the Opening hours:
programme of the sessions. Wednesday, March 4 to Saturday, March 7: . . . . . . . . . . . . . . 09:00–18:00
Sunday, March 8: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 09:00–15:00
STATE OF THE ART SYMPOSIA
These sessions are intended to inform the audience about the ‘real state WIRELESS LAN
of the art’ of a given subject. Each of the lecturers is an expert on the Free wireless LAN access is available throughout the congress venue and
topic as a whole or on some specific aspect of the topic, which will be all lecture rooms. The name of the public WiFi is ‘ECR’.
the subject of the respective session. The presentations are followed by
a discussion conducted by the panellists, led by the chairman. Places are
allocated on a first-come, first-served basis. Please refer to page 92 for
the programme of the sessions.

www.myESR.org Final Programme | ECR 2015 21


General Information

CME at ECR 2015

GENERAL INFORMATION Worldwide


Each ECR delegate has access to confirmation of all activities attended CME points claimed at the ECR are accepted by the majority of national
(CME confirmation and record of attendance). It is possible to claim a CME authorities worldwide, which have mandatory CME for their physicians.
maximum of 40 CME points for attendance of scientific sessions at the Please consult your national jurisdiction for the maximum number of CME
ECR. Please note that this number may differ from the maximum number points they will approve following your attendance at ECR 2015.
of credits your national jurisdiction approves for your continuous medical
education.

CME ACCREDITATION CME ACQUISITION PROCEDURE


Europe The ESR is happy to introduce our new fully digital CME acquisition system
The following European countries accept and recognise the ECR 2015 for ECR 2015. Not only will we save tons of paper and become an even
CME accreditation: greener and more sustainable meeting, but the system provides a lot more
» Austria* flexibility to delegates in regard to evaluating sessions and obtaining CME
» Albania credits. At ECR 2015, you will have several opportunities to complete the
» Bulgaria electronic questionnaires for each session.
» Cyprus
» Estonia Evaluation and CME acquisition will be possible via
» Germany » The official ECR app, ECR 2015, available via the App Store (iOS)
» Ireland and Google play (Android)
» Israel » More than 160 laptops in the ECR Live & EPOS™ Lounge located
» Italy on the first level
» Lithuania » The registration counters on the entrance level
» Netherlands from Friday, March 6, 13:00 onwards
» Poland » The CME & Evaluation terminals located on the first level
» Romania
» Slovakia CME credits will only be awarded if
» Switzerland
» You are logged into www.webges.com/cslide/ecr2015/myevaluations/
» Turkey
login with your username and PID (printed on your badge)
» United Kingdom
» You have fully completed the electronic questionnaire for each session
* The Österreichische Ärztekammer (Austrian Medical Chamber) has granted a maximum
of 40 DFP (Diplom-Fortbildungs-Programm der Österreichischen Akademie der Ärzte) Please note that evaluation of the sessions is only possible
credits for ECR 2015.
March 4–9, 2015.

If your country is not included in this list, it may be because they have a The combined participation and evaluation questionnaire is of great
different system or no mandatory CME at all. For more information, please value to the organising committee when selecting topics for future ECRs.
consult your national jurisdiction. Evaluation forms differ depending on the type of scientific event.

The Österreichische Ärztekammer (Austrian Medical Chamber) has GUIDANCE


approved ECR 2015 for 40 CME points and this accreditation is accepted Confirmation of participation in the scientific programme may be obtained
by all European countries which have mandatory CME for their physicians. as follows:
No further accreditation with the UEMS has been applied for.
Scientific Sessions
USA 1. Attend the session.
As ECR 2015 has not applied for UEMS accreditation, the agreement of 2. Log in to www.webges.com/cslide/ecr2015/myevaluations/login or use
mutual recognition by the American Medical Association (AMA) is not the ECR 2015 app to evaluate the session.
applicable. Please consult your regional, state or national jurisdiction for 3. Fill out this form completely during or aer the session.
information on approval of the CME points granted at ECR 2015.
If you do not have a smartphone, tablet or laptop with you, please visit
one of the locations mentioned above and evaluate the session(s) you
visited on one of the CME & Evaluation terminals there.

22 ECR 2015 | Final Programme www.myESR.org


General Information

CME at ECR 2015

Scientific Exhibition
1. Enter EPOS™ (Electronic Presentation Online System) on one of the 160
laptops in the ECR Live & EPOS™ Lounge and view posters.
2. Log in to www.webges.com/cslide/ecr2015/myevaluations/login or use
the ECR 2015 app to evaluate the session.
3. Fill out this form completely aer visiting the electronic scientific
exhibition.

A maximum of 3 hours of attendance at the scientific exhibition


will be listed if the participant has completed and submitted the online
evaluation form.

CME CONFIRMATION
Every participant will be able to view and print their own personal record
of attendance via the internet in the MyUserArea on the condition that
the above procedures have been carried out.

This service will be available from two weeks aer the congress
via the MyUserArea on the ESR website (www.myESR.org).

Please note that your Personal ID, which is printed on your badge, is
required for login.
The printout of your record should be submitted to your national juris-
diction (usually responsible for accreditation) for approval of your CME
points. Please note that the record of attendance will be issued only to
the participant. It will not be supplied to any accreditation agency or other
organisation.

Although participants may partially attend multiple concurrent sessions,


the total number of hours printed at the end of the list limits the credit to
the equivalent of a single session during that time slot.

For further information, please contact ECR CME Support at


cme@myESR.org.

www.myESR.org Final Programme | ECR 2015 23


General Information
Headline Sessions

Information from A–Z

Headline Sessions
24 ECR 2015 | Final Programme www.myESR.org
General
Headline
Information
Sessions

Information from A–Z


OPENING CEREMONY
Wednesday, March 4, 17:45–19:00, Room A

Lorenzo Bonomo; Rome/IT


ESR President

Bernd Hamm; Berlin/DE


ECR 2015 Congress President

JOSEF LISSNER HONORARY LECTURE


James A. Brink;
Boston, MA/US Thursday, March 5, 12:15–12:45, Room A
Is the ‘Art of Medicine’ dead in the era
of population health management?

WILHELM CONRAD RÖNTGEN


HONORARY LECTURE
Gerald Antoch;
Düsseldorf/DE Friday, March 6, 12:15–12:45, Room A
Hybrid imaging: let the two worlds of radiology
and nuclear medicine come together

NIKOLA TESLA HONORARY LECTURE


Anne G. Osborn; Saturday, March 7, 12:15–12:45, Room A
Salt Lake City,
UT/US Brain tumour update 2015:
what’s new and why you should care

IMAGE INTERPRETATION QUIZ


COUPLES FOR EUROPE
Friday, March 6, 14:00–15:30, Room A
Moderator: Cornelia M. Schaefer-Prokop; Amersfoort/NL

JUNIOR IMAGE INTERPRETATION QUIZ


BATTLE FOR THE AUDIENCE
Saturday, March 7, 13:00–14:00, Room A
Moderator: Marc Dewey; Berlin/DE

www.myESR.org Final Programme | ECR 2015 25


General Information

(Junior) Image Interpretation Quizzes

The Image Interpretation sessions, two traditional highlights of every ECR, provide both education and entertainment.
Two panels of distinguished radiologists will share their knowledge and diagnosis strategies with you.

The slogan for this year’s ‘senior’ quiz is ‘Couples for Europe’. Radiologists will challenge each other in an enjoyable and
exciting competition where they will face some tricky cases.

In the ‘junior’ quiz, with its theme ‘Battle for the audience’, the panellists will compete with each other in teams.
While solving a variety of cases, the moderator will guarantee a scientifically challenging and entertaining session.

Both quizzes will be interactive with the use of an electronic voting system via one’s own device
(smartphone, tablet or laptop) at no costs.

Friday, March 6, 14.00–15:30, Room A Saturday, March 7, 13:00–14:00, Room A


Image Interpretation Quiz (IIQ) Junior Image Interpretation Quiz (JIIQ)
Couples for Europe Battle for the audience
Moderator: C.M. Schaefer-Prokop; Amersfoort/NL Moderator: M. Dewey; Berlin/DE
» Team 1: » Team A:
M.G. Mack; Munich/DE A. Ntorkou; Thesprotia/GR
P.C. Maly Sundgren; Lund/SE A. Caric; Split/HR
» Team 2: P. Flechsig; Heidelberg/DE
A.A. Bankier; Boston, MA/US N. Cardobi; Verona/IT
F. Pugliese; London/UK » Team B:
» Team 3: M. Faure; Antwerp/BE
J.J. Fütterer; Nijmegen/NL D. Uceda Navarro; Valencia/ES
G. Zamboni; Verona/IT E. Herin; Paris/FR
A. Chopra; Sheffield/UK

= Interactive session with electronic voting/self assessment

26 ECR 2015 | Final Programme www.myESR.org


General Information

MIR @ ECR

Management in Radiology is a subcommittee of the ESR Quality, Safety and Standards Committee.
Those involved in the field of healthcare are experiencing a time of increasing pressure, stress and change.
The demand for efficiency and effectiveness in all business and administrative matters is constantly growing.
MIR addresses current challenges and provides a forum for education and the exchange of ideas and concepts.

Find out more about MIR at www.mir-online.org

Friday, March 6, 13:00–15:00, Room D2 Friday, March 6, 15:30–17:30, Room D2


MIR @ ECR Session 1 MIR @ ECR Session 2
MIR: Best of professional issues Improving quality and safety
in radiology in radiology
Moderators: S. Morozov; Moscow/RU Moderators: J.A. Brink; Boston, MA/US
E. Schouman-Claeys; Paris/FR R. FitzGerald; Shropshire/UK
» 13:00 Overview on MIR activities and » 15:30 First experiences from a nation-wide peer
why attending MIR conferences review in radiology
P. Mildenberger; Mainz/DE A. Brady; Cork/IE
» 13:10 Update on radiology: a strategy for the future » 15:50 How to organise meaningful audits
E. Denton; Norwich/UK in radiology
» 13:30 Update on imaging biobanks P. Cavanagh, Taunton/UK
E. Neri; Pisa/IT » 16:10 Errors in radiology:
» 13:50 Update on decision support for radiology how to learn from a systematic approach
K. Dreyer; Boston, MA/US D.A. Koff; Hamilton, ON/CA
» 14:10 Update on social media in radiology » 16:30 Round table discussion:
S. Morozov; Moscow/RU Learning from critical situations or errors:
examples from around the world
» 14:30 Update on economics
E. Denton; Norwich/UK
B. Brkljačić; Zagreb/HR
J.A. Jakobsen; Oslo/NO
» 14:50 Discussion U. Senol; Antalya/TR
J.A. Brink; Boston, MA/US
C.E. Kahn; Philadelphia, PA/US
M. Fatehi; Tehran/IR
P. Valdes Solis; Marbella/ES

www.myESR.org Final Programme | ECR 2015 27


General Information

EPOS™ – Scientific Exhibition

OPENING HOURS SCIENTIFIC EXHIBITION AWARDS


Wednesday, March 4 to Sunday, March 8: 08:00–18:00 A jury of European radiologists has judged all scientific and educational
exhibits with regard to their scientific content, educational value, originality
The staff of the EPOS™ Service Desk will be glad to assist you during and visual impression. Taking advantage of EPOS™, the rating was carried
these times. out online, prior to the congress, enabling a detailed and considered assess-
ment. On this basis, the Scientific Exhibition Committee has awarded the
LOCATION best posters with Magna Cum Laude, Cum Laude and Certificate of Merits.
ECR Live & EPOS™ Lounge, 1st level Awardees can pick up their certificates at the EPOS™ Service Desk. Each
of the Magna Cum Laude awardees will also be granted free ECR 2016
WHAT’S IN EPOS™ AT ECR 2015? registration.
» Access to ECR Live and ECR on demand All awarded posters are flagged in EPOS™ and will be published on the
» Over 2,000 new scientific and educational exhibits and scientific paper ESR website and on myESR.org/epos.
presentations
» 20 new Cases-of-the-Day (five new cases each day) ATTENDANCE CME AND EVALUATION
» e-learning including self assessment modules on ECR 2015 courses Confirmation of participation in the Scientific Exhibition may be obtained
» EURORAD – Europe’s largest radiological case database as follows:
1. Enter EPOS™ (Electronic Presentation Online System) on one of the
160 laptops in the ECR Live & EPOS™ Lounge and view posters.
2. Log in to www.webges.com/cslide/ecr2015/myevaluations/login or
use the ECR 2015 app to evaluate the session.
3. Fill out this form completely aer visiting the electronic scientific
exhibition.

A maximum of 3 hours of attendance at the scientific exhibition


will be listed if the participant has completed and submitted the online
evaluation form.

28 ECR 2015 | Final Programme www.myESR.org


General Information

EPOS™ – Scientific Exhibition

ESR THANKS ALL REVIEWERS Sofia Gourtsoyianni; London/UK Annie Paterson; Belfast/UK
We cordially thank the members of the Scientific Ali Guermazi; Boston/US Luis J. Pina Insausti; Pamplona/ES
Subcommittees (see pages 66–68) and the Katja Pinker-Domenig; Vienna/AT
Andreas Hansch; Jena/DE
EPOS Reviewers who reviewed abstracts and Tadeusz J. Popiela; Krakow/PL
Birgitta Hansson; Stockholm/SE
graded electronic posters in the past months, Panos K. Prassopoulos; Alexandroupolis/GR
Johannes Heverhagen; Bern/CH
establishing the basis for presenting the awards. Lorenzo Preda; Milan/IT
Jérome Hodel; Paris/FR
Stefan Puig; Vienna/AT
(in alphabetical order) Anna Maria Ierardi; Marsala/IT
Emilio Quaia; Trieste/IT
Emel Ada; Izmir/TR Alan Jackson; Manchester/UK
Helen C. Addley; Cambridge/UK Daniele Regge; Candiolo-Torino/IT
Tobias Jakobs; Munich/DE
Hojjat Ahmadzadehfar; Bonn/DE Soraya Robinson; Vienna/AT
Jarl A. Jakobsen; Oslo/NO
Angel Alberich-Bayarri; Valencia/ES Janeth Romero; Boston/US
Ehymia Alexopoulou; Athens/GR Nektarios Kalyvas; Athens/GR Alejandro Rovira-Canellas; Barcelona/ES
Hatem Alkadhi; Zurich/CH Aikaterini Kanavaki; Geneva/CH Reinhard Rzanny; Jena/DE
Paraskevi Argyropoulou; Alexandroupolis/GR Ara Kassarjian; Majadahonda, Madrid/ES
Roberto Sanz-Requena; Valencia/ES
Irina Arkhipova; Moscow/RU Caroline Keyzer; Brussels/BE
Martina Scharitzer; Vienna/AT
Loukas G. Astrakas; Ioannina/GR Friedrich Knollmann; Sacramento/US
Karl Schürmann; Aachen/DE
Paraskevi Kosta; Ioannina/GR
Nuria Bargalló Alabart; Barcelona/ES Teik Choon See; Cambridge/UK
Elmar Kotter; Freiburg/DE
Irene Bargellini; Pisa/IT Ashley Shaw; Cambridge/UK
Karl-Friedrich Kreitner; Mainz/DE
Antonio Barile; L’Aquila/IT Martin J. Shelly; Dublin/IE
Miltiadis Krokidis; Cambridge/UK
Antonio Basile; Catania/IT Paul Sijens; Groningen/NL
Gorka Bastarrika; Toronto/CA Andrea Laghi; Latina/IT Gustavo N. Simao; Ribeirao Preto/BR
Tobias Baumann; Freiburg/DE Andrea Lakatos; Miskolc/HU Stefan Steens; Nijmegen/NL
Kunwar S.S. Bhatia; Hong Kong/HK Marc Lemmerling; Beervelde/BE Wolfram Stiller; Heidelberg/DE
Johan G. Blickman; Rochester/US Eva Llopis; Alzira-Valencia/ES Misa Sumi; Nagasaki/JP
Einat Blumfield; New York/US Roberto Llorens; Valencia/ES
Denis Tack; Braine-L’Alleud/BE
Alessandro Bozzao; Roma/IT Elizabeth Loney; Bradford/UK
Adele Taibbi; Palermo/IT
Ioana Gabriela Lupescu; Bucharest/RO
Cem Calli; Izmir/TR Stuart A. Taylor; London/UK
Fabrizio Calliada; Pavia/IT Andreas Mahnken; Marburg/DE Gail Thornbury; Belfast/UK
Robert S.D. Campbell; Liverpool/UK Lorenzo Mannelli; New York/US Michael Toepker; Vienna/AT
Davide Caramella; Pisa/IT Katharina Marten-Engelke; Göttingen/DE Michael Torkzad; Milford/UK
Nelson M.G. Caserta; Campinas/BR Celso Matos; Brussels/BE Ioannis A. Tsalafoutas; Athens/GR
Josephine McHugo; Birmingham/UK Dimitrios K. Tsetis; Iraklion/GR
John Damilakis; Iraklion/GR Frederick J.A. Meijer; Nijmegen/NL Athina Tsili; Ioannina/GR
Adelard I. B. De Backer; Ghent/BE Elena Mershina; Moscow/RU
Albert de Roos; Leiden/NL Sara Upponi; Cambridge/UK
Peter Mildenberger; Mainz/DE
Savas Deereos; Alexandroupolis/GR Manabu Minami; Ibaraki/JP Edwin J. Van Beek; Edinburgh/UK
Stefan Delorme; Heidelberg/DE Penelope L. Moyle; Cambridge/UK Will J.M. van der Putten; Galway/IE
Valdair F. Muglia; Ribeirao Preto/BR Berit Verbist; Leiden/NL
Olle Ekberg; Malmö/SE
Johny A. Verschakelen; Leuven/BE
Stephanie Nougaret; St Clement de Riviere/FR
Yann Fargeaudou; Clichy/FR
Matthew G. Wallis; Cambridge/UK
Eduardo F.C. Fleury; Sao Paulo/BR Amaka Offiah; Sheffield/UK
Dag Wormanns; Berlin/DE
Anastasia Fotiadou; Huntingdon/UK Anastasia Oikonomou; Toronto/CA
Klaus Wörtler; Munich/DE
Ferdinand Frauscher; Innsbruck/AT Yumiko Oishi Tanaka; Tsukuba/JP
Ximena Wortsman; Santiago/CL
Susan Freeman; Cambridge/UK Mihaela Onu; Bucharest/RO
Petra Wunderlich; Radebeul/DE
Matthew T.G. Gaskarth; Cambridge/UK Leo Pallwein-Prettner; Linz/AT
Vasilis Xydis; Ioannina/GR
Jonn-Terje Geitung; Bergen/NO Miguel Palm; Maastricht/NL
Abraham Ghiatas; Ekali-Athens/GR Valeria Panebianco; Rome/IT Giulia Zamboni; Verona/IT
Anastasia Glantzouni; Ioannina/GR Gerald Pärtan; Vienna/AT Anastasia Zikou; Ioannina/GR

www.myESR.org Final Programme | ECR 2015 29


General Information

Information from A–Z

Enjoy Vienna’s
cultural highlights

Special Exhibition at the Albertina:


Degas, Cezanne, Seurat. The dream archive from the Musée D’Orsay
William Degouve de Nuncques, Night mood in the royal park of Brussels: avenues crossing, 1897

© RMN-Grand Palais (Musée d´Orsay) / Hervé Lewandowski

www.albertina.at

More about museums and exhibitions in Vienna: www.myESR.org/arts_culture

30 ECR 2015 | Final Programme www.myESR.org


General Information

Social Media Guide


myESR, @myESR & #ECR2015

Tweet and post about the ECR to win prizes


During last year’s congress, thousands of messages were exchanged between ECR fans via social media.
On Facebook, Twitter, Instagram and the built-in message function in our online streaming service,
ECR Live, people talked about their congress experiences and shared their special ECR moments with the world.
If you want to get involved and wow everyone with your ECR engagement, check out our guide to the ECR 2015
social media world for a few helpful hints.

WELCOME TO ECR 2015 SPREAD THE WORD


CHECK IN AT THE CONGRESS VENUE YOUR FRIENDS BACK HOME CAN JOIN US ONLINE
Just like you, we’re moving to the congress venue for the duration of Your colleagues can also join you at the ECR, online and live via our video
ECR 2015. Look out for the official venues on Foursquare (ECR 2015) and and social media stream. Sessions will be streamed for free: just visit
Facebook (myESR) and check yourself in to let others know where you are. the myESR.org homepage and look out for ECR Live. And don’t forget to
subscribe to our YouTube channel: www.youtube.com/myESR
GET THE LATEST NEWS
LIKE MYESR ON FACEBOOK AND FOLLOW US ON TWITTER TWEET DURING SESSIONS
myESR will give you full congress coverage, daily photos, news, com- MAKE SURE YOUR MESSAGE APPEARS IN THE RIGHT PLACE
petitions and much more. All you have to do is become a myESR fan on Each room being streamed on ECR Live has its own Social Media Wall. As
Facebook or follow @myESR on Twitter. an example, the following will appear on the Social Media Wall for room ‘Q’
1. Anything posted in the chatbox for the ECR Live stream from room Q
SHARE YOUR THOUGHTS 2. Any post on Twitter that includes the hashtag #ECR2015Q
POST ON OUR FACEBOOK WALL OR USE THE OFFICIAL HASHTAG 3. Any post on the myESR Facebook page that includes the hashtag
But that’s only the half of it. We would love to hear your comments, ideas, #ECR2015Q
thoughts, and congress experiences. Post them on our Facebook page,
mention @myESR or use the official hashtag #ECR2015 in your tweets. To work out an individual room’s hashtag, simply add the room code to the
general #ECR2015 hashtag, e.g. #ECR2015A, #ECR2015L1, #ECR2015MB2.
CONNECT ANYWHERE You can also use hashtags for a particular session, using the session code.
ENJOY THE CONGRESS VIA ECR LIVE AND ON MULTIPLE DEVICES For instance, if you wish to post a message about session SF 16c, and
Bring all your ECR 2015 social media activity together in one place by the lecture is in room Q, you would use both #ECR2015Q and #SF16C.
using our ECR Social Media Wall. The wall will collect posts and tweets in For further examples, see the congress newspaper, ECR Today, which
one convenient stream, which will be visible to participants throughout includes the relevant hashtags with all of its articles on this year’s sessions.
the congress venue. Access it from the congress, in your hotel room, at
home, or anywhere, no matter if you’re using a smartphone, laptop, or our
onsite internet terminals.
LINKS
ECR Live: live.myESR.org
Social Media Wall: smw.myESR.org

www.myESR.org Final Programme | ECR 2015 31


General Information

Information from A–Z

32 ECR 2015 | Final Programme www.myESR.org


General Information

Free Publications

Broaden your horizons with


Free Publications at ECR 2015
The Free Publications initiative will run for the ninth consecutive year
aer attracting increasing levels of attention at ECR 2014. The Free
Publications booth will be located on the first level of the ACV within the
Preview Area (next to the ECR Live & EPOS Lounge). The booth will be
richly stocked with a galaxy of fascinating reading material from many of
our associated organisations and publishing houses from around the world,
such as Globetech, Diagnostic Imaging and European Hospital.

In addition to a broad library of print media, internet terminals will


also be installed nearby, providing access to a wide variety of online
publications.

About 20 publishers will provide more than 30 different titles for


this initiative, ranging from copies of the ESR’s flagship journals European
Radiology and Insights into Imaging, to issues from as far afield as South
America, many of which will also be available online. Interested dele-
gates can pick up a copy of International Hospital and browse the online
Touch Medical Media, among others. It is a rare chance to learn from so
many diverse medical imaging communities from around the globe, so we
encourage you to make the very best of the opportunity.

We are of course grateful for the enthusiasm of our friends in the publishing
industry for making the Free Publications initiative possible, and allowing
us to provide ECR participants with the chance to pick up some literature
and broaden their medical imaging horizons.

FREE PUBLICATIONS BOOTH:


1st level, within the ECR Live & EPOS™ Lounge.

www.myESR.org Final Programme | ECR 2015 33


General Information

Information from A–Z

LET’S
KEEP OUR
CONGRESS
GREEN
The ECR 2015 will be a green meeting designed to meet environmental sustainability criteria
set by the ‘Federal Ministry of Agriculture, Forestry, Environment and Water Management’
(Austria’s national eco-friendly certificate).

We encourage our employees, partners and customers to adopt practices that promote
awareness of environmental conservation and sustainable use and we endeavour to adhere
to these principles throughout our entire enterprise.

Here are some ways you can contribute to our goal of becoming a green meeting:
• If possible, please choose an environmentally friendly form of transport like
public transport or car sharing
• Please follow your hotel’s eco-friendly advice (e.g. changing towels and bed sheets only
when necessary) and please switch off all lights and electronic devices when
leaving your hotel room
• Please choose drinks served in glass, food served on reusable dishes and avoid cans, plastic
bottles and products in disposable packaging
• Please dispose of your waste (PET, glass, paper, residual waste, metal)
by using the separate bins in your hotel and at the congress venue.
• Please use online registration and non-printed media instead of paper
• Please return your badge to the info point aer the congress has ended

We’re not saying it’ll be easy, but we know that it’ll be worth it.

Thank you for your support!

34 ECR 2015 | Final Programme www.myESR.org


General Information

ECR 2015 welcomes its industry partners

The ESR welcomes its Supporting Members


The ESR gives a warm welcome to all its existing and newly joined support-
ing membership companies. As the ECR puts a special focus on innovation
and keeping up to date with recent developments in the field, a close
cooperation with the industry leaders is indispensable.
The companies contribute with their active involvement to the success of
the society and its congress with their continuous support for the cause
of radiology in Europe.

ESR Supporting Members:


4STAR: 3STAR:

Agfa HealthCare Shenzhen Mindray Bio-Medical Electronics

Bayer HealthCare TeraRecon

Bracco Imaging
2STAR:
Carestream Health
Alpinion Medical Systems
Esaote
Paramed Medical Systems
Fujifilm Europe
Shimadzu Europa
GE Healthcare
Swissray Medical
Guerbet
Vinno Technology
Hitachi Medical Systems Europe
‘ESR MEETS’ COUNTRIES
Philips Healthcare Each year the ECR places a special focus on its ‘ESR meets’ countries –
in 2015 namely Germany, Republic of Korea and Turkey – with particular
Samsung Medison emphasis on their scientific and technological developments. The ESR,
industry companies and the national societies work closely together to
Siemens Healthcare highlight these countries.
Additionally, we are proud to present you the ‘ESR meets’ partner discipline;
Toshiba EAU (European Association of Urology).

Thank you for your involvement!

www.myESR.org Final Programme | ECR 2015 35


General Information

Information from A–Z

36 ECR 2015 | Final Programme www.myESR.org


General Information

Information from A–Z

www.myESR.org Final Programme | ECR 2015 37


General Information

Information from A–Z

Top radiologists read more than just images


www.european-radiology.org
38 ECR 2015 | Final Programme www.myESR.org
General Information

ESR Journals

EUROPEAN RADIOLOGY
European Radiology at your fingertips!
Carry Europe’s leading radiology journal with you wherever you go – with
the European Radiology App – download the app from iTunes or via
the QR code below.

European Radiology is the official journal of the ESR and official organ
of numerous subspecialty organisations. It acts as a flagship, publishing
original scientific papers in the radiological field with an Impact Factor
of 4.338 for 2013.

Full access to the online version of European Radiology is included in the


ESR membership fee.
ESR members can also arrange subscriptions for the printed version at
special rates in the MyUserArea (www.myESR.org/MyUserArea under
‘MyJournals’).
Don’t miss any further issue of the special cover illustrations (on all
printed issues in 2015), and subscribe to the printed version now.

INSIGHTS INTO IMAGING


The clearest insights … for all to see!
Insights into Imaging is the ESR journal for education and strategies
in radiology. Besides excellent review articles, it publishes articles on
professional issues, several official documents and political statements.

Insights into Imaging is an Open Access journal on the SpringerOpen


platform – therefore all articles published are freely available. As benefit
for ESR members, ESR covers the Article Processing Charges for all its
active members!

www.european-radiology.org
www.i3-journal.org

www.myESR.org Final Programme | ECR 2015 39


General Information

Information from A–Z

40 ECR 2015 | Final Programme www.myESR.org


Underground Line (U-Bahn)
Commuter Train (S-Bahn)
City Airport Train
Urban Train (Lokalbahn)

www.myESR.org
Vienna International Busterminal
Customer Service Centre
(U3 Erdberg)

Infopoints
Ticket Sales ECR STOP:

A
C
Kaisermühlen /

V
Vienna Int. Centre
Park & Ride

Final Programme | ECR 2015


41
Underground Map
General Information
General Information

Information from A–Z

Customise
your congress!
Plan and personalise your ECR 2015 experience
with the Interactive Programme Planner.

The IPP offers a great, convenient way to explore the whole ECR programme
online and create a custom timetable. You can search or browse for sessions
and posters, read full abstracts, create a personal calendar, and even print your own
personalised Book of Abstracts. It’s also optimised for mobile devices, meaning you can
keep every detail that’s important to you exactly where you need it – right in your hand.

Plan your own personalised congress and you’ll never lose track again ...

ipp.myESR.org
42 ECR 2015 | Final Programme www.myESR.org
Floor Plans

1 – First Level ACV

Floor Plans

www.myESR.org Final Programme | ECR 2015 43


44
CONGRESS
Floor Plans

OFFICE

1
CHE

CK
T
Room BROADCAST ZONE

Partner Publishers
Partner Publishers
Room

CHECOAT
COACK 2
E2 F1 TOSHIBA
Industry Workshop
BROADCAST ROOM Room 0.90

ths

Soc
Boo

hs

iety
Room

Soc
Room

oot
ie t
iety

Boo
yB
yB

ie t
Soc

ths
SIEMENS

oot

Soc
E1 F2 Industry Workshop

hs
Room 0.93
ESR MEETS

ECR 2015 | Final Programme


REG
ION IST
RAT RAT
M Building
IST ION
REG
S
ie ty B oooc ie ty 0  ENTRANCE LEVEL
S o co o th s th s
B
So
ore Boociety
kst ths
Boo

ESR
WELCOME
LOUNGE
S BAG
S
BAG

BU
MB INTERNET
uild
CORNER

PRE SINES
SS S C
ing

OFF ENT
AND
ICE RE
R
M OE

E egis
Mondial 68

o
W- s a
Info

S xhib trat
MB1

Exp nd
Austrian M OE

MAerviceitors’ion
Airlines
M4
M6

Travel Service 69
M OE 61
Arts & Culture M OE 60

Restaurant M OE 59
Reservations M OE 58
M5

= CASH DISPENSER / ATM


M OE M OE M OE
0 – Entrance Level ACV + M Building

100 79 75

MAIN ENTRANCE MOBILE UNIT


M OE M OE M OE M OE
27 07 05 03

TO / FROM UNDERGROUND EDIR EXAMINATION AREA


All Rooms on this level, with the exception of Room MB1 and the Diploma Zone - are Meeting Rooms.

EXPO A EXTENSION EXPO A

NETWORK
RECREATION ZONE 6
AREA EXHIBITION

www.myESR.org
Floor Plans

0 – Entrance Level ACV

CONGRESS
OFFICE

Partner Publishers

Partner Publishers

CHE
COACK 2
1
CHECOAT
CK

T
Room Room BROADCAST ZONE

E2 F1 TOSHIBA
Industry Workshop
BROADCAST ROOM Room 0.90

ths
Soc

Boo
iety

hs
Room

Soc
Room

oot

iety
Boo

ie t
E1

yB
F2 SIEMENS

yB

S oc
ths

ie t

oot
Soc
Industry Workshop

hs
Room 0.93
ESR MEETS
REG
ION IST
RAT RAT
IST ION
REG
S
ie t
y B oooc ie t
S o co o t h s ths y
B
So
re Boociety
ksto ths
Boo

ESR
WELCOME
S
LOUNGE BAG
MB
uild
PRE SINES

BAG S
BU
SS S C

ing
OFF ENT
ICE RE
AND

MAerviceitors’ion
S xhib trat
E egis
W- s a
R

Exp nd

Info
Mondial
o

Austrian
Airlines
Travel Service

Arts & Culture

Restaurant
Reservations
= CASH DISPENSER / ATM

MAIN ENTRANCE MOBILE UNIT

TO / FROM UNDERGROUND

EXPO A EXTENSION EXPO A

NETWORK
RECREATION ZONE 6
AREA EXHIBITION

www.myESR.org Final Programme | ECR 2015 45


Floor Plans

1 – First Level ACV

Meeting Room 1.85


EVALUATION & CME TERMINALS

SSR DIA
Meeting Room 1.86
Q
OOM
CLA LTIME
MU om
Ro

Room Room

M N
BROADCAST ZONE EXPO GALLERY

BROADCAST ZONE

MAMMOTOME
Industry Workshop
Room 1.98

GIOTTO IMS
Industry Workshop Room
Room L8 Room L1
STUDIO 2015
HOLOGIC Room
Industry Workshop
Room L7 L2
PREVIEW
CENTRE ECR LIVE &
FREE PUBLICATIONS & EPOSTM LOUNGE POSTER EXHIBITION
FUTURE MEETINGS

46 ECR 2015 | Final Programme www.myESR.org


Floor Plans

2 – Second Level ACV

Meeting Room 2.82

Meeting Room 2.61


Meeting Room 2.83

BR
RS

OA
S TA

DC
NG

Room Room
ING

AS
FL &
OU

TZ
C
RIS

ON
RT

E
BROADCAST ROOM Meeting Room 2.95

Room

Rooms 2.41 + 2.42


A
Meeting Room 2.34

Meeting Room 2.11


GE
Industry Workshop
Room 2.33 Meeting Room 2.12

GE Meeting Room 2.13


Industry Workshop Room
Room 2.32 Meeting Room 2.14
Z BAYER
Industry Workshop
RESTAURANT Room 2.15

Meeting Room 2.17

www.myESR.org Final Programme | ECR 2015 47


Floor Plans

3 – Third Level ACV

OFF
.66

ICE
3–3

S3
3.4

.77
S

–3.
ICE
OFF

97
15
–3.
.12
Meeting Room 3.34
S3

Meeting Room 3.33


ICE

PRESIDENTS’
OFF

Meeting Room 3.32


OFFICE
Past Presidents Circle

48 ECR 2015 | Final Programme www.myESR.org


Floor Plans

-2 – Lower Level ACV

MEDITATION & PRAYER ZONE


BROADCAST ROOM HOLOGIC
Industry Workshop
Room -2.83 / -2.84
FUJI
Industry Workshop
Room -2.61/62

BR
OA
DC
T

AS
Room Room

RAN

TZ
TAU G K

ON
E
RES

3
CK COA
T CHE TC
HEC
COA K4

Room

D1
T
EXP O
OE
Room

D2

EXPO FOYER D

TO EXPO
B/C/E

EXPO E

EXPO C

EXPO B

www.myESR.org Final Programme | ECR 2015 49


Floor Plans

0 – Entrance Level M Building

INTERNET
CORNER
A
RANC V
ENT
M OE
LEV CE MB1
68
EL
M4

M6

M OE
69
M OE 61
M OE 60
M OE 59
M OE 58
M5

M OE M OE M OE
100 79 75

M OE M OE M OE M OE
27 07 05 03
EDIR EXAMINATION AREA
All Rooms on this level, with the exception of Room MB1 and the Diploma Zone - are Meeting Rooms.

50 ECR 2015 | Final Programme www.myESR.org


Floor Plans

1 – First Level M Building

BROADCAST ZONE

MB 2

MB 4

MB 3

www.myESR.org Final Programme | ECR 2015 51


Floor Plans

2 – Second Level M Building

BROADCAST ZONE
MB 5

52 ECR 2015 | Final Programme www.myESR.org


ESR Dignitaries

ESR Dignitaries

ESR Dignitaries

www.myESR.org Final Programme | ECR 2015 53


ESR Dignitaries

ESR Dignitaries

N. Reed Dunnick N. Reed Dunnick is the Fred Jenner Hodges Professor of Radiol-
ogy and chair of the department of radiology at the University of
Ann Arbor, MI/US Michigan Health System in Ann Arbor. He served as the 2014 pres-
ident of the Radiological Society of North America.
Honorary Member Graduating with a medical degree from Cornell University Medical
College in 1969, he went on to spend two years in internal medicine
at the University of Rochester’s Strong Memorial Hospital in New
York before taking up a radiology residency at Stanford University
school of Medicine in California, where he served as chief resident
in his final year. He was appointed assistant professor at Stanford in
1976, and later that year he took up a post in the diagnostic radiol-
ogy department at the National Institutes of Health. He then moved
to Duke University Medical Center, where he held a number of posts
between 1980 and 1992, including professor of radiology, chief of
uroradiology and director of the division of diagnostic imaging.

A strong advocate for research, Prof. Dunnick is a former president


of the Academy for Radiology Research, and he testified before the
United States Congress on the need to establish a new institute,
which was signed into law in 2000 as the National Institute of Bio-
medical Imaging and Bioengineering.

Throughout his career, Prof. Dunnick has actively participated in


professional radiology organisations. He has served as president
In recognition of his major of the Society of Uroradiology (SUR) and the Society of Computed
contributions to scientific research Body Tomography & Magnetic Resonance. He is also a former pres-
and his commitment to transatlantic ident of the American Roentgen Ray Society (ARRS), the Michigan
cooperation and exchange in radiology, Radiological Society (MRS), the American Board of Radiology, the
Professor N. Reed Dunnick from Association of University Radiologists and the Society of Chairmen
of Academic Radiology Departments.
Ann Arbor, US, will receive Honorary
Membership of the European Society of Prof. Dunnick has written 310 scientific papers, 62 book chapters
Radiology at ECR 2015. and ten books on various aspects of radiology, in particular diag-
nostic oncology, uroradiology and, more recently, administration.
He has served as a visiting professor at 77 medical centres, a guest
member of faculty for 448 medical education courses and has
delivered 26 named lectures. He has also served on the boards of
13 peer-reviewed journals.

Due to his dedication throughout his career, Prof. Dunnick has


received a great number of awards and honours, including gold
medals from the ARRS, SUR, AUR, MRS and the American College
of Radiology, as well as the Mexican Federation of Radiology and
Imaging’s Radiology Merit Award. He is also an honorary mem-
ber of the American Society of Radiation Oncology and the Japan
Radiological Society.

At ECR 2015 Prof. Dunnick will receive Honorary Membership of


the European Society of Radiology.

54 ECR 2015 | Final Programme www.myESR.org


ESR Dignitaries

ESR Dignitaries

Tae-Hwan Lim is professor of radiology at the University of Ulsan


College of Medicine and a radiologist at the Asan Medical Center’s Tae-Hwan Lim
department of radiology in Seoul, Republic of Korea.
Seoul/KR
Aer graduating with a degree in medicine from Seoul National
University in 1978, Prof. Lim continued his studies there, earning a
Honorary Member
Master of Science degree in 1981 and a Ph.D. in 1987. During this
time he worked as an intern and resident at Seoul National Univer-
sity Hospital. He later served as director of radiology at the Korean
Armed Forces Capitol Hospital. Since 1987, he spent one and a
half years in the United States as a research fellow in magnetic
resonance imaging at the University of California San Francisco’s
department of radiology under the supervision of Dr. C.B. Higgins.
In 1989, he started his career at Asan Medical Center, University of
Ulsan College of Medicine, Seoul, as an assistant professor, and has
since been working as associate professor and full professor. In
1990, he was appointed director of the NMR laboratory at the Asan
Institute for Life Sciences. Eight years later he became chairman
of the department of radiology at Asan Medical Center, a post he
held until 2000.

With a clear commitment to developing and advancing cardiovas-


cular imaging in Korea and Asia, Prof. Lim has played a major role
in promoting and developing training in MR and CT in Korea, as
well as in Asia. He also founded the Asian Society of Cardiovas-
cular Imaging (ASCI) in 2007 and served as the first and second In recognition of his outstanding
president. contributions to the field of
cardiovascular imaging and his
Prof. Lim is also devoted to improving general public healthcare dedication to building closer ties
and has held a number of senior government posts and is a mem- between radiologists from around the
ber of several national committees. He is currently the president of
the National Evidence-based Healthcare Collaborating Agency and
world, Professor Tae-Hwan Lim from
was a member of the Korean Ministry of Health & Welfare’s Health Seoul, Republic of Korea, will be awarded
Technology Assessment Committee for six years. Honorary Membership of the European
Society of Radiology at ECR 2015.
At ECR 2015 Prof. Lim will receive Honorary Membership of the
European Society of Radiology.

www.myESR.org Final Programme | ECR 2015 55


ESR Dignitaries

ESR Dignitaries

Anne G. Osborn Anne G. Osborn is Distinguished Professor of Radiology at the


University Of Utah School of Medicine in Salt Lake City. She also
Salt Lake City, UT/US holds the William H. and Patricia W. Child Presidential Chair in
Radiology at the University of Utah.
Honorary Member & Prof. Osborn received her Bachelor of Arts degree in psychology
Honorary Lecturer and her Medical degree from Stanford University in California,
where she also completed her residency in diagnostic radiology.
She joined the faculty at the University of Utah’s School of Med-
icine in 1974, spending her first three years as a James Picker
Advance Academic Fellow in Neuroradiology. She has also served
as a visiting professor at many of the world’s premier medical insti-
tutions including Harvard, Stanford, Johns Hopkins and the Karo-
linska Institute in Stockholm.

A renowned neuroradiologist, Prof. Osborn has authored several


texts considered to be definitive references in her field. Her latest
comprehensive textbook, Osborn’s Brain, won the 2013 American
Medical Writers Association award for Best Book Written by a Phy-
sician.

The first woman to be elected president of the American Society


of Neuroradiology, Prof. Osborn has received numerous awards,
including honorary membership from a number of international
radiology professional societies, the Marie Curie Award from the
In recognition of her major American Association of Women in Radiology, the Gold Medal from
achievements in the field of the Chicago Radiological Society, the Rosenblatt Prize for Excel-
neuroradiology and her commitment to lence, the Distinguished Service Award from the University of Utah,
education and cooperation in radiology, the 2002 Béclère Medal from the International Society of Radiol-
Professor Ann G. Osborn from Salt ogy, the 2003 gold medal from the American Society of Neurora-
diology, and the Magna Cum Laude Scientific Exhibit Award from
Lake City, US, will be awarded Honorary the Radiological Society of North America (RSNA).
Membership of the European Society of
Radiology and deliver the Nikola Tesla In November, 2000 she was named the first-ever recipient of the
Honorary Lecture at ECR 2015. RSNA’s Outstanding Educator Award. She has also received gold
medal awards from the RSNA, the Asian-Oceanian Congress of
Radiology, the Federation of Mexican Societies of Radiology and
Imaging, the Turkish Society of Radiology, and the Hong Kong Col-
lege of Radiologists, as well as being named an honorary founding
member of the Russian Society of Neuroradiology in 2012.

At ECR 2015 Prof. Osborn will receive Honorary Membership


of the European Society of Radiology. In addition, she will deliver
the Nikola Tesla Honorary Lecture entitled ‘Brain tumour
update 2015: what’s new and why you should care’.

56 ECR 2015 | Final Programme www.myESR.org


ESR Dignitaries

ESR Dignitaries

Claus D. Claussen is professor of radiology at Eberhard-Karls


Universität Tübingen in Germany and was chairman of the depart- Claus D. Claussen
ment of radiology at University Hospital Tübingen from 1988 to
the end of March 2014. He has been director of metabolic imaging
Tübingen/DE
at the German Diabetes Center in Tübingen since April 2014. Gold Medallist
In 1971, Prof. Claussen graduated from Heidelberg University with
a degree in medicine. He later completed a residency in radiol-
ogy at the University of Heidelberg and worked as a staff radiol-
ogist until 1979. During his time from 1979 until 1988 working
in the department of radiology at the university hospital in Berlin
(since 1990 Charité) he became vice-chairman of the department
in 1984 and was promoted to professor of radiology in 1986. He
moved to the University of Tübingen in 1988 and served as chair-
man and full professor of radiology until 2014. He also served as
a visiting professor at the Mayo Clinic Rochester in Minnesota,
United States.

Over the last four decades, he has been one of the pioneers in
developing and introducing new imaging modalities, together with
his team, into clinical practice; dynamic-CT (1980), gadolinium
contrast MRI (1983), cardiac CT (1998), 3T MRI (2000), whole-
body MRI (2004 ). With a particular interest in MR/PET, Prof.
Claussen has been involved in the development of hybrid MR/PET
imaging technology since 2006, which has major potential in the
field of molecular imaging. Over the last ten years, together with In recognition of his pioneering
Prof. Pichler, he has built up one of Europe’s largest and most suc- work in novel imaging technology
cessful preclinical molecular imaging laboratories in Tübingen. and his dedication to strengthening
ties between radiologists in Europe,
He has published in a large range of highly regarded peer-reviewed Professor Claus D. Claussen, from
scientific journals, including the New England Journal of Medi-
cine, Nature Medicine, Circulation, JACC, Radiology and European
Tübingen, Germany, will be awarded the
Radiology. He has also served as a reviewer for Radiology, Euro- Gold Medal of the European Society of
pean Radiology and the Journal of Nuclear Medicine. Radiology at ECR 2015.
Prof. Claussen also works to support international cooperation and
has served as president of the German Radiological Society and
the European Society of Gastrointestinal and Abdominal Radiolo-
gy’s congress in 1999. He is president of the Society for Promot-
ing Biotechnology and Medical Technology South-West Germany,
Stuttgart, and served as chairman of the ESR’s Ethical Compliance
Subcommittee until autumn 2014.

In recognition of his work, Prof. Claussen has received numerous


awards and honours, including honorary membership of the Aus-
trian, French, and German Society of Radiology and ESGAR.

At ECR 2015 Prof. Claussen will receive the Gold Medal of the
European Society of Radiology.

www.myESR.org Final Programme | ECR 2015 57


ESR Dignitaries

ESR Dignitaries

Yves Menu Yves Menu is professor of radiology and chairman of the depart-
ment of radiology at Saint Antoine Hospital, Pierre & Marie Curie
Paris/FR University in Paris, France.

Gold Medallist Originally from Dijon in the east of France, Prof. Menu graduated
from the University of Paris VI Medical School in 1976, and began
his residency in neurosurgery, endocrinology and radiology at the
Assistance Publique Hôpitaux de Paris and University of Paris in
1977. He became a board certified radiologist in 1981 and then
a fellow at Beaujon Hospital’s department of radiology in Clichy.
At Beaujon Hospital, he was promoted to professor of radiology,
and in 1990 he was appointed chairman of the department of
radiology at Bichat Hospital in Paris. He returned to Beaujon Hos-
pital in 1993 and served as chairman of the radiology department
until 2003, when he assumed until 2008 the post of chairman of
Bicêtre Hospital’s department of radiology and professor of radiol-
ogy at the University of Paris XI.

Prof. Menu’s main areas of interest are in the fields of gastroin-


testinal radiology, oncologic imaging and emergency radiology. He
has published 191 peer-reviewed scientific articles, 19 book chap-
ters and a book. He has also delivered 290 lectures, presentations
and invited talks around the world. From 1992 to 1996, he was
editor-in-chief of the Journal de Radiologie, the official journal of
the French Society of Radiology, and served as reviewer for other
In recognition of his long and dedicated journals like Intensive Care Medicine, European Journal of Radiol-
service to the European Society of ogy, Gastroentérologie Clinique et Biologique, Translational Oncol-
Radiology and his outstanding work ogy and Radiology. In 2010, he received the Editor’s Recognition
in the field of gastrointestinal radiology, Award from the journal Radiology, for his many years of service as
Professor Yves Menu from Paris, France a reviewer, and he is now an associate editor for this journal. He is
an honorary member of the RSNA, Tunisian Society of Radiology
will be awarded the Gold Medal and the Romanian Society of Radiology.
of the European Society of Radiology
at ECR 2015. A long-time and active member of the ESR, Prof. Menu has been
committed to advancing the profession and science of radiology.
He served as president of ECR 2011 and on many ECR’s Pro-
gramme Planning Committees. He was also chairman of the
Professional Organisation Committee and is now the scientific
director of the European Board of Radiology (EBR).

At ECR 2015 Prof. Menu will receive the Gold Medal of the
European Society of Radiology.

58 ECR 2015 | Final Programme www.myESR.org


ESR Dignitaries

ESR Dignitaries

András Palkó is chairman and head of the department of radiol-


ogy at Szeged University Medical School. He is also editor-in-chief András Palkó
of the journal Magyar Radiológia.
Szeged/Hungary
A native of Budapest, Hungary, Prof. Palkó graduated from the Uni-
versity of Pécs Medical School in 1977 and became a board-cer-
Gold Medallist
tified radiologist in 1981. He also received his Ph.D. degree from
the University of Pécs in 1994. In 1993, he spent a year working as
a senior registrar in Kuwait, and has also visited the United States
and Germany during his career. From 1996 to 1999, he served
as head of the department of radiology at Pécs County Hospital
before becoming chairman and head of the department of radiol-
ogy at Szeged University Medical School.

A dedicated teacher, Prof. Palkó has received several ‘best teacher’


awards from his students over the years. His main field of interest
is abdominal-gastrointestinal radiology, with a special emphasis on
oncologic and emergency imaging.

Prof. Palkó has been an active member of the ESR for many years
and served on the ESR’s Board of Directors between 2009 and
2013 and as president in 2012. Since its foundation, Prof. Palkó
has been actively involved in the work of the European School of
Radiology and now serves as editor-in-chief of the ESR Education
on Demand service. He is also a member of the European Society
of Abdominal and Gastrointestinal Radiology and currently serves In recognition of his dedication to
as its secretary-general. international cooperation and relations,
as well as his outstanding contribution
During his long and distinguished career, Prof Palkó has published to radiological education, Professor
91 articles in peer-reviewed journals and 31 book chapters. He has András Palkó, from Szeged, Hungary,
also delivered more than 200 invited lectures around the world.
He has received widespread recognition for his achievements and
will be awarded the Gold Medal of
contributions to radiology, having previously been awarded honor- the European Society of Radiology at
ary membership by the Austrian, French, Irish, Polish, Romanian, ECR 2015.
and Serbian radiological societies, as well as the Radiological Soci-
ety of North America.

At ECR 2015 Prof. Palkó will receive the Gold Medal of the
European Society of Radiology.

www.myESR.org Final Programme | ECR 2015 59


ESR Dignitaries

ESR Dignitaries

Gerald Antoch Gerald Antoch is professor of radiology and chairman of the


department of diagnostic and interventional radiology at Düssel-
Düsseldorf/DE dorf University Hospital.

Honorary Lecturer Aer completing his medical training, Prof. Antoch began work-
ing in general surgery before starting his training in diagnostic and
interventional radiology at Essen University Hospital. He became a
board certified radiologist in 2004. From 2004 to 2008, he worked
as a consultant radiologist and became vice chairman of the
department of radiology at Essen University Hospital in 2008. In
2010 he was appointed chairman of the department of diagnostic
and interventional radiology at Düsseldorf University Hospital.

Prof. Antoch’s scientific research focuses on clinical hybrid imag-


ing. He has published 209 original scientific articles and reviews,
as well as 20 book chapters. He has received widespread recog-
nition for his work with a number of awards. In 2003, he received
the Alavi-Mandell Award from the Society of Nuclear Medicine,
United States, and that same year he won Aunt Minnie’s Best Sci-
entific Paper Award, which he won again in 2004. In 2005 he was
awarded the Lodwick Award at Harvard Medical School followed
by awards from the Bavarian Association of Nuclear Medicine and
the German Cancer Research Center in the same year. In 2007 the
German Radiological Society presented Prof. Antoch with the Wil-
helm Conrad Röntgen Award.
In recognition of his significant expertise
in the field of hybrid imaging and his Apart from his scientific and clinical work, Prof. Antoch is an active
great achievements in the field of member of several scientific societies including the German Radio-
research, Professor Gerald Antoch, from logical Society, the German Society for Interventional Radiology,
Düsseldorf, Germany, has been invited the Röntgen Society of North-Rhein-Westfalia, the German Soci-
ety for Radiation Protection in Medicine, the German Society for
to deliver the Wilhelm Conrad Röntgen Interdisciplinary Medicine and, of course, the European Society of
Honorary Lecture at ECR 2015. Radiology. He is also no stranger to the ECR, where he has lectured
and served on the ECR 2015 Programme Planning Committee.

At ECR 2015, Prof. Antoch will deliver the Wilhelm Conrad Rönt-
gen Honorary Lecture entitled ‘Hybrid imaging: let the two
worlds of radiology and nuclear medicine come together’.

60 ECR 2015 | Final Programme www.myESR.org


ESR Dignitaries

ESR Dignitaries

James A. Brink is radiologist-in-chief at Massachusetts General


Hospital, Boston and Juan M. Taveras Professor of Radiology at James A. Brink
Harvard Medical School, in the United States.
Boston, MA/US
Before completing his residency and fellowship at Massachusetts
General Hospital in 1990, he received a Bachelor of Science degree
Honorary Lecturer
in electrical engineering from Purdue University, Indiana and his
medical degree from Indiana University. He then joined the fac-
ulty at the Mallinckrodt Institute of Radiology at the Washington
University School of Medicine in St. Louis, where he was promoted
to associate professor. He then went to Yale University in 1997
and served as chair of the department of diagnostic radiology from
2006 to 2013 before returning to Massachusetts General Hospital
as radiologist-in-chief.

A highly experienced clinical radiologist, especially in the areas of


the utilisation and management of imaging resources, Prof. Brink
also has a particular interest and expertise in issues related to the
monitoring and control of medical radiation exposure.

A major figure in the field of medical radiation protection, Prof.


Brink serves as scientific vice-president for radiation protection
in medicine on the National Council for Radiation Protection and
Measurements. He is past-president of the American Roentgen
Ray Society and a fellow of the Society of Computed Body Tomog-
raphy & Magnetic Resonance, as well as a fellow of the American In recognition of his outstanding
College of Radiology, where he also serves as vice-chair of the achievements in the field of radiation
Board of Chancellors. safety and his commitment to
improving safety in radiology, Professor
Over the course of his career, Prof. Brink has written 119 publica- James A. Brink has been invited to
tions and 19 book chapters. He has also given 239 presentations.
In acknowledgement of his many achievements, he has received
deliver the Josef Lissner Honorary
honorary membership from the Italian Society of Medical Radiol- Lecture at ECR 2015.
ogy and the American Association of Physicists in Medicine.

At ECR 2015, Prof. Brink will deliver the Josef Lissner Honorary
Lecture entitled ‘Is the ‘Art of Medicine’ dead in the era of
population health management?’.

www.myESR.org Final Programme | ECR 2015 61


ESR Dignitaries

ESR Dignitaries

Visit the TECHNICAL EXHIBITION


And learn all about the most recent developments in
healthcare technology.

EXPO Halls and EXPO Foyer D


Thursday, March 5 to Saturday, March 7: 10:00–17:00
Sunday, March 8: 10:00–14:00

First Level (Gallery)


Wednesday, March 4: 14:00–17:00
Thursday, March 5 to Sunday, March 8: 10:00–17:00

myESR.org
62 ECR 2015 | Final Programme www.myESR.org
ECR 2015 Committees

Scientific Subcommittees

Committees

www.myESR.org Final Programme | ECR 2015 63


ECR 2015 Committees

ESR Executive Council

President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo Bonomo; Rome/IT


1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Luis Donoso; Barcelona/ES
2nd Vice-President. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul Parizel; Antwerp/BE
Past-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Guy Frija; Paris/FR
Communication and External Affairs Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Boris Brkljačić; Zagreb/HR
Congress Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bernd Hamm; Berlin/DE
1st Vice-Chairperson of the Congress Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Katrine Åhlström Riklund; Umea/SE
Education Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Birgit Ertl-Wagner; Munich/DE
ESOR Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nicholas Gourtsoyiannis; Athens/GR
Finance and Internal Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Fuchsjäger; Graz/AT
National Societies Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deniz Akata; Ankara/TR
Nominations and Awards Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Guy Frija; Paris/FR
Publications Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo E. Derchi; Genoa/IT
Quality, Safety and Standards Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Jane Adam; London/UK
Research Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hans-Ulrich Kauczor; Heidelberg/DE
Strategic Review Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE
Subspecialties and Allied Sciences Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Catherine M. Owens; London/UK
Executive Director. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Peter Baierl; Vienna/AT

64 ECR 2015 | Final Programme www.myESR.org


ECR 2015 Committees

Congress Committee

Chairperson (Congress President). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Hamm; Berlin/DE


1st Vice-Chairperson (1st Congress Vice-President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Åhlström Riklund; Umea/SE
Ordinary Member . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vilgrain; Clichy/FR
Ordinary Member . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.I. Argyropoulou; Ioannina/GR
ESR President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Bonomo; Rome/IT
ESR 1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Donoso; Barcelona/ES
ESR Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Baierl; Vienna/AT
Chairperson of the Finance and Internal Affairs Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT
Chairperson of the Publications Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi; Genoa/IT

Programme Planning Committee

POSTGRADUATE EDUCATIONAL PROGRAMME E³  RISING STARS PROGRAMME


Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M. Parizel; Antwerp/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R.G.H. Beets-Tan; Maastricht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE e-LEARNING
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.J. Grainger; Leeds/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Palkó; Szeged/HU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Haliloglu; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.-U. Kauczor; Heidelberg/DE CASES OF THE DAY
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Paulo; Coimbra/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Vilar; Valencia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Pozzi-Mucelli; Verona/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Robinson; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.K. Tsetis; Iraklion/GR ESMRMB REPRESENTATIVE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Segebarth; Sainte Marie du Mont/FR
SCIENTIFIC PAPERS
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. Vilgrain; Clichy/FR IMAGE INTERPRETATION QUIZ
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Erik Andersen; Odense/DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.M. Schaefer-Prokop; Amersfoort/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.I. Argyropoulou; Ioannina/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I. Boric; Zabok/HR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.R. Kool; Nijmegen/NL JUNIOR IMAGE INTERPRETATION QUIZ
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Loewe; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.-P. Schlemmer; Heidelberg/DE
EVALUATION
EPOS EDITOR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Weishaupt; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.I. Argyropoulou; Ioannina/GR
ESR EDUCATION COMMITTEE CHAIRPERSON
E³  EUROPEAN EXCELLENCE IN EDUCATION
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Ertl-Wagner; Munich/DE
Hybrid Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Antoch; Düsseldorf/DE,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Åhlström Riklund; Umea/SE
ESR QUALITY, SAFETY AND STANDARDS COMMITTEE CHAIRPERSON
Image-Guided Interventions in Oncology . . . . . . . . . . . . . . . . . . . . . F. Orsi; Milan/IT
Diagnostic Urogenital Radiology . . . . . . . . . . . . . . . . . . . . . H.C. Thoeny; Berne/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.J. Adam; London/UK
Interactive Teaching Sessions . . . . . . . . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE
Modern Imaging of the GI Tract . . . . . . . . . . . . . . . . . . . . . S.A. Taylor; London/UK ESR PUBLICATIONS COMMITTEE CHAIRPERSON
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L.E. Derchi, Genoa/IT

ESR SUBSPECIALTIES AND ALLIED SCIENCES COMMITTEE CHAIRPERSON


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Owens; London/UK

www.myESR.org Final Programme | ECR 2015 65


ECR 2015 Committees

Scientific Subcommittees

ABDOMINAL AND GASTROINTESTINAL CARDIAC


The ESR would like to thank ESGAR for their cooperation on this subcommittee The ESR would like to thank the ESCR for their cooperation on this subcommittee

Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Vliegenthart; Groningen/NL


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Stoupis; Männedorf/CH
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I. Carbone; Rome/IT
Abdominal Viscera . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Croisille; Saint-Etienne/FR
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.R. Ayuso; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Donato; Coimbra/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Blachar; Tel Aviv/IL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Kallifatidis; Thessaloniki/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.S. Guimaraes; Porto/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Kawel-Böhm; Basle/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.A. Jackson; Plymouth/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G.I. Kirova-Nedialkova; Sofia/BG
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Karcaaltincaba; Ankara/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Nikolaou; Tübingen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Lewin-Zeitoun; Villejuif/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R.J. Perea; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I.G. Lupescu; Bucharest/RO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.D. Rud; St. Petersburg/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Manfredi; Verona/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Urbanczyk-Zawadzka; Krakow/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Maniatis; Aabenraa/DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.J.R. van Beek; Edinburgh/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Phoa; Amsterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Wolf; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Stroszczynski; Regensburg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vandecaveye; Leuven/BE
CHEST
GI Tract The ESR would like to thank ESTI for their cooperation on this subcommittee
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Gryspeerdt; Roeselare/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Hellström; Gothenburg/SE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Castañer; Sabadell/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Hoeffel; Reims/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Kölblinger; Ried im Innkreis/AT Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Biederer; Groß-Gerau/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.M. Lambregts; Maastricht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.-Y. Brillet; Bobigny/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.C. Lauenstein; Essen/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Cesar; Golnik/SI
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Maccioni; Rome/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.E.J.G. Coche; Brussels/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Maksimović; Belgrade/RS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Das; Maastricht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Ramalho; Almada/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Devaraj; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Rimola; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E. Eisenhuber-Stadler; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Sosna; Jerusalem/IL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Feragalli; Chieti/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Votrubová; Prague/CZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Frauenfelder; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E. Mershina; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P. Parkar; Bergen/NO
BREAST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Persson; Linköping/SE
The ESR would like to thank EUSOBI for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . F. Sardanelli; San Donato Milanese/IT COMPUTER APPLICATIONS


The ESR would like to thank EuSoMII for their cooperation on this subcommittee
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.S. Balleyguier; Villejuif/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.A.T. Baltzer; Vienna/AT Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Gibaud; Rennes/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Bick; Berlin/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Brkljačić; Zagreb/HR Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Bergh; Heidelberg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.J. Gilbert; Cambridge/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.M.L. Bosmans; Ghent/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Kinkel; Chêne-Bougeries/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Bruijne; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R.M. Mann; Nijmegen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Pokieser; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.J. Pina Insausti; Pamplona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Regge; Turin/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Z. Tarján; Budapest/HU

66 ECR 2015 | Final Programme www.myESR.org


ECR 2015 Committees

Scientific Subcommittees

MOLECULAR IMAGING INTERVENTIONAL RADIOLOGY


The ESR would like to thank ESMOFIR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.M.A. Kiessling; Aachen/DE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Bezzi; Rome/IT

Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Jong; Rotterdam/NL Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Bale; Innsbruck/AT


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.A. Gallagher; Cambridge/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Bérczi; Budapest/HU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.H. Helbich; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Burrel; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Lassau; Villejuif/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Denys; Lausanne/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Lopci; Rozzano/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Filippiadis; Athens/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.K. Helmberger; Munich/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G.J. Munneke; London/UK
GENITOURINARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Pellerin; Paris/FR
The ESR would like to thank ESUR for their cooperation on this subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Peynircioglu; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Válek; Brno/CZ
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.M. Cunha; Lisbon/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.A.A.J. van den Bosch; Utrecht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Vilares Morgado; Porto/PT
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.D. Alt; Hamburg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Bertolotto; Trieste/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.M. Bongartz; Basle/CH MUSCULOSKELETAL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.E.A. Dahlman; Uppsala/SE The ESR would like to thank the ESSR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R. Forstner; Salzburg/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Ivanac; Zagreb/HR Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Klauser; Innsbruck/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. McHugo; Birmingham/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Nicolau; Barcelona/ES Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Adriaensen; Heerlen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Nikolic; Novi Sad/RS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Andreisek; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Rouvière; Lyon/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Aydingoz; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Secil; Izmir/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J.S. Bauer; Munich/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Yakar; Nijmegen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Boutry; Lille/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Cerezal; Santander/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Plagou; Athens/GR
HEAD AND NECK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Robinson; Leeds/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L.M. Sconfienza; San Donato Milanese/IT
The ESR would like to thank the ESHNR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Shahabpour; Brussels/BE
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Verbist; Leiden/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vasilevska Nikodinovska; Skopje/MK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Vieira; Porto/PT
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Frühwald-Pallamar; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Gerevini; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Haba; Iasi/RO NEURO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kohler; Sion/CH The ESR would like to thank the ESNR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lell; Erlangen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Loney; Bradford/UK Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Muto; Naples/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Petrovic; Nis/RS
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Dörfler; Erlangen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.-A. Varoquaux; Marseille/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.R. Jäger; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.A. Lucic; Sremska Kamenica/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Y. Özsunar; Aydin/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A. Papathanasiou; Athens/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Pierot; Reims/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I.N. Pronin; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Ramos; Madrid/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B.F. Schuknecht; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Venstermans; Antwerp/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.P. Wattjes; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Zlatareva; Sofia/BG

www.myESR.org Final Programme | ECR 2015 67


ECR 2015 Committees

Scientific Subcommittees

PAEDIATRIC VASCULAR
The ESR would like to thank the ESPR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . C. Adamsbaum; Le Kremlin-Bicêtre/FR Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Sabharwal; London/UK

Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Balassy; Vienna/AT Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Brisbois; Liège/BE


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.B. Damasio; Genoa/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K.A. Hausegger; Klagenfurt/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. del Pozo; Madrid/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Karnabatidis; Patras/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Hanquinet; Geneva/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Keeling; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.D. Humphries; London/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Melchiorre; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R.A.J. Nievelstein; Utrecht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Müller-Hülsbeck; Flensburg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.-S. Ording Müller; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.-P. Pelage; Caen/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Raissaki; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P.F. Sousa; Ermesinde/PT

PHYSICS IN RADIOLOGY ONCOLOGIC IMAGING


The ESR would like to thank EFOMP for their cooperation on this subcommittee The ESR would like to thank ESOI for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Tsapaki; Athens/GR Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.G. Rockall; London/UK

Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Bor; Ankara/TR Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Coenegrachts; Bruges/BE


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.J. Caruana; Msida/MT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.J. Fütterer; Nijmegen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Damilakis; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.J. Johnston; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Gilligan; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.R. Larici; Rome/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Kachelrieß; Heidelberg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Martí-Bonmatí; Valencia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.J. Lurie; Aberdeen/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Müller-Schimpfle; Frankfurt a. Main/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Pedersen; Østerås/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.E. Sundin; Stockholm/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Trianni; Udine/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Thomassin-Naggara; Paris/FR

RADIOGRAPHERS EMERGENCY RADIOLOGY


The ESR would like to thank the EFRS and the ISRRT for their cooperation on The ESR would like to thank ESER for their cooperation on this subcommittee
this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Stajgis; Poznan/PL
Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Paulo; Coimbra/PT Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Alkadhi; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.M. Artigas; Zaragoza/ES
Members:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Agadakos; Athens/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Basilico; Chieti/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Bezzina; Msida/MT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F.H. Berger; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Hafslund; Nesttun/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Ilves; Tartu/EE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Henderson; Aberdeen/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Popa; Bucharest/RO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Kowalik; Poznan/PL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Schouman-Claeys; Paris/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T. Roding; Haarlem/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Wirth; Munich/DE

68 ECR 2015 | Final Programme www.myESR.org


ECR 2015 Committees

ECR 2015 Topic Coordinators

EUROPEAN EXCELLENCE IN EDUCATION E3 MINI COURSE

E³ – Rising Stars Programme: Joint Course of ESR and RSNA


. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL (Radiological Society of North America):
Case-Based Diagnosis Training . . . . . . . . . . . . . . . . . . K.M. Friedrich; Vienna/AT Emergency Radiology
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Robinson; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.D. Gean; San Francisco, CA/US
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Linsenmaier; Munich/DE
E³ – The Beauty of Basic Knowledge: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S.E. Mirvis; Baltimore, MD/US
Skeletal Radiology . . . . . . . . . . . . . . . . . . .V.N. Cassar-Pullicino; Oswestry/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Palkó; Szeged/HU
Breast Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Smits; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Zagoria; San Francisco, CA/US
E³ – European Diploma Prep Sessions:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Ertl-Wagner; Munich/DE
MULTIDISCIPLINARY SESSIONS
E³ – ECR Academies: Management of rectal cancer:
Hybrid Imaging . . . . . . . . . . . . . . . . . . . . . . . . G. Antoch; Düsseldorf/DE (basic) a paradigm shi . . . . . . . . . . . . . . . . . . . . . . . .R.G.H. Beets-Tan; Maastricht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Åhlström Riklund; Umea/SE (advanced) Solving the crossword puzzle in
Image-Guided Interventions in Oncology . . . . . . . . . . . . . . . . . . . F. Orsi; Milan/IT diffuse interstitial lung disease (DILD) . . . . . . .H.-U. Kauczor; Heidelberg/DE
Diagnostic Urogenital Radiology . . . . . . . . . . . . . . . . . . . .H.C. Thoeny; Berne/CH Critical limb ischemia (CLI):
Interactive Teaching Sessions. . . . . . . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE limb salvage or life salvage? . . . . . . . . . . . . . . . . .J.A. Reekers; Amsterdam/NL
Modern Imaging of the GI Tract . . . . . . . . . . . . . . . . . . . S.A. Taylor; London/UK

E³ – Master Classes: PROS AND CONS SESSION


Abdominal and Gastrointestinal (ESGAR) . . . . . . . . . . S.A. Taylor; London/UK
Breast (EUSOBI) . . . . . . . . . . . . . . . . . . F. Sardanelli; San Donato Milanese/IT Breast cancer:
Cardiac (ESCR) . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Vliegenthart; Groningen/NL to screen or not to screen? . . . . . . . . F. Sardanelli; San Donato Milanese/IT
Chest (ESTI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Castañer; Sabadell/ES
Molecular Imaging (ESMOFIR) . . . . . . . . . . . . . . . F.M.A. Kiessling; Aachen/DE
Genitourinary (ESUR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.C. Thoeny; Berne/CH
Head and Neck (ESHNR) . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Verbist; Leiden/NL
Interventional Radiology (CIRSE) . . . . . . . . . . . . . . . . . . . . . . . M. Bezzi; Rome/IT
Musculoskeletal (ESSR) . . . . . . . . . . . . . . . . . . . . . . . . .A. Klauser; Innsbruck/AT
Neuro (ESNR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Muto; Naples/IT
Paediatric (ESPR). . . . . . . . . . . . . . . . C. Adamsbaum; Le Kremlin-Bicêtre/FR
Vascular (CIRSE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Sabharwal; London/UK
Oncologic Imaging (ESOI) . . . . . . . . . . . . . . . . . . . . . . . A.G. Rockall; London/UK
Emergency Radiology (ESER) . . . . . . . . . . . . . . . . . . . . . . M. Stajgis; Poznan/PL

www.myESR.org Final Programme | ECR 2015 69


ECR 2015 Committees

Scientific Subcommittees

Pick up some fiction at Buchkontor's ECR Bookstore.


Entrance Hall

www.buchkontor.at

70 ECR 2015 | Final Programme www.myESR.org


Programme Overviews

Title

Programme
Overviews

www.myESR.org Final Programme | ECR 2015 71


Programme Overviews

Wednesday, March 4
Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 121 RC 101 SF 1a RC 113 RC 105
08:30- E³ - ECR Abdominal Special Focus Physics in Computer
Academies: Viscera Session Radiology Applications
09:00 Interactive Pitfalls in Acute Cone-beam CT Mobile IT in
Teaching interpretation in gastrointestinal radiology
Sessions pancreatic imaging tract emergencies:
09:00- Changes of the an update
09:30 gastrointestinal
tract aer
treatment
09:30-
10:00

10:00-
10:30
E³ 221 SS 201a SS 202a SS 206 SS 201b SS 203a SY 1 SS 215
10:30- E³ - ECR Abdominal Breast Molecular Gastrointestinal Cardiac Siemens Vascular
Academies: Viscera Imaging for Imaging Tract Tissue Healthcare Pre- and post-
11:00 Interactive Liver MRI neoadjuvant Clinical molecular Improving characterisation and interventional
Teaching chemotherapy imaging abdominopelvic Bayer HealthCare work-up
Sessions imaging: Joint
11:00- The treated breast: technical aspects Satellite
11:30 what you need to Symposium*
know

11:30-
12:00

12:00-
12:30 SY 2
Siemens
E³ 25A SY 6 SY 27 Healthcare
12:30- E³ - The Beauty of SuperSonic HIMSS and
Basic Knowledge: Imagine Satellite Bayer HealthCare
13:00 Breast Imaging Satellite Symposium* Joint
Breast ultrasound: Symposium* Satellite
a primer Symposium*
13:00- 12:15–13:45
13:30

13:30-
14:00
SS 302a SS 301a SS 302b SS 305 SS 301b SS 303a SY 3 SS 315
14:00- Breast Abdominal Breast Computer Gastrointestinal Cardiac Siemens Vascular
Breast density and Viscera Risk imaging and Applications Tract Coronary Healthcare Innovations in
14:30 imaging biomarkers Diffuse liver and stratification Imaging biomarkers Gastro-oesophageal atherosclerosis Satellite vascular imaging
pancreatic diseases and small bowel Symposium*
imaging
14:30-
15:00

15:00-
15:30

15:30-
16:00
RC 401 SF 4 PC 4b RC 411 SY 4
16:00- GI Tract Special Focus Professional Neuro Siemens
Misses and Session Challenges Imaging findings Healthcare
16:30 difficulties in Pancreatic lesions Session in treated brain Satellite
abdominal imaging - the solid, the What are the tumours Symposium*
cystic, and the concrete benefits
16:30- diffuse: benign or of structured
17:00 malignant? reporting?

17:00-
17:30

17:45–19:00 Room A: Opening Ceremony / Presentation of Honorary Members

Registration: Tuesday, March 3: 12:00–18:00 / Wednesday, March 4: 07:00–18:00 / Thursday, March 5 to Sunday, March 8: 07:30–18:00

72 ECR 2015 | Final Programme www.myESR.org


Programme Overviews Programme Overviews

Wednesday, March 4 Wednesday, March 4


Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/ MB 1 MB 2 MB 3 MB 4 MB 5 Room/
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level Entrance Level 1st Level 1st Level 1st Level 2nd Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time (M Building) (M Building) (M Building) (M Building) (M Building) Time
SF 1b SF 1c RC 116 RC 102 RC 104 RC 108 RC 107 RC 111 RC 106 RC 103 RC 109 RC 117 RC 112
Special Focus Special Focus Oncologic Breast Chest Head and Neck Genitourinary Neuro 08:30- Molecular Cardiac Interventional Emergency Paediatric 08:30-
Session Session Imaging Breast ultrasound Pulmonary Head and neck Stone disease: The paediatric brain Imaging Hybrid Radiology Radiology Autoimmune
Up-to-date imaging Internal How about the 2015 vasculitis and emergency: for the new concepts and spine: 09:00 Functional and cardiovascular Image fusion for Polytrauma: disorders in children 09:00
for hearing loss derangement of lymph nodes? collagen vascular general radiologist not only tumours multimodality imaging: where image-guided comprehensive
joints: choosing the diseases or the patient? neuroimaging should we go? interventions management
right test for the 09:00- guidelines for 09:00-
problem 09:30 imaging 09:30

09:30- 09:30-
10:00 10:00

10:00- 10:00-
10:30 10:30
SS 210 SS 211a SS 216 SS 213 SS 202b SS 209 SS 207 SS 214 SS 208 SS 212 SS 203b SS 217 SS 211b
Musculoskeletal Neuro Oncologic Physics in Breast Interventional Genitourinary Radiographers 10:30- Head and Neck Paediatric Cardiac Emergency Neuro 10:30-
Intervention Inflammatory Imaging Radiology Axillary imaging and Radiology Gynaecological Musculoskeletal Advanced imaging Chest imaging and Heart rate: Radiology Vascular disorders,
and degenerative Thoracic oncology Advances in CT nodal staging Peripheral arterial malignancies radiography 11:00 in salivary glands dosimetry disorders and Emergency diagnosis and 11:00
disorders imaging and venous and lymph imaging issues imaging: treatment
interventions nodes, including how to be more
11:00- elastography precise 11:00-
11:30 11:30

11:30- 11:30-
12:00 12:00

12:00- 12:00-
12:30 12:30
E³ 24A LBCT SY 5
E³ - The Beauty of Late-Breaking Bayer HealthCare 12:30- 12:30-
Basic Knowledge: Clinical Trials Satellite
Skeletal Radiology Symposium* 13:00 13:00
Plain radiographs:
analysis and
interpretation 13:00- 13:00-
13:30 13:30

13:30- 13:30-
14:00 14:00
SS 310 SS 311a SS 316 SS 313 SS 304 SS 309 SS 307 SS 314 SS 308 SS 312 SS 303b SS 317 SS 311b
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Radiographers 14:00- Head and Neck Paediatric Cardiac Emergency Neuro 14:00-
Fractures, spinal Brain trauma, Imaging Radiology Interventional Radiology Prostate MR Quality issues Temporal bone and Bone and so Cardiac function Radiology Hypertension and
injuries and spine degenerative and Molecular imaging Advances in MR procedures and Musculoskeletal imaging 14:30 temporomandibular tissue imaging and flow Update on imaging stenosis 14:30
spine diseases and new agents technology follow-up interventions joint imaging approach in trauma
and new MRI patients
14:30- techniques 14:30-
15:00 15:00

15:00- 15:00-
15:30 15:30

15:30- 15:30-
16:00 16:00
RC 410 PC 4a RC 402 RC 404 RC 408 RC 407 E³ 418 RC 415 RC 403 RC 409 RC 417 RC 412
Musculoskeletal Professional Breast Chest Head and Neck Genitourinary E³ - ECR 16:00- Vascular Cardiac Interventional Emergency Paediatric 16:00-
Trauma to the Challenges Radio-pathological HRCT - patterns in The orbit: Prostate imaging: Academies: Basic principles Quantification Radiology Radiology Imaging of foetus
paediatric skeleton Session correlation: chest radiology: you can‘t see what how I do it Hybrid Imaging 16:30 of varicose vein of myocardial Basic principles ‚Special patients‘ and infant 16:30
Radiologist: more important back to basics and you haven‘t learnt (basic) diagnosis and perfusion: of percutaneous in the
imager or doctor? than you thought beyond Scanners and endovascular which test is the tumour ablation emergency room:
tracers 16:30- treatment best (PET, MRI, when and how to 16:30-
17:00 MDCT)? image them? 17:00

17:00- 17:00-
17:30 17:30

Technical Exhibition: EXPO First Level (Gallery): 14:00–17:00

* Not CME accredited EPOS™ – Scientific Exhibition: 08:00–18:00

www.myESR.org Final Programme | ECR 2015 73 www.myESR.org


Programme Overviews

Thursday, March 5
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 521 RC 501 SF 5 Joint Session of RC 513 E³ 519 E³ - Rising Stars
08:30-
Wednesday, March 4 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
The many faces of
Special Focus
Session
Advanced
ESR and EFSUMB
Advances in
diagnostic
Physics in
Radiology
Artifacts and pitfalls
E³ - ECR
Academies:
Image-Guided
Programme
Basic 1:
Breast imaging
Teaching benign liver lesions applications in ultrasound: better in tomography Interventions in
Sessions ultrasound results through Oncology
09:00- What to look for integration Hepatic primary
Room A OPENING CEREMONY 09:30 aer treatment of tumours:
lung cancer ‚prime time‘ for
17:45–19:00 Prof. Bonomo & Prof. Hamm interventional
09:30- radiologists?
officially open ECR 2015 10:00
Presentation of Honorary Members
Musical Entertainment by Red Bull Flying Bach 10:00-
10:30
Room A E³ 121 E³ - ECR Academies:
E³ 621 SS 601a SS 602 SS 605 SS 601b SS 603a E³ - Rising Stars SS 615
08:30–10:00 Interactive Teaching Sessions 10:30- E³ - ECR Abdominal Breast Computer Gastrointestinal Cardiac Programme Vascular
Academies: Viscera Imaging techniques Applications Tract Myocardial Basic 2: Vascular imaging in
Changes of the gastrointestinal 11:00 Interactive Focal liver lesions and interventions Dose tracking: Inflammatory bowel infarction Neuroradiology systemic diseases
tract aer treatment Teaching
Sessions
assessment and
reduction of
disease and coronary
intervention
11:00- The treated liver artefacts
Room A E³ 221 E³ - ECR Academies: 11:30
10:30–12:00 Interactive Teaching Sessions
11:30-
The treated breast:
12:00
what you need to know
12:00-
Room B E³ 25A E³ - The Beauty of Basic Knowledge: 12:30 HL 1
Headline Session
12:30–13:30 Breast Imaging Josef Lissner -
Honorary Lecture E³ 25B SY 11 SY 10
Breast ultrasound: a primer 12:30- 12:15–12:45 E³ - The Beauty of Siemens Siemens
Basic Knowledge: Healthcare Healthcare
13:00 Breast Imaging Satellite Satellite
Room D1 E³ 24A E³ - The Beauty of Basic Knowledge: Cracking the Symposium* Symposium*
mystery of needles
12:30–13:30 Skeletal Radiology 13:00- and gauges
Plain radiographs: 13:30
analysis and interpretation
13:30-
Room D2 LBCT Late-Breaking Clinical Trials 14:00
12:30–13:30 E³ 721 SS 701a SS 702 SS 715 EuroSafe ESOR Session E³ - Rising Stars EIBIR Session 1
14:00- E³ - ECR Abdominal Breast Vascular Imaging Striving in Programme The complexity
Academies: Viscera Breast: Arteries and veins Session 1 radiological Student Session 1 of personalised
14:30
Room Z PC 4b What are the concrete benefits Interactive
Teaching
Liver steatosis and
fibrosis
diffusion-weighted
MR imaging (DWI)
Clinical Decision
Support: making
education breast care

16:00–17:30 of structured reporting? 14:30- Sessions imaging referral


The treated spine guidelines work for
15:00 and joints patients, doctors
Room E2 PC 4a Radiologist: and hospital
managers
16:00–17:30 imager or doctor? 15:00-
15:30
Room K E³ 418 E³ - ECR Academies:
16:00–17:30 Hybrid Imaging (basic) 15:30-
Scanners and tracers 16:00
E³ 821 SF 8a PS 827 MS 8 E³ 819 E³ - Rising Stars PC 8b
16:00- E³ - ECR Special Focus Pros & Cons Multidisciplinary E³ - ECR Programme Professional
Academies: Session Session Session Academies: Student Session 2 Challenges
16:30 Interactive Advanced brain Breast cancer: Critical limb Image-Guided Session
Teaching MRI techniques in to screen or not to ischemia (CLI): Interventions in Imaging in
Sessions paediatrics: screen? limb salvage or life Oncology population-based
16:30- Central nervous toys or tools in daily salvage? Kidney, lung and studies
17:00 system changes practice? bone: an update on
aer treatment: oncologic therapy
what you need to
17:00- know
17:30

Registration: 07:30–18:00

EPOS™ – Scientific Exhibition: 08:00–18:00

74 ECR 2015 | Final Programme www.myESR.org


Programme Overviews Programme Overviews

Thursday, March 5 Thursday, March 5


Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/ MB 1 MB 2 MB 3 MB 4 MB 5 Room/
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level Entrance Level 1st Level 1st Level 1st Level 2nd Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time (M Building) (M Building) (M Building) (M Building) (M Building) Time
SA 5 PC 5a RC 516 PC 5b RC 504 RC 508 RC 511 E³ 518 RC 515 RC 503 RC 509 MC 528 E³ 520
State of the Art Professional Oncologic Professional Chest Head and Neck Neuro E³ - ECR 08:30- Vascular Cardiac Interventional Joint Course of E³ - ECR 08:30-
Symposium Challenges Imaging Challenges COPD, airways Pitfalls in Cerebrovascular Academies: Imaging and Imaging of cardiac Radiology ESR and RSNA: Academies:
Rethinking ductal Session Gastro-entero- Session disease and beyond interpretation of disease Hybrid Imaging 09:00 intervention in valves: Percutaneous Emergency Diagnostic 09:00
carcinoma in situ Looking into the pancreatic Imaging biobanks: head and neck (basic) acute ischaemic new trends treatment of Radiology Urogenital
(DCIS) future of radiology neuro-endocrine from genomic to disease Imaging protocols stroke chronic back pain Abdominal Radiology
tumours radiomic in the era for PET/CT and 09:00- and sciatica emergencies Kidney 09:00-
(GEP-NET): of personalised MR/PET 09:30 09:30
a multidisciplinary medicine
update
09:30- 09:30-
10:00 10:00

10:00- 10:00-
10:30 10:30
MM 6 SS 610a SS 611 SS 616 SS 612 SS 604 SS 609 SS 607a SS 610b SS 608 SS 607b SS 603b MC 628 E³ 620
Multimedia Musculoskeletal Neuro Oncologic Paediatric Chest Interventional Genitourinary Musculoskeletal 10:30- Head and Neck Genitourinary Cardiac Joint Course of E³ - ECR 10:30-
Classroom Shoulder, brachial Brain tumour (1) Imaging Foetal and Pulmonary nodule Radiology DWI in prostate Lower extremity (1) Oncologic imaging: Benign Valvular disease ESR and RSNA: Academies:
Cardiac CT (1) plexus Whole-body paediatric Neuro interventions cancer 11:00 CT, MRI and PET gynaecological Emergency Diagnostic 11:00
imaging of systemic neuroimaging pathology Radiology Urogenital
tumour spreading Chest emergencies Radiology
11:00- Retroperitoneum 11:00-
11:30 and adrenals 11:30

11:30- 11:30-
12:00 12:00

12:00- 12:00-
12:30 12:30
SY 8 SY 7 E³ 24B SY 12 SY 9
Bracco Bayer HealthCare E³ - The Beauty of Toshiba Medical GE Healthcare 12:30- 12:30-
Satellite Satellite Basic Knowledge: Systems Satellite
Symposium* Symposium* Skeletal Radiology Satellite Symposium* 13:00 13:00
The concept of Symposium*
degeneration:
the tendons 13:00- 13:00-
13:30 13:30

13:30- 13:30-
14:00 14:00
MM 7 SS 710 SS 711 SS 716 SS 713 SS 704 SS 709a SS 707 SS 709b SS 708 SS 701b SS 703 MC 728 E³ 720
Multimedia Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Interventional 14:00- Head and Neck Gastrointestinal Cardiac Joint Course of E³ - ECR 14:00-
Classroom Lower extremity (2) Brain tumour (2) Imaging Radiology Lung cancer: Radiology New frontiers and Radiology CT including cone Tract Work-up of ESR and RSNA: Academies:
CT angiography (1) Urogenital oncology Innovations in CT screening and TIPS and portal vein contrast agents in Biopsy techniques 14:30 beam CT: Colonic imaging coronary artery Emergency Diagnostic 14:30
technology staging intervention GU imaging and solid tumour image quality, disease Radiology Urogenital
ablation dosimetry and CNS emergencies Radiology
14:30- clinical applications Prostate 14:30-
15:00 15:00

15:00- 15:00-
15:30 15:30

15:30- 15:30-
16:00 16:00
MM 8 RC 810 SF 8b PC 8a SF 8c E³ 826 RC 808 RC 807 E³ 818 RC 815 RC 803 RC 809 MC 828 E³ 820
Multimedia Musculoskeletal Special Focus Professional Special Focus E³ - ECR Master Head and Neck Genitourinary E³ - ECR 16:00- Vascular Cardiac Interventional Joint Course of E³ - ECR 16:00-
Classroom The ankle and foot Session Challenges Session Classes Head and neck Lessons I learned Academies: EVAR endoleaks: Imaging of heart Radiology ESR and RSNA: Academies:
Oncologic imaging New frontiers Session Breast imaging Lung cancer staging imaging: from mistakes in Hybrid Imaging 16:30 imaging and failure Current trends Emergency Diagnostic 16:30
(1) in brain tumour Integration of modalities: don‘t sell your kidney and adrenal (basic) management in transarterial Radiology Urogenital
imaging imaging biomarker beyond the ultrasound yet! imaging Essentials of hybrid chemoembolisation General principles: Radiology
activities on a conventional imaging 16:30- (TACE) and paediatric and ENT Upper and lower 16:30-
European level 17:00 radioembolisation emergencies urinary tract 17:00
for HCC

17:00- 17:00-
17:30 17:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

* Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

www.myESR.org Final Programme | ECR 2015 75 www.myESR.org


Programme Overviews

Friday, March 6
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 921 RC 901 SF 9a ESR Research in E³ 919 E³ - Rising Stars
08:30-
Thursday, March 5 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Technical advances
Special Focus
Session
Evaluation of
Education and
Training Session
Research for
E³ - ECR
Academies:
Image-Guided
Programme
Student Session 3

Teaching in liver and treatment response trainees made easy: Interventions in


Sessions pancreatic imaging in head and neck critical reading of Oncology
09:00- Thoracic changes cancer the literature Colorectal liver
Room A HL 1 JOSEF LISSNER HONORARY LECTURE 09:30 aer treatment metastases: the
emerging role
12:15–12:45 Is the ‘Art of Medicine’ dead in the era of interventional
09:30- radiologists in
of population health management? 10:00
oncology
James A. Brink; Boston, MA/US
10:00-
Room E1 SA 5 Rethinking ductal carcinoma 10:30
08:30–10:00 in situ (DCIS)
E³ 1021 EM 1 SS 1002 SS 1015 SS 1013 SS 1003a E³ - Rising Stars EIBIR Session 2
10:30- E³ - ECR ESR meets Breast Vascular Physics in Cardiac Programme What’s new in
Room E2 PC 5a Looking into the future Academies: Germany Breast MRI Low dose and low Radiology Myocardial Student Session 4 biomedical imaging
11:00 Interactive Tradition goes indications and contrast in vascular Optimisation of perfusion imaging research: an update
08:30–10:00 of radiology Teaching digital: MR-guided biopsy imaging patient dose in CT of EIBIR activities
Sessions getting ready for
11:00- Head and neck the future
Room F2 PC 5b Imaging biobanks: 11:30 cancer aer
treatment:
08:30–10:00 from genomic to radiomic what you need
in the era of personalised medicine 11:30- to know
12:00
Rising Stars Lounge RTF QUIZ 12:00-
13:30–14:30 HL 2
12:30 Headline Session
Wilhelm Conrad Röntgen
Room C PS 827 Breast cancer: - Honorary Lecture E³ 25C SY 20 SY 19 SY 18
12:30- 12:15–12:45 E³ - The Beauty Toshiba Medical Samsung Philips
16:00–17:30 to screen or not to screen? 13:00 of Basic Systems Satellite Satellite
Knowledge: Satellite Symposium* Symposium*
Breast Imaging Symposium*
Room M MS 8 Critical limb ischaemia (CLI): 13:00- Breast cancer
staging:
16:00–17:30 limb salvage or life salvage? 13:30 why and how

E³ - Rising Stars
Room L1 PC 8b Imaging in population-based 13:30- Programme
Ultrasound
16:00–17:30 studies 14:00 Workshop
I - FAST, lung,
IIQ EM 5 SY 22 SY 21 SY 28 Joint Session EIBIR Session 3 echo, intervention /
Room F1 PC 8a Integration of imaging biomarker 14:00- Image EFRS meets Hologic GE Healthcare HIMSS of the ESR and MITIGATE phantoms
Interpretation Germany Satellite Russia Satellite ESMRMB consortium:
16:00–17:30 activities on a European level 14:30 Quiz High-end and Symposium* Satellite Symposium* The ABC and 123 state of the art
Couples for Europe hybrid technology Symposium* of perfusion MRI: imaging and
Room D1 E³ 826 E³ - ECR Master Classes: in clinical and DSC, DCE and ASL therapy in GIST
14:30- research work of explained
16:00–17:30 Chest 15:00 radiographers in
Germany
Lung cancer staging
15:00-
15:30

15:30-
16:00
E³ 1221 EM 2 E³ 1222 PC 12b RC 1213 E³ 1219 E³ - Rising Stars
16:00- E³ - ECR ESR meets EAU E³ - ECR Professional Physics in E³ - ECR Programme
Academies: Joint ECR-EAU Academies: Challenges Radiology Academies: Basic 3:
16:30 Interactive prostate cancer Modern Imaging Session Good radiation Image-Guided Oncologic imaging
Teaching session of the GI Tract Medicolegal and bad radiation? Interventions in
Sessions Perianal fistula aspects in daily How to assess Oncology
16:30- Unexpected disease: practice and communicate The cutting-edge
17:00 findings all you need radiation risk technologies in
on brain MRI to know to patients and image-guided
referring physicians tumour therapy
17:00-
17:30

Registration: 07:30–18:00

EPOS™ – Scientific Exhibition: 08:00–18:00

76 ECR 2015 | Final Programme www.myESR.org


Programme Overviews Programme Overviews

Friday, March 6 Friday, March 6


Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/ MB 1 MB 2 MB 3 MB 4 MB 5 Room/
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level Entrance Level 1st Level 1st Level 1st Level 2nd Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time (M Building) (M Building) (M Building) (M Building) (M Building) Time
PC 9 NH 9 RC 916 MS 9 SF 9b RC 914 EF 1 E³ 918 E³ 926c E³ 926a E³ 926b RC 917 E³ 920
Professional New Horizons Oncologic Multidisciplinary Special Focus Radiographers EFOMP Workshop E³ - ECR 08:30- E³ - ECR Master E³ - ECR Master E³ - ECR Master Emergency E³ - ECR 08:30-
Challenges Session Imaging Session Session Enhancing patient Multi-energy Academies: Classes Classes Classes Radiology Academies:
Session Image-guided New insights in Management of The forgotten joints safety culture in imaging: Hybrid Imaging 09:00 Uterine and Advances in The leading role Acute pain: Diagnostic 09:00
Personalised interventions of the bone tumour rectal cancer: Radiology from physics to (basic) prostate paediatric imaging of interventional your friend Urogenital
medicine in prostate imaging a paradigm shi diagnosis I Indications for embolisation radiology in a major and enemy in Radiology
radiology hybrid imaging in … 09:00- trauma center emergency Gynaecology 09:00-
09:30 radiology 09:30

09:30- 09:30-
10:00 10:00

10:00- 10:00-
10:30 10:30
MM 10 SS 1010a SS 1011 SS 1016 SS 1001 SS 1004 SS 1009 EF 2 SS 1014 SS 1008 SS 1012 SS 1003b SS 1010b E³ 1020
Multimedia Musculoskeletal Neuro Oncologic Gastrointestinal Chest Interventional EFOMP Workshop Radiographers 10:30- Head and Neck Paediatric Cardiac Musculoskeletal E³ - ECR 10:30-
Classroom Tumours, systemic Ischaemic stroke Imaging Tract Pulmonary Radiology Multi-energy Radiation dose Thyroid and Abdominal imaging Non-ischaemic Hand, upper Academies:
MDCT in diseases and (1) Advances in Rectal cancer and hypertension and Percutaneous imaging: optimisation 11:00 parathyroid imaging myocardial disease extremity Diagnostic 11:00
emergencies (1) muscles imaging metastatic anorectal imaging thromboembolic ablation in liver from physics to Urogenital
disease disease tumours diagnosis II Radiology
11:00- Emergencies 11:00-
11:30 11:30

11:30- 11:30-
12:00 12:00

12:00- 12:00-
12:30 12:30
SY 14 SY 13 E³ 24C SY 16 SY 15
Bracco Bayer HealthCare E³ - The Beauty of Guerbet GE Healthcare 12:30- 12:30-
Satellite and Basic Knowledge: Satellite Satellite
Symposium* Siemens Skeletal Radiology Symposium* Symposium* 13:00 13:00
Healthcare Inflammatory/
Joint Satellite infectious disorders MIR @ ECR
Symposium* Session 1 13:00- 13:00-
MIR:
best of professional 13:30 13:30
issues in radiology
13:30- 13:30-
14:00 14:00
MM 11 EuroSafe
Multimedia 14:00- Imaging 14:00-
Classroom Session 2
CT angiography (2) 14:30 EuroSafe imaging 14:30
call for action
14:30- 14:30-
15:00 15:00

Coffee break
15:00- 15:00-
15:30 15:30
MIR @ ECR
Session 2 15:30- 15:30-
Improving quality
and safety in 16:00 16:00
radiology
MM 12 RC 1210 SF 12 SA 12 PC 12a RC 1204 E³ 1226a E³ 1218 E³ 1226d E³ 1226c RC 1205 E³ 1226b RC 1212
Multimedia Musculoskeletal Special Focus State of the Art Professional Chest E³ - ECR Master E³ - ECR 16:00- E³ - ECR Master E³ - ECR Master Computer E³ - ECR Master Paediatric 16:00-
Classroom Sports injuries to Session Symposium Challenges Mediastinal disease Classes Academies: Classes Classes Applications Classes Hepatobiliary
Cardiac CT (2) the knee: Interventional Fleischner Session revisited Urogenital radiology Hybrid Imaging 16:30 Chemical exchange Cardiac MR imaging Update on Acute postoperative imaging in children 16:30
improving my radiology in venous guidelines for Harmonised in 2015: (advanced) saturation transfer computer-aided complications
report thromboembolism nodules: approach for beyond MR/PET - the future (CEST): diagnosis (CAD) in the abdomen:
and chronic venous theory and practice imaging in Europe: morphology? of hybrid imaging? 16:30- a new toy for from diagnosis 16:30-
disease myth or reality? 17:00 molecular imaging? to therapy 17:00

17:00- 17:00-
17:30 17:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

* Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

www.myESR.org Final Programme | ECR 2015 77 www.myESR.org


Programme Overviews

Saturday, March 7
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 1321 RC 1301 E³ 1322 Joint Session RC 1313 E³ 1323 E³ - Rising Stars
08:30-
Friday, March 6 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Pancreatic
E³ - ECR
Academies:
Modern Imaging
of the ESR and
EORTC
Imaging in
Physics in
Radiology
IT tools for
E³ - European
Diploma Prep
Sessions
Programme
Basic 4:
Musculoskeletal
Teaching inflammation of the GI Tract multicenter clinical dose tracking Chest trauma
Sessions Imaging the oncological trials and workflow
09:00- Diagnostic postoperative optimisation
Room A HL 2 WILHELM CONRAD RÖNTGEN 09:30 evaluation of bone patient
tumours
12:15–12:45 HONORARY LECTURE 09:30-
Hybrid imaging: 10:00
let the two worlds of radiology and
nuclear medicine come together 10:00-
Gerald Antoch; Düsseldorf/DE 10:30
E³ 1422 EM 3 SS 1402 SS 1406 TF 1 E³ 1423 E³ - Rising Stars ESR-PAG 1
Room E1 PC 9 Personalised medicine 10:30- E³ - ECR ESR meets the Breast Molecular Radiology E³ - European Programme ESR Patient
Academies: Republic of Digital breast Imaging Trainees Forum Diploma Prep Basic 5: Advisory Group
08:30–10:00 in radiology 11:00 Modern Imaging Korea tomosynthesis: Experimental Highlighted Sessions Thoracic The challenges
of the GI Tract CT in lung cancer the new molecular imaging Lectures Gastrointestinal and emergencies of providing true
Inflammatory bowel screening and COPD mammography and exploratory abdominal patient-centred
Room E2 NH 9 Image-guided interventions 11:00- disease evaluation clinical studies care: moving
08:30–10:00 of the prostate 11:30 forward together

Room F2 MS 9 Management of rectal cancer: 11:30-


08:30–10:00 a paradigm shi 12:00
E³ - Rising Stars
12:00- Programme
Room B EM 1 ESR meets Germany 12:30 HL 3 Ultrasound
Headline Session Workshop
10:30–12:00 Tradition goes digital: Nikola Tesla - II – MSK
Honorary Lecture E³ 25D SY 24 SY 23 SY 25 SY 26
getting ready for the future 12:30- 12:15–12:45 E³ - The Beauty of GE Healthcare Bracco Philips Philips
Basic Knowledge: Satellite Satellite Satellite Satellite
13:00 Breast Imaging Symposium* Symposium* Symposium* Symposium*
Room A IIQ IMAGE INTERPRETATION QUIZ Ductal carcinoma in
JIIQ situ (DCIS):
14:00–15:30 Couples for Europe 13:00- Junior Image small tumour but
Interpretation
13:30 Quiz
big problem
Room B EM 5 EFRS meets Germany Battle for the
audience
14:00–15:30 (European Federation of Radiographer Societies) 13:30-
High-end and hybrid technology 14:00
in clinical and research work 14:00-
E³ 1521 E³ 1526 E³ 1522 Joint Session RC 1512 E³ 1523 E³ - Rising Stars EuroSafe
E³ - ECR E³ - ECR Master E³ - ECR of the ESR and Paediatric E³ - European Programme Imaging
of radiographers in Germany 14:30 Academies: Classes Academies: ESTRO 1 Key issues in Diploma Prep Student Final Session 3
Interactive Advances in liver Modern Imaging Non surgical paediatric imaging Sessions Session Dose-tracking leads
Teaching imaging of the GI Tract approach to early Musculoskeletal the way
Room B EM 2 ESR meets EAU 14:30- Sessions Rectal cancer lung cancer: to dose-reduction
Skull base lesions perspectives
16:00–17:30 (European Association of Urology) 15:00 of imaging and
radiation-based
Joint ESR-EAU prostate cancer Session disciplines E³ - Rising Stars
15:00- Programme
Room Z PC 12b Medicolegal aspects Ultrasound
15:30 Workshop
16:00–17:30 in daily practice III – Train the tutor
15:30- 15:00–17:00

Room F1 SA 12 Fleischner guidelines for nodules: 16:00


16:00–17:30 theory and practice E³ 1621 RC 1601 E³ 1622 Joint Session RC 1613 E³ 1623 MS 16 EuroSafe
16:00- E³ - ECR GI Tract E³ - ECR of the ESR and Physics in E³ - European Multidisciplinary Imaging
Academies: From my Academies: ESTRO 2 Radiology Diploma Prep Session Session 4
Room F2 PC 12a Harmonised approach for imaging 16:30 Interactive workstation: Modern Imaging Radiology and MR: artifacts and Sessions Solving the How can clinical
Teaching difficult cases on of the GI Tract radiation oncology: devices Breast crossword puzzle in audit enhance
16:00–17:30 in Europe: myth or reality? 16:30- Sessions review Oesophageal and new chances for a diffuse interstitial patient safety?
Cardiac imaging gastric cancer partnership lung disease (DILD)
17:00

For Friday’s Master Classes 17:00-


see page 47 17:30

Registration: 07:30–18:00

EPOS™ – Scientific Exhibition: 08:00–18:00

78 ECR 2015 | Final Programme www.myESR.org


Programme Overviews

Saturday, March 7
Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/
ECR Master Classes
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time
RC 1310 RC 1311 E³ 1326 RC 1302 RC 1304 RC 1314 RC 1307 E³ 1318
08:30-
Musculoskeletal
How I do and report
Neuro
Reporting spine
imaging studies
E³ - ECR Master
Classes
Imaging tumour
Breast
Tailoring breast
Chest
Occupational lung
cancer screening to diseases the known
Radiographers
Radiography and
evidence-based
Genitourinary
Female pelvic
imaging:
E³ - ECR
Academies:
Hybrid Imaging 09:00 Friday, March 6
phenotype: risk level and the less known research: how I do it? (advanced)
the future is now the way forward Advanced imaging
with tracers 09:00-
beyond FDG 09:30 Room MB 1 E³ 926c Vascular
09:30-
08:30–10:00 Uterine and prostate embolisation
10:00
Room MB 2 E³ 926a Paediatric
10:00- 08:30–10:00 Advances in paediatric imaging
10:30
Room MB 3 E³ 926b Interventional Radiology
MM 14 SS 1410 SS 1411 SS 1416 SS 1401 SS 1404 SS 1409 SS 1407 SS 1414
Multimedia Musculoskeletal Neuro Oncologic Gastrointestinal Chest Interventional Genitourinary Radiographers 10:30- 08:30–10:00 The leading role of interventional
Classroom Spine Ischaemic stroke Imaging Tract CT dose reduction Radiology Adrenal and kidney Dose management radiology in a major trauma centre
Oncologic imaging (2) Prostate cancer Abdominal and and MR indications Radioembolisation imaging in medical imaging 11:00
(2) imaging vascular imaging and
chemoembolisation
in liver tumours 11:00- Room G E³ 1226a Genitourinary
11:30 16:00–17:30 Urogenital radiology in 2015:
beyond morphology?
11:30-
12:00 Room MB 1 E³ 1226d Molecular Imaging
12:00-
16:00–17:30 Chemical exchange saturation
12:30
transfer (CEST):
a new toy for molecular imaging?
E³ 24D
E³ - The Beauty of 12:30-
Basic Knowledge:
13:00 Room MB 2 E³ 1226c Cardiac
Skeletal Radiology
Tumoural and 16:00–17:30 Cardiac MR imaging
pseudotumoural
MSK lesions 13:00-
13:30 Room MB 4 E³ 1226b Emergency Radiology
16:00–17:30 Acute postoperative complications
13:30- in the abdomen:
14:00 from diagnosis to therapy
MM 15 RC 1510 NH 15 SF 15 RC 1502 RC 1504 RC 1514 RC 1511 E³ 1518
Multimedia Musculoskeletal New Horizons Special Focus Breast Chest Radiographers Neuro E³ - ECR 14:00-
Classroom The hand and wrist Session Session Update on BI-RADS Pulmonary arterial CT from A to Z White spots Academies:
MDCT Optical molecular Cardiac CT: hypertension in the brain Hybrid Imaging 14:30
in emergencies
(2)
imaging:
a new dimension
for radiology
cutting edge
techniques
(advanced)
Advanced hybrid
imaging of brain 14:30-
Saturday, March 7
15:00

15:00- Room F1 E³ 1326 Oncologic Imaging


15:30 08:30–10:00 Imaging tumour phenotype:
the future is now
15:30-
16:00 Room B E³ 1526 Abdominal and Gastrointestinal
E³ 1626a SF 16 SA 16 E³ 1626b RC 1614 E³ 1626c E³ 1618 14:00–15:30 Advances in liver imaging
E³ - ECR Master Special Focus State of the Art E³ - ECR Master Radiographers E³ - ECR Master E³ - ECR 16:00-
Classes Session Symposium Classes MRI from the cradle Classes Academies:
Cone-beam vs Imaging biomarkers Controversies in Breast imaging: to the future Epilepsy Hybrid Imaging 16:30 Room E1 E³ 1626a Head and Neck
multi-detector CT in degenerative comprehensive improving the (advanced)
in head and neck joint disease imaging of coronary information to Advanced hybrid
16:30- 16:00–17:30 Cone-beam vs multi-detector CT
imaging artery disease women imaging in oncology
17:00 in head and neck imaging

17:00- Room F2 E³ 1626b Breast


17:30 16:00–17:30 Breast imaging:
improving the information to women
Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00 Room G E³ 1626c Neuro
* Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00 16:00–17:30 Epilepsy

www.myESR.org Final Programme | ECR 2015 79


Programme Overviews

Sunday, March 8
Today’s Highlights Room/ A B C Z M N Studio 2015 L1 L2
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
E³ 1721 RC 1701 E³ 1722 EDiR talk RC 1712 Joint Session of E³ - Rising Stars
08:30-
Saturday, March 7 09:00
E³ - ECR
Academies:
Interactive
Abdominal
Viscera
Colorectal cancer
E³ - ECR
Academies:
Modern Imaging
FA(b)Q frequently
asked (burning)
questions - with
Paediatric
Imaging the head
and skull base
the ESR and ERS
Lung cancer
screening: why and
Programme
Basic 6:
Interventional
Teaching liver metastases: of the GI Tract answers how to implement radiology
Sessions assessing tumour Gastrointestinal a comprehensive
09:00- Cardiac CT: response stromal tumours preventive
Room A HL 3 NIKOLA TESLA HONORARY LECTURE 09:30 from stenosis (GIST) programme
assessment to risk
12:15–12:45 Brain tumour update 2015: stratification
09:30-
What’s new and why you should care 10:00
Anne G. Osborn; Salt Lake City, UT/US
10:00-
Room Z Joint Session of the ESR and EORTC 10:30
08:30–10:00 (European Organisation for Research and
E³ 1821 EM 4 SS 1802 SS 1805 SS 1801 E³ 1823 SS 1803 ESR-PAG 2
Treatment of Cancer) 10:30- E³ - ECR ESR meets Breast Computer Abdominal E³ - European Cardiac ESR Patient
Academies: Turkey Population-based Applications Viscera Diploma Prep Biomarkers in Advisory Group
Imaging in multicentre clinical 11:00 Interactive Turkey welcomes screening Data sharing and HCC diagnosis and Sessions cardiac imaging Communicating the
oncological trials Teaching
Sessions
ECR content-based data
retrieval
treatment Neuro results of radiologic
studies to patients:
11:00- Evaluation of from high-tech
Room B EM 3 ESR meets the Republic of Korea 11:30 patients with lung to human-touch
emphysema imaging
10:30–12:00 CT in lung cancer screening and
11:30-
COPD evaluation
12:00
Room A JIIQ JUNIOR IMAGE INTERPRETATION QUIZ 12:00-
E³ - Rising Stars
Programme
13:00–14:00 Battle for the Audience 12:30 Ultrasound
Workshop
IV – Abdomen
E³ 25E ESR
Room Z Joint Session of the ESR and ESTRO 12:30- E³ - The Beauty of General
(European Society for Radiotherapy and Oncology) 13:00 Basic Knowledge: Assembly
Breast Imaging
14:00–15:30 ESTRO 1 Non-surgical approach to early lung High risk lesions:
Case-Based
solving the
cancer: perspectives of imaging and 13:00- dilemma Diagnosis Training
Part I
radiation-based disciplines 13:30
13:00–14:00
16:00–17:30 ESTRO 2 Radiology and radiation oncology: 13:30- Case-Based
new chances for a partnership 14:00 Diagnosis Training
Interlude: Spot the
SS 1902a SS 1901a SS 1902b SS 1905 SS 1901b E³ 1923 implant - can you
Room E2 NH 15 Optical molecular imaging: 14:00- Breast Abdominal Breast Computer Abdominal E³ - European identify common
and unusual
14:00–15:30 a new dimension for radiology 14:30 Multiparametric
MRI and PET
Viscera
Pancreas: tumours,
Preoperative
imaging
Applications
Methods for image
Viscera
Liver CT and
Diploma Prep
Sessions medical devices
pancreatitis interpretation and ultrasound: Principles of inside the body?
Studio 2015 MS 16 Solving the crossword puzzle in reporting new techniques imaging and 14:00–14:30
14:30- radiation protection
16:00–17:30 diffuse interstitial lung disease (DILD) 15:00 Case-Based
Diagnosis Training
15:00- Part II
Room F1 SA 16 Controversies in comprehensive 14:30–15:30
16:00–17:30 imaging of coronary artery disease 15:30

For Saturday’s Master Classes


see page 47

Registration: 07:30–18:00

EPOS™ – Scientific Exhibition: 08:00–18:00

80 ECR 2015 | Final Programme www.myESR.org


Programme Overviews Programme Overviews

Sunday, March 8 Notes


Q / Multimedia
Classroom E1 E2 F1 F2 D1 D2 G K Room/
1st Level Entrance Level Entrance Level Entrance Level Entrance Level Lower Level Lower Level Lower Level Lower Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) Time
E³ 1726 NH 17 SF 17b RC 1702 SF 17a RC 1714 RC 1711 SF 17c
E³ - ECR Master New Horizons Special Focus Breast Special Focus Radiographers Neuro Special Focus 08:30-
Classes Session Session Emerging Session Looking into Screening for Session
Osteomyelitis vs Comprehensive Congenital breast imaging Metabolic bone PET-CT cerebral aneurysms Technology 09:00
gout: what are the personalised heart disease: technologies diseases for supporting
pearls? imaging of from infancy to clinical research in
cardiothoracic adulthood radiology 09:00-
diseases 09:30

09:30-
10:00

10:00-
10:30
SS 1810 SS 1811 SS 1816 SS 1813 SS 1804 SS 1809 SS 1807 SS 1814
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Radiographers 10:30-
Arthritis Brain epilepsy and Imaging Radiology Obstructive Radiology GU special topics Professional
inflammation Response Novel digital pulmonary diseases GI and abdominal challenges for 11:00
assessment: imaging techniques and reduced lung interventions radiographers
new concepts function
11:00-
11:30

11:30-
12:00

12:00-
12:30
E³ 24E
E³ - The Beauty of 12:30-
Basic Knowledge:
Skeletal Radiology 13:00
Metabolic,
endocrine and
marrow disease 13:00-
13:30

13:30-
14:00
SS 1910 SS 1911 SS 1916 SS 1913 SS 1904 SS 1909a SS 1907 SS 1909b
Musculoskeletal Neuro Oncologic Physics in Chest Interventional Genitourinary Interventional 14:00-
Knee Advanced imaging Imaging Radiology Infection, Radiology Urinary stones, Radiology
Oncologic imaging Patient and staff transplantation and Embolotherapy ureters and bladder Aortic interventions 14:30
of the GI tract dose studies quality issues pathology
14:30-
15:00

15:00-
15:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–14:00

www.myESR.org Final Programme | ECR 2015 81 www.myESR.org


Today’s Highlights
Sunday, March 8
Experience everything
Room Z EDiR talk
ESR Education
08:30–10:00 (European Diploma in Radiology)
FA(b)Q frequently asked (burning)
questions - with answers
has to offer
Studio 2015 Joint Session of the ESR and ERS
08:30–10:00 (European Respiratory Society)
Lung cancer screening:
why and how to implement ESOR  EUROPEAN SCHOOL OF RADIOLOGY
a comprehensive preventive programme Courses, fellowships, and more
www.esor.org
Room E1 E³ 1726 E³ - ECR Master Classes:
08:30–10:00 Musculoskeletal INSIGHTS INTO IMAGING
Osteomyelitis vs gout:
Education and strategies in European radiology
what are the pearls?
ESR’s open access journal
Room E2 NH 17 Comprehensive personalised imaging www.i3-journal.org
08:30–10:00 of cardiothoracic diseases
EPOSTM  ELECTRONIC PRESENTATION ONLINE SYSTEM
Room B EM 4 ESR meets Turkey Browse through more than 20,000 posters
10:30–12:00 Turkey welcomes ECR Visit the EPOS Lounge on the 1st level or online at
www.myESR.org/epos
Room L1 ESR-PAG 2 ESR Patient Advisory Group
10:30–12:00 Communicating the results
of radiological studies to patients: EURORAD  RADIOLOGICAL CASE DATABASE
from high-tech to human touch imaging Learn from more than 5,500 case reports
Go to www.eurorad.org
Studio 2015 Case-based Diagnosis Training
13:00–15:30 EUROPEAN TRAINING CURRICULUM FOR RADIOLOGY
Know what to know!
Visit www.myESR.org/trainingcurriculum
Scientific
Programme
Please note that sessions are marked with a logo to indicate their classification
according to the European Training Curriculum.

First three years of training


Fourth and fih years of training (general radiologist standard)
Subspecialty training standard

ESR/EFRS meets Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85


New Horizons Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91
Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
Professional Challenges Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97
Multidisciplinary Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101
European Excellence in Education (E³) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Rising Stars Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105
European Diploma Prep Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .111
The Beauty of Basic Knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .113
ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115
ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123
Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .127
Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .129
Multimedia Classroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .131
Refresher Courses / Scientific Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .133
Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .161

83
ESR/EFRS meets
Sessions
Once again, the ESR will welcome three countries and a partner discipline to share
their expertise as part of the ‘ESR meets’ programme during ECR 2015, next March
in Vienna.
The national radiological societies of Germany, the Republic of Korea, and Turkey,
as well as the European Association of Urology (EAU), will present their most
recent scientific developments in joint sessions, and try to strengthen links
between professionals from different countries and disciplines. The European
Federation of Radiographer Societies (EFRS) will also host its own ‘meets’ session
for radiographers, in conjunction with their colleagues from Germany (German
Association of Medical Technologists and Analysts).
Both the ESR and the EFRS warmly welcome these societies, and hope to see ECR
delegates attend the sessions in large numbers.

85
Scientific Programme

ESR/EFRS meets Sessions

Friday, March 6, 10:30–12:00, Room B Friday, March 6, 16:00–17:30, Room B


ESR meets Germany ESR meets EAU
EM 1 Tradition goes digital: getting (European Association of Urology)
ready for the future EM 2 Joint ESR-EAU prostate cancer session
Moderators: B. Hamm; Berlin/DE
N. Hosten; Greifswald/DE Moderators: P.-A. Abrahamsson; Malmö/SE
» Welcome by the ESR President B. Hamm; Berlin/DE
L. Bonomo; Rome/IT » Welcome by the ESR President
» Introduction [A-374] L. Bonomo; Rome/IT
N. Hosten; Greifswald/DE » Introduction [A-416]
» State-of-the-art teaching in German radiology: P.-A. Abrahamsson; Malmö/SE
Akademie online [A-375] B. Hamm; Berlin/DE
M.G. Mack; Munich/DE » PSA screening: the EAU view [A-417]
» Interlude I: Radiation protection: the concept of P.-A. Abrahamsson; Malmö/SE
‘justifying indication’ [A-376] » Role of a multiparametric MRI
R.W.R. Loose; Nürnberg/DE in early detection [A-418]
» Population-based MRI: SHIP (study of health in G.M. Villeirs; Gent/BE
Pomerania) and the national cohort [A-377] » Active surveillance strategies
K. Hegenscheid; Greifswald/DE in prostate cancer [A-419]
» Interlude II: The Röntgenhaus: Wilhelm Conrad A. Villers; Lille/FR
Röntgen’s birthplace [A-378] » Role of imaging in active surveillance [A-420]
B. Lewerich; Berlin/DE A.R. Padhani; London/UK
» MRI-PET: a new modality for clinical imaging [A-379] » Panel discussion:
C.D. Claussen; Tübingen/DE When should MRI be used? Before or aer prostate
N. Schwenzer; Tübingen/DE biopsy? Qualitative or quantitative MRI reading?
» Panel discussion: Cost-effectiveness of mpMRI as a tool for prostate
Cross-linking radiology: opportunity or threat? cancer screening. Can mpMRI detect clinically
significant prostate cancer?

Friday, March 6, 14:00–15:30, Room B


EFRS meets Germany
(European Federation of Radiographer Societies)
EM 5 High-end and hybrid technology
in clinical and research work of
radiographers in Germany
Moderators: C. Vandulek; Kaposvár/HU
A. Ohmstede; Oldenburg/DE
» Introduction [A-396]
C. Vandulek; Kaposvár/HU
A. Ohmstede; Oldenburg/DE
» Teaching and learning with VERT (Virtual
Environment for Radiation Therapy Training) [A-397]
C. Garske; Berlin/DE
» Selective Internal Radiation Therapy (SIRT) [A-398]
B. Kulitzscher; Berlin/DE
» Interlude: German Röntgen Museum [A-399]
B. Lewerich; Berlin/DE
» PET-CT [A-400]
K. Hägele; Böbingen/DE
» MRI-PET [A-401]
V. Diehl; Bremen/DE

86 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

ESR/EFRS meets Sessions

Saturday, March 7, 10:30–12:00, Room B Sunday, March 8, 10:30–12:00, Room B


ESR meets the Republic of Korea ESR meets Turkey
EM 3 CT in lung cancer screening and COPD EM 4 Turkey welcomes ECR
evaluation
Moderators: A. Coşkun; Kayseri/TR
Moderators: B. Hamm; Berlin/DE B. Hamm; Berlin/DE
T.-H. Lim; Seoul/KR » Welcome by the ESR President
» Welcome by the ESR President L. Bonomo; Rome/IT
L. Bonomo; Rome/IT » Introduction [A-727]
» Introduction: Korean Society of Radiology - A. Coşkun; Kayseri/TR
evolution and new challenges [A-536] » Liver hydatid cysts: percutaneous treatment [A-728]
T.-H. Lim; Seoul/KR O. Akhan; Ankara/TR
» Lung cancer screening in Korea [A-537] » Interlude I: Music show [A-729]
K.S. Lee; Seoul/KR İ. Barutçu; Trabzon/TR, M. Burçin Derçin; Trabzon/TR
» Interlude: Republic of Korea (South Korea): » fMRI of the brain: beyond expectations? [A-730]
Korean people and culture [A-538] C. Calli; Izmir/TR
J. Hur; Seoul/KR » Interlude II: Music show [A-731]
» Computer-aided nodule detection and volumetry: İ. Barutçu; Trabzon/TR, M. Burçin Derçin; Trabzon/TR
role in lung cancer screening [A-539] » Advanced hepatopancreaticobiliary imaging [A-732]
J.M. Goo; Seoul/KR Ş.M. Ertürk; Istanbul/TR
» Interlude: Introduction of the Korean Society of » Panel discussion
Thoracic Radiology (KSTR) [A-540]
J. Hur; Seoul/KR
» CT in COPD: now and future [A-541]
J.B. Seo; Seoul/KR
» Panel discussion:
Is CT an effective tool for management
of lung cancer screening and COPD?

www.myESR.org Final Programme | ECR 2015 87


Enjoy Vienna’s
cultural highlights

Special Exhibition at the mumok (Museum of Modern Art):


Ludwig goes Pop
Roy Lichtenstein, Still Life with Pitcher and Apple, 1972, Museum Ludwig, Köln
© Estate of Roy Lichtenstein / Bildrecht Wien, 2014

www.mumok.at

More about museums and exhibitions in Vienna: www.myESR.org/arts_culture


New Horizons
Sessions
The New Horizons Sessions aim to provide practitioners with an overview of
the new developments in a specific area of practice, whether it is a subspecialty,
a particular technique, or certain diseases. These developments may become
routine within a few years, or may indicate a new direction for research and clinical
application. Each session is 90 minutes long and features an introduction from a
chairman, followed by three or four brief presentations on different aspects of the
main subject, and concluded by a panel discussion that will hopefully answer some
critical questions.
Places are allocated on a first-come, first-served basis.

89
Scientific Programme

New Horizons Sessions

Friday, March 6, 08:30–10:00, Room E2 Sunday, March 8, 08:30–10:00, Room E2


NH 9 Image-guided interventions of the NH 17 Comprehensive personalised imaging
prostate of cardiothoracic
diseases
» Chairman’s introduction: defining the target [A-327]
A.R. Padhani; London/UK » Chairman’s introduction:
» MR-targeted prostate biopsy [A-328] how to prepare for the future? [A-698]
J.J. Fütterer; Nijmegen/NL T. Benedek; Targu Mures/RO
» MR-US fusion prostate biopsy [A-329] » Patients with acute and chronic chest pain [A-699]
F. Cornud; Paris/FR C. Loewe; Vienna/AT
» Image-guided tumour ablations [A-330] » Patients with acute shortness of breath [A-700]
H.U. Ahmed; London/UK J. Bremerich; Basle/CH
» Prostate artery embolisation (PAE) » Patients with chronic shortness of breath [A-701]
for benign hypertrophy [A-331] E.J.R. van Beek; Edinburgh/UK
F.C. Carnevale; Sao Paulo/BR » Early detection for cardiothoracic disease
» Panel discussion: in smokers [A-702]
Do organ-sparing prostatic treatments make sense? M. Rémy-Jardin; Lille/FR
» Panel discussion:
Comprehensive imaging and education
Saturday, March 7, 14:00–15:30, Room E2 in cardiothoracic diseases
NH 15 Optical molecular imaging:
a new dimension for
radiology
» Chairman’s introduction [A-589]
C.-C. Glüer; Kiel/DE
» Reporter gene imaging [A-590]
C.W.G.M. Löwik; Leiden/NL
» Cerenkov - faster than the speed of light [A-591]
J. Grimm; New York, NY/US
» The kiss of light and sound - optoacoustics [A-592]
V. Ntziachristos; Munich/DE
» Panel discussion:
Potential of optical imaging for translation
to human applications

90 ECR 2015 | Final Programme www.myESR.org


State of the Art
Symposia
These sessions will inform the audience about the ‘real state of the art’ of a given
subject. Each of the lecturers is an expert on the given topic as a whole or on a
specific aspect of the topic.
The 90-minute sessions are chaired by a moderator who will introduce three to four
speakers addressing various issues within wider subjects such as anatomical regions,
specific diseases, or particular techniques. The presentations will be followed by a
discussion conducted by the panellists, led by the chairman.
Places are allocated on a first-come, first-served basis.

91
Scientific Programme

State of the Art Symposia

Thursday, March 5, 08:30–10:00, Room E1 Saturday, March 7, 16:00–17:30, Room F1


SA 5 Rethinking ductal carcinoma SA 16 Controversies in comprehensive
in situ (DCIS) imaging of coronary artery
disease
» Chairman’s introduction [A-151]
G. Forrai; Budapest/HU » Chairman’s introduction: what is the
» New molecular pathologic knowledge on DCIS [A-152] evidence? [A-651]
T. Tot; Falun/SE M. Dewey; Berlin/DE
» Diagnosing DCIS with MRI [A-153] » Computed tomography is all you need [A-652]
C.K. Kuhl; Aachen/DE H. Alkadhi; Zurich/CH
» Image-guided interventions for DCIS [A-154] » Magnetic resonance will take the lead [A-653]
R.M. Pijnappel; Utrecht/NL M. Francone; Rome/IT
» Panel discussion: Patient with DCIS: » Hybrid nuclear imaging shows no defeat [A-654]
how to plan her therapy in 2015? S. Kajander; Turku/FI
» Panel discussion:
Imaging of coronary artery disease in 2020
Friday, March 6, 16:00–17:30, Room F1
SA 12 Fleischner guidelines for nodules:
theory and practice
» Chairman’s introduction [A-448]
C.M. Schaefer-Prokop; Amersfoort/NL
» The 2011 classification of adenocarcinomas:
rationale and implications for nodule
management [A-449]
A. Nicholson; London/UK
» The Fleischner guidelines for solid and subsolid
nodules: theory and practice [A-450]
A.A. Bankier; Boston, MA/US
» Estimating the risk for malignancy of pulmonary
nodules [A-451]
B. van Ginneken; Nijmegen/NL
» Panel discussion: Fleischner guidelines:
what have we learned?

92 ECR 2015 | Final Programme www.myESR.org


Special Focus
Sessions
The concept of a Special Focus Session is to deal with a topic at the cutting edge
of development and clinical application. A traditional approach is inappropriate for
such a session, which should reflect the lecturers’ forthright personal views on a
developing subject. The topics of these sessions should be presented in such a
way as to promote debate and give an in-depth analysis.
The chairman will introduce each aspect of the topic and the panellists will then
discuss their different perspectives and opinions. The audience will have the
opportunity to discuss their ideas with the lecturers. Session length: 90 minutes;
three to four speakers.
Places are allocated on a first-come, first-served basis.

93
Scientific Programme

Special Focus Sessions

Wednesday, March 4, 08:30–10:00, Room C Wednesday, March 4, 16:00–17:30, Room C


SF 1a Acute gastrointestinal tract SF 4 Pancreatic lesions - the solid,
emergencies: an update the cystic, and the diffuse:
benign or malignant?
» Chairman’s introduction [A-007]
F. Caseiro-Alves; Coimbra/PT » Chairman’s introduction [A-073]
» The acute abdomen: inflammation and C. Matos; Brussels/BE
its mimics [A-008] » The solid pancreatic lesion [A-074]
M. Zins; Paris/FR R. Manfredi; Verona/IT
» Mechanical bowel obstruction [A-009] » The cystic pancreatic lesion [A-075]
D.J.M. Tolan; Leeds/UK J. Wessling; Münster/DE
» Evaluation of the ischaemic bowel [A-010] » The diffuse pancreatic lesion [A-076]
S. Romano; Naples/IT C. Triantopoulou; Athens/GR
» The acute GI bleed [A-011] » Panel discussion:
O.M. van Delden; Amsterdam/NL Pitfalls and problems in pancreatic lesions
» Panel discussion:
How should acute GI tract emergencies be managed?
Thursday, March 5, 08:30–10:00, Room C
SF 5 Advanced applications
Wednesday, March 4, 08:30–10:00, Room E1 in ultrasound
SF 1b Up-to-date imaging for
hearing loss » Chairman’s introduction [A-133]
T. Fischer; Berlin/DE
» Chairman’s introduction [A-019] » Contrast-enhanced ultrasound
A. Trojanowska; Lublin/PL of the pancreas [A-134]
» New devices in the treatment of hearing loss [A-020] M. D’Onofrio; Verona/IT
B. Ozgen Mocan; Ankara/TR » Molecular ultrasound and dynamic
» Pre- and postoperative imaging in middle contrast-enhanced US for antiangiogenic
ear implants [A-021] therapy monitoring [A-135]
E. Loney; Bradford/UK N. Lassau; Villejuif/FR
» Pre- and postoperative imaging in inner ear and » State-of-the-art ultrasound technologies:
brainstem implants [A-022] elastography and microvascular imaging -
B. Verbist; Leiden/NL are they useful? [A-136]
» Panel discussion: A.K.P. Lim; London/UK
Changing demands for imaging in hearing loss » ShearWave elastography, ultrafast Doppler
and image fusion [A-137]
J.-M. Correas; Paris/FR
Wednesday, March 4, 08:30–10:00, Room E2 » Panel discussion:
SF 1c Internal derangement of joints: How could these technologies improve
choosing the right test for the clinical routine?
problem
» Chairman’s introduction [A-023]
A.J. Grainger; Leeds/UK
» CT arthrography:
acceptable if MR availability is limited? [A-024]
B. Vande Berg; Brussels/BE
» MR arthrography:
exquisite so tissue contrast [A-025]
E. Rowbotham; Leeds/UK
» MRI: when is it enough? [A-026]
C.W.A. Pfirrmann; Zurich/CH
» Panel discussion:
Can one technique ever fulfil all the roles? How will
our optimal techniques change in the next 5 years?

94 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Special Focus Sessions

Thursday, March 5, 16:00–17:30, Room B Friday, March 6, 08:30–10:00, Room C


SF 8a Advanced brain MRI techniques SF 9a Evaluation of treatment response
in paediatrics: toys or tools in head and neck cancer
in daily practice?
» Chairman’s introduction [A-308]
» Chairman’s introduction [A-236] M. Becker; Geneva/CH
A. Rossi; Genoa/IT » Prognostic factors influencing treatment choice and
» Arterial spin-labelling: measuring perfusion treatment response [A-309]
non-invasively in neonates and children [A-237] R. Hermans; Leuven/BE
J. Hendrikse; Utrecht/NL » Evaluation of early treatment response:
» MR spectroscopy: information vs time [A-238] can MRI techniques make a difference? [A-310]
J.F. Schneider; Basle/CH H.C. Thoeny; Berne/CH
» Diffusion tensor imaging: connecting the dots [A-239] » Post treatment imaging:
T.A.G.M. Huisman; Baltimore, MD/US is PET a reliable indicator for tumour viability? [A-311]
» Panel discussion: S. Bisdas; Tübingen/DE
Do advanced brain MRI techniques really change » Panel discussion:
current practice? Can we provide accurate information for
the evaluation of treatment response?

Thursday, March 5, 16:00–17:30, Room E2


SF 8b New frontiers in brain tumour imaging Friday, March 6, 08:30–10:00, Room D1
SF 9b The forgotten joints

» Chairman’s introduction [A-259] » Chairman’s introduction [A-340]


H.R. Jäger; London/UK M. Padrón; Madrid/ES
» Imaging correlates of brain tumour genotypes [A-260] » Fingers and toes: little joints, big trouble? [A-341]
M. Smits; Rotterdam/NL A. Klauser; Innsbruck/AT
» Multi-parametric MR tumour imaging in brain tumour » The symphysis pubis [A-342]
diagnosis and monitoring [A-261] C.W.A. Pfirrmann; Zurich/CH
M.A. Lucic; Sremska Kamenica/RS » The acromioclavicular joint: patterns of injury [A-343]
» MR/PET in brain tumour diagnosis: D. Barron; Leeds/UK
the added value of combining structural and » Panel discussion:
molecular imaging [A-262] Are these topics never to be forgotten?
F. Fraioli; London/UK
» Panel discussion:
Modalities and parameters - what do we really need? Friday, March 6, 16:00–17:30, Room E2
SF 12 Interventional radiology
in venous thromboembolism
Thursday, March 5, 16:00–17:30, Room F2 and chronic venous disease
SF 8c Breast imaging modalities:
beyond the conventional » Chairman’s introduction [A-443]
D.K. Tsetis; Iraklion/GR
» Chairman’s introduction [A-269] » Current endovascular treatment
M. Lobbes; Maastricht/NL in iliofemoral DVT [A-444]
» Contrast-enhanced mammography [A-270] R. Uberoi; Oxford/UK
C. Dromain; Villejuif/FR » Vena cava filters: an update [A-445]
» Breast CT [A-271] M.J. Lee; Dublin/IE
W.A. Kalender; Erlangen/DE » Interventional treatment of severe/massive
» Non-contrast MRI [A-272] pulmonary embolism [A-446]
P.A.T. Baltzer; Vienna/AT G. Carrafiello; Varese/IT
» Panel discussion: » Techniques and tools in endovenous
Is there still room for conventional breast imaging? thermal ablation [A-447]
D.J. West; Stoke-on-Trent/UK
» Panel discussion:
What does the interventional radiologist need to
know about modern anticoagulation treatment?

www.myESR.org Final Programme | ECR 2015 95


Scientific Programme

Special Focus Sessions

Saturday, March 7, 14:00–15:30, Room F1 Sunday, March 8, 08:30–10:00, Room F1


SF 15 Cardiac CT: SF 17b Congenital heart disease:
cutting-edge techniques from infancy to adulthood
» Chairman’s introduction: » Chairman’s introduction [A-703]
overview of the cutting-edge techniques [A-593] M. Haliloglu; Ankara/TR
R. Salgado; Antwerp/BE » Cardiac CT: challenges in congenital
» Estimation of coronary flow reserve by CT: heart diseases [A-704]
a new arrival [A-594] M. Kantarci; Erzurum/TR
G. Bastarrika; Pamplona/ES » Segmental approach to MR imaging
» Myocardial perfusion imaging in clinical routine: of congenital heart disease [A-705]
ready for prime time? [A-595] A.M. Taylor; London/UK
K. Kitagawa; Mie/JP » Imaging of congenital heart disease in adults [A-706]
» Plaque imaging with cardiac CT: S. Leschka; St. Gallen/CH
coming of age? [A-596] » Panel discussion:
J. Hoe; Singapore/SG What is the impact of radiologists in the evaluation
» Panel discussion: of congenital heart disease?
Which technique will change clinical practice?

Sunday, March 8, 08:30–10:00, Room K


Saturday, March 7, 16:00–17:30, Room E2 SF 17c Technology for supporting clinical
SF 16 Imaging biomarkers in degenerative research in radiology
joint disease
» Chairman’s introduction [A-721]
» Chairman’s introduction [A-647] D. Caramella; Pisa/IT
S. Trattnig; Vienna/AT » Online tools and soware solutions
» Proteoglycan-specific quantitative imaging for effective clinical research [A-722]
in osteoarthritis and cartilage repair - part 1 [A-648] A. Scarsbrook; Leeds/UK
E.H.G. Oei; Rotterdam/NL » PACS for research [A-723]
» Proteoglycan-specific quantitative imaging D. Regge; Turin/IT
in osteoarthritis and cartilage repair - part 2 [A-649] » Using electronic case report forms
M.-A. Weber; Heidelberg/DE for clinical imaging trials [A-724]
» Degenerative joint disease: collagen-specific T. Bäuerle; Erlangen/DE
quantitative imaging of menisci and tendons [A-650] » Panel discussion:
K.M. Friedrich; Vienna/AT Are online tools, PACS, or electronic case report
» Panel discussion: forms suitable for clinical research?
What are the new imaging biomarkers
in degenerative MSK disease?

Sunday, March 8, 08:30–10:00, Room D1


SF 17a Metabolic bone diseases
» Chairman’s introduction [A-710]
G. Guglielmi; Andria/IT
» A critical appraisal of vertebral fracture
identification [A-711]
A. Bazzocchi; Bologna/IT
» Metabolic bone disorders in patients
with malabsorption [A-712]
C.M. Phan; Paris/FR
» Bone quality beyond BMD: what do we know already
and what more does the future hold? [A-713]
J.S. Bauer; Munich/DE
» Panel discussion:
How do radiologists get involved?

96 ECR 2015 | Final Programme www.myESR.org


Professional
Challenges
Sessions
The idea of these sessions is to communicate and exchange information on
professional issues related to radiology, such as training and education, research
networking, radiological management and professional developments.
90-minute sessions; introduction by one or two chairmen; three to four lecturers;
panel discussion.
Places are allocated on a first-come, first-served basis.

97
Scientific Programme

Professional Challenges Sessions

Wednesday, March 4, 16:00–17:30, Room E2 Thursday, March 5, 08:30–10:00, Room F2


PC 4a Radiologist: PC 5b Imaging biobanks:
imager or doctor? from genomic to radiomic in the era
of personalised medicine
» Chairman’s introduction [A-088]
J.A. Reekers; Amsterdam/NL » Chairmen’s introduction [A-163]
» Which type of radiologist is future proof? [A-089] G. Frija; Paris/FR
N.H. Strickland; London/UK E. Neri; Pisa/IT
» Is subspecialisation the answer? [A-090] » The biobanks: genomic, moleculomic and proteomic -
J.A. Reekers; Amsterdam/NL Which link to radiomics? [A-164]
» Is teleradiology a threat to radiology? [A-091] M. Simmaco; Rome/IT
A. Palkó; Szeged/HU » Radiomic: report from the ESR Working Group
» Radiology training for the future [A-092] on Imaging Biobanks [A-165]
B. Ertl-Wagner; Munich/DE H.-U. Kauczor; Heidelberg/DE
» Panel discussion: How do radiologists stay relevant » Existing imaging biobanks [A-166]
and what is the role of the ESR? A. Jackson; Manchester/UK
» Extraction and analysis of biomarkers
from medical images [A-167]
Wednesday, March 4, 16:00–17:30, Room Z B. Gibaud; Rennes/FR
PC 4b What are the concrete benefits of » Panel discussion: Future strategies for the
structured reporting? development and the federation of biobanks,
definition of standards, etc.
» Chairman’s introduction [A-077]
L. Donoso; Barcelona/ES
» For the radiologist [A-078] Thursday, March 5, 16:00–17:30, Room F1
P. Mildenberger; Mainz/DE PC 8a Integration of imaging
» For the referring physician [A-079] biomarker activities
J.M.L. Bosmans; Ghent/BE on a European level
» For the patient [A-080] » Chairman’s introduction [A-263]
C.E. Kahn; Philadelphia, PA/US G. Frija; Paris/FR
» The ESR/RSNA structured reporting initiative [A-081] » From qualitative to quantitative imaging:
O. Ratib; Geneva/CH a paradigm shi in radiology [A-264]
» Panel discussion: What are the concrete benefits S. Trattnig; Vienna/AT
of structured reporting? » Experience of the Quantitative Imaging Alliance
(QIBA) of the RSNA [A-265]
R. Boellaard; Amsterdam/NL
Thursday, March 5, 08:30–10:00, Room E2
» Introduction to the Quantitative Imaging European
PC 5a Looking into the future Task Force [A-266]
of radiology H.-U. Kauczor; Heidelberg/DE
» Chairmen’s introduction [A-155] » Clinical validation of imaging biomarkers and
M.H. Fuchsjäger; Graz/AT their role in European Medicine Agency (EMA)
G. Paulo; Coimbra/PT applications [A-267]
O. Clément; Paris/FR
» Health technology assessment (HTA) [A-156]
E.J. Adam; London/UK » The role of imaging biomarkers in the EORTC
clinical trials [A-268]
» The influence of health economics systems N.M. deSouza; Sutton/UK
on radiology [A-157]
D. Katsifarakis; Athens/GR » Panel discussion: How to strengthen the role
of imaging biomarkers in clinical trials
» Quo vadis radiology professions?
A pragmatic approach [A-158]
G.P. Krestin; Rotterdam/NL
» Panel discussion: What is the role of European
societies in building a sustainable model
for radiology?

98 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Professional Challenges Sessions

Thursday, March 5, 16:00–17:30, Room L 1 Friday, March 6, 16:00–17:30, Room F2


PC 8b Imaging in population-based PC 12a Harmonised approach for imaging
studies in Europe: myth or reality?
» Chairman’s introduction [A-250] » Chairman’s introduction [A-452]
N. Hosten; Greifswald/DE L. Donoso; Barcelona/ES
» Population imaging for the prediction » Current heterogeneities in imaging in Europe [A-453]
of neuro-degenerative diseases [A-251] G. Frija; Paris/FR
G.P. Krestin; Rotterdam/NL » Imaging equipment: an ESR perspective [A-454]
» The German National Cohort: population based B. Brkljačić; Zagreb/HR
imaging in a nation-wide multi-centre setting [A-252] » Equipment age - COCIR [A-455]
F. Bamberg; Munich/DE N. Denjoy; Brussels/BE
» Population-based cardiac imaging [A-253] » Training and certification [A-456]
S. Petersen; London/UK B. Ertl-Wagner; Munich/DE
» The Trauma Cohort: a joint project of the German » Issues related to coding terminology and
Röntgen Society and the German Society of Trauma IT access [A-457]
Surgery [A-254] P. Mildenberger; Mainz/DE
S. Langner; Greifswald/DE
» Panel discussion: A global plan for imaging
» Ethical aspects of population imaging [A-255]
J. Griebel; Neuherberg/DE (HERCA Chair of the Working Group
R. Schmücker; Münster/DE
on Medical Applications - BfS, Germany)
» Panel discussion: What does the individual gain
T. Peetso; Brussels/BE (Policy Officer of Unit ‘Health and
from population imaging studies?
Wellbeing’ - DG CNECT, European Commission)
A. Rys; Brussels/BE (Director Health systems and products -
Friday, March 6, 08:30–10:00, Room E1 DG SANCO, European Commission)
PC 9 Personalised medicine G. Simeonov; Luxembourg/LU (Policy Officer Radiation
in radiology Protection Unit - DG ENER, European Commission)

» Chairman’s introduction [A-322]


R. Manfredi; Verona/IT Friday, March 6, 16:00–17:30, Room Z
» Imaging is everywhere in personalised PC 12b Medicolegal aspects
medicine [A-323] in daily practice
A. van der Lugt; Rotterdam/NL
» Chairman’s introduction [A-425]
» Personalised prevention:
J.I. Bilbao; Pamplona/ES
population-based imaging and
image-based screening [A-324] » Inadequate consent, missed lesions
F. Bamberg; Munich/DE and misinterpretation: legal challenges
in radiology [A-426]
» Integrated diagnostics:
E.J. Adam; London/UK
towards one diagnostic department [A-325]
E. Zampella; Naples/IT » When is a radiologic error simply an error and
when is it malpractice? [A-427]
» Interventional radiology:
A. Cannavale; Rome/IT
a paradigm for personalised medicine [A-326]
S.N. Goldberg; Jerusalem/IL » The lawyer´s point of view [A-428]
M. Ludvik; Vienna/AT
» Panel discussion: How can we best accelerate
the adoption of personalised medicine » Panel discussion: How present are medicolegal
in radiological practice? aspects in our daily clinical practice?

www.myESR.org Final Programme | ECR 2015 99


Enjoy Vienna’s
cultural highlights

Special Exhibition at the Kunst Haus Wien:


Lillian Bassman & Paul Himmel. Two lives for photography
Lillian Bassman, Barbara Mullen, New York, ca. 1958, reinterpreted 1994
© Estate Lillian Bassman

www.kunsthauswien.com

More about museums and exhibitions in Vienna: www.myESR.org/arts_culture


Multidisciplinary
Sessions
The concept of these sessions is to promote a multidisciplinary approach to detection
and treatment, integrating radiologists and other clinicians to share their expertise.
Places are allocated on a first-come, first-served basis.

101
Scientific Programme

Multidisciplinary Sessions

Thursday, March 5, 16:00–17:30, Room M Saturday, March 7, 16:00–17:30, Studio 2015


MS 8 Critical limb ischaemia (CLI): MS 16 Solving the crossword puzzle in
limb salvage or life diffuse interstitial lung disease (DILD)
salvage?
» Chairman’s introduction: critical limb ischaemia » Chairman’s introduction [A-634]
in daily practise [A-243] H.-U. Kauczor; Heidelberg/DE
J.A. Reekers; Amsterdam/NL » Pulmologist’s approach: the clinical aspects [A-635]
» Diagnostic imaging and outcome [A-244] F.J.F. Herth; Heidelberg/DE
M. Koelemay; Amsterdam/NL » Pathologist’s approach and diagnosis [A-636]
» The diabetic foot patient [A-245] A. Gschwendtner; Amberg/DE
N.C. Schaper; Maastricht/NL » Radiologist’s approach, patterns and
» Multidisciplinary team case discussion diagnosis [A-637]
C.P. Heussel; Heidelberg/DE
» DILD-board: Multidisciplinary case presentation
Friday, March 6, 08:30–10:00, Room F2 and discussion
MS 9 Management of rectal cancer:
a paradigm shi
» Chairman’s introduction [A-336]
R.G.H. Beets-Tan; Maastricht/NL
» Organ-saving treatment:
what does the surgeon want to know? [A-337]
G.L. Beets; Maastricht/NL
» Organ-saving treatment:
what does the radiation oncologist want
to know? [A-338]
V. Valentini; Rome/IT
» Organ-saving treatment:
what is the radiologist’s role? [A-339]
R.G.H. Beets-Tan; Maastricht/NL
» Interactive case discussion:
What do clinicians expect from us in organ-saving
treatment management?

102 ECR 2015 | Final Programme www.myESR.org


European
Excellence in
Education (E³)
The E³ programme emphasises the importance of lifelong learning.
It covers the entire range of educational issues, from undergraduate medical
education to subspecialised continuing professional development.
For the first time at ECR 2015, the E³ programme is structured according
to the different levels defined by the European Training Curriculum for Radiology.
The E³ programme consists of the following five branches, which reflect the different
levels of education in radiology, as well as the different stages of an individual’s
professional career:
Rising Stars Programme
European Diploma Prep Sessions
The Beauty of Basic Knowledge
ECR Academies
ECR Master Classes

103
When you’ve checked in to ECR 2015 on
catch up with the latest #ECR2015 news on
become a fan and post us a photo on
and then check out our videos on
’ECR 2015’ on 4sq - twitter.com/myESR - facebook.com/myESR - youtube.com/myESR
3
E
Rising Stars
Programme
The Rising Stars Programme is designed especially for residents, students,
radiographers and trainee radiographers.
It consists of Basic Sessions, Student Sessions, Student Hands-on Workshops on
Ultrasound, Case-Based Diagnosis Training sessions, and the Radiology Trainees
Forum Programme including the RTF Highlighted Lectures and the RTF Quiz.

105
myESR.org/RisingStars
facebook.com/ESRRisingStars

ECR STUDENT REGISTRATION FOR ONLY €40


Students and radiographers-in-training under the age of 30, without any academic degree, can register for just €40.
SIX BASIC SESSIONS
Renowned professors from all over Europe give basic lectures.
STUDENT SESSIONS
The submitting authors of the best 20 abstracts will be invited to the ECR to present their work, with their
accommodation and travel expenses paid by the European Society of Radiology.
STUDENT HANDSON WORKSHOPS
Student workshops on ultrasound, for beginners and advanced participants. Practical training made easy.
Scientific Programme

E3 – Rising Stars Programme


Basic Sessions
Special sessions suitable for residents, students,
radiographers and radiographers-in-training

Thursday, March 5, 08:30–10:00, Studio 2015 Saturday, March 7, 08:30–10:00, Studio 2015
Basic Session 1: Basic Session 4:
Breast imaging Musculoskeletal trauma
» Mammography [A-148] » Shoulder [A-504]
F.J. Gilbert; Cambridge/UK M. Zanetti; Zurich/CH
» Breast US [A-149] » Knee [A-505]
C.S. Balleyguier; Villejuif/FR K. Verstraete; Ghent/BE
» Breast MRI [A-150] » Ankle [A-506]
F. Sardanelli; San Donato Milanese/IT J. Kramer; Linz/AT

Thursday, March 5, 10:30–12:00, Studio 2015 Saturday, March 7, 10:30–12:00, Studio 2015
Basic Session 2: Basic Session 5:
Neuroradiology Thoracic emergencies
» Aging and degeneration in the brain [A-199] » Vascular [A-549]
B. Gómez-Ansón; Barcelona/ES T. Jargiello; Lublin/PL
» Brain trauma [A-200] » Pulmonary [A-550]
M. Stajgis; Poznan/PL C.M. Schaefer-Prokop; Amersfoort/NL
» Vascular malformations [A-201] » Cardiac [A-551]
P. Vilela; Almada/PT V.E. Sinitsyn; Moscow/RU

Friday, March 6, 16:00–17:30, Studio 2015 Sunday, March 8, 08:30–10:00, Room L 1


Basic Session 3: Basic Session 6:
Oncologic imaging Interventional radiology
» Prostate cancer [A-437] » Uterine fibroid embolisation [A-692]
J.O. Barentsz; Nijmegen/NL T.J. Kroencke; Augsburg/DE
» Pancreatic cancer [A-438] » Management of trauma patients [A-693]
F. Caseiro-Alves; Coimbra/PT M. Krokidis; Cambridge/UK
» Musculoskeletal neoplasms [A-439] » Varicocele [A-694]
M.F. Reiser; Munich/DE P. Haage; Wuppertal/DE

www.myESR.org Final Programme | ECR 2015 107


Scientific Programme

E3 – Rising Stars Programme


Student Sessions
Students will present their work

Thursday, March 5, 14:00–15:30, Studio 2015 Friday, March 6, 08:30–10:00, Studio 2015
Student Session 1 Student Session 3
» SWI or T2* – which MRI sequence to use » Gastrostomy tube insertion without the use
in the detection of cerebral microbleeds? of barium sulphate as a contrast medium reduces
The Karolinska Imaging Dementia Study radiation dose received by the patient in a paediatric
S. Shams; Stockholm/SE interventional radiology setting
» Background parenchymal enhancement on breast B.S. Kelly; Dublin/IE
MRI in women receiving chest radiotherapy » Abdominal x-rays during pregnancy
for childhood Hodgkin’s lymphoma P.-M. Boarescu; Cluj-Napoca/RO
W. Abutaleb; Cambridge/UK » An investigation into the cardiologists’ opinion/
» 3D quantitative assessment of lesion response awareness of radiation risk as part of routine patient
to MR-guided high-intensity focused ultrasound consent for cardiac interventional procedures
treatment of uterine fibroids I. Banerjee; Dublin/IE
J. Savic; Berlin/DE » Mammography phantoms experiment:
» Evaluation of choroid plexus with foetal MRI: is automatic mode the best for shooting?
what happens in ventriculomegaly? O. Alekseeva; Moscow/RU
C. Turam; Istanbul/TR » Mammographic screening and detection of breast
» Anatomic and morphometric variations arterial calcification as an independent predictor of
of the intracranial vertebrobasilar system coronary atherosclerotic disease in a single ethnic
on MSCT and MR angiography cohort of African American women
S. Jankovic; Nis/RS J.H. Nunez; Charleston, SC/US

Thursday, March 5, 16:00–17:30, Studio 2015 Friday, March 6, 10:30–12:00, Studio 2015
Student Session 2 Student Session 4
» The positive effects on CT reporting with » Teaching cross-sectional imaging to medical
a radiologist present at the initial clinical evaluation students using Apple iBooks:
of polytrauma a novel educational resource
V. Sanfilippo; Catania/IT M. Sia; London/UK
» An audit of the practices of reporting of staging » Sono4Students: peer-to-peer teaching ultrasound
CT scans in primary malignancies in a medical curriculum
R.D.T. Price; Birmingham/UK K. Baharian; Bonn/DE
» Reproducibility of a novel semi-automated soware » Student’s FAST learning and teaching project
programme for Pre-TAVR CT assessment M. Skoczyński; Lublin/PL
K. Rohan; Belfast/UK » Fuzzy clustering for the quantification of resting
» Analysing CT images of patients who died state network characteristics in single patients
aer thrombolysis Z. Klimaj; Budapest/HU
E. Tarjányi; Debrecen/HU » Development of a new image operation
» Trunk paediatric CT diagnostic reference levels system on screen using a Leap Motion sensor
D. Fernandes; Coimbra/PT for dental radiology
Y. Yasumoto; Maebashi-City/JP

108 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

E3 – Rising Stars Programme


Student Hands-on Case-Based Diagnosis Training
Workshops on Ultrasound Special programme for residents and general radiologists
An expert team of tutors from around the world will lead students through
four innovative workshops with different educational topics, improved
since 2014. During one workshop, students will try four different stations, Sunday, March 8, 13:00–14:00, Studio 2015
giving participants a chance to familiarise themselves with the wide Case-Based Diagnosis Training – Part I
range of possibilities in ultrasound. Small groups, of only five students, will
be guided by one expert tutor, ensuring that individual students get the Moderators: K.M. Friedrich; Vienna/AT
attention they need. The courses have been extremely successful over S. Robinson; Vienna/AT
the last few years and are in great demand. » Neuro
D. Prayer; Vienna/AT
Friday, March 6, 2015, 13:30–15:30, Room L2 » Maxillofacial
Hands-on Workshop on Ultrasound 1 S. Robinson; Vienna/AT
FAST, Lung, Echo, Intervention / Phantoms » Musculoskeletal
F. Kainberger; Vienna/AT
Saturday, March 7, 2015, 12:00–14:00, Room L2 » Liver
Hands-on Workshop on Ultrasound 2 L. Martí-Bonmatí; Valencia/ES
MSK » Breast
M.H. Fuchsjäger; Graz/AT
Saturday, March 7, 2015, 15:00–17:00, Room L2
Hands-on Workshop on Ultrasound 3 Sunday, March 8, 14:00–14:30, Studio 2015
Train the Tutor Interlude: Spot the implant – can you
identify common and unusual medical
Sunday, March 8, 2015, 12:00–14:00, Room L2 devices inside the body?
Hands-on Workshop on Ultrasound 4
Moderators: W. Drahanowsky; Vienna/AT
Abdomen
S. Robinson; Vienna/AT

Radiology Trainees Sunday, March 8, 14:30–15:30, Studio 2015


Forum Programme Case-Based Diagnosis Training – Part II
Moderators: K.M. Friedrich; Vienna/AT
Thursday, March 5, 13:30–14:30, Rising Stars Lounge S. Robinson; Vienna/AT
RTF Quiz » Head and neck
C. Czerny; Vienna/AT
Quiz-Master: J. Cáceres; Barcelona/ES
» Chest
H. Prosch; Vienna/AT
Saturday, March 7, 10:30–12:00, Room M » Spine
RTF Highlighted Lectures K.M. Friedrich; Vienna/AT
» Gastrointestinal
Moderators: M. Basta-Nikolic; Novi Sad/RS W. Schima; Vienna/AT
C.A. Minoiu; Bucharest/RO
» Genitourinary
» Ischemic cardiomyopathy - coronary arteries and M. Toepker; Vienna/AT
myocardium: two sides of the same coin? [A-542]
R. Marano; Rome/IT
» MRI appearances of incidental focal liver lesions:
role of hepatocyte-specific contrast agents
and DWI [A-543]
S. Gourtsoyianni; London/UK
» Radiology and sports injuries:
more than reading the image! [A-544]
M. Maas; Amsterdam/NL
(Member of ACES, Academic Center Evidence
= Interactive lecture with electronic voting/self assessment
Based Sportsmedicine)

www.myESR.org Final Programme | ECR 2015 109


ACTIVITIES 2015

Visiting Schools
Visiting Seminars
ESOR Courses for EDiR
Scholarship Programmes
Fellowship Programmes
Teach-the-Teachers Programme
Visiting Professorship Programme
Online Courses
Tutorials
myESR.org/esor

Education in partnership
3
E
European Diploma
Prep Sessions
The European Diploma Prep Sessions aim to prepare prospective candidates for
the European Diploma in Radiology (EDiR).
They are also suitable for residents who want an overview of the various topics
relevant to imaging and for those preparing for their national board examinations.
The content of the programme reflects Level I and Level II European Training
Curriculum (ETC) learning objectives across a two-year cycle. The sessions are held
in close cooperation with the European Board of Radiology (EBR).
Each of the six sessions is led by three lecturers and moderated by one chairman.

111
Scientific Programme

E3 – European Diploma Prep Sessions

Saturday, March 7, 08:30–10:00, Room N Saturday, March 7, 16:00–17:30, Room N


E³ 1323 Chest E³ 1623 Breast
» Chairman’s introduction [A-500] » Chairman’s introduction [A-630]
J. Vilar; Valencia/ES F. Pediconi; Rome/IT
A. Fundamentals of chest imaging [A-501] A. Fundamentals of mammography [A-631]
D. Tack; Baudour/BE S. Barter; Cambridge/UK
B. Inflammation and tumours of the lung [A-502] B. Breast cancer diagnosis and interventions [A-632]
H. Prosch; Vienna/AT M. Müller-Schimpfle; Frankfurt a. Main/DE
C. Mediastinum, pleura and chest wall [A-503] C. Advanced imaging of the female breast [A-633]
N. Howarth; Chêne-Bougeries/CH R.M. Mann; Nijmegen/NL

Saturday, March 7, 10:30–12:00, Room N Sunday, March 8, 10:30–12:00, Room N


E³ 1423 Gastrointestinal and E³ 1823 Neuro
abdominal
» Chairman’s introduction [A-733]
» Chairman’s introduction [A-545] B. Ertl-Wagner; Munich/DE
C. Stoupis; Männedorf/CH A. Congenital and white matter disorders
A. Hepatobiliary system [A-546] of the brain [A-734]
Y. Menu; Paris/FR A. Rossi; Genoa/IT
B. Pancreas and spleen [A-547] B. Neurovascular disorders and trauma
W. Schima; Vienna/AT of the brain [A-735]
C. Imaging of the gastrointestinal tract [A-548] M. Forsting; Essen/DE
R.G.H. Beets-Tan; Maastricht/NL C. Tumours of the brain and spine [A-736]
M.M. Thurnher; Vienna/AT

Saturday, March 7, 14:00–15:30, Room N


E³ 1523 Musculoskeletal Sunday, March 8, 14:00–15:30, Room N
E³ 1923 Principles of imaging and radiation
» Chairman’s introduction [A-576] protection
F.M.H.M. Vanhoenacker; Antwerp/BE
A. Traumatic disorders of the musculoskeletal » Chairman’s introduction [A-743]
system [A-577] P. Vock; Spiegel/CH
M. Maas; Amsterdam/NL A. Principles of computed tomography [A-744]
B. Bone tumours [A-578] W.A. Kalender; Erlangen/DE
S.L.J. James; Birmingham/UK B. Principles of magnetic resonance imaging [A-745]
C. Degenerative and inflammatory disorders of T. Metens; Brussels/BE
the musculoskeletal system [A-579] C. Radiation protection [A-746]
K.-G.A. Hermann; Berlin/DE M. Mahesh; Baltimore, MD/US
This session is part of the EuroSafe Imaging campaign.

112 ECR 2015 | Final Programme www.myESR.org


3
E
The Beauty of
Basic Knowledge
The Beauty of Basic Knowledge programmes focus on knowledge essential to the
daily practice of radiology. The format of these sessions reflects the tradition of
conventional teaching sessions, in which an experienced teacher shares his or her
insights into a topic of particular relevance with a group of attendees.
A Beauty of Basic Knowledge session typically consists of a 45-minute lecture held
by one speaker (plus 15 minutes for conclusions and discussion). The teaching
format is usually case based with some interaction with the attendees.
The content of the sessions is mostly tied to the Level I and Level II European
Training Curriculum (ETC) learning objectives. The Beauty of Basic Knowledge
sessions are suited to residents and board-certified radiologists who want to refresh
their knowledge in basic topics of imaging and image-guided therapy.

113
Scientific Programme

E³ – The Beauty of Basic Knowledge


Skeletal Radiology Breast Imaging
The programme will be concluded with a self-assessment test, The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’. published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level). through the work stations in the ECR Live & EPOS™ Lounge (1st level).
Moderator: V.N. Cassar-Pullicino; Oswestry/UK Moderator: J. Camps Herrero; Valencia/ES

Wednesday, March 4, 12:30–13:30, Room D1 Wednesday, March 4, 12:30–13:30, Room B


E³ 24A Plain radiographs: analysis and E³ 25A Breast ultrasound:
interpretation [A-068] a primer [A-067]
I.W. McCall; Devon/UK A. Tardivon; Paris/FR

Thursday, March 5, 12:30–13:30, Room D1 Thursday, March 5, 12:30–13:30, Room B


E³ 24B The concept of degeneration: E³ 25B Cracking the mystery of needles
the tendons [A-210] and gauges [A-209]
K. Bohndorf; Vienna/AT R.M. Pijnappel; Utrecht/NL

Friday, March 6, 12:30–13:30, Room D1 Friday, March 6, 12:30–13:30, Room B


E³ 24C Inflammatory/infectious E³ 25C Breast cancer staging:
disorders [A-395] why and how [A-394]
V.N. Cassar-Pullicino; Oswestry/UK K. Kinkel; Chêne-Bougeries/CH

Saturday, March 7, 12:30–13:30, Room D1 Saturday, March 7, 12:30–13:30, Room B


E³ 24D Tumoural and pseudotumoural E³ 25D Ductal carcinoma in situ (DCIS):
MSK lesions [A-558] small tumour but big
problem [A-557]
K. Verstraete; Ghent/BE
G. Forrai; Budapest/HU

Sunday, March 8, 12:30–13:30, Room D1


E³ 24E Metabolic, endocrine and Sunday, March 8, 12:30–13:30, Room B
marrow disease [A-742] E³ 25E High risk lesions:
solving the dilemma [A-741]
B. Vande Berg; Brussels/BE
A. Linda; Udine/IT

114 ECR 2015 | Final Programme www.myESR.org


3
E
ECR Academies
The ECR Academies consist of a series of four to six sessions relevant to a particular
area of radiology. This may be a classic organ-based field or a technically oriented
area of another field related to radiology, such as management. Each ECR Academy
spans several days, in which the different facets of the area in question are covered
by experts in the field. An ECR Academy is a coherent course in which the different
sessions complement one another in order to reflect the entirety of the field.
The ECR Academies are particularly suited to general radiologists or radiologists
with a subspecialisation.

115
Scientific Programme

E3 – ECR Academies
Hybrid Imaging (basic) Hybrid Imaging (advanced)
The programme will be concluded with a self-assessment test, The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’. published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level). through the work stations in the ECR Live & EPOS™ Lounge (1st level).

Wednesday, March 4, 16:00–17:30, Room K Friday, March 6, 16:00–17:30, Room K


E³ 418 Scanners and tracers E³ 1218 MR/PET - the future of hybrid
imaging?
Moderator: G. Antoch; Düsseldorf/DE
A. Hybrid imaging: what systems are available and Moderator: R.A. Coulden; Leicester/UK
how do they work [A-108] A. For which indications is MR/PET better
T. Beyer; Vienna/AT than PET/CT? [A-464]
B. Radionuclides for PET/CT and MR/PET [A-109] L. Umutlu; Essen/DE
M. Hacker; Vienna/AT B. MR/PET technology: state of the art [A-465]
C. Radiopharmaceuticals for SPECT/CT [A-110] R. Assante; Naples/IT
J.R. Ballinger; London/UK C. Diffusion weighted MRI vs PET in oncology [A-466]
F. Giesel; Heidelberg/DE

Thursday, March 5, 08:30–10:00, Room K


E³ 518 Imaging protocols for PET/CT Saturday, March 7, 08:30–10:00, Room K
and MR/PET E³ 1318 Advanced imaging with
tracers beyond FDG
Moderator: C. Pfannenberg; Tübingen/DE
A. Does it make sense to use CT-contrast agents Moderator: J. Votrubová; Prague/CZ
in PET/CT [A-178] A. Neuroendocrine tumours [A-529]
G. Antoch; Düsseldorf/DE S. Fanti; Bologna/IT
B. PET/CT imaging protocols [A-179] B. Prostate cancer [A-530]
A. Scarsbrook; Leeds/UK M.C. Roethke; Heidelberg/DE
C. MR/PET imaging protocols [A-180] C. Coronary atherosclerotic plaque [A-531]
O. Ratib; Geneva/CH M.R. Dweck; Edinburgh/UK

Thursday, March 5, 16:00–17:30, Room K Saturday, March 7, 14:00–15:30, Room K


E³ 818 Essentials of hybrid imaging E³ 1518 Advanced hybrid imaging
of brain
Moderator: R. McDermott; Dublin/IE
A. Normal variants and pitfalls [A-283] Moderator: G. Morana; Genoa/IT
G. Cook; London/UK A. Memory decline [A-610]
B. The SUV: when does its use make sense? [A-284] L. Nyberg; Umea/SE
P. Veit-Haibach; Zurich/CH B. Minimal cognitive impairment and dementia [A-611]
C. Indications for hybrid imaging in radiation J.O. Rinne; Turku/FI
therapy planning [A-285] C. Brain tumours [A-612]
D. Georg; Vienna/AT P. Bartenstein; Munich/DE

Friday, March 6, 08:30–10:00, Room K Saturday, March 7, 16:00–17:30, Room K


E³ 918 Indications for hybrid E³ 1618 Advanced hybrid imaging
imaging in ... in oncology
Moderator: T.H. Helbich; Vienna/AT Moderator: K. Åhlström Riklund; Umea/SE
A. Oncology [A-352] A. In female pelvis [A-666]
N. Schwenzer; Tübingen/DE P.R. Ros; Cleveland, OH/US
B. Neurology [A-353] B. In head neck cancer [A-667]
A. Buck; Zurich/CH M. Becker; Geneva/CH
C. Cardiology [A-354] C. In modern planning of radiation treatment [A-668]
S.G. Nekolla; Munich/DE U. Nestle; Freiburg/DE

116 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

E3 – ECR Academies
Image-Guided Interventions in Oncology
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).

Thursday, March 5, 08:30–10:00, Room N Friday, March 6, 08:30–10:00, Room N


E³ 519 Hepatic primary tumours: E³ 919 Colorectal liver metastases:
‘prime time’ for interventional the emerging role of interventional
radiologists? radiologists in oncology
» Chairman’s introduction [A-144] » Chairman’s introduction [A-318]
M. Bezzi; Rome/IT P.L. Pereira; Heilbronn/DE
A. Percutaneous techniques: the clinical value of A. Tumour ablation: when and how in a modern
minimally invasive options [A-145] oncological setting [A-319]
B. Gebauer; Berlin/DE V. Válek; Brno/CZ
B. Intra-arterial therapies 2.0: the embolising B. Intra-arterial drug delivery: the state of art [A-320]
techniques in the era of the micro-beads [A-146] M. Bezzi; Rome/IT
A. Denys; Lausanne/CH C. Intra-arterial radiation delivery - when and how:
C. Intra-arterial therapies 2.0: radioembolisation the clinical evidence [A-321]
as a common daily practice [A-147] T.K. Helmberger; Munich/DE
J.I. Bilbao; Pamplona/ES

Friday, March 6, 16:00–17:30, Room N


Thursday, March 5, 16:00–17:30, Room N E³ 1219 The cutting-edge technologies
E³ 819 Kidney, lung and bone: an update in image-guided tumour
on oncologic therapy therapy
» Chairman’s introduction [A-246] » Chairman’s introduction [A-433]
A.D. Kelekis; Athens/GR M. Krokidis; Cambridge/UK
A. Renal cell carcinoma: when and how can we A. HIFU: The ultrasound guidance [A-434]
an compete with surgeons [A-247] F. Orsi; Milan/IT
R.F. Grasso; Rome/IT B. HIFU: The magnetic resonance guidance [A-435]
B. Lung tumours: the clinical evidence for A. Napoli; Rome/IT
percutaneous techniques [A-248] C. Update on irreversible electroporation [A-436]
T. de Baère; Villejuif/FR A. Nilsson; Uppsala/SE
C. Image-guided therapies for bone tumours [A-249]
A. Gangi; Strasbourg/FR

www.myESR.org Final Programme | ECR 2015 117


Scientific Programme

E3 – ECR Academies
Diagnostic Urogenital Radiology
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).

Thursday, March 5, 08:30–10:00, Room MB 5 Thursday, March 5, 16:00–17:30, Room MB 5


E³ 520 Kidney E³ 820 Upper and lower
urinary tract
Moderator: C. Nicolau; Barcelona/ES
A. Differential diagnoses of cystic renal masses [A-194] Moderator: N. Grenier; Bordeaux/FR
M. Claudon; Vandoeuvre-les-Nancy/FR A. CTU and MRU of the upper urinary tract [A-300]
B. Differential diagnoses of solid renal masses [A-195] N.C. Cowan; Portsmouth/UK
S.H. Kim; Seoul/KR B. Imaging of kidney and ureter [A-301]
C. Acute and chronic renal infection [A-196] M.A. Cova; Trieste/IT
J. Lopes Dias; Lisbon/PT C. Imaging of bladder and urethra [A-302]
T. El-Diasty; Mansoura/EG

Thursday, March 5, 10:30–12:00, Room MB 5


E³ 620 Retroperitoneum and Friday, March 6, 08:30–10:00, Room MB 5
adrenals E³ 920 Gynaecology
Moderator: F.M. Danza; Rome/IT Moderator: T.M. Cunha; Lisbon/PT
A. Anatomy and imaging techniques of the A. MR imaging techniques and normal
retroperitoneum [A-205] anatomy of the female pelvis [A-369]
M.C. Roethke; Heidelberg/DE C.S. Balleyguier; Villejuif/FR
B. Differential diagnoses of retroperitoneal B. Staging of cervical cancer [A-370]
masses [A-206] R. Forstner; Salzburg/AT
M.-F. Bellin; Le Kremlin-Bicêtre/FR C. Differential diagnoses of adnexal masses [A-371]
C. Differential diagnoses of adrenal lesions [A-207] S. Swi; Leeds/UK
G. Heinz-Peer; St. Pölten/AT

Friday, March 6, 10:30–12:00, Room MB 5


Thursday, March 5, 14:00–15:30, Room MB 5 E³ 1020 Emergencies
E³ 720 Prostate
Moderator: R.H. Oyen; Leuven/BE
Moderator: J.J. Fütterer; Nijmegen/NL A. Male pelvis emergencies [A-390]
A. Ultrasound of the prostate [A-231] M. Bertolotto; Trieste/IT
J. Venancio; Lisbon/PT B. Gynaecological emergencies [A-391]
B. Multiparametric MRI of the prostate [A-232] R.A. Kubik-Huch; Baden/CH
G.M. Villeirs; Gent/BE C. Imaging of obstetric and puerperal
C. Staging of prostate cancer [A-233] emergencies [A-392]
A.R. Padhani; London/UK J. McHugo; Birmingham/UK

= Interactive session with electronic voting/self assessment

118 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

E3 – ECR Academies
Modern Imaging of the GI Tract
The programme will be concluded with a self-assessment test,
published in the new platform ‘ESR Education on demand’.
ECR delegates can access the platform and the self-assessment tests
through the work stations in the ECR Live & EPOS™ Lounge (1st level).

Friday, March 6, 16:00–17:30, Room C Saturday, March 7, 14:00–15:30, Room C


E³ 1222 Perianal fistula disease: E³ 1522 Rectal cancer
all you need to know
Moderator: L. Blomqvist; Stockholm/SE
Moderator: D. Weishaupt; Zurich/CH A. Imaging protocols [A-564]
A. Perianal anatomy and imaging techniques [A-421] S. Gourtsoyianni; London/UK
K. Horsthuis; Amsterdam/NL B. Challenges in staging, treatment decisions and
B. Perianal fistula disease: the basics [A-422] surgery for high rectal cancer [A-565]
S. Halligan; London/UK L. Curvo-Semedo; Coimbra/PT
C. Perianal fistula disease: advanced [A-423] C. Assessment aer neoadjuvant treatment [A-566]
F. Maccioni; Rome/IT R.G.H. Beets-Tan; Maastricht/NL
D. Interactive case discussion [A-424] D. Interactive case discussion [A-567]
D. Weishaupt; Zurich/CH L. Blomqvist; Stockholm/SE

Saturday, March 7, 08:30–10:00, Room C Saturday, March 7, 16:00–17:30, Room C


E³ 1322 Imaging the postoperative E³ 1622 Oesophageal and
patient gastric cancer
Moderator: A. Graser; Munich/DE Moderator: W. Schima; Vienna/AT
A. What the surgeon does: surgical procedures and A. Modern imaging: an update [A-619]
normal postoperative anatomy [A-489] A. Ba-Ssalamah; Vienna/AT
M.M. Maher; Cork/IE B. How to provide the perfect staging report [A-620]
B. Do I need to re-operate? Postoperative imaging R.M. Mendelson; Perth, WA/AU
and immediate complications [A-490] C. Assessment aer treatment [A-621]
D.J.M. Tolan; Leeds/UK A.M. Riddell; Sutton/UK
C. It still hurts: follow-up imaging and D. Interactive case discussion [A-622]
long-term complications [A-491] W. Schima; Vienna/AT
L. Curvo-Semedo; Coimbra/PT
D. Interactive case discussion [A-492]
A. Graser; Munich/DE Sunday, March 8, 08:30–10:00, Room C
E³ 1722 Gastrointestinal stromal
tumours (GIST)
Saturday, March 7, 10:30–12:00, Room A
E³ 1422 Inflammatory bowel Moderator: M. Zins; Paris/FR
disease A. Pathology and treatment options [A-675]
B. Seddon; London/UK
Moderator: S.A. Taylor; London/UK B. Disease staging and treatment planning [A-676]
A. Cross-sectional imaging protocols [A-532] C. Hoeffel; Reims/FR
M.A. Patak; Zurich/CH C. Treatment response assessment and
B. Small bowel disease [A-533] disease follow-up [A-677]
J. Stoker; Amsterdam/NL A. Graser; Munich/DE
C. Colitis [A-534] D. Interactive case discussion [A-678]
J. Rimola; Barcelona/ES M. Zins; Paris/FR
D. Interactive case discussion [A-535]
S.A. Taylor; London/UK

= Interactive session with electronic voting/self assessment

www.myESR.org Final Programme | ECR 2015 119


Scientific Programme

E3 – ECR Academies
Interactive Teaching Sessions

Wednesday, March 4, 08:30–10:00, Room A Thursday, March 5, 14:00–15:30, Room A


E³ 121 Changes of the gastrointestinal E³ 721 The treated spine and joints
tract aer treatment
A. Imaging of the postoperative spine [A-211]
A. Gastrointestinal tumours [A-001] P.N.M. Tyrrell; Oswestry/UK
M. Rengo; Latina/IT B. Imaging of joint replacement [A-212]
B. Non-tumoural intestinal diseases [A-002] M. Zanetti; Zurich/CH
J. Rimola; Barcelona/ES

Thursday, March 5, 16:00–17:30, Room A


Wednesday, March 4, 10:30–12:00, Room A E³ 821 Central nervous system changes
E³ 221 The treated breast: aer treatment:
what you need to know what you need to know
A. Imaging aer treatment of benign A. Drug-related conditions [A-234]
breast conditions [A-065] F. Barkhof; Amsterdam/NL
J. Camps Herrero; Valencia/ES B. Imaging of treated brain tumours [A-235]
B. Imaging aer treatment of breast cancer [A-066] J. Alvarez-Linera; Madrid/ES
M.H. Fuchsjäger; Graz/AT

Friday, March 6, 08:30–10:00, Room A


Thursday, March 5, 08:30–10:00, Room A E³ 921 Thoracic changes aer
E³ 521 What to look for aer treatment treatment
of lung cancer
A. Drug-related conditions [A-303]
A. Imaging of surgically treated lung cancer [A-128] T. Franquet; Barcelona/ES
C.P. Heussel; Heidelberg/DE B. Device-related conditions [A-304]
B. Imaging of non-surgical treatment G.R. Ferretti; Grenoble/FR
of lung cancer [A-129]
B. Ghaye; Brussels/BE
Friday, March 6, 10:30–12:00, Room A
E³ 1021 Head and neck cancer aer
Thursday, March 5, 10:30–12:00, Room A treatment:
E³ 621 The treated liver what you need to know
A. Imaging of liver transplantation [A-197] A. Imaging aer surgical treatment [A-372]
J.B. Karani; London/UK M. Lell; Erlangen/DE
B. Imaging of treated liver tumours [A-198] B. Imaging aer radiotherapy/chemotherapy [A-373]
I. Bargellini; Pisa/IT T. Beale; London/UK

= Interactive session with electronic voting/self assessment

120 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

E3 – ECR Academies
Interactive Teaching Sessions

Friday, March 6, 16:00–17:30, Room A Sunday, March 8, 08:30–10:00, Room A


E³ 1221 Unexpected findings E³ 1721 Cardiac CT: from stenosis
on brain MRI assessment to risk stratification
A. Large ventricles: normal or abnormal? [A-414]
S. Langner; Greifswald/DE A. CT for risk stratification [A-669]
B. Incidental lesions on a brain MRI [A-415] R. Marano; Rome/IT
E.T. Tali; Ankara/TR B. Cardiac CT in the emergency room [A-670]
G. Feuchtner; Innsbruck/AT

Saturday, March 7, 08:30–10:00, Room A


E³ 1321 Diagnostic evaluation Sunday, March 8, 10:30–12:00, Room A
of bone tumours E³ 1821 Evaluation of patients
with lung emphysema
A. Bone tumours: benign or malignant? [A-484]
H.-J. van der Woude; Amsterdam/NL A. Pretherapeutic evaluation of lung emphysema [A-725]
B. Pseudotumours: mimic bone tumours [A-485] M. Prokop; Nijmegen/NL
F.M.H.M. Vanhoenacker; Antwerp/BE B. Diagnostic work-up aer treatment
of lung emphysema [A-726]
N. Sverzellati; Parma/IT
Saturday, March 7, 14:00–15:30, Room A
E³ 1521 Skull base lesions
A. Imaging of the cavernous sinus and the
anterior skull base [A-559]
D. Farina; Brescia/IT
B. Imaging of the central skull base [A-560]
D.-A. Varoquaux; Marseille/FR

Saturday, March 7, 16:00–17:30, Room A


E³ 1621 Cardiac imaging
A. Patterns of delayed enhancement [A-613]
P. Hunold; Lübeck/DE
B. Cardiomyopathies: from diagnosis
to prognosis [A-614]
A. Jacquier; Marseille/FR

= Interactive session with electronic voting/self assessment

www.myESR.org Final Programme | ECR 2015 121


Star Alliance™ Conventions Plus
SAVE UP TO 20% ON TRAVEL WITH THE STAR ALLIANCE™ NETWORK

The Star Alliance member airlines are pleased to be appointed


as the Official Airline Network for European Congress of Radiology.
To obtain the Star Alliance Conventions Plus discounts please follow the below
steps to access the Conventions Plus online booking tool:

» Visit www.staralliance.com/conventionsplus/delegates
» Under ‘Delegates login’ enter conventions code OS18S15
» The online booking tool opens in a separate window

Registered participants travelling to the event qualify for a discount of up to 20%,


depending on fare and class of travel booked.

The participating airlines for this event are:


Adria Airways, Aegean Airlines, Air Canada, Air China, Air India, Air New Zealand, ANA, Asiana Airlines,
Austrian Airlines, Avianca, Brussels Airlines, Copa Airlines, Croatia Airlines, EgyptAir, Ethiopian Airlines,
EVA Airways, LOT Polish Airlines, Lufthansa, Scandinavian Airlines, Shenzhen Airlines,
Singapore Airlines, South African Airways, SWISS, TAP Portugal, THAI, Turkish Airlines, United.

Discounts are offered on most published business and economy class fares, excluding


website/internet fares, senior and youth fares, group fares and Star Alliance Round the World fares.

The following Star Alliance airlines are offering special discounts for travel to/from Japan:
Austrian Airlines, Air India, Turkish Airlines, Scandinavian Airlines.

To obtain these discounts for travel to/from Japan please contact


the respective Star Alliance member airlines’ booking office.

Contact details can be found on www.staralliance.com/conventionsplus/delegates/


under ‘Conventions Plus Booking Contacts’.

Please quote the following event code OS18S15 for ticket reservation.
3
E
ECR Master Classes
The ECR Master Classes focus on continuous professional development and lifelong
learning. The classes are designed for subspecialised radiologists seeking cutting-
edge information in their particular fields of interest. They are held by experts in the
field and reflect state-of-the-art knowledge, as well as emerging trends.
During the ECR, one ECR Master Class is offered for each subspecialty in radiology
(CIRSE [one on vascular and one on interventional radiology], ESCR, ESER, ESGAR,
ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI, ESUR, EUSOBI).

123
Scientific Programme

E3 – ECR Master Classes

Thursday, March 5, 16:00–17:30, Room D1 Friday, March 6, 08:30–10:00, Room MB 1


Chest Vascular
E³ 826 Lung cancer staging E³ 926c Uterine and prostate
embolisation
Moderator: E. Castañer; Sabadell/ES
A. Limitations and perspectives [A-273] Moderator: T. Sabharwal; London/UK
A.R. Larici; Rome/IT A. Symptomatic uterine fibroids [A-355]
B. CT phenotypes of adenocarcinoma [A-274] J.-P. Pelage; Caen/FR
M. Das; Maastricht/NL B. Benign hypertrophy of the prostate [A-356]
C. Functional imaging of lung cancer H. Rio Tinto; Lisbon/PT
heterogeneity [A-275] C. Post-partum haemorrhage (PPH) [A-357]
O.L. Sedlaczek; Heidelberg/DE T.J. Kroencke; Augsburg/DE

Friday, March 6, 08:30–10:00, Room MB 2 Friday, March 6, 16:00–17:30, Room G


Paediatric Genitourinary
E³ 926a Advances in paediatric E³ 1226a Urogenital radiology in 2015:
imaging beyond morphology?
Moderator: P. Tomà; Rome/IT Moderator: H.C. Thoeny; Berne/CH
A. The CNS [A-358] A. Where are we in measuring kidney function
J.F. Schneider; Basle/CH with imaging? [A-461]
B. The MSK - infectious inflammatory disorders [A-359] N. Grenier; Bordeaux/FR
M. Alison; Paris/FR B. The added value of DWI in gynaecological
C. The abdomen [A-360] malignancies: the ADC and beyond [A-462]
M. Raissaki; Iraklion/GR A.G. Rockall; London/UK
C. Will genomics change imaging?
Renal cancer as a case study [A-463]
Friday, March 6, 08:30–10:00, Room MB 3 P.L. Choyke; Bethesda, MD/US
Interventional Radiology
E³ 926b The leading role of interventional
radiology in a major trauma Friday, March 6, 16:00–17:30, Room MB 4
centre Emergency Radiology
E³ 1226b Acute postoperative
» Chairman’s introduction: logistics and imaging complications in the abdomen:
of trauma: what do we really need? [A-361] from diagnosis to therapy
A.-M. Belli; London/UK
A. Chest trauma [A-362] » Chairman’s introduction: the role of imaging in the
J. Lammer; Vienna/AT early detection of postsurgical complications [A-477]
B. Upper abdominal trauma [A-363] D.R. Kool; Nijmegen/NL
O.M. van Delden; Amsterdam/NL A. Gastrointestinal tract [A-478]
C. Pelvic trauma: not only arteries [A-364] M.A. Patak; Zurich/CH
R. Bale; Innsbruck/AT B. Liver and pancreas [A-479]
S. Wirth; Munich/DE
C. Genitourinary tract [A-480]
R.H. Oyen; Leuven/BE
» Panel discussion: Time is gold - where and
when can we go faster?

= Interactive session with electronic voting/self assessment

124 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

E3 – ECR Master Classes

Friday, March 6, 16:00–17:30, Room MB 2 Saturday, March 7, 14:00–15:30, Room B


Cardiac Abdominal and Gastrointestinal
E³ 1226c Cardiac MR imaging E³ 1526 Advances in liver imaging
Moderator: P. Croisille; Saint-Etienne/FR Moderator: F. Caseiro-Alves; Coimbra/PT
A. T1 and T2 mapping [A-470] A. Molecular imaging: where do we go? [A-561]
C. Lücke; Leipzig/DE F.M.A. Kiessling; Aachen/DE
B. Quantification of myocardial perfusion by MRI [A-471] B. Liver perfusion or diffusion? [A-562]
K. Kitagawa; Mie/JP M. Ronot; Clichy/FR
C. 4D MR perfusion imaging of the myocardium [A-472] C. MR/PET: blessing or curse? [A-563]
R. Manka; Zurich/CH P.R. Ros; Cleveland, OH/US

Friday, March 6, 16:00–17:30, Room MB 1 Saturday, March 7, 16:00–17:30, Room E1


Molecular Imaging Head and Neck
E³ 1226d Chemical exchange saturation E³ 1626a Cone-beam vs multi-detector CT
transfer (CEST): a new toy in head and neck imaging
for molecular imaging?
Moderator: A. Trojanowska; Lublin/PL
Moderator: O. Clément; Paris/FR A. Understanding image quality and radiation dose
A. Physical principle [A-467] in MDCT and CBCT [A-643]
M. Bock; Freiburg/DE M. Kachelrieß; Heidelberg/DE
B. Probes [A-468] B. My finest cone-beam CT cases [A-644]
S. Aime; Turin/IT J.W. Casselman; Bruges/BE
C. Clinical applications [A-469] C. What can be missed on cone-beam CT:
S. Walker-Samuel; London/UK pitfalls and challenges [A-645]
R. Maroldi; Brescia/IT
» Panel discussion: Cone-beam vs multi-detector CT:
Saturday, March 7, 08:30–10:00, Room F1 pros and cons [A-646]
Oncologic Imaging A. Trojanowska; Lublin/PL
E³ 1326 Imaging tumour phenotype:
the future is now
Saturday, March 7, 16:00–17:30, Room F2
Moderator: D. Regge; Turin/IT Breast
A. Radiogenomics for cancer: phenotypic and E³ 1626b Breast imaging: improving the
genomic heterogeneity [A-513] information to women
P.L. Choyke; Bethesda, MD/US
B. Imaging tumour heterogeneity and perfusion: » Chairman’s introduction [A-655]
predicting tumour behaviour [A-514] F. Sardanelli; San Donato Milanese/IT
V.J. Goh; London/UK A. Overdiagnosis in breast cancer screening [A-656]
C. Molecular imaging: visualising the characteristics N. Houssami; Sydney/AU
of cancer cells [A-515] B. Breast density, interval cancers, and
G. Cook; London/UK underdiagnosis [A-657]
R.M. Pijnappel; Utrecht/NL
C. Preoperative breast MRI [A-658]
K. Pinker-Domenig; Vienna/AT
» Panel discussion: How to deliver information to
women on difficult and complex issues?

= Interactive session with electronic voting/self assessment

www.myESR.org Final Programme | ECR 2015 125


Scientific Programme

E3 – ECR Master Classes

Saturday, March 7, 16:00–17:30, Room G


Neuro
E³ 1626c Epilepsy
Moderator: T. Stosic-Opincal; Belgrade/RS
A. How to image epilepsy in children and adults [A-663]
K. Koprivsek; Sremska Kamenica/RS
B. How to report MRI in patients with epilepsy [A-664]
D. Zlatareva; Sofia/BG
C. MRI, electroclinical and
neuropathological correlations [A-665]
N. Colombo; Milan/IT

Sunday, March 8, 08:30–10:00, Room E1


Musculoskeletal
E³ 1726 Osteomyelitis vs gout:
what are the pearls?
Moderator: L.M. Sconfienza; San Donato Milanese/IT
A. X-ray: classical patterns and
challenging features [A-695]
A. Cotten; Lille/FR
B. MRI features and their differential diagnosis [A-696]
S. J. Ostlere; Oxford/UK
C. Ultrasound and DECT features in gout [A-697]
A. Klauser; Innsbruck/AT

126 ECR 2015 | Final Programme www.myESR.org


Mini
Course
The Joint Course of the ESR and RSNA (Radiological Society of North America)
focuses on emergency radiology.
Places are allocated on a first-come, first-served basis.
Please note that you can only take part in electronic voting via your own device
(smartphone, tablet, laptop) by connecting to the WiFi network of the lecture
room you are in. Once connected, you will be automatically directed to the voting
website. No app required.

127
Scientific Programme

Mini Course
Joint Course of the ESR and RSNA (Radiological Society of North America):
Emergency Radiology
Thursday, March 5, 08:30–10:00, Room MB 4 Thursday, March 5, 14:00–15:30, Room MB 4
MC 528 Abdominal emergencies MC 728 CNS emergencies
Moderator: A. Palkó; Szeged/HU Moderator: A. Palkó; Szeged/HU
A. Abdominal injuries [A-191] A. CNS trauma and neurovascular injury [A-228]
A. Palkó; Szeged/HU H.A. Rowley; Madison, WI/US
B. The enemy within: non-traumatic abdominal B. CNS non-traumatic emergencies [A-229]
emergencies [A-192] M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US C. Interactive case discussion [A-230]
C. Interactive case discussion [A-193] H.A. Rowley; Madison, WI/US
A. Palkó; Szeged/HU M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US

Thursday, March 5, 16:00–17:30, Room MB 4


Thursday, March 5, 10:30–12:00, Room MB 4 MC 828 General principles: paediatric
MC 628 Chest emergencies and ENT emergencies
Moderator: A. Palkó; Szeged/HU Moderator: A. Palkó; Szeged/HU
A. Thoracic injuries [A-202] A. General principles [A-297]
M. Brink; Nijmegen/NL U. Linsenmaier; Munich/DE
B. Non-traumatic thoracic emergencies [A-203] B. Challenges of imaging paediatric abdominal
C.M. Schaefer-Prokop; Amersfoort/NL emergencies [A-298]
C. Interactive case discussion [A-204] C.J. Sivit; Cleveland, OH/US
M. Brink; Nijmegen/NL C. Imaging in ENT emergencies [A-299]
C.M. Schaefer-Prokop; Amersfoort/NL D. Nunez; New Haven, CT/US

= Interactive session with electronic voting/self assessment

128 ECR 2015 | Final Programme www.myESR.org


Pros & Cons
Session
The Pros & Cons Session will examine the controversial topic:
‘Breast cancer: to screen or not to screen?’ The session will be split into one
interactive and one non-interactive part.

Thursday, March 5, 16:00–17:30, Room C


PS 827 Breast cancer:
to screen or not to screen?
Coordinator: F. Sardanelli; San Donato Milanese/IT
Teaser: N. Houssami; Sydney/AU
A. Mammographic screening: pros [A-240]
A. Frigerio; Turin/IT
B. Mammographic screening: cons [A-241]
A.B. Miller; Toronto, ON/CA
» Questions and answers [A-242]
F. Sardanelli; San Donato Milanese/IT
N. Houssami; Sydney/AU

= Interactive session with electronic voting/self assessment

129
Multimedia
Classroom
Coordinators:
E. Neri; Pisa/IT
D. Regge; Turin/IT

Due to its remarkable success at ECR 2014, the Multimedia Classroom will take
place again at ECR 2015.
In this classroom, participants get a chance to solve cases on workstations
supplied by several different companies.
2D and 3D image review and processing at the workstation are essential steps
in the radiological workflow, which lead to the final diagnosis and report.
Every radiologists needs to be trained in these tasks.
Places are allocated on a first-come, first-served basis.

131
Scientific Programme

Multimedia Classroom

Thursday, March 5, 10:30–12:00, Room Q Friday, March 6, 14:00–15:30, Room Q


MM 6 Cardiac CT (1) MM 11 CT angiography (2)
Chairman: F. Cademartiri; Monastier di Treviso/IT Chairman: C. Catalano; Rome/IT
Speaker of the Case review: Speaker of the Case review:
G. Bastarrika; Pamplona/ES I. Carbone; Rome/IT
Tutors: Tutors:
K. Gruszczynska; Katowice/PL L. Saba; Cagliari/IT
C. Peebles; Southampton/UK G. Groezinger; Tubingen/DE
M. Rengo; Latina/IT M. Anzidei; Rome/IT
J. Habets; Utrecht/NL
D. Beitzke; Vienna/AT
Thursday, March 5, 14:00–15:30, Room Q
MM 7 CT angiography (1)
Friday, March 6, 16:00–17:30, Room Q
Chairman: C. Catalano; Rome/IT MM 12 Cardiac CT (2)
Speaker of the Case review:
Chairman: F. Cademartiri; Monastier di Treviso/IT
I. Carbone; Rome/IT
Speaker of the Case review:
Tutors:
G. Bastarrika; Pamplona/ES
L. Saba; Cagliari/IT
G. Groezinger; Tubingen/DE Tutors:
M. Anzidei; Rome/IT K. Gruszczynska; Katowice/PL
J. Habets; Utrecht/NL C. Peebles; Southampton/UK
D. Beitzke; Vienna/AT M. Rengo; Latina/IT

Thursday, March 5, 16:00–17:30, Room Q Saturday, March 7, 10:30-12:00, Room Q


MM 8 Oncologic imaging (1) MM 14 Oncologic imaging (2)
Chairman: V.J. Goh; London/UK Chairman: V.J. Goh; London/UK
Speaker of the Case review: Speaker of the Case review:
I. Bargellini; Pisa/IT I. Bargellini; Pisa/IT
Tutors: Tutors:
F. Nensa; Essen/DE F. Nensa; Essen/DE
M. Schammann; Heilbronn/DE M. Schammann; Heilbronn/DE
D. Prezzi; Brighton/UK D. Prezzi; Brighton/UK
F. Astegiano; Sommariva Perno/IT F. Astegiano; Sommariva Perno/IT
C.N. De Cecco; Rome/IT C.N. De Cecco; Rome/IT
E. Rachetta; Candiolo/IT E. Rachetta; Candiolo/IT

Friday, March 6, 10:30–12:00, Room Q Saturday, March 7, 14:00–15:30, Room Q


MM 10 MDCT in emergencies (1) MM 15 MDCT in emergencies (2)
Chairman: M. Scaglione; Castel Volturno/IT Chairman: M. Scaglione; Castel Volturno/IT
Speaker of the Case review: Speaker of the Case review:
U. Linsenmaier; Munich/DE U. Linsenmaier; Munich/DE
Tutors: Tutors:
G. Goh; Melbourne/AU G. Goh; Melbourne/AU
S. Vaidya; London/UK S. Vaidya; London/UK
V. Miele; Rome/IT V. Miele; Rome/IT

132 ECR 2015 | Final Programme www.myESR.org


Refresher Courses
Scientific Sessions
Refresher Courses, as the name suggests, aim to refresh knowledge, reviewing and
updating the more basic subjects for those who have not kept up to speed with
certain developments, or who just need a reminder – something of interest not
only to young radiologists but also experienced doctors.
The length of each course is 90 minutes (classic Refresher Course: three parts of
30 minutes each, including the introduction and time for discussion; integrated
Refresher Course: three parts of 23 minutes each, leaving enough time for the
introduction by the chairpersons and the panel discussion).
The course will be given by two or three lecturers and led by one or two moderator(s)
on a defined subject of clinical imaging, imaging technique, interventional radiology
and related subjects.

Accepted papers for oral presentation are presented in the Scientific Sessions.
Places are allocated on a first-come, first-served basis.
For the first time at ECR 2015, at the end of each Scientific Session, attendees will
be asked to vote, via smartphones or tablets, for their favourite paper. The presenter
of the most popular paper will be awarded a certificate by the session moderators.

133
Scientific Programme

Refresher Courses / Scientific Sessions


Abdominal and Gastrointestinal

Wednesday, March 4, 08:30–10:00, Room B Wednesday, March 4, 16:00–17:30, Room B


RC 101 Pitfalls in interpretation in pancreatic RC 401 Misses and difficulties
imaging in abdominal imaging
» Chairman’s introduction [A-003] » Chairman’s introduction [A-069]
R. Pozzi-Mucelli; Verona/IT J. Stoker; Amsterdam/NL
A. Pancreatic cancer or pancreatitis [A-004] A. Mesentery and peritoneum [A-070]
R. Manfredi; Verona/IT D. Akata; Ankara/TR
B. Cystic tumours vs pseudocysts [A-005] B. Occult GI bleeding [A-071]
M.A. Bali; Brussels/BE A. Filippone; Chieti/IT
C. Incidental findings [A-006] C. Bowel dilatation [A-072]
C. Stoupis; Männedorf/CH E. Danse; Brussels/BE
» Panel discussion: How do we manage difficult cases » Panel discussion: What have I learned from misses?
and incidental findings? Can improvements be made to reduce misses?

Wednesday, March 4, 10:30–12:00, Room B Thursday, March 5, 08:30–10:00, Room B


SS 201a Liver MRI RC 501 The many faces
[B-0001 – B-0011] of benign liver lesions
Moderators: S. Phoa; Amsterdam/NL Moderator: L. Grenacher; Heidelberg/DE
F. Regini; Florence/IT A. Vascular [A-130]
M. Karcaaltincaba; Ankara/TR
B. Cystic-Biliary [A-131]
Wednesday, March 4, 10:30–12:00, Room M G. Brancatelli; Palermo/IT
SS 201b Improving abdominopelvic imaging:
C. Hepatocellular [A-132]
technical aspects R.L. Baron; Chicago, IL/US
[B-0034 – B-0044]
Moderators: D.J. Breen; Southampton/UK Thursday, March 5, 10:30–12:00, Room B
R. Malago; Verona/IT SS 601a Focal liver lesions
[B-0423 – B-0432]
Wednesday, March 4, 14:00–15:30, Room B Moderators: M. Krokidis; Cambridge/UK
SS 301a Diffuse liver and pancreatic diseases B. Marincek; Cleveland, OH/US
[B-0217 – B-0227]
Moderators: M.A. Bali; Brussels/BE Thursday, March 5, 10:30–12:00, Room M
L. Cevasco; Genoa/IT SS 601b Inflammatory bowel disease
[K-08, B-0456 – B-0465]

Wednesday, March 4, 14:00–15:30, Room M Moderators: R. Del Vescovo; Rome/IT


C. Hohl; Siegen/DE
SS 301b Gastro-oesophageal and small
bowel imaging
[B-0250 – B-0260] Thursday, March 5, 14:00–15:30, Room B
SS 701a Liver steatosis and fibrosis
Moderators: D. Akata; Ankara/TR [K-15, B-0605 – B-0614]
S. Bickelhaupt; Heidelberg/DE
Moderators: K.J. Beiderwellen; Essen/DE
L. Martí-Bonmatí; Valencia/ES

Thursday, March 5, 14:00–15:30, Room MB 2


SS 701b Colonic imaging
[B-0735 – B-0745]
Moderators: P. Lefere; Roeselare/BE
T. Mang; Vienna/AT

134 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Abdominal and Gastrointestinal

Friday, March 6, 08:30–10:00, Room B Sunday, March 8, 08:30–10:00, Room B


RC 901 Technical advances in liver and RC 1701 Colorectal cancer liver metastases:
pancreatic imaging assessing tumour response
Moderator: C. Bartolozzi; Pisa/IT » Chairman’s introduction [A-671]
A. CEUS and elastography [A-305] C.D. Becker; Geneva/CH
G.H. Mostbeck; Vienna/AT A. Current treatment options [A-672]
B. MRI: diffusion, perfusion and elastography [A-306] T.K. Helmberger; Munich/DE
B.E. Van Beers; Clichy/FR B. Morphological biomarkers [A-673]
C. Liver-specific contrast agents [A-307] S. Skehan; Dublin/IE
B.J. Op de Beeck; Antwerp/BE C. Functional biomarkers [A-674]
D.-M. Koh; Sutton/UK
» Panel discussion:
Friday, March 6, 10:30–12:00, Room F2 The ’vanishing’ lesions: what should you do?
SS 1001 Rectal cancer and anorectal imaging
[K-19, B-0832 – B-0841]
Moderators: L. Curvo-Semedo; Coimbra/PT Sunday, March 8, 10:30–12:00, Room M
F. Maccioni; Rome/IT SS 1801 HCC diagnosis and treatment
[K-25, B-1046 – B-1055]
Moderators: C. Ayuso Colella; Barcelona/ES
Saturday, March 7, 08:30–10:00, Room B A. Furlan; Pittsburgh, PA/US
RC 1301 Pancreatic inflammation
Moderator: G. Morana; Treviso/IT
Sunday, March 8, 14:00–15:30, Room B
A. Acute pancreatitis [A-486]
M. Zins; Paris/FR
SS 1901a Pancreas: tumours, pancreatitis
[B-1164 – B-1174]
B. Chronic pancreatitis and IPMN [A-487]
C. Matos; Brussels/BE Moderators: V. Maniatis; Aabenraa/DK
C. Paraduodenal and autoimmune pancreatitis [A-488] P. Rodríguez; Madrid/ES
S.A. Jackson; Plymouth/UK

Sunday, March 8, 14:00–15:30, Room M


Saturday, March 7, 10:30–12:00, Room F2 SS 1901b Liver CT and ultrasound:
SS 1401 Abdominal and vascular imaging new techniques
[B-0972 – B-0981] [B-1196 – B-1206]

Moderators: M.M. Maher; Cork/IE Moderators: M. Laniado; Dresden/DE


M. Ronot; Clichy/FR V. Vandecaveye; Leuven/BE

Saturday, March 7, 16:00–17:30, Room B


RC 1601 From my workstation:
difficult cases on review
» Chairman’s introduction [A-615]
A. Maier; Vienna/AT
A. Pancreas [A-616]
C. Triantopoulou; Athens/GR
B. Small bowel [A-617]
E. Biscaldi; Genoa/IT
C. Rectum [A-618]
D.M. Lambregts; Maastricht/NL
» Panel discussion:
What can we learn from challenging cases?

www.myESR.org Final Programme | ECR 2015 135


Scientific Programme

Refresher Courses / Scientific Sessions


Breast

Wednesday, March 4, 08:30–10:00, Room F2 Wednesday, March 4, 16:00–17:30, Room F2


RC 102 Breast ultrasound 2015 RC 402 Radio-pathological correlation:
more important than
Moderator: K. Kinkel; Chêne-Bougeries/CH you thought
A. Evidence for screening in dense breasts [A-031]
V. Girardi; Brescia/IT » Chairman’s introduction [A-093]
B. Elastosonography: true advances or false F.J. Gilbert; Cambridge/UK
hope? [A-032] A. Pre-treatment planning [A-094]
C.S. Balleyguier; Villejuif/FR C.K. Kuhl; Aachen/DE
C. Nodal staging of breast cancer: still needed? [A-033] B. Intra-operative specimen evaluation [A-095]
S.C.E. Diepstraten; Utrecht/NL J. Camps Herrero; Valencia/ES
C. Radiologist meets pathologist [A-096]
B. Ingold-Heppner; Berlin/DE
Wednesday, March 4, 10:30–12:00, Room C
» Panel discussion: How to enhance the interaction
SS 202a Imaging for neoadjuvant between radiologists and pathologists?
chemotherapy
[B-0012 – B-0022]
Moderators: P. Martínez-Miravete; Zaragoza/ES Thursday, March 5, 10:30–12:00, Room C
F. Thibault; Paris/FR SS 602 Imaging techniques and interventions
[B-0434 – B-0444]
Moderators: F. Engelken; Berlin/DE
Wednesday, March 4, 10:30–12:00, Room D1
F. Pediconi; Rome/IT
SS 202b Axillary imaging and nodal staging
[B-0109 – B-0119]
Moderators: A. Athanasiou; Athens/GR Thursday, March 5, 14:00–15:30, Room C
M. Dietzel; Jena/DE SS 702 Breast: diffusion-weighted
MR imaging (DWI)
[B-0615 – B-0625]
Wednesday, March 4, 14:00–15:30, Room A
Moderators: G. Forrai; Budapest/HU
SS 302a Breast density and imaging C. Iacconi; Carrara/IT
biomarkers
[B-0206 – B-0216]
Moderators: L.A. Carbonaro; San Donato Milanese/IT Friday, March 6, 10:30–12:00, Room C
C. Colin; Lyon/FR SS 1002 Breast MRI indications and
MR-guided biopsy
[B-0757 – B-0767]
Wednesday, March 4, 14:00–15:30, Room C
Moderators: G. Esen; Istanbul/TR
SS 302b Risk imaging and stratification S. Schrading; Aachen/DE
[B-0228 – B-0238]
Moderators: E. Azavedo; Stockholm/SE
P.A.T. Baltzer; Vienna/AT

136 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Breast

Saturday, March 7, 08:30–10:00, Room F2 Sunday, March 8, 08:30–10:00, Room F2


RC 1302 Tailoring breast cancer screening RC 1702 Emerging breast imaging
to risk level technologies
Moderator: B. Brkljačić; Zagreb/HR Moderator: P. Skaane; Oslo/NO
A. Calculating, using and improving individual A. Digital breast tomosynthesis (DBT) [A-707]
risk estimates [A-516] D. Bernardi; Trento/IT
S.W. Duffy; London/UK B. Multiparametric high-field MRI and more [A-708]
B. Intermediate risk: the grey zone [A-517] T.H. Helbich; Vienna/AT
S.H. Heywang-Köbrunner; Munich/DE C. High-resolution radionuclide breast imaging
C. High risk: MRI alone? [A-518] (PEM and molecular imaging) [A-709]
F. Sardanelli; San Donato Milanese/IT M. Herranz; Santiago/ES

Saturday, March 7, 10:30–12:00, Room C Sunday, March 8, 10:30–12:00, Room C


SS 1402 Digital breast tomosynthesis: SS 1802 Population-based screening
the new mammography [K-24, B-1025 – B-1034]
[K-21, B-0918 – B-0927]
Moderators: E.J. Cornford; Nottingham/UK
Moderators: A.M.J. Bluekens; Breda/NL K. Pinker-Domenig; Vienna/AT
R. Schulz-Wendtland; Erlangen/DE

Sunday, March 8, 14:00–15:30, Room A


Saturday, March 7, 14:00–15:30, Room F2 SS 1902a Multiparametric MRI and PET
RC 1502 Update on BI-RADS [B-1153 – B-1162]
Moderator: L.J. Pina Insausti; Pamplona/ES Moderators: E.M. Fallenberg; Berlin/DE
A. Mammography [A-597] V. Girardi; Brescia/IT
U. Bick; Berlin/DE
B. Ultrasound [A-598]
A. Evans; Dundee/UK Sunday, March 8, 14:00–15:30, Room C
SS 1902b Preoperative imaging
C. MRI [A-599]
[B-1175 – B-1184]
P.A.T. Baltzer; Vienna/AT
Moderators: P. Panizza; Milan/IT
S. Perez Rodrigo; Madrid/ES

www.myESR.org Final Programme | ECR 2015 137


Scientific Programme

Refresher Courses / Scientific Sessions


Cardiac

Wednesday, March 4, 08:30–10:00, Room MB 2 Wednesday, March 4, 16:00–17:30, Room MB 2


RC 103 Hybrid cardiovascular imaging: RC 403 Quantification of myocardial
where should we go? perfusion: which test is the best
(PET, MRI, MDCT)?
Moderator: G. Feuchtner; Innsbruck/AT
A. PET/CT: present state and future prospects [A-051] Moderator: M. Williams; Edinburgh/UK
S.G. Nekolla; Munich/DE A. PET for evaluation of perfusion, absolute myocardial
B. SPECT/CT: is it just PET/CT’s little brother? [A-052] blood flow and coronary flow reserve [A-114]
M. Hacker; Vienna/AT S. Kajander; Turku/FI
C. MR/PET: do we really need it? [A-053] B. Stress perfusion CT imaging for the detection and
H.H. Quick; Essen/DE quantification of relevant coronary stenosis [A-115]
F. Bamberg; Munich/DE
C. Analysis of myocardial perfusion using MRI [A-116]
Wednesday, March 4, 10:30–12:00, Room N R. Manka; Zurich/CH
SS 203a Tissue characterisation
[B-0045 – B-0055]
Thursday, March 5, 08:30–10:00, Room MB 2
Moderators: N. Kawel-Böhm; Chur/CH RC 503 Imaging of cardiac valves:
B. Velthuis; Utrecht/NL new trends
Moderator: F. Pugliese; London/UK
Wednesday, March 4, 10:30–12:00, Room MB 3 A. Echocardiography remains
SS 203b Heart rate: the reference technique [A-184]
disorders and imaging issues T. Binder; Vienna/AT
[B-0173 – B-0183] B. MRI is the best comprehensive approach [A-185]
M. Francone; Rome/IT
Moderators: M. Grothoff; Leipzig/DE
R.J. Perea; Barcelona/ES C. Does CT have a role in diagnosing
valvular disease? [A-186]
G. Feuchtner; Innsbruck/AT
Wednesday, March 4, 14:00–15:30, Room N
SS 303a Coronary atherosclerosis
[K-05, B-0261 – B-0270] Thursday, March 5, 10:30–12:00, Room N
SS 603a Myocardial infarction and
Moderators: N.R. Mollet; Turnhout/BE coronary intervention
M. Urbanczyk-Zawadzka; Krakow/PL [K-09, B-0466 – B-0475]
Moderators: M. Francone; Rome/IT
Wednesday, March 4, 14:00–15:30, Room MB 3 M. Gutberlet; Leipzig/DE
SS 303b Cardiac function and flow
[B-0390 – B-0400]
Thursday, March 5, 10:30–12:00, Room MB 3
Moderators: P. Croisille; Saint-Etienne/FR SS 603b Valvular disease
P. Donato; Coimbra/PT [K-14, B-0595 – B-0604]
Moderators: G. Feuchtner; Innsbruck/AT
M. Gardarsdottir; Reykjavik/IS

Thursday, March 5, 14:00–15:30, Room MB 3


SS 703 Work-up of coronary artery disease
[B-0746 – B-0756]
Moderators: M. Das; Maastricht/NL
S. Mirsadraee; Edinburgh/UK

138 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Cardiac

Thursday, March 5, 16:00–17:30, Room MB 2 Sunday, March 8, 10:30–12:00, Studio 2015


RC 803 Imaging of heart failure SS 1803 Biomarkers in cardiac imaging
[B-1056 – B-1066]
» Chairman’s introduction [A-289]
M. Gutberlet; Leipzig/DE Moderators: A. Kallifatidis; Thessaloniki/GR
A. Current ESC and AHA guidelines: how to choose T. Leiner; Utrecht/NL
imaging techniques in heart failure patients? [A-290]
J.T. Ortiz-Pérez; Barcelona/ES
B. Differentiating the causes for heart failure:
is MRI the indisputable gold standard? [A-291]
T. Leiner; Utrecht/NL
C. SPECT as an alternative imaging technique [A-292]
F. Caobelli; Hannover/DE
» Panel discussion: What is the preferred
comprehensive imaging test in heart failure?

Friday, March 6, 10:30–12:00, Room N


SS 1003a Myocardial perfusion imaging
[B-0789 – B-0799]
Moderators: R.W. Bauer; Frankfurt/DE
G.I. Kirova-Nedialkova; Sofia/BG

Friday, March 6, 10:30–12:00, Room MB 3


SS 1003b Non-ischaemic myocardial disease
[B-0896 – B-0905]
Moderators: I. Carbone; Rome/IT
S.D. Rud; St. Petersburg/RU

www.myESR.org Final Programme | ECR 2015 139


Scientific Programme

Refresher Courses / Scientific Sessions


Chest

Wednesday, March 4, 08:30–10:00, Room D1 Thursday, March 5, 08:30–10:00, Room D1


RC 104 Pulmonary vasculitis and collagen RC 504 COPD, airways disease and
vascular diseases beyond
Moderator: A. Persson; Linköping/SE » Chairman’s introduction [A-168]
A. Pulmonary manifestations of collagen P.A. Grenier; Paris/FR
vascular diseases [A-034] A. COPD in HRCT: what should we report? [A-169]
S.R. Desai; London/UK N. Sverzellati; Parma/IT
B. Large-vessel vasculitis [A-035] B. Airways disease: the role of expiratory CT [A-170]
J. Vilar; Valencia/ES A. Devaraj; London/UK
C. HRCT patterns in pulmonary vasculitis [A-036] C. Is there a role for MRI? [A-171]
C.M. Schaefer-Prokop; Amersfoort/NL M.O. Wielpütz; Heidelberg/DE
D. Inflammation and remodelling [A-037] » Panel discussion: When should we do expiratory CT,
A.A. Bankier; Boston, MA/US and when should we consider doing an MRI?

Wednesday, March 4, 14:00–15:30, Room D1 Thursday, March 5, 10:30–12:00, Room D1


SS 304 Interventional procedures and SS 604 Pulmonary nodule
follow-up [K-12, B-0531 – B-0540]
[B-0326 – B-0336]
Moderators: C. Mueller-Mang; Vienna/AT
Moderators: I. Vollmer; Barcelona/ES M. Sánchez; Barcelona/ES
J.E. Wildberger; Maastricht/NL

Thursday, March 5, 14:00–15:30, Room D1


Wednesday, March 4, 16:00–17:30, Room D1 SS 704 Lung cancer: screening and staging
RC 404 HRCT - patterns in chest radiology: [K-16, B-0681 – B-0690]
back to basics and beyond
Moderators: F. Gleeson; Oxford/UK
» Chairman’s introduction [A-097] T. Henzler; Mannheim/DE
H. Prosch; Vienna/AT
A. Secondary pulmonary lobule anatomy:
essential to tackle with the nodular pattern [A-098] Friday, March 6, 10:30–12:00, Room D1
T. Frauenfelder; Zurich/CH SS 1004 Pulmonary hypertension and
B. Linear and reticular pattern [A-099] thromboembolic disease
F. Molinari; Lille/FR [B-0842 – B-0852]
C. GGO opacities and consolidation [A-100] Moderators: E.E.J.G. Coche; Brussels/BE
I.E. Tyurin; Moscow/RU B. Graca; Coimbra/PT
» Panel discussion: Is it always easy to detect
a pattern? Tips for success
Friday, March 6, 16:00–17:30, Room D1
RC 1204 Mediastinal disease
revisited
Moderator: J. Dinkel; Munich/DE
A. The crucial role of chest x-ray:
mediastinal lines and stripes [A-458]
J. Cáceres; Barcelona/ES
B. Mediastinal masses: role of CT [A-459]
V.E. Sinitsyn; Moscow/RU
C. A new look at the mediastinum:
role of MRI and PET/CT [A-460]
E.J.R. van Beek; Edinburgh/UK

140 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Chest

Saturday, March 7, 08:30–10:00, Room D1 Sunday, March 8, 10:30–12:00, Room D1


RC 1304 Occupational lung diseases: the SS 1804 Obstructive pulmonary diseases and
known and the less known reduced lung function
[B-1109 – B-1119]
Moderator: N. Karabulut; Denizli/TR
A. Silicosis and coal workers’ pneumoconiosis [A-519] Moderators: G.R. Ferretti; Grenoble/FR
K. Marten-Engelke; Göttingen/DE A.P. Parkar; Bergen/NO
B. Asbestos-related disease [A-520]
S.J. Copley; London/UK
Sunday, March 8, 14:00–15:30, Room D1
C. Uncommon occupational lung diseases [A-521]
L. Flors; Charlottesville, VA/US
SS 1904 Infection, transplantation and
quality issues
[B-1249 – B-1259]
Saturday, March 7, 10:30–12:00, Room D1 Moderators: C.J. Herold; Vienna/AT
SS 1404 CT dose reduction and MR N.J. Screaton; Cambridge/UK
indications
[B-0982 – B-0992]
Moderators: J. Broncano; Cordoba/ES
E.J. Stern; Seattle, WA/US

Saturday, March 7, 14:00–15:30, Room D1


RC 1504 Pulmonary arterial
hypertension
Moderator: R. Cesar; Golnik/SI
A. An overview of pulmonary artery
hypertension [A-600]
N.J. Screaton; Cambridge/UK
B. CT in pulmonary artery hypertension [A-601]
M.-P. Revel; Paris/FR
C. MRI in pulmonary artery hypertension [A-602]
J. Biederer; Groß-Gerau/DE

www.myESR.org Final Programme | ECR 2015 141


Scientific Programme

Refresher Courses / Scientific Sessions


Computer Applications

Wednesday, March 4, 08:30–10:00, Room N Friday, March 6, 16:00–17:30, Room MB 3


RC 105 Mobile IT in radiology RC 1205 Update on computer-aided
diagnosis (CAD)
» Chairman’s introduction [A-015]
E. Neri; Pisa/IT » Chairman’s introduction [A-473]
A. Tablet-computers: a technical overview [A-016] M. Langer; Freiburg/DE
J. Fernandez-Bayó; Sabadell/ES A. CT colonography and CAD [A-474]
B. Reading DICOM images on the tablet [A-017] S.A. Taylor; London/UK
O. Ratib; Geneva/CH B. CAD for lung nodules [A-475]
C. Mobile teleradiology: A.R. Larici; Rome/IT
radiological features of the tablet-computer [A-018] C. CAD for breast cancer detection [A-476]
E.R. Ranschaert; ‘s-Hertogenbosch/NL U. Bick; Berlin/DE
» Panel discussion: Confidence in the use of tablets » Panel discussion: Is CAD ready for prime time?
in our clinical practice

Sunday, March 8, 10:30–12:00, Room Z


Wednesday, March 4, 14:00–15:30, Room Z SS 1805 Data sharing and content-based
SS 305 Imaging biomarkers data retrieval
[B-0239 – B-0249] [B-1035 – B-1045]
Moderators: A. Alberich-Bayarri; Valencia/ES Moderators: P. Sögner; Feldkirch/AT
M. de Bruijne; Rotterdam/NL C.G. Trumm; Munich/DE

Thursday, March 5, 10:30–12:00, Room Z Sunday, March 8, 14:00–15:30, Room Z


SS 605 Dose tracking: assessment and SS 1905 Methods for image interpretation
reduction of artefacts and reporting
[B-0445 – B-0455] [K-28, B-1186 – B-1195]
Moderators: N. Kachenoura; Paris/FR Moderators: M. Fatehi; Tehran/IR
J.H. Thrall; Boston, MA/US W.J. Niessen; Rotterdam/NL

142 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Molecular Imaging

Wednesday, March 4, 08:30–10:00, Room MB 1 Saturday, March 7, 10:30–12:00, Room Z


RC 106 Functional and multimodality SS 1406 Experimental molecular imaging
neuroimaging and exploratory clinical studies
[B-0930 – B-0938]
Moderator: T.H. Helbich; Vienna/AT
A. MR/PET chances and challenges [A-048] Moderators: N. Lassau; Villejuif/FR
V. Schulz; Aachen/DE M. Wildgruber; Munich/DE
B. Advanced MR neuroimaging techniques [A-049]
M. Smits; Rotterdam/NL
C. Clinical applications of PET/CT in neurology [A-050]
A.H. Jacobs; Münster/DE

Wednesday, March 4, 10:30–12:00, Room Z


SS 206 Clinical molecular imaging
[B-0023 – B-0033]
Moderators: M. Eisenblätter; Münster/DE
F.A. Gallagher; Cambridge/UK

www.myESR.org Final Programme | ECR 2015 143


Scientific Programme

Refresher Courses / Scientific Sessions


Genitourinary

Wednesday, March 4, 08:30–10:00, Room G Thursday, March 5, 10:30–12:00, Room G


RC 107 Stone disease: SS 607a DWI in prostate cancer
new concepts [B-0552 – B-0562]

» Chairman’s introduction [A-041] Moderators: T. Durmus; Berlin/DE


A. Magnusson; Uppsala/SE G.M. Villeirs; Gent/BE
A. From the Stone Age to the New Age [A-042]
N.C. Cowan; Portsmouth/UK
Thursday, March 5, 10:30–12:00, Room MB 2
B. The contribution of imaging in planning urinary SS 607b Benign gynaecological pathology
stone therapy [A-043]
[B-0586 – B-0594]
U. Patel; London/UK
C. Urolithiasis: changing concepts in medical Moderators: J. Arnáiz; Doha/QA
and surgical approach [A-044] R.N. Lucas; Lisbon/PT
G. Kramer; Vienna/AT
» Panel discussion: How do density and/or volume of
the stone in failure dictate how to efficiently treat Thursday, March 5, 14:00–15:30, Room G
stone disease? SS 707 New frontiers and contrast agents
in GU imaging
[B-0702 – B-0712]
Wednesday, March 4, 10:30–12:00, Room G
SS 207 Gynaecological malignancies Moderators: S.M. Dudea; Cluj-Napoca/RO
[K-03, B-0131 – B-0140] M.R. Onur; Elazig/TR

Moderators: M. Horta; Lisbon/PT


K. Kinkel; Chêne-Bougeries/CH Thursday, March 5, 16:00–17:30, Room G
RC 807 Lessons I learned from mistakes in
kidney and adrenal imaging
Wednesday, March 4, 14:00–15:30, Room G
SS 307 Prostate MR imaging » Chairman’s introduction [A-279]
[K-06, B-0348 – B-0357] G. Heinz-Peer; St. Pölten/AT
A. Renal cancer [A-280]
Moderators: D. Junker; Innsbruck/AT T. Bäuerle; Erlangen/DE
J. Rørvik; Bergen/NO
B. PET/CT in nephrourology [A-281]
M. Notohamiprodjo; Tübingen/DE
Wednesday, March 4, 16:00–17:30, Room G C. Ablation mistakes in tumour
RC 407 Prostate imaging: percutaneous RFA [A-282]
how I do it W.W. Mayo-Smith; Boston, MA/US
» Panel discussion: How to avoid mistakes
» Chairman’s introduction [A-104] using imaging modalities in other kidney and
H.-P. Schlemmer; Heidelberg/DE adrenal diseases?
A. Detection and assessment of aggressiveness [A-105]
P. Puech; Lille/FR
B. Image-guided biopsy and staging [A-106]
F. Cornud; Paris/FR
C. Role of imaging in active surveillance
and detection of recurrence [A-107]
V. Logager; Copenhagen/DK
» Panel discussion: How can multiparametric MRI
be implemented as clinical standard across
multiple centres?

144 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Genitourinary

Saturday, March 7, 08:30–10:00, Room G Sunday, March 8, 10:30–12:00, Room G


RC 1307 Female pelvic imaging: SS 1807 GU special topics
how I do it [B-1131 – B-1141]
Moderator: K. Kinkel; Chêne-Bougeries/CH Moderators: A. Tsili; Ioannina/GR
A. Imaging female congenital anomalies [A-526] A. Wibmer; Vienna/AT
I. Thomassin-Naggara; Paris/FR
B. PET-CT in the female pelvis: how I do it [A-527]
A.G. Rockall; London/UK Sunday, March 8, 14:00–15:30, Room G
SS 1907 Urinary stones, ureters and
C. How to image cystic tumours of the ovary [A-528]
R. Forstner; Salzburg/AT
bladder pathology
[B-1270 – B-1280]
Moderators: M. Bertolotto; Trieste/IT
Saturday, March 7, 10:30–12:00, Room G L. Ponhold; St. Pölten/AT
SS 1407 Adrenal and kidney imaging
[B-1003 – B-1013]
Moderators: C.D. Alt; Hamburg/DE
O. Nikolic; Novi Sad/RS

www.myESR.org Final Programme | ECR 2015 145


Scientific Programme

Refresher Courses / Scientific Sessions


Head and Neck

Wednesday, March 4, 08:30–10:00, Room D2 Thursday, March 5, 08:30–10:00, Room D2


RC 108 Head and neck emergency: RC 508 Pitfalls in interpretation of head
for the general radiologist or and neck disease
the patient?
Moderator: M.M. Lemmerling; Ghent/BE
Moderator: M. Díez Blanco; Santander/ES A. Anatomical variants without
A. Findings that can’t wait for follow-up [A-038] clinical consequence [A-172]
M.G. Mack; Munich/DE F.A. Pameijer; Utrecht/NL
B. Imaging infection: when, how and why? [A-039] B. Anatomical variants posing surgical risks [A-173]
M. Becker; Geneva/CH T. Beale; London/UK
C. Where medical history and previous images C. Distinct head and neck disease or
help to rule out tumour [A-040] systemic disease? [A-174]
D. Farina; Brescia/IT B.F. Schuknecht; Zurich/CH

Wednesday, March 4, 10:30–12:00, Room MB 1 Thursday, March 5, 10:30–12:00, Room MB 1


SS 208 Advanced imaging in salivary SS 608 Oncologic imaging: CT, MRI and PET
glands and lymph nodes, [K-13, B-0574 – B-0583]
including elastography
Moderators: S. Bisdas; Tübingen/DE
[B-0152 – B-0162]
C. Czerny; Vienna/AT
Moderators: S.J. Golding; Oxford/UK
L. Grzycka-Kowalczyk; Lublin/PL
Thursday, March 5, 14:00–15:30, Room MB 1
SS 708 CT including cone beam CT:
Wednesday, March 4, 14:00–15:30, Room MB 1 image quality, dosimetry and
SS 308 Temporal bone and clinical applications
temporomandibular joint imaging [B-0724 – B-0734]
and new MRI techniques
Moderators: B. Gómez-Ansón; Barcelona/ES
[B-0368 – B-0378]
D.-A. Varoquaux; Marseille/FR
Moderators: J. Frühwald-Pallamar; Vienna/AT
S. Petrovic; Nis/RS
Thursday, March 5, 16:00–17:30, Room D2
RC 808 Head and neck imaging: don‘t sell
Wednesday, March 4, 16:00–17:30, Room D2 your ultrasound yet!
RC 408 The orbit: you can‘t see
Moderator: S.S. Özbek; Izmir/TR
what you haven‘t learnt
A. Salivary gland imaging with ultrasound [A-276]
Moderator: Ü.Y. Ayaz; Mersin/TR N. Gritzmann; Vienna/AT
A. Anatomy and commonly encountered B. Masses of the so parts of the neck [A-277]
postoperative findings [A-101] S. Robinson; Vienna/AT
N. Hosten; Greifswald/DE C. Lymph nodes: differential diagnosis and
B. Congenital and inflammatory disease [A-102] fine-needle aspiration [A-278]
T.A. Ferreira; Leiden/NL R. Maroldi; Brescia/IT
C. Benign and malignant neoplastic tumours [A-103]
W. Müller-Forell; Mainz/DE
Friday, March 6, 10:30–12:00, Room MB 1
SS 1008 Thyroid and parathyroid imaging
[B-0874 – B-0884]
Moderators: A. Levai; Budapest/HU
J. Olliff; Birmingham/UK

146 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Interventional Radiology

Wednesday, March 4, 08:30–10:00, Room MB 3 Thursday, March 5, 08:30–10:00, Room MB 3


RC 109 Image fusion for image-guided RC 509 Percutaneous treatment of chronic
interventions back pain and sciatica
» Chairman’s introduction [A-054] » Chairman’s introduction [A-187]
V. Bérczi; Budapest/HU A. Gangi; Strasbourg/FR
A. Cone-beam CT in vascular and non-vascular A. Sacroiliac joint syndrome [A-188]
interventional procedures [A-055] D.J. Wilson; Oxford/UK
T.F. Jakobs; Munich/DE B. Facet joint syndrome [A-189]
B. US image fusion [A-056] A.D. Kelekis; Athens/GR
C. Ewertsen; Copenhagen/DK C. Intervertebral disc syndrome [A-190]
C. How can we improve targeting in image-guided D. Filippiadis; Athens/GR
interventions: stereotaxis, robotics and » Panel discussion: How can imaging methods identify
advanced techniques [A-057] candidates for percutaneous therapy or surgery?
R. Bale; Innsbruck/AT
» Panel discussion: Practical and economic issues in
using high-end guidance for interventional radiology Thursday, March 5, 10:30–12:00, Room D2
SS 609 Neuro interventions
[B-0541 – B-0550]
Wednesday, March 4, 10:30–12:00, Room D2
SS 209 Peripheral arterial and Moderators: N. Amoretti; Nice/FR
venous interventions A. Ringelstein; Essen/DE
[B-0120 – B-0130]
Moderators: E. Dósa; Budapest/HU Thursday, March 5, 14:00–15:30, Room D2
K. Schürmann; Dortmund/DE SS 709a TIPS and portal vein intervention
[B-0691 – B-0701]

Wednesday, March 4, 14:00–15:30, Room D2 Moderators: A. Krajina; Hradec Králové/CZ


SS 309 Musculoskeletal interventions A. Massmann; Homburg/DE
[B-0337 – B-0347]
Moderators: J.L. del Cura Rodriguez; Bilbao/ES Thursday, March 5, 14:00–15:30, Room K
T. Lehnert; Frankfurt a. Main/DE SS 709b Biopsy techniques and
solid tumour ablation
[B-0713 – B-0723]
Wednesday, March 4, 16:00–17:30, Room MB 3
RC 409 Basic principles of percutaneous Moderators: O. Akhan; Ankara/TR
tumour ablation M. Reiter; Vienna/AT

» Chairman’s introduction [A-117]


T. de Baère; Villejuif/FR
A. Thermal ablation with RF [A-118]
V. Válek; Brno/CZ
B. Microwave ablation: what is the difference? [A-119]
P.L. Pereira; Heilbronn/DE
C. Cryoablation: ice can be better than heat [A-120]
D.J. Breen; Southampton/UK
D. Irreversible electroporation: principles,
technique and clinical applications [A-121]
A. Nilsson; Uppsala/SE
» Panel discussion: Selection of ablation modalities:
operator’s preference or evidence-based?

www.myESR.org Final Programme | ECR 2015 147


Scientific Programme

Refresher Courses / Scientific Sessions


Interventional Radiology

Thursday, March 5, 16:00–17:30, Room MB 3 Sunday, March 8, 10:30–12:00, Room D2


RC 809 Current trends in transarterial SS 1809 GI and abdominal interventions
chemoembolisation (TACE) and [B-1120 – B-1130]
radioembolisation for HCC
Moderators: A.D. Karaosmanoglu; Ankara/TR
» Chairman’s introduction [A-293] A. Veltri; Turin/IT
T.K. Helmberger; Munich/DE
A. Imaging in therapy planning and follow-up [A-294]
Sunday, March 8, 14:00–15:30, Room D2
V. Vilgrain; Clichy/FR
SS 1909a Embolotherapy
B. TACE and TAE for HCC: new agents, new schedules, [K-31, B-1260 – B-1269]
new combinations [A-295]
R. Lencioni; Pisa/IT Moderators: A. Bharadwaz; Aarhus/DK
C. Radioembolisation: critical appraisal of techniques O. Pellerin; Paris/FR
and guidelines for treatment [A-296]
J.I. Bilbao; Pamplona/ES
» Panel discussion: The intermediate HCC patient: Sunday, March 8, 14:00–15:30, Room K
how can we stratify patients and allocate them SS 1909b Aortic interventions
to different therapies? [K-32, B-1281 – B-1290]
Moderators: M. Köcher; Olomouc/CZ
Friday, March 6, 10:30–12:00, Room D2 B. Peynircioglu; Ankara/TR
SS 1009 Percutaneous ablation
in liver tumours
[K-20, B-0853 – B-0862]
Moderators: T. Denecke; Berlin/DE
F. Orsi; Milan/IT

Saturday, March 7, 10:30–12:00, Room D2


SS 1409 Radioembolisation and
chemoembolisation in liver tumours
[K-23, B-0993 – B-1001]
Moderators: R.F. Dondelinger; Liège/BE
T.A. Heusner; Hamm/DE

148 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Musculoskeletal

Wednesday, March 4, 10:30–12:00, Room E1 Thursday, March 5, 10:30–12:00, Room E1


SS 210 Intervention SS 610a Shoulder, brachial plexus
[B-0066 – B-0076] [B-0487 – B-0499]
Moderators: I. Iacucci; Rome/IT Moderators: K.-F. Kreitner; Mainz/DE
E. Llopis; Valencia/ES D. Maric; Banja Luka/BA

Wednesday, March 4, 14:00–15:30, Room E1 Thursday, March 5, 10:30–12:00, Room K


SS 310 Fractures, spinal injuries and spine SS 610b Lower extremity (1)
[B-0282 – B-0292] [B-0563 – B-0573]
Moderators: M. Muto; Naples/IT Moderators: K. Kapuscinska; Krakow/PL
G. Scheurecker; Linz/AT M. Tzalonikou; Athens/GR

Wednesday, March 4, 16:00–17:30, Room E1 Thursday, March 5, 14:00–15:30, Room E1


RC 410 Trauma to the paediatric SS 710 Lower extremity (2)
skeleton [B-0637 – B-0647]
Moderator: K. Rosendahl; Bergen/NO Moderators: A.M. Ierardi; Varese/IT
A. Pelvis/hips [A-085] M. Reijnierse; Leiden/NL
N. Boutry; Lille/FR
B. Elbow [A-086]
K.J. Johnson; Birmingham/UK Thursday, March 5, 16:00–17:30, Room E1
RC 810 The ankle and foot
C. Spine [A-087]
L.B.O. Jans; Ghent/BE Moderator: J.L. Bloem; Leiden/NL
A. Ankle sprain: patterns of injury [A-256]
J.L.M.A. Gielen; Antwerp/BE
B. Inflammatory disorders [A-257]
R. Lalam; Oswestry/UK
C. Tumours and tumour-like lesions [A-258]
I.-M. Noebauer-Huhmann; Vienna/AT

www.myESR.org Final Programme | ECR 2015 149


Scientific Programme

Refresher Courses / Scientific Sessions


Musculoskeletal

Friday, March 6, 10:30–12:00, Room E1 Saturday, March 7, 08:30–10:00, Room E1


SS 1010a Tumours, systemic diseases RC 1310 How I do it and report
and muscles
[B-0800 – B-0810] Moderator: K. Wörtler; Munich/DE
A. MRI of the hip [A-507]
Moderators: M.C. De Jonge; Amsterdam/NL J. Teh; Oxford/UK
A. Yakimov; Moscow/RU B. MRI of the spine and sacroiliac joints [A-508]
C. Schueller-Weidekamm; Vienna/AT
C. MRI of the hand [A-509]
Friday, March 6, 10:30–12:00, Room MB 4
M. Shahabpour; Brussels/BE
SS 1010b Hand, upper extremity
[B-0907 – B-0917]
Moderators: I. Beggs; Edinburgh/UK Saturday, March 7, 10:30–12:00, Room E1
E.E. Drakonaki; Iraklion/GR SS 1410 Spine
[K-22, B-0939 – B-0948]
Moderators: M.A. Cova; Trieste/AT
Friday, March 6, 16:00–17:30, Room E1
C. Giraudo; Vienna/AT
RC 1210 Sports injuries to the knee:
improving my report
Moderator: P. Robinson; Leeds/UK Saturday, March 7, 14:00–15:30, Room E1
A. Reporting meniscal tears: pitfalls and
RC 1510 The hand and wrist
how I avoid them [A-440] Moderator: A. Plagou; Athens/GR
G. Andreisek; Zurich/CH
A. Patterns of injury [A-586]
B. The collateral ligaments and posterolateral corner: A. Navas Canete; Leiden/NL
what are they, why do they matter and how do I
B. Inflammatory disorders [A-587]
assess them? [A-441]
H. Guerini; Paris/FR
V. Vasilevska Nikodinovska; Skopje/MK
C. Tumours and tumour-like lesions [A-588]
C. The patellofemoral joint and osteochondral injuries:
E. Llopis; Valencia/ES
how do I assess and what do I report? [A-442]
C. Schaeffeler; Chur/CH
Sunday, March 8, 10:30–12:00, Room E1
SS 1810 Arthritis
[K-26, B-1067 – B-1076]
Moderators: A. Cotten; Lille/FR
S. Weckbach; Heidelberg/DE

Sunday, March 8, 14:00–15:30, Room E1


SS 1910 Knee
[K-29, B-1207 – B-1216]
Moderators: L. Cerezal; Santander/ES
L.M. Sconfienza; San Donato Milanese/IT

150 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Neuro

Wednesday, March 4, 08:30–10:00, Room K Wednesday, March 4, 16:00–17:30, Room N


RC 111 The paediatric brain and spine: RC 411 Imaging findings in treated
not only tumours brain tumours
Moderator: T.A.G.M. Huisman; Baltimore, MD/US Moderator: B.F. Schuknecht; Zurich/CH
A. Congenital abnormalities of the brain [A-045] A. How to perform imaging in the postoperative patient:
B. Ertl-Wagner; Munich/DE imaging protocols, normal and abnormal
B. Paediatric brain neuro emergencies [A-046] findings aer surgery [A-082]
M.I. Argyropoulou; Ioannina/GR M.A. Lucic; Sremska Kamenica/RS
C. The paediatric spine: tips and tricks [A-047] B. Understanding radiation- and chemotherapy-induced
A. Rossi; Genoa/IT changes aer treatment of brain tumours [A-083]
Y. Özsunar; Aydin/TR
C. Treated brain tumours:
Wednesday, March 4, 10:30–12:00, Room E2 progression or pseudoprogression? [A-084]
SS 211a Inflammatory and P.C. Maly Sundgren; Lund/SE
degenerative disorders
[K-02, B-0077 – B-0086]
Thursday, March 5, 08:30–10:00, Room G
Moderators: A. Bozzao; Rome/IT RC 511 Cerebrovascular disease
N. Guberina; Essen/DE
Moderator: M.P. Wattjes; Amsterdam/NL
A. Vascular distribution territories:
Wednesday, March 4, 10:30–12:00, Room MB 5 arterial and venous [A-175]
SS 211b Vascular disorders, diagnosis A. Dörfler; Erlangen/DE
and treatment B. Detecting microhaemorrhages:
[B-0195 – B-0205] why are they important? What are they?
Should we use GRE T2* or SWI or both? [A-176]
Moderators: K.D. Kurz; Stavanger/NO H.R. Jäger; London/UK
Z. Merhemic; Sarajevo/BA
C. Cerebral perfusion studies in cerebrovascular disease:
techniques, indications and applications [A-177]
P.M. Parizel; Antwerp/BE
Wednesday, March 4, 14:00–15:30, Room E2
SS 311a Brain trauma, degenerative
and spine diseases Thursday, March 5, 10:30–12:00, Room E2
[B-0293 – B-0303] SS 611 Brain tumour (1)
Moderators: P. Barsi; Budapest/HU [K-10, B-0500 – B-0509]
J. Hodel; Lille/FR Moderators: N. Bargalló; Barcelona/ES
Y. Özsunar; Aydin/TR
Wednesday, March 4, 14:00–15:30, Room MB 5
SS 311b Hypertension and stenosis Thursday, March 5, 14:00–15:30, Room E2
[B-0412 – B-0422] SS 711 Brain tumour (2)
Moderators: D. Gürbüz; Istanbul/TR [B-0648 – B-0658]
T.A. Yousry; London/UK Moderators: J.S. Bauer; Munich/DE
P. Due-Tonnessen; Oslo/NO

www.myESR.org Final Programme | ECR 2015 151


Scientific Programme

Refresher Courses / Scientific Sessions


Neuro

Friday, March 6, 10:30–12:00, Room E2 Sunday, March 8, 08:30–10:00, Room G


SS 1011 Ischaemic stroke (1) RC 1711 Screening for cerebral
[B-0811 – B-0821] aneurysms
Moderators: E. Avdagic; Sarajevo/BA Moderator: A. van der Lugt; Rotterdam/NL
A. Bonafe; Montpelier/FR A. Who are the patients that I should screen for
aneurysms? Why should I screen?
What are the medicolegal ramifications? [A-718]
Saturday, March 7, 08:30–10:00, Room E2 M. Muto; Naples/IT
RC 1311 Reporting spine imaging B. Which technique to use? CT angiography,
studies time-of-flight MR angiography, contrast-enhanced
MR angiography, catheter angiography [A-719]
Moderator: M.A. Papathanasiou; Athens/GR
M. Voormolen; Antwerp/BE
A. Disc nomenclature and treatment strategy [A-510]
C. The interventional neuroradiology perspective on
M. Gallucci; L’Aquila/IT
diagnosis, management and follow-up [A-720]
B. What to say and not to say in your report [A-511] L. Pierot; Reims/FR
M.M. Thurnher; Vienna/AT
C. Introduction to structured reporting
in the spine [A-512] Sunday, March 8, 10:30–12:00, Room E2
J. Van Goethem; Antwerp/BE SS 1811 Brain epilepsy and inflammation
[B-1077 – B-1087]

Saturday, March 7, 10:30–12:00, Room E2 Moderators: T. Kau; Klagenfurt/AT


SS 1411 Ischaemic stroke (2) M. Mantatzis; Alexandroupolis/GR
[B-0950 – B-0959]
Moderators: A. Biondi; Besançon/FR Sunday, March 8, 14:00–15:30, Room E2
W. Van Hecke; Antwerp/BE SS 1911 Advanced imaging
[B-1218 – B-1227]

Saturday, March 7, 14:00–15:30, Room G Moderators: M.T. Fernández Taranilla; Toledo/ES


RC 1511 White spots in the brain L. Pierot; Reims/FR

Moderator: E.T. Tali; Ankara/TR


A. White spots and blots in the brain:
what are they? [A-607]
T.A. Yousry; London/UK
B. How can I improve my reporting
of T2-hyperintense lesions? [A-608]
A. Rovira-Cañellas; Barcelona/ES
C. Is there a need for quantitative reporting
of white matter lesions? [A-609]
F. Barkhof; Amsterdam/NL

152 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Paediatric

Wednesday, March 4, 08:30–10:00, Room MB 5 Friday, March 6, 10:30-12:00, Room MB 2


RC 112 Autoimmune disorders SS 1012 Abdominal imaging
in children [B-0885 – B-0895]
Moderator: V. Donoghue; Dublin/IE Moderators: M. Haliloglu; Ankara/TR
A. The joints in juvenile idiopathic arthritis [A-062] A.S. Littooij; Leiden/NL
L.-S. Ording Müller; Oslo/NO
B. The digestive tract [A-063]
E. Alexopoulou; Athens/GR Friday, March 6, 16:00–17:30, Room MB 5
RC 1212 Hepatobiliary imaging
C. Multiple sclerosis in children [A-064]
C. Adamsbaum; Le Kremlin Bicêtre/FR
in children
Moderator: D. Akinci; Ankara/TR
A. Imaging of liver masses [A-481]
Wednesday, March 4, 10:30-12:00, Room MB 2 D. Roebuck; London/UK
SS 212 Chest imaging and dosimetry
B. Imaging of biliary disorders [A-482]
[K-04, B-0163 – B-0172]
S.G.F. Robben; Maastricht/NL
Moderators: L.-S. Ording Müller; Oslo/NO C. Intervention in the hepatobiliary system [A-483]
C. Owens; London/UK S. Franchi-Abella; Le Kremlin-Bicêtre/FR

Wednesday, March 4, 14:00-15:30, Room MB 2 Saturday, March 7, 14:00–15:30, Room M


SS 312 Bone and so tissue imaging RC 1512 Key issues in paediatric
[B-0379 – B-0389] imaging
Moderators: O.J. Arthurs; London/UK » Chairman’s introduction [A-572]
A. Kanavaki; Athens/GR R.A.J. Nievelstein; Utrecht/NL
A. Communicating effectively with parents
and carers [A-573]
Wednesday, March 4, 16:00–17:30, Room MB 5 J. McNulty; Dublin/IE
RC 412 Imaging of foetus
B. Paediatric imaging: when less is more [A-574]
and infant J. Portelli; Msida/MT
Moderator: D. Prayer; Vienna/AT C. The importance of clinically acceptable
A. Foetal neuro imaging [A-125] image quality [A-575]
A. Rossi; Genoa/IT E. Sorantin; Graz/AT
B. Foetal body imaging [A-126] » Panel discussion: What are the essentials in
M. Cassart; Brussels/BE education and training for paediatric imaging?
C. Foetal and neonatal urinary tract imaging [A-127]
C. Garel; Paris/FR
Sunday, March 8, 08:30–10:00, Room M
RC 1712 Imaging the head
Thursday, March 5, 10:30-12:00, Room F2 and skull base
SS 612 Foetal and paediatric neuroimaging Moderator: J.W. Casselman; Bruges/BE
[B-0520 – B-0530]
A. Faciocraniosynostoses revisited [A-685]
Moderators: I. Boric; Zabok/HR F. Di Rocco; Paris/FR
P.C. Maly Sundgren; Lund/SE B. All about the paediatric pituitary gland [A-686]
M.I. Argyropoulou; Ioannina/GR
C. Imaging of the orbit: the globe and
the lacrimal gland [A-687]
P.C. Maly Sundgren; Lund/SE

www.myESR.org Final Programme | ECR 2015 153


Scientific Programme

Refresher Courses / Scientific Sessions


Physics in Radiology

Wednesday, March 4, 08:30–10:00, Room M Friday, March 6, 16:00–17:30, Room M


RC 113 Cone-beam CT RC 1213 Good radiation and bad radiation?
How to assess and communicate
Moderator: J.N. Vassileva; Vienna/AT radiation risk to patients and
A. Fundamentals of cone-beam CT [A-012] referring physicians
J. Kuntz; Heidelberg/DE
B. Medical applications of cone-beam CT [A-013] Moderator: O. Ciraj-Bjelac; Belgrade/RS
M. Grass; Hamburg/DE A. Radiation risk: a patient’s perspective [A-429]
C. 3D dentomaxillofacial imaging [A-014] E. Briers; Hasselt/BE
H. Bosmans; Leuven/BE B. Radiation risks for patients and staff [A-430]
P. Gilligan; Dublin/IE
C. Risk in MRI [A-431]
Wednesday, March 4, 10:30–12:00, Room F2 R. Peeters; Leuven/BE
SS 213 Advances in CT imaging D. Communicating risks to patients and the public [A-432]
[B-0098 – B-0108] N. Leitgeb; Graz/AT
Moderators: J. Geleijns; Leiden/NL This session is part of the EuroSafe Imaging campaign.
A. Stratis; Leuven/BE
Saturday, March 7, 08:30–10:00, Room M
RC 1313 IT tools for dose tracking and
Wednesday, March 4, 14:00–15:30, Room F2 workflow optimisation
SS 313 Advances in MR technology
[B-0315 – B-0325] Moderator: A. Trianni; Udine/IT
A. Digital Imaging and Communication in Medicine
Moderators: E. Atalar; Ankara/TR (DICOM) and Integrating the Healthcare Enterprise
J. Theysohn; Essen/DE (IHE) standards [A-497]
D. Peck; Detroit, MI/US
B. Patient dose tracking: a must have? [A-498]
Thursday, March 5, 08:30–10:00, Room M D. Zamora; Seattle, WA/US
RC 513 Artefacts and pitfalls C. Optimising technique using patient dose
in tomography tracking soware - tips and tricks [A-499]
Moderator: J. Damilakis; Iraklion/GR D. Murphy; Dublin/IE
A. CT [A-141] Saturday, March 7, 16:00–17:30, Room M
M. Kachelrieß; Heidelberg/DE RC 1613 MR: artefacts and devices
B. PET/CT [A-142]
T. Beyer; Vienna/AT Moderator: D. Bor; Ankara/TR
C. MR/PET [A-143] A. Image artefacts in MRI and their mitigation [A-627]
H.H. Quick; Essen/DE D.J. Lurie; Aberdeen/UK
B. Imaging around metal implants:
artefact reduction in MRI [A-628]
Thursday, March 5, 14:00–15:30, Room F2 C. McGrath; Belfast/IE
SS 713 Innovations in CT technology C. Artefacts in perfusion and diffusion MRI [A-629]
[B-0670 – B-0680] I. Tsougos; Larissa/GR
Moderators: P.E. Colombo; Milan/IT
Sunday, March 8, 10:30–12:00, Room F2
I. Sechopoulos; Atlanta, GA/US
SS 1813 Novel digital imaging techniques
[B-1098 – B-1108]
Friday, March 6, 10:30–12:00, Room M Moderators: M. Brink; Nijmegen/NL
SS 1013 Optimisation of patient dose in CT N. Kalyvas; Athens/GR
[K-17, B-0779 – B-0788]
Sunday, March 8, 14:00–15:30, Room F2
Moderators: A. Del Guerra; Pisa/IT
A. Kowalik; Poznan/PL
SS 1913 Patient and staff dose studies
[K-30, B-1239 – B-1248]
Moderators: H. de las Heras Gala; Madrid/ES
G. Paulo; Coimbra/PT

154 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Radiographers

Wednesday, March 4, 10:30–12:00, Room K Saturday, March 7, 08:30–10:00, Room D2


SS 214 Musculoskeletal radiography RC 1314 Radiography and evidence-based
[B-0141 – B-0151] research: the way forward
Moderators: A.J. Grainger; Leeds/UK » Chairmen’s introduction [A-522]
V. Syrgiamiotis; Athens/GR I. Henderson; Aberdeen/UK
M.G.M. Hunink; Rotterdam/NL
A. The fundamentals of evidence-based research [A-523]
Wednesday, March 4, 14:00–15:30, Room K G. Paulo; Coimbra/PT
SS 314 Quality issues
B. Application of evidence-based research
[K-07, B-0358 – B-0367]
into practice [A-524]
Moderators: J. McNulty; Dublin/IE M. Gellert; Odense/DK
J. Wieczorek; Warsaw/PL C. Improvement of patient outcomes
by evidence-based research [A-525]
K.G. Vikestad; Oslo/NO
Friday, March 6, 08:30–10:00, Room D2 » Panel discussion: How to promote research as
RC 914 Enhancing patient safety culture a tool for professional development?
in radiology
» Chairmen’s introduction [A-344] Saturday, March 7, 10:30–12:00, Room K
P. Bezzina; Msida/MT SS 1414 Dose management
L. Donoso; Barcelona/ES in medical imaging
A. Patient safety culture: the importance [B-1014 – B-1024]
of EU clinical audit guidelines [A-345]
S. Mc Fadden; Newtownabbey/UK Moderators: H.H. Hjemly; Oslo/NO
B. Quality assurance of radiology equipment: C. Loewe; Vienna/AT
the first step to creating a safe working
environment [A-346]
J. Santos; Coimbra/PT Saturday, March 7, 14:00–15:30, Room D2
C. From medical imaging referral to final outcome:
RC 1514 CT from A to Z
a critical analysis of the process [A-347]
» Chairmen’s introduction [A-603]
D. Remedios; Harrow/UK
E. Agadakos; Athens/GR
» Panel discussion: Teamwork as a fundamental M. Prokop; Nijmegen/NL
concept for creating a patient safety culture in
A. Exploring and exploiting CT technology:
a medical imaging department: why and how?
back to the future [A-604]
D. Pekarovic; Ljubljana/SI
Friday, March 6, 10:30–12:00, Room K B. Patient safety in CT: radiation dose and
SS 1014 Radiation dose optimisation CM administration [A-605]
F. Zarb; Msida/MT
[B-0863 – B-0873]
C. Tips and tricks for CT optimisation [A-606]
Moderators: D.R. Kool; Nijmegen/NL R. Booij; Rotterdam/NL
D. Pekarovic; Ljubljana/SI » Panel discussion: How should a radiographer develop
the interface between patient and technology?

www.myESR.org Final Programme | ECR 2015 155


Scientific Programme

Refresher Courses / Scientific Sessions


Radiographers

Saturday, March 7, 16:00–17:30, Room D2 Sunday, March 8, 08:30–10:00, Room D2


RC 1614 MRI from the cradle to the future RC 1714 Looking into PET/CT
» Chairmen’s introduction [A-659] » Chairmen’s introduction [A-714]
B. Hafslund; Nesttun/NO K. Åhlström Riklund; Umea/SE
M. Maas; Amsterdam/NL D. Pekarovic; Ljubljana/SI
A. MRI sequences made easy [A-660] A. Clinical indications of PET/CT [A-715]
S. Brandão; Porto/PT P.H. Hogg; Manchester/UK
B. Functional MRI: new clinical applications [A-661] B. Quality control for PET/CT [A-716]
C. Malamateniou; London/UK W. van den Broek; Nijmegen/NL
C. Safety in MRI: all you have to know [A-662] C. Safety in PET/CT [A-717]
C. Vandulek; Kaposvár/HU J. Rio; Coimbra/PT
» Panel discussion: What to expect from MRI » Panel discussion:
in the future of medical imaging? What is the role of a radiographer in PET/CT?

Sunday, March 8, 10:30–12:00, Room K


SS 1814 Professional challenges
for radiographers
[B-1142 – B-1152]
Moderators: S. Geers-van Gemeren; Utrecht/NL
C. Roche; Galway/IE

156 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Vascular

Wednesday, March 4, 10:30–12:00, Room L 1 Thursday, March 5, 08:30–10:00, Room MB 1


SS 215 Pre- and post-interventional RC 515 Imaging and intervention
work-up in acute ischaemic stroke
[K-01, B-0056 – B-0065]
Moderator: P. Zampakis; Patras/GR
Moderators: E. Brountzos; Athens/GR A. Acute stroke imaging [A-181]
P. Vilela; Almada/PT K.-O. Løvblad; Geneva/CH
B. Indications for intervention [A-182]
N. Kocer; Istanbul/TR
Wednesday, March 4, 14:00–15:30, Room L 1
C. Mechanical revascularisation [A-183]
SS 315 Innovations in vascular imaging T. van der Zijden; Edegem/BE
[B-0272 – B-0281]
Moderators: D. Brisbois; Liège/BE
H. Hoppe; Berne/CH Thursday, March 5, 10:30–12:00, Room L 1
SS 615 Vascular imaging in systemic diseases
[B-0476 – B-0486]
Wednesday, March 4, 16:00–17:30, Room MB 1
Moderators: D. Karnabatidis; Patras/GR
RC 415 Basic principles of varicose D. Tomais; Athens/GR
vein diagnosis and
endovascular treatment
Moderator: D. Karnabatidis; Patras/GR Thursday, March 5, 14:00–15:30, Room Z
A. Diagnostic cross-sectional imaging [A-111]
SS 715 Arteries and veins
H. Hoppe; Berne/CH [B-0626 – B-0636]
B. Saphenous vein ablation [A-112] Moderators: A. Capelastegui; Galdakao/ES
A. Rampoldi; Milan/IT L. Mailli; London/UK
C. Ultrasound guided sclerotherapy [A-113]
J. Brookes; London/UK
Thursday, March 5, 16:00–17:30, Room MB 1
RC 815 EVAR endoleaks:
imaging and management
Moderator: F. Fanelli; Rome/IT
A. The role of US: Doppler, 3D US, CEUS [A-286]
U.K.M. Teichgräber; Jena/DE
B. CTA and MRA: current concepts [A-287]
A. Bücker; Homburg a.d. Saar/DE
C. Endovascular management [A-288]
M.A. Funovics; Vienna/AT

Friday, March 6, 10:30–12:00, Room Z


SS 1015 Low dose and low contrast
in vascular imaging
[B-0768 – B-0777]
Moderators: K. Nikolaou; Tübingen/DE
G. Tsoumakidou; Strasbourg/FR

www.myESR.org Final Programme | ECR 2015 157


Scientific Programme

Refresher Courses / Scientific Sessions


Oncologic Imaging

Wednesday, March 4, 08:30–10:00, Room F1 Thursday, March 5, 14:00–15:30, Room F1


RC 116 How about the lymph SS 716 Urogenital oncology
nodes? [B-0659 – B-0669]

» Chairman’s introduction [A-027] Moderators: R.A. Kubik-Huch; Baden/CH


J.J. Fütterer; Nijmegen/NL I. Thomassin-Naggara; Paris/FR
A. The current criteria for nodal involvement
on CT/MRI [A-028]
W. Schima; Vienna/AT Friday, March 6, 08:30–10:00, Room F1
RC 916 New insights in bone
B. MRI techniques: what do they contribute? [A-029]
H.C. Thoeny; Berne/CH
tumour imaging
C. Nuclear medicine: PET and other techniques [A-030] » Chairman’s introduction [A-332]
T. Barwick; London/UK D. Vanel; Bologna/IT
» Panel discussion: When and how will imaging make A. New insights in treatment-associated changes
diagnostic biopsy unnecessary? in patients with bone tumours [A-333]
C.R. Krestan; Vienna/AT
Wednesday, March 4, 10:30–12:00, Room F1 B. New insights in staging and restaging
SS 216 Thoracic oncology musculoskeletal tumours introduction [A-334]
[B-0087 – B-0097] J.L. Bloem; Leiden/NL
C. New insights in hybrid imaging
Moderators: I.E. Tyurin; Moscow/RU for multiple myeloma [A-335]
A. Vilaplana; Sevilla/ES G. Sommer; Basle/CH
» Panel discussion: The future of bone tumour imaging
Wednesday, March 4, 14:00–15:30, Room F1
SS 316 Molecular imaging and new agents
[B-0304 – B-0314] Friday, March 6, 10:30–12:00, Room F1
SS 1016 Advances in imaging
Moderators: A. Pomoni; Lausanne/CH metastatic disease
A.E. Sundin; Stockholm/SE [K-18, B-0822 – B-0831]

Thursday, March 5, 08:30–10:00, Room F1 Moderators: D. Filippiadis; Athens/GR


M. Müller-Schimpfle; Frankfurt a. Main/DE
RC 516 Gastro-entero-pancreatic neuro-
endocrine tumours (GEP-NET):
a multidisciplinary update Saturday, March 7, 10:30–12:00, Room F1
SS 1416 Prostate cancer imaging
» Chairman’s introduction [A-159]
[B-0960 – B-0970]
A.E. Sundin; Stockholm/SE
A. Tumour biology, pathogenesis and Moderators: E.C. Pereira Mendes Serrao; Cambridge/UK
classification [A-160] G. Petralia; Milan/IT
M. Pavel; Berlin/DE
B. The current role of nuclear medicine [A-161]
S. Fanti; Bologna/IT Sunday, March 8, 10:30–12:00, Room F1
C. Anatomical imaging: transabdominal US, SS 1816 Response assessment:
endoscopic US, MDCT and MRI: which is the most new concepts
appropriate imaging approach? [A-162] [K-27, B-1088 – B-1097]
V. Vilgrain; Clichy/FR
Moderators: B. Banko; Belgrade/RS
» Panel discussion: The future of hybrid imaging A. Sohaib; London/UK

Thursday, March 5, 10:30–12:00, Room F1


SS 616 Whole-body imaging of systemic Sunday, March 8, 14:00–15:30, Room F1
tumour spreading SS 1916 Oncologic imaging of the GI tract
[K-11, B-0510 – B-0519] [B-1228 – B-1238]

Moderators: K.N. De Paepe; Leuven/BE Moderators: G. Conte; Milan/IT


C.J. Johnston; Dublin/IE J. Sosna; Jerusalem/IL

158 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Refresher Courses / Scientific Sessions


Emergency Radiology

Wednesday, March 4, 08:30–10:00, Room MB 4 Friday, March 6, 08:30–10:00, Room MB 4


RC 117 Polytrauma: RC 917 Acute pain: your friend and enemy
comprehensive management in emergency radiology
guidelines for imaging
» Chairman’s introduction: patients with acute pain -
» Chairman’s introduction: management priorities management and therapeutic pathways [A-365]
in patients aer polytrauma [A-058] J. Walecki; Warsaw/PL
M. Stajgis; Poznan/PL A. Head [A-366]
A. Chest and abdomen [A-059] P.C. Maly Sundgren; Lund/SE
M. Scaglione; Castel Volturno/IT B. Chest [A-367]
B. Spine and pelvis [A-060] J.E. Wildberger; Maastricht/NL
F.H. Berger; Amsterdam/NL C. Abdomen [A-368]
C. Extremities [A-061] R. Basilico; Chieti/IT
U. Linsenmaier; Munich/DE » Panel discussion:
» Panel discussion: How to speed up the diagnosis and Where does radiology fit in the pathway?
further management of polytrauma patients

Wednesday, March 4, 10:30–12:00, Room MB 4


SS 217 Emergency imaging:
how to be more precise
[B-0184 – B-0194]
Moderators: K.H. Nieboer; Brussels/BE
G. Schueller; Opfikon/CH

Wednesday, March 4, 14:00–15:30, Room MB 4


SS 317 Update on imaging approach
in trauma patients
[B-0401 – B-0411]
Moderators: J.B. Dormagen; Oslo/NO
L.M. Lenghel; Cluj-Napoca/RO

Wednesday, March 4, 16:00–17:30, Room MB 4


RC 417 ‚Special patients‘ in the
emergency room: when and
how to image them?
Moderator: S. Wirth; Munich/DE
A. Children [A-122]
V. Miele; Rome/IT
B. Pregnant patients [A-123]
H. Alkadhi; Zurich/CH
C. Elderly patients [A-124]
K. Katulska; Poznan/PL

www.myESR.org Final Programme | ECR 2015 159


HOST YOUR
COURSE, SEMINAR
OR WORKSHOP IN
BARCELONA
For more information including rates,
please contact learningcentre@myESR.org

ESR Learning Centre


Passeig de Gràcia, 86, planta 8
08008 Barcelona
Spain

www.esrlearningcentre.com
Joint
Sessions

161
Scientific Programme

Joint Sessions

Wednesday, March 4, 2015, 12:30-13:30, Room D2 Thursday, March 5, 08:30–10:00, Room Z


Late-Breaking Clinical Trials Joint Session of ESR and EFSUMB
(European Federation of Societes for
Moderators: M. Dewey; Berlin/DE Ultrasound in Medicine and Biology)
N.R. Dunnick; Ann Arbor, MI/US Advances in diagnostic ultrasound:
» Image-based structural and functional phenotyping better results through integration
of the German COPD cohort (COSYCONET) using
MRI and CT Moderators: G.H. Mostbeck; Vienna/AT
B. Jobst; Heidelberg/DE P.S. Sidhu; London/UK
Discussant: J.B. Seo; Seoul/KR » Diagnosis, characterisation and staging of tumours
» A pragmatic randomised controlled trial of the of the female pelvis [A-138]
comparative effectiveness of computed tomography D. DeFriend; Abbotskerswell, Devon/UK
versus invasive coronary angiography for the A.G. Rockall; London/UK
management of stable chest pain patients: » Diagnosis, characterisation and staging of renal
Methods of the multicentre DISCHARGE trial tumours [A-139]
R. Haase; Berlin/DE S. Freeman; Plymouth/UK
Discussant: K. Kitagawa; Mie/JP N. Grenier; Bordeaux/FR
» Economic evaluation of gadoxetic acid-enhanced » Diagnosis, characterisation and staging of liver
magnetic resonance imaging (Gd-EOB-DTPA-MRI) tumours [A-140]
in the diagnosis of colorectal-cancer metastasis in H.-P. Weskott; Hannover/DE
the liver: results from the VALUE trial A. Ba-Ssalamah; Vienna/AT
C.J. Zech; Basle/CH
Discussant: V. Vilgrain; Clichy/FR
» Proteus trial: comparing neoplasia yield and Thursday, March 5, 14:00–15:30, Room L 1
attendance of sigmoidoscopy and CT colonography EIBIR Session
in a colorectal cancer screening setting (European Institute for Biomedical Imaging
D. Regge; Candiolo/IT Research)
Discussant: A. Laghi; Latina/IT The complexity of personalised
breast care
» Chairman’s introduction [A-223]
T.H. Helbich; Vienna/AT
» Breast cancer epidemiology and control - one size
does not fit all [A-224]
I. dos Santos Silva; London/UK
» VPH-PRISM aiding the therapy decision making
process by quantitative evaluation of personal
imaging and non-imaging data [A-225]
H.K. Hahn; Bremen/DE
» Stroma and peritumoural stiffness: latest evidence
for its importance and novel stroma imaging
approaches to predict therapy response [A-226]
A. Evans; Dundee/UK
» Personalised treatment decisions: how to reason
using multi-modal, multi-disciplinary data [A-227]
R.M. Mann; Nijmegen/NL

162 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Joint Sessions

Thursday, March 5, 14:00–15:30, Room M Friday, March 6, 08:30–10:00, Room G


EuroSafe Imaging Session 1 EFOMP Workshop
Clinical Decision Support: (European Federation of
making imaging referral guidelines work Organisations for Medical Physics)
for patients, doctors and EF 1 Multi-energy imaging:
hospital managers from physics to diagnosis I
» Chairman’s introduction [A-213] Moderators: P. Sharp; Aberdeen/UK
G. Frija; Paris/FR V. Tsapaki; Athens/GR
» CDS impact on guidelines » Chairman’s introduction [A-348]
development [A-214] P. Sharp; Aberdeen/UK
K.J. Dreyer; Boston, MA/US » Image-based material decomposition with
» Adapting and updating guidelines [A-215] energy-selective detectors in multi-energy CT:
M.G.M. Hunink; Rotterdam/NL a review [A-349]
M. Kachelrieß; Heidelberg/DE
» ACR select implementation experience [A-216]
J.A. Brink; Boston, MA/US » Novel applications of multi-energy CT [A-350]
J. Sosna; Jerusalem/IL
» ESR iGuide [A-217]
L. Donoso; Barcelona/ES » New frontiers in CT: functional and
multi-energy imaging [A-351]
» Discussion A. Persson; Linköping/SE

Thursday, March 5, 14:00–15:30, Room N Friday, March 6, 08:30–10:00, Room M


ESOR Session ESR Research in Education and Training Session
(European School of Radiology) Research for trainees made easy:
Striving in radiological education critical reading of the literature
Moderators: L. Bonomo; Rome/IT Moderator: J. Hodler; Zurich/CH
N. Gourtsoyiannis; Athens/GR
» Introduction [A-312]
» Introduction [A-218] J. Hodler; Zurich/CH
L. Bonomo; Rome/IT
» Overwhelmed by the available information?
» ESOR in action 2015 [A-219] How to organise yourself [A-313]
N. Gourtsoyiannis; Athens/GR P. Rodríguez; Madrid/ES
» The role of the European Training Curriculum: » Errors you should detect when reading scientific
present and future [A-220] papers [A-314]
B. Ertl-Wagner; Munich/DE A.K. Dixon; Cambridge/UK
» Spoon-feeding: present and future [A-221] » Clinical relevance of publications:
P.R. Ros; Cleveland, OH/US influence on outcome [A-315]
» E-learning portfolios: present and future [A-222] D.J. Wilson; Oxford/UK
M. Maas; Amsterdam/NL » Do not be afraid of basic science papers [A-316]
N. Grenier; Bordeaux/FR
Awards » Summary [A-317]
During the session, scholars and fellows will be J. Hodler; Zurich/CH
awarded certificates for successfully completing the
2014 ESOR Scholarship and Fellowship Programmes.

www.myESR.org Final Programme | ECR 2015 163


Scientific Programme

Joint Sessions

Friday, March 6, 10:30–12:00, Room G Friday, March 6, 13:00–15:00, Room D2


EFOMP Workshop MIR @ ECR Session 1
(European Federation of (Management in Radiology)
Organisations for Medical Physics) MIR: Best of professional issues
EF 2 Multi-energy imaging: in radiology
from physics to diagnosis II
Moderators: S. Morozov; Moscow/RU
Moderators: J. Damilakis; Iraklion/GR E. Schouman-Claeys; Paris/FR
A. Torresin; Milan/IT » 13:00 Overview on MIR activities and
» Chairman’s introduction [A-386] why attending MIR conferences [A-747]
J. Damilakis; Iraklion/GR P. Mildenberger; Mainz/DE
» Multi-energy imaging in the thorax [A-387] » 13:10 Update on radiology:
P. Vock; Spiegel/CH a strategy for the future [A-748]
» Dual-energy CT in oncology [A-388] E. Denton; Norwich/UK
C.N. De Cecco; Rome/IT » 13:30 Update on imaging biobanks [A-749]
» Clinical application of multi-energy imaging L. Faggioni; Pisa/IT
in digital mammography [A-389] » 13:50 Update on decision support
C. Dromain; Villejuif/FR for radiology [A-750]
K.J. Dreyer; Boston, MA/US
» 14:10 Update on social media in radiology [A-751]
Friday, March 6, 10:30–12:00, Room L 1 S. Morozov; Moscow/RU
EIBIR Session » 14:30 Update on economics [A-752]
(European Institute for Biomedical Imaging B. Brkljačić; Zagreb/HR
Research) » 14:50 Discussion
What‘s new in biomedical imaging research:
an update of EIBIR activities Management in Radiology is a subcommittee
of the ESR Professional Organisation Committee.
» Chairman’s introduction [A-380] Those involved in the field of healthcare are experiencing a time of
G.P. Krestin; Rotterdam/NL increasing pressure, stress and change. The demand for efficiency
» Presentation from the European Commission and effectiveness in all business and administrative matters is
on Horizon 2020 [A-381] constantly growing. MIR addresses current challenges and provides
A.-S. Costescu; Brussels/BE a forum for education and the exchange of ideas and concepts.
» EIBIR Joint Initiative for Paediatric Radiology [A-382]
K. Rosendahl; Bergen/NO
» EIBIR Joint Initiative:
Biomedical Image Analysis Platform [A-383]
W.J. Niessen; Rotterdam/NL
» EIBIR Joint Initiative
for Image Guided Radiotherapy [A-384]
V. Valentini; Rome/IT
» EIBIR Joint Initiative for Euro-BioImaging [A-385]
S. Aime; Turin/IT

164 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Joint Sessions

Friday, March 6, 14:00–15:30, Room MB 2 Friday, March 6, 14:00–15:30, Studio 2015


EuroSafe Imaging Session 2 Joint Session of the ESR and ESMRMB
EuroSafe imaging call for action (European Society for Magnetic
Resonance in Medicine and Biology)
» Chairman’s introduction [A-408] The ABC and 123 of perfusion MRI:
G. Frija; Paris/FR DSC, DCE and ASL explained
» EuroSafe imaging call for action [A-409]
G. Frija; Paris/FR Moderators: X. Golay; London/UK
M. Smits; Rotterdam/NL
» EuroSafe imaging training and education
activities and data collection project » Perfusion MRI: DSC, DCE and ASL [A-402]
“Are you EuroSafe?” [A-410] L. Knutsson; Lund/SE
P. Vock; Spiegel/CH » Clinical applications of brain perfusion MRI [A-403]
» Role of radiographers in medical radiation protection H.R. Jäger; London/UK
in the context of EuroSafe imaging [A-411] » DCE-MRI in oncology - when is quantitative
G. Paulo; Coimbra/PT imaging essential? [A-404]
» Role of medical physicists in medical radiation A.R. Padhani; London/UK
protection in the context of EuroSafe imaging [A-412] » Panel discussion
J. Damilakis; Iraklion/GR
» New European approaches to medical
low-dose research [A-413] Friday, March 6, 14.00–15:30, Room A
J. Repussard; Paris/FR Image Interpretation Quiz (IIQ)
» Panel discussion: EuroSafe Imaging - feedback, Couples for Europe
contributions, future activities, endorsement Moderator: C.M. Schaefer-Prokop; Amersfoort/NL
N. Bedlington; Vienna/AT (European Patients Forum)
N. Denjoy; Brussels/BE (COCIR) » Team 1:
G. Simeonov; Luxembourg/LU (European Commission) M.G. Mack; Munich/DE
M. Perez; Geneva/CH (WHO) P.C. Maly Sundgren; Lund/SE
O. Holmberg; Vienna/AT (IAEA) » Team 2:
A.A. Bankier; Boston, MA/US
F. Pugliese; London/UK
Friday, March 6, 14:00–15:30, Room L 1 » Team 3:
EIBIR Session J.J. Fütterer; Nijmegen/NL
(European Institute for Biomedical Imaging G. Zamboni; Verona/IT
Research)
MITIGATE consortium: state of the
art imaging and therapy in GIST
Chairpersons: S.O. Schönberg; Mannheim/DE
I. Virgolini; Innsbruck/AT
» Selective internal radiotherapy in GIST
patients [A-405]
S. Diehl; Mannheim/DE
» Multimodal imaging in GIST [A-406]
D.L. Longo; Turin/IT
» Principle of X-Nuclei MR imaging:
what the radiologist should know [A-407]
L. Schad; Mannheim/DE

= Interactive session with electronic voting/self assessment

www.myESR.org Final Programme | ECR 2015 165


Scientific Programme

Joint Sessions

Friday, March 6, 15:30–17:30, Room D2 Saturday, March 7, 08:30–10:00, Room Z


MIR @ ECR Session 2 Joint Session of the ESR and EORTC
(Management in Radiology) (European Organisation for Research and
Improving quality and safety Treatment of Cancer)
in radiology Imaging in multicentre clinical
oncological trials
Moderators: J.A. Brink; Boston, MA/US
R. FitzGerald; Shifnal/UK Moderators: L.S. Fournier; Paris/FR
» 15:30 First experiences from a nation-wide peer Y. Liu; Brussels/BE
review in radiology [A-753] » Imaging in clinical trials:
A. Brady; Cork/IE the EORTC perspective [A-493]
» 15:50 How to organise meaningful audits Y. Liu; Brussels/BE
in radiology [A-754] » Standardisation and quality assessment of imaging
P. Cavanagh, Taunton/UK as surrogate endpoints [A-494]
» 16:10 Errors in radiology: N.M. deSouza; Sutton/UK
how to learn from a systematic » Optimised imaging for trials in brain tumours [A-495]
approach [A-755] M. Smits; Rotterdam/NL
D.A. Koff; Hamilton, ON/CA » Multiparametric MRI in breast and
» 16:30 Round table discussion: prostate cancer [A-496]
Learning from critical situations or errors: T.H. Helbich; Vienna/AT
examples from around the world [A-756]
E. Denton; Norwich/UK
J.A. Jakobsen; Oslo/NO Saturday, March 7, 10:30–12:00, Room L 1
U. Senol; Antalya/TR ESR Patient Advisory Group
J.A. Brink; Boston, MA/US ESR-PAG 1 The challenges of providing
C.E. Kahn; Philadelphia, PA/US true patient-centred care:
M. Fatehi; Tehran/IR
P. Valdes Solis; Marbella/ES
moving forward together
» Chairmen’s introduction [A-552]
Management in Radiology is a subcommittee N. Bedlington; Vienna/AT
of the ESR Professional Organisation Committee. P. Cavanagh; Taunton/UK
Those involved in the field of healthcare are experiencing a time of » Ethics in patient-centred radiology [A-553]
increasing pressure, stress and change. The demand for efficiency C.D. Claussen; Tübingen/DE
and effectiveness in all business and administrative matters is
» Lost in radiology: is there a doctor in the
constantly growing. MIR addresses current challenges and provides
department? [A-554]
a forum for education and the exchange of ideas and concepts.
E. Briers; Hasselt/BE
» An ESR framework for delivering patient-centred care
in radiology’s services [A-555]
P. Cavanagh; Taunton/UK
» Panel discussion: on the ‘driver diagram for
patient-centred care in clinical radiology’

166 ECR 2015 | Final Programme www.myESR.org


Scientific Programme

Joint Sessions

Saturday, March 7, 13:00–14:00, Room A Saturday, March 7, 14:00–15:30, Room L 1


Junior Image Interpretation Quiz (JIIQ) EuroSafe Imaging Session 3
Battle for the audience Dose-tracking leads the way
Moderator: M. Dewey; Berlin/DE to dose-reduction
» Team A:
A. Ntorkou; Thesprotia/GR » Chairman’s introduction: dose-tracking
A. Caric; Split/HR leads to dose-reduction: why radiologists
P. Flechsig; Heidelberg/DE MUST get involved [A-580]
N. Cardobi; Verona/IT P.M. Parizel; Antwerp/BE
» Team B: » The legislative environment in Europe:
M. Faure; Antwerp/BE the new EU Directive and the goals
D. Uceda Navarro; Valencia/ES of EuroSafe Imaging [A-581]
E. Herin; Paris/FR J. Griebel; Neuherberg/DE
A. Chopra; Sheffield/UK » Implementing a dose management solution
in your department: where to start and
what to expect? [A-582]
Saturday, March 7, 14:00–15:30, Room Z D. Weishaupt; Zurich/CH
Joint Session of the ESR and ESTRO » Developing a multi-disciplinary team
(European Society for Radiotherapy and Oncology) in dose management (CT example) [A-583]
ESTRO 1 Non-surgical approach to early lung L. Martí-Bonmatí; Valencia/ES
cancer: perspectives of imaging and » PiDRL - European Commission Tender Project
radiation-based disciplines on diagnostic reference levels in paediatric
Moderators: T. Franquet; Barcelona/ES imaging [A-584]
Y. Lievens; Ghent/BE J. Damilakis; Iraklion/GR
» Imaging requirements to guide non-surgical » Deploying a dose management strategy across
treatment in early lung cancer [A-568] multiple sites [A-585]
C.M. Schaefer-Prokop; Amersfoort/NL K. Katsari; Athens/GR
» The most up-to-date evidence from the » Panel discussion
interventional oncology perspective [A-569]
R. Lencioni; Pisa/IT
» The most up-to-date evidence from the
Saturday, March 7, 16:00–17:30, Room L 1
radiation oncology perspective [A-570] EuroSafe Imaging Session 4
S. Senan; Amsterdam/NL How can clinical audit enhance
» Imaging follow-up of non-surgical treatments [A-571]
patient safety?
A.R. Larici; Rome/IT
» Chairman’s introduction [A-638]
» Discussion E.J. Adam; London/UK
» A new approach to clinical audit and
safety by the ESR [A-639]
P. Cavanagh; Taunton/UK
» Models of external audit in the Netherlands [A-640]
S. Geers-van Gemeren; Utrecht/NL
» Clinical audit in cardiac CT: the UK experience [A-641]
S. Harden; Southampton/UK
E. Castellano; London/UK
» The European Radiation Protection Regulator’s
perspective on audit [A-642]
S. Ebdon-Jackson; Didcot/UK
» Panel discussion

= Interactive session with electronic voting/self assessment

www.myESR.org Final Programme | ECR 2015 167


Scientific Programme

Joint Sessions

Saturday, March 7, 16:00–17:30, Room Z Sunday, March 8, 08:30–10:00, Studio 2015


Joint Session of the ESR and ESTRO Joint Session of the ESR and ERS
(European Society for Radiotherapy and Oncology) (European Respiratory Society)
ESTRO 2 Radiology and radiation oncology: Lung cancer screening: why and how to
new chances for implement a comprehensive preventive
a partnership programme
Moderator: L. Bonomo; Rome/IT Moderator: M. Prokop; Nijmegen/NL
P.M.P. Poortmans; Nijmegen/NL J.-P. Sculier; Brussels/BE
» Introduction [A-623] » Should we do lung cancer screening now?
L. Bonomo; Rome/IT The evidence [A-688]
» Imaging in oncology: C.J. Herold; Vienna/AT
achievements and limitations [A-624] » CT requirements and nodule workup [A-689]
V.J. Goh; London/UK F. Gleeson; Oxford/UK
» Interventional radiology in oncology: » Diagnostic and treatment approaches to lesions
achievements and limitations [A-625] found in CT screening [A-690]
J.I. Bilbao; Pamplona/ES F.J.F. Herth; Heidelberg/DE
» Interventional radiology and radiation oncology: » Designing a screening programme [A-691]
working together [A-626] N. Peled; Petach Tiqwa/IL
D. Verellen; Brussels/BE
» Panel discussion: The future partnership between
radiology and radiation oncology Sunday, March 8, 10:30–12:00, Room L 1
ESR Patient Advisory Group
ESR-PAG 2 Communicating the results of
Sunday, March 8, 08:30–10:00, Room Z radiological studies to patients:
EDiR talk from high-tech to human
(European Diploma in Radiology) touch imaging
FA(b)Q frequently asked (burning) questions -
with answers » Chairmen’s introduction [A-737]
The participants will learn about the EDiR structure and become N. Bedlington; Vienna/AT
familiar with its format. They will learn very useful information B. Brkljačić; Zagreb/HR
about their EDiR examination and its preparation and will receive » Who is the patient of the radiologist? [A-738]
an answer to all questions they may have related to the exam. L.E. Derchi; Genoa/IT
» Communicating results of radiological studies to the
Moderator: Y. Menu; Paris/FR patient with breast cancer: view of the patient who
» Questions about registration [A-679] is also a physician [A-739]
Y. Menu; Paris/FR A. Balenović; Zagreb/HR
E. Jordan; Barcelona/ES » Brain disorder - the communication challenge [A-740]
» Questions about preparation [A-680] D. Walsh; Dublin/IE
W. Schima; Vienna/AT M. Messmer-Wullen; Lochau/AT
» Questions about written examination [A-681] » Panel discussion: From high-tech to human touch -
S. Barter; Cambridge/UK how do we ensure this transition and what are the
» Questions about oral examination [A-682] roles for the ESR and member societies?
L. McKnight; Langland, Swansea/UK
» Questions about the future [A-683]
Y. Menu; Paris/FR
V. Iranzo; Barcelona/ES
» Panel discussion: More FA(b)Q and
its answers [A-684]
J. Vilar; Valencia/ES

168 ECR 2015 | Final Programme www.myESR.org


Postgraduate
Educational
Programme
Session numbers are prefixed by
3
CC, E , EF, EM, HL, MC, MS, NH, OL, PC, RC, SA, SF, TF

Presentation numbers are prefixed by the letter A

Key to Abbreviations
CC Categorical Course
E3 European Excellence in Education
EF EFOMP Workshop
EM ESR meets Session
HL Honorary Lecture
MC Mini Course
MS Multidisciplinary Session
NH New Horizons Session
OL Opening Lecture
PC Professional Challenges Session
RC Refresher Course
SA State of the Art Symposium
SF Special Focus Session
TF Radiology Trainees Forum

169
Postgraduate Educational Programme

08:30–10:00 Room A Panel discussion:


09:44 How do we manage difficult cases and incidental findings?
E³ - ECR Academies:
Image-Guided Interventions in Oncology 08:30–10:00 Room C

E³ 121 Changes of the gastrointestinal tract Special Focus Session


aer treatment
SF 1a Acute gastrointestinal tract
08:30 emergencies: an update
A-001 A. Gastrointestinal tumours
M. Rengo; Latina/IT 08:30
Learning Objectives: A-007 Chairman’s introduction
1. To become familiar with common findings after medical treatment of F. Caseiro-Alves; Coimbra/PT
gastrointestinal tumours. Session Objectives:
2. To become familiar with changes after radiotherapy for 1. To understand the advantages and shortcomings of the different
gastrointestinal tumours. imaging techniques.
3. To understand the changes which occur after surgery for 2. To understand how imaging techniques drive patient management.
gastrointestinal tumours. 3. To appreciate the role of interventional radiology.
09:15 08:34
A-002 B. Non-tumoural intestinal diseases A-008 The acute abdomen: inflammation and its mimics
J. Rimola; Barcelona/ES M. Zins; Paris/FR
Learning Objectives: Learning Objectives:
1. To become familiar with useful signs after medical treatment of 1. To describe and propose an effective diagnostic imaging strategy for
Crohn’s disease. the assessment of acute abdominal pain.
2. To understand the changes which occur after recurrence in Crohn’s 2. To describe typical and atypical findings of appendicitis, colonic
disease. diverticulitis and cholecystitis from different imaging modalities.
3. To understand the alterations which occur after treatment of 3. To discuss alternative diagnoses in right and left lower abdominal
infectious intestinal processes. pain including epiploic appendagitis, infarction of the greater
omentum and inflammatory bowel disease.

08:30–10:00 Room B 08:52


A-009 Mechanical bowel obstruction
Abdominal Viscera D.J.M. Tolan; Leeds/UK
Learning Objectives:
RC 101 Pitfalls in interpretation 1. To appreciate the imaging findings on cross-sectional imaging to
in pancreatic imaging diagnose large and small bowel obstruction.
2. To learn to differentiate between the common aetiologies for
08:30 mechanical obstruction of the large bowel and the small bowel.
3. To learn features that differentiate mechanical obstruction from ileus.
A-003 Chairman’s introduction 4. To understand the features that warrant emergency intervention to
R. Pozzi-Mucelli; Verona/IT
relieve obstruction.
08:35 09:10
A-004 A. Pancreatic cancer or pancreatitis A-010 Evaluation of the ischaemic bowel
R. Manfredi; Verona/IT S. Romano; Naples/IT
Learning Objectives: Learning Objectives:
1. To learn about the inflammatory lesions which can mimic a 1. To learn about pathophysiology of the vascular diseases of the bowel.
pancreatic tumour. 2. To understand radiological signs of bowel ischaemia and infarction.
2. To become familiar with the imaging features which can support the 3. To appreciate the role of cross-sectional imaging in emergencies for
differential diagnosis between pancreatic cancer and pancreatitis. an effective diagnosis.
3. To understand the value of the integration of the imaging modalities 4. To describe the different stages of vascular bowel injury.
that define the correct diagnosis.
09:28
08:58 A-011 The acute GI bleed
A-005 B. Cystic tumours vs pseudocysts O.M. van Delden; Amsterdam/NL
M.A. Bali; Brussels/BE
Learning Objectives:
Learning Objectives: 1. To learn about the pathophysiology and different types of common of
1. To become familiar with the imaging features of cystic tumours and acute GI haemorrhage.
pseudocysts. 2. To learn about the diagnostic work-up of and imaging algorithms for
2. To become familiar with the clinical presentation and the radiological investigating acute GI hemorrhage.
signs that may be observed in cystic tumours and pseudocysts. 3. To learn about the role of interventional radiology for acute GI
3. To understand the value of the integration of the imaging modalities haemorrhage including results and complications of interventional
that define the correct diagnosis. procedures.
09:21
Panel discussion:
A-006 C. Incidental findings 09:46 How should acute GI tract emergencies be managed?
C. Stoupis; Maennedorf/CH
Learning Objectives:
1. To become familiar with the most common incidental findings in the
pancreas with different imaging modalities.
2. To understand how to define the correct diagnosis.
3. To discuss how to manage incidental findings.

170 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room M 09:21


A-018 C. Mobile teleradiology: radiological features of the
Physics in Radiology tablet-computer
E.R. Ranschaert; ‚s-Hertogenbosch/NL
RC 113 Cone-beam CT Learning Objectives:
Moderator: J. Vassileva; Sofia/BG 1. To learn about mobile teleradiology within the hospital.
2. To learn about mobile teleradiology outside the hospital.
08:30 3. To appreciate the potential risks: data security, confidentiality.
A-012 A. Fundamentals of cone-beam CT
J. Kuntz; Heidelberg/DE Panel discussion:
Learning Objectives: 09:44 Confidence in the use of tablets in our clinical practice
1. To understand the principles of volumetric image formation with flat
detectors.
2. To understand the difference between cone-beam CT (CBCT) and 08:30–10:00 Room E1

Wednesday
multi-slice CT (MSCT).
3. To learn about reconstruction techniques and image processing. Special Focus Session
4. To become acquainted with the important image quality parameters.
09:00 SF 1b Up-to-date imaging for hearing loss
A-013 B. Medical applications of cone-beam CT 08:30
M. Grass; Hamburg/DE
A-019 Chairman’s introduction
Learning Objectives: A. Trojanowska; Lublin/PL
1. To become acquainted with the applications of cone-beam CT.
2. To learn about systems’ designs and parameters. Session Objectives:
3. To understand image quality characteristics. 1. To understand the problem of conductive and sensorineural hearing
4. To learn how to use cone-beam images in image-guided loss and the role of radiologist in treatment planning.
interventions. 2. To discuss commonly used devices for hearing augmentation and
restoration and their radiological appearance.
09:30 3. To know how to evaluate images in cases of treatment failure.
A-014 C. 3D dentomaxillofacial imaging 08:35
H. Bosmans, A. Stratis, G. Zhang; Leuven/BE
A-020 New devices in the treatment of hearing loss
Learning Objectives: B. Ozgen Mocan; Ankara/TR
1. To become acquainted with cone-beam CT systems for
dentomaxillofacial imaging. Learning Objectives:
2. To learn about image quality characteristics. 1. To understand the mechanism of hearing loss.
3. To understand patient dose compared with other techniques in 2. To become familiar with treatment options.
dentomaxillofacial imaging. 3. To review most the most popular devices for hearing augmentation
and restoration.
09:00
08:30–10:00 Room N
A-021 Pre- and postoperative imaging in middle ear implants
E. Loney; Bradford/UK
Computer Applications Learning Objectives:
1. To learn how to image temporal bone prior to surgery and implant
RC 105 Mobile IT in radiology placement.
2. To review the most popular types of surgical procedures in the
08:30 middle ear.
A-015 Chairman’s introduction 3. To apprehend the typical appearance of reconstructed ossicular chain
E. Neri; Pisa/IT and possible complications.
Session Objectives:
1. To appreciate the current state of tablet technology and its practical
09:25
use in radiology. A-022 Pre- and postoperative imaging in inner ear and brainstem
2. To understand the pros and cons of the use of tablets. implants
3. To learn about specific critical areas of utilisation (DICOM images B. Verbist, J.H.M. Frijns; Leiden/NL
reading and teleradiology). Learning Objectives:
08:35 1. To know how to evaluate temporal bone in order to qualify for
implant placement.
A-016 A. Tablet-computers: a technical overview 2. To understand how cochlear and brainstem implants work.
J. Fernandez-Bayó; Sabadell/ES 3. To discuss possible complications and the role of imaging studies.
Learning Objectives:
1. To learn about the PC evolution: from desktops, to laptops and Panel discussion:
tablets. 09:50 Changing demands for imaging in hearing loss
2. To appreciate the versatile features of a tablet.
3. To understand the hardware features for display and networking.
08:58
A-017 B. Reading DICOM images on the tablet
O. Ratib; Geneva/CH
Learning Objectives:
1. To learn which DICOM readers are available for tablets.
2. To appreciate the local and remote approaches and the PACS/tablet
integration.
3. To understand the pros and cons of image quality and display.

www.myESR.org Final Programme | ECR 2015 171


Postgraduate Educational Programme

08:30–10:00 Room E2 08:35


A-028 A. The current criteria for nodal involvement on CT/MRI
Special Focus Session W. Schima; Vienna/AT
Learning Objectives:
SF 1c Internal derangement of joints: 1. To understand the role of local nodal staging and its importance for
choosing the right test for the problem management and prognosis.
2. To become familiar with the current imaging criteria for assessment
08:30 of nodal metastases.
A-023 Chairman’s introduction 3. To understand the diagnostic performance of cross-sectional
A.J. Grainger; Leeds/UK imaging.
Session Objectives: 08:58
1. To become familiar with the imaging techniques commonly used for A-029 B. MRI techniques: what do they contribute?
internal derangements of joints. H.C. Thoeny; Berne/CH
2. To understand how the role of these techniques has changed as
technology improves. Learning Objectives:
3. To appreciate the advantages and disadvantages of the techniques 1. To understand the principle of DWI of nodes.
discussed, appreciating their strengths and weaknesses. 2. To learn about the appearances of malignant nodes on Diffusion-
4. To be aware of the potential for further optimisation of the weighted MRI.
techniques in the future. 3. To be familiar with node-specific enhanced MRI.

08:35 09:21
A-024 CT arthrography: acceptable if MR availability is limited? A-030 C. Nuclear medicine: PET and other techniques
B. Vande Berg; Brussels/BE T. Barwick; London/UK
Learning Objectives: Learning Objectives:
1. To appreciate the current indications for CT arthrography and how 1. To learn the typical appearance on nodal metastatic disease on FDG.
they may evolve. 2. To recognise the pitfalls for interpretation.
2. To understand the technique and requirements for CT arthrography. 3. To become familiar with new radiotracers, including choline PET, for
3. To become familiar with the limitations of CT arthrography. the demonstration of nodal disease.
4. To recognise how CT arthrography complements other techniques.
Panel discussion:
09:00 09:44 When and how will imaging make diagnostic biopsy
A-025 MR arthrography: exquisite so tissue contrast unnecessary?
E.L. Rowbotham; Leeds/UK
Learning Objectives:
1. To appreciate the current indications for MR arthrography and how
08:30–10:00 Room F2
they may evolve.
2. To understand the technique and requirements for MR arthrography. Breast
3. To become familiar with the limitations of MR arthrography and
appreciate its pitfalls. RC 102 Breast ultrasound 2015
Moderator: K. Kinkel; Chêne-Bougeries/CH
09:25
A-026 MRI: when is it enough? 08:30
C.W.A. Pfirrmann; Zurich/CH
A-031 A. Evidence for screening in dense breasts
Learning Objectives: V. Girardi; Brescia/IT
1. To understand the limitations of non-arthrographic MRI. Learning Objectives:
2. To appreciate how MRI can be optimised to minimise the need for 1. To understand the masking effect of breast density negatively
invasive arthrographic techniques. impacting on sensitivity of screening mammography.
3. To recognise where MRI is enough and where arthrographic 2. To know the results of additional screening methods in women with
techniques are still needed. dense breasts.
3. To be aware of cost considerations for additional screening methods.
Panel discussion:
09:50 Can one technique ever fulfil all the roles? 09:00
How will our optimal techniques change in the next 5 years? A-032 B. Elastosonography: true advances or false hope?
C.S. Balleyguier; Villejuif/FR
Learning Objectives:
08:30–10:00 Room F1 1. To understand physical principles of elastosonography.
2. To become familiar with the technique of shear-wave
Oncologic Imaging elastosonography of the breast.
3. To appreciate reproducibility and clinical value of elastosonography
RC 116 How about the lymph nodes? in clinical practice.

08:30 09:30
A-027 Chairman’s introduction A-033 C. Nodal staging of breast cancer: still needed?
J.J. Fütterer; Nijmegen/NL S.C.E. Diepstraten; Utrecht/NL
Session Objectives: Learning Objectives:
1. To learn the criteria for nodal staging on CT, MRI and PET. 1. To know the current debate on sentinel node biopsy and axillary
2. To understand the pitfalls and challenges of nodal staging on lymph node dissection.
imaging. 2. To appreciate the clinical role of staging of the axilla using ultrasound
with selective ultrasound-guided needle biopsy.
3. To understand the need for discriminating between minimal versus
advanced nodal metastatic involvement.

172 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room D1 09:30


A-040 C. Where medical history and previous images help
Chest to rule out tumour
D. Farina; Brescia/IT
RC 104 Pulmonary vasculitis and collagen Learning Objectives:
vascular diseases 1. To understand the importance of medical history and previous
Moderator: A. Persson; Linköping/SE images.
2. To become familiar with typical post-surgical and post-radiation
08:30 imaging findings.
A-034 A. Pulmonary manifestations 3. To learn about less common anatomical variants without clinical
consequence.
of collagen vascular diseases
S.R. Desai; London/UK
Learning Objectives: 08:30–10:00 Room G

Wednesday
1. To learn about the different collagen vascular diseases that affect
the lung.
2. To become familiar with pulmonary abnormalities due to collagen
Genitourinary
vascular diseases.
RC 107 Stone disease: new concepts
08:52
A-035 B. Large-vessel vasculitis 08:30
J. Vilar; Valencia/ES A-041 Chairman’s introduction
Learning Objectives: A. Magnusson; Uppsala/SE
1. To learn about the different types of large-vessel vasculitis. Session Objectives:
2. To become familiar with histopathological correlates in vasculitis. 1. To become familiar with accurate imaging modalities in patients with
3. To appreciate the different manifestations and imaging appearances flank pain or already known stone disease.
of large-vessel thoracic vasculitis. 2. To learn about therapeutic algorithm of stone disease.
09:15 08:35
A-036 C. HRCT patterns in pulmonary vasculitis A-042 A. From the Stone Age to the New Age
C.M. Schaefer-Prokop; Amersfoort/NL N.C. Cowan; Portsmouth/UK
Learning Objectives: Learning Objectives:
1. To learn when HRCT is of value in investigating 1. To become familiar with the symptoms, signs, risk factors and
pulmonary vasculitis. significance of stone disease in the urinary tract.
2. To appreciate the different appearances of pulmonary vasculitis 2. To understand the strengths and weaknesses of Stone Age to New
on HRCT. Age imaging techniques for stone disease.
3. To become familiar with a state-of-the-art diagnostic imaging
09:37 pathway for urinary tract
A-037 D. Inflammation and remodelling stone disease.
A.A. Bankier; Boston, MA/US
08:58
Learning Objectives:
1. To learn about the different causes of pulmonary inflammation. A-043 B. The contribution of imaging in planning urinary
2. To understand how the lung responds to inflammation. stone therapy
3. To become familiar with pulmonary changes following inflammation. U. Patel; London/UK
Learning Objectives:
1. To understand how stone morphology, constituency and intrarenal
08:30–10:00 Room D2 anatomy influence treatment of urinary tract stones.
2. To learn about how to carry out 3. CT reconstruction of the renal
Head and Neck collecting system, and understand key technical factors necessary for
recreating accurate anatomical or surgical maps.
RC 108 Head and neck emergency: for the 3. To understand what information the interventionist or urologist
needs for planning urinary stone therapy.
general radiologist or the patient?
Moderator: M. Díez Blanco; Santander/ES 09:21
A-044 C. Urolithiasis: changing concepts in medical and
08:30 surgical approach
A-038 A. Findings that can’t wait for follow-up G. Kramer; Vienna/AT
M.G. Mack; Munich/DE
Learning Objectives:
Learning Objectives: 1. To learn about new findings in epidemiology and pathogenesis of
1. To learn about vascular head and neck emergencies. urinary stone disease.
2. To understand the variable appearances of foreign bodies. 2. To become familiar with the usefulness of screening concepts.
3. To understand main pathways of skull base invasion. 3. To learn about the role of medical and new minimally invasive
treatment options.
09:00 4. To learn about post-treatment imaging algorithms.
A-039 B. Imaging infection: when, how and why?
M. Becker; Geneva/CH 09:44 How do density and/or volume of the stone in failure
Learning Objectives: dictate how to efficiently treat stone disease?
1. To learn how to choose and tailor imaging techniques according to
the clinical presentation.
2. To become familiar with neck spaces and spread of infection.
3. To be able to recognise complications.

www.myESR.org Final Programme | ECR 2015 173


08:30–10:00 Room K 08:30–10:00 Room MB 2

Neuro Cardiac
RC 111 The paediatric brain and spine: RC 103 Hybrid cardiovascular imaging:
not only tumours where should we go?
Moderator: T.A.G.M. Huisman; Baltimore, MD/US Moderator: G. Feuchtner; Innsbruck/AT

08:30 08:30
A-045 A. Congenital abnormalities of the brain A-051 A. PET/CT: present state and future prospects
B. Ertl-Wagner; Munich/DE S.G. Nekolla; Munich/DE
Learning Objectives: Learning Objectives:
1. To become familiar with the typical clinical presentations of CBA. 1. To become aware of the present state of PET/CT in cardiovascular
2. To consolidate knowledge of the typical imaging patterns of the imaging.
major CBA. 2. To become familiar with appropriate indications for PET/CT studies
3. To explain the importance of a precise diagnosis in relation to of the heart.
potential therapy. 3. To learn about technical innovations in PET/CT imaging.
09:00 09:00
A-046 B. Paediatric brain neuro emergencies A-052 B. SPECT/CT: is it just PET/CT’s little brother?
M.I. Argyropoulou; Ioannina/GR M. Hacker; Vienna/AT
Learning Objectives: Learning Objectives:
1. To become familiar with the most common PNEs. 1. To appreciate the scope of information a SPECT/CT cardiac study
2. To learn how to make a differential diagnosis between different PNEs. can deliver.
3. To explain the diagnostic and therapeutic road map in PNEs. 2. To become familiar with protocols of SPECT/CT studies.
3. To learn a structured approach to performing and reporting a
09:30 SPECT/CT study.
A-047 C. The paediatric spine: tips and tricks
A. Rossi; Genoa/IT 09:30
Learning Objectives: A-053 C. MR/PET: do we really need it?
1. To learn the difference between benign and malignant paediatric H.H. Quick; Essen/DE
spine findings. Learning Objectives:
2. To understand the imaging strategy for paediatric spine emergencies. 1. To learn about technical requirements for performing cardiac
3. To become confident with the most common paediatric spine MR/PET studies.
emergencies. 2. To learn if cardiac MR/PET can be successfully performed
in clinical routine.
3. To become familiar with the principal advantages/disadvantages
08:30–10:00 Room MB 1 of MR/PET compared to other hybrid imaging technologies.

Molecular Imaging
08:30–10:00 Room MB 3
RC 106 Functional and multimodality Interventional Radiology
neuroimaging
Moderator: T.H. Helbich; Vienna/AT
RC 109 Image fusion for image-guided
08:30 interventions
A-049 A. MR/PET chances and challenges 08:30
V. Schulz; Aachen/DE
Learning Objectives: A-054 Chairman’s introduction
V. Bérczi; Budapest/HU
1. To understand the fundamentals of MR physics relevant to MR/PET
imaging. 08:35
2. To appreciate the advantages of MR/PET and its complementary role
in diagnostic neuroimaging. A-055 A. Cone-beam CT in vascular and non-vascular
3. To learn about the benefits and challenges of combined MR/PET. interventional procedures
T.F. Jakobs; Munich/DE
09:00 Learning Objectives:
A-050 B. Advanced MR neuroimaging techniques 1. To learn how to use cone-beam CT in guiding IR procedures.
M. Smits; Rotterdam/NL 2. To learn when to use this technique in oncologic biopsies and
Learning Objectives: ablations.
1. To learn about functional MRI (fMRI) and diffusion tensor imaging 3. To learn how to use this technique in improving efficacy and safety
(DTI). of intra-arterial procedures.
2. To understand the application of these techniques in the study of the
healthy and diseased human brain. 08:58
3. To learn about the brain’s activity and its connections. A-056 B. US image fusion
C. Ewertsen; Copenhagen/DK
09:30 Learning Objectives:
A-048 C. Clinical applications of PET/CT in neurology 1. To learn about the technologies used to fuse CT/US and
A.H. Jacobs; Münster/DE MRI/US images.
Learning Objectives: 2. To understand how to use them in clinical practice.
1. To become familiar with the role of PET/CT in neurology. 3. To understand the indications for these technologies in difficult cases.
2. To learn about radiotracers that can be used in neuroimaging.
3. To understand PET/CT applications in relationship to disease
presentations.

174 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

09:21 08:30–10:00 Room MB 5


A-057 C. How can we improve targeting in image-guided
interventions: stereotaxis, robotics and advanced Paediatric
techniques RC 112 Autoimmune disorders in children
R. Bale; Innsbruck/AT
Moderator: V. Donoghue; Dublin/IE
Learning Objectives:
1. To become familiar with principles of stereotaxis and robotics for
guiding interventions.
08:30
2. To learn about new and advanced techniques in image-guided A-062 A. The joints in juvenile idiopathic arthritis
therapies. L.-S. Ording Müller; Oslo/NO
3. To understand when and how to use these techniques in oncologic Learning Objectives:
and non-oncologic interventions. 1. To learn about the different joint lesions in JIA.
2. To understand when to use US or MRI.
Panel discussion: 3. To learn how to recognise the typical imaging patterns.

Wednesday
09:44 Practical and economic issues in using high-end guidance
for interventional radiology 09:00
A-063 B. The digestive tract
E. Alexopoulou; Athens/GR
08:30–10:00 Room MB 4 Learning Objectives:
1. To learn the basics of mechanisms related to autoimmune enteritis.
Emergency Radiology 2. To appreciate the role of US, CT and MRI.
3. To become familiar with imaging findings useful in the diagnosis.
RC 117 Polytrauma: comprehensive 09:30
management guidelines for imaging A-064 C. Multiple sclerosis in children
C. Adamsbaum, B. Husson, K. Deiva, M. Tardieu; Le Kremlin-Bicêtre/FR
08:30 Learning Objectives:
A-058 Chairman’s introduction: management priorities in 1. To understand the difference between children and adults.
patients aer polytrauma 2. To become familiar with imaging findings.
M. Stajgis; Poznan/PL 3. To learn about the principle differential diagnosis.

08:35
A-059 A. Chest and abdomen 10:30–12:00 Room A
M. Scaglione; Castel Volturno/IT
Learning Objectives: E³ - ECR Academies:
1. To understand the impact of imaging findings on patient
management.
Interactive Teaching Sessions
2. To learn about common classification and trauma scoring systems.
3. To be familiar with the most common, typical and atypical imaging E³ 221 The treated breast:
findings. what you need to know
08:59 10:30
A-060 B. Spine and pelvis A-065 A. Imaging aer treatment of benign breast conditions
F.H. Berger; Amsterdam/NL
J. Camps Herrero; Valencia/ES
Learning Objectives:
Learning Objectives:
1. To understand the pathomechanisms and practical classifications of
1. To understand common features related to breast surgery.
spinal and pelvic trauma.
2. To recognise changes related to non-surgical treatments.
2. To become familiar with image interpretation rules in the
traumatised spine and pelvis. 11:15
3. To learn about posttraumatic findings in CT and MR imaging. A-066 B. Imaging aer treatment of breast cancer
09:23 M.H. Fuchsjäger; Graz/AT
A-061 C. Extremities Learning Objectives:
U. Linsenmaier; Munich/DE 1. To understand common features related to breast surgery.
2. To recognise changes related to non-surgical treatments.
Learning Objectives:
1. To be familiar with life-threatening injuries and current classifications
systems.
12:30–13:30 Room B
2. To learn about imaging strategies and the role of different imaging
methods.
3. To comprehend imaging findings and their impact on patient
E³ - The Beauty of Basic Knowledge:
management. Breast Imaging
Panel discussion: E³ 25A Breast ultrasound: a primer
09:47 How to speed up the diagnosis and further management
of polytrauma patients Moderator: J. Camps Herrero; Alzira/ES

12:30
A-067 Breast ultrasound: a primer
A. Tardivon; Paris/FR
Learning Objectives:
1. To review the technical issues tied to a state-of-the-art US exam
and new developments.
2. To learn how to deal with the most common clinical situations
where breast US is involved.
3. To know the basic semiology of US lesions.

www.myESR.org Final Programme | ECR 2015 175


Postgraduate Educational Programme

12:30–13:30 Room D1 16:00–17:30 Room C

E³ - The Beauty of Basic Knowledge: Special Focus Session


Skeletal Radiology SF 4 Pancreatic lesions - the solid,
E³ 24A Plain radiographs: the cystic, and the diffuse:
analysis and interpretation benign or malignant?
Moderator: V. Cassar-Pullicino; Oswestry/UK 16:00
12:30 A-073 Chairman’s introduction
C. Matos; Brussels/BE
A-068 Plain radiographs: analysis and interpretation Session Objectives:
I.W. McCall; Devon/UK
1. To address how imaging helps make the differential diagnosis of
Learning Objectives: solid, cystic and diffuse benign and malignant lesions of the pancreas.
1. To learn about the current role of plain radiographs. 2. To discuss the role of diagnostic imaging modalities in determining
2. To appreciate the strengths and weaknesses of plain radiographs in options for patient management.
musculoskeletal disease.
3. To understand methods for analysing radiographic abnormalities and 16:05
an approach to their correct interpretation. A-074 The solid pancreatic lesion
R. Manfredi; Verona/IT
Learning Objectives:
16:00–17:30 Room B 1. To learn about the common and uncommon imaging presentations
of solid lesions of the pancreas.
GI Tract 2. To understand the role of imaging in the detection and differentiation
of solid lesions of the pancreas.
RC 401 Misses and difficulties 3. To explain when imaging features indicate surgical management.
in abdominal imaging 16:28
16:00 A-075 The cystic pancreatic lesion
J. Wessling; Münster/DE
A-069 Chairman’s introduction
J. Stoker; Amsterdam/NL Learning Objectives:
1. To describe the main imaging features and diagnosis of cystic lesions
Session Objective:
of the pancreas.
1. To briefly present how imaging diagnosis can be challenging
2. To discuss the differential diagnosis of cystic lesions of the pancreas
in patients with peritoneal or mesenteric masses, occult GI bleeding
with the emphasis on imaging signs of malignancy.
or bowel dilatation.
3. To explain when imaging features indicate surgical management.
16:05 16:51
A-070 A. Mesentery and peritoneum A-076 The diffuse pancreatic lesion
D. Akata; Ankara/TR
C. Triantopoulou; Athens/GR
Learning Objectives:
Learning Objectives:
1. To learn about the imaging characteristics of peritoneal and
1. To learn about the pathological entities resulting
mesenteric masses and their differentials.
in diffuse pancreatic lesions.
2. To appreciate the great potential, as well as the limitations,
2. To describe the common and uncommon imaging features
of imaging techniques in the detection of such lesions.
that allow differentiation between Inflammation and cancer.
3. To understand the common pitfalls in diagnosis.
3. To compare the advantages and drawbacks of MR imaging compared
16:28 to CT for the workup of diffuse pancreatic lesions.
A-071 B. Occult GI bleeding
A. Filippone; Chieti/IT Panel discussion:
17:14 Pitfalls and problems in pancreatic lesions
Learning Objectives:
1. To understand the causes of GI bleeding and underlying
pathophysiology. 16:00–17:30 Room Z
2. To appreciate the strengths and limitations of the imaging
techniques used in diagnosis.
3. To learn about common pitfalls in diagnosis.
Professional Challenges Session
16:51 PC 4b What are the concrete benefits
A-072 C. Bowel dilatation
E. Danse; Brussels/BE
of structured reporting?
Learning Objectives: 16:00
1. To become familiar with the normal appearances of the bowel A-077 Chairman’s introduction
and the physiological causes of bowel dilatation. L. Donoso; Barcelona/ES
2. To learn about the different imaging techniques to diagnose bowel
Session Objectives:
dilatation and their limitations.
1. To learn about the importance of structured reporting (SR)
3. To understand common pitfalls in diagnosis.
in daily practice.
2. To understand its role in the radiologist workflow.
Panel discussion: 3. To appreciate its benefit as a communication tool.
17:14 What have I learned from misses?
Can improvements be made to reduce misses? 16:05
A-078 For the radiologist
P. Mildenberger; Mainz/DE
Learning Objectives:
1. To explore the impact on reporting workflow.
2. To learn about the value for follow-up studies.
3. To understand how to develop one’s own templates.

176 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:23 17:00
A-079 For the referring physician A-084 C. Treated brain tumours:
J.M.L. Bosmans; Ghent/BE progression or pseudoprogression?
Learning Objectives: P.C. Maly Sundgren; Lund/SE
1. To understand the needs of referring clinicians concerning content Learning Objectives:
and presentation of imaging results. 1. To understand the challenges and limitations of routine MRI
2. To become familiar with existing initiatives to meet referring in monitoring brain tumour treatment.
clinicians’ requirements. 2. To become familiar with the role of advanced imaging biomarkers
3. To learn about clinicians’ evaluations of SR in real life. for early assessment of treatment response.
16:41 3. To learn how to integrate routine and advance MRI into clinical
practice after tumour therapy.
A-080 For the patient
C.E. Kahn; Philadelphia, PA/US
Learning Objectives: 16:00–17:30 Room E1

Wednesday
1. To explore the impact of SR on patient care.
2. To learn about its role in supporting quality improvement and
patient safety.
Musculoskeletal
3. To describe how it enables clinical and translational research.
RC 410 Trauma to the paediatric skeleton
16:59 Moderator: K. Rosendahl; Bergen/NO
A-081 The ESR/RSNA structured reporting initiative
O. Ratib; Geneva/CH 16:00
Learning Objectives: A-085 A. Pelvis/hips
1. To understand the concept of SR using the MRRT IHE standard. N. Boutry, E. Amzallag-Bellenger; Lille/FR
2. To review the current status of the ESR/RSNA joint initiative. Learning Objectives:
3. To learn about the ESR/RSNA technical setup and how to participate 1. To become familiar with the types of injuries seen
in and benefit from it. in the paediatric pelvis/hips.
4. To learn about new trends in multilingual syntax management 2. To understand the strengths and weaknesses
and translation. of different imaging modalities.

Panel discussion: 16:30


17:17 What are the concrete benefits of structured reporting? A-086 B. Elbow
K.J. Johnson; Birmingham/UK
Learning Objectives:
16:00–17:30 Room N 1. To become familiar with the types of injuries seen
in the paediatric elbow.
Neuro 2. To understand the strengths and weaknesses
of different imaging modalities.
RC 411 Imaging findings in treated 17:00
brain tumours A-087 C. Spine
Moderator: B.F. Schuknecht; Zurich/CH L.B.O. Jans; Ghent/BE
Learning Objectives:
16:00 1. To become familiar with the types of injuries seen
A-082 A. How to perform imaging in the postoperative patient: in the paediatric spine.
imaging protocols, normal and abnormal findings 2. To understand the strengths and weaknesses
of different imaging modalities.
aer surgery
M.A. Lucic; Sremska Kamenica/RS
Learning Objectives: 16:00–17:30 Room E2
1. To show the diagnostic protocol in post-operative brain tumours.
2. To learn how to differentiate between tumoural and non-tumoural Professional Challenges Session
disease using different sequence.
3. To consolidate knowledge on how to combine different acquisitions.
PC 4a Radiologist: imager or doctor?
16:30
A-083 B. Understanding radiation- and chemotherapy-induced 16:00
changes aer treatment of brain tumours A-088 Chairman’s introduction
Y. Özsunar; Aydin/TR J.A. Reekers; Amsterdam/NL
Learning Objectives: Session Objectives:
1. To understand why perfusion imaging is routinely needed 1. To learn how radiology can become future-proof.
for post-operative brain tumours evaluation. 2. To understand how radiology can be more visible in the hospital.
2. To become familiar with principles, applications, and pitfalls 3. To learn how teleradiology might threaten radiology.
of various perfusion imaging techniques. 16:05
3. To consolidate knowledge of MR imaging to understand
post-therapy changes. A-089 Which type of radiologist is future proof?
N.H. Strickland; London/UK
Learning Objectives:
1. To understand that radiology is changing.
2. To learn about these changes.
3. To discuss possible the solutions.

www.myESR.org Final Programme | ECR 2015 177


Postgraduate Educational Programme

16:23 Panel discussion:


A-090 Is subspecialisation the answer? 17:14 How to enhance the interaction between radiologists
J.A. Reekers; Amsterdam/NL and pathologists?
Learning Objectives:
1. To understand the potential outcomes of subspecialisation. 16:00–17:30 Room D1
2. To learn how subspecialisation can be of added value.
3. To appreciate that advantages of subspecialisation also come
with risks.
Chest
16:41 RC 404 HRCT - patterns in chest radiology:
A-091 Is teleradiology a threat to radiology?
A. Palkó; Szeged/HU
back to basics and beyond
Learning Objectives: 16:00
1. To understand what teleradiology really is. A-097 Chairman’s introduction
2. To learn how teleradiology might replace hospital radiology. H. Prosch; Vienna/AT
3. To appreciate the risks and benefits of teleradiology. Session Objectives:
16:59 1. To emphasise the importance of anatomy in reading HRCT.
2. To appreciate the need for defining patterns to improve radiological
A-092 Radiology training for the future HRCT diagnoses.
B. Ertl-Wagner; Munich/DE
Learning Objectives: 16:05
1. To understand what the ESR training curriculum is. A-098 A. Secondary pulmonary lobule anatomy:
2. To learn how this curriculum can be used for training radiologists
in Europe.
essential to tackle with the nodular pattern
T. Frauenfelder; Zurich/CH
3. To appreciate the value of uniform training and
diploma accreditation. Learning Objectives:
1. To become confident in recognising the anatomical compartments
of the lung on HRCT.
Panel discussion:
2. To describe typical nodular imaging patterns of lung disease
17:17 How do radiologists stay relevant and what is the role
on HRCT using appropriate terminology.
of the ESR?
16:28
16:00–17:30 Room F2
A-099 B. Linear and reticular pattern
F. Molinari; Lille/FR
Breast Learning Objectives:
1. To recognise and interpret typical reticular imaging patterns
on HRCT.
RC 402 Radio-pathological correlation: 2. To differentiate acute and chronic diseases which cause septal pattern.
more important than you thought 16:51
16:00 A-100 C. GGO opacities and consolidation
I.E. Tyurin; Moscow/RU
A-093 Chairman’s introduction
F.J. Gilbert; Cambridge/UK Learning Objectives:
1. To appreciate the different conditions which cause GGO pattern
16:05 and consolidation.
A-094 A. Pre-treatment planning 2. To learn how to interpret GGO and consolidation in different
C.K. Kuhl; Aachen/DE clinical settings.
Learning Objectives:
1. To know the role of the imaging methods for preoperative staging. Panel discussion:
2. To understand the need for imaging-guided needle sampling and 17:14 Is it always easy to detect a pattern?
localisation for a tailored surgery. Tips for success
3. To appreciate the need for changing surgical guidelines for treating
breast cancer.
16:00–17:30 Room D2
16:28
A-095 B. Intra-operative specimen evaluation Head and Neck
J. Camps Herrero; Valencia/ES
Learning Objectives: RC 408 The orbit:
1. To learn about different imaging techniques for intraoperative you can’t see what you haven’t learnt
specimen evaluation. Moderator: Ü.Y. Ayaz; Mersin/TR
2. To become familiar with methods for specimen orientation and
handling. 16:00
3. To understand the need for immediate reporting/reaction from
radiological department to surgical room. A-101 A. Anatomy and commonly encountered
postoperative findings
16:51 N. Hosten, P.-C. Krüger; Greifswald/DE
A-096 C. Radiologist meets pathologist Learning Objectives:
B. Ingold-Heppner; Berlin/DE 1. To become familiar with the examination technique according
Learning Objectives: to the clinical presentation.
1. To understand what pathologists would always know from 2. To learn about the anatomic compartments of the orbit.
radiologists. 3. To understand post-treatment imaging findings.
2. To learn about the most frequent breast-associated
immunohistochemical markers and their interpretation.
3. To learn about the most applied techniques in pathology, including
gene expression tests.

178 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:30 16:00–17:30 Room K


A-102 B. Congenital and inflammatory disease
T.A. Ferreira; Leiden/NL E³ - ECR Academies: Hybrid Imaging (basic)
Learning Objectives:
1. To appreciate imaging findings in congenital globe and orbit disease. E³ 418 Scanners and tracers
2. To learn about inflammation and infection. Moderator: G. Antoch; Düsseldorf/DE
3. To become familiar with the complications and pathways
of orbital infections. 16:00
17:00 A-108 A. Hybrid imaging:
A-103 C. Benign and malignant neoplastic tumours what systems are available and how do they work
T. Beyer; Vienna/AT
W.S. Müller-Forell; Mainz/DE
Learning Objectives:
Learning Objectives:
1. To understand the basic design of hybrid imaging systems.
1. To become acquainted with the differential diagnoses
2. To become familiar with scanner technology.

Wednesday
of orbital masses.
3. To learn about different approaches to PET attenuation correction.
2. To learn an approach to differentiating orbital tumours.
3. To appreciate the typical imaging findings of benign and 16:30
malignant orbital neoplasm.
A-109 B. Radionuclides for PET/CT and MR/PET
M. Hacker; Vienna/AT
16:00–17:30 Room G Learning Objectives:
1. To understand the principle of FDG in oncology.
Genitourinary 2. To become familiar with non-FDG radionuclides and
their indications.
3. To consolidate knowledge of tracer kinetics.
RC 407 Prostate imaging: how I do it
17:00
16:00 A-110 C. Radiopharmaceuticals for SPECT/CT
A-104 Chairman’s introduction J.R. Ballinger; London/UK
H.-P. Schlemmer; Heidelberg/DE Learning Objectives:
Session Objectives: 1. To learn about the basic radionuclides for SPECT/CT.
1. To learn how to perform and interpret multiparametric MRI for best 2. To understand tracer kinetics in SPECT.
possible detection and biologic characterisation of cancer foci within 3. To appreciate SPECT tracers and their indications.
the prostate.
2. To become familiar with the current options of image-guided biopsy.
3. To understand the clinical relevance of multiparametric MRI for 16:00–17:30 Room MB 1
treatment decision-making during active surveillance and after
initial therapy. Vascular
16:05
A-105 A. Detection and assessment of aggressiveness
RC 415 Basic principles of varicose vein
P.A. Puech; Lille/FR diagnosis and endovascular treatment
Learning Objectives: Moderator: D. Karnabatidis; Patras/GR
1. To understand the different types of prostate cancer within the gland.
2. To become familiar with common pitfalls of prostate cancer 16:00
semiology at multiparametric MRI. A-111 A. Diagnostic cross-sectional imaging
3. To understand the MRI “biomarkers” of prostate cancer H. Hoppe; Berne/CH
aggressiveness. Learning Objectives:
16:28 1. To become familiar with the whole spectrum
of varicose vein pathology.
A-106 B. Image-guided biopsy and staging 2. To learn about technical principles of a state-of-the-art lower limb
F. Cornud, C. Escourrou, N.B. Delongchamps; Paris/FR venous ultrasonograhic study.
Learning Objectives: 3. To learn how to extrapolate ultrasonographic findings
1. To understand the techniques of prostate biopsy. into endovascular treatment.
2. To become familiar with the MR-guided and MR/TRUS
fusion approach. 16:30
3. To learn about the optimal imaging protocol for the staging A-112 B. Saphenous vein ablation
of prostate cancer. A. Rampoldi; Milan/IT
16:51 Learning Objectives:
1. To understand the principles of ablation therapy.
A-107 C. Role of imaging in active surveillance and detection 2. To learn the technique for ablation and how to avoid complications.
of recurrence 3. To learn about outcomes and complications.
V. Logager; Copenhagen/DK
Learning Objectives:
17:00
1. To learn about the role of multiparametric MRI in guiding therapy A-113 C. Ultrasound guided sclerotherapy
towards active surveillance. J. Brookes; London/UK
2. To learn about the imaging findings in local recurrence after Learning Objectives:
treatment. 1. To learn about the principles of venous sclerotheraphy.
3. To understand the impact in treatment planning as a consequence 2. To learn about technical principles of US-guided sclerosis
of these findings. of lower limb veins.
3. To learn about pros and cons of US-guided sclerosis versus
Panel discussion: endovascular ablation.
17:14 How can multiparametric MRI be implemented as clinical
standard across multiple centres?

www.myESR.org Final Programme | ECR 2015 179


Postgraduate Educational Programme

16:00–17:30 Room MB 2 16:41


A-120 C. Cryoablation: ice can be better than heat
Cardiac D.J. Breen; Southampton/UK
Learning Objectives:
RC 403 Quantification of myocardial perfusion: 1. To learn about the physical and technical basis of cryoablation.
which test is the best 2. To understand the advantages and limitations of the technique.
3. To become familiar with the current indications in oncology.
(PET, MRI, MDCT)?
Moderator: M. Williams; Edinburgh/UK 16:59
A-121 D. Irreversible electroporation: principles, technique and
16:00 clinical applications
A-114 A. PET for evaluation of perfusion, absolute myocardial A. Nilsson; Uppsala/SE
blood flow and coronary flow reserve Learning Objectives:
S. Kajander; Turku/FI 1. To understand the physical and technical basis of irreversible
Learning Objectives: electroporation (IRE).
1. To understand the molecular tracers used to asses myocardial 2. To understand the advantages and limitations of the technique.
perfusion by PET. 3. To become familiar with the current indications in oncology.
2. To appreciate the strengths and limitations of PET in evaluating
myocardial perfusion. Panel discussion:
3. To become familiar with its role in different clinical scenarios. 17:17 Selection of ablation modalities:
16:30 operator’s preference or evidence-based?
A-115 B. Stress perfusion CT imaging for the detection and
quantification of relevant coronary stenosis 16:00–17:30 Room MB 4
F. Bamberg; Tübingen/DE
Learning Objectives: Emergency Radiology
1. To learn about protocol setup and interpretation of stress myocardial
perfusion CT. RC 417 ‘Special patients’
2. To understand the prognostic implications and therapeutic
considerations of CT perfusion parameters.
in the emergency room:
3. To appreciate the value of stress myocardial perfusion CT for the when and how to image them?
detection of significant coronary stenosis. Moderator: S. Wirth; Munich/DE
17:00 16:00
A-116 C. Analysis of myocardial perfusion using MRI A-122 A. Children
R. Manka; Zurich/CH V. Miele; Rome/IT
Learning Objectives: Learning Objectives:
1. To learn about protocol setup and interpretation of stress myocardial 1. To be familiar with common non-traumatic emergencies
perfusion CT. in the paediatric population.
2. To understand the role of CMR perfusion imaging as a tool for 2. To comprehend the rationale of using different diagnostic
diagnosis and prognosis of coronary artery disease. imaging methods in emergency situations.
3. To discuss how CMR perfusion can be utilised in the assessment of 3. To be aware of the impact of imaging findings
microvascular disease. on patient management.
16:30
16:00–17:30 Room MB 3 A-123 B. Pregnant patients
H. Alkadhi; Zurich/CH
Interventional Radiology Learning Objectives:
1. To be familiar with the most common non-traumatic emergencies
RC 409 Basic principles of percutaneous in pregnant women.
tumour ablation 2. To learn which tests to choose in pregnant patients for the diagnostic
evaluation of pulmonary embolism and acute abdomen.
16:00 3. To know current guidelines and recommendations for contrast media
administration in pregnancy.
A-117 Chairman’s introduction
T. de Baère; Villejuif/FR 17:00
16:05 A-124 C. Elderly patients
K. Katulska; Poznan/PL
A-118 A. Thermal ablation with RF Learning Objectives:
V. Válek; Brno/CZ
1. To be familiar with typical and atypical clinical emergency situations
Learning Objectives: in the elderly.
1. To learn about the physical and technical basis 2. To understand imaging strategies and the role of different imaging
of radiofrequency ablation. methods in elderly patients.
2. To understand the advantages and limitations of the technique. 3. To learn common and specific imaging findings
3. To become familiar with the current indications in oncology. in the elderly population.
16:23
A-119 B. Microwave ablation: what is the difference?
P.L. Pereira; Heilbronn/DE
Learning Objectives:
1. To learn about the physical and technical basis of microwave ablation.
2. To understand the advantages and limitations of the technique as
compared to RF ablation.
3. To become familiar with the current indications in oncology.

180 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room MB 5

Paediatric
RC 412 Imaging of foetus and infant
Moderator: D. Prayer; Vienna/AT

16:00
A-125 A. Foetal neuro imaging
A. Rossi; Genoa/IT
Learning Objectives:
1. To learn how to perform prenatal brain MRI and to recognise normal
features at various gestational weeks.
2. To highlight the complementary role of brain MRI to prenatal

Wednesday
ultrasound for various indications, with a particular focus on the
problem of ventriculomegaly.
3. To familiarise oneself with the MRI features of the main congenital
malformations and clastic injury affecting the foetal brain.
16:30
A-126 B. Foetal body imaging
M. Cassart; Brussels/BE
Learning Objectives:
1. To have an overview of foetal abdominal diseases and malformations.
2. To learn about the complementary roles of US and MRI.
3. To understand how prenatal imaging helps in the management of the
foetus and the newborn.
17:00
A-127 C. Foetal and neonatal urinary tract imaging
C. Garel; Paris/FR
Learning Objectives:
1. To learn about the changing appearance of the urinary tract
throughout pregnancy and at birth.
2. To become familiar with the main causes of obstruction and
their possible impact on the kidneys.
3. To learn about the main causes of hyperechoic kidneys.

www.myESR.org Final Programme | ECR 2015 181


Postgraduate Educational Programme

182 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room A 08:30–10:00 Room C

E³ - ECR Academies: Special Focus Session


Interactive Teaching Sessions SF 5 Advanced applications in ultrasound
E³ 521 What to look for aer treatment 08:30
of lung cancer A-133 Chairman’s introduction
T. Fischer; Berlin/DE
08:30 Session Objectives:
A-128 A. Imaging of surgically treated lung cancer 1. To understand the physics and clinical potential of advanced
C.P. Heussel; Heidelberg/DE ultrasound applications such as CEUS, shear wave elastography or
Learning Objectives: ultrafast Doppler.
1. To appreciate the complications after surgery for lung cancer. 2. To learn in detail about the clinical use of CEUS in pancreatic
2. To understand the anatomic changes which occur after surgery diseases, molecular imaging and antiangiogenic treatment.
for lung cancer. 3. To appreciate the potential clinical utility of shear wave elastography
and new Doppler techniques.
09:15
A-129 B. Imaging of non-surgical treatment of lung cancer 08:35
B. Ghaye; Brussels/BE A-134 Contrast-enhanced ultrasound of the pancreas
Learning Objectives: M. D’Onofrio; Verona/IT
1. To learn about sequelae after radiotherapy. Learning Objectives:
2. To learn about sequential changes after percutaneous ablation 1. To learn the appropriate protocols and settings for contrast-enhanced
of lung tumours. ultrasound (CEUS) examination of the pancreas.
2. To describe the technique for CEUS of the pancreas.
3. To detail the clinical use of CEUS in the evaluation of

Thursday
08:30–10:00 Room B pancreatic pathologies.
4. To know the best indications for CEUS in the main pancreatic
Abdominal Viscera diseases.
5. To describe CEUS findings for the characterisation of focal
pancreatic masses.
RC 501 The many faces of benign liver lesions 6. To compare CEUS to CT and MRI findings in studying
Moderator: L. Grenacher; Heidelberg/DE pancreatic pathologies.
7. To discuss the possible different role of CEUS in the diagnostic
08:30 work-up of focal pancreatic lesions.
A-130 A. Vascular
M. Karcaaltincaba; Ankara/TR 08:53
Learning Objectives: A-135 Molecular ultrasound and dynamic contrast-enhanced US
1. To become familiar with typical and infrequent manifestations for antiangiogenic therapy monitoring
of benign hypervascular focal liver lesions. N. Lassau; Villejuif/FR
2. To learn how to differentiate between benign and malignant lesions. Learning Objectives:
3. To appreciate the limitations and complementary roles of CT 1. To understand physics and clinical potential of molecular imaging
and MR. and new markers with ultrasound.
09:00 2. To understand technologies of dynamic contrast-enhanced
ultrasound (DCEUS) and ways of quantification.
A-131 B. Cystic-Biliary 3. To describe the protocols and results of a large multicentre study
G. Brancatelli; Palermo/IT performed with quantitative DCEUS.
Learning Objectives: 4. To discuss application in routine clinical practice and future outlook.
1. To understand the features of congenital and infectious cystic
liver lesions. 09:11
2. To learn how to differentiate between benign and malignant A-136 State-of-the-art ultrasound technologies: elastography
cystic lesions. and microvascular imaging - are they useful?
A.K.P. Lim; London/UK
09:30
Learning Objectives:
A-132 C. Hepatocellular 1. To understand the physics and technologies of elastography
R.L. Baron; Chicago, IL/US
and microvascular imaging.
Learning Objectives: 2. To describe the differing elastography techniques
1. To understand the typical aspect of hepatocellular benign lesions and microvascular imaging.
on US, CT and MRI. 3. To detail the potential clinical utility of elastography
2. To learn when a liver-specific contrast medium can help us and microvascular imaging.
in the proper characterisation of hepatocellular benign liver lesions. 4. To discuss the evidence for the use of these technologies
3. To understand the classification of liver adenomas, prognosis and in routine clinical practice.
imaging characteristics.
09:29
A-137 ShearWave elastography, ultrafast Doppler and
image fusion
J.-M. Correas; Paris/FR
Learning Objectives:
1. To understand the physics and technologies of shearwave
elastography and ultrafast Doppler.
2. To describe the differing elastography techniques.
3. To detail the potential clinical utility of elastography and
image fusion.
4. To discuss the evidence for the use of these technologies in routine
clinical practice.

www.myESR.org Final Programme | ECR 2015 183


Postgraduate Educational Programme

Panel discussion: 09:30


09:47 How could these technologies improve clinical routine? A-143 C. MR/PET
H.H. Quick; Essen/DE
08:30–10:00 Room Z Learning Objectives:
1. To identify frequent artefacts in MR and PET imaging.
2. To understand the physical origin of and methods to resolve artefacts
Joint Session of the ESR and EFSUMB in MR/PET imaging.
3. To understand the interrelation of MR artefacts and bias in PET
Advances in diagnostic ultrasound: quantification in MR/PET imaging.
better results through integration
Moderators: G. Mostbeck; Vienna/AT, P.S. Sidhu; London/UK
08:30–10:00 Room N
08:30
A-138 Diagnosis, characterisation and staging of tumours E³ - ECR Academies: Image-Guided
of the female pelvis
A.G. Rockall1, D. DeFriend2; 1London/UK, 2Abbotskerswell/UK
Interventions in Oncology
Learning Objectives: E³ 519 Hepatic primary tumours:
1. To appreciate the respective roles of US, MR and CT in patients with
ovarian and uterine tumours.
‘prime time’ for interventional
2. To understand when US can be considered a definitive examination radiologists?
and when CT and/or MR are needed to characterise pelvic masses.
3. To recognise when a US examination can be useful after MR and/or 08:30
CT identification of a tumour of the female pelvis. A-144 Chairman’s introduction
M. Bezzi; Rome/IT
09:00
Session Objectives:
A-139 Diagnosis, characterisation and staging of renal tumours 1. To learn about the role of interventional radiology in the therapeutic
S. Freeman1, N. Grenier2; 1Plymouth/UK, 2Bordeaux/FR
strategies for hepatocellular carcinoma.
Learning Objectives: 2. To understand the added clinical value of image-guided interventions
1. To appreciate the respective roles of US, MR and CT in patients with in different stages of hepatocellular carcinoma.
renal tumours. 3. To become familiar with the several image-guided techniques
2 To understand when US can be considered a definitive examination available.
and when CT and/or MR are needed to characterise renal masses.
3. To recognise when a US examination can be useful after MR and/or 08:33
CT identification of a tumour of the kidney. A-145 A. Percutaneous techniques:
09:30 the clinical value of minimally invasive options
B. Gebauer; Berlin/DE
A-140 Diagnosis, characterisation and staging of liver tumours
H.-P. Weskott , A. Ba-Ssalamah ; Hannover/DE, Vienna/AT
1 2 1 2 Learning Objectives:
1. To understand when percutaneous ablation is indicated
Learning Objectives: (BCLC guidelines).
1. To appreciate the respective roles of US, MR and CT in patients with 2. To understand when radiofrequency ablation (RFA) and when
liver tumours. microwaves ablation (MW) are indicated and which guidance
2. To understand when US can be considered a definitive examination is recommended.
and when CT and/or MR are needed to characterise hepatic masses. 3. To consolidate knowledge of results from the literature.
3. To recognise when a US examination can be useful after MR and/or
CT identification of a tumour of the liver. 09:02
A-146 B. Intra-arterial therapies 2.0:
08:30–10:00 Room M the embolising techniques in the era of the micro-beads
A. Denys; Lausanne/CH
Physics in Radiology Learning Objectives:
1. To understand when intra-arterial treatments (transarterial bland
embolisation, conventional chemoembolisation, drug-eluting beads
RC 513 Artefacts and pitfalls in tomography chemoembolisation) are indicated (BCLC guideline).
Moderator: J. Damilakis; Iraklion/GR 2. To learn about essential technical issues.
3. To consolidate knowledge of results from the literature.
08:30
A-141 A. CT 09:31
M. Kachelrieß; Heidelberg/DE A-147 C. Intra-arterial therapies 2.0:
Learning Objectives: radioembolisation as a common daily practice
1. To understand the source of artefacts in clinical CT. J.I. Bilbao; Pamplona/ES
2. To learn about aliasing, beam hardening, effects of metal and of Learning Objectives:
motion, photon starvation, sampling artefacts, and linear and 1. To understand when transarterial radioembolisation is indicated
non-linear partial volume effects. (BCLC guideline).
3. To get an idea of the most important correction methods. 2. To learn about technical and anatomical considerations
4. To find out what artefact correction techniques are actually provided for transarterial radioembolisation.
by the CT vendors in their systems. 3. To consolidate knowledge results from the literature.
09:00
A-142 B. PET/CT
T. Beyer; Vienna/AT
Learning Objectives:
1. To understand image distortions, artefacts and bias from
methodological pitfalls in PET/CT imaging.
2. To appreciate and understand solutions to frequent image distortions
in PET/CT.
3. To understand the methodological limitations of PET/CT.

184 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room E1 08:55


A-157 The influence of health economics systems on radiology
Breast D. Katsifarakis; Athens/GR
Learning Objectives:
SA 5 Rethinking ductal carcinoma 1. To become familiar with health economics concepts.
in situ (DCIS) 2. To understand how health systems models influence radiology.
3. To appreciate how to develop effective and efficient radiology
08:30 departments.
A-151 Chairman’s introduction 09:15
G. Forrai; Budapest/HU
A-158 Quo vadis radiology professions? A pragmatic approach
Session Objectives: G.P. Krestin; Rotterdam/NL
1. To become familiar with the state-of-the-art preoperative workup
of DCIS. Learning Objectives:
2. To appreciate the degree of over- and underestimation of DCIS 1. To appreciate the main pillars of professional development.
by imaging. 2. To become familiar with the implications of technological
3. To understand the relevance of histological subtypes in the therapy development in professional practice.
planning. 3. To understand the importance of teamwork for the future of
radiology professions.
08:34
A-152 New molecular pathologic knowledge on DCIS Panel discussion:
T. Tot; Falun/SE 09:35 What is the role of European societies in building a sustainable
Learning Objectives:
model for radiology?
1. To describe the molecular phenotypes of DCIS.
2. To analyse the relation of the molecular phenotype of DCIS
to multifocality and radiological manifestation.
08:30–10:00 Room F1

Thursday
3. To evaluate the prognostic impact and therapeutic implications
of phenotyping DCIS. Oncologic Imaging
08:56 RC 516 Gastro-entero-pancreatic
A-153 Diagnosing DCIS with MRI neuro-endocrine tumours (GEP-NET):
C.K. Kuhl; Aachen/DE
Learning Objectives:
a multidisciplinary update
1. To understand the pathophysiological basis of DCIS detection 08:30
in mammography and MRI.
2. To list imaging features of DCIS. A-159 Chairman’s introduction
3. To appreciate current and future applications of MRI A.E. Sundin; Uppsala/SE
for diagnosing DCIS. Session Objectives:
1. To become familiar with the clinical and pathological aspects of
09:18 GEP-NET.
A-154 Image-guided interventions for DCIS 2. To learn about the role of cross-sectional and nuclear medicine
R.M. Pijnappel; Utrecht/NL imaging techniques in GEP-NET.
Learning Objectives: 08:35
1. To learn about underestimation in core needle biopsy in comparison
with vacuum-assisted biopsy. A-160 A. Tumour biology, pathogenesis and classification
2. To understand the importance of pathologic proof of non-mass M.E. Pavel; Berlin/DE
enhancement on MRI. Learning Objectives:
3. To become familiar with low grade versus high grade DCIS. 1. To learn about the basic aspects of GEP-NET biology, pathogenesis
and classification.
Panel discussion: 2. To understand the epidemiology and current treatment options.
09:40 Patient with DCIS: how to plan her therapy in 2015? 3. To become familiar with rational clinical management.
08:58
08:30–10:00 Room E2 A-161 B. The current role of nuclear medicine
S. Fanti; Bologna/IT
Professional Challenges Session Learning Objectives:
1. To learn about the cellular properties and GEP-NET used in
molecular imaging.
PC 5a Looking into the future of radiology 2. To become familiar with the different modalities and new tracers
08:30 being used.
3. To learn about the performance of the different methods available.
A-155 Chairmen’s introduction
M.H. Fuchsjäger1, G. Paulo2; 1Graz/AT, 2Coimbra/PT 09:21
Session Objectives: A-162 C. Anatomical imaging: transabdominal US, endoscopic
1. To learn about external factors that influence radiology. US, MDCT and MRI: which is the most appropriate imaging
2. To become familiar with health economics concepts.
3. To understand the changing roles of the radiology professions.
approach?
V. Vilgrain, M. Ronot, M.-P. Vullierme, P. Ruszniewski; Clichy/FR
08:35 Learning Objectives:
A-156 Health technology assessment (HTA) 1. To learn how to recognise the specific imaging features of GEP-NET.
E.J. Adam; London/UK 2. To learn about the strengths and weaknesses of the different imaging
modalities.
Learning Objectives:
3. To understand the optimal use of the different imaging modalities in
1. To learn about HTA concepts.
relation to tumour location and staging.
2. To become familiar with the role of radiology professions in HTA.
3. To understand the influence of HTA on decision-making in the field
of radiology. Panel discussion:
09:44 The future of hybrid imaging

www.myESR.org Final Programme | ECR 2015 185


Postgraduate Educational Programme

08:30–10:00 Room F2 08:35


A-169 A. COPD in HRCT: what should we report?
Professional Challenges Session N. Sverzellati; Parma/IT
Learning Objectives:
PC 5b Imaging biobanks: 1. To learn about the classification of COPD.
from genomic to radiomic in the era 2. To appreciate the role of HRCT in COPD.
of personalised medicine 08:58
08:30 A-170 B. Airways disease: The role of expiratory CT
A. Devaraj; London/UK
A-163 Chairmen’s introduction Learning Objectives:
G. Frija1, E. Neri2; 1Paris/FR, 2Pisa/IT
1. To become familiar with different diseases that affect the airways.
Session Objective: 2. To learn when inspiratory and expiratory CT may be of value in
1. To briefly introduce the concepts and the link between them: patients with lung disease.
quantitative imaging, biomarker, radiomic, imaging biobank,
personalised medicine. 09:21
08:33 A-171 C. Is there a role for MRI?
M.O. Wielpütz; Heidelberg/DE
A-164 The biobanks: genomic, moleculomic and proteomic - Learning Objectives:
Which link to radiomics? 1. To learn about different MRI techniques used to assess
M. Borro, G. Chillemi, M. Simmaco; Rome/IT pulmonary disease.
Learning Objective: 2. To appreciate when MRI may be of value in patients
1. To report the rationale of linking genomic, moleculomic and with pulmonary disease.
proteomic (the so called “omics”) with radiomic.
Panel discussion:
08:51 09:44 When should we do expiratory CT, and when should
A-165 Radiomic: report from the ESR Working Group we consider doing an MRI?
on Imaging Biobanks
H.-U. Kauczor; Heidelberg/DE
Learning Objective: 08:30–10:00 Room D2
1. To report the rationale of the Imaging Biobanks Working Group
and the stage. Head and Neck
09:09 RC 508 Pitfalls in interpretation of head and
A-166 Existing imaging biobanks neck disease
A. Jackson; Manchester/UK
Moderator: M.M. Lemmerling; Ghent/BE
Learning Objective:
1. To report the experience carried out with the existing imaging
biobanks (i.e. UK Biobank).
08:30
A-172 A. Anatomical variants without clinical consequence
09:27 F.A. Pameijer; Utrecht/NL
A-167 Extraction and analysis of biomarkers Learning Objectives:
from medical images 1. To get insight into the great variability of head and neck anatomy.
B. Gibaud; Rennes/FR 2. To be able to recognise pseudolesions.
Learning Objective: 09:00
1. To describe how we can extract the relevant information from
medical images and how these can be analysed and correlated A-173 B. Anatomical variants posing surgical risks
T. Beale; London/UK
with other kinds of information (lab values, genotypes, etc.).
Learning Objectives:
Panel discussion: 1. To learn about structures at risk during functional endoscopic sinus
09:45 Future strategies for the development and the federation surgery (FESS).
of biobanks, definition of standards, etc. 2. To become familiar with vascular variants in head and neck.
3. To appreciate surgical anatomical landmarks in head and neck.
09:30
08:30–10:00 Room D1
A-174 C. Distinct head and neck disease or systemic disease?
B.F. Schuknecht; Zurich/CH
Chest Learning Objectives:
1. To recognise head and neck manifestations of systemic disease.
RC 504 COPD, airways disease and beyond 2. To understand patterns of spread.
08:30
A-168 Chairman’s introduction
P.A. Grenier; Paris/FR
Session Objectives:
1. To learn about the role of HRCT in the classification of COPD.
2. To learn tips for getting the most out of CT techniques for the
morphological and quantitative evaluation of COPD and airway
diseases.
3. To become familiar with the future growing role of MRI in the
assessment of lung disease.

186 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room G 09:30


A-180 C. MR/PET imaging protocols
Neuro O. Ratib; Geneva/CH
Learning Objectives:
RC 511 Cerebrovascular disease 1. To become familiar with different imaging protocols in MR/PET.
Moderator: M.P. Wattjes; Amsterdam/NL 2. To appreciate the indications for diffusion-weighted imaging
in MR/PET.
08:30 3. To understand indications for contrast agents in MR/PET.
A-175 A. Vascular distribution territories: arterial and venous
A. Dörfler, T. Engelhorn; Erlangen/DE
Learning Objectives: 08:30–10:00 Room MB 1
1. To become familiar with a comprehensive vascular anatomy
of the brain. Vascular
2. To understand the advantages and limitations of CTA and MRA.
3. To recognise the different imaging patterns in stroke and their RC 515 Imaging and intervention in acute
prognostic value. ischaemic stroke
09:00 Moderator: P. Zampakis; Patras/GR
A-176 B. Detecting microhaemorrhages: why are they 08:30
important? What are they? Should we use GRE T2* or
A-181 A. Acute stroke imaging
SWI or both? K.-O. Lovblad; Geneva/CH
H.R. Jäger; London/UK
Learning Objectives:
Learning Objectives: 1. To learn about parenchymal and vascular stroke imaging.
1. To show the basic physics of the two sequences. 2. To become familiar with appropriate imaging protocols
2. To understand the role of both sequences in stroke and for all imaging modalities.

Thursday
other disorders. 3. To learn about the pros and cons of each modality.
3. To recognise imaging patterns that may mimic stroke clinically
and radiologically. 09:00
09:30 A-182 B. Indications for intervention
N. Kocer; Istanbul/TR
A-177 C. Cerebral perfusion studies in cerebrovascular disease: Learning Objectives:
techniques, indications and applications 1. To learn how to define the indication for treatment.
P.M. Parizel, F. De Belder, C. Venstermans, T. Van der Zijden, J. Huyskens, 2. To learn about the treatment decision-making process.
J. Van Goethem, L. van den Hauwe, M. Voormolen; Antwerp/BE
3. To learn about the classification of lesions and indications
Learning Objectives: for treatment.
1. To understand how imaging can help select patients for treatment
of acute ischaemic stroke. 09:30
2. To show the importance of collateral flow in ischaemic patients. A-183 C. Mechanical revascularisation
3. To explain the actual EBM treating patients with acute ischaemic T. van der Zijden, M. Voormolen, O. d’Archambeau, F. de Belder, C. Venstermans,
stroke. L. van den Hauwe, J. Van Goethem, P.M. Parizel; Edegem/BE
Learning Objectives:
1. To learn the difference between mechanical and pharmacological
08:30–10:00 Room K stroke treatment.
2. To learn about different mechanical revascularisation techniques.
E³ - ECR Academies: Hybrid Imaging (basic) 3. To learn how to manage complications.

E³ 518 Imaging protocols for PET/CT and


MR/PET 08:30–10:00 Room MB 2
Moderator: C. Pfannenberg; Tübingen/DE Cardiac
08:30
A-178 A. Does it make sense to use CT contrast agents in PET/CT RC 503 Imaging of cardiac valves: new trends
G. Antoch; Düsseldorf/DE Moderator: F. Pugliese; London/UK
Learning Objectives: 08:30
1. To become familiar with indications for CT contrast agents
in PET/CT. A-184 A. Echocardiography remains the reference technique
2. To understand the effect of CT contrast on PET tracer quantification. T. Binder; Vienna/AT
3. To learn about contrast-associated artefacts in PET/CT. Learning Objectives:
1. To learn about state-of-the-art echo techniques to evaluate cardiac
09:00 valves.
A-179 B. PET/CT imaging protocols 2. To provide a practical approach to assessing valve pathology based
A. Scarsbrook; Leeds/UK on echocardiography.
Learning Objectives: 3. To become familiar with the role of echo in the diagnosis,
1. To learn about different imaging protocols in PET/CT. clinical management and prognosis.
2. To appreciate an indication-based selection of different imaging 09:00
protocols.
3. To consolidate knowledge of available image reconstruction A-185 B. MRI is the best comprehensive approach
parameters. M. Francone; Rome/IT
Learning Objectives:
1. To learn about the role of MRI in diagnosis and evaluation
of valvular disease.
2. To become familiar with state-of-the-art MRI techniques
to evaluate valvular disease.
3. To learn about typical imaging findings in MRI with impact
on clinical management.

www.myESR.org Final Programme | ECR 2015 187


Postgraduate Educational Programme

09:30 09:00
A-186 C. Does CT have a role in diagnosing valvular disease? A-192 B. The enemy within:
G. Feuchtner; Innsbruck/AT non-traumatic abdominal emergencies
Learning Objectives: R.J. Zagoria; San Francisco, CA/US
1. To learn about state-of-the-art CT techniques to evaluate cardiac Learning Objectives:
valves at low dose. 1. To learn how to better analyse CT scans for non-traumatic causes of
2. To review CT appearance of the most common conditions causing abdominal pain.
valvular disease. 2. To learn about the CT signs and causes of bowel ischaemia.
3. To become familiar with the role of CT in the diagnosis and clinical 3. To learn about the CT findings of common causes of an ‘acute’
management. abdomen.
4. To learn about the imaging findings of acute, non-traumatic urinary
tract and GI tract emergencies.
08:30–10:00 Room MB 3
09:30
Interventional Radiology A-193 C. Interactive case discussion
A. Palkó1, R.J. Zagoria2; 1Szeged/HU, 2San Francisco, CA/US
RC 509 Percutaneous treatment of chronic Learning Objectives:
back pain and sciatica 1. To learn how to better analyse CT scans for traumatic and
non-traumatic causes of abdominal pain.
08:30 2. To learn about the CT signs and causes of bowel ischaemia
and injuries.
A-187 Chairman’s introduction 3. To learn about the CT findings of common causes of traumatic
A. Gangi; Strasbourg/FR
and non-traumatic ‘acute’ abdomen.
08:35 4. To learn about the imaging findings of acute, traumatic and
non-traumatic urinary tract and GI tract emergencies.
A-188 A. Sacroiliac joint syndrome
D.J. Wilson; Oxford/UK
Learning Objectives: 08:30–10:00 Room MB 5
1. To learn about relevant anatomy and clinical presentations
of the syndrome. E³ - ECR Academies:
2. To learn more about the available treatments.
3. To learn about clinical results and possible further developments. Diagnostic Urogenital Radiology
08:58
A-189 B. Facet joint syndrome
E³ 520 Kidney
A.D. Kelekis; Athens/GR Moderator: C. Nicolau; Barcelona/ES
Learning Objectives: 08:30
1. To understand the difference between facet joint and disc disease.
2. To learn about different treatment options for facet disease.
A-194 A. Differential diagnoses of cystic renal masses
M. Claudon; Vandoeuvre-les-Nancy/FR
3. To learn how to manage patients.
Learning Objectives:
09:21 1. To become familiar with the updated Bosniak classification.
A-190 C. Intervertebral disc syndrome 2. To learn about the differential diagnoses of complex cystic
D. Filippiadis; Athens/GR renal masses.
Learning Objectives: 3. To become familiar with typical surgical and non-surgical lesions.
1. To understand possible treatment techniques for disc disease. 09:00
2. To learn more about clinical and imaging findings in treatment.
3. To learn about published results on percutaneous disc treatment.
A-195 B. Differential diagnoses of solid renal masses
S.H. Kim; Seoul/KR
Panel discussion: Learning Objectives:
09:44 How can imaging methods identify candidates 1. To learn about the differential diagnoses of solid renal lesions.
for percutaneous therapy or surgery? 2. To become familiar with typical imaging findings of the renal cell
carcinoma subtypes.
3. To become familiar with potential criteria for active surveillance
08:30–10:00 Room MB 4 of solid renal masses.
09:30
Joint Course of ESR and RSNA A-196 C. Acute and chronic renal infection
(Radiological Society of North America): J. Lopes Dias; Lisbon/PT
Learning Objectives:
Emergency Radiology 1. To learn about the different etiologies of acute renal infection,
including typical imaging findings.
MC 528 Abdominal emergencies 2. To learn about the time-point and possibilities for interventions.
Moderator: A. Palkó; Szeged/HU 3. To understand the causes of chronic renal infection, including typical
imaging findings.
08:30
A-191 A. Abdominal injuries
A. Palkó; Szeged/HU
Learning Objectives:
1. To understand the significance of injury mechanism and its role
in the formation of consequent abdominal lesions and their
complications.
2. To learn about the role of proper imaging technique and diagnostic
algorithm in the sufficiently fast diagnosis of abdominal injuries.
3. To learn more about the typical and unusual findings of various
abdominal traumatic conditions.

188 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

10:30–12:00 Room A 11:30


A-204 C. Interactive case discussion
E³ - ECR Academies: M. Brink1, C.M. Schaefer- Prokop2; 1Nijmegen/NL, 2Amersfoort/NL
Interactive Teaching Sessions
10:30–12:00 Room MB 5
E³ 621 The treated liver
10:30 E³ - ECR Academies:
A-197 A. Imaging of liver transplantation
J.B. Karani; London/UK
Diagnostic Urogenital Radiology
Learning Objectives: E³ 620 Retroperitoneum and adrenals
1. To understand the common imaging findings after liver Moderator: F.M. Danza; Rome/IT
transplantation.
2. To recognise significant complications following liver transplantation. 10:30
11:15 A-205 A. Anatomy and imaging techniques
A-198 B. Imaging of treated liver tumours of the retroperitoneum
I. Bargellini; Pisa/IT M.C. Roethke; Heidelberg/DE
Learning Objectives: Learning Objectives:
1. To understand the common imaging findings after chemotherapy 1. To become familiar with new insights into the normal anatomy
for liver tumours. of the retroperitoneum.
2. To recognise common imaging findings after radiofrequency ablation 2. To understand the spreading of retroperitoneal diseases
of liver tumours. across spaces.
3. To be aware of the common imaging findings following transarterial 3. To learn about the optimal CT and MR protocols for imaging
treatment of liver tumours. of the retroperitoneum.

Thursday
11:00
10:30–12:00 Room MB 4 A-206 B. Differential diagnoses of retroperitoneal masses
M.-F. Bellin, L. Rocher; Le Kremlin-Bicêtre/FR
Joint Course of ESR and RSNA Learning Objectives:
1. To be familiar with the typical imaging features
(Radiological Society of North America): of retroperitoneal lesions.
2. To learn about the differential diagnoses of benign and
Emergency Radiology malignant retroperitoneal masses.
3. To understand how recognise the exact extent
MC 628 Chest emergencies of retroperitoneal masses.
Moderator: A. Palkó; Szeged/HU
11:30
10:30 A-207 C. Differential diagnoses of adrenal lesions
G. Heinz-Peer; St. Pölten/AT
A-202 A. Thoracic injuries
M. Brink; Nijmegen/NL Learning Objectives:
Learning Objectives: 1. To learn about the imaging protocols of adrenal glands,
1. To learn how to differentiate traumatic aortic injuries from congenital including functional imaging.
variants that mimic injury, to distinguish minor from major aortic 2. To understand the typical imaging features of an adenoma
injuries, and to understand how injury classification can influence on CT and MRI.
management. 3. To become familiar with typical signs of malignancy.
2. To become familiar with the various CT appearances suggesting and
verifying major airway injury.
3. To understand the various CT appearances of blood/bleeding in the 12:15–12:45 Room A
chest and how the location, quantity of blood/bleeding and patient
clinical status determine initial treatment. Plenary Session
4. To appreciate the spectrum of cardiac injuries that can be diagnosed
on admission contrast-enhanced CT and those that require urgent HL 1 Josef Lissner - Honorary Lecture
intervention. Presiding: B. Hamm; Berlin/DE
11:00 12:15
A-203 B. Non-traumatic thoracic emergencies A-208 Is the ‘Art of Medicine’ dead in the era of population
C.M. Schaefer-Prokop; Amersfoort/NL
Learning Objectives:
health management?
J.A. Brink; Boston, MA/US
1. To illustrate typical CXR findings made in patients entering the
ER with acute dyspnoea and to learn when CT is indicated and Learning Objectives:
diagnostically useful. 1. To learn the principles of population health management.
2. To learn how to analyse and interpret HRCT patterns of pulmonary 2. To consider the impact of variation in the practice radiology
opacifications in patients with acute respiratory insufficiency. on population health.
3. To learn about radiological key features helpful for differential 3. To understand the potential roles that radiologists can play
diagnosis and how to integrate clinical information. to improve population health.
4. To study the impact of these changes on the art and science
of medicine.

www.myESR.org Final Programme | ECR 2015 189


Postgraduate Educational Programme

12:30–13:30 Room B 14:00–15:30 Room M

E³ - The Beauty of Basic Knowledge: EuroSafe Imaging Session


Breast Imaging EuroSafe 1 Clinical Decision Support:
E³ 25B Cracking the mystery of needles making imaging referral guidelines
and gauges work for patients, doctors and
Moderator: J. Camps Herrero; Alzira/ES hospital managers
12:30 14:00
A-209 Cracking the mystery of needles and gauges A-213 Chairman’s introduction
R.M. Pijnappel; Utrecht/NL G. Frija; Paris/FR
Learning Objectives: Session Objectives:
1. To learn about the choice of techniques used for guidance 1. To understand the impact of Clinical Decision Support on the
in breast interventions. development of imaging referral guidelines.
2. To know the different breast biopsy systems and their indications. 2. To learn about the localisation of evidence-based imaging referral
3. To learn the most common practical tips and pitfalls guidelines.
in these procedures. 3. To learn about the implementation of ACR Select as a case study
from the US.
4. To learn about the introduction of ESR iGuide, a CDS product
12:30–13:30 Room D1 for imaging referral guidelines in Europe.
14:05
E³ - The Beauty of Basic Knowledge: A-214 CDS impact on guidelines development
Skeletal Radiology K.J. Dreyer; Boston, MA/US
Learning Objectives:
E³ 24B The concept of degeneration: 1. To understand the process of developing imaging referral guidelines
for use in a CDS system.
the tendons 2. To understand the different impacts text-based and IT-based
Moderator: V. Cassar-Pullicino; Oswestry/UK guidelines have on clinical practice.
3. To learn about the advantages of CDS for updating and
12:30 revising guidelines.
A-210 The concept of degeneration: the tendons 14:23
K. Bohndorf; Vienna/AT
Learning Objectives: A-215 Adapting and updating guidelines
M.G.M. Hunink; Rotterdam/NL
1. To learn about ultrastucture and anatomy of tendons.
2. To understand the concept of degeneration. Learning Objectives:
3. To understand imaging features of tendon degeneration. 1. To understand how guidelines can be adapted to regional/local/
institutional needs and circumstances.
2. To learn about the impact of non-scientific factors (financial,
14:00–15:30 Room A available equipment, legal) on otherwise evidence-based guidelines.
3. To understand the difficulties in moving towards guidelines with
E³ - ECR Academies: common terminology and standards.

Interactive Teaching Sessions 14:41


A-216 ACR select implementation experience
J.A. Brink; Boston, MA/US
E³ 721 The treated spine and joints
Learning Objectives:
14:00 1. To appreciate the advantages of implementing CDS in practice.
A-211 A. Imaging of the postoperative spine 2. To understand the challenges in management and medical practice of
P.N.M. Tyrrell; Oswestry/UK introducing CDS.
3. To become familiar with real-life case studies.
Learning Objectives:
1. To understand changes related to surgery. 14:59
2. To learn about changes related to non-surgical treatments. A-217 ESR iGuide
L. Donoso; Barcelona/ES
14:45
A-212 B. Imaging of joint replacement Learning Objectives:
M. Zanetti; Zurich/CH 1. To learn about the specific challenges of developing guidelines for the
heterogeneous European market.
Learning Objectives: 2. To become familiar with the process of adapting the ACR
1. To learn about changes related to surgery. Appropriateness Criteria to the European setting.
2. To understand changes related to non-surgical treatments. 3. To learn about the potential benefits of implementing CDS into
clinical practice in Europe.

15:17 Discussion

190 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

14:00–15:30 Room N 15:00


A-226 Stroma and peritumoural stiffness:
ESOR Session Striving in radiological education latest evidence for its importance and novel stroma
Moderators: L. Bonomo; Rome/IT, N. Gourtsoyiannis; Athens/GR
imaging approaches to predict therapy response
14:00 A. Evans; Dundee/UK
A-218 Introduction Learning Objectives:
L. Bonomo; Rome/IT 1. To appreciate the importance and role of the tumour-surrounding
tissue to promote or prevent cancerous growth.
Session Objectives: 2. To learn about the microscopic and macroscopic tissue alterations
1. To understand the importance of a homogenous education path in the stroma occurring during cancer growth.
in each European country and its impact on young radiologists’ 3. To understand the yield of imaging these changes for early detection,
training. differential diagnosis, and therapy success prediction.
2. To illustrate which steps ESR and ESOR are going to take
in the future to implement the education project. 15:15
14:05 A-227 Personalised treatment decisions:
A-219 ESOR in action 2015 how to reason using multi-modal, multi-disciplinary data
N. Gourtsoyiannis; Athens/GR R.M. Mann; Nijmegen/NL
Learning Objectives:
14:15 1. To understand the importance of carefully selected imaging protocols
A-220 The role of the European Training Curriculum: in reliable diagnosis and decision making.
2. To learn of the integration of multi-disciplinary data in the decision
present and future making process.
B. Ertl-Wagner; Munich/DE
3. To understand the technical issues and potential solutions for
14:35 automated sense-making in multi-disciplinary, multi-modal data.
A-221 Spoon-feeding: present and future

Thursday
P.R. Ros; Cleveland, OH/US
14:00–15:30 Room MB 4
14:55
A-222 E-learning portfolios: present and future
Joint Course of ESR and RSNA
M. Maas; Amsterdam/NL (Radiological Society of North America):
15:15 Awards Emergency Radiology
MC 728 CNS emergencies
14:00–15:30 Room L 1 Moderator: A. Palkó; Szeged/HU

EIBIR Session 14:00


A-228 A. CNS trauma and neurovascular injury
EIBIR 1 The complexity of H.A. Rowley; Madison, WI/US
personalised breast care Learning Objectives:
1. To become familiar with traumatic brain injury demographics
14:00 and classification schemes.
A-223 Chairman’s introduction 2. To learn how to apply appropriateness criteria for head trauma
T.H. Helbich; Vienna/AT imaging in children and adults.
3. To identify key imaging patterns and pitfalls in the evaluation
14:15 of brain and neurovascular trauma.
A-224 Breast cancer epidemiology and control - 14:30
one size does not fit all A-229 B. CNS non-traumatic emergencies
I. dos Santos Silva; London/UK M. Smits; Rotterdam/NL
Learning Objectives: Learning Objectives:
1. To learn about the complex interplay of genetic and non-genetic risk 1. To learn about the modalities (CT/MRI) and protocols
factors on the aetiology of breast cancer. for non-traumatic neurological emergencies.
2. To understand how factors throughout a woman’s life affect 2. To learn how to diagnose the main non-traumatic neurological
her breast cancer risk. vascular and non-vascular emergencies.
3. To appreciate the way epidemiological research may inform breast 3. To become aware of the pitfalls and limitations of clinical
cancer control strategies and clinical decision making. presentation and imaging findings in non-traumatic neurological
14:45 emergencies.
A-225 VPH-PRISM aiding the therapy decision making process 15:00
by quantitative evaluation of personal imaging and A-230 C. Interactive case discussion
non-imaging data H.A. Rowley1, M. Smits2; 1Madison, WI/US, 2Rotterdam/NL
H.K. Hahn, M. Harz; Bremen/DE Learning Objectives:
Learning Objectives: 1. To learn about traumatic brain injury (TBI) and non-traumatic
1. To inform about the importance of quantitative predictors neurological emergencies.
in image-based decision making. 2. To become familiar with imaging manifestations of TBI and
2. To understand how predictors gained from different modalities non-traumatic neurological emergencies.
and disciplines can be fused. 3. To understand the clinical implications of radiological imaging
findings in TBI and non-traumatic neurological emergencies.
4. To learn about the state-of-the-art radiological imaging options
for the assessment of acute TBI and non-traumatic neurological
emergencies.

www.myESR.org Final Programme | ECR 2015 191


Postgraduate Educational Programme

14:00–15:30 Room MB 5 16:00–17:30 Room B

E³ - ECR Academies: Special Focus Session


Diagnostic Urogenital Radiology SF 8a Advanced brain MRI techniques
E³ 720 Prostate in paediatrics: toys or tools
Moderator: J.J. Fütterer; Nijmegen/NL in daily practice?
14:00 16:00
A-231 A. Ultrasound of the prostate A-236 Chairman’s introduction
J. Venancio; Lisbon/PT A. Rossi; Genoa/IT
Learning Objectives: Session Objectives:
1. To become familiar with the technical requirements to perform 1. To understand the indications of advanced MRI techniques
US of the prostate. (arterial spin-labelling perfusion imaging, MR spectroscopy,
2. To learn about the anatomy of the prostate. and diffusion tensor imaging) in the study of the paediatric brain
3. To understand to detect suspicious lesions under normal and abnormal conditions.
for ultrasound-guided biopsy. 2. To learn how to practically implement these techniques
in daily practice and to avoid pitfalls and artefacts.
14:30 3. To appreciate the potential applications and future trends
A-232 B. Multiparametric MRI of the prostate of research in this field.
G.M. Villeirs; Gent/BE
16:03
Learning Objectives:
1. To become familiar with technical aspects of DCE-MRI,
A-237 Arterial spin-labelling: measuring perfusion non-
DWI and MR spectroscopy. invasively in neonates and children
2. To understand to recognise the advantages and limitations J. Hendrikse; Utrecht/NL
of each technique. Learning Objectives:
3. To understand to detect significant disease of prostate cancer 1. To learn about the technical possibilities and challenges of the use
in the peripheral zone. of different arterial spin-labelling MRI methods (pulsed, continuous)
in neonates and children.
15:00 2. To understand potential sources of artefacts and pitfalls of arterial
A-233 C. Staging of prostate cancer spin-labelling MRI image interpretation.
A.R. Padhani; London/UK 3. To become familiar with the interpretation of arterial spin-labelling
Learning Objectives: MRI images in neonates and children.
1. To become familiar with the imaging techniques used for staging, 16:27
including functional MRI.
2. To become familiar with the common sites of metastases. A-238 MR spectroscopy: information vs time
3. To learn about what technique to use for follow-up J.F. Schneider; Basle/CH
of metastatic disease, including functional techniques. Learning Objectives:
1. To become familiar with the principal metabolites in the brain
evaluated by proton spectroscopy.
16:00–17:30 Room A 2. To identify factors that can potentially interfere with obtaining
spectroscopy results.
E³ - ECR Academies: 3. To assess the results from a patient’s single- or multivoxel
spectroscopy analysis.
Interactive Teaching Sessions 16:51
E³ 821 Central nervous system changes A-239 Diffusion tensor imaging: connecting the dots
T.A.G.M. Huisman; Baltimore, MD/US
aer treatment: Learning Objectives:
what you need to know 1. To become familiar with the basics of diffusion tensor imaging (DTI)
and fibre tractography (FT) in paediatric neuroradiology.
16:00 2. To understand the significance of DTI/FT for the exploration
A-234 A. Drug-related conditions of the developing brain.
F. Barkhof; Amsterdam/NL 3. To learn how to use DTI/FT to better classify complex brain
Learning Objectives: malformations.
1. To understand changes related to systemic treatment.
2. To learn about CNS treatment agents. Panel discussion:
17:15 Do advanced brain MRI techniques really
16:45 change current practice?
A-235 B. Imaging of treated brain tumours
J. Alvarez-Linera; Madrid/ES
Learning Objectives:
1. To appreciate CNS manifestations after surgery.
2. To understand CNS changes after radiotherapy and
other non-surgical treatments.

192 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room C 16:40


A-245 The diabetic foot patient
Pros & Cons Session N. Schaper; Maastricht/NL
Learning Objectives:
PS 827 Breast cancer: 1. To learn about the clinical problems in diabetic foot disease.
to screen or not to screen? 2. To understand the different types of diabetic foot patients.
Coordinator: F. Sardanelli; San Donato Milanese/IT 3. To appreciate how radiology and clinicians can work together.
Teaser: N. Houssami; Sydney/AU 17:00
16:00 Multidisciplinary team case discussion
1. To learn how a MDT should work.
A-240 A. Mammographic screening: pros 2. To understand the role of the interventional radiologist.
A. Frigerio; Turin/IT
3. To discuss the various treatment option for CLI.
Learning Objectives: 4. To learn about the role of imaging.
1. To be aware of estimates of breast cancer mortality reduction
and overdiagnosis from screening mammography.
2. To evaluate the cost-effectiveness of population-based 16:00–17:30 Room N
mammographic screening.
3. To show ways for improving population-based
mammographic screening.
E³ - ECR Academies:
16:25 Image-Guided Interventions in Oncology
A-241 B. Mammographic screening: cons E³ 819 Kidney, lung and bone:
A.B. Miller; Toronto, ON/CA
Learning Objectives: an update on oncologic therapy
1. To show limitations of mammographic screening in terms
16:00

Thursday
of population outcomes.
2. To evaluate the real impact of screening programmes in comparison A-246 Chairman’s introduction
with effectiveness of available therapies of breast cancer. A.D. Kelekis; Athens/GR
3. To outline a scenario for fighting against breast cancer Session Objectives:
without screening. 1. To become familiar with the several available image-guided
techniques for treating renal, lung and bone tumours.
16:50 2. To understand when image-guided techniques are clinically
A-242 Questions and answers indicated in the management of patients affected by renal, lung
F. Sardanelli1, N. Houssami2; 1San Donato Milanese/IT, 2Sydney/AU and bone tumours.
Learning Objectives: 3. To consolidate knowledge of clinical results available
The discussion will address the following issues: from the literature.
1. How much of the breast cancer mortality reduction in the last
decades can be attributed to screening? 16:03
2. Do we really have reliable estimates for overdiagnosis? A-247 A. Renal cell carcinoma: when and how can we compete
3. How can we reduce interval cancer rate? with surgeons
4. Are there technical or clinical improvements to be implemented R.F. Grasso; Rome/IT
in screening programmes? Learning Objectives:
5. Is the comparison between countries having/not having 1. To understand the current indications for ablation in renal cancer.
screening useful for understanding advantages/disadvantages 2. To learn about when radiofrequency ablation, microwaves ablation
of screening programmes? and cryo ablation are indicated.
6. What are the societal and ethical implications in stopping 3. To consolidate knowledge of results from personal experience
population screening mammography programmes? and the literature.
16:32
16:00–17:30 Room M A-248 B. Lung tumours: the clinical evidence for percutaneous
techniques
Multidisciplinary Session T. de Baère, F. Deschamps, L. Tselikas; Villejuif/FR
Learning Objectives:
MS 8 Critical limb ischaemia (CLI): 1. To understand the indications for percutaneous ablation in primary
limb salvage or life salvage? and metastatic disease.
2. To learn about technical issues.
16:00 3. To consolidate knowledge of results from literature.
A-243 Chairman’s introduction: 17:01
critical limb ischaemia in daily practise A-249 C. Image-guided therapies for bone tumours
J.A. Reekers; Amsterdam/NL A. Gangi; Strasbourg/FR
Session Objectives: Learning Objectives:
1. To learn what critical limb ischaemia is. 1. To understand how to select bone lesions to be ablated.
2. To understand what treatment options are available. 2. To learn about technical issues for both palliation and curative aims.
3. To appreciate a critical review of new technological treatment 3. To become familiar with clinical results.
developments.
16:20
A-244 Diagnostic imaging and outcome
M. Koelemay; Amsterdam/NL
Learning Objectives:
1. To learn about the value of diagnostic imaging.
2. To understand the outcome of treatment.
3. To appreciate how outcome can be tested.
4. To introduce Patient-Reported Outcome Measurements (PROM).

www.myESR.org Final Programme | ECR 2015 193


Postgraduate Educational Programme

16:00–17:30 Room L 1 Panel discussion:


17:18 What does the individual gain from population imaging
Professional Challenges Session studies?

PC 8b Imaging in population-based studies 16:00–17:30 Room E1


16:00
A-250 Chairman’s introduction Musculoskeletal
N. Hosten; Greifswald/DE
Session Objectives:
RC 810 The ankle and foot
1. To understand how population imaging studies can generate Moderator: J.L. Bloem; Leiden/NL
high-level evidence for radiological methods.
2. To understand the importance of governance in defining the role 16:00
of medical specialties in population studies. A-256 A. Ankle sprain: patterns of injury
3. To understand radiology’s role in setting ethical standards J.L.M.A. Gielen, P. Van Dyck, J. Veryser; Antwerp/BE
in population imaging studies. Learning Objectives:
16:03 1. To learn more about the imaging appearances of soft tissue
and osteoarticular injury.
A-251 Population imaging for the prediction 2. To become familiar with the patterns of bone and soft tissue injury
of neuro-degenerative diseases in the ankle and foot.
G.P. Krestin; Rotterdam/NL
Learning Objectives:
16:30
1. To understand the role of population-based imaging studies A-257 B. Inflammatory disorders
in predicting outcome. R. Lalam; Oswestry/UK
2. To present the most relevant imaging biomarkers for predicting Learning Objectives:
neurodegenerative diseases. 1. To learn more about the imaging appearances of soft tissue
3. To explain the association between genotype and imaging and osteoarticular inflammation.
phenotypes in neurodegenerative diseases. 2. To become familiar with imaging findings of specific
inflammatory conditions.
16:18
A-252 The German National Cohort: population based imaging 17:00
in a nation-wide multi-centre setting A-258 C. Tumours and tumour-like lesions
F. Bamberg; Tübingen/DE I.-M. Noebauer-Huhmann; Vienna/AT
Learning Objectives: Learning Objectives:
1. To learn about the scientific potential and challenges that whole-body 1. To learn more about the spectrum of intra and para-articular
MRI pose to the imaging community in large-scale multi-centric soft tissue tumours, and tumour-like soft tissue lesions.
cohort studies. 2. To become familiar with US and MRI findings of specific soft
2. To understand the rationale and design tissue lesions.
of the German National Cohort MRI Study.
3. To appreciate the current state of the data acquisition and
post-processing of the German National Cohort MRI Study. 16:00–17:30 Room E2
16:33 Special Focus Session
A-253 Population-based cardiac imaging
S. Petersen; London/UK SF 8b New frontiers in brain tumour imaging
Learning Objectives:
1. To appreciate the opportunities provided by population-based 16:00
cardiac imaging. A-259 Chairman’s introduction
2. To acknowledge the challenges posed by population-based H.R. Jäger; London/UK
cardiac imaging.
Session Objectives:
3. To discuss first-hand experiences from the UK Biobank -
1. To become familiar with recent advances in brain tumour imaging.
the largest ongoing population-based cardiac imaging project.
2. To understand the role of structural, physiological and molecular
16:48 imaging methods.
3. To learn how these methods contribute to individualised
A-254 The Trauma Cohort: a joint project of the German Röntgen management of brain tumour patients.
Society and the German Society of Trauma Surgery
S. Langner; Greifswald/DE 16:05
Learning Objectives: A-260 Imaging correlates of brain tumour genotypes
1. To understand the rationale and design of the Trauma Cohort. M. Smits; Rotterdam/NL
2. To appreciate the scientific potential and challenges of a large-scale Learning Objectives:
multi-centric polytrauma imaging study. 1. To become familiar with the most relevant molecular and gene
3. To learn the differences between population-based imaging studies abnormalities of glial and other neuroepithelial tumours.
of healthy subjects and severely injured patients. 2. To understand how these molecular and gene abnormalities
17:03 influence patient outcome and treatment response.
3. To learn about the imaging correlates of the most important
A-255 Ethical aspects of population imaging molecular and genetic tumour subtypes.
R. Schmücker; Münster/DE
Learning Objectives:
1. To learn about the diversity of ethical problems occurring
in MRI research.
2. To understand the methodological relevance of the ethics of
incidental findings for the validity of population-based studies.
3. To present some preliminary solutions to the most urgent
ethical challenges.

194 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:30 16:35
A-261 Multi-parametric MR tumour imaging in brain tumour A-266 Introduction to the Quantitative Imaging
diagnosis and monitoring European Task Force
M.A. Lucic; Sremska Kamenica/RS H.-U. Kauczor; Heidelberg/DE
Learning Objectives: Learning Objectives:
1. To become familiar with the use of MR perfusion, MR diffusion 1. To learn about existing activities in imaging biomarkers.
imaging and MR spectroscopy in brain tumour imaging. 2. To appreciate the importance of a new European structure for
2. To understand how these methods can add value to structural integrated imaging biomarker development.
MR imaging of brain tumours. 3. To acknowledge the benefit of imaging biomarkers for radiology.
3. To learn how multiparametric MR imaging can be used
in the differential diagnosis and prediction of treatment response 16:50
of brain tumours. A-267 Clinical validation of imaging biomarkers and their role
16:55 in European Medicine Agency (EMA) applications
O. Clément; Paris/FR
A-262 MR/PET in brain tumour diagnosis: the added value Learning Objectives:
of combining structural and molecular imaging 1. To learn about the role of clinical validation for imaging biomarkers.
F. Fraioli; London/UK 2. To understand how imaging biomarkers may become surrogate
Learning Objectives: endpoints in clinical trials.
1. To become familiar with the most important PET tracers currently 3. To become familiar with the requirements of the EMA.
used in brain tumour imaging.
2. To understand the different aspects of tumour metabolism that 17:05
can be measured with these tracers. A-268 The role of imaging biomarkers in the EORTC clinical trials
3. To learn about the advantages and pitfalls of simultaneous acquisition N.M. deSouza; Sutton/UK
of structural and molecular information in brain tumours using Learning Objectives:
PET MRI. 1. To learn about the EORTC’s role and its performance of clinical trials.

Thursday
2. To become familiar with the tasks and opportunities of the imaging
Panel discussion: group within the EORTC.
17:20 Modalities and parameters - what do we really need? 3. To understand how to implement imaging biomarkers
in the clinical EORTC trials.

16:00–17:30 Room F1 Panel discussion:


17:20 How to strengthen the role of imaging biomarkers
Professional Challenges Session in clinical trials

PC 8a Integration of imaging biomarker


16:00–17:30 Room F2
activities on a European level
16:00 Special Focus Session
A-263 Chairman’s introduction SF 8c Breast imaging modalities:
G. Frija; Paris/FR
Session Objectives: beyond the conventional
1. To understand the importance of imaging biomarkers for radiology.
2. To become familiar with ESR activities related to imaging 16:00
biomarkers. A-269 Chairman’s introduction
3. To appreciate a new structure for coordinated imaging biomarker M. Lobbes; Maastricht/NL
activities in Europe. Session Objectives:
1. To become familiar with the latest developments in the field
16:05 of CESM, breast CT and non-enhanced breast MRI techniques.
A-264 From qualitative to quantitative imaging: 2. To understand their advantages and disadvantages.
a paradigm shi in radiology 3. To appreciate the current scientific evidence for these
S. Trattnig; Vienna/AT novel techniques.
Learning Objectives: 16:05
1. To learn about the difference between qualitative and
quantitative imaging. A-270 Contrast-enhanced mammography
2. To understand the role of quantitative imaging in clinical trials. C. Dromain, F. Bidault, S. Ammari, M. Saghatchian, M.-C. Mathieu,
C.S. Balleyguier; Villejuif/FR
3. To become familiar with quantitative imaging as a prerequisite
for imaging biomarkers. Learning Objectives:
1. To become familiar with the CESM examination technique.
16:20 2. To know the clinical performance of CESM in comparison
A-265 Experience of the Quantitative Imaging Alliance (QIBA) with conventional mammography and MRI.
of the RSNA 3. To understand and illustrate major clinical indications.
R. Boellaard; Amsterdam/NL 4. To give an overview of future improvements and developments
of CESM.
Learning Objectives:
1. To outline the structure of the QIBA of the RSNA. 16:30
2. To learn about the main goals of the QIBA of the RSNA. A-271 Breast CT
3. To appreciate the value of standardisation and technical validation. W.A. Kalender; Erlangen/DE
Learning Objectives:
1. To become familiar with previous trials of using CT
for breast imaging.
2. To learn about the potential of advanced CT technologies
for breast CT.
3. To appreciate that breast CT can be obtained with very high
3. spatial resolution at screening mammography dose levels.

www.myESR.org Final Programme | ECR 2015 195


Postgraduate Educational Programme

16:55 17:00
A-272 Non-contrast MRI A-278 C. Lymph nodes: differential diagnosis and
P.A.T. Baltzer; Vienna/AT fine-needle aspiration
Learning Objectives: R. Maroldi; Brescia/IT
1. To become familiar with the current status of unenhanced MRI Learning Objectives:
techniques for detection and classification of breast lesions. 1. To get acquainted with normal and abnormal findings.
2. To understand possible clinical applications of unenhanced breast 2. To understand the patterns of nodal involvement.
MRI. 3. To learn about technique of fine needle aspiration.
3. To appreciate the limitations of unenhanced breast MRI.

Panel discussion: 16:00–17:30 Room G


17:20 Is there still room for conventional breast imaging?
Genitourinary
16:00–17:30 Room D1 RC 807 Lessons I learned from mistakes
E³ - ECR Master Classes (Chest) in kidney and adrenal imaging
16:00
E³ 826 Lung cancer staging A-279 Chairman’s introduction
Moderator: E. Castañer; Sabadell/ES G. Heinz-Peer; St. Pölten/AT
16:00 Session Objectives:
1. To understand RECIST criteria of kidney tumours in light
A-273 A. Limitations and perspectives of molecular medicine and functional imaging.
A.R. Larici; Rome/IT
2. To learn about pitfalls and challenges in kidney and adrenal imaging.
Learning Objectives:
1. To consolidate knowledge about lung cancer staging. 16:05
2. To understand the radiological limitations: size measurement, A-280 A. Renal cancer
multifocal disease, lymphangitic carcinomatosis, etc. T. Bäuerle; Erlangen/DE
3. To appreciate mediastinal lymph node staging as Learning Objectives:
a multidisciplinary process. 1. To understand molecular processes in the pathophysiology
16:30 of renal cancer.
2. To become familiar with strategies for treatment and response
A-274 B. CT phenotypes of adenocarcinoma assessment of renal cancer.
M. Das; Maastricht/NL
3. To learn about pitfalls of multimodal imaging techniques
Learning Objectives: for renal cancer.
1. To know about the implications of the new lung adenocarcinoma
classification. 16:28
2. To understand the correlation between CT phenotypes and A-281 B. PET/CT in nephrourology
the new IASLC classification. M. Notohamiprodjo; Tübingen/DE
17:00 Learning Objectives:
1. To become familiar with appropriate use of PET/CT method
A-275 C. Functional imaging of lung cancer heterogeneity in pathological entities of nephrourology.
O.L. Sedlaczek; Heidelberg/DE
2. To learn about the basic and advanced imaging findings of PET/CT
Learning Objectives: in nephrourology.
1. To become familiar with the therapeutic impact of tumour 3. To become familiar with the common sources of mistake in PET/CT
heterogeneity. in the area of nephrourology.
2. To learn about the potential of functional MRI.
3. To learn about the potential of PET/CT and MR/PET. 16:51
A-282 C. Ablation mistakes in tumour percutaneous RFA
W.W. Mayo-Smith; Boston, MA/US
16:00–17:30 Room D2 Learning Objectives:
1. To describe adrenal and renal ablation techniques to avoid mistakes.
Head and Neck 2. To learn what to look for before and during ablation to avoid
mistakes.
RC 808 Head and neck imaging: 3. To learn what to look for after adrenal and renal ablation
don’t sell your ultrasound yet! to detect mistakes.
Moderator: S.S. Özbek; Izmir/TR
Panel discussion:
16:00 17:14 How to avoid mistakes using imaging modalities
in other kidney and adrenal diseases?
A-276 A. Salivary gland imaging with ultrasound
N. Gritzmann; Vienna/AT
Learning Objectives:
1. To understand the limitations of clinical examination.
2. To learn about the diagnostic approach to salivary glands.
3. To appreciate how to differentiate salivary gland pathology.
16:30
A-277 B. Masses of the so parts of the neck
S. Robinson; Vienna/AT
Learning Objectives:
1. To become familiar with cervical ultrasound anatomy.
2. To learn about benign neck masses.
3. To understand the value of US in oncologic imaging.

196 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room K 17:00


A-288 C. Endovascular management
E³ - ECR Academies: M.A. Funovics; Vienna/AT
Hybrid Imaging (basic) Learning Objectives:
1. To learn about the indications for endovascular treatment
of EVAR endoleaks.
E³ 818 Essentials of hybrid imaging 2. To appreciate the different interventional techniques.
Moderator: R. McDermott; Dublin/IE 3. To learn about the pros and cons of each technique.
16:00
A-283 A. Normal variants and pitfalls 16:00–17:30 Room MB 2
G. Cook; London/UK
Learning Objectives: Cardiac
1. To learn to identify normal variants.
2. To become familiar with typical pitfalls in hybrid imaging. RC 803 Imaging of heart failure
3. To appreciate artefacts in hybrid images.
16:30 16:00
A-284 B. The SUV: when does its use make sense? A-289 Chairman’s introduction
M. Gutberlet; Leipzig/DE
P. Veit-Haibach; Zurich/CH
Learning Objectives: 16:05
1. To appreciate different ways to calculate the SUV. A-290 A. Current ESC and AHA guidelines: how to choose imaging
2. To understand the indication for the SUV in tumour diagnosis.
3. To become familiar with the indication for the SUV in therapy techniques in heart failure patients?
J.T. Ortiz-Perez; Barcelona/ES
response assessment.
Learning Objectives:

Thursday
17:00 1. To become familiar with the diagnostic algorithm of heart failure
A-285 C. Indications for hybrid imaging in radiation therapy according to current guidelines.
planning 2. To learn the strengths and weaknesses of the different imaging
D. Georg; Vienna/AT techniques in heart failure patients.
3. To discuss the role of imaging techniques to guide clinicians
Learning Objectives:
in diagnosis, treatment and follow-up.
1. To become familiar with PET/CT-based radiation therapy planning.
2. To appreciate the information desired by the radiation oncologist. 16:28
3. To understand the effect of functional data on the target volume. A-291 B. Differentiating the causes for heart failure:
Panel discussion: is MRI the indisputable gold standard?
T. Leiner; Utrecht/NL
17:18 What does the individual gain from population imaging studies?
Learning Objectives:
1. To learn about MRI techniques to evaluate heart failure and
16:00–17:30 Room MB 1 its potential causes.
2. To learn a practical approach for differentiating the causes
Vascular of heart failure using MRI.
3. To become familiar with the role of MRI in the clinical management
and prognosis.
RC 815 EVAR endoleaks:
imaging and management 16:51
Moderator: F. Fanelli; Rome/IT A-292 C. SPECT as an alternative imaging technique
F. Bengel, F. Caobelli; Hannover/DE
16:00 Learning Objectives:
A-286 A. The role of US: Doppler, 3D US, CEUS 1. To learn about nuclear imaging techniques in the detection
U.K.M. Teichgräber; Jena/DE of heart failure.
2. To appreciate imaging findings in the diagnosis of heart failure
Learning Objectives:
and its causes.
1. To appreciate the rationale behind ultrasonographic imaging
3. To become familiar with the role of nuclear imaging
of EVAR endoleaks.
for diagnosis and prognosis in heart failure.
2. To become familiar with the principles
of each ultrasonographic modality.
3. To understand the relative indications Panel discussion:
of each ultrasonographic modality. 17:14 What is the preferred comprehensive imaging test
in heart failure?
16:30
A-287 B. CTA and MRA: current concepts
A. Bücker; Homburg a.d. Saar/DE
Learning Objectives:
1. To learn about the indications for CTA and MRA
in EVAR endoleak imaging.
2. To become familiar with technical aspects of each modality
in EVAR endoleak imaging.
3. To learn about the pros and cons of each modality.

www.myESR.org Final Programme | ECR 2015 197


Postgraduate Educational Programme

16:00–17:30 Room MB 3 16:30


A-298 B. Challenges of imaging paediatric abdominal
Interventional Radiology emergencies
C.J. Sivit; Cleveland, OH/US
RC 809 Current trends in transarterial Learning Objectives:
chemoembolisation (TACE) and 1. To understand the variations of pathology that cause abdominal pain
radioembolisation for HCC and vomiting in infants and children.
2. To learn how to plan safe and effective imaging protocols using US,
16:00 CT, and MRI.
3. To recognise pitfalls in the diagnosis of paediatric abdominal
A-293 Chairman’s introduction emergencies with imaging.
T.K. Helmberger; Munich/DE
17:00
16:05
A-299 C. Imaging in ENT emergencies
A-294 A. Imaging in therapy planning and follow-up D. Nunez; New Haven, CT/US
V. Vilgrain1, M. Burrel2; 1Clichy/FR, 2Barcelona/ES
Learning Objectives:
Learning Objectives: 1. To understand imaging findings in patients presenting with acute
1. To learn how imaging influences the selection of the embolisation head and neck conditions using a systematic spatial approach.
strategy in HCC. 2. To get an understanding of the role and indications of CT and MR
2. To learn about standard and advanced imaging techniques in the in acute non-traumatic ENT case management.
follow-up after treatment. 3. To learn how to identify the extent of disease and recognise specific
3. To learn how imaging may guide the decision about re-treatment. complications of cervicofacial infections.
16:28
A-295 B. TACE and TAE for HCC: new agents, new schedules, 16:00–17:30 Room MB 5
new combinations
R. Lencioni; Pisa/IT E³ - ECR Academies:
Learning Objectives:
1. To learn about the results of new treatment schedules and treatment Diagnostic Urogenital Radiology
combinations.
2. To learn about the rationale of recent and ongoing trials. E³ 820 Upper and lower urinary tract
3. To learn about clinical results and possible further developments. Moderator: N. Grenier; Bordeaux/FR
16:51
16:00
A-296 C. Radioembolisation: critical appraisal of techniques
A-300 A. CTU and MRU of the upper urinary tract
and guidelines for treatment N.C. Cowan; Portsmouth/UK
J.I. Bilbao; Pamplona/ES
Learning Objectives:
Learning Objectives: 1. To learn about the technical requirements of CTU and MRU.
1. To learn about critical aspects of techniques and dosimetry. 2. To learn about indications, diagnostic accuracy, diagnostic strategies,
2. To become familiar with ongoing trials and guidelines for treatment. advantages and limitations of CTU and MRU.
3. To understand the relative role of TACE/TAE and radioembolisation 3. To understand the normal imaging findings.
in HCC.
16:30
Panel discussion: A-301 B. Imaging of kidney and ureter
17:14 The intermediate HCC patient: M.A. Cova; Trieste/IT
how can we stratify patients and allocate them Learning Objectives:
to different therapies? 1. To learn about the typical signs of urothelial carcinoma in the kidney
and ureter, including rare manifestations.
2. To learn about the most frequent differential diagnoses.
16:00–17:30 Room MB 4 3. To understand the potential pitfalls.
Joint Course of ESR and RSNA 17:00
(Radiological Society of North America): A-302 C. Imaging of bladder and urethra
T.A. El-Diasty; Mansoura/EG
Emergency Radiology Learning Objectives:
1. To become familiar with various diseases of the bladder and urethra.
MC 828 General principles: 2. To learn about the typical imaging findings of malignant and
nonmalignant disease.
paediatric and ENT emergencies 3. To learn about the most frequent differential diagnoses.
Moderator: Palkó; Szeged/HU

16:00
A-297 A. General principles
U. Linsenmaier; Munich/DE
Learning Objectives:
1. To learn about general principles of diagnostic imaging in emergency
radiology in traumatic and non-traumatic emergencies.
2. To understand the etiology, background and management
of common radiological emergencies.
3. To appreciate the role, indications and protocols
for US, CR, MDCT in modern emergency radiology.

198 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room A 08:30–10:00 Room C

E³ - ECR Academies: Special Focus Session


Interactive Teaching Sessions SF 9a Evaluation of treatment response
E³ 921 Thoracic changes aer treatment in head and neck cancer
08:30 08:30
A-303 A. Drug-related conditions A-308 Chairman’s introduction
M. Becker; Geneva/CH
T. Franquet; Barcelona/ES
Session Objectives:
Learning Objectives:
1. To become familiar with treatment options in head and neck cancer.
1. To understand pulmonary changes related to treatment.
2. To understand the concept of personalised treatment based
2. To understand the mechanisms of injury to the lung
on morphologic, functional and molecular imaging findings.
in drug-related conditions.
3. To review the key imaging findings affecting treatment choice i
09:15 n head and neck cancer.
A-304 B. Device-related conditions 4. To learn which CT, MRI and PET/CT findings allow for correct
G.R. Ferretti; Grenoble/FR assessment of treatment response.
5. To learn how to report the relevant imaging findings
Learning Objectives: in a structured fashion.
1. To understand changes related to lines and wires in ICU patients.
2. To learn about findings related to surgery. 08:35
A-309 Prognostic factors influencing treatment choice and
08:30–10:00 Room B treatment response
R. Hermans; Leuven/BE
Abdominal Viscera Learning Objectives:
1. To become familiar with key imaging issues affecting treatment
choice in head and neck cancer.
RC 901 Technical advances in liver 2. To understand which main imaging findings affect the outcome
and pancreatic imaging of radiation therapy.
Moderator: C. Bartolozzi; Pisa/IT 3. To learn how to report the findings and which measurements
to perform in clinical routine.
08:30 09:00
A-305 A. CEUS and elastography A-310 Evaluation of early treatment response:
G. Mostbeck; Vienna/AT
Learning Objectives: can MRI techniques make a difference?
H.C. Thoeny; Berne/CH
1. To become familiar with novel technical applications that are useful

Friday
in liver and pancreatic diseases. Learning Objectives:
2. To understand the underlying pathophysiologic processes. 1. To learn what additional information is acquired by MRI with
3. To learn about the strengths and limitations of CEUS compared diffusion-weighted and perfusion sequences.
with CT and MRI in the study of focal liver lesions and 2. To appreciate the clinical importance of this examination in the early
pancreatic diseases. follow-up of head and neck cancer patients.
3. To learn how to interpret results and how to avoid mistakes.
09:00
A-306 B. MRI: diffusion, perfusion and elastography 09:25
B. Van Beers; Clichy/FR A-311 Post treatment imaging:
Learning Objectives: is PET a reliable indicator for tumour viability?
1. To learn about the technical requirements necessary S. Bisdas; Tübingen/DE
for diffusion-weighted MRI and how to avoid artefacts. Learning Objectives:
2. To learn about the technical requirements for CT and MRI perfusion. 1. To understand what additional information is provided by PET/CT
3. To become familiar with imaging biomarkers useful in the post-treatment setting.
in tumour evaluation. 2. To appreciate the clinical relevance of PET/CT and its effect
on patient management.
09:30 3. To learn how to interpret PET/CT examinations and how to avoid
A-307 C. Liver-specific contrast agents interpretation pitfalls.
B.J. Op de Beeck; Antwerp/BE
Learning Objectives: Panel discussion:
1. To learn about the principals and recent technical advances 09:50 Can we provide accurate information for the evaluation
in the use of liver-specific contrast agents for liver imaging. of treatment response?
2. To appreciate the similarities and differences between the classes
of contrast agents.
3. To become familiar with indications of liver-specific contrast
in biliary diseases.
4. To learn about future directions of MRI contrast agents.

www.myESR.org Final Programme | ECR 2015 199


Postgraduate Educational Programme

08:30–10:00 Room M 08:30–10:00 Room N

ESR Research in Education E³ - ECR Academies:


and Training Session Image-Guided Interventions in Oncology
Research for trainees made easy: E³ 919 Colorectal liver metastases:
critical reading of the literature the emerging role of interventional
Moderator: J. Hodler; Zurich/CH radiologists in oncology
08:30 08:30
A-312 Introduction A-318 Chairman’s introduction
J. Hodler; Zurich/CH P.L. Pereira; Heilbronn/DE
Session Objectives:
08:35 1. To become familiar with the several image-guided interventions
A-313 Overwhelmed by the available information? in the multidisciplinary clinical management of patients affected
How to organise yourself by liver metastases from colorecatal cancer.
P. Rodríguez; Madrid/ES 2. To understand the role of interventional radiology in the treatment
Learning Objectives: algorithm for metastases from colorectal cancer.
1. To learn how to cope with the overwhelming amount of available 3. To learn about the clinical evidence for image-guided interventions
information. in this field.
2. To become familiar with resources adequate for trainees. 08:33
3. To learn how colleagues with similar experience levels assess
literature. A-319 A. Tumour ablation: when and how in a modern
oncological setting
08:55 V. Válek; Brno/CZ
A-314 Errors you should detect when reading scientific papers Learning Objectives:
A.K. Dixon; Cambridge/UK 1. To understand the role of percutaneous ablation in clinical practice.
Learning Objectives: 2. To learn about essential technical issues.
1. To learn about typical errors in study design. 3. To consolidate the knowledge of clinical results.
2. To recognise such errors while reading publications.
3. To understand the meaning and severity of scientific fraud. 09:02
A-320 B. Intra-arterial drug delivery: the state of art
09:15 M. Bezzi; Rome/IT
A-315 Clinical relevance of publications: influence on outcome Learning Objectives:
D.J. Wilson; Oxford/UK 1. To become familiar with the current indications for intra-arterial
Learning Objectives: chemotherapy in liver metastases.
1. To recognise the clinical relevance of publications. 2. To learn about how to implant a hepatic intra-arterial
2. To understand characteristics of clinically relevant papers. infusion system.
3. To be able to plan clinically relevant scientific evaluations. 3. To learn about results coming from personal experience and
from the literature.
09:35
A-316 Do not be afraid of basic science papers 09:31
N. Grenier; Bordeaux/FR A-321 C. Intra-arterial radiation delivery - when and how:
Learning Objectives: the clinical evidence
1. To appreciate the role of basic research in radiology. T.K. Helmberger; Munich/DE
2. To become familiar with typical methodology in basic research. Learning Objectives:
3. To understand differences and similarities between clinical and basic 1. To become familiar with the main indications for TARE/TACE
research. in liver metastatic disease.
09:55 2. To learn about techniques for both intra-arterial treatments.
3. To consolidate knowledge of results from the literature.
A-317 Summary
J. Hodler; Zurich/CH
08:30–10:00 Room E1

Professional Challenges Session


PC 9 Personalised medicine in radiology
08:30
A-322 Chairman’s introduction
R. Manfredi; Verona/IT
Session Objectives:
1. To understand the concept of personalised medicine (PM).
2. To learn about the role of imaging in PM.
08:35
A-323 Imaging is everywhere in personalised medicine
A. van der Lugt; Rotterdam/NL
Learning Objectives:
1. To understand the concept of personalised medicine.
2. To appreciate the role of imaging in personalised medicine.
3. To understand why personalised medicine cannot flourish
without imaging (and radiologists).

200 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:55 09:11
A-324 Personalised prevention: A-330 Image-guided tumour ablations
population-based imaging and image-based screening H.U. Ahmed; London/UK
F. Bamberg; Tübingen/DE Learning Objectives:
Learning Objectives: 1. To present the pros and cons of different physical/chemical methods
1. To understand the concept of screening. that are used for focal therapy of prostate cancer.
2. To become familiar with population-based imaging. 2. To discuss patient selection criteria and show how tumour/prostate
3. To understand how imaging can improve personalised prevention. gland treatments are undertaken in practice.
3. To present the oncologic results of image-guided
09:15 prostate tumour ablations.
A-325 Integrated diagnostics: 09:31
towards one diagnostic department
A. Cuocolo, C. Nappi, E. Zampella; Naples/IT A-331 Prostate artery embolisation (PAE) for benign hypertrophy
F.C. Carnevale; Sao Paulo/BR
Learning Objectives:
Learning Objectives:
1. To understand the concept of biomarkers and their role
1. To understand the pros and cons of PAE in relation
in personalised medicine.
to other methods for treating benign hyperplasia.
2. To appreciate the differences and synergies between blood-
2. To discuss patient selection criteria and show how PAE
and tissue-based biomarkers and imaging biomarkers.
is undertaken.
3. To learn from other diagnostic departments about accuracy
3. To review the literature on complications, efficacy outcomes
and validation of biomarkers.
of urinary function, symptoms and quality of life and
09:35 on Long-term results.
A-326 Interventional radiology:
a paradigm for personalised medicine Panel discussion:
S.N. Goldberg; Jerusalem/IL 09:51 Do organ-sparing prostatic treatments make sense?
Learning Objectives:
1. To understand how functional imaging can improve tissue sampling. 08:30–10:00 Room F1
2. To appreciate the personalised approach in interventional radiology.
3. To become familiar with targeted therapies in interventional
radiology.
Oncologic Imaging
Panel discussion: RC 916 New insights in bone tumour imaging
09:55 How can we best accelerate the adoption
of personalised medicine in radiological practice? 08:30
A-332 Chairman’s introduction
D. Vanel; Bologna/IT
08:30–10:00 Room E2 Session Objectives:

Friday
1. To become familiar with the appearances and treatment strategies
New Horizons Session in bone tumours.
2. To learn about the role of current imaging techniques in management
NH 9 Image-guided interventions of bone tumours.
of the prostate 08:35
A-333 A. New insights in treatment-associated changes in
08:30 patients with bone tumours
A-327 Chairman’s introduction: defining the target C.R. Krestan; Vienna/AT
A.R. Padhani; London/UK
Learning Objectives:
Session Objectives: 1. To understand treatment strategies in bone tumours.
1. To introduce the concept of the index prostatic cancer lesion as 2. To learn the essentials in sarcoma imaging.
a valid target that determines patient therapy and outcomes. 3. To understand chemo- and radiation-induced bone marrow changes
2. To illustrate the concordance between the MRI-depicted and in patients with bone tumours.
histologically defined intraprostatic target.
08:58
08:35 A-334 B. New insights in staging and restaging musculoskeletal
A-328 MR-targeted prostate biopsy tumours introduction
J.J. Fütterer; Nijmegen/NL J.L. Bloem; Leiden/NL
Learning Objectives: Learning Objectives:
1. To understand the pros and cons of MRI-guided biopsies versus 1. To learn how to cooperate with physicist and technicians in
ultrasound approaches. optimising MR protocol.
2. To understand how to perform MRI-targeted biopsies. 2. To understand the role of MR imaging in staging and restaging.
3. To discuss patients selection and appreciate how MRI-targeted biopsy 3. To analyse clinical MR studies.
results affects management of patients with positive and
negative results. 09:21
08:53 A-335 C. New insights in hybrid imaging for multiple myeloma
G. Sommer; Basle/CH
A-329 MR-US fusion prostate biopsy
F. Cornud, C. Escourrou, N.B. Delongchamps; Paris/FR Learning Objectives:
1. To understand the current concepts of evaluation of multiple
Learning Objectives: myeloma with FDG PET/CT and MR/PET.
1. To understand the pros and cons of different US-guided biopsy 2. To understand the role of diffusion-weighted MR imaging
approaches. in patients with multiple myeloma.
2. To understand how to perform US-targeted biopsies.
3. To discuss patient selection and appreciate and how US-targeted
biopsies affect management of patients with positive and negative
Panel discussion:
results.
09:44 The future of bone tumour imaging

www.myESR.org Final Programme | ECR 2015 201


Postgraduate Educational Programme

08:30–10:00 Room F2 08:30–10:00 Room D1

Multidisciplinary Session Special Focus Session


MS 9 Management of rectal cancer: SF 9b The forgotten joints
a paradigm shi 08:30
08:30 A-340 Chairman’s introduction
M. Padrón; Madrid/ES
A-336 Chairman’s introduction
R.G.H. Beets-Tan; Maastricht/NL Session Objectives:
Session Objectives: 1. To become familiar with the usual patterns of disease in these joints.
1. To learn about new organ-saving treatments in rectal cancer and 2. To learn about the role of imaging in the different disease processes.
the clinical background. 3. To understand how imaging can assist in the management of these
2. To understand the new role of radiologists within and the questions lesions.
from the multidisciplinary team during the selection and follow-up 08:35
of these patients.
3. To learn how radiologists can answer the relevant clinical questions A-341 Fingers and toes: little joints, big trouble?
A. Klauser; Innsbruck/AT
and which are the most accurate imaging methods.
Learning Objectives:
08:35 1. To understand the imaging strategies available for diagnosis.
A-337 Organ-saving treatment: 2. To differentiate inflammatory, traumatic and degenerative changes.
what does the surgeon want to know? 3. To learn about the management of these injuries.
G.L. Beets; Maastricht/NL 09:00
Learning Objectives: A-342 The symphysis pubis
1. To learn about new organ-saving treatments in rectal cancer and C.W.A. Pfirrmann; Zurich/CH
the clinical background.
2. To understand the pros and cons of organ-saving treatment. Learning Objectives:
3. To know how to select patients and understand the factors relevant 1. To learn the imaging anatomy of the structures around
for clinical decision making. the symphysis pubis.
4. To understand what the surgeon wants to know from radiologists 2. To be able to set up an MR imaging protocol for the assessment
during the selection and follow-up of these patients. of the symphysis pubis.
3. To understand the pattern of disease around the symphysis pubis.
08:55
09:25
A-338 Organ-saving treatment:
A-343 The acromioclavicular joint: patterns of injury
what does the radiation oncologist want to know? D.A. Barron; Leeds/UK
V. Valentini; Rome/IT
Learning Objectives:
Learning Objectives: 1. To become familiar with the usual mechanisms of injury.
1. To learn about pathways of rectal tumour and nodal spread. 2. To understand the imaging strategies available for diagnosis.
2. To understand what radiation oncologists will do with the anatomical 3. To become familiar with the imaging findings and classification
information from imaging and how it will influence the radiation of acromioclavicular joint injury.
fields. 4. To learn about the management of these injuries.
3. To become familiar with various preoperative radiation treatment
schedules with or without chemotherapy.
Panel discussion:
4. To know how radiation treatment can improve the number of
09:50 Are these topics never to be forgotten?
patients with complete response and whom can be offered an organ-
saving treatment.
09:15 08:30–10:00 Room D2
A-339 Organ-saving treatment:
what is the radiologist’s role?
Radiographers
R.G.H. Beets-Tan; Maastricht/NL
Learning Objectives:
RC 914 Enhancing patient safety culture
1. To understand the role of radiologists in the multidisciplinary in radiology
management of patients both during the selection and follow-up for
organ-saving treatment. 08:30
2. To learn how radiologists can answer the relevant clinical questions. A-344 Chairmen’s introduction
3. To know the imaging tools and their capacities for identifying viable P. Bezzina1, L. Donoso2; 1Msida/MT, 2Barcelona/ES
disease in bowel wall and (extra) mesorectal nodes. Session Objectives:
4. To become familiar with the imaging features and pitfalls in 1. To understand the importance of patient safety in radiology.
interpretation. 2. To learn the fundamentals of implementing a patient safety culture.
3. To appreciate the importance of teamwork for developing
Interactive case discussion: a safe radiology department.
09:35 What do clinicians expect from us
in organ-saving treatment management? 08:35
A-345 A. Patient safety culture:
the importance of EU clinical audit guidelines
S. Mc Fadden; Newtownabbey/UK
Learning Objectives:
1. To learn about the importance of clinical audit under the new EU
Basic Safety Standards.
2. To comprehend the role of clinical audit in radiology practice.
3. To understand how to facilitate clinical audit locally and nationally.

202 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:58 08:30–10:00 Room K


A-346 B. Quality assurance of radiology equipment:
the first step to creating a safe working environment E³ - ECR Academies: Hybrid Imaging (basic)
J. Santos; Coimbra/PT
Learning Objectives: E³ 918 Indications for hybrid imaging in ...
1. To become familiar with international recommendations and Moderator: T.H. Helbich; Vienna/AT
guidelines for radiology quality control procedures.
2. To be aware of the importance of the radiographer in quality 08:30
assurance of radiology equipment. A-352 A. Oncology
3. To recognise the need for quality assurance in systematic evaluation N. Schwenzer; Tübingen/DE
as a tool for promoting radiation safety. Learning Objectives:
09:21 1. To appreciate indications for PET/CT and MR/PET in oncology.
2. To become familiar with FDG- and non-FDG-indications
A-347 C. From medical imaging referral to final outcome: in oncology.
a critical analysis of the process 3. To understand where MR/PET may be advantageous over PET/CT.
D. Remedios; Harrow/UK
Learning Objectives:
09:00
1. To understand the requirements for justification. A-353 B. Neurology
2. To be aware of the need for appropriate imaging. A. Buck; Zurich/CH
3. To recognise the barriers to appropriate imaging. Learning Objectives:
4. To appreciate the strategies for improvement. 1. To learn about indications for PET/CT and MR/PET in neurology.
2. To appreciate the different radionuclides available
Panel discussion: for neurological imaging.
09:44 Teamwork as a fundamental concept for creating a patient 3. To understand where MR/PET may be beneficial over MRI alone.
safety culture in a medical imaging department: why and how?
09:30
A-354 C. Cardiology
08:30–10:00 Room G S.G. Nekolla; Munich/DE
Learning Objectives:
EFOMP Workshop 1. To learn about indications for SPECT/CT and PET/CT in cardiology.
2. To appreciate radionuclides available for cardiac hybrid imaging.
EF 1 Multi-energy imaging: 3. To understand potential indications for MR/PET.
from physics to diagnosis I
Moderators: P. Sharp; Aberdeen/UK, V. Tsapaki; Athens/GR 08:30–10:00 Room MB 1
08:30 E³ - ECR Master Classes (Vascular)

Friday
A-348 Chairman’s introduction
P. Sharp; Aberdeen/UK E³ 926c Uterine and prostate embolisation
Session Objectives: Moderator: T. Sabharwal; London/UK
1. To become familiar with the principles of multi-energy imaging.
2. To understand the applications of multi-energy CT. 08:30
3. To appreciate the advantages and limitations
of multi-energy imaging.
A-355 A. Symptomatic uterine fibroids
J.-P. Pelage; Caen/FR
08:35 Learning Objectives:
A-349 Image-based material decomposition with energy- 1. To understand clinical indications and contraindications
for UAE embolisation.
selective detectors in multi-energy CT: a review 2. To become familiar with the technique of uterine artery embolisation.
M. Kachelrieß; Heidelberg/DE
3. To learn about complications and outcomes.
Learning Objectives:
1. To understand how multi-energy CT can provide material 09:00
identification and differentiation. A-356 B. Benign hypertrophy of the prostate
2. To understand the effect of detector choice on material identification. H. Rio Tinto; Lisbon/PT
3. To understand the issues of radiation dose.
Learning Objectives:
09:05 1. To understand clinical indications and contraindications
for prostate artery embolisation.
A-350 Novel applications of multi-energy CT 2. To become familiar with the technique of prostate artery
J. Sosna; Jerusalem/IL
embolisation.
Learning Objectives: 3. To learn about complications and outcomes.
1. To become familiar with the concept of virtual non-enhanced images.
2. To explore image segmentation techniques. 09:30
3. To learn about image artefacts. A-357 C. Post-partum haemorrhage (PPH)
T.J. Kroencke; Augsburg/DE
09:35
Learning Objectives:
A-351 New frontiers in CT: functional and multi-energy imaging 1. To become familiar with the clinical background of PPH.
A. Persson; Linköping/SE
2. To learn about different endovascular techniques to treat PPH.
Learning Objectives: 3. To learn about complications and outcomes.
1. To appreciate the advantages and limitations of multi-energy CT.
2. To learn about functional imaging in CT.
3. To understand the problems of radiation dose
in these new techniques.

www.myESR.org Final Programme | ECR 2015 203


Postgraduate Educational Programme

08:30–10:00 Room MB 2 09:33


A-364 C. Pelvic trauma: not only arteries
E³ - ECR Master Classes (Paediatric) R. Bale; Innsbruck/AT
Learning Objectives:
E³ 926a Advances in paediatric imaging 1. To learn the appropriate diagnostic imaging techniques and protocols
Moderator: P. Tomà; Rome/IT in major pelvic trauma and how to modify them according to clinical
requirements.
08:30 2. To learn about results, the failures and complications of endovascular
A-358 A. The CNS treatment of traumatic pelvic haemorrhage.
J.F. Schneider; Basle/CH 3. To learn about non-endovascular techniques that can be used in
Learning Objectives: pelvic trauma to deal with pelvic bone and genitourinary injuries.
1. To become familiar with advanced imaging protocols.
2. To understand how best to use DTI, fMRI and spectroscopy.
3. To be able to recognise age-related normal patterns from disease. 08:30–10:00 Room MB 4

09:00 Emergency Radiology


A-359 B. The MSK - infectious inflammatory disorders
M. Alison, A. Tanase, A. Rega, L. Cardoen, G. Sebag; Paris/FR RC 917 Acute pain: your friend and enemy
Learning Objectives: in emergency radiology
1. To become familiar with the complementary role of US,
bone scan and MRI. 08:30
2. To learn about optimised imaging protocols. A-365 Chairman’s introduction: patients with acute pain -
3. To be able to differentiate age-related normal patterns from disease.
management and therapeutic pathways
09:30 J. Walecki; Warsaw/PL
A-360 C. The abdomen 08:35
M. Raissaki; Iraklion/GR
Learning Objectives: A-366 A. Head
P.C. Maly Sundgren; Lund/SE
1. To become familiar with advanced imaging protocols.
2. To understand how best to use MR enterography and MR urography. Learning Objectives:
3. To understand the complementary role of high resolution 1. To be familiar with common clinical conditions resulting in acute
ultrasonography and MRI in the investigation headache.
of the paediatric abdomen. 2. To understand the choice of the best-suited proper imaging modality.
3. To learn typical imaging findings in the most common clinical
scenarios.
08:30–10:00 Room MB 3 08:59
E³ - ECR Master Classes A-367 B. Chest
J.E. Wildberger, S.C.A.M. Bekkers; Maastricht/NL
(Interventional Radiology) Learning Objectives:
1. To be familiar with clinical conditions resulting with acute pain in
E³ 926b The leading role of interventional chest.
2. To understand which additional data influence on choosing the
radiology in a major trauma centre proper imaging modality.
3. To learn the typical imaging findings in patient with acute chest pain.
08:30
A-361 Chairman’s introduction: logistics and imaging of trauma: 09:23
what do we really need? A-368 C. Abdomen
A.-M. Belli; London/UK R. Basilico; Chieti/IT
Learning Objectives:
08:39 1. To be familiar with common clinical conditions resulting
A-362 A. Chest trauma in acute abdominal pain.
J. Lammer; Vienna/AT 2. To know which clinical information influence the choice
Learning Objectives: of the best suited imaging modality.
1. To learn about the importance of selecting the appropriate imaging 3. To learn typical and untypical imaging findings in patients
technique to allow for the detection of arterial involvement in chest with acute abdomen.
trauma patients.
2. To understand the most important information urgently needed for Panel discussion:
treatment decisions and planning. 09:47 Where does radiology fit in the pathway?
3. To learn about basic and advanced techniques in the management of
chest trauma and deceleration injuries.
09:06
A-363 B. Upper abdominal trauma
O.M. van Delden; Amsterdam/NL
Learning Objectives:
1. To be able to take part in decision making and to determine which
cases deserve management by interventional radiology.
2. To learn about indications and techniques for endovascular treatment
of traumatic abdominal haemorrhage.
3. To learn about results, the failures and complications of endovascular
treatment of traumatic abdominal haemorrhage.

204 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room MB 5 10:30–12:00 Room B

E³ - ECR Academies: ESR meets Germany


Diagnostic Urogenital Radiology EM 1 Tradition goes digital:
E³ 920 Gynaecology getting ready for the future
Welcome by the ESR President
Moderator: T.M. Cunha; Lisbon/PT L. Bonomo; Rome/IT
08:30 Presiding
B. Hamm; Berlin/DE
A-369 A. MR imaging techniques and normal anatomy N. Hosten; Greifswald/DE
of the female pelvis
C.S. Balleyguier, S. Canale, E. Zareski; Villejuif/FR 10:30
Learning Objectives: A-374 Introduction
1. To learn about the different MR protocols according N. Hosten; Greifswald/DE
to the clinical question. Session Objectives:
2. To become familiar with normal imaging findings 1. To present landmark projects established by Deutsche
of the female pelvis. Röntgengesellschaft.
3. To become familiar with potential pitfalls. 2. To show how landmark projects can enhance the standing of
09:00 a national society in a competitive environment.
3. To discuss ideas for these and similar projects.
A-370 B. Staging of cervical cancer
R. Forstner; Salzburg/AT 10:35
Learning Objectives: A-375 State-of-the-art teaching in German radiology:
1. To learn about the MR appearance of cervical cancer, Akademie online
including mimics. M.G. Mack1, F. Mayer2, A. Aschoff3, M. Uder4; 1Munich/DE, 2Osnabrück/DE,
2. To be familiar with the spread of disease. 3
Kempten/DE, 4Erlangen/DE
3. To understand the impact of imaging on therapeutic Learning Objectives:
decision making. 1. To learn about the concept of an internet-based teaching platform.
09:30 2. To understand the potential and risks of web-based teaching and
education.
A-371 C. Differential diagnoses of adnexal masses 3. To appreciate the improvement in flexibility of course delivery and
S. Swi; Leeds/UK
the reduction in education costs.
Learning Objectives:
1. To understand to identify the origin of the suspicious adnexal mass. 10:55
2. To learn about how to differentiate benign from malignant adnexal A-376 Interlude I: Radiation protection:
masses, also applying functional techniques. the concept of ‘justifying indication’

Friday
3. To understand to differentiate between benign surgical and R.W.R. Loose; Nuernberg/DE
non-surgical lesions.
Learning Objectives:
1. To learn about the concept of justifying radiological examinations
and interventions.
10:30–12:00 Room A
2. To understand the level of justification and associated radiation risks.
3. To understand the impact of the new European Basic Safety
E³ - ECR Academies: Standards (EU-BSS).
Interactive Teaching Sessions 11:03
A-377 Population-based MRI:
E³ 1021 Head and neck cancer aer treatment: SHIP (study of health in Pomerania) and
what you need to know the national cohort
K. Hegenscheid; Greifswald/DE
10:30
Learning Objectives:
A-372 A. Imaging aer surgical treatment 1. To present the objectives, concepts, and infrastructure
M. Lell; Erlangen/DE
of population-based imaging studies in Germany.
Learning Objectives: 2. To learn about the potential of population-based versus clinical
1. To become familiar with the different surgical techniques. imaging research.
2. To become familiar with the imaging findings after surgery. 3. To understand special ethical implications
of population-based imaging.
11:15
A-373 B. Imaging aer radiotherapy/chemotherapy 11:23
T. Beale; London/UK A-378 Interlude II: The Röntgenhaus:
Learning Objectives: Wilhelm Conrad Röntgen’s birthplace
1. To become familiar with common findings after medically treated B. Lewerich; Berlin/DE
head and neck tumours. Learning Objectives:
2. To become familiar with changes after radiotherapy for head and 1. To learn about the history of the 250-year-old house
neck tumours. where W.C. Roentgen was born.
2. To appreciate the importance of scientific landmarks f
or creating enduring public and political interest.
3. To invite and motivate radiologists to support the activities
of the Röntgen House Foundation.

www.myESR.org Final Programme | ECR 2015 205


Postgraduate Educational Programme

11:31 11:05
A-379 MRI-PET: A new modality for clinical imaging A-388 Dual-energy CT in oncology
C.D. Claussen, N. Schwenzer; Tübingen/DE C.N. De Cecco; Rome/IT
Learning Objectives: Learning Objectives:
1. To understand the technical requirements of hybrid MR/PET. 1. To learn about the application of multi-energy CT in oncology.
2. To realise the impact of MR/PET on workflow. 2. To explore the possibilities of material identification and
3. To learn about potential clinical applications of MR/PET. differentiation with multi-energy imaging.
3. To appreciate the effect on the management of cancer patients.
Panel discussion:
11:51 Cross-linking radiology: opportunity or threat? 11:35
A-389 Clinical application of multi-energy imaging
in digital mammography
10:30–12:00 Room L 1 C. Dromain, J. Arfi-Rouche, A.-M. Tardivel, J.-R. Garbay, S. Delaloge,
C.S. Balleyguier; Villejuif/FR
EIBIR Session Learning Objectives:
1. To learn about the application of multi-energy imaging
EIBIR 2 What’s new in biomedical imaging to mammography.
2. To appreciate how multi-energy imaging compares
research: an update of EIBIR activities with other mammographic imaging modalities.
10:30
A-380 Chairman’s introduction 10:30–12:00 Room MB 5
G.P. Krestin; Rotterdam/NL

10:45 E³ - ECR Academies:


A-381 Presentation from the European Commission Diagnostic Urogenital Radiology
on Horizon 2020
A.-S. Costescu; Brussels/BE E³ 1020 Emergencies
Moderator: R.H. Oyen; Leuven/BE
11:00
A-382 EIBIR Joint Initiative for Paediatric Radiology 10:30
K. Rosendahl; Bergen/NO A-390 A. Male pelvis emergencies
M. Bertolotto; Trieste/IT
11:15
Learning Objectives:
A-383 EIBIR Joint Initiative: Biomedical Image Analysis Platform 1. To be familiar with various male pelvis emergencies.
W.J. Niessen; Rotterdam/NL
2. To learn about the correct imaging techniques.
3. To understand the differential diagnoses.
11:30
A-384 EIBIR Joint Initiative for Image Guided Radiotherapy 11:00
V. Valentini; Rome/IT A-391 B. Gynaecological emergencies
R.A. Kubik-Huch; Baden/CH
11:45 Learning Objectives:
A-385 EIBIR Joint Initiative for Euro-BioImaging 1. To be familiar with various emergencies of the female pelvis.
S. Aime; Turin/IT 2. To learn about the correct imaging techniques.
3. To understand the differential diagnoses.

10:30–12:00 Room G 11:30


A-392 C. Imaging of obstetric and puerperal emergencies
EFOMP Workshop J. McHugo; Birmingham/UK
Learning Objectives:
EF 2 Multi-energy imaging: 1. To learn about the imaging techniques performed in pregnancy.
2. To learn about the differential diagnosis of obstetric
from physics to diagnosis II and puerperal emergencies.
Moderators: J. Damilakis; Iraklion/GR, A. Torresin; Milan/IT 3. To become familiar with typical imaging findings
of most common pathologies.
10:30
A-386 Chairman’s introduction
J. Damilakis; Iraklion/GR 12:15–12:45 Room A
Session Objectives:
1. To explore the clinical applications of multi-energy CT. Plenary Session
2. To assess the role of multi-energy in the management of patients.
3. To explore the problems raised by radiation dose. HL 2 Wilhelm Conrad Röntgen -
10:35 Honorary Lecture
A-387 Multi-energy imaging in the thorax Presiding: B. Hamm; Berlin/DE
P. Vock; Spiegel/CH
Learning Objectives:
12:15
1. To learn about the application of multi-energy CT in the thorax. A-393 Hybrid imaging: let the two worlds of radiology
2. To appreciate its effect on patient management. and nuclear medicine come together!
3. To understand image artefacts. G. Antoch; Düsseldorf/DE
4. To learn about reducing radiation dose. Learning Objectives:
1. To acknowledge that expertise in function and morphology
is essential to read and interpret hybrid imaging data sets.
2. To learn about ways of cooperation between radiology
and nuclear medicine.

206 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

12:30–13:30 Room B 14:41


A-399 Interlude: German Röntgen Museum
E³ - The Beauty of Basic Knowledge: B. Lewerich; Berlin/DE
Breast Imaging Learning Objectives:
1. To learn about highly sophisticated non medial applications of X-rays
2. To understand other methods of producing X-rays
E³ 25C Breast cancer staging: why and how 3. To appreciate the benefits of non-medical technical applications
Moderator: J. Camps Herrero; Alzira/ES
14:54
12:30 A-400 PET-CT
A-394 Breast cancer staging: why and how K. Hägele; Böbingen/DE
K. Kinkel; Chêne-Bougeries/CH Learning Objectives:
Learning Objectives: 1. To demonstrate the use of PET-CT in oncology.
1. To learn the timing, limitation and advantages 2. To learn about the tracers used in PET.
of the different imaging techniques in staging breast cancer. 3. To understand the principle and technique of the examination.
2. To know how to deal with additional lesions and 4. To become familiar with the process
their clinical meaning. (patient preparation and aftercare).
3. To understand the critical role of the radiologist 5. To appreciate the benefits of the examination.
in the pretreatment evaluation of breast cancer.
15:12
A-401 MRI-PET
12:30–13:30 Room D1 V. Diehl, C. Franzius, M. Lentschig; Bremen/DE
Learning Objectives:
E³ - The Beauty of Basic Knowledge: 1. To learn about the basics of the combination of MRI and PET.
2. To understand the simultaneous acquisition of morphology
Skeletal Radiology and metabolism.
3. To appreciate the clinical applications with the example
E³ 24C Inflammatory/infectious disorders of oncologic imaging and neurological imaging.
Moderator: V. Cassar-Pullicino; Oswestry/UK

12:30 14:00–15:30 Room Studio 2015


A-395 Inflammatory/infectious disorders Joint Session of the ESR and ESMRMB
V.N. Cassar-Pullicino; Oswestry/UK
Learning Objectives:
1. To learn about the pathomechanisms involved in inflammatory The ABC and 123 of perfusion MRI:
and infectious disorders. DSC, DCE and ASL explained
2. To understand the imaging appearances and their differential Moderators: X. Golay; London/UK, M. Smits; Rotterdam/NL

Friday
diagnosis in the acute, sub-acute and chronic phases of infection.
3. To become familiar with the spectrum of imaging features of 14:00
inflammatory disorders in the axial and peripheral skeleton. A-402 Perfusion MRI: DSC, DCE and ASL
L. Knutsson; Lund/SE
14:00–15:30 Room B Learning Objectives:
1. To understand the basic principles of dynamic susceptibility contrast
(DSC), dynamic contrast-enhanced (DCE) and arterial spin-labelling
EFRS meets Germany (ASL) perfusion MRI.
2. To know the perfusion MRI protocols and post-processing.
EM 5 High-end and hybrid technology 3. To know the parameters that are derived from perfusion MRI, e.g.
in clinical and research work of cerebral blood volume (CBV), cerebral blood flow (CBF), and ktrans.
radiographers in Germany 14:30
Presiding A-403 Clinical applications of brain perfusion MRI
C. Vandulek; Kaposvár/HU H.R. Jäger; London/UK
A. Ohmstede; Oldenburg/DE
Learning Objectives:
14:00 1. To know the current indications for brain perfusion MRI
in the clinical routine.
A-396 Introduction 2. To understand which perfusion MRI technique and parameters
C. Vandulek1, A. Ohmstede2; 1Kaposvár/HU, 2Oldenburg/DE
to use for which indication.
14:05 3. To learn about future applications of brain perfusion MRI
in clinical practice.
A-397 Teaching and learning with VERT
(Virtual Environment for Radiation Therapy Training)
C. Garske; Berlin/DE
Learning Objectives:
1. To learn about our work with VERT.
2. To understand the advantages of VERT.
3. To appreciate the better preparation of our students
for the practical course.
14:23
A-398 Selective Internal Radiation Therapy (SIRT)
B. Kulitzscher; Berlin/DE
Learning Objectives:
1. To learn about the procedure background.
2. To become familiar with the material used.
3. To appreciate the outcome of SIRT.

www.myESR.org Final Programme | ECR 2015 207


Postgraduate Educational Programme

14:55 14:05
A-404 DCE-MRI in oncology - when is quantitative A-409 EuroSafe imaging call for action
imaging essential? G. Frija; Paris/FR
A.R. Padhani; London/UK Learning Objectives:
Learning Objectives: 1. To learn about EuroSafe Imaging’s strategy to establish
1. To show that the implementation of perfusion DCE-MRI into clinical a patient safety culture in Europe.
practice has been delayed/hindered by the complexities 2. To understand how EuroSafe Imaging’s Call for Action will
of the technical analysis. contribute towards the implementation of the IAEA and
2. To demonstrate that complex quantitative analysis has roles in WHO ‘Bonn Call for Action’.
validation, drug development and is needed for multiparametric 3. To learn more about the specific plan of activities
assessments. of EuroSafe Imaging.
3. To illustrate that the key role of quantitative DCE-MRI is in the 14:15
validation phase of biomarker development but that clinical
deployment can be reductive provided that sensitivity is maintained. A-410 EuroSafe imaging training and education activities
4. To discuss future work, which should focus on incorporating and data collection project “Are you EuroSafe?”
perfusion imaging as part of multiparametric assessments so as P. Vock; Spiegel/CH
to improve understanding of tumour heterogeneity, including Learning Objectives:
response in the era of targeted/precision medicine. 1. To have an overview of the EuroSafe imaging education activities.
2. To understand the importance of training and education
15:20 Panel discussion to improve radiation protection practices.
3. To learn more about CT practices in Europe based on the results
of the survey.
14:00–15:30 Room L 1 4. To understand what action needs to be taken as a result
of the data collection.
EIBIR Session 14:30
EIBIR 3 MITIGATE consortium: A-411 Role of radiographers in medical radiation protection
state of the art imaging and in the context of EuroSafe imaging
G. Paulo; Coimbra/PT
therapy in GIST Learning Objectives:
Moderators: S.O. Schönberg; Mannheim/DE, I. Virgolini; Innsbruck/AT 1. To understand the role of radiographers
in medical radiation protection.
14:00 2. To learn more about the ‘division of labour’ between radiologists
A-405 Selective internal radiotherapy in GIST patients and radiographers.
S.J. Diehl; Mannheim/DE 3. To learn more about the impact technical issues and quality
of equipment have on radiation protection.
14:30
A-406 Multimodal imaging in GIST 14:45
D.L. Longo; Turin/IT A-412 Role of medical physicists in medical radiation protection
in the context of EuroSafe imaging
15:00 J. Damilakis; Iraklion/GR
A-407 Principle of X-Nuclei MR imaging: what the radiologist Learning Objectives:
should know 1. To understand the role of medical physicists
L.R. Schad; Mannheim/DE in medical radiation protection.
2. To learn more about the added value medical physicists provide
in radiology departments.
14:00–15:30 Room MB 2 15:00
EuroSafe Imaging Session A-413 New European approaches to medical low-dose research
J. Repussard; Paris/FR
EuroSafe 2 EuroSafe imaging call for action Learning Objectives:
1. To raise awareness about existing knowledge gaps,
14:00 and related research programs.
2. To learn about the opportunities for participation
A-408 Chairman’s introduction to research project with field.
G. Frija; Paris/FR
Session Objectives: Panel discussion:
1. To learn more about the ESR’s strategy to establish a new quality 15:15 EuroSafe Imaging - feedback, contributions,
and safety culture across Europe through the EuroSafe Imaging future activities, endorsement
campaign. N. Bedlington; Vienna/AT (European Patients Forum)
2. To learn about CT practices in Europe based on the results N. Denjoy; Brussels/BE (COCIR)
of an ESR data collection survey. G. Simeonov; Luxembourg/LU (European Commission)
3. To learn more about EuroSafe Imaging’s training and education M. Perez; Geneva/CH (WHO)
activities in the area of radiation protection. O. Holmberg; Vienna/AT (IAEA)
4. To understand that medical radiation protection is
a multi-disciplinary team effort.

208 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room A 16:59


A-420 Role of imaging in active surveillance
E³ - ECR Academies: A.R. Padhani; London/UK
Interactive Teaching Sessions Learning Objectives:
1. To discuss the role of mpMRI for confirming eligibility for active
surveillance (which means to highlight the benefits of mpMRI
E³ 1221 Unexpected findings on brain MRI for detecting cases at higher risk and thus unsuited for active
surveillance).
16:00 2. To monitor patients under AS.
A-414 A. Large ventricles: normal or abnormal? 3. To optimise biopsy targeting during monitoring on AS.
S. Langner; Greifswald/DE
Learning Objectives: Panel discussion:
1. To learn the anatomy and physiology of the ventricular system. 17:17 When should MRI be used? Before or aer prostate biopsy?
2. To differentiate hydrocephalus from physiologic changes. Qualitative or quantitative MRI reading?
Cost-effectiveness of mpMRI for as a tool
16:45 for prostate cancer screening.
A-415 B. Incidental lesions on a brain MRI Can mpMRI detect clinically significant prostate cancer?
E.T. Tali; Ankara/TR
Learning Objectives:
1. To identify incidental findings on a brain MRI. 16:00–17:30 Room C
2. To learn how to characterise the lesions.
3. To learn how to handle the incidental findings. E³ - ECR Academies:
Modern Imaging of the GI Tract
16:00–17:30 Room B
E³ 1222 Perianal fistula disease:
ESR meets EAU all you need to know
Moderator: D. Weishaupt; Zurich/CH
EM 2 Joint ESR-EAU prostate cancer session
Welcome by the ESR President 16:00
L. Bonomo; Rome/IT A-421 A. Perianal anatomy and imaging techniques
Presiding K. Horsthuis; Amsterdam/NL
P.-A. Abrahamsson; Malmö/SE
B. Hamm; Berlin/DE Learning Objectives:
1. To understand anal canal anatomy.
16:00 2. To become familiar with state-of-the-art protocols for imaging
the anal canal.
A-416 Introduction 3. To learn about normal variants which mimic anal disease.
P.-A. Abrahamsson1, B. Hamm2; 1Malmö/SE, 2Berlin/DE

Friday
Session Objectives: 16:20
1. To understand therapeutic decision-making from the urologist’s A-422 B. Perianal fistula disease: the basics
point of view. S. Halligan; London/UK
2. To understand the role of imaging in the early detection Learning Objectives:
of prostate cancer. 1. To understand the pathophysiology and classification
3. To learn about the new role of imaging in active surveillance. of perianal fistula disease.
16:05 2. To become familiar with the role of US and MRI in assessing
fistula disease.
A-417 PSA screening: the EAU view 3. To learn about the basic reporting of non-complex fistula disease.
P.-A. Abrahamsson; Malmö/SE
Learning Objectives: 16:40
1. To be aware of the limitations of PSA. A-423 C. Perianal fistula disease: advanced
2. To understand how to personalise prostate cancer screening. F. Maccioni; Rome/IT
3. To understand the indications for prostate MRI from the urological Learning Objectives:
point of view. 1. To learn about complex perianal fistula disease, notably extensions
16:23 and abscesses.
2. To understand the role of imaging in patient follow-up and
A-418 Role of a multiparametric MRI in early detection treatment monitoring.
G.M. Villeirs; Gent/BE
3. To learn about benign inflammatory conditions which may affect
Learning Objectives: the anal canal, including hydradenitis and pilonidal disease and
1. To understand the basic principles of mpMRI. how they are differentiated from perianal fistulae.
2. To be aware of the advantages and limitations of each MR technique.
3. To understand the PIRADS classification system. 17:00
16:41 A-424 D. Interactive case discussion
D. Weishaupt; Zurich/CH
A-419 Active surveillance strategies in prostate cancer Learning Objectives:
A. Villers; Lille/FR
1. To become familiar with typical cases demonstrating
Learning Objectives: the crucial role of imaging perianal fistula disease.
1. To understand the paradigm shift from invasive treatment 2. To learn about typical imaging findings.
to active surveillance (rationale for active surveillance). 3. To be aware of potential pitfalls in imaging perianal fistula disease.
2. To learn how to select patients for active surveillance
(comparison between the different available criteria).
3. To identify triggers for active treatment (tumour progression).

www.myESR.org Final Programme | ECR 2015 209


Postgraduate Educational Programme

16:00–17:30 Room Z 16:15


A-430 B. Radiation risks for patients and staff
Professional Challenges Session P. Gilligan; Dublin/IE
Learning Objectives:
PC 12b Medicolegal aspects in daily practice 1. To get the latest information on stochastic and deterministic risks
in radiology.
16:00 2. To learn about quantitative risk assessment in typical scenarios:
A-425 Chairman’s introduction pregnant patient undergoing a CT scan; child undergoing a CT brain
J.I. Bilbao; Pamplona/ES scan; adult undergoing a high-dose fluoroscopy procedure.
Session Objectives: 16:40
1. To understand the consequences of misinterpretation.
2. To learn about the concepts of error, undesirable results A-431 C. Risk in MRI
and malpractice. R. Peeters; Leuven/BE
3. To become familiar with the point of view of the lawyer. Learning Objectives:
1. To learn about the risks for patients from MRI procedures.
16:05 2. To learn about the contraindications for MRI scans.
A-426 Inadequate consent, missed lesions and 3. To learn about risks for staff in an MRI department.
misinterpretation: legal challenges in radiology 17:05
E.J. Adam; London/UK
Learning Objectives:
A-432 D. Communicating risks to patients and the public
N. Leitgeb; Graz/AT
1. To understand the need to accurately inform the patient about
the procedure and the expected results. Learning Objectives:
2. To know how to deal with lesions which have been missed 1. To become familiar with communicating risk according
in a report. to the imaging modality.
3. To become familiar with the consequences that a misinterpretation 2. To become familiar with important rules in communication.
may have in the process of attending to a patient. 3. To understand the relationship between threat/hazard and
parents’ perception regarding imaging of their child.
16:25 4. To learn how to select a risk-communication strategy suited
A-427 When is a radiologic error simply an error and to parents and children.
when is it malpractice?
A. Cannavale, M. Santoni, F. Fanelli; Rome/IT
16:00–17:30 Room N
Learning Objectives:
1. To understand that some errors may be the result of negligent E³ - ECR Academies:
conduct of the radiologist.
2. To understand that some undesirable results are not malpractice.
3. To become familiar with the concept of “standard of care” in daily
Image-Guided Interventions in Oncology
clinical practice.
E³ 1219 The cutting-edge technologies
16:45 in image-guided tumour therapy
A-428 The lawyer’s point of view
M. Ludvik; Vienna/AT 16:00
Learning Objectives: A-433 Chairman’s introduction
1. To understand the legal concept of malpractice. M. Krokidis; Cambridge/UK
2. To become familiar with the point of view of a lawyer Session Objectives:
about ‘standard of care’ in clinical practice. 1. To become familiar with the new emerging image-guided
techniques in oncology.
Panel discussion: 2. To learn about physical and technical basics of the presented
17:05 How present are medicolegal aspects techniques.
in our daily clinical practice? 3. To understand the clinical and technical indications
for these new technologies.

16:00–17:30 Room M 16:03


A-434 A. HIFU: The ultrasound guidance
Physics in Radiology F. Orsi; Milan/IT
Learning Objectives:
RC 1213 Good radiation and bad radiation? 1. To understand physical and technical basics of ultrasound-guided
high intensity focused ultrasound (USgHIFU).
How to assess and communicate 2. To become familiar with the current indications in oncology.
radiation risk to patients and 3. To consolidate knowledge of results from personal experience
referring physicians and from the literature.
Moderator: O. Ciraj-Bjelac; Belgrade/RS 16:32
16:00 A-435 B. HIFU: The magnetic resonance guidance
A. Napoli, G. Brachetti; Rome/IT
A-429 A. Radiation risk: a patient’s perspective Learning Objectives:
E. Briers; Hasselt/BE
1. To understand physical and technical basics of magnetic
Learning Objectives: resonance-guided high intensity focused ultrasound (MRgHIFU).
1. To understand the fears of patients. 2. To become familiar with the current indications in oncology.
2. To learn what is expected from physicians and techs. 3. To consolidate knowledge of results from personal experience
3. To learn about ideal communication strategies. and form the literature.

210 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

17:01 16:05
A-436 C. Update on irreversible electroporation A-444 Current endovascular treatment in iliofemoral DVT
A. Nilsson; Uppsala/SE R. Uberoi; Oxford/UK
Learning Objectives: Learning Objectives:
1. To understand the physical and technical basics of irreversible 1. To learn about the typical clinical and imaging features of acute
electroporation (IRE). and chronic iliofemoral DVT.
2. To become familiar with the current indications in oncology. 2. To become familiar with common interventional techniques
3. To consolidate knowledge of results from personal experience and in acute and chronic iliofemoral DVT.
from the literature. 3. To understand current evidence and management recommendations
based on this evidence.

16:00–17:30 Room E1 16:25


A-445 Vena cava filters: an update
Musculoskeletal M.J. Lee; Dublin/IE
Learning Objectives:
RC 1210 Sports injuries to the knee: 1. To learn about indications and contraindications of IVC filters.
2. To become familiar with different IVC filter types.
improving my report 3. To highlight tips and tricks regarding IVC placement and retrieval.
Moderator: P. Robinson; Leeds/UK 4. To understand current evidence regarding safety and efficacy
of IVC filters.
16:00
A-440 A. Reporting meniscal tears: pitfalls and how I avoid them 16:45
G. Andreisek; Zurich/CH A-446 Interventional treatment of severe/massive
Learning Objectives: pulmonary embolism
1. To understand the normal anatomy which may simulate G. Carrafiello; Varese/IT
meniscal tears. Learning Objectives:
2. To understand pitfalls in the diagnosis of meniscal tears. 1. To understand the indications and contraindications
for IR treatment in severe/massive pulmonary embolism.
16:30 2. To become familiar with the techniques of catheter-directed
A-441 B. The collateral ligaments and posterolateral corner: thrombolysis and percutaneous thrombectomy
what are they, why do they matter and in pulmonary embolism.
how do I assess them? 3. To learn about safety and efficacy of IR treatment
V. Vasilevska Nikodinovska; Skopje/MK for pulmonary embolism.
Learning Objectives: 17:05
1. To appreciate the significance of the collateral ligaments
and posterolateral corner.
A-447 Techniques and tools in endovenous thermal ablation
D.J. West; Stoke-on-Trent/UK
2. To understand pitfalls in the diagnosis of posterolateral
Learning Objectives:

Friday
corner injuries.
1. To understand the principles of endovenous thermal ablation.
17:00 2. To become familiar with the procedural technique.
A-442 C. The patellofemoral joint and osteochondral injuries: 3. To learn how to build a dedicated service.
how do I assess and what do I report?
C. Schaeffeler; Chur/CH Panel discussion:
17:25 What does the interventional radiologist need
Learning Objectives: to know about modern anticoagulation treatment?
1. To improve the reporting of osteochondral injuries.
2. To improve the reporting of patellofemoral abnormalities.
16:00–17:30 Room F1
16:00–17:30 Room E2
State of the Art Symposium
Special Focus Session SA 12 Fleischner guidelines for nodules:
SF 12 Interventional radiology in venous theory and practice
thromboembolism and chronic 16:00
venous disease A-448 Chairman’s introduction
C.M. Schaefer-Prokop; Amersfoort/NL
16:00
Session Objectives:
A-443 Chairman’s introduction 1. To learn about the patho-radiological correlation during
D.K. Tsetis; Iraklion/GR the development of pulmonary adenocarcinomas.
Session Objectives: 2. To realise the value of CT as an imaging biomarker for the detection
1. To understand when the interventional radiologist should intervene of early lung cancer.
to treat venous thromboembolism and venous insufficiency. 3. To become familiar with the content of the Fleischner guidelines and
2. To learn about the principles and procedural challenges of the how to apply them in various clinical situations.
different endovascular techniques. 4. To learn about the options and limitations of using CT for growth
3. To appreciate the importance of building a dedicated interventional assessment and nodule character.
radiological service. 5. To learn about the fine line between estimation of risk, necessity
to control and performance of imaging features.

www.myESR.org Final Programme | ECR 2015 211


Postgraduate Educational Programme

16:05 16:35
A-449 The 2011 classification of adenocarcinomas: A-455 Equipment age - COCIR
rationale and implications for nodule management N. Denjoy; Brussels/BE
A. Nicholson; London/UK Learning Objective:
Learning Objectives: 1. To provide information on the age of CT equipment across Europe.
1. To become familiar with the most recent pathological classification 16:50
of pulmonary adenocarcimomas and to understand the rationale
behind it. A-456 Training and certification
2. To understand how pathologists determine the histological B. Ertl-Wagner; Munich/DE
composition of a nodular lesion and its implication on nodule Learning Objective:
management, tumour staging and patient prognosis. 1. To provide information on the training and certification disparities in
Europe, and to present the ESR tools to support harmonisation
16:30 in this area.
A-450 The Fleischner guidelines for solid and subsolid nodules:
17:05
theory and practice
A.A. Bankier; Boston, MA/US A-457 Issues related to coding terminology and IT access
P. Mildenberger; Mainz/DE
Learning Objectives:
1. To illustrate the role of CT as an imaging biomarker with examples Learning Objective:
of patho-radiological correlation. 1. To highlight the current European disparities in coding and
2. To become familiar with and understand the rationale behind the to propose a unified approach for imaging.
content of the Fleischner guidelines for solid and subsolid nodules.
3. To realise the impact of applying the Fleischner guidelines in clinical Panel discussion:
practice. 17:20 A global plan for imaging
4. To learn how the Fleischner guidelines may have to be adapted J. Griebel; Neuherberg/DE
to incorporate the most recent knowledge about the biological (HERCA Chair of the Working Group on Medical Applications - BfS, Germany)
behaviour of pulmonary nodules. T. Peetso; Brussels/BE
(Policy Officer of Unit ‘Health and Wellbeing’ - DG CNECT, European Commission)
16:55 A. Rys; Brussels/BE
A-451 Estimating the risk for malignancy of pulmonary nodules (Director Health systems and products - DG SANCO, European Commission)
B. van Ginneken; Nijmegen/NL
G. Simeonov; Luxembourg/LU
Learning Objectives: (Policy Officer Radiation Protection Unit - DG ENER, European Commission)
1. To learn about 2. and 3. methods of assessing nodule growth
and their accuracy.
2. To understand the different demands of solid and subsolid nodules 16:00–17:30 Room D1
with respect to growth assessment.
3. To learn about the role of computers in assessing the risk Chest
of malignancy of pulmonary nodules.

Panel discussion: RC 1204 Mediastinal disease revisited


17:20 Fleischner guidelines: what have we learned? Moderator: J. Dinkel; Munich/DE

16:00
16:00–17:30 Room F2 A-458 A. The crucial role of chest x-ray:
mediastinal lines and stripes
Professional Challenges Session J. Cáceres; Barcelona/ES
Learning Objectives:
PC 12a Harmonised approach for imaging 1. To become familiar with the signs that indicate
in Europe: myth or reality? mediastinal pathology.
2. To confidently identify and localise a mediastinal mass
16:00 on chest plain films.
A-452 Chairman’s introduction 16:30
L. Donoso; Barcelona/ES
A-459 B. Mediastinal masses: role of CT
Session Objectives: V.E. Sinitsyn; Moscow/RU
1. To present the basis for a Call for Action for medical imaging
Learning Objectives:
in Europe and beyond.
1. To learn the most common causes of mediastinal masses.
2. To highlight the current European disparities in terms of manpower,
2. To recognise signs which allow us to characterise mediastinal lesions.
education and training, and equipment.
16:05 17:00
A-453 Current heterogeneities in imaging in Europe A-460 C. A new look at the mediastinum: role of MRI and PET/CT
E.J.R. van Beek; Edinburgh/UK
G. Frija; Paris/FR
Learning Objectives:
Learning Objective:
1. To learn when and how to apply MR for mediastinal disease.
1. To provide information on the status of EU Member states regarding
2. To learn when and how to apply PET/CT for mediastinal masses.
key issues: equipment distribution, manpower, practices and
compliance with EURATOM Directives.
16:20
A-454 Imaging equipment: an ESR perspective
B. Brkljacic; Zagreb/HR
Learning Objective:
1. To present the ESR policy regarding the standards of equipment.

212 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room G 17:00


A-466 C. Diffusion-weighted MRI vs PET in oncology
E³ - ECR Master Classes (Genitourinary) F. Giesel1, A. Mehndiratta2, C. Kratochwil1; 1Heidelberg/DE, 2Dehli/IN
Learning Objectives:
E³ 1226a Urogenital radiology in 2015: 1. To learn about Diffusion-weighted MRI.
beyond morphology? 2. To understand the differences from PET.
Moderator: H.C. Thoeny; Berne/CH 3. To consolidate the use of advanced imaging protocols in oncology.

16:00
16:00–17:30 Room MB 1
A-461 A. Where are we in measuring kidney function
with imaging?
N. Grenier; Bordeaux/FR
E³ - ECR Master Classes
Learning Objectives: (Molecular Imaging)
1. To become familiar with the renal physiological parameters
to be quantified. E³ 1226d Chemical exchange saturation
2. To learn about the techniques available for evaluating the function.
3. To understand the limitations of each technique
transfer (CEST):
in clinical applications. a new toy for molecular imaging?
Moderator: O. Clément; Paris/FR
16:30
A-462 B. The added value of DWI in gynaecological malignancies: 16:00
the ADC and beyond A-467 A. Physical principle
A.G. Rockall; London/UK M. Bock; Freiburg/DE
Learning Objectives: Learning Objectives:
1. To describe the role of diffusion weighed MRI (DW-MRI) 1. To understand the physical principle of CEST imaging.
in lesion detection and characterisation. 2. To understand the requirements for a molecule to be suited
2. To review the added clinical value of DW-MRI in staging and for CEST imaging.
follow-up of patients with gynaecologic malignancies. 3. To learn about MR sequences used for CEST imaging.
3. To highlight technical and interpretation challenges of DW-MRI
in evaluation of gynaecologic malignancies. 16:30
A-468 B. Probes
17:00 S. Aime; Turin/IT
A-463 C. Will genomics change imaging? Learning Objectives:
Renal cancer as a case study 1. To learn about available endogenous and exogenous contrast agents
P.L. Choyke; Bethesda, MD/US and probes.
Learning Objectives: 2. To understand the advantages of para-CEST agents.

Friday
1. To identify the major genetic abnormalities associated 3. To discuss the potential of hyper-CEST.
with renal cancer.
2. To discuss how these genetic abnormalities affect the imaging
17:00
of renal cancer. A-469 C. Clinical applications
3. To describe how the interplay between genomics and S. Walker-Samuel; London/UK
imaging affects management of patients. Learning Objectives:
1. To understand the clinical potential of CEST.
2. To learn about gluco-CEST.
16:00–17:30 Room K 3. To discuss CEST applications in the orthopaedic and oncologic field.

E³ - ECR Academies:
16:00–17:30 Room MB 2
Hybrid Imaging (advanced)
E³ - ECR Master Classes (Cardiac)
E³ 1218 MR/PET - the future of hybrid imaging?
Moderator: R.A. Coulden; Edmonton, AB/CA E³ 1226c Cardiac MR imaging
Moderator: P. Croisille; Saint-Etienne/FR
16:00
A-464 A. For which indications is MR/PET better than PET/CT? 16:00
L. Umutlu; Essen/DE A-470 A. T1 and T2 mapping
Learning Objectives: C. Lücke; Leipzig/DE
1. To understand the advantage of using MRI instead of CT together Learning Objectives:
with PET. 1. To understand the principles of T1 and T2 mapping.
2. To become familiar with scanner technology. 2. To learn about the current insights and potential role
3. To consolidate the situation in advanced hybrid imaging. of T1 and T2 mapping.
16:30 16:30
A-465 B. MR/PET technology: state of the art A-471 B. Quantification of myocardial perfusion by MRI
A. Cuocolo, C. Nappi, R. Assante; Naples/IT K. Kitagawa; Mie/JP
Learning Objectives: Learning Objectives:
1. To understand the different demands of a PET System 1. To understand the different approaches to quantification
with MR instead of CT. of myocardial perfusion by MRI.
2. To become familiar with challenges in attenuation correction 2. To learn about the clinical potential of imaging
in PET/MR. perfusion quantification.
3. To consolidate knowledge of the new technique.

www.myESR.org Final Programme | ECR 2015 213


Postgraduate Educational Programme

17:00 16:05
A-472 C. 4D MR perfusion imaging of the myocardium A-478 A. Gastrointestinal tract
R. Manka; Zurich/CH M.A. Patak; Zurich/CH
Learning Objectives: Learning Objectives:
1. To understand the disadvantages of standard approaches 1. To describe the main techniques for surgery and
to MR perfusion imaging. list their potential complications.
2. To learn about the clinical potential of 4. perfusion imaging. 2. To become familiar with imaging features of postoperative
complications.
16:00–17:30 Room MB 3 3. To understand the indications and contraindications
for interventional and surgical procedures.
Computer Applications 16:29
A-479 B. Liver and pancreas
RC 1205 Update on computer-aided S. Wirth, M. Rentsch; Munich/DE
diagnosis (CAD) Learning Objectives:
1. To be familiar with surgical procedures and
16:00 their common complications.
A-473 Chairman’s introduction 2. To learn typical imaging findings in patients
M. Langer; Freiburg/DE with postsurgical complications.
Session Objectives: 3. To learn the guidelines for interventional radiological procedures.
1. To give an overview of the most important clinical applications 16:53
of CAD.
2. To describe results of clinical trials that use CAD for lesion detection
A-480 C. Genitourinary tract
R.H. Oyen; Leuven/BE
and interpretation.
3. To summarise advantages and limitations of CAD technology. Learning Objectives:
1. To be familiar with surgical procedures often resulting
16:05 in clinical complications.
A-474 A. CT colonography and CAD 2. To learn how to choose the best imaging modality
S.A. Taylor; London/UK to diagnose these complications.
Learning Objectives: 3. To understand the impact of imaging findings
1. To describe the reading paradigms of CAD applied on further management of patients.
to CT colonography.
2. To present the results of clinical trials adopting CAD as Panel discussion:
an additional tool to report CT colonography. 17:17 Time is gold - where and when can we go faster?
3. To describe indications, advantages and pit-falls of using CAD
in clinical practice.
16:00–17:30 Room MB 5
16:28
A-475 B. CAD for lung nodules Paediatric
A.R. Larici; Rome/IT
Learning Objectives: RC 1212 Hepatobiliary imaging in children
1. To describe CAD algorithms for nodule detection and Moderator: D. Akinci; Ankara/TR
volume measurement.
2. To underline advantages and limitations of the use of CAD 16:00
for lung nodule detection. A-481 A. Imaging of liver masses
3. To review the importance of lung nodule volume measurements. D.J. Roebuck; London/UK
16:51 Learning Objectives:
A-476 C. CAD for breast cancer detection 1. To learn about imaging protocols.
U. Bick; Berlin/DE 2. To learn about common benign and malignant lesions and
differential diagnosis.
Learning Objectives:
3. To become familiar with the role of new imaging techniques and
1. To describe different types of CAD algorithms for detection and
hepatocytes-specific contrast agents.
characterisation of breast lesions.
2. To review the results of clinical trials that use CAD for detection 16:30
of breast lesions. A-482 B. Imaging of biliary disorders
3. To give an overview of the potential role of CAD applied S.G.F. Robben; Maastricht/NL
to new technologies.
Learning Objectives:
1. To become familiar with the roles of US, CT and MRI.
Panel discussion:
2. To learn about manifestations of common diseases.
17:14 Is CAD ready for prime time?
3. To discuss the role of hepatobiliary contrast agents.

16:00–17:30 Room MB 4 17:00


A-483 C. Intervention in the hepatobiliary system
E³ - ECR Master Classes S. Franchi-Abella, D. Pariente; Le Kremlin-Bicêtre/FR
Learning Objectives:
(Emergency Radiology) 1. To become familiar with liver biopsy in focal and
diffuse hepatic disorders.
E³ 1226b Acute postoperative complications 2. To highlight the role of interventional radiology in biliary disorders.
in the abdomen: 3. To learn about the role of interventional radiology
in hepatic vascular disorder.
from diagnosis to therapy
16:00
A-477 Chairman’s introduction: the role of imaging in the early
detection of postsurgical complications
D.R. Kool; Nijmegen/NL

214 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room A 08:30–10:00 Room C

E³ - ECR Academies: E³ - ECR Academies:


Interactive Teaching Sessions Modern Imaging of the GI Tract
E³ 1321 Diagnostic evaluation of bone tumours E³ 1322 Imaging the postoperative patient
Moderator: A. Graser; Munich/DE
08:30
A-484 A. Bone tumours: benign or malignant? 08:30
H.-J. van der Woude; Amsterdam/NL A-489 A. What the surgeon does:
Learning Objectives: surgical procedures and normal postoperative anatomy
1. To learn the features on conventional radiographs that distinguish M.M. Maher; Cork/IE
benign and malignant bone tumours. Learning Objectives:
2. To learn the features on MRI and CT that distinguish benign and 1. To understand common surgical procedures performed in the
malignant bone tumours. esophagus, stomach, small bowel and colon.
09:15 2. To appreciate the normal appearance of an enteric anastamosis on
fluoroscopic and cross-sectional imaging.
A-485 B. Pseudotumours: mimic bone tumours 3. To understand the normal appearances of haemostatic packing and
F.M.H.M. Vanhoenacker, B. Peters; Antwerp/BE
other surgical devices on radiological investigations.
Learning Objectives:
1. To recognise the range of lesions which mimic tumours of the bone. 08:50
2. To learn the features that identify pseudotumours of the bone. A-490 B. Do I need to re-operate?
Postoperative imaging and immediate complications
D.J.M. Tolan; Leeds/UK
08:30–10:00 Room B
Learning Objectives:
1. To understand the best imaging options for investigating suspected
Abdominal Viscera postoperative complications.
2. To appreciate the normal appearances of the abdomen and pelvis
RC 1301 Pancreatic inflammation after surgery, in particular with regard to free fluid, haematoma and
Moderator: G. Morana; Treviso/IT free gas, and when to suspect complications.
3. To become familiar with the radiological appearances of common
08:30 and more unusual post-operative complications and their
A-486 A. Acute pancreatitis interventional radiological management.
M. Zins; Paris/FR
09:10
Learning Objectives:
1. To learn how imaging should be scheduled for patients
A-491 C. It still hurts: follow-up imaging and
with acute pancreatitis. long-term complications
2. To become familiar with the imaging features and the terminology L. Curvo-Semedo; Coimbra/PT
proposed in the Atlanta classification. Learning Objectives:
1. To become familiar with the long-term complications of surgery
09:00 to the GI tract.
A-487 B. Chronic pancreatitis and IPMN 2. To appreciate the appropriate use of imaging in the assessment
C. Matos; Brussels/BE of long-term complications.
Learning Objectives: 3. To learn about the radiological investigation of suspected
1. To learn the classical aspect of IPMN on imaging. postoperative adhesions.
2. To learn how it merges with chronic pancreatic disease and
09:30

Saturday
how we can differentiate both.
3. To understand the role of different imaging techniques in assessing A-492 D. Interactive case discussion
both diseases. A. Graser; Munich/DE

09:30
A-488 C. Paraduodenal and autoimmune pancreatitis 08:30–10:00 Room Z
S.A. Jackson; Plymouth/UK
Learning Objectives: Joint Session of the ESR and EORTC
1. To become familiar with the clinical presentation and the radiological
signs that may be observed in autoimmune pancreatitis. Imaging in multicentre clinical oncological trials
2. To become familiar with the diagnostic criteria for the disease. Moderators: L. Fournier; Paris/FR, Y. Liu; Brussels/BE
3. To learn strategies for managing doubtful clinical situations.
08:30
A-493 Imaging in clinical trials: the EORTC perspective
Y. Liu; Brussels/BE
Learning Objectives:
1. To become familiar with the importance of imaging
in oncologic trials.
2. To learn about the role of the EORTC Imaging Group.
3. To appreciate how standardisation enhances the role of imaging
in oncologic trials.

www.myESR.org Final Programme | ECR 2015 215


Postgraduate Educational Programme

08:53 08:30–10:00 Room N


A-494 Standardisation and quality assessment of imaging
as surrogate endpoints E³ - European Diploma Prep Sessions
N.M. deSouza; Sutton/UK
Learning Objectives: E³ 1323 Chest
1. To become familiar with approaches to the standardisation of
imaging methods.
08:30
2. To learn about the role of imaging biomarkers in oncologic trials. A-500 Chairman’s introduction
3. To appreciate the interactions of quantitative imaging with the results J. Vilar; Valencia/ES
from biobanks. Session Objectives:
1. To describe the most important signs in chest imaging.
09:16 2. To differentiate the imaging features of benign and malignant lesions
A-495 Optimised imaging for trials in brain tumours of the lung.
M. Smits; Rotterdam/NL 3. To differntiate the imaging appearance of common lesions of the
Learning Objectives: mediastinum, pleara and chest wall.
1. To consolidate knowledge about state-of-art quantitative MRI.
2. To learn about standardisation and validation.
08:33
3. To appreciate the value of quantitative MRI in grading and A-501 A. Fundamentals of chest imaging
therapy response. D. Tack; Baudour/BE
Learning Objectives:
09:38 1. To understand the anatomy and normal variants of the respiratory
A-496 Multiparametric MRI in breast and prostate cancer system, heart and vessels, mediastinum and chest wall and to
T.H. Helbich; Vienna/AT confidently identify these on radiographs, CT and MRI.
Learning Objectives: 2. To understand the technical aspects, exposure doses and post-
1. To consolidate knowledge about state-of-art techniques. processing of radiographs and CT of the chest.
2. To become familiar with the reading schemes. 3. To have an in-depth understanding of the most common chest
3. To appreciate the role of tissue characterisation and therapy response. radiography signs (including silhouette sign, air bronchogram, air
crescent sign, cervicothoracic sign, tapered margins, gloved finger
sign, golden sign, deep sulcus sign).
08:30–10:00 Room M 4. To describe the appearance and correct position of monitoring and
support devices (tubes and lines).
Physics in Radiology 09:02
A-502 B. Inflammation and tumours of the lung
RC 1313 IT tools for dose tracking and H. Prosch; Vienna/AT
workflow optimisation Learning Objectives:
Moderator: A. Trianni; Udine/IT 1. To understand the imaging features and differential diagnoses of
diffuse infiltrative and alveolar lung disease and atelectasis.
08:30 2. To differentiate solitary and multiple pulmonary nodules, benign and
A-497 A. Digital Imaging and Communication in Medicine malignant neoplasms, hyperlucencies and their potential aetiology
(DICOM) and Integrating the Healthcare Enterprise (IHE) and evaluation.
3. To differentiate thoracic diseases in immunocompetent,
standards immunocompromised and posttransplant patients.
D. Peck; Detroit, MI/US
4. To describe the imaging features of congenital disorders of the lung.
Learning Objectives:
1. To understand the current DICOM standard. 09:31
2. To learn about new DICOM efforts which will significantly impact A-503 C. Mediastinum, pleura and chest wall
imaging systems operations. N. Howarth; Chêne-Bougeries/CH
3. To understand how IHE coordinates the integration and Learning Objectives:
management of DICOM objects. 1. To differentiate the imaging features of common pathologies of the
09:00 diaphragm, pleura and chest wall on radiography, CT and MRI
of the chest.
A-498 B. Patient dose tracking: a must have? 2. To analyse and explain the imaging features and causes of mediastinal
D. Zamora; Seattle, WA/US
and hilar diseases.
Learning Objectives: 3. To describe the imaging features of disorders of the pulmonary
1. To identify informatics and tools for tracking patient radiation dose. vascular system and great vessels.
2. To learn about some possible uses in clinical practice. 4. To differentiate imaging features of the postoperative chest.
3. To learn about some examples of patient radiation dose tracking.
09:30
08:30–10:00 Room E1
A-499 C. Optimising technique using patient dose
tracking soware - tips and tricks
D. Murphy; Dublin/IE
Musculoskeletal
Learning Objectives: RC 1310 How I do it and report
1. To learn how to use the information in the DICOM header Moderator: K. Wörtler; Munich/DE
to improve technique and outcome for the patient.
2. To learn how to use the information in the DICOM header 08:30
to improve performance of the AEC system.
3. To take advantage of dose tracking information in order A-507 A. MRI of the hip
to compare and contrast technique among several CT scanners. J. Teh; Oxford/UK
Learning Objectives:
1. To learn about standardised imaging.
2. To understand the MRI-specific findings that aid diagnosis.
3. To learn a structured approach to reporting.

216 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

09:00 09:00
A-508 B. MRI of the spine and sacroiliac joints A-514 B. Imaging tumour heterogeneity and perfusion:
C. Schueller-Weidekamm; Vienna/AT predicting tumour behaviour
Learning Objectives: V.J. Goh; London/UK
1. To learn about standardised imaging. Learning Objectives:
2. To understand the MRI-specific findings that aid diagnosis. 1. To be familiar with the techniques for measuring tumour
3. To learn a structured approach to reporting. heterogeneity on imaging.
09:30 2. To know the main findings of perfusion imaging in predicting
tumour behaviour.
A-509 C. MRI of the hand 3. To be familiar with current research in this field.
M. Shahabpour, C. Boulet, M. De Maeseneer; Brussels/BE
Learning Objectives: 09:30
1. To learn about standardised imaging. A-515 C. Molecular imaging:
2. To understand the MRI-specific findings that aid diagnosis. visualising the characteristics of cancer cells
3. To learn a structured approach to reporting. G. Cook; London/UK
Learning Objectives:
1. To learn about important imaging targets in cancer cells.
08:30–10:00 Room E2 2. To be familiar with specific radiotracers currently in early phase
cancer imaging studies.
Neuro 3. To be familiar with the potential role of new tracers
in patient management.
RC 1311 Reporting spine imaging studies
Moderator: M.A. Papathanasiou; Athens/GR
08:30–10:00 Room F2
08:30
A-510 A. Disc nomenclature and treatment strategy Breast
M. Gallucci; L’Aquila/IT
Learning Objectives: RC 1302 Tailoring breast cancer screening
1. To become familiar with the different nomenclatures in degenerative to risk level
disk disease. Moderator: B. Brkljacic; Zagreb/HR
2. To learn how to differentiate between degenerative disease and
other pathologies. 08:30
3. To learn whether or not disc nomenclature influences
treatment strategy. A-516 A. Calculating, using and improving individual
risk estimates
09:00 S.W. Duffy; London/UK
A-511 B. What to say and not to say in your report Learning Objectives:
M.M. Thurnher; Vienna/AT 1. To know the different models for risk evaluation.
Learning Objectives: 2. To understand the limitations of risk modelling for predicting
1. To understand the legal value of a report. the individual risk.
2. To demonstrate how detailed a report should be. 3. To appreciate the potential applications of risk modelling for tailoring
3. To understand the importance of a clinical correlation and breast cancer screening.
previous exam correlation.
09:00
09:30 A-517 B. Intermediate risk: the grey zone
A-512 C. Introduction to structured reporting in the spine S.H. Heywang-Köbrunner; Munich/DE
J. Van Goethem1, L. van den Hauwe1, F. De Belder1, C. Venstermans1, F. Ramon2, Learning Objectives:
P.M. Parizel1; 1Antwerp/BE, 2Sint-Niklaas/BE

Saturday
1. To become familiar with the concept of increased breast cancer risk.
Learning Objectives: 2. To discuss the role of breast density in relation to cancer risk.
1. To understand if it is always helpful to have a structured report. 3. To evaluate the evidence in favour of intensive screening protocols
2. To learn what a structured report is. in women at intermediate risk.
3. To learn whether or not we can escape through structured reporting.
09:30
A-518 C. High risk: MRI alone?
08:30–10:00 Room F1 F. Sardanelli; San Donato Milanese/IT
Learning Objectives:
E³ - ECR Master Classes 1. To appreciate the evidence in favour of MRI for screening high-risk
women in terms of diagnostic performance and patient outcome.
(Oncologic Imaging) 2. To become aware of the value of MRI alone for screening women
with high-risk genes.
E³ 1326 Imaging tumour phenotype: 3. To become aware of the need for using mammography as an adjunct
the future is now to MRI when screening women who have had previous thoracic
radiation therapy.
Moderator: D. Regge; Turin/IT

08:30
A-513 A. Radiogenomics for cancer: phenotypic and genomic
heterogeneity
P.L. Choyke; Bethesda, MD/US
Learning Objectives:
1. To be familiar with the concept of radiogenomics.
2. To understand the potential role of radiogenomic studies
in evaluating cancer.
3. To be familiar with the research objectives in this field.

www.myESR.org Final Programme | ECR 2015 217


Postgraduate Educational Programme

08:30–10:00 Room D1 08:58


A-524 B. Application of evidence-based research into practice
Chest M. Gellert, M. Andersen; Odense/DK
Learning Objectives:
RC 1304 Occupational lung diseases: 1. To learn how research outcomes can be used to enhance
the known and the less known professional practice.
Moderator: N. Karabulut; Denizli/TR 2. To be aware of the current gap between research and clinical
practice and the importance of minimising it by developing
08:30 proactive cooperation.
3. To appreciate “learning by development”, a concept
A-519 A. Silicosis and coal workers’ pneumoconiosis of including radiographers and radiography students
K. Marten-Engelke; Göttingen/DE
into clinical practice research.
Learning Objectives:
1. To recognise clinical features and occupational history of silicosis 09:21
and CWP. A-525 C. Improvement of patient outcomes
2. To appreciate HRCT features of these disorders as well as important by evidence-based research
differential diagnoses. K.G. Vikestad; Oslo/NO
09:00 Learning Objectives:
A-520 B. Asbestos-related disease 1. To learn how applying research outcomes can translate into
S.J. Copley; London/UK measurable improvements in diagnosis or treatment.
2. To understand how changes and improvements of patient outcomes
Learning Objectives:
can be measured.
1. To know the wide range of findings associated
3. To identify opportunities to improve patient outcomes
with asbestos exposure.
in the workplace.
2. To appreciate the role of CT-HRCT in the assessment
of these patients.
Panel discussion:
09:30 09:44 How to promote research as a tool
A-521 C. Uncommon occupational lung diseases for professional development?
L. Flors; Charlottesville, VA/US
Learning Objectives: 08:30–10:00 Room G
1. To illustrate the HRCT features of patients with uncommon
occupational lung diseases.
2. To understand the importance of connecting the HRCT findings
Genitourinary
with clinical features and occupational history to improve
the diagnostic accuracy of these diseases. RC 1307 Female pelvic imaging: how I do it
Moderator: K. Kinkel; Chêne-Bougeries/CH

08:30–10:00 Room D2 08:30


A-526 A. Imaging female congenital anomalies
Radiographers I. Thomassin-Naggara, N. Perrot, M.-F. Carette, M. Bazot; Paris/FR
Learning Objectives:
RC 1314 Radiography and evidence-based 1. To learn about the embryology of normal and abnormal female
research: the way forward genital tract.
2. To understand the role of different available imaging techniques
08:30 for female congenital anomalies: ISG, TV-US and MRI.
3. To learn about the examination technique and understand
A-522 Chairmen’s introduction the imaging findings of MRI in the different classes of female
I. Henderson1, M.G.M. Hunink2; 1Aberdeen/UK, 2Rotterdam/NL
congenital anomalies.
Session Objectives:
1. To outline the importance of a robust evidence base in supporting 09:00
the development of professional practice. A-527 B. PET-CT in the female pelvis: how I do it
2. To demonstrate how the evidence base can be used to develop A.G. Rockall; London/UK
services for the benefit of patients. Learning Objectives:
3. To provide guidance on how radiographers can contribute 1. To understand the role of PET/CT in staging of various pelvic
to the evidence base through research. tumours and detection of tumour recurrence.
08:35 2. To learn about the advantages and limitations of PET/CT in imaging
the female pelvis.
A-523 A. The fundamentals of evidence-based research 3. To appreciate the role of PET/CT with respect to other imaging
S. Mathers1, G. Paulo2; 1Aberdeen/UK, 2Coimbra/PT
techniques in the diagnostic algorithms of pelvic tumours.
Learning Objectives:
1. To appreciate the importance and necessity 09:30
of evidence-based practice. A-528 C. How to image cystic tumours of the ovary
2. To develop a strategy to search, retrieve and evaluate sources R. Forstner; Salzburg/AT
of evidence. Learning Objectives:
3. To understand how evidence-based practice can be translated into 1. To learn about specific imaging algorithms of ovarian cystic tumours.
practice using examples with demonstrable impact. 2. To understand certain imaging features that can differentiate ovarian
from non-ovarian cystic tumours in the pelvis.
3. To become familiar with the pitfalls in imaging of ovarian cystic
tumours and the lessons to be learned from them.

218 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room K 11:10


A-534 C. Colitis
E³ - ECR Academies: J. Rimola; Barcelona/ES
Hybrid Imaging (advanced) Learning Objectives:
1. To learn about the cross-sectional imaging features of colitis.
2. To become familiar with differentiating infectious, inflammatory and
E³ 1318 Advanced imaging ischaemic conditions based on cross-sectional imaging criteria.
with tracers beyond FDG 3. To appreciate an integrated approach to the use of cross-sectional
Moderator: J. Votrubová; Prague/CZ imaging in colonic inflammatory bowel disease.

08:30 11:30
A-529 A. Neuroendocrine tumours A-535 D. Interactive case discussion
S. Fanti; Bologna/IT S.A. Taylor; London/UK
Learning Objectives:
1. To become familiar with PET imaging of neuroendocrine tumours
with PET. 10:30–12:00 Room B
2. To understand the biochemistry.
3. To learn about challenges in advanced imaging ESR meets the Republic of Korea
of neuroendocrine tumours.
09:00
EM 3 CT in lung cancer screening and
A-530 B. Prostate cancer
COPD evaluation
M.C. Roethke; Heidelberg/DE Welcome by the ESR President
L. Bonomo; Rome/IT
Learning Objectives:
Presiding
1. To learn about tracers for PET imaging of prostate cancer. B. Hamm; Berlin/DE
2. To learn about advanced MRI imaging of prostate cancer. T.-H. Lim; Seoul/KR
3. To consolidate knowledge in PET/MR imaging of prostate cancer.
09:30 10:30
A-531 C. Coronary atherosclerotic plaque A-536 Introduction: Korean Society of Radiology -
M.R. Dweck; Edinburgh/UK evolution and new challenges
T.-H. Lim; Seoul/KR
Learning Objectives:
1. To learn about tracers for PET imaging of atherosclerosis. Session Objectives:
2. To learn about advanced MRI imaging of atherosclerosis. 1. To learn about smoking-related pulmonary diseases.
3. To consolidate knowledge in PET/MR imaging of atheroscperosis. 2. To discuss the role of CT in lung cancer screening and COPD.
3. To learn about recent results of clinical trials in lung cancer screening
and COPD.
10:30–12:00 Room A 10:35
E³ - ECR Academies: A-537 Lung cancer screening in Korea
K.S. Lee; Seoul/KR
Modern Imaging of the GI Tract Learning Objectives:
1. To understand issues related to cancer screening.
E³ 1422 Inflammatory bowel disease 2. To learn about the results of recent clinical trials
of lung cancer screening.
Moderator: S.A. Taylor; London/UK
3. To present the situation and results of lung cancer screening in Korea.
10:30 10:55

Saturday
A-532 A. Cross-sectional imaging protocols A-538 Interlude: Republic of Korea (South Korea):
M.A. Patak; Zurich/CH
Korean people and culture
Learning Objectives: J. Hur; Seoul/KR
1. To understand state-of-the-art MRI, CT and US protocols
Learning Objectives:
for imaging IBD.
1. To briefly introduce Korean culture, food and people.
2. To appreciate the comparative advantages and disadvantages
2. To introduce unique tourist attractions in Korea.
of enterography and enteroclysis protocols.
3. To learn about protocol modifications when evaluating the colon. 11:00
10:50 A-539 Computer-aided nodule detection and volumetry:
A-533 B. Small bowel disease role in lung cancer screening
J. Stoker; Amsterdam/NL J.M. Goo; Seoul/KR
Learning Objectives: Learning Objectives:
1. To learn about the classifications of small bowel Crohn’s disease. 1. To understand basic ideas of computer-aided nodule detection
2. To become familiar with cross-sectional imaging signs of disease and volumetry.
activity and complications. 2. To learn the results of computer-aided nodule detection and
3. To understand a rational deployment of cross-sectional imaging volumetry in nodule management.
techniques according to clinical indication, highlighting the main 3. To discuss the measurement variability and related issues
advantages and disadvantages of CT, MRI and US. in nodule volumetry.
11:20
A-540 Interlude: Introduction of the Korean Society
of Thoracic Radiology (KSTR)
J. Hur; Seoul/KR
Learning Objectives:
1. To introduce the Korean Society of Thoracic Radiology (KSTR).
2. To introduce the “Weekly Chest Cases” website.

www.myESR.org Final Programme | ECR 2015 219


Postgraduate Educational Programme

11:25 10:33
A-541 CT in COPD: now and future A-546 A. Hepatobiliary system
J.B. Seo; Seoul/KR Y. Menu; Paris/FR
Learning Objectives: Learning Objectives:
1. To know the current role of CT in clinical practice of COPD. 1. To differentiate the anatomy, normal variants and congenital
2. To know the early results of clinical researches in quantification disorders of the hepatobiliary system.
of emphysema and airway wall inflammation with CT of COPD. 2. To describe the primary and secondary imaging features of acute and
3. To know several new potential CT techniques in evaluating COPD, chronic diffuse liver diseases.
such as analysis of peripheral vascular changes, air trapping, 3. To differentiate the causes and imaging features of benign and
diaphragmatic morphology and so on. malignant focal liver lesions, including cysts, hemangiomas,
adenomas, focal nodular hyperplasia, hepatocellular carcinomas and
Panel discussion: metastases.
11:45 Is CT an effective tool for management 4. To differentiate the various causes and imaging features of benign
of lung cancer screening and COPD? and malignant diseases of the biliary tract and gallbladder.
11:02
10:30–12:00 Room M A-547 B. Pancreas and spleen
W. Schima; Vienna/AT
RTF - Radiology Trainees Forum Learning Objectives:
1. To describe the anatomy, normal variants and congenital disorders
TF 1 Highlighted Lectures of the pancreas.
2. To differentiate the causes and imaging features of benign and
Moderators: M. Basta-Nikolic; Novi Sad/RS, C.A. Minoiu; Bucharest/RO
malignant pancreatic tumours.
3. To understand the imaging features of acute and chronic pancreatitis
10:30 and its potential complications.
A-542 Ischemic cardiomyopathy - coronary arteries and 4. To list the causes and imaging features of focal and
myocardium: two sides of the same coin? diffuse splenic abnormalities.
R. Marano; Rome/IT
11:31
11:00 A-548 C. Imaging of the gastrointestinal tract
A-543 MRI appearances of incidental focal liver lesions: R.G.H. Beets-Tan; Maastricht/NL
role of hepatocyte-specific contrast agents and DWI Learning Objectives:
S. Gourtsoyianni; London/UK 1. To differentiate the anatomy, normal variants and congenital
Learning Objectives: disorders of the oesophagus, stomach, duodenum, small bowel,
1. To learn about typical MRI imaging characteristics of the most colon, rectum and anal canal.
commonly encountered focal liver lesions in non-cirrhotic patients. 2. To describe the imaging features of colonic diverticulosis,
2. To become familiar with different available MRI contrast diverticulitis, tumour stenosis, ileocolic intussusception, colonic
mechanisms; including hepatocyte-specific contrast agents and DWI fistula, paracolic abscess, epiploic appendagitis, intra-peritoneal fluid
acquisition protocols. collection, colonic pneumatosis and pneumoperitoneum.
3. To appreciate additional information that can be gained towards the 3. To understand radiological manifestations of inflammatory bowel
detection and characterisation of focal liver lesions when using the diseases, malabsorption syndromes, infection and bowel ischemia.
afforementioned contrast mechanisms. 4. To be familiar with the the staging of tumours of the gastrointestinal
tract, including features that indicate nonresectability.
11:30
A-544 Radiology and sports injuries:
10:30–12:00 Room L 1
more than reading the image!
M. Maas; Amsterdam/NL
ESR Patient Advisory Group (PAG)
10:30–12:00 Room N ESR-PAG 1 The challenges of providing true
patient-centred care:
E³ - European Diploma Prep Sessions moving forward together
E³ 1423 Gastrointestinal and abdominal 10:30
A-552 Chairmen’s introduction
10:30 N. Bedlington1, P. Cavanagh2; 1Vienna/AT, 2Taunton/UK
A-545 Chairman’s introduction Session Objectives:
C. Stoupis; Männedorf/CH 1. To introduce a framework for delivering patient-centred care
Session Objectives: in radiology.
1. To describe typical imaging features of benign and malignant lesions 2. To understand the need for balance between professional
of the heaptobiliary system. responsibility and patient autonomy.
2. To differentiate the imaging features of benign and malignant lesions 3. To understand the patient’s needs and concerns.
of the pancreas and spleen. 4. To become familiar with methods and examples of good practice
3. To be familiar with the methodological basis and to differentiate and how to improve the patient-doctor relationship.
typical features in imaging examinations of the gastrointestinal tract.
10:40
A-553 Ethics in patient-centred radiology
C.D. Claussen1, G. Marckmann2; 1Tübingen/DE, 2Munich/DE
Learning Objectives:
1. To learn about the basic ethical principles that guide patient-centred
medical practice.
2. To understand some of the more specific ethical issues that arise
in clinical radiology.
3. To develop perspectives of how to deal appropriately with these
ethical issues in daily practice.

220 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

11:00 12:30–13:30 Room D1


A-554 Lost in radiology: is there a doctor in the department?
E. Briers; Hasselt/BE E³ - The Beauty of Basic Knowledge:
Learning Objectives: Skeletal Radiology
1. To understand the patient’s needs and concerns.
2. To learn about the importance of informed consent
(raise awareness and knowledge for medical imaging methods). E³ 24D Tumoural and pseudotumoural
3. To become familiar with methods and examples of good practice MSK lesions
and on how to improve the patient-doctor relationship. Moderator: V. Cassar-Pullicino; Oswestry/UK
4. To appreciate the contributions patients and their representatives
can bring to realise true patient-centered care. 12:30
11:20 A-558 Tumoural and pseudotumoural MSK lesions
K. Verstraete; Ghent/BE
A-555 An ESR framework for delivering patient-centred care
Learning Objectives:
in radiology’s services 1. To become familiar with the common pathological features of bone
P. Cavanagh; Taunton/UK
and soft tissue tumoural lesions.
Learning Objectives: 2. To appreciate the imaging hallmarks of pseudotumoural bone and
1. To comprehend existing good practice regarding patient-centred soft tissue lesions.
models in radiology. 3. To learn how best to use imaging modalities in differential diagnosis.
2. To understand the concept of driver diagrams in quality
improvement.
3. To introduce this approach in patient-centred care. 14:00–15:30 Room A
11:40
Panel discussion: on the ‘driver diagram for patient-centred care
E³ - ECR Academies:
in clinical radiology’ Interactive Teaching Sessions
E³ 1521 Skull base lesions
12:15–12:45 Room A
14:00
Plenary Session A-559 A. Imaging of the cavernous sinus and
the anterior skull base
HL 3 Nikola Tesla - Honorary Lecture D. Farina; Brescia/IT
Presiding: B. Hamm; Berlin/DE Learning Objectives:
1. To learn the anatomy.
12:15 2. To learn the most common lesions and their differential diagnosis.
A-556 Brain tumour update 2015:
what’s new and why you should care 14:45
A.G. Osborn; Salt Lake City, UT/US A-560 B. Imaging of the central skull base
A.D. Varoquaux1, A. Reyre1, N. Martin-Duverneuil1, F. Benoudiba2, F. Dubrulle3,
Learning Objectives: G. Moulin1; 1Marseille/FR, 2Paris/FR, 3Lille/FR
1. To understand the crucial importance of molecular profiles in the
new integrated approach to the diagnosis of brain tumours. Learning Objectives:
2. To appreciate the importance of molecular profiling in stratifying 1. To learn the anatomy.
patients for treatment decisions. 2. To learn the most common lesions and their differential diagnosis.
3. To be able to identify which imaging features may suggest
the preoperative diagnosis of specific tumor molecular subtypes
(“radiogenomics”). 14:00–15:30 Room B

Saturday
E³ - ECR Master Classes
12:30–13:30 Room B
(Abdominal and Gastrointestinal)
E³ - The Beauty of Basic Knowledge: E³ 1526 Advances in liver imaging
Breast Imaging Moderator: F. Caseiro Alves; Coimbra/PT

E³ 25D Ductal carcinoma in situ (DCIS): 14:00


small tumour but big problem A-561 A. Molecular imaging: where do we go?
F.M.A. Kiessling; Aachen/DE
Moderator: J. Camps Herrero; Alzira/ES
Learning Objectives:
12:30 1. To describe the basics of perfusion and diffusion in the liver imaging.
2. To give an overview in clinical application on focal or
A-557 Ductal carcinoma in situ (DCIS): diffuse liver disease.
small tumour but big problem 3. To emphasise and illustrate the importance of functional imaging
G. Forrai; Budapest/HU in routine clinical practice and its potential applications over
Learning Objectives: morphology imaging in the future.
1. To understand the differences between DCIS and invasive ductal
carcinoma (IDC) in terms of pathology and imaging and the clinical
implications thereof.
2. To learn the semiologic gamut of DCIS in the different techniques.
3. To know how to stage DCIS.

www.myESR.org Final Programme | ECR 2015 221


Postgraduate Educational Programme

14:30 14:00–15:30 Room Z


A-562 B. Liver perfusion or diffusion?
M. Ronot; Clichy/FR Joint Session of the ESR and ESTRO
Learning Objectives:
1. To describe the basics of perfusion and diffusion in the liver imaging. ESR/ESTRO 1 Non-surgical approach to early
2. To give an overview in clinical application on focal or lung cancer: perspectives of
diffuse liver disease.
3. To emphasise and illustrate the importance of functional imaging
imaging and radiation-based
in routine clinical practice and its potential applications disciplines
over morphology imaging in the future. Moderators: T. Franquet; Barcelona/ES, Y. Lievens; Ghent/BE
15:00 14:00
A-563 C. MR/PET: blessing or curse? A-568 Imaging requirements to guide non-surgical treatment
P.R. Ros; Cleveland, OH/US
in early lung cancer
Learning Objectives: C.M. Schaefer-Prokop; Amersfoort/NL
1. To give a specific overview of this imaging modality, expressing
Learning Objectives:
the cellular and functional applications of MR/PET.
1. To be aware of the possible spectrum of early lung cancer appearance
2. To describe advantages and disadvantages over
in imaging.
the other known single or fused imaging modalities
2. To understand what radiologists need to know and report in order
(PET/CT, MRI, PET, Dual CT etc).
to accurately guide non-surgical treatments.
3. To emphasise the role of MR/PET in molecular and
3. To understand the current role of PET-CT for managing early
oncologic imaging.
lung cancer.
14:20
14:00–15:30 Room C A-569 The most up-to-date evidence from the interventional
E³ - ECR Academies: oncology perspective
R. Lencioni; Pisa/IT
Modern Imaging of the GI Tract Learning Objectives:
1. To understand the basic principles of the various ablation techniques.
E³ 1522 Rectal cancer 2. To understand the indications and contradictions for lung tumour
ablation, as well as to know how to choose the right ablation
Moderator: L. Blomqvist; Stockholm/SE
technique for each lesion.
14:00 3. To know the main reported procedural complications and the basics
for prevention and treatment of such complications.
A-564 A. Imaging protocols
S. Gourtsoyianni; London/UK 14:40
Learning Objectives: A-570 The most up-to-date evidence from the radiation
1. To become familiar with state-of-the-art MRI and US protocols for oncology perspective
rectal cancer staging. S. Senan; Amsterdam/NL
2. To understand the normal appearances of the rectum and perirectal Learning Objectives:
tissues on cross-sectional imaging. 1. To learn about the most recent radiation therapy options to treat early
3. To understand the advantages and disadvantages of imaging lung cancer.
techniques in evaluating the rectum. 2. To know the strengths and weaknesses of the modern radiotherapy
14:20 for treatment of the early lung cancer with respect to other
treatment options.
A-565 B. Challenges in staging, treatment decisions and 3. To understand how to effectively determine the most appropriate
surgery for high rectal cancer and personalised treatment.
L. Curvo-Semedo; Coimbra/PT
Learning Objectives: 15:00
1. To learn about the clinical relevance of tumour height A-571 Imaging follow-up of non-surgical treatments
in rectal cancer. A.R. Larici; Rome/IT
2. To become familiar with the treatment options in high rectal cancer Learning Objectives:
and their pros and cons. 1. To learn about the morphologic changes in imaging induced
3. To appreciate the challenges in staging high rectal cancer and by radiation and ablation therapies in early lung cancer and
approaches to improving staging accuracy. at the time of their appearance.
14:40 2. To know the radiological criteria necessary to differentiate between
a therapeutic response and recurrence after non-surgical treatments.
A-566 C. Assessment aer neoadjuvant treatment 3. To understand the actual role of PET-CT in the follow-up of early
R.G.H. Beets-Tan; Maastricht/NL lung cancer treated with non-surgical treatments.
Learning Objectives:
1. To understand the role of imaging in treatment response assessment 15:20 Discussion
of rectal cancer.
2. To learn about imaging features which identify viable disease after
chemo-radiation.
3. To appreciate the role of imaging in the modern management
of patients with rectal cancer.
15:00
A-567 D. Interactive case discussion
L. Blomqvist; Stockholm/SE

222 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

14:00–15:30 Room M 14:32


A-578 B. Bone tumours
Paediatric S.L.J. James; Birmingham/UK
Learning Objectives:
RC 1512 Key issues in paediatric imaging 1. To describe the typical imaging features of common bone tumours.
2. To differentiate the typical imaging features of “don´t touch”
14:00 (“leave-me-alone”) lesions.
A-572 Chairman’s introduction 3. To understand the imaging manifestations
R.A.J. Nievelstein; Utrecht/NL of heamatological disorders.
Session Objectives: 15:01
1. To learn about effective communication with paediatric patients,
their parents or carers. A-579 C. Degenerative and inflammatory disorders
2. To understand the importance of dose reduction parameters. of the musculoskeletal system
3. To learn how to improve image quality in paediatric patients. K.-G.A. Hermann; Berlin/DE
Learning Objectives:
14:05 1. To understand the imaging presentation of degenerative disorders
A-573 A. Communicating effectively with parents and carers of the joints and to appreciate their clinical relevance.
J. McNulty; Dublin/IE 2. To have an in-depth knowledge of the imaging features and clinical
Learning Objectives: features of degenerative disease of the spine, disc and facet joints.
1. To explore potential issues arising from ineffective communication by 3. To understand the imaging manifestations of infection, inflammation
radiographers and radiologists in the medical imaging department. and metabolic diseases of the musculoskeletal system.
2. To consider the value of improved public relations and the marketing
of medical imaging professionals to paediatric patients, their parents
or carers. 14:00–15:30 Room L 1
3. To review approaches to enhancing effective communication
in the paediatric medical imaging environment. EuroSafe Imaging Session
14:28
A-574 B. Paediatric imaging: when less is more
EuroSafe 3 Dose-tracking leads the way
J. Portelli; Msida/MT to dose-reduction
Learning Objectives:
1. To become familiar with radiation dose associated with certain
14:00
paediatric imaging examinations. A-580 Chairman’s introduction: dose-tracking leads
2. To learn about dose reduction parameters. to dose-reduction: why radiologists MUST get involved
3. To understand practical aspects of imaging. P.M. Parizel, T. De Bondt, M. Geldof, F. Deferme; Antwerp/BE
14:51 Session Objectives:
1. To understand how dose tracking contributes to dose-reduction
A-575 C. The importance of clinically acceptable image quality without compromising quality of care.
E. Sorantin; Graz/AT 2. To understand the role of radiologists in dose tracking.
Learning Objectives:
1. To become familiar with standards of acceptable image quality. 14:05
2. To learn about the image quality and patient dose. A-581 The legislative environment in Europe:
3. To learn about the effect of poor-quality images. the new EU Directive and the goals of EuroSafe Imaging
J. Griebel; Neuherberg/DE
Panel discussion: Learning Objectives:
15:14 What are the essentials in education and training 1. To learn more about the EU radiation protection legislation.
for paediatric imaging? 2. To learn more about the implementation of the EU basic safety

Saturday
standards directive.
3. To learn more about EuroSafe Imaging’s activities in relation
14:00–15:30 Room N to the legal and regulatory environment.
E³ - European Diploma Prep Sessions 14:20
A-582 Implementing a dose management solution in your
E³ 1523 Musculoskeletal department: where to start and what to expect?
D. Weishaupt; Zurich/CH
14:00 Learning Objectives:
A-576 Chairman’s introduction 1. To understand the challenges of implementing dose management
F.M.H.M. Vanhoenacker; Antwerp/BE in radiology departments.
Session Objectives: 2. To learn from practical examples of dose management
1. To understand typical and atpyical imaging features of traumatic implementation.
disorders of the musculoskeletal system.
2. To differentiate imaging features of benign and malignant bone
14:35
tumours. A-583 Developing a multi-disciplinary team
3. To describe the imaging appearance of degenerative and in dose management (CT example)
inflammatory disorders of the musculoskeletal system. L. Martí-Bonmatí; Valencia/ES
14:03 Learning Objectives:
1. To understand which disciplines are required
A-577 A. Traumatic disorders of the musculoskeletal system on a CT dose management team.
M. Maas; Amsterdam/NL 2. To learn more about the advantages of multi-disciplinary
Learning Objectives: collaboration.
1. To describe the anatomy and normal variants of the musculoskeletal
system.
2. To understand common imaging presentations of acute and chronic
trauma involving the skeleton and soft tissue.
3. To understand common pitfalls in trauma imaging of the
musculoskeletal system.

www.myESR.org Final Programme | ECR 2015 223


Postgraduate Educational Programme

14:50 14:05
A-584 PiDRL - European Commission Tender Project A-590 Reporter gene imaging
on diagnostic reference levels in paediatric imaging C.W.G.M. Löwik, E.L. Kaijzel, L. Mezzanotte; Leiden/NL
J. Damilakis; Iraklion/GR Learning Objectives:
Learning Objectives: 1. To learn about the methodology of creating reporter genes.
1. To understand the methodology for establishing and using DRLs 2. To understand the differences between reporter gene imaging
for paediatric imaging. and other methods of labeling used in optical imaging.
2. To learn about the specific requirements for paediatric DRLs 3. To become familiar with successful examples
(in comparison to DRLs for adults). of reporter gene imaging.

15:05 14:30
A-585 Deploying a dose management strategy across A-591 Cerenkov - faster than the speed of light
J. Grimm; New York, NY/US
multiple sites
K. Katsari; Athens/GR Learning Objectives:
1. To understand the method of Cerenkov imaging.
Learning Objectives:
2. To become familiar with representative applications
1. To understand the challenges of implementing a dose management
of Cerenkov imaging.
strategy in different locations.
3. To appreciate strength and limitations of this approach compared
2. To learn more about practical examples of dose management
to other methods of molecular imaging.
strategies implemented across multiple sites.
14:55
15:20 Panel discussion
A-592 The kiss of light and sound - optoacoustics
V. Ntziachristos; Munich/DE
14:00–15:30 Room E1 Learning Objectives:
1. To understand the method of optoacoustics.
Musculoskeletal 2. To become familiar with representative applications
of optoacoustic imaging.
3. To appreciate the strengths and limitations of this approach
RC 1510 The hand and wrist compared to other methods of molecular imaging.
Moderator: A. Plagou; Athens/GR
Panel discussion:
14:00 15:20 Potential of optical imaging for translation
A-586 A. Patterns of injury to human applications
A. Navas Canete; Leiden/NL
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue and 14:00–15:30 Room F1
osteoarticular injury.
2. To become familiar with the patterns of bone and soft tissue injury Special Focus Session
in the hand and wrist.
14:30 SF 15 Cardiac CT: cutting-edge techniques
A-587 B. Inflammatory disorders 14:00
H. Guerini; Paris/FR
A-593 Chairman’s introduction:
Learning Objectives:
1. To learn more about the imaging appearances of soft tissue overview of the cutting-edge techniques
R. Salgado; Antwerp/BE
and osteoarticular inflammation.
2. To become familiar with imaging findings Session Objectives:
of specific inflammatory conditions. 1. To learn about new developing technologies in cardiac-CT.
2. To understand their potential benefits and limitations
15:00 in clinical practice.
A-588 C. Tumours and tumour-like lesions 3. To learn about their current state of scientific evidence.
E. Llopis; Valencia/ES
14:05
Learning Objectives:
1. To learn more about the spectrum of intra and para-articular soft A-594 Estimation of coronary flow reserve by CT: a new arrival
G. Bastarrika; Pamplona/ES
tissue tumours, and soft tissue tumour-like lesions.
2. To become familiar with US and MRI findings Learning Objectives:
of specific soft tissue lesions. 1. To understand the principles and clinical significance of fractional
flow reserve (FFR).
2. To describe the rationale of CT-derived FFR (CT-FFR).
14:00–15:30 Room E2 3. To provide insights into the usefulness of CT-FFR to assess ischemia-
causing coronary lesions.
New Horizons Session 14:30
A-595 Myocardial perfusion imaging in clinical routine: ready for
NH 15 Optical molecular imaging: a new prime time?
dimension for radiology K. Kitagawa; Mie/JP
Learning Objectives:
14:00 1. To learn about state-of-the-art imaging techniques for myocardial
A-589 Chairman’s introduction perfusion and viability.
C.-C. Glüer; Kiel/DE 2. To appreciate clinical usefulness of comprehensive cardiac CT
Session Objectives: protocol.
1. To appreciate the versatility and power of optical imaging methods. 3. To get informed about current limitations of myocardial perfusion
2. To appreciate the difference in strengths and limitations of these imaging by CT.
methods.
3. To become familiar with state-of-the-art preclinical imaging
concepts.

224 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

14:55 15:00
A-596 Plaque imaging with cardiac CT: coming of age? A-602 C. MRI in pulmonary artery hypertension
J. Hoe; Singapore/SG J. Biederer; Groß-Gerau/DE
Learning Objectives: Learning Objectives:
1. To understand pathophysiology of coronary plaque and clinical effect 1. To learn about the MRI diagnosis of pulmonary artery hypertension.
of plaque rupture. 2. To appreciate the role of MRI in the assessment of pulmonary
2. To learn how CT can be used to detect, quantify and characterise artery hypertension.
coronary plaque. 3. To become familiar with MRI techniques in the assessment
3. To become informed about clinical value and outcomes of plaque of pulmonary artery hypertension.
detected by CT.

Panel discussion: 14:00–15:30 Room D2


15:20 Which technique will change clinical practice?
Radiographers
14:00–15:30 Room F2 RC 1514 CT from A to Z
Breast 14:00
A-603 Chairmen’s introduction
RC 1502 Update on BI-RADS E. Agadakos1, M. Prokop2; 1Athens/GR, 2Nijmegen/NL
Moderator: L.J. Pina Insausti; Pamplona/ES Session Objectives:
1. To learn about the new developments in CT technology.
14:00 2. To understand how to maximise the use of new CT technology.
A-597 A. Mammography 3. To appreciate the importance of developing radiographers’
U. Bick; Berlin/DE competencies in CT.
Learning Objectives: 14:05
1. To learn about the recently updated BI-RADS® lexicon.
2. To become familiar with the mammography descriptors. A-604 A. Exploring and exploiting CT technology:
3. To understand the usefulness of the BI-RADS® categories and their back to the future
clinical application. D. Pekarovic, U. Zdešar; Ljubljana/SI
Learning Objectives:
14:30 1. To learn about the basics of state-of-the-art CT technology.
A-598 B. Ultrasound 2. To become familiar with the newly available CT features.
A. Evans; Dundee/UK 3. To understand how to optimise protocols by maximising technology.
Learning Objectives:
1. To learn about the recently updated BI-RADS® lexicon.
14:28
2. To become familiar with the ultrasound descriptors. A-605 B. Patient safety in CT:
3. To understand the usefulness of the BI-RADS® categories and radiation dose and CM administration
their clinical application. F. Zarb; Msida/MT
15:00 Learning Objectives:
1. To appreciate risks associated with radiation doses used with current
A-599 C. MRI CT scanning techniques.
P.A.T. Baltzer; Vienna/AT
2. To learn about practical methods for optimising patient radiation
Learning Objectives: dose and maximising patient safety.
1. To learn about the recently updated BI-RADS® lexicon. 3. To be aware of the general risks associated with contrast media
2. To become familiar with the MRI descriptors. administration during CT examinations.
3. To understand the usefulness of the BI-RADS® categories and 4. To become familiar with best practice guidelines concerning the safe

Saturday
their clinical application. use of contrast media.
14:51
14:00–15:30 Room D1 A-606 C. Tips and tricks for CT optimisation
R. Booij; Rotterdam/NL
Chest Learning Objectives:
1. To learn how to effectively use scan parameters and innovative
RC 1504 Pulmonary arterial hypertension technologies to optimise CT protocols.
Moderator: R. Cesar; Golnik/SI 2. To appreciate the need for well-educated and -trained radiographers
for optimal use of CT innovations.
14:00 3. To learn about iterative reconstruction processes and
their quality impact.
A-600 A. An overview of pulmonary artery hypertension 4. To recognise CT artefacts and learn how to deal with them.
N.J. Screaton; Cambridge/UK
Learning Objectives: Panel discussion:
1. To learn about the epidemiology of pulmonary artery hypertension. 15:14 How should a radiographer develop the interface
2. To become familiar with the clinical symptoms, signs and causes of between patient and technology?
pulmonary artery hypertension.
3. To appreciate the importance and difficulties of treating pulmonary
artery hypertension.
14:30
A-601 B. CT in pulmonary artery hypertension
M.-P. Revel; Paris/FR
Learning Objectives:
1. To learn about the CT diagnosis of pulmonary artery hypertension.
2. To become familiar with the causes of pulmonary artery
hypertension on CT.

www.myESR.org Final Programme | ECR 2015 225


Postgraduate Educational Programme

14:00–15:30 Room G 16:00–17:30 Room A

Neuro E³ - ECR Academies:


RC 1511 White spots in the brain Interactive Teaching Sessions
Moderator: E.T. Tali; Ankara/TR
E³ 1621 Cardiac imaging
14:00
16:00
A-607 A. White spots and blots in the brain: what are they?
T.A. Yousry; London/UK A-613 A. Patterns of delayed enhancement
P. Hunold; Lübeck/DE
Learning Objectives:
1. To understand what white spots are. Learning Objectives:
2. To make differential diagnoses in brain white spots. 1. To learn the different patterns of delayed enhancement.
3. To demonstrate how to study patients with brain white spots. 2. To understand the influence regarding the prognosis.

14:30 16:45
A-608 B. How can I improve my reporting A-614 B. Cardiomyopathies: from diagnosis to prognosis
A. Jacquier; Marseille/FR
of T2-hyperintense lesions? Learning Objectives:
A. Rovira-Cañellas; Barcelona/ES
1. To understand the diagnostic work-up of cardiomyopathies.
Learning Objectives: 2. To review the association between diagnostic findings
1. To understand if it is possible to use a structured report and clinical outcome.
with white brain abnormality.
2. To learn how to define a comprehensive imaging protocol
for those patients. 16:00–17:30 Room B
3. To appreciate the role of modern imaging techniques
for defining white brain hyperintense T2 lesions.
GI Tract
15:00
A-609 C. Is there a need for quantitative reporting RC 1601 From my workstation:
of white matter lesions? difficult cases on review
F. Barkhof; Amsterdam/NL
Learning Objectives: 16:00
1. To understand the importance of quantitative analysis A-615 Chairman’s introduction
in white matter lesions. A. Maier; Vienna/AT
2. To show how to perform the quantitative analysis.
3. To understand the importance of follow-up in in patients 16:05
with white matter lesions. A-616 A. Pancreas
C. Triantopoulou; Athens/GR
Learning Objectives:
14:00–15:30 Room K 1. To appreciate the challenging variants in pancreatic anatomy.
2. To learn about the most important pitfalls in pancreatic imaging.
E³ - ECR Academies: 3. To understand the management of these challenging cases.
Hybrid Imaging (advanced) 16:28
A-617 B. Small bowel
E³ 1518 Advanced hybrid imaging of brain E. Biscaldi; Genoa/IT
Moderator: G. Morana; Genoa/IT Learning Objectives:
1. To learn about the normal anatomy and normal variants.
14:00 2. To learn about the most important pitfalls in imaging assessment
A-610 A. Memory decline of small bowel lesions.
L. Nyberg; Umea/SE 3. To understand the management of these challenging cases.
Learning Objectives: 16:51
1. To learn about PET imaging in cognition.
2. To learn about advanced MRI in cognition.
A-618 C. Rectum
D.M.J. Lambregts; Maastricht/NL
3. To understand PET/MRI in cognition.
Learning Objectives:
14:30 1. To learn about normal rectal anatomy and normal variants.
A-611 B. Minimal cognitive impairment and dementia 2. To learn about the most important pitfalls in imaging assessment
J.O. Rinne; Turku/FI of rectal cancer or rare tumours of the rectum.
Learning Objectives: 3. To understand the management of these challenging cases.
1. To learn about PET tracers in minimal cognitive impairment (MCI)
and dementia. Panel discussion:
2. To learn about MRI in MCI and dementia. 17:14 What can we learn from challenging cases?
3. To understand the role of advanced hybrid imaging in MCI
and dementia.
15:00
A-612 C. Brain tumours
P. Bartenstein, N. Jansen; Munich/DE
Learning Objectives:
1. To learn about PET tracers in brain tumours.
2. To learn about advanced MRI in brain tumours.
3. To understand the use of advanced hybrid imaging in brain tumours.

226 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:00–17:30 Room C 16:25


A-625 Interventional radiology in oncology:
E³ - ECR Academies: achievements and limitations
Modern Imaging of the GI Tract J.I. Bilbao; Pamplona/ES
Learning Objectives:
E³ 1622 Oesophageal and gastric cancer 1. To learn about the best indications for interventional radiology
in oncology.
Moderator: W. Schima; Vienna/AT
2. To learn about the results of interventional procedures in comparison
to other treatment options in the most common tumours.
16:00 3. To understand how interventional radiologists and radiation
A-619 A. Modern imaging: an update oncologists can work together.
A. Ba-Ssalamah; Vienna/AT
Learning Objectives: 16:50
1. To learn about the appropriate use of modern imaging techniques A-626 Interventional radiology and radiation oncology:
in the staging of oesophageal and gastric cancer. working together
2. To become familiar with optimised imaging acquisition protocols, D. Verellen, J. de Mey, F. Vandenbroucke, N. Buls, M. De Ridder; Brussels/BE
including patient preparation. Learning Objectives:
3. To appreciate the use of emerging visualisation techniques, 1. To understand the radiation oncologist’s perspective regarding
including virtual gastroscopy. interventional radiology in oncology.
16:20 2. To learn about the image-guided radiotherapy technologies
in comparison with other treatment.
A-620 B. How to provide the perfect staging report 3. To learn how radiation oncologists and interventional radiologists
R.M. Mendelson; Perth/AU
can work together.
Learning Objectives:
1. To learn about the latest TMN staging in oesophageal and Panel discussion:
gastric cancer. 17:10 The future partnership between radiology
2. To appreciate the imaging criteria for local, nodal and metastatic and radiation oncology
disease, and understand the accuracy of imaging staging.
3. To become familiar with the structure of a perfect imaging report.
16:40 16:00–17:30 Room M
A-621 C. Assessment aer treatment Physics in Radiology
A.M. Riddell; Sutton/UK
Learning Objectives:
1. To understand the role of imaging in treatment response assessment. RC 1613 MR: artefacts and devices
2. To appreciate the imaging signs of viable or recurrent tumour Moderator: D. Bor; Ankara/TR
after therapy.
3. To learn about the common surgical procedures and potential pitfalls 16:00
in interpreting postoperative imaging. A-627 A. Image artefacts in MRI and their mitigation
D.J. Lurie; Aberdeen/UK
17:00
Learning Objectives:
A-622 D. Interactive case discussion 1. To identify common types of artefacts in MR images.
W. Schima; Vienna/AT 2. To learn about the physical origins of artefacts in MRI.
3. To learn methods of minimising artefacts on MR images.

16:00–17:30 Room Z 16:30


A-628 B. Imaging around metal implants:
Joint Session of the ESR and ESTRO artefact reduction in MRI

Saturday
C. McGrath; Belfast/UK
ESR/ESTRO 2 Radiology and radiation oncology: Learning Objectives:
new chances for a partnership 1. To re-familiarise the listener with the origin of signal in MRI.
2. To understand the concept of magnetic susceptibility and
Moderators: P.M.P. Poortmans; Nijmegen/NL, L. Bonomo; Rome/IT
how differences between magnetic susceptibilities determine
16:00 metal artefacts in MRI.
3. To understand the MRI physics of artefact reduction around
A-623 Introduction metal implants.
L. Bonomo; Rome/IT 4. To understand the parameters used in an optimised
Session Objectives: imaging protocol.
1. To understand how collaboration between radiology and radiation
oncology presents great opportunities to both the disciplines. 17:00
2. To learn how interventional radiology can achieve excellent clinical A-629 C. Artefacts in perfusion and diffusion MRI
results in oncologic patients. I. Tsougos; Larissa/GR
3. To understand how the partnership between radiology and radiation Learning Objectives:
oncology offers the best treatment to patients. 1. To review the artefacts and pitfalls of diffusion MRI on a qualitative
16:05 basis, especially in terms of eddy currents and sensitivity to motion.
2. To review and evaluate the possible issues that can affect the accuracy
A-624 Imaging in oncology: achievements and limitations of measurements regarding dynamic susceptibility contrast
V.J. Goh; London/UK (DSC)-MRI (measurements of cerebral blood flow (CBF),
Learning Objectives: cerebral blood volume (CBV), and mean transit time (MTT)).
1. To learn about the actual capabilities of imaging for the management 3. To introduce possible strategies that have been developed
of oncologic patients. to mitigate or overcome these artefacts and pitfalls.
2. To become familiar with functional techniques applied
to oncologic patients.
3. To understand how imaging can help radiation oncologists.

www.myESR.org Final Programme | ECR 2015 227


Postgraduate Educational Programme

16:00–17:30 Room N 16:05


A-635 Pulmologist’s approach: the clinical aspects
E³ - European Diploma Prep Sessions F.J.F. Herth; Heidelberg/DE
Learning Objectives:
E³ 1623 Breast 1. To learn about the different aetiologies, epidemiology and prognosis.
2. To know the clinical criteria for diagnosing DILD.
16:00 3. To understand the clinical course: natural history, exacerbations,
A-630 Chairman’s introduction treatment options.
F. Pediconi; Rome/IT 4. To become aware of current non-invasive diagnostic procedures.
Session Objectives: 16:25
1. To understand the methodological principles of mammography.
2. To know the mammographic appearance of benign and malignant A-636 Pathologist’s approach and diagnosis
lesions of the breast. A. Gschwendtner; Amberg/DE
3. To become familiar with the imaging appearance if benign and Learning Objectives:
malignant breast lesions. 1. To appreciate the potential of histopathology.
2. To appreciate the limitations of histopathology.
16:03 3. To learn about the role of novel molecular markers.
A-631 A. Fundamentals of mammography
S. Barter; Cambridge/UK 16:40
Learning Objectives: A-637 Radiologist’s approach, patterns and diagnosis
1. To understand the anatomy, normal variants and abnormalities C.P. Heussel; Heidelberg/DE
of the female breast. Learning Objectives:
2. To describe the technical aspects diagnostic mammography, 1. To know about the appropriate protocols for CT and MRI.
especially in regard to dose and image quality. 2. To consolidate knowledge about the typical radiological patterns.
3. To explain principles of current practice and risk/benefit analysis 3. To understand the atypical radiological patterns.
in breast cancer screening.
DILD-board:
16:32 16:55 Multidisciplinary case presentation and discussion
A-632 B. Breast cancer diagnosis and interventions
M. Müller-Schimpfle; Frankfurt a. Main/DE
Learning Objectives: 16:00–17:30 Room L 1
1. To recognise the different presentation of normal breast patterns
and the appearance of common benign diseases and of breast cancer EuroSafe Imaging Session
at mammography, ultrasound, and MRI.
2. To understand principles and basic application of a standardised EuroSafe 4 How can clinical audit enhance
diagnostic categorization systems such as the ACR breast imaging
reporting and data system (BI-RADS®). patient safety?
3. To describe indications, contraindications and technical aspects
of image-guided interventional breast procedures
16:00
(fine needle aspiration, core needle biopsy, vacuum-assisted biopsy, A-638 Chairman’s introduction
presurgical localisation). E.J. Adam; London/UK
Session Objectives:
17:01 1. To understand the regulatory framework underpinning patient safety.
A-633 C. Advanced imaging of the female breast 2. To gain insight into how clinical audit can be carried out, and
R.M. Mann; Nijmegen/NL its scope.
Learning Objectives: 3. To learn how clinical audit is used in different countries and
1. To describe imaging techniques of the breast other than clinical settings.
mammography and to put these into a correct diagnostic pathway.
2. To recognise the different presentations of normal breast patterns
16:05
and the appearance of common benign diseases and of breast cancer A-639 A new approach to clinical audit and safety by the ESR
at ultrasound and MRI. P. Cavanagh; Taunton/UK
3. To understand the various post-therapeutic imaging patterns Learning Objectives:
of the treated breast. 1. To learn about the ESR’s proposed clinical audit tool.
4. To be familiar with the staging of breast cancer. 2. To understand the role of the ESR’s Audit and
Standards Subcommittee.

16:00–17:30 Room Studio 2015 16:20


A-640 Models of external audit in the Netherlands
Multidisciplinary Session S. Geers-van Gemeren; Utrecht/NL
Learning Objectives:
MS 16 Solving the crossword puzzle in diffuse 1. To learn about practical examples of external audit.
2. To understand the advantages and disadvantages of external audits.
interstitial lung disease (DILD)
16:40
16:00 A-641 Clinical audit in cardiac CT: the UK experience
A-634 Chairman’s introduction S. Harden1, I. Castellano2; 1Southampton/UK, 2London/UK
H.-U. Kauczor; Heidelberg/DE
Learning Objectives:
Session Objectives: 1. To understand issues specific to clinical audit in cardiac CT.
1. To become familiar with the multidisciplinary diagnosis. 2. To learn from practical experiences in the UK.
2. To understand the roles of the radiologist, pulmonologist
and pathologist.
3. To consolidate knowledge on the radiological patterns.

228 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

17:00 16:05
A-642 The European Radiation Protection Regulators’ A-648 Proteoglycan-specific quantitative imaging
perspective on audit in osteoarthritis and cartilage repair - part 1
S. Ebdon-Jackson; Didcot/UK E.H.G. Oei; Rotterdam/NL
Learning Objectives: Learning Objectives:
1. To understand the legal and regulatory environment 1. To learn about the basic principles of delayed gadolinium-enhanced
for clinical audits. MRI of cartilage (dGEMRIC).
2. To learn more about the role and expectations of radiation protection 2. To learn about imaging protocol issues and analysis methods
regulatory authorities in clinical audit. for dGEMRIC.
3. To understand the advantages and disadvantages of dGEMRIC
17:15 Panel Discussion for clinical research and patient care.
4. To appreciate the additional value of dGEMRIC for the follow-up
of cartilage repair procedures.
16:00–17:30 Room E1
16:28
E³ - ECR Master Classes (Head and Neck) A-649 Proteoglycan-specific quantitative imaging
in osteoarthritis and cartilage repair - part 2
E³ 1626a Cone-beam vs multi-detector CT M.-A. Weber, C. Rehnitz; Heidelberg/DE
in head and neck imaging Learning Objectives:
Moderator: A. Trojanowska; Lublin/PL 1. To understand basic principles of chemical exchange saturation
transfer (CEST) in cartilage imaging.
16:00 2. To become familiar with possible clinical applications of gagCEST.
3. To learn about the advantages and disadvantages of gagCEST
A-643 A. Understanding image quality and radiation dose compared to other compositional methods.
in MDCT and CBCT 4. To appreciate current challenges and future perspectives of CEST
M. Kachelrieß; Heidelberg/DE in comprehensive cartilage assessment.
Learning Objectives:
1. To review the working of multi-detector computed tomography
16:51
(MDCT). A-650 Degenerative joint disease: collagen-specific quantitative
2. To understand the basic principles of cone-beam CT (CBCT). imaging of menisci and tendons
3. To become familiar with strategies for dose optimisation in CT. K.M. Friedrich, V. Juras, P. Szomolanyi, S. Trattnig; Vienna/AT
16:35 Learning Objectives:
1. To understand the basic principles of T2. mapping and ultra-short
A-644 B. My finest cone-beam CT cases TE methods in MSK imaging.
J. Casselman1, B. De Foer2; 1Bruges/BE, 2Antwerp/BE
2. To become familiar with T2. mapping and ultra-short TE methods
Learning Objectives: in meniscal and tendon disease.
1. To describe the application of CBCT in head and neck imaging. 3. To understand the benefits of these quantitative MRI techniques
2. To present examples of the value of CBCT in head and neck compared to morphological MRI.
pathology. 4. To learn about the limitations and future applications of these
quantitative MRI techniques in MSK imaging.
16:55
A-645 C. What can be missed on cone-beam CT: Panel discussion:
pitfalls and challenges 17:14 What are the new imaging biomarkers
R. Maroldi; Brescia/IT in degenerative MSK disease?
Learning Objectives:
1. To discuss exclusion criteria for CBCT scanning.
2. To learn about pitfalls in CBCT imaging. 16:00–17:30 Room F1

Saturday
17:15 State of the Art Symposium
A-646 Panel discussion: Cone-beam vs multi-detector CT:
pros and cons SA 16 Controversies in comprehensive
A. Trojanowska; Lublin/PL
imaging of coronary artery disease
16:00
16:00–17:30 Room E2 A-651 Chairman’s introduction: what is the evidence?
M. Dewey; Berlin/DE
Special Focus Session Session Objectives:
1. To appreciate the different modalities used for coronary
SF 16 Imaging biomarkers in degenerative disease imaging.
joint disease 2. To understand the open research questions for coronary
disease imaging.
16:00 3. To learn what coronary disease imaging could look like in the future.
A-647 Chairman’s introduction 16:05
S. Trattnig; Vienna/AT
Session Objectives:
A-652 Computed tomography is all you need
H. Alkadhi; Zurich/CH
1. To provide an overview of possible quantitative imaging biomarkers
in the musculoskeletal system. Learning Objectives:
2. To discuss the requirements of imaging biomarkers in degenerative 1. To understand the high diagnostic accuracy of coronary CT
diseases of the musculoskeletal system. angiography.
3. To present the clinical impact of imaging biomarkers in degenerative 2. To learn about the great clinical potential of CT to rule out significant
diseases of the musculoskeletal system. coronary stenosis.
3. To appreciate in which patients CT may become the single test
needed for coronary disease imaging.

www.myESR.org Final Programme | ECR 2015 229


Postgraduate Educational Programme

16:28 Panel discussion:


A-653 Magnetic resonance will take the lead 17:05 How to deliver information to women on difficult and complex
M. Francone; Rome/IT issues?
Learning Objectives:
1. To understand the unique comprehensive potential of MRI 16:00–17:30 Room D2
for coronary disease.
2. To learn about the high accuracy of MRI to assess
myocardial ischaemia.
Radiographers
3. To appreciate in which patients MRI may become the single test
needed for coronary disease imaging. RC 1614 MRI from the cradle to the future
16:51 16:00
A-654 Hybrid nuclear imaging shows no defeat A-659 Chairmen’s introduction
S. Kajander; Turku/FI B. Hafslund1, M. Maas2; 1Nesttun/NO, 2Amsterdam/NL
Learning Objectives: Session Objectives:
1. To understand the high accuracy and prognostic power 1. To learn about MRI basic principles and state-of-the-art technology.
of nuclear imaging. 2. To understand the role of fMRI in clinical settings.
2. To learn about how hybrid imaging can guide therapy. 3. To appreciate the importance of safety procedures in MRI settings.
3. To appreciate in which patients hybrid imaging may become
the single test needed for coronary disease imaging. 16:05
A-660 A. MRI sequences made easy
Panel discussion: S. Brandão; Porto/PT
17:14 Imaging of coronary artery disease in 2020 Learning Objectives:
1. To consolidate in-depth knowledge of the basic principles
of MRI sequences.
16:00–17:30 Room F2 2. To recognise main applications, advantages and disadvantages
of different MRI sequences.
E³ - ECR Master Classes (Breast) 3. To understand the main types of pulse sequences currently in use.
16:28
E³ 1626b Breast imaging: A-661 B. Functional MRI: new clinical applications
improving the information to women C. Malamateniou; London/UK
16:00 Learning Objectives:
1. To understand the basic principles of fMRI.
A-655 Chairman’s introduction 2. To become familiar with clinical applications of fMRI.
F. Sardanelli; San Donato Milanese/IT 3. To be aware of future developments and research priorities in fMRI.
Session Objectives:
1. To understand the relevance of delivering correct information 16:51
to women about breast imaging. A-662 C. Safety in MRI: all you have to know
2. To define the most important controversial topics. C. Vandulek; Kaposvár/HU
3. To learn to present balanced views allowing women to make Learning Objectives:
an informed choice. 1. To describe common hazards and dangers associated with MRI
16:05 environment.
2. To understand procedures for screening patients prior to performing
A-656 A. Overdiagnosis in breast cancer screening MRI exams.
N. Houssami; Sydney/AU 3. To learn about guidelines and safety recommendations to prevent
Learning Objectives: accidents and injuries.
1. To understand what overdiagnosis is and what its relation is 4. To become familiar with MRI safety and preventive measures.
with early diagnosis.
2. To understand why the estimates of overdiagnosis can be Panel discussion:
greatly different. 17:14 What to expect from MRI in the future of medical imaging?
3. To learn how to inform women about overdiagnosis.
16:25
16:00–17:30 Room G
A-657 B. Breast density, interval cancers, and underdiagnosis
R.M. Pijnappel; Utrecht/NL
Learning Objectives:
E³ - ECR Master Classes (Neuro)
1. To learn how to inform women about the role of breast density
as a masking factor.
E³ 1626c Epilepsy
2. To learn how to inform women about the role of breast density Moderator: T. Stosic-Opincal; Belgrade/RS
as a risk factor.
3. To learn how to inform women about interval cancers and 16:00
underdiagnosis. A-663 A. How to image epilepsy in children and adults
K. Koprivsek; Sremska Kamenica/RS
16:45 Learning Objectives:
A-658 C. Preoperative breast MRI 1. To explain how to study patients affected by epileptic seizures.
K. Pinker-Domenig; Vienna/AT 2. To explain the difference between sequences and when to perform
Learning Objectives: contrast media injection.
1. To become familiar with the debate about preoperative breast MRI. 3. To show different diagnostic strategies in paediatric and
2. To learn how to inform women about potential advantages adult populations.
of preoperative breast MRI.
3. To learn how to inform women about potential disadvantages
of preoperative breast MRI.

230 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

16:30
A-664 B. How to report MRI in patients with epilepsy
D. Zlatareva; Sofia/BG
Learning Objectives:
1. To understand if it is possible to use a structured report
in those patients.
2. To explain the medico-legal value of your report.
3. To demonstrate the importance of the report at follow-up.
17:00
A-665 C. MRI, electroclinical and neuropathological correlations
N. Colombo; Milan/IT
Learning Objectives:
1. To understand the importance of a multimodality approach in
patients with epilepsy.
2. To show the importance of high field MR in those patients.
3. To show MR and neuropathological correlation.

16:00–17:30 Room K

E³ - ECR Academies:
Hybrid Imaging (advanced)
E³ 1618 Advanced hybrid imaging in oncology
Moderator: K. Ahlström Riklund; Umea/SE

16:00
A-666 A. In female pelvis
P.R. Ros; Cleveland, OH/US
Learning Objectives:
1. To learn about indications for PET/CT and PET/MR in female pelvis.
2. To become familiar with evaluation.
3. To understand where MR/PET may be advantageous over PET/CT.
16:30
A-667 B. In head neck cancer
M. Becker; Geneva/CH
Learning Objectives:
1. To learn about indications for PET/CT and PET/MR
in head-neck cancer.
2. To become familiar with evaluation of head-neck imaging data.
3. To understand where PET/MR may be beneficial over other imaging
of head-neck cancer.
17:00
A-668 C. Modern planning of radiation treatment

Saturday
U. Nestle; Freiburg/DE
Learning Objectives:
1. To learn about dose painting in radiation treatment.
2. To understand the role of hybrid imaging in radiation
treatment planning.
3. To understand potential strength of hybrid imaging
in radiation treatment.

www.myESR.org Final Programme | ECR 2015 231


Postgraduate Educational Programme

232 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room A 08:30–10:00 Room C

E³ - ECR Academies: E³ - ECR Academies:


Interactive Teaching Sessions Modern Imaging of the GI Tract
E³ 1721 Cardiac CT: from stenosis assessment E³ 1722 Gastrointestinal stromal tumours
to risk stratification (GIST)
Moderator: M. Zins; Paris/FR
08:30
A-669 A. CT for risk stratification 08:30
R. Marano; Rome/IT A-675 A. Pathology and treatment options
Learning Objectives: B. Seddon; London/UK
1. To learn the different criteria for risk stratification. Learning Objectives:
2. To learn the practical way of doing image assessment. 1. To learn about the prevalence and typical location of GIST tumours.
09:15 2. To understand the histological and genetic characteristics of GIST
tumours and the differential diagnosis.
A-670 B. Cardiac CT in the emergency room 3. To become familiar with the treatment options for GIST tumours.
G. Feuchtner, F. Plank; Innsbruck/AT
Learning Objectives: 08:50
1. To understand the imaging technique. A-676 B. Disease staging and treatment planning
2. To become familiar with the differential diagnosis. C. Hoeffel; Reims/FR
Learning Objectives:
1. To appreciate the imaging modalities available for staging GIST
08:30–10:00 Room B tumours, and to understand the advantages and disadvantage of each.
2. To learn about optimised acquisition protocols.
Abdominal Viscera 3. To become familiar with the imaging differential diagnosis of GIST
tumours and the role of biopsy.
RC 1701 Colorectal cancer liver metastases: 4. To appreciate the radiological staging of GIST tumours, including
typical sites of metastatic disease.
assessing tumour response
09:10
08:30 A-677 C. Treatment response assessment and disease follow-up
A-671 Chairman’s introduction A. Graser; Munich/DE
C.D. Becker; Geneva/CH
Learning Objectives:
1. To understand the role of imaging in disease treatment response
08:35 assessment and the pros and cons of available modalities.
A-672 A. Current treatment options 2. To appreciate the imaging criteria used in the assessment
T.K. Helmberger; Munich/DE of disease response.
Learning Objectives: 3. To learn how imaging can help guide appropriate therapy.
1. To understand the different scenarios in which liver metastases may
present in relation to patient prognosis and therapeutic options. 09:30
2. To understand the existing therapeutic approaches to liver metastases A-678 D. Interactive case discussion
in different scenarios. M. Zins; Paris/FR
08:58
A-673 B. Morphological biomarkers
S. Skehan; Dublin/IE
Learning Objectives:
1. To learn about the algorithm for detecting and characterising
liver metastases.
2. To understand conventional imaging criteria for assessing
tumour response.
3. To learn about the rationale for monitoring patients after radical
and palliative treatments.
09:21
A-674 C. Functional biomarkers
D.-M. Koh; Sutton/UK
Sunday

Learning Objectives:
1. To understand the different functional imaging techniques
that can be used to monitor response to therapy including perfusion,
diffusion MRI and PET/CT.
2. To learn about efficient algorithms for assessing therapeutic response
of liver metastases that influence prognosis.
3. To understand how functional biomarkers are incorporated
into multicentric trials.

Panel discussion:
09:44 The “vanishing” lesions: what should you do?

www.myESR.org Final Programme | ECR 2015 233


Postgraduate Educational Programme

08:30–10:00 Room Z 08:30–10:00 Room Studio 2015


EDiR talk FA(b)Q frequently asked (burning) Joint Session of the ESR and ERS
questions - with answers
Lung cancer screening:
08:30 why and how to implement
A-679 Questions about registration a comprehensive preventive programme
Y. Menu1, E. Jordan2; 1Paris/FR, 2Barcelona/ES
Moderators: M. Prokop; Nijmegen/NL, J.-P. Sculier; Brussels/BE
08:45
A-680 Questions about preparation 08:30
W. Schima; Vienna/AT A-688 Should we do lung cancer screening now? The evidence
C.J. Herold; Vienna/AT
09:00 Learning Objectives:
A-681 Questions about written examination 1. To learn about the evidence generated by randomised controlled
S. Barter; Cambridge/UK trials using CT.
2. To appreciate the caveats of the current evidence.
09:15 3. To understand the potential impact of the evidence on health-care
A-682 Questions about oral examination in Europe.
L. McKnight; Swansea/UK
08:52
09:30 A-689 CT requirements and nodule workup
F. Gleeson; Oxford/UK
A-683 Questions about the future
Y. Menu1, V. Iranzo2; 1Paris/FR, 2Barcelona/ES Learning Objectives:
1. To consolidate knowledge of the requirements of a standardised
09:45 quality-controlled low dose CT protocol.
A-684 Panel discussion: More FA(b)Q and its answers 2. To become familiar with the challenges of CAD-supported
J. Vilar; Valencia/ES measurements of size, volume and growth.
3. To acknowledge the rationale for follow-up intervals
for positive CT scans.
08:30–10:00 Room M 09:14
A-690 Diagnostic and treatment approaches to lesions found
Paediatric in CT screening
F.J.F. Herth; Heidelberg/DE
RC 1712 Imaging the head and skull base Learning Objectives:
Moderator: J.W. Casselman; Bruges/BE 1. To appreciate the size-adapted approach to diagnose and
treat lesions found at CT.
08:30 2. To understand the limitations of diagnosis and the possibility
A-685 A. Faciocraniosynostoses revisited of overdiagnosis.
F. Di Rocco, E. Arnaud; Paris/FR 3. To become familiar with the possibility of complications during
Learning Objectives: diagnostic work-up and treatment.
1. To learn about the imaging patterns of faciocraniosynostoses. 09:36
2. To learn how and when to image.
3. To become familiar with associated brain anomalies. A-691 Designing a screening programme
N. Peled; Tel-Aviv/IL
09:00 Learning Objectives:
A-686 B. All about the paediatric pituitary gland 1. To appreciate the rationale for a longitudinal and comprehensive
M.I. Argyropoulou; Ioannina/GR preventive programme.
Learning Objectives: 2. To learn about the possibilities to increase pretest probability,
1. To become familiar with age-related changes of the normal e.g. novel biomarkers.
pituitary gland. 3. To understand the potential of broadening the scope
2. To learn about congenital and acquired pathology of the CT-read-outs.
of the hypothalamo-pituitary axis.
3. To understand the pathophysiologic substrate of different
imaging patterns. 08:30–10:00 Room E1
09:30 E³ - ECR Master Classes (Musculoskeletal)
A-687 C. Imaging of the orbit: the globe and the lacrimal gland
P.C. Maly Sundgren; Lund/SE E³ 1726 Osteomyelitis vs gout:
Learning Objectives: what are the pearls?
1. To understand the embryology and imaging findings of the most
Moderator: L.M. Sconfienza; Milan/IT
common malformations.
2. To learn about space-occupying lesions and the differential diagnosis
of tumours and inflammatory conditions.
08:30
3. To be aware of the role of conventional and advanced MR sequences A-695 A. X-ray: classical patterns and challenging features
in the diagnostic approach to lesions in the orbit. A. Cotten; Lille/FR
Learning Objectives:
1. To review the appearance of gouty changes.
2. To learn more about differential diagnosis.

234 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

09:00 09:29
A-696 B. MRI features and their differential diagnosis A-702 Early detection for cardiothoracic disease in smokers
S.J. Ostlere; Oxford/UK M. Rémy-Jardin; Lille/FR
Learning Objectives: Learning Objectives:
1. To learn more about the appearance of gout using MRI. 1. To become familiar with the broad spectrum of smoking-related
2. To become familiar with differential diagnosis in acute settings. diseases in the chest.
2. To learn about comprehensive imaging protocols for diagnoses
09:30 of all smoking-related diseases of lung, heart and vessels.
A-697 C. Ultrasound and DECT features in gout 3. To appreciate the necessity of software tools for computer-assisted
A. Klauser; Innsbruck/AT detection and quantitation: opportunities and limitations.
Learning Objectives:
1. To review the appearance of gouty changes in DECT. Panel discussion:
2. To understand strengths and weakness of US. 09:47 Comprehensive imaging and education
in cardiothoracic diseases

08:30–10:00 Room E2
08:30–10:00 Room F1
New Horizons Session
Special Focus Session
NH 17 Comprehensive personalised imaging
of cardiothoracic diseases SF 17b Congenital heart disease:
from infancy to adulthood
08:30
A-698 Chairman’s introduction: how to prepare for the future? 08:30
T. Benedek; Targu-Mures/RO A-703 Chairman’s introduction
Session Objectives: M. Haliloglu; Ankara/TR
1. To understand the unique potential of radiologists Session Objectives:
to comprehensively assess cardiothoracic diseases. 1. To recognise the role of multimodality imaging
2. To learn about the diversity of etiologies that can be addressed in congenital heart disease.
by radiology. 2. To become familiar with the common features
3. To appreciate the comprehensive approach needed for having clinical of congenital heart disease.
utility by imaging cardiothoracic diseases. 3. To understand how to evaluate postoperative patients
with congenital heart disease.
08:35
A-699 Patients with acute and chronic chest pain 08:35
C. Loewe; Vienna/AT A-704 Cardiac CT: challenges in congenital heart diseases
Learning Objectives: M. Kantarci; Erzurum/TR
1. To understand the clinical utility of CT and MRI in acute chest pain. Learning Objectives:
2. To understand the clinical utility of CT and MRI in chronic 1. To become familiar with new cardiac CT techniques.
chest pain. 2. To understand benefits and limitations of the cardiac CT applications.
3. To appreciate comprehensive assessment of anatomy and 3. To understand cardiac CT characteristics.
function feasible in chest pain patients.
09:00
08:53 A-705 Segmental approach to MR imaging
A-700 Patients with acute shortness of breath of congenital heart disease
J. Bremerich; Basle/CH A.M. Taylor; London/UK
Learning Objectives: Learning Objectives:
1. To understand the high diagnostic accuracy of CT and MRI 1. To learn about MR techniques.
for assessing acute pulmonary embolism. 2. To become familiar with the benefits and limitations of MR imaging.
2. To learn about comprehensive approaches for assessing acute 3. To understand MR imaging features.
lung injury.
3. To appreciate the strengths of comprehensive cardiothoracic imaging 09:25
for diagnosis of the most common diseases leading to acute shortness A-706 Imaging of congenital heart disease in adults
of breath. S. Leschka; St. Gallen/CH
09:11 Learning Objectives:
1. To become familiar with imaging features of adult patients.
A-701 Patients with chronic shortness of breath 2. To understand imaging characteristics of postoperative patients.
E.J.R. van Beek; Edinburgh/UK
3. To learn about management in terms of diagnostic approaches
Learning Objectives:
Sunday

in adult patients with postoperative assessment.


1. To become familiar with the most frequent diseases leading
to chronic shortness of breath. Panel discussion:
2. To consolidate knowledge about the etiologies of pulmonary 09:50 What is the impact of radiologists in the evaluation
hypertension and end-stage lung disease. of congenital heart disease?
3. To understand the appropriate application of radiological imaging
in the comprehensive diagnosis of chronic shortness of breath.

www.myESR.org Final Programme | ECR 2015 235


Postgraduate Educational Programme

08:30–10:00 Room F2 09:25


A-713 Bone quality beyond BMD: what do we know already
Breast and what more does the future hold?
J.S. Bauer; Munich/DE
RC 1702 Emerging breast imaging technologies Learning Objectives:
Moderator: P. Skaane; Oslo/NO 1. To learn about clinical implications of low bone quality.
2. To understand differences between bone mass and bone quality.
08:30 3. To review recent advances in imaging of bone quality.
A-707 A. Digital breast tomosynthesis (DBT)
D. Bernardi; Trento/IT Panel discussion:
Learning Objectives: 09:50 How do radiologists get involved?
1. To become familiar with the technique of DBT.
2. To understand the results of DBT in the screening and
diagnostics settings. 08:30–10:00 Room D2
3. To learn about the potential role of DBT in the breast
radiological algorithm. Radiographers
09:00
A-708 B. Multiparametric high-field MRI and more
RC 1714 Looking into PET/CT
T.H. Helbich; Vienna/AT 08:30
Learning Objectives: A-714 Chairmen’s introduction
1. To understand the management of breast lesions based K. Åhlström Riklund1, D. Pekarovic2; 1Umea/SE, 2Ljubljana/SI
on current MRI applications.
2. To learn how to improve the specificity of breast MRI Session Objectives:
by adding new developing techniques. 1. To learn about PET/CT procedures and the clinical indications.
3. To appreciate future developments and limitations. 2. To be aware of the importance of a quality control program and
safety principles in PET/CT.
09:30 3. To understand the role of radiographers in PET/CT.
A-709 C. High-resolution radionuclide breast imaging 08:35
(PEM and molecular imaging) A-715 A. Clinical indications of PET/CT
M. Herranz, I. Dominguez-Prado, S. Argibay-Vazquez, P. Aguiar, A. Ruibal; Santiago/ES P.H. Hogg; Manchester/UK
Learning Objectives: Learning Objectives:
1. To become familiar with the current status: what is available 1. To become familiar with contemporary indications of PET/CT
and how does it work? in diagnosis and radiotherapy planning.
2. To understand the indications: local staging, distant staging, 2. To appreciate the bases of PET radiopharmaceutical localisation
therapy monitoring and limitations. in molecular imaging.
3. To learn about future prospects: MR/PET and targeted tracers. 3. To be aware of the potential of PET/CT in molecular imaging.
08:58
08:30–10:00 Room D1 A-716 B. Quality control for PET/CT
W.J.M. van den Broek; Nijmegen/NL
Special Focus Session Learning Objectives:
1. To understand how a successful Quality Assurance (QA) programme
SF 17a Metabolic bone diseases will reduce image artefacts.
2. To become familiar with the range and performance frequency
08:30 of quality control procedures that should be conducted
A-710 Chairman’s introduction on PET/CT devices.
G. Guglielmi; Andria/IT 3. To comprehend how the most frequently required PET quality
Session Objectives: control procedures should be conducted.
1. To become familiar with recognising fractures in metabolic 4. To be aware of the tolerance criteria and actions to be taken
bone diseases. if these tolerance criteria are exceeded.
2. To understand the role of malabsorption on fracture risk. 09:21
3. To learn the impact of metabolic bone diseases on bone quality.
A-717 C. Safety in PET/CT
08:35 J. Rio; Coimbra/PT
A-711 A critical appraisal of vertebral fracture identification Learning Objectives:
A. Bazzocchi; Bologna/IT 1. To understand the principles of PET/CT technology.
Learning Objectives: 2. To learn about PET/CT safety procedures.
1. To understand the impact of discovering an osteoporotic vertebral 3. To become familiar with the knowledge, skills and competences
fracture, and to know how this may impact the patient. needed to apply radiation protection measures for staff and patients
2. To learn about the definition of “vertebral fracture” in metabolic in PET/CT.
bone diseases.
3. To review the techniques and methods, both conventional and Panel discussion:
non-conventional, useful in the identification and characterisation 09:44 What is the role of a radiographer in PET/CT?
of vertebral fractures.
09:00
A-712 Metabolic bone disorders in patients with malabsorption
C.M. Phan; Paris/FR
Learning Objectives:
1. To learn about osteoporosis, osteopenia and osteomalacia in patients
with malabsorption.
2. To understand the radiological findings of metabolic bone disorders
associated with inflammatory bowel diseases.
3. To learn how to screen and follow up on patients with malabsorption.

236 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

08:30–10:00 Room G 08:58


A-723 PACS for research
Neuro D. Regge; Turin/IT
Learning Objectives:
RC 1711 Screening for cerebral aneurysms 1. To understand how research can be enhanced with PACS.
Moderator: A. van der Lugt; Rotterdam/NL 2. To learn about the advantages and difficulties of using PACS
for research purposes.
08:30 3. To review the technical requirements to achieve inter-connectivity
A-718 A. Who are the patients that I should screen and give practical examples on the use of PACS in clinical research.
for aneurysms? Why should I screen? 09:21
What are the medicolegal ramifications? A-724 Using electronic case report forms
M. Muto, G. Guarnieri; Naples/IT
for clinical imaging trials
Learning Objectives: T. Bäuerle; Erlangen/DE
1. To understand which patients with cerebral aneurysms should
Learning Objectives:
be screened, and why.
1. To understand the fundamentals of electronic case report forms.
2. To explain the medico-legal issue of screening patients
2. To learn about how to set up electronic case report forms
with cerebral aneurysms.
for clinical trials in radiology.
3. To demonstrate how long screening and follow-up are necessary
3. To understand the added value of working with clinical
in those patients.
research organisations.
09:00
A-719 B. Which technique to use? CT angiography, time-of-flight Panel discussion:
09:44 Are online tools, PACS, or electronic case report forms
MR angiography, contrast-enhanced MR angiography, suitable for clinical research?
catheter angiography
M. Voormolen, T. van der Zijden, O. d‘Archambeau, C. Venstermans, F. De Belder,
L. Van den Hauwe, J. Van Goethem, R. Salgado, P.M. Parizel; Antwerp/BE 10:30–12:00 Room A
Learning Objectives:
1. To understand the potential ways to screen those patients.
2. To become familiar with how to report abnormal findings.
E³ - ECR Academies:
3. To clarify in which cases it is necessary to perform cerebral Interactive Teaching Sessions
angiography.
09:30 E³ 1821 Evaluation of patients
A-720 C. The interventional neuroradiology perspective with lung emphysema
on diagnosis, management and follow-up 10:30
L. Pierot, S. Soize, A. Benaissa; Reims/FR
Learning Objectives:
A-725 A. Pretherapeutic evaluation of lung emphysema
M. Prokop; Nijmegen/NL
1. To show the point of view of interventional neuroradiology reporting
vascular pathology. Learning Objectives:
2. To understand when to treat those aneurysms. 1. To understand the different types of lung emphysema.
3. To explain why it is important to follow up with those patients. 2. To quantify the lung emphysema.
11:15
08:30–10:00 Room K A-726 B. Diagnostic work-up aer treatment of lung emphysema
N. Sverzellati; Parma/IT
Special Focus Session Learning Objectives:
1. To learn the different types of treatment for lung emphysema.
2. To recognise the complications of treatment.
SF 17c Technology for supporting clinical
research in radiology
10:30–12:00 Room B
08:30
A-721 Chairman’s introduction ESR meets Turkey
D. Caramella; Pisa/IT
Session Objectives: EM 4 Turkey welcomes ECR
1. To understand the challenges and opportunities of the different Welcome by the ESR President
information technology that can be used for facilitating clinical L. Bonomo; Rome/IT
research in radiology. Presiding
Sunday

2. To become familiar with the limitations of current information A. Coskun; Kayseri/TR


technology for supporting research. B. Hamm; Berlin/DE
3. To appreciate the opportunities of innovative approaches
to clinical research. 10:30
08:35 A-727 Introduction
A. Coşkun; Kayseri/TR
A-722 Online tools and soware solutions
Session Objectives:
for effective clinical research 1. To summarise the history of the TSR.
A. Scarsbrook; Leeds/UK
2. To explain radiology education in Turkey.
Learning Objectives: 3. To give an overview of the radiological service quality in Turkey.
1. To become familiar with a range of web-based tools which provide
efficient ways of staying up-to-date with and searching for relevant
scientific literature.
2. To review a range of free (open-source) software which can be
effectively utilised to support clinical research in radiology.

www.myESR.org Final Programme | ECR 2015 237


Postgraduate Educational Programme

10:35 11:02
A-728 Liver hydatid cysts: percutaneous treatment A-735 B. Neurovascular disorders and trauma of the brain
O. Akhan; Ankara/TR M. Forsting; Essen/DE
Learning Objectives: Learning Objectives:
1. To learn about the epidemiology and some structural characteristics 1. To describe the normal anatomy and normal variants
of the disease. of the craniocervical arterial and venous system and its relevance
2. To appreciate the importance of imaging, classifications and to interventional neuroradiology.
stage-specific approach. 2. To understand the causes and imaging features of stroke,
3. To become familiar with the indications and techniques haemorrhage and other common vascular lesions of the brain.
for the percutaneous treatment. 3. To differentiate the imaging features of traumatic injury
4. To learn about the results of percutaneous treatment in comparison to the brain and spine.
with surgical results.
5. To understand complications of percutaneous treatment and 11:31
their management. A-736 C. Tumours of the brain and spine
M.M. Thurnher; Vienna/AT
10:55 Learning Objectives:
A-729 Interlude I: Music show 1. To describe the normal anatomy and normal variants of the spine,
I. Barutçu, M. Burçin Derçin; Trabzon/TR spinal cord and nerve roots.
2. To understand imaging features of benign and malignant tumours
11:00 of the neurocranium.
A-730 fMRI of the brain: beyond expectations? 3. To differentiate imaging features of benign and malignant tumours
C. Calli; Izmir/TR of the spine.
Learning Objectives:
1. To give an introduction to the fMRI techniques.
2. To discuss the limitations and advantages of fMRI. 10:30–12:00 Room L 1
3. To give some interesting examples of fMRI studies.
4. To discuss the future projects of fMRI. ESR Patient Advisory Group (PAG)
11:20
A-731 Interlude II: Music show
ESR-PAG 2 Communicating the results of
I. Barutçu, M. Burçin Derçin; Trabzon/TR radiological studies to patients:
from high-tech to human
11:25 touch imaging
A-732 Advanced hepatopancreaticobiliary imaging
S.M. Ertürk; Istanbul/TR 10:30
Learning Objectives: A-737 Chairmen’s introduction
1. To understand novel imaging approaches that are used N. Bedlington1, B. Brkljacic2; 1Vienna/AT, 2Zagreb/HR
in the diagnostic work-up of pathologies of the liver, pancreas Session Objectives:
and biliary system. 1. To understand the importance of patient-doctor communication.
2. To understand state-of-the-art imaging algorithms regarding 2. To learn how the patient wants to be informed by the radiologist
the pathologies of liver, pancreas, and biliary system. about the relevant findings.
3. To learn pearls and pitfalls regarding the imaging 3. To learn strategies on how to facilitate communication between
of the hepatopancreaticobiliary system. patients and radiologists.
11:45 Panel Discussion 10:40
A-738 Who is the patient of the radiologist?
L.E. Derchi; Genoa/IT
10:30–12:00 Room N
Learning Objectives:
E³ - European Diploma Prep Sessions 1. To comprehend existing good practice regarding patient-doctor
communication models in radiology.
2. To understand the importance of informed consent.
E³ 1823 Neuro 3. To become familiar with techniques/methods to deliver news
to a patient.
10:30
A-733 Chairman’s introduction 11:00
B. Ertl-Wagner; Munich/DE A-739 Communicating results of radiological studies
Session Objectives: to the patient with breast cancer:
1. To describe relevant imaging and interventional algorithms and view of the patient who is also a physician
important imaging features of neurovascular disorders of the brain A. Balenovic; Zagreb/HR
and spine.
Learning Objectives:
2. To understand imaging features and prognostic implications
1. To present a personal experience regarding communication
of tumours of the brain and spine.
by a radiologist at the time diagnosis was established and during
10:33 follow-up examinations.
2. To present the need for radiological presentation of mammographic
A-734 A. Congenital and white matter disorders of the brain findings, communication during ultrasound examinations, core
A. Rossi; Genoa/IT
biopsy of the breast, and breast MRI from the patient’s point of view.
Learning Objectives: 3. To present the need for psychological support for women treated for
1. To describe the development, normal anatomy and normal variants breast cancer and to discuss the position of the radiologist from the
of the brain. point of view of the chair of the patient group dedicated to providing
2. To differentiate common congenital disorders of the brain and psychological support to women with breast cancer.
neurocutaneous syndromes.
3. To understand imaging features and differential diagnoses
of white matter disease, inflammation and neurodegeneration.

238 ECR 2015 | Final Programme www.myESR.org


Postgraduate Educational Programme

11:20 14:00–15:30 Room N


A-740 Brain disorder - the communication challenge
D. Walsh1, M. Messmer-Wullen2; 1Brussels/BE, 2Lochau/AT E³ - European Diploma Prep Sessions
Learning Objectives:
1. To understand how communication with those affected by brain E³ 1923 Principles of imaging and
disorders is especially challenging - in terms of the neurological radiation protection
deficits of patients, coupled with the complexity of the pathology and
the severity of the diagnosis. 14:00
2. To appreciate that doctors and patients have different views on what A-743 Chairman’s introduction
makes good and effective communication, and to discuss ways in P. Vock; Spiegel/CH
which these differences can be bridged.
3. To learn what steps patient organisations are taking to improve the Session Objectives:
communication and understanding for both patients and doctors, 1. To understand the technical and methodological principles
and to explore how the health professionals can become involved. of computed tomography.
2. To understand the technical and methodological principles
of magnetic resonance tomography.
Panel discussion: 3. To know the principles of radiation biology and radiation protection.
11:40 From high-tech to human touch -
how do we ensure this transition and what are 14:03
the roles for the ESR and member societies? A-744 A. Principles of computed tomography
W.A. Kalender; Erlangen/DE
12:30–13:30 Room B Learning Objectives:
1. To have an understanding of the physical basis of image formation
of computed tomography and of the physics of helical, multidetector
E³ - The Beauty of Basic Knowledge: and dual-source CT.
Breast Imaging 2. To explain the scale of Hounsfield units and the principle of window
centre and width.
3. To list the major sources of artefacts in CT.
E³ 25E High-risk lesions: solving the dilemma 4. To describe the principles of optimising protocols for a variety of CT
Moderator: J. Camps Herrero; Alzira/ES scanner types and examination including the principles of contrast
media application, reconstruction algorithms and kernels.
12:30
A-741 High-risk lesions: solving the dilemma 14:32
A. Linda; Udine/IT A-745 B. Principles of magnetic resonance imaging
Learning Objectives: T. Metens; Brussels/BE
1. To learn about the most common high risk lesions and their Learning Objectives:
respective breast cancer risk. 1. To have a basic understanding of the physical basis of image
2. To know how to manage these lesions in a multimodal way. formation in MRI including the principles of pulse sequences
3. To understand how to deal with these lesions in terms of intervention and relaxation times.
and follow-up. 2. To describe the principles and main diagnostic applications for the
most commonly used sequences in MRI, including T2-weighted
sequences, T1-weighted sequences, STIR sequences, FLAIR
12:30–13:30 Room D1 sequences, other inversion recovery sequences, T2*- / susceptibility
weighted sequences and MR angiography sequences.
E³ - The Beauty of Basic Knowledge: 3. To describe typical artefacts on MR imaging and to discuss
their respective causes.
Skeletal Radiology 4. To explain absolute or relative contraindications against
MR imaging and safety issues in the MR environment
E³ 24E Metabolic, endocrine and with regard to patients and staff.
marrow disease 15:01
Moderator: V. Cassar-Pullicino; Oswestry/UK A-746 C. Radiation protection
M. Mahesh; Baltimore, MD/US
12:30 Learning Objectives:
A-742 Metabolic, endocrine and marrow disease 1. To explain the phenomena of x-ray interaction with matter
B. Vande Berg; Brussels/BE and the consequences for image generation, image quality and
Learning Objectives: radiation exposure.
1. To appreciate the musculoskeletal manifestations of systemic 2. To describe types and magnitudes of radiation exposure from natural
disorders and their underlying pathomechanisms. and artificial sources and the concepts of dose determination and
2. To understand the pathological processes involved dose measurement for patients, occupationally exposed personnel
Sunday

in these imaging abnormalities. and the public.


3. To appreciate the strengths and weaknesses of imaging modalities 3. To describe types and magnitudes of radiation risk from radiation
in assessing these disorders. exposure in medicine.
4. To describe the basic principles of radiation protection, as outlined by
the ICRP (International Commission on Radiological Protection).
5. To explain the concepts and tools for dose management in radiology
with regard to adult and paediatric patients.

www.myESR.org Final Programme | ECR 2015 239


Postgraduate Educational Programme

240 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions
and
Late-Breaking Clinical Trials
Session numbers are prefixed by SS
Presentation numbers are prefixed by the letter B
The Late-Breaking Clinical Trials session is listed at the end of this section. (page 313)

241
Scientific Sessions

10:30–12:00 Room B 11:50


B-0011 An increased flip angle in late phase Gd-EOB-DTPA MRI
Abdominal Viscera shows improved performance in bile duct visualisation
SS 201a Liver MRI compared to T2w-MRCP
L. Stelter, P. Freyhardt, C. Grieser, T. Walter, D. Seehofer, T. Denecke; Berlin / DE
Moderators: S. Phoa; Amsterdam/NL, F. Regini; Florence/IT

10:30
B-0002 Hepatic lipid assessment: 10:30–12:00 Room C
Multi echo Dixon technique versus MR spectroscopy
at 3T scanner
Breast
1 1 1 2 3
M. Abd Ellah , B. Henninger , C. Kremser , S. Kannengießer , X. Zhong ,
W.R. Jaschke1; 1Innsbruck / AT, 2Erlangen / DE, 3Malvern, PA / US SS 202a Imaging for neoadjuvant chemotherapy
Moderators: P. Martínez-Miravete; Zaragoza/ES, F. Thibault; Paris/FR
10:38
B-0001 Diagnostic accuracy of a three-step magnetic 10:30
resonance imaging approach for the assessment B-0012 Predictability of complete response through apparent
of hepatic steatosis in a healthy general population diffusion coefficient measured before neoadjuvant
H. Hetterich1, C. Bayerl1, A. Peters2, C. Meisinger2, H. Kramer1, B. Ertl-Wagner1, chemotherapy in breast cancer depends on tumour
M.F. Reiser1, F. Bamberg1; 1Munich / DE, 2Neuherberg / DE
phenotype
E. Bufi, P. Belli, M. Costantini, A. Cipriani, A. Bonatesta, G. Franceschini,
10:46 D. Terribile, L. Bonomo; Rome / IT
B-0003 Does hepatic steatosis influence the detection rate
of metastases in hepatobiliary phase of Gd-EOB-DTPA 10:38
enhanced MRI with conventional 3D-T1-weighted B-0013 Shrinkage patterns of tumour regression aer
fat-saturated sequences? neoadjuvant chemotherapy on magnetic resonance
J.H. Rothe, T. Denecke, T. Weissmann, C. Grieser, B. Hamm, W. Brenner, imaging: correlation with tumour biological subtypes
I.G. Steffen; Berlin / DE
and pathological response aer therapy
S. Gigli, L. Ballesio, F. Di Pastena, C. Petriglia, C. Catalano; Rome / IT
10:54
B-0004 Gd-EOB-DTPA-enhanced liver MRI for prediction of 10:46
liver growth aer portal vein occlusion B-0014 What happens to the DCIS in HER 2 positive cancers
B.K. Barth, M.A. Fischer, C.S. Reiner; Zurich / CH
treated with NACT and trastuzumab?
R. Millican-Slater, K. Horgan, M. McMahon, D. Dodwell, B. Dall, N. Sharma;
11:02 Leeds / UK
B-0005 T1 segmental hyperintensity in liver cholestasis
on MRI: in vitro explanation 10:54
I.L. Gubskiy, O.N. Sergeeva, V. Panov, I.E. Tyurin, B. Dolgushin; Moscow / RU B-0015 Breast MRI in the evaluation of patients undergoing
neoadjuvant chemotherapy: assessment of tumour
11:10
features and predictive markers of response according
B-0006 Quantitative analysis of diffusion-weighted MRI
to histopathology
at 3T: which parameter is more useful in differential E. Schiani, C. Losio, F. Ballati, M. Panzeri, G. Cristel, M. Rodighiero, F. De Cobelli,
diagnosis of focal solid liver lesions? A. Del Maschio; Milan / IT
K.K. Lomovtseva , N.A. Karelskaya , G.G. Karmazanovsky ; Vidnoe / RU,
1 2 2 1
2
Moscow / RU 11:02
B-0016 Before the tumour shrinks: apparent diffusion
11:18
coefficient in early assessment of breast cancer
B-0007 Image quality of the hepatic arterial phase
response to neoadjuvant chemotherapy
in gadoxetic acid-enhanced liver MRI: M. Nadrljanski, R. Maksimovic, V. Plesinac-Karapandzic, M. Nikitovic,
analysis of respiratory pattern and image quality Z. Milosevic; Belgrade / RS
Y. Park, C. Lee, J. Lee, J. Choi, K. Kim, C. Park; Seoul / KR
11:10
11:26 B-0017 Apparent diffusion coefficient and fractional
B-0008 Performance of magnetic resonance elastography anisotropy values as biomarkers for treatment
for the staging of liver fibrosis: in terms of comparison response in breast cancer
between patients with chronic hepatitis B and those E.A. Joyce, A.J. Fagan, J.P. McMorrow, D. Byrne, M.J. Kennedy, J.F. Meaney,
with other etiologies S.A. O’Keeffe; Dublin / IE
W. Chang, J. Lee, J. Han, B. Choi; Seoul / KR
11:18
11:34 B-0018 A new parameter to assess response to neoadjuvant
B-0009 Characterisation and evaluation of longitudinal extent chemotherapy by quantitative vascular mapping in
of perihilar biliary strictures: does diffusion-weighted patients with locally advanced breast cancer
MRI provide additional value? C. Rebellato, G. Gennaro, L. Evangelista, E. Bezzon, I. Polico, L. Pescarini;
K. Choi, J. Lee, I. Joo, J. Han, B. Choi; Seoul / KR Padova / IT

11:42 11:26
B-0010 MR evaluation of biliary-enteric anastomoses B-0019 MRI parameters as imaging biomarker for prediction
with Gd-EOB-DTPA-enhanced MR cholangiography: of response in patients with breast cancer receiving
comparison with conventional T2-weighted MR neoadjuvant therapy
S. Viganò1, A.J. Patterson2, M.A. McLean2, H. Earl2, R. Bedair2, W.G. Matthew2,
cholangiography M.J. Graves2, E. Provenzano2, F.J. Gilbert2; 1Milan / IT, 2Cambridge / UK
P. Boraschi, F. Donati, F. Pacciardi, G. Gherarducci, R. Gigoni, F. Falaschi,
C. Bartolozzi; Pisa / IT

242 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:18
B-0020 Factors influencing the accuracy of magnetic B-0029 Simultaneous PET/MRI for primary staging of patients
resonance imaging in the assessment of disease with cervical cancer: preliminary results
response following neoadjuvant chemotherapy in J. Grueneisen1, B.M. Schaarschmidt2, M. Heubner1, V. Ruhlmann1,
T.C. Lauenstein1, M. Forsting1, L. Umutlu1; 1Essen / DE, 2Düsseldorf / DE
early and locally advanced breast cancer
J. Murphy, K. James, P. Nicholson, L. Duddy, N. Marshall, M.F. Ryan, J. Barry; 11:26
Cork / IE
B-0030 Translational imaging in diagnostic workup
11:42 of neurodegenerative parkinsonian syndrome
B-0021 The value of multi-parameter strategy of ultrasound C. Paschetta, F. Buttari, D. Gned, M. Iudicello, A. Skanjeti, A. Veltri, V. Podio;
Orbassano / IT
in the assessment of neoadjuvant chemotherapy for
breast cancer 11:34
Y. Jin, L.Y. Peng, Y.B. Ma; Chengdu / CN
B-0031 Implementation of a fast-protocol for simultaneous

Wednesday
11:50 PET/MR imaging for whole-body staging of female
B-0022 Evaluation with digital breast tomosynthesis of the patients with recurrent pelvic malignancies:
pathological response to neoadjuvant chemotherapy a comparison to the PET/CT
J. Grueneisen1, B.M. Schaarschmidt2, M. Heubner1, S. Kinner1, V. Ruhlmann1,
in locally advanced breast cancer T.C. Lauenstein1, M. Forsting1, L. Umutlu1; 1Essen / DE, 2Düsseldorf / DE
G. Mariscotti, M. Durando, E. Sardo, E. Regini, P. Campanino, G. Donato,
C. Bogetti, P. Fonio, G. Gandini; Turin / IT 11:42
B-0032 Blood oxygen level-dependent magnetic resonance
10:30–12:00 Room Z imaging (BOLD-MRI) evaluating human visceral
adipose tissue (AT) oxygenation induced by salt
Molecular Imaging loading/depletion: feasibility study
L. Zheng1, Z. Zhang2; 1Shanghai / CN, 2Chicago, IL / US
SS 206 Clinical molecular imaging 11:50
Moderators: M. Eisenblaetter; Münster/DE, F.A. Gallagher; Cambridge/UK
B-0033 The hybrid tracer ICG-99mTc-nanocolloid for combined
10:30 radio- and fluorescence-guidance to the sentinel node
B-0023 SECURE study: observational post-marketing study in the groin
N.S. van den Berg1, G.H. KleinJan1, O.R. Brouwer2, S. Horenblas2, R.A. Valdés
on the safety profile of gadoterate meglumine: Olmos2, H.G. van der Poel2, F.W.B. van Leeuwen1; 1Leiden / NL, 2Amsterdam / NL
final results in 35,499 patients
R. Souillard-Scemama, C. Mellerio, C. Oppenheim, J.-F. Meder, P. Soyer;
Paris / FR
10:30–12:00 Room M
10:38
B-0024 68Ga-labelled PSMA- versus 11C-Choline PET/CT GI Tract
in the detection of recurrent prostate cancer
H. Rempp, J. Schwenck, G. Reischl, K. Nikolaou, C. La Fougère, C. Pfannenberg; SS 201b Improving abdominopelvic imaging:
Tübingen / DE technical aspects
Moderators: D. Breen; Southampton/UK, R. Malago; Verona/IT
10:46
B-0025 Navigation in an intraoperatively acquired freehand 10:30
SPECT scan has the potential to improve lesion B-0034 Does abdominal ultrasound show equivalence to
identification computed tomography and magnetic resonance
N.S. van den Berg1, T. Engelen1, G.H. KleinJan1, R.A. Valdés Olmos2, W.M.C. Klop2,
F.W.B. van Leeuwen1; 1Leiden / NL, 2Amsterdam / NL enterography in predicting disease severity and
complications?
10:54 A. Wadhwani, S. Batool, K. Novak, S. Wilson; Calgary, AB / CA
B-0026 Diagnosing relapse in brain tumours utilising 10:38
integrated [11C]-methionin PET/MRI B-0035 Reduction of contrast and radiation dose in
1 1 1 1 1 2
L. Umutlu , T. Pöppel , K. Wrede , O. Müller , C. Pöttgen , P. Heusch ,
T.C. Lauenstein1, M. Forsting1, M. Schlamann1; 1Essen / DE, 2Düsseldorf / DE multidetector computed tomography (MDCT)
using individualised tailored protocols
11:02 A. Vanzulli1, L. Romano2, N. Flor1, A. Carriero3, T. Albrecht4, M. Prokop5;
B-0027 Role of 11C-methionine PET as a prognostic factor
1
Milan / IT, 2Naples / IT, 3Novara / IT, 4Berlin / DE, 5Nijmegen / NL
in patients with primary brain gliomas eligible 10:46
for surgery B-0036 Low-dose fluoroscopic examinations of the upper
E. Lopci, L. Bello, L. Olivari, M. Riva, M. Simonelli, F. Raneri, A. Chiti; Rozzano / IT
gastrointestinal tract: assessment of image quality
11:10 and radiation levels
B-0028 Impact of attenuation correction on quantification J. Weiß1, A. Pomschar2, K. Neumaier2, W. Flatz2, B. Ertl-Wagner2, M. Li2,
M. Notohamiprodjo2; 1Tübingen / DE, 2Munich / DE
of tracer uptake in a fully integrated PET/MR system:
comparison between MR- and CT-based attenuation 10:54
correction B-0037 Clinical impact of double reading of abdominal
F. Seith, S. Gatidis, H. Schmidt, I. Bezrukov, C. La Fougère, K. Nikolaou,
C. Pfannenberg, N. Schwenzer; Tübingen / DE CT scans of surgical patients
P.M. Lauritzen1, J. Andersen2, M. Stokke3, A. Tennstrand4, T. Heggelund1,
R. Aamodt1, P. Hurlen1, G. Sandbæk2, P. Gulbrandsen5; 1Lørenskog / NO,
2
Oslo / NO, 3Drammen / NO, 4Bærum / NO, 5Nordbyhagen / NO

www.myESR.org Final Programme | ECR 2015 243


Scientific Sessions

11:02 11:02
B-0038 Diagnostic efficacy of a low-radiation B-0049 Myocardial extracellular volume fraction quantified
high-contrast dose protocol in single-pass abdominal by cardiovascular magnetic resonance compared with
multi-detector CT (MDCT): a prospective comparison histological and organic blood markers
with a standard protocol J. Izaaryene, A. Jacquier; Marseille / FR
L. Camera, I. Liccardo, F. Romano, S. De Fronzo, A. Rispo, R. Liuzzi, M. Imbriaco,
F. Castiglione, M. Salvatore; Naples / IT 11:10
B-0050 Automatic soware for extracellular volume (ECV)
11:10 fraction map generation of the myocardium
B-0039 Comparison of water and mannitol as negative N. Galea, L. Altabella, C. Borrazzo, E. Di Castro, M. Francone, C. Catalano,
contrast agents in abdominal staging CT I. Carbone; Rome / IT
T. Kaireit, C. Lutat, M.J. Peperhove, F. Wacker, K.I. Ringe; Hannover / DE
11:18
11:18 B-0051 Accuracy and reproducibility of native myocardial
B-0041 Comparison between two different techniques for T1 mapping using 9, 10, and 11 heartbeat MOLLI
dynamic magnetic resonance imaging of the pelvic acquisition schemes
floor, one with gel rectal filling and the other with air S. Mangold1, A. Varga-Szemes1, C.N. De Cecco1, G. Muscogiuri1, P.M. Cannaò1,
J.L. Wichmann1, P. Suranyi1, W.G. Rehwald2, U.J. Schoepf1; 1Charleston, SC / US,
balloon rectal distention in the evaluation of pelvic 2
Durham, NC / US
floor disorders
N. Al Ansari, F. Maccioni, V. Buonocore, F. Mazzamurro, C. Catalano; Rome / IT 11:26
B-0052 Le ventricular myocardial remodeling in pulmonary
11:26
hypertension: a non-contrast magnetic resonance T1
B-0042 Radiation dose of 3rd generation CT colonography
D. Skripkin; Omsk / RU mapping study
U. Reiter1, G. Reiter1, G. Kovacs1, G. Adelsmayr1, A. Greiser2, H. Olschewski1,
M.H. Fuchsjäger1; 1Graz / AT, 2Erlangen / DE
11:34
B-0043 Pelvic static MR vs MR-defecography in the study of 11:34
woman’s pelvic floor disorders B-0053 Native T1-mapping for visualisation of septal le
A. Ambrosi, G. De Franco, F. Lorusso, M. Cascarano, A. Scardapane, G. Angelelli;
Bari / IT ventricular fibrosis in chronic thromboembolic
pulmonary hypertension (CTEPH)
11:42 F.C. Roller, C. Schneider, G.A. Krombach; Giessen / DE
B-0044 Semi-automatic computed tomography volumetry 11:42
of esophageal cancer: a reproducible method for B-0054 Early non-invasive detection of microvascular
assessment of primary tumour size insensitive to disfunction and myocardial damage in systemic
radiologist experience
Y.-H. Zhang, M. Fisher, A. Tomson, H. Lehmann, G. Herlin, I. Rouvelas, L. Lundell, sclerosis (SSc): a cardiovascular magnetic resonance
T.B. Brismar; Stockholm / SE N. Galea, G. Barchetti, A. Fiorelli, M. Francone, E. Rosato, C. Catalano, I. Carbone;
Rome / IT

11:50
10:30–12:00 Room N B-0055 Quantification and optimisation of computed
Cardiac tomography myocardial late enhancement imaging
with correlation to magnetic resonance imaging
M.C. Williams, N. Weir, C. Gray, T. MacGillivray, E.J.R. van Beek, D.E. Newby,
SS 203a Tissue characterisation S. Mirsadraee; Edinburgh / UK
Moderators: N. Kawel-Böhm; Chur/CH, B.K. Velthuis; Utrecht/NL

10:30 10:30–12:00 Room L 1


B-0045 Integrated FDG PET/MRI in the assessment of cardiac
tumours
F. Nensa, T.D. Poeppel, C.J. Jensen, P. Heusch, T. Schlosser, K. Nassenstein;
Vascular
Essen / DE
SS 215 Pre- and post-interventional work-up
10:38 Moderators: E. Brountzos; Athens/GR, P. Vilela; Almada/PT
B-0046 Extramedullary hematopoiesis (EMH) is associated 10:30
with lower cardiac iron loading in regularly K-01 Keynote lecture
politransfused thalassaemia patients E. Brountzos; Athens / GR
1 2 3 1 1 2
F. Terrazzino , A. Meloni , P. Ricchi , N. Giunta , D. Messana , A. Pepe ;
1
Palermo / IT, 2Pisa / IT, 3Naples / IT 10:39
10:46 B-0056 Median arcuate ligement syndrome: accurate
B-0047 Quantitative T2 mapping in the distinction diagnosis by 64 slice MDCT mesenteric angiography
S.S. Pathak; Mumbai / IN
of salvaged and infarcted myocardium within
the ischemic area-at-risk: validation and comparison 10:47
with T2-weighted images B-0057 Value of ultrasound contrast agents in the endoleak
L.-M. Wu, A.-L. Andong, J.-R. Xu; Shanghai / CN
diagnosis in patients AAA treated stentgra
10:54 implantations
A. Drelich-Zbroja, T. Jargiello, M. Sojka, M. Szczerbo-Trojanowska; Lublin / PL
B-0048 T1 ratios are superior to actual T1 values for
assessment of myocardial injury and le ventricular
remodelling in coronary chronic total occlusion
Y. Chen, S. Yang, H. Yun, H. Jin, M. Zeng; Shanghai / CN

244 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:55 10:46
B-0058 Type III endoleak aer endovascular aortic repair: B-0068 Symptomatic Osteoartrhitis (OA) of the knee:
incidence, etiology and management treatment with platelet rich plasma in comparison
L. Poorteman1, B. Saint-Lèbes2, S. Heye1, S. Houthoofd1, H. Rousseau2, with hialuronic acid group control
G. Maleux1; 1Leuven / BE, 2Toulouse / FR A. La Marra, F. Arrigoni, S. Mariani, L.M. Gregori, A. Mancini, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT
11:03
B-0059 Post-EVAR split-bolus CT-angiography using 10:54
dual-energy CT: all you need in a single scan! B-0069 Targeted ultrasound-guided hydrodilatation via the
R. Iezzi, M. Nestola, G. Coppola, A. Contegiacomo, F. Snider, L. Bonomo; rotator interval for adhesive capsulitis
Rome / IT D. McKean1, P. Yoong2, S.W. Duffy3, N.P. Hujairi4, R. Mansour1, J. Teh1;
1
Oxford / UK, 2Reading / UK, 3Norwich / UK, 4London / UK
11:11
B-0060 Dual-energy computed tomography (DECT): 11:02

Wednesday
hard plaque imaging for endoleak detection B-0070 Morphometric analysis of radiation dose and
R. Müller-Wille, T. Borgmann, C. Stroszczynski, C. Dornia; Regensburg / DE procedure time during percutaneous radiofrequency
11:19 ablation of osteoid osteomas
P. Magyar, P.N. Kaposi, D. Kozics, B. Kovács, J. Kiss, I. Kalina, K. Karlinger,
B-0061 Long-term results aer EVAR: aorto-monoiliac M. Szendrői, V. Bérczi; Budapest / HU
configuration increases the risk of complications and
aneurysm-related death 11:10
A.M. Morales Vargas, G. Garzón Moll, M. Martí de Gracia; Madrid / ES B-0072 Four years of clinical and MRI follow-up aer
intratendinous US-guided platelet rich plasma (PRP)
11:27 injection in patients with degenerative tendinopathy
B-0062 Accuracy of MDCT angiography of the anterior of rotator cuff tendons of the shoulder
abdominal wall in the planning of the mammary F. Arrigoni, A. La Marra, S. Mariani, L.M. Gregori, L. Zugaro, A. Barile,
reconstruction with DIEP-flap in mastectomised C. Masciocchi; L’Aquila / IT
patients 11:18
F. Carbonetti, A. Cremona, P. Aloisio, N. Maltzeff, G. Argento, C. Capotondi,
V. David; Rome / IT B-0073 Comparison of ultrasound guided collagenase
clostridium histolyticum injections and blinded
11:35 injections in treatment of Dupuytren’s contracture
B-0063 Intra-arterial ultra low-iodine volume CT of renal V. Higueras, E. Llopis, L. Aguillella, R. Perez, E. Belloch; Alzira-Valencia / ES
transplant arteries
C.E. Althoff, R.W. Günther, B. Hamm, M. Rief; Berlin / DE 11:26
B-0074 Prognostic factors in needle aspiration of calcific
11:43 deposits (NACD) for calcific tendinitis of the rotator
B-0064 Effect of TIPS on splanchnic arterial and portal venous cuff
blood flow in 4D flow MRI measurement at 3Tesla B.W. Oudelaar1, S.B.A. van der Valk2, A.J.H. Vochteloo1, R. Huis in t Veld1,
Z. Stankovic1, M. Roessle2, W. Euringer2, M. Schultheiss2, R. Salem1, A. Barker1, E.M. Ooms1, R. Schepers-Bok2; 1Hengelo / NL, 2Almelo / NL
M. Langer2, M. Markl1, J. Collins1; 1Chicago, IL / US, 2Freiburg / DE
11:34
11:51 B-0075 Can PRP US-guided injection accelerate healing and be
B-0065 Evaluation of cranial DAVF: alternative to surgery for patients with Achilles and
use of 4D CTA before and aer embolisation patellar tendinopathy?
B. Tian, J. Lu, B. Xu, M. Wang, Q. Liu; Shanghai / CN A. La Marra, S. Mariani, F. Arrigoni, L.M. Gregori, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT

10:30–12:00 Room E1 11:42


B-0071 Sonoelastography in carpal tunnel syndrome patients:
Musculoskeletal findings aer injection
M. Abd Ellah1, H. Miyamoto2, C. Martinoli3, A. Tagliafico3, G. Feuchtner1,
SS 210 Intervention F. Plank1, W.R. Jaschke1, A. Klauser1; 1Innsbruck / AT, 2Tokyo / JP, 3Genoa / IT
Moderators: I. Iacucci; Rome/IT, E. Llopis; Valencia/ES
11:50
10:30 B-0076 Meralgia paresthetica: ultrasound guided injection
B-0066 MR guided focused ultrasound surgery (MRgFUS) with 12-month follow-up data
M.M. Abd Ellah1, C.M. Siedentopf1, C. Martinoli2, G. Feuchtner1, F. Plank1,
in the treatment of epiphyseal benign bone lesions: W.R. Jaschke1, A. Klauser1; 1Innsbruck / AT, 2Genoa / IT
results aer three year of experience
F. Arrigoni, S. Mariani, A. La Marra, L.M. Gregori, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT

10:38
B-0067 Ultrasound / MRI fusion imaging guided lumbar nerve
root blocks; preliminary experience
D.J. Wilson, G.M. Allen; Oxford / UK

www.myESR.org Final Programme | ECR 2015 245


10:30–12:00 Room E2 11:51
B-0086 Transcranial magnetic stimulation and MR with DTI
Neuro in ALS patients: combination and correlations
SS 211a Inflammatory and degenerative of their measurements
A. Stecco, M. Perchinunno, I. Divenuto, E. Migazzo, A. Carriero; Novara / IT
disorders
Moderators: A. Bozzao; Rome/IT, N. Guberina; Essen/DE
10:30–12:00 Room F1
10:30
K-02 Keynote lecture Oncologic Imaging
T.A. Yousry; London / UK

10:39
SS 216 Thoracic oncology
Moderators: I.E. Tyurin; Moscow/RU, A. Vilaplana; Seville/ES
B-0077 Improved Alzheimer’s disease diagnostic
performance using structural MRI: 10:30
validation of the MRI combination biomarker B-0087 CT perfusion of lung tumour: do morphological and
that won the CADDementia challenge functional heterogeneity correlate?
L. Sørensen1, M. Lillholm1, A. Pai1, I. Balas1, C. Anker2, C. Igel1, M. Nielsen1; D. Barone1, A. Bevilacqua2, S. Baiocco2, G. Gavelli1; 1Meldola / IT, 2Bologna / IT
1
Copenhagen / DK, 2Kgs. Lyngby / DK
10:38
10:47 B-0088 Virtual monoenergetic dual-energy CT:
B-0078 MRI-based automated hippocampal volumetry as a optimisation of keV-settings in lung cancer
screening tool for Alzheimer’s disease in subjects with M. Kaup, J.-E. Scholtz, A. Engler, R.W. Bauer, M. Kerl, T.J. Vogl, J.L. Wichmann;
memory complaints supplemented by FDG-PET/CT Frankfurt a. Main / DE
I. Sacarea1, P. Suppa2, L. Spies3, M. Pixberg1, J. Müller-Hübenthal1; 1Cologne / DE,
2
Berlin / DE, 3Hamburg / DE 10:46
B-0089 Potential influence of automated volumetry on
10:55 treatment response classifications in lung cancer
B-0079 Association of MR features, clinical presentation lesions
and levels of glutathione and glutatione peroxidase K. Akbari; Linz / AT
in erythrocytes of patients with clinically isolated
syndrome and relapsing remiting multiple sclerosis 10:54
D. Stojanov, S. Ljubisavljevic, I. Stojanovic, S. Vojinovic; Nis / RS B-0090 Prognostic value of additional findings in CT scans
of patients with cancer-related pulmonary embolism:
11:03 data from 208 consecutive cases from
B-0080 Disrupted small-world networks in never treated the EPIPHANY study
schizophrenia patients with long illness duration D. Calvo-Temprano1, J. Plasencia2, P. Jiménez-Fonseca1, M. Solis1, M. Benegas3,
L. Yao1, W. Deng1, W. Liao2, F. Li1, Y. Xiao1, W. Zhang1, J. Sweeney3, Q. Gong1, M. Sanchez3, S. Hernandez4, D. Martinez de la Haza3, A. Carmona-Bayonas2;
S. Lui1; 1Chengdu / CN, 2Hangzhou / CN, 3Dallas, TX / US 1
Oviedo / ES, 2Murcia / ES, 3Barcelona / ES, 4Madrid / ES

11:11 11:02
B-0081 The different pattern of functional and structural B-0091 High diagnostic performance for MRI-based regional
changes depending on the rate of cognitive decline in lymph node staging in NSCLC:
Parkinson’s disease with mild cognitive impairment results from a meta-analysis
I. Kim1, J. Kwon2, N.-Y. Shin1; 1Seoul / KR, 2Gongju / KR J. Peerlings, E.G.C. Troost, P.J. Nelemans, A.L. Hoffmann, R.G.H. Beets-Tan;
Maastricht / NL
11:19
B-0082 Comparison of 3T and 7T susceptibility weighted 11:10
angiography of the substantia Nigra in diagnosing B-0092 Diagnostic accuracy of different MRI pulse sequences
Parkinson’s disease in non-small cell lung cancer in a dedicated, thoracic
M. Cosottini, D. Frosini, I. Pesaresi, G. Donatelli, P. Cecchi, M. Costagli, L. Biagi, 18F-FDG PET/MRI protocol
R. Ceravolo, M. Tosetti; Pisa / IT B.M. Schaarschmidt1, C. Buchbender1, C. Rubbert1, F. Hild2, V. Ruhlmann3,
V. Ruhlmann3, H.H. Quick3, G. Antoch1, P. Heusch1; 1Dusseldorf / DE, 2Hamm / DE,
11:27 3
Essen / DE
B-0083 Pattern of spontaneus neuronal activity within default
11:18
mode network in patients with Parkinson’s disease
E. Seliverstova, Y. Seliverstov, R. Konovalov, M. Krotenkova, S. Illarioshkin; B-0093 Multi-parametric PET-CT correlates with hypoxia,
Moscow / RU angiogenesis and ALK expression in non-small cell
lung cancer
11:35 D. Neriman, B. Ganeshan, A. Groves; London / UK
B-0084 Estimating the need for MRI conditionally safe deep
brain stimulation systems in Parkinson’s disease 11:26
patients: a European perspective B-0094 Correlation between CT features and KRAS mutation in
C. Gunnarsson1, G. Barnett2, S. Autiero Walleser3, J. Hinnenthal4, Y. Safriel5, patients with stage I lung adenocarcinoma and their
M. Ryan1; 1Cincinnati, OH / US, 2Dunganaghy / IE, 3Tolochenaz / CH, 4Minneapolis,
MN / US, 5Clearwater, FL / US prognostic value
H. Wang1, Y. Liu2, O. Grove2, Y. Balagurunathan2, J. Heine2, S. Eschrich2, Z. Ye1,
R. Gillies2; 1Tianjin / CN, 2Tampa, FL / US
11:43
B-0085 Susceptibility weighted imaging improves
the diagnostic accuracy of brain MRI in the work-up
of parkinsonism
F.J.A. Meijer, B.A.C.M. Fasen, A. van Rumund, B.R. Bloem, B. Goraj; Nijmegen / NL

246 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:26
B-0095 CT of the lung: distinct features of NSCLC harbouring B-0105 Attenuation values in virtual non-contrast
the EML4-ALK translocation dual-energy CT: effect of acquisition protocol,
U.G. Mueller-Lisse, A. Tufman, H.A. Zimmermann, C. Reiners, A. Borgmeier, phantom size and contrast agent concentration
F. Gamarra, S. Reu, M.F. Reiser, R.M. Huber; Munich / DE K. Matsubara, K. Sakuda, H. Kawashima, T. Takata, K. Ichikawa, K. Koshida,
T. Gabata; Kanazawa / JP
11:42
B-0096 Epidermal growth factor receptor mutation in lung 11:34
adenocarcinomas: comparing CT characteristics with B-0106 Model-based iterative reconstruction in CT thorax:
and without activating EGFR mutation first quantitative clinical results
J. Zhao, C. Heußel, J. Dinkel, H.-U. Kauczor, H.-P. Schlemmer, a. Warth, C.C. Brussaard1, B. Ilsen1, J. Milles2, W. Giepmans2, J. de Mey1; 1Brussels / BE,
P. Schnabel, T. Muley, M. Steins; Heidelberg / DE 2
Eindhoven / NL

11:50 11:42

Wednesday
B-0097 NSCLC with EGFR and KRAS positive genes mutations. B-0107 Advanced modelled iterative reconstruction for
Do CT findings help in differentiating these from other abdominal CT: qualitative and quantitative evaluation
forms of NSCLC? S. Gordic1, L. Desbiolles2, P. Stolzmann1, L. Gantner1, S. Leschka2, D.B. Husarik1,
A. Sabri, M. Batool, Z. Xu, D. Bethune, D. Manos; Halifax, NS / CA H. Alkadhi1; 1Zurich / CH, 2St. Gallen / CH

11:50
10:30–12:00 Room F2 B-0108 Adaptative statistical iterative reconstruction
and model based iterative reconstuction in liver
Physics in Radiology multiphase CT: quality image impact
E. Hérin1, M. Chiaradia1, F. Gardavaud1, L. Baranes1, P. Richard2, F. Legou1,
J.-F. Deux1, A. Rahmouni1, A. Luciani1; 1Créteil / FR, 2Buc / FR
SS 213 Advances in CT imaging
Moderators: J. Geleijns; Leiden/NL, A. Stratis; Leuven/BE

10:30 10:30–12:00 Room D1


B-0098 Dose performance of a new CT system optimised for Breast
low kV imaging in whole liver dynamic studies
U. Haberland, E. Klotz, B. Schmidt; Forchheim / DE
SS 202b Axillary imaging and nodal staging
10:38 Moderators: A. Athanasiou; Athens/GR, M. Dietzel; Erlangen/DE
B-0099 Formation of a well-defined arterial input function 10:30
for contrast-enhanced CT using a pre-determined B-0109 Risk stratification for axillary lymph node metastases
patient-specific circulatory function for individual in breast cancer patients
contrast-agent bolus-shaping E. Song, S. Yun, Y.-M. Sohn, H. Lee; Seoul / KR
J. Hansen, M.O. Wielpütz, G. Pahn, S. Skornitzke, L. Grenacher, H.-U. Kauczor,
W. Stiller; Heidelberg / DE 10:38
10:46 B-0111 Axillary lymph node ultrasound features that can
B-0100 Renal versus splenic maximum slope based perfusion predict malignancy in patients with primary invasive
CT modeling in patients with liver cirrhosis and breast cancer
P.A.C. Teixeira, N. de Barros, L.F. Chala, C. Shimizu, J.R. Filassi; São Paulo / BR
portal-hypertension
M.A. Fischer, K. Brehmer, B. Leidner, A. Svensson, P. Aspelin, T.B. Brismar; 10:46
Stockholm / SE
B-0112 Feasibility of axillary sentinel lymph node detection
10:54 using intradermal microbubble injections for staging
B-0101 X-ray phase-contrast CT: a novel method for breast cancer
differentiation of renal tumour subtypes ex-vivo T. Seaton, P. Thiruchelvam, K. Satchithananda, D. Cosgrove, D. Cunningham,
M. Braunagel1, L. Birnbacher2, M. Willner2, M. Notohamiprodjo3, A. Lim; London / UK
S. Notohamiprodjo1, T. Saam1, M.F. Reiser1, F. Pfeiffer2, J. Herzen2; 1Munich / DE,
2
Garching / DE, 3Tübingen / DE 10:54
B-0113 The role of magnetic resonance imaging in axillary
11:02 lymph node staging of breast cancer patients:
B-0102 Visualisation of pulmonary emphysema and fibrosis in a systematic review
living mice using x-ray dark-field CT imaging M. Lobbes, V. Kuijs, M. Moosdorff, R.J. Schipper, R.G.H. Beets-Tan, M. Smidt;
A. Yaroshenko1, K. Hellbach2, A. Velroyen1, S. Auweter2, M. Bech3, F.G. Meinel2, Maastricht / NL
M.F. Reiser2, F. Pfeiffer1; 1Garching / DE, 2Munich / DE, 3Lund / SE
11:02
11:10 B-0114 Preoperative axillary lymph node evaluation
B-0103 An MR-PET-CT phantom for quality assurance, in breast cancer patients by breast magnetic
research and development resonance imaging (MRI):
P. Mann1, T. Heußer1, H. de las Heras Gala2, M. Kachelrieß1, P. Bachert1;
1
Heidelberg / DE, 2Zorneding / DE can breast MRI exclude advanced nodal disease?
S. Hyun, M. Kim, J. Yoon, H. Moon, E.-K. Kim; Seoul / KR
11:18
B-0104 Identifying iodine and calcium solutions and
estimating their concentration using caterial
decomposition images generated by spectral detector
dual-layer CT
I. Leichter, T. Lipschuetz, T. Vichter, Z. Romman, J. Sosna; Jerusalem / IL

www.myESR.org Final Programme | ECR 2015 247


Scientific Sessions

11:10 11:02
B-0115 The diagnostic performance of dedicated axillary B-0125 Interventional radiology service provision:
T2- and diffusion-weighted MRI for nodal staging can we treat safely peripheral vascular disease
in breast cancer in a day unit setting?
R. Schipper1, M. Lobbes1, R.G.H. Beets-Tan1, P. Nelemans1, B. de Vries1, A. Cannavale, S. Ilyas, N. Shaida, C. Cousins, M. Krokidis; Cambridge / UK
E. Heuts1, K. van de Vijver2, K. Keymeulen1, M. Smidt1; 1Maastricht / NL,
2
Amsterdam / NL 11:10
11:18 B-0126 Analysis of outcome aer PTA in patients with
B-0116 Potential role of Dixon sequences on predicting infrainguinal TASC A and TASC B arterial lesions
D. Ilic, T. Kokovic, V. Vucaj-Cirilovic, V. Till, S. Stojanovic; Novi Sad / RS
metastatic axillary lymph nodes in patients with
breast cancer: preliminary results 11:18
M. Marcon, V. Bertani, P. Clauser, A. Linda, C. Zuiani, M. Bazzocchi; Udine / IT B-0127 Recanalisation of femoro-popliteal chronic total
11:26 occlusions: no fancy devices, just a crossing catheter
A. Cannavale, M. Krokidis; Cambridge / UK
B-0117 Role of DWI assessing nodal involvement and
response to neoadjuvant chemotherapy in advanced 11:26
breast cancer B-0128 Peripherally inserted central venous catheter-related
C. Buccheri, E. Bufi, A. Bonatesta, R. Fubelli, M. Tumino, F. Padovano, infections in a large cohort of hospitalised adult
F. Patrolecco, P. Belli, L. Bonomo; Rome / IT
patients
C. Bouzad1, S. Duron2, A. Bousquet3, L. Valbousquet3, G. Weber-Donat1,
11:34 J. Baccialone1, J. Potet1; 1Clamart / FR, 2Marseille / FR, 3Saint-Mandé / FR
B-0118 The diagnostic performance of
gadofosveset-enhanced axillary MRI for nodal 11:34
(re-)staging in breast cancer patients: B-0129 Endovenous laser ablation of symptomatic varicose
can the initial promising results be reproduced? veins: experience of a tertiary health care center
R. Schipper, M. Smidt, L. van Roozendaal, P. Nelemans, B. Brans, K. Keymeulen, in India
J.E. Wildberger, R.G.H. Beets-Tan, M. Lobbes; Maastricht / NL P. Jagia, S. Sharma, G. Gulati; New Delhi / IN
11:42 11:42
B-0119 Correlation between enlarged axillary lymph nodes B-0130 A comparative study of RFA and EVLT in treatment
to breast silicone implants tears seen on MRI of symptomatic varicose veins patients
E. Klang, O. Helshtok, A. Rundstein, A. Shalmon, Y. Servadio, M. Gotlieb, K.B. Taori; Nagpur / IN
M. Sklair-Levy; Ramat Gan / IL

10:30–12:00 Room G
10:30–12:00 Room D2

Interventional Radiology Genitourinary


SS 209 Peripheral arterial and venous SS 207 Gynaecological malignancies
Moderators: M. Horta; Lisbon/PT, K. Kinkel; Chêne-Bougeries/CH
interventions
Moderators: E. Dósa; Budapest/HU, K. Schürmann; Dortmund/DE 10:30
K-03 Keynote lecture
10:30 K. Kinkel; Chêne-Bougeries / CH
B-0120 Advanced age and renal dysfunction in cathlab:
what should we do? 10:39
R. Accardi, F. Pellone; Macerata / IT B-0131 Analysis of the heterogenity in DCE MR imaging
of adnexal masses:
10:38 a new tool for improving tumoural characterisation
B-0121 The role of cutting balloon angioplasty for the N. Souahli, D. Balvay, C.-A. Cuenod, M. Bazot, I. Thomassin-Naggara; Paris / FR
treatment of short infrapopliteal bifurcation
steno-obstructive disease 10:47
A. Posa, R. Iezzi, E. Antonuccio, M. Santoro, F. Snider, L. Bonomo; Rome / IT B-0132 Multiparametric
18F-Fluorodeoxyglucose/18F-Fluoromisonidazole
10:46 PET/MRI of cervix cancer: a feasibility study
B-0123 Patency rates of self-expandable bare metal stents K. Pinker-Domenig, P. Andrzejewski, W. Wadsak, A. Sturdza, G. Karanikas,
aer endovascular treatment of peripheral occlusive R. Poetter, T.H. Helbich, D. Georg, P. Georg; Vienna / AT
artery disease: a matter of stent design? 10:55
K.M. Treitl, B. Wörner, M.F. Reiser, M. Treitl; Munich / DE
B-0133 Differentiation of primary fallopian tube cancer
10:54 from epithelial ovarian cancer and salpingitis on
B-0124 Acute thrombosis of Viabahn stents 3-T PET/MRI
in the peripheral arteries: is the incidence S. Park, C. Kim, J. Park, J. Bae, B. Park; Seoul / KR
much higher than initially anticipated? 11:03
A. Parthipun, S. Lamki, A. Diamantopoulos, Y. Gupta, K. Katsanos; London / UK
B-0134 Sonoelastography in differentiation of the benign and
malignant ovarian tumours
A.E. Khalmukhamedova, V.E. Gazhonova; Moscow / RU

248 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:11 11:02
B-0135 Differentiation of tuberculous peritonitis, and B-0145 Air gap in hip joint axiolateral projection
peritoneal carcinomatosis in normal-sized ovarian S.H. Kivistö, A. Henner, U. Kuismin, M. Jaakkola, A. Kotiaho; Oulu / FI
carcinoma in female patients on CT 11:10
S. Shim, J. Lee, Y. Jeong; Ulsan / KR
B-0146 Balancing image quality and effective radiation dose
11:19 in orbital X-ray screening for ferromagnetic IOFBs:
B-0136 Haemodynamic evaluation of normal ovaries and a pilot study
different ovarian tumours: 3.0T DCE-MRI study S.A. Jessop1, G. Hart1, A.R. Santiago2, J. Guerreiro2, Y. Cottier3, B. Markali4,
Q. Ji; Tianjin / CN E.N. Andersen4, J. Jorge3, A.E. England1; 1Manchester / UK, 2Lisbon / PT,
3
Lausanne / CH, 4Oslo / NO
11:27 11:18
B-0137 Value of DWI sequences in cervical cancer recurrence: B-0147 Orthopaedic surgery occupational exposure using

Wednesday
can we skip contrast?
R.N. Lucas, J. Lopes Dias, T. Cunha; Lisbon / PT active dosimeters
J. Francisco, N. Lopes, R. Ferreira, J. Santos, G. Paulo; Coimbra / PT
11:35 11:26
B-0138 Diffusion-weighted MRI of endometrial cavity B-0148 Pelvic radiography: patient orientation
pathologies: differentiation of benign and L. Khaledian, J. Ebadi; Tehran / IR
malign lesions and preoperative assessment
of myometrial invasion 11:34
M. Cavusoglu, D. Sözmen Cılız, A. Özsoy, S. Duran, E. Elverici, C. Atalay, B-0149 Does using a lower kVp offer a greater potential
B. Sakman; Ankara / TR
for fracture detection in hip radiography?
H. Milne, A.E. England; Manchester / UK
11:43
B-0139 Utility of MRI findings in differentiation of type I 11:42
and type II endometrial cancer: B-0150 The effect of patient shielding in intraoral
comparison of MRI and endometrial biopsy dental imaging
T. Manabe, H. Yoshida, M. Yoshida, T. Kato, M. Ishikawa, S. Ikeda, Y. Arai; T. Klemenčič, N. Mekiš; Ljubljana / SI
Tokyo / JP
11:50
11:51 B-0151 Musculotendinous structure changes evaluated
B-0140 Comparison of DWI and T2 TSE with gadolinium by ultrasound in elderly population submitted to
ehanced sequences for the staging of the uterine a physical activity programme
cervical cancer R. Santos, A. Amaral; Coimbra / PT
V. Vinci, S. Bernardo, M. Saldari, L. Manganaro; Rome / IT

10:30–12:00 Room MB 1
10:30–12:00 Room K

Radiographers Head and Neck


SS 208 Advanced imaging in salivary
SS 214 Musculoskeletal radiography glands and lymph nodes, including
Moderators: A.J. Grainger; Leeds/UK, V. Syrgiamiotis; Athens/GR
elastography
10:30 Moderators: S.J. Golding; Oxford/UK, L. Grzycka-Kowalczyk; Lublin/PL
B-0141 Development and validation of a psychometric scale
10:30
for the visual assessment of AP pelvis image quality
H.A.A.B. Mraity1, A.E. England1, A.D. Dominguez2, P.H. Hogg1; 1Manchester / UK, B-0152 Simultaneous visualisation of the intraparotid facial
2
Lausanne / CH nerve and parotid duct using a micro-surface coil and
3D-FISP-FS sequence
10:38 G. Hong; Guangzhou / CN
B-0142 Radiography of the knee joint:
a comparative study of the partial flexion PA 10:38
projection and the fully extended AP projection B-0153 MR sialography of sialadenitis related with radioactive
E. Farrugia Wismayer, F. Zarb; Msida / MT Iodine treatment in patients with postoperative
thyroid cancer, using 3D fast recovery fast spin echo
10:46
sequence at 3T
B-0143 Optimisation of radiography practice in paediatric Y. Shin, H. Lee, N. Kim, M. Lim, Y. Kang, J. Lim, S. Cho; Incheon / KR
computed radiography for full spine curvature
measurements: a pilot phantom study 10:46
C.S. Reis1, J. Ndlovu2, C. Serrenho1, I. Akhtar2, S. de Haan3, J. Garcia4, D. de Linde5, B-0154 Diffusion-weighted imaging (DWI) and dynamic
M. Thorskog5, L. Franco4, C. Lança1, P.H. Hogg2; 1Lisbon / PT, 2Salford / UK,
3
Groningen / NL, 4Lausanne / CH, 5Oslo / NO contrast-enhanced MRI (DCE-MRI) in common parotid
gland tumours with reference to histopathologic
10:54 examination
B-0144 Knowledge, attitudes and organisational determinants K. Markiet, B. Mikaszewski, A. Smugala, D. Stodulski, B. Kowalska,
C. Stankiewicz, E. Szurowska; Gdansk / PL
of positioning techniques for radiography
S. Germonpré1, P. Gemmel2, D. Beeckman2, J. Trybou2; 1Brussels / BE, 2Ghent / BE

www.myESR.org Final Programme | ECR 2015 249


Scientific Sessions

10:54 10:47
B-0155 Role of perfusion computed tomography B-0164 CT angiography findings of cardiovascular anomalies
in assessing submandibular gland in aortopulmonary window:
radiochemotherapy-induced injury a rare congenital heart disease
U. Lamot, K. Šurlan Popovič, M. Harej, T. Furlan, P. Popovič, P. Strojan; A. Bhatia, K.S. Sodhi, A.K. Saxena, M. Singhal, M.K. Rohit, N. Khandelwal;
Ljubljana / SI Chandigarh / IN

11:02 10:55
B-0156 Comparison of fine needle aspiration and core needle B-0165 Detection of pulmonary nodules in children with a free
biopsy under ultrasonography guidance for detecting breathing MRI technique compared to CT scans
malignancy and for the tissue-specific diagnosis of H.P. Schemuth, S. Sirin, B. Schweiger, J. Schelhorn, S. Kinner; Essen / DE
salivary gland tumours 11:03
H.-J. Eom, J. Lee, J. Baek, Y. Choi, M.-S. Ko, K. Cho, S. Nam, R. Yoon; Seoul / KR
B-0166 Coronary assessment in young children with
11:10 congenital heart disease:
B-0157 A study on serum antithyroglobulin antibodies comparing a novel spiral acquisition technique
interference in thyroglobulin measurement in to the standard sequential one in coronary CT
fine-needle aspirationin diagnosing lymph node angiography with dual-source CT
metastasis in postoperative patients A. Secinaro, T. Santangelo, C. Napolitano, B. Leonardi, M. Chinali, G. Rinelli,
J. Lee, J. Kwak, H. Shin, E.-K. Kim; Seoul / KR P. Tomà; Rome / IT

11:18 11:11
B-0158 ShearWave elastography in lymph nodes B-0167 Image quality criteria for paediatric CT thorax -
F. Houari, O. Lucidarme, J. Gabarre, F. Charlotte, C. Pellot-Barakat, M. Lefort, a useful tool?
L. Chami; Paris / FR L. Heiberg, S. Flatabo, A. Aarsnes, H. Olerud, C. de Lange; Oslo / NO

11:26 11:19
B-0159 ‘Illusion of blue’; role of ultrasound elastography in B-0168 Assessment of bronchiectasis in children with cystic
cervical lymph nodes fibrosis by comparing airway and artery dimensions
R. Arkar, V. Kasi Arunachalam, R. Renganathan, M. Cherian; Coimbatore / IN to normal controls on inspiratory and expiratory
11:34 spirometer guided chest computed tomography
W. Kuo1, M. de Bruijne1, K. Nasserinejad1, H. Ozturk1, Y. Chen2, A. Perez-Rovira1,
B-0160 Role of ultrasonographic elastography H.A.W.M. Tiddens1; 1Rotterdam / NL, 2Ningxia / CN
in differentiating benign and malignant
cervical lymph nodes 11:27
P.A.R.P. Sathiadoss, S. Narayanasamy, S. Wahab, E. Ullah, I. Ahmad; Aligarh / IN B-0169 Paediatric fluoroscopic imaging - comparison
of simulation results using an anthropomorphic
11:42 phantom representing a 1-year old child examined
B-0161 Elastography and histogram of Kikuchi disease: on an image-intensifier and a flat-panel detector
the comparison with reactive hyperplasia of cervical based system
lymph nodes M. Weidner1, A.A. Schegerer2, T. Diehm1, U. Lechel2, S.O. Schoenberg1, G. Brix2,
K. Lee, J. Ryu; Busan / KR K.W. Neff1; 1Mannheim / DE, 2Neuherberg / DE

11:50 11:35
B-0162 Real-time ultrasound elastographic features of B-0170 Dosimetric study of varicocele embolisation
primary open angle glaucoma in paediatric patients
Ö. Ünal, N. Cay, M. Gumus, F. Yulek; Ankara / TR A. Gioppo, F. Melchiorre, R. Azzeroni, C. Khouri Chalouhi, G. Cornalba; Milan / IT

11:43
10:30–12:00 Room MB 2 B-0171 CT dose monitoring and optimisation in paediatric CT
using radiation dose tracking Soware
Paediatric M. Twomey, F. Moloney, C. Bogue, M. Sheehy, O.J. O’ Connor, M.M. Maher;
Cork / IE
SS 212 Chest imaging and dosimetry 11:51
Moderators: L.-S. Ording Müller; Oslo/NO, C. Owens; London/UK
B-0172 Comparison of radiation dose between an image
10:30 intensifier system and a flat-panel detector system
K-04 Keynote lecture - evaluation of clinical imaging in a paediatric
C. Owens; London / UK population
M. Weidner, C. Hagelstein, T. Diehm, S.O. Schoenberg, K.W. Neff; Mannheim / DE
10:39
B-0163 Real-time ultrasound-guided pigtail catheter
placement in supine position for drainage of
symptomatic pleural effusions in paediatric patients
who underwent liver transplantation
M. D’Amico, R. Miraglia, L. Maruzzelli, G. Gallo, A. Luca; Palermo / IT

250 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:30–12:00 Room MB 3 11:34


B-0181 Le atrial fibrosis in healthy volunteers and patients
Cardiac with and without atrial fibrillation according to LGE
SS 203b Heart rate: MRI
O. Aparina, O. Stukalova, D. Parkhomenko, N. Mironova, S.K. Ternovoj,
disorders and imaging issues S.P. Golitsyn; Moscow / RU
Moderators: M. Grothoff; Leipzig/DE, R.J. Perea; Barcelona/ES
11:42
10:30 B-0182 Myocardial substrate of recurrent ventricular
B-0173 Effect of heart rate on image quality using 320-row tachycardia: relationship between late-enhancement
coronary computed tomography angiography: multidetector computed tomography (MDCT-LE) and
a pulsating cardiac phantom study electroanatomic mapping
P. Kozma, C. Kendziorra, F. Richter, M. Dewey; Berlin / DE A. Palmisano, A. Esposito, C. Colantoni, F. De Cobelli, G. Maccabelli, P. Della
Bella, A. Del Maschio; Milan / IT

Wednesday
10:38
B-0174 Coronary CT angiography on 128-slice dual-source CT: 11:50
comparison of incidence and location of artefacts B-0183 Effect of a novel motion correction algorithm on the
in high-pitch spiral and prospectively ECG-gated image quality of low-dose coronary CTA
M. Komarova, V. Sinitsyn, E.A. Mershina; Moscow / RU
sequential acquisitions
F. Laffranchi, D. Farina, E. Gavazzi, A. Borghesi, M. Ravanelli, R. Maroldi;
Brescia / IT
10:30–12:00 Room MB 4
10:46
B-0175 Comparison of coronary CT angiography (CCTA) for Emergency Radiology
patients with high heart rates using a 512-slice
new-generation MDCT and a 128-slice CT: SS 217 Emergency imaging:
image quality and radiation dose how to be more precise
L. Macron, J.-L. Sablayrolles, J. Feignoux; Saint Denis / FR Moderators: K.H. Nieboer; Brussels/BE, G. Schueller; Opfikon/CH

10:54 10:30
B-0176 Coronary angiography by 320-row CT in patients with B-0184 Simple CBF grading based on MR perfusion to
atrial fibrillation: prospective intention-to-diagnose anticipate long-term clinical outcome in severe stroke
comparison with conventional coronary angiography patients due to the carotid artery occlusion
E. Zimmermann1, S. Feger1, M. Rief1, P. Schlattmann2, M. Laule1, M. Dewey1; T. Mori, T. Iwata, Y. Tanno, S. Kasakura, Y. Aoyagi, K. Yoshioka; Kamakura / JP
1
Berlin / DE, 2Jena / DE
10:38
11:02 B-0185 Prevalence of pulmonary embolism during pregnancy
B-0177 Influence of iodinated contrast agents on heart S. Schmidt, V. Dunet, R. Meuli, O. Hugli, V. Ilic; Lausanne / CH
rate variation during CT angiography of the
10:46
coronary arteries aer intravenous administration
of beta blocker B-0186 Intensive care patients with elevated laboratory
C. Loewe, L. Reider, A. Wielandner, V. Schoepf, S. Unterhumer, D. Beitzke, inflammatory parameters: indications to perform
F. Wolf; Vienna / AT a CT examination of the head, chest and abdomen
to search for the focus of infection
11:10 N.N.N. Naguib, B. Dana, N.-E.A. Nour-eldin, M. Albrecht, T. Gruber-rouh, V. Jacobi,
B-0178 Influence of atrial fibrillation on le atrial appendage T.J. Vogl; Frankfurt a. Main / DE
movement and sizing evaluated with cardiac
10:54
computed tomography angiography
F. Avogliero, A. Clemente, T. Liguori, A. Monteleone, D. Della Latta, D. Chiappino; B-0187 The emerging role of contrast-enhanced CT to assess
Massa / IT esophageal necrosis aer corrosive ingestion
D. Bouda, A.-M. Zagdanski, F. Sabatier, P. Bourrier, C. De Margerie, E. De
11:18 Kerviler, M. Chirica, P. Cattan; Paris / FR
B-0179 Cardiac CT vs cardiac MRI for characterisation
11:02
of le atrium anatomy before radiofrequency
catheter ablation of atrial fibrillation: B-0188 Patients with acute pancreatitis:
impact on radiation exposure and outcome is computed tomography always necessary?
M. Karul, M. Avanesov, T. Kraus, K. Bachmann, T. Derlin, G. Adam, J. Yamamura;
E. Bertella, D. Andreini, M. Petullà, E. Russo, E. Innocenti, A. Baggiano, Hamburg / DE
S. Mushtaq, V. Beltrama, G. Pontone; Milan / IT

11:26 11:10
B-0180 Point-by-point correlation between electroanatomic B-0189 The CT “capsular sign”:
mapping (EAM) and 3D-model from a specific finding of acute adrenal ischemia
M. Moschetta, M. Telegrafo, A. Pignatelli, A. Stabile Ianora, G. Angelelli; Bari / IT
multidectector-computed tomography (3D-CT-model)
in patients affected by ventricular tachycardia (VT) 11:18
C. Colantoni, A. Esposito, A. Palmisano, S. Antunes, F. De Cobelli, G. Maccabelli, B-0190 Acute appendicitis - CT or ultrasound in patients
P. Della Bella, G. Rizzo, A. Del Maschio; Milan / IT
with differing body mass indices:
a comparative assessment
M. Khanna, S. Abusamaan, S. Ramanathan, H. Hena, D. Panwar, B. Rao;
Doha / QA

www.myESR.org Final Programme | ECR 2015 251


Scientific Sessions

11:26 11:18
B-0191 Is CT transrectal enema useful in staging acute B-0201 Comparison of image quality and radiation dose:
colonic diverticulitis? cerebral CT angiography (CTA) using 120 kVP vs 100
M. Gentiluomo, D. Artioli, G. Chirico, A. Mariani, L. Ponzini, O. Chiara, S. Sironi, kVP protocols in patients with clipped aneurysm
A. Vanzulli; Milan / IT H. Park, H. Choi, B.-M. Gil, J. Jang, S. Jung, K.-J. Ahn, B.-S. Kim; Seoul / KR
11:34 11:26
B-0192 Utilising contrast-enhanced CT for detecting B-0202 Final report of the Polish multicentre study
post-traumatic placental abruption: for evaluation of CT angiography in the diagnosis
assessing accuracy and comparison with ultrasound of brain death
P. Jha1, G. Melendres2, B. Bijan2; 1San Francisco, CA / US, 2Sacramento, CA / US M. Sawicki1, R. Bohatyrewicz1, A. Walecka1, J. Walecki2, O. Rowiński2,
J. Sołek-Pastuszka1, Z. Czajkowski1, P. Skrzywanek3, M. Guziński4; 1Szczecin / PL,
11:42 2
Warsaw / PL, 3Poznań / PL, 4Wrocław / PL
B-0193 High-pitch low-dose paranasal sinus CT
in drunken emergency room patients aer assault: 11:34
initial results on image quality and dose with B-0203 Postmortem interval estimation:
third-generation dual-source CT value of postmortem cerebral CT
C. Frellesen, P. Dewes, B. Schulz, J.-E. Scholtz, M. Kerl, T.J. Vogl, R. Bauer; D.H.J.L. Koopmanschap, A.R. Bayat, D. Bosboom, K. Kamphuis-Van Ulzen,
Frankfurt a. Main / DE W.M. Prokop, W.M. Klein; Nijmegen / NL

11:50 11:42
B-0194 Intravenous and oral contrast vs intravenous contrast B-0204 Evaluation of the degree of arteriovenous shunting
alone CT for the visualisation of appendix and in intracranial arteriovenous malformations using
diagnosis of appendicitis in adult ED patients pseudo-continuous arterial spin labeling MRI
A. Wadhwani, L. Guo, E. Saude, H. Els, E. Lang, A. MacRae, D. Bhayana; Calgary, L. Sunwoo, C.-H. Sohn; Seoul / KR
AB / CA
11:50
B-0205 Evaluation of contrast-enhanced MR angiography and
10:30–12:00 Room MB 5 time of flight MR angiography at 3 Tesla in previously
coiled intracranial aneurysms
Neuro N. Khandelwal, A. Mahajan, V. Gupta, A. Kumar, S. Mathuriya, S. Gupta;
Chandigarh / IN
SS 211b Vascular disorders, diagnosis and
treatment 14:00–15:30 Room A
Moderators: K.D. Kurz; Stavanger/NO, Z. Merhemic; Sarajevo/BA

10:30 Breast
B-0195 Feasibility and validity of monitoring subarachnoid SS 302a Breast density and imaging biomarkers
haemorrhage by a noninvasive MRI imaging perfusion Moderators: L.A. Carbonaro; San Donato Milanese/IT, C. Colin; Lyon/FR
technique: pulsed arterial spin labelling (PASL)
M. Labriffe, A. Ter Minassian, A. Pasco-Papon, S. N’Guyen, C. Aubé; Angers / FR 14:00
10:38 B-0206 Mammographic density is the main correlate
B-0196 Intra-arterial infusion of milrinone in the treatment of tumours detected on ultrasound but not on
of severe symptomatic cerebral vasospasm in patients mammography
P.A. Fasching, B. Brehm, L. Haeberle, S.M. Jud, A. Hartmann, M. Meier-Meitinger,
with aneurysmal subarachnoid haemorrhage: M. Uder, M.W. Beckmann, R. Schulz-Wendtland; Erlangen / DE
first experience
F. Thaher, N. Hopf, P. Kurucz, A.-K. Hickmann, M. Aguilar Pérez, W. Kurre, 14:08
O. Ganslandt, H. Henkes; Stuttgart / DE B-0207 A preliminary retrospective study to determine early
10:46 mammographic breast density reduction following
B-0197 Safety and efficacy of a new device for the treatment treatment
L. Metaxa1, L. Leong2, S. W Duffy1, T. Suaris1; 1London / UK, 2Singapore / SG
of wide neck bifurcation aneurysms (pCONus):
initial results and long-term follow-up 14:16
M. Aguilar Pérez, W. Kurre, E. Henkes, O. Ganslandt, H. Bäzner, H. Henkes; B-0208 Inter-rater variability for breast density classification
Stuttgart / DE
between American and British radiologists
10:54 W. Alomaim1, S. Foley1, J. Ryan1, M. Evanoff2, L.A. Rainford1, D. O’Leary3;
1
Dublin / IE, 2Tucson, AZ / US, 3Hatfield / UK
B-0198 Flow diverters: a curative endovascular treatment
for ruptured intracranial blister-like aneurysms 14:24
S. Deepalam, S. Joseph, N. Mulimani; Chennai / IN B-0209 Comparison of two soware-based methods for
11:02 volumetric breast composition analysis
F. Engelken, C. Schmachtenberg, U. Bick; Berlin / DE
B-0199 Basilar tip aneurysms and fetal PCAs:
do they really coexist? 14:32
M.C. Diogo1, I. Fragata1, J. Nunes2, J. Pamplona1, J. Reis1; 1Lisbon / PT, 2Gaia / PT B-0210 Low mammographic breast density and other
11:10 mammographic characteristics are linked to
B-0200 Optimising the resting state fMRI processing pipeline Hyaluronan and HAS1-3 staining and survival in
using a data-driven approach patients with early breast cancer
A.N.J. Masarwah, M. Sudah, A. Sutela, S. Oikari, M. Tammi, R. Vanninen,
L.R. Kozák, G. Dávid, Á. Szabó, G. Rudas, S. Dávid; Budapest / HU P. Auvinen; Kuopio / FI

252 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:40 14:32
B-0211 Does the synthesised digital mammography (3D-DM) B-0221 Can ultrasound imaging predict the outcomes of an
change the ACR density pattern? experimental steatofibrosis model?
P. Martínez-Miravete1, M. Millor Muruzábal2, P. García-Barquín2, A. Elizalde2, R. Turkay, F.A. Aydin, E. Inci, B. Bakir, E. Hocaoglu, I. Dogan-Ekici, I. Bingul,
L. Pina2, J. Etxano2, P. Bartolomé2; 1Zaragoza / ES, 2Pamplona / ES C. Kucukgergin, M. Uysal; Istanbul / TR

14:48 14:40
B-0212 Automated texture scoring for assessing breast B-0222 Value of gadoxetate disodium enhanced MRI in
cancer masking risk in full field digital mammography patients with primary sclerosing cholangitis (PSC) for
M.G. Kallenberg1, K. Petersen1, M. Lilholm1, D.R. Jørgensen1, P. Diao1, assessment of hepatic function
K. Holland2, N. Karssemeijer2, C. Igel1, M. Nielsen1; 1Copenhagen / DK, J. Hinrichs, T. Kaireit, H. Lenzen, F. Wacker, K.I. Ringe; Hannover / DE
2
Nijmegen / NL
14:48
14:56
B-0223 Correlation between MRI examination and biopsy

Wednesday
B-0213 Association of ultrasound features of invasive ductal
of the liver in patients with primary sclerosing
mammary carcinoma with tumour grade and hormone
cholangitis: a retrospective study
receptor status J. Yamamura, C. Schramm, H. Ittrich, G. Adam, S. Keller; Hamburg / DE
I. Rehman, I.K. Niazi, A. Murtaza; Lahore / PK
14:56
15:04
B-0224 Pancreatic volume, iron and fat assessment
B-0214 Fully automated measurement of background
by MRI-T2* in B-Thalassemia major patients.
parenchymal enhancement using open source
Predictive value in development of diabetes:
soware
J.D. Balkman; Lebanon, NH / US a retrospective study
P. Arcuri1, M. Galati1, G. Raiola1, S. Roccia2, M. Cadioli3, G. Fodero1;
15:12
1
Catanzaro / IT, 2Lamezia Terme / IT, 3Monza / IT
B-0215 Triple negative breast cancer: 15:04
MRI features in comparison to other breast B-0225 Pancreatic iron assessment by MRI-R2* in patients
cancer subtypes with correlation to prognostic with transfusional siderosis and haemochromatosis
pathologic factors J. Yamamura1, S. Keller1, C. Pfeifer1, B. Schönnagel1, R. Grosse1, G. Adam1,
N.A.M. Chalabi, N. Osman, N. Abdraboh; Cairo / EG J. Wang2, R. Fischer1; 1Hamburg / DE, 2Dallas, TX / US

15:20 15:12
B-0216 Is choline concentration measured by MR B-0226 Application of fat suppression in T2* relaxometry for
Spectroscopy at 3.0T correlated to the outcome the quantification of pancreatic iron overload
of breast cancer prognostic indicators? F. Terrazzino1, A. Meloni2, G. Restaino3, T. Casini4, D. Messana1, A. Pepe2;
L. Camera, I. Baglio, F. Caumo, G. Meliadò, C. Cavedon, S. Montemezzi;
1
Palermo / IT, 2Pisa / IT, 3Campobasso / IT, 4Florence / IT
Verona / IT
15:20
B-0227 Comparison of spleen stiffness in HCV-positive
14:00–15:30 Room B and healthy/non-HCV patients using Shear wave
elastography (SWE): the pilot study
Abdominal Viscera A. Pawluś, M. Inglot, D. Hołownia, K. Szymańska, K. Kaczorowski, A. Szymczak,
J. Gąsiorowski, M. Inglot, U. Zaleska-Dorobisz; Wrocław / PL
SS 301a Diffuse liver and pancreatic diseases
Moderators: M.A. Bali; Brussel/BE, L. Cevasco; Genoa/IT
14:00–15:30 Room C
14:00
B-0217 Noninvasive liver iron content determination by Breast
dual-source dual-energy CT: initial results in patients
suspected of liver iron-overload
SS 302b Risk imaging and stratification
X. Luo, J. Yan, W. Chai, H. Zhang, F. Yan; Shanghai / CN Moderators: E. Azavedo; Stockholm/SE, P.A.T. Baltzer; Vienna/AT

14:08 14:00
B-0218 Multivariable analysis of clinical influence factors on B-0228 A prospective evaluation of a multimodal screening
liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI regimen in BRCA carriers
N. Verloh, M. Haimerl, C. Stroszczynski, C. Fellner, P. Wiggermann; J.C.M. van Zelst1, R.M. Mann1, G.H. Woldringh1, R.D.M. Mus1, P. Bult1,
Regensburg / DE M.J.C.M. Rutten2, N. Hoogerbrugge1, N. Karssemeijer1; 1Nijmegen / NL,
2
’s-Hertogenbosch / NL
14:16 14:08
B-0219 Obliterative portal venopathy (OPV) vs. liver cirrhosis: B-0229 Breast cancer in women previously exposed to chest
appraisal of vascular changes on CT
A. Arora, S. Rajesh, S.K. Sarin; New Delhi / IN radiation therapy: single centre experience
L. Bonello, G. Trecate, F. Cartia, A. Vella, S. Viganò, G. Scaperotta, P. Panizza;
Milan / IT
14:24
B-0220 Acute extrahepatic infectious or inflammatory 14:16
diseases are a cause of transient sinusoidal dilatation B-0230 Foci on breast magnetic resonance imaging (MRI)
1 1 1 2 1 1
M. Ronot , P.-E. Rautou , A. Kerbaol , G. Brancatelli , P. Bodossa , D. Valla ,
V. Vilgrain1; 1Clichy / FR, 2Palermo / IT in high-risk women: cancer or not?
P. Clauser1, A. De Nicolò1, A. Rotili2, B. Bonanni2, C. Zuiani1, M. Bazzocchi1,
E. Cassano2; 1Udine / IT, 2Milan / IT

www.myESR.org Final Programme | ECR 2015 253


Scientific Sessions

14:24 14:16
B-0231 Determination of recall rates in women B-0242 Impact of post-processing algorithms on the
undergoing annual surveillance breast MRI: reproducibility of apparent diffusion coefficient (ADC):
is a rate of less than 10% achievable? is it really quantitative?
N.A. Healy, K. Holohan, S. Cosgrove, T. Kwa, F. O’ Driscoll, G. Offiah, Y. Roden, M. Zeilinger1, M. Lell1, P.A.T. Baltzer2, M. Uder1, M. Dietzel1; 1Erlangen / DE,
S. Seboui, S.A. O’Keeffe; Dublin / IE 2
Vienna / AT

14:32 14:24
B-0232 Automated detection of breast cancer as an aid B-0243 Implementation of a phase detection algorithm for
in the interpretation of screening MRI dynamic cardiac computed tomography analysis based
A. Gubern Mérida1, S. Vreemann1, R. Martí2, J. Melendez1, S. Lardenoije1, on time dependent contrast agent distribution
R.M. Mann1, B. Platel1, N. Karssemeijer1; 1Nijmegen / NL, 2Girona / ES C. Kendziorra, H. Meyer, M. Dewey; Berlin / DE
14:40 14:32
B-0233 A critical audit of a breast MRI screening B-0244 Large-scale objective comparison of 29 novel
programme for intermediate and high risk patients algorithms for computer-aided diagnosis of dementia
in clinical practice based on structural MRI
S. Vreemann, A. Gubern Mérida, S. Lardenoije, B. Platel, N. Karssemeijer, E.E. Bron1, M. Smits1, F. Barkhof2, A.J. Bastos-Leite3, J.C. van Swieten1,
R.M. Mann; Nijmegen / NL W.J. Niessen1, S. Klein1; 1Rotterdam / NL, 2Amsterdam / NL, 3Porto / PT
14:48 14:40
B-0234 Can biannual ultrasound surveillance detect cancers B-0245 Volume measurement by using super-resolution MRI:
earlier in patients with breast cancer history? application to prostate volumetry
M. Kim, E.-K. Kim; Seoul / KR E. Oubel1, H. Beaumont1, A. Iannessi2; 1Valbonne / FR, 2Nice / FR
14:56 14:48
B-0235 A history of breast cancer and older age may warrant B-0246 CT perfusion studies of lung cancer: automatic
upgrade into BI-RADS 4 among patients assigned detection of misleading structures and artefacts
mammographic BI-RADS 3 in the diagnostic setting D. Barone1, A. Bevilacqua2, S. Malavasi2, G. Gavelli1; 1Meldola / IT, 2Bologna / IT
M. Benndorf1, Y. Wu2, E. Burnside2; 1Freiburg / DE, 2Madison, WI / US
14:56
15:04 B-0247 Water content calculation in cartilage through
B-0236 Towards personalised breast screening protocols: MR estimation: design and validation
validation of mammographic density estimation from of a mathematical model
full-field digital mammograms J.M. Shiguetomi-Medina1, J.L. Ramirez-GarciaLuna2, H. Stødkilde-Jørgensen3,
M. Abdolell, K.M. Tsuruda, E.E. McDougall, S. Iles, C.B. Lightfoot, J. Caines; B. Møller-Madsen1; 1Aarhus / DK, 2San Luis Potosi / MX, 3Skejby / DK
Halifax, NS / CA
15:04
15:12 B-0248 A novel approach for estimating fracture risk
B-0237 Tabár parenchymal patterns and breast cancer risk: by computerised processing of routine proximal
a case-control study adjusting for percent area femur radiographs
mammographic density and standard risk factors I. Leichter, B. Fargun, O. Rozengarten, O. Safran, M. Liebergall; Jerusalem / IL
M. Abdolell, S. Iles, K.M. Tsuruda, J. Payne, C.B. Lightfoot, J. Caines; Halifax,
NS / CA 15:12
15:20 B-0249 Clinical applicability of advanced trabecular
microarchitecture assessment using multi-detector
B-0238 Should volumetric breast density be included in breast
computed tomography
cancer prediction models? Proposal of an integrated A. Valentinitsch1, L. Fischer2, J.M. Patsch2, J.S. Bauer1, F. Kainberger2, G. Langs2,
quantitative and reproducible approach M. DiFranco2; 1Munich / DE, 2Vienna / AT
S. Ciatti1, G. Gennaro2, V. Mungai1, G. Nannini1; 1Prato / IT, 2Padova / IT

14:00–15:30 Room M
14:00–15:30 Room Z
GI Tract
Computer Applications
SS 301b Gastro-oesophageal and small bowel
SS 305 Imaging biomarkers imaging
Moderators: A. Alberich-Bayarri; Valencia/ES, M. de Bruijne; Rotterdam/NL
Moderators: D. Akata; Ankara / TR, S. Bickelhaupt; Heidelberg / DE
14:00 14:00
B-0239 Choice of deconvolution algorithm: B-0250 Metabolic volumetric parameters assessed with
impact on the perfusion analysis of human gliomas 18F-FDG PET/CT are superior to SUVmax and CT
1 2 1 1 3 1
M. Dietzel , N. Thanh , M. Schmidt , S. Kloska , M. Essig , A. Dörfler ;
1
Erlangen / DE, 2Ottawa, ON / CA, 3Winnipeg, MB / CA volumetry for predicting long-term outcome in
patients with esophageal cancer aer neoadjuvant
14:08 chemotherapy and resection
B-0241 Accurate and reproducible splenic volume estimation D. Tamandl, B. Fueger, M. Paireder, A. Haug, S. Schoppmann, A. Ba-Ssalamah;
in patients with splenomegaly from multidetector-row Vienna / AT
CT data using a quick stereological method
M. Mazonakis, J. Stratakis, J. Damilakis; Iraklion / GR

254 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:08 14:00–15:30 Room N


B-0251 The application of magnetic resonance imaging in the
staging of oesophageal cancer: ready for clinical use? Cardiac
F. Giganti, E. Orsenigo, E. Mazza, L. Albarello, C. Staudacher, A. Del Maschio,
F. De Cobelli; Milan / IT SS 303a Coronary atherosclerosis
Moderators: N.R. Mollet; Turnhout/BE, M. Urbanczyk-Zawadzka;
14:16 Krakow / PL
B-0252 Dynamic contrast-enhanced CT of gastric cancers:
relationship between enhancement pattern and 14:00
histological type K-05 Keynote lecture
D. Tsurumaru, M. Miyasaka, Y. Nishimuta, S. Kawanami, Y. Asayama, A. Nishie, R. Vliegenthart; Groningen / NL
H. Honda; Fukuoka / JP
14:09
14:24 B-0261 Calibration of Agatston calcium score using iterative

Wednesday
B-0253 Application of spectral CT on T staging of gastric image reconstruction (AIDR 3D) at 120, 100 and 80
carcinoma: evaluation of iodine concentration kVp instead of the standard reference protocol (FBP
of perigastric fat tissue adjacent to tumour at 120 kVp)
for diagnosing serosal invasion compared with J. Blobel, J. Mews, J.D. Schuijf, W. Overlaet; Zoetermeer / NL
pathological T staging 14:17
J. Xing, H.H. Limbu, J.B. Gao; Zhengzhou / CN
B-0262 Coronary calcium scoring at low radiation dose
14:32 using iterative reconstruction:
B-0254 Role of diffusion-weighted imaging and apparent intraindividual comparison with standard dose
diffusion coefficient in prediction of metastatic scanning using filtered back projection
regional lymph nodes in gastric cancer: A. Lembcke1, R. Luhur1, J. Mews2, B. Hamm1, J. Blobel2; 1Berlin / DE,
2
Zoetermeer / NL
comparison with morphological criteria
Y. Mao, F. Lv, Z. Wang; Chongqing / CN 14:25
14:40 B-0263 Detectability of small calcifications in patients
B-0255 PET/MR enterography for the assessment of different sizes: a stationary phantom study
M. Vonder1, G. Pelgrim1, S.E.M. Huijsse1, M.J.W. Greuter1, J.C. Gratama2,
of the small bowel: first experience M. Oudkerk1, R. Vliegenthart1; 1Groningen / NL, 2Apeldoorn / NL
1 1 1 2 1 1
K. Beiderwellen , S. Kinner , B. Gomez , P. Heusch , L. Umutlu , A. Bockisch ,
T.C. Lauenstein1; 1Essen / DE, 2Düsseldorf / DE 14:33
14:48 B-0264 The impact of Sn-filter on detection and quantification
B-0256 Clinical significance of pneumatosis of the bowel wall: of coronary calcification using third generation
correlation of MDCT findings with patients’ dual-source CT at ultra-low dose: a phantom study
M. Vonder1, G. Pelgrim1, S.E.M. Huijsse1, M. Meyer2, M.J.W. Greuter1, M. Oudkerk1,
management and outcome T. Henzler2, R. Vliegenthart1; 1Groningen / NL, 2Mannheim / DE
S. Schmidt, J.-F. Knebel, A. Denys, R. Meuli, M.-O. Treyvaud; Lausanne / CH
14:41
14:56
B-0265 Approaches to ultra-low radiation dose coronary
B-0257 Differentiate intestinal tuberculosis and Crohn’s artery calcium scoring using 3rd generation
disease on CT Enterography: an initial experience dual-source CT: a phantom study
S.R. Agrawal; New Delhi / IN
G. Muscogiuri, C.N. De Cecco, A. McQuiston, F.G. Meinel, J.L. Wichmann,
A. Varga-Szemes, P.M. Cannaò, U.J. Schoepf; Charleston, SC / US
15:04
B-0258 Redefining the mesenteric swirl sign (MSS) in the 14:49
diagnosis of internal herniation (IH) aer Roux-Y B-0266 Impact of iterative reconstruction algorithms
gastric bypass (RYGBP) on calcified plaque quantification with coronary
J. Maier, A. Floyd; Køge / DK
computed tomography angiography
M. Károlyi1, B. Szilveszter1, M. Kolossváry1, R. Raaijmakers2, W. Giepmans2,
15:12 P. Kitslaar3, T. Horváth1, B. Merkely1, P. Maurovich-Horvat1; 1Budapest / HU,
B-0259 Mesenteric panniculitis: review of abdominal MDCT 2
Best / NL, 3Leiden / HU
examinations with a matched-pair analysis
L. Protin-Catteau1, G. Thiefin1, P. Soyer2, M. Belkebir1, S. Deguelte1, C. Hoeffel1; 14:57
1
Reims / FR, 2Paris / FR B-0268 Optimising radiation dose by using advanced iterative
15:20 reconstruction in high-pitch coronary CT angiography
S. Gordic1, D.B. Husarik1, S. Wildermuth2, H. Alkadhi1, S. Leschka2; 1Zurich / CH,
B-0260 Lower stage migration rate of early gastric cancer 2
St.Gallen / CH
with a new reconstruction algorithm of images in dual
energy CT: preliminary study 15:05
C. Shi, H. Zhang, J. Yan; Shanghai / CN B-0269 CT coronary angiography with iterative image
reconstruction and low iodine (270mgI/mL)
concentration: comparison of image quality and
injection pressure with standard (320mgI/mL) iodine
concentration
L. Faggioni, M. Gabelloni, E. Galati, M. Bianchi, P. Marraccini, E. Neri,
C. Bartolozzi; Pisa / IT

www.myESR.org Final Programme | ECR 2015 255


Scientific Sessions

15:13 15:04
B-0270 Dose reduction with iterative reconstruction B-0280 Efficacy of knowledge-based iterative reconstruction
for cardiac computed tomography angiography: on CT abdominal angiography
a systematic review and meta-analysis K.K.P. Lau, A. Kuganesan, K. Buchan, T. Lau; Melbourne / AU
A.M. den Harder1, M.J. Willemink1, Q.M.B. de Ruiter1, P.A. de Jong1,
A.M.R. Schilham1, T. Leiner1, R.P.J. Budde2; 1Utrecht / NL, 2Rotterdam / NL 15:12
B-0281 Nephrogenic systemic fibrosis in patients with chronic
kidney disease undergoing MRI with the injection of
14:00–15:30 Room L 1 gadobenate dimeglumine or gadoteridol:
findings from prospective cohort studies
Vascular G. Soulez1, D.C. Bloomgarden2, N.M. Rofsky3, M. Smith4, H.H. Abujudeh4,
D. Morgan5, M.A. Kirchin6, G. Pirovano7, A. Spinazzi7; 1Montreal, QC / CA,
SS 315 Innovations in vascular imaging 2
Milwaukee, WI / US, 3Dallas, TX / US, 4Boston, MA / US, 5Birmingham, AL / US,
6
Milan / IT, 7Monroe, NJ / US
Moderators: D. Brisbois; Liège/BE, H. Hoppe; Berne/CH

14:00
B-0272 Non-contrast 3D and QISS magnetic resonance 14:00–15:30 Room E1
angiography for pre-operative TAVR evaluation Musculoskeletal
P.M. Cannaò1, A. Varga-Szemes1, G. Muscogiuri1, C.N. De Cecco1, M. Renker1,
S. Mangold1, D. Piccini2, S. Giri3, U.J. Schoepf1; 1Charleston, SC / US,
2
Lausanne / CH, 3Chicago, IL / US SS 310 Fractures, spinal injuries and spine
Moderators: M. Muto; Naples/IT, G. Scheurecker; Linz/AT
14:08
B-0273 Free breathing navigated 3D T1w black-blood MRI at 14:00
3T for the diagnosis of thoracic large vessel vasculitis B-0282 Extremity CT and ultrasound in the assessment of
T. Saam1, S. Maurus1, N.N. Kammer1, H. Kooijman2, M. Treitl1, E. Coppenrath1, ankle injuries - occult fractures
M.F. Reiser1, K.M. Treitl1; 1Munich / DE, 2Hamburg / DE D.J. Wilson, G.M. Allen, S. Bullock; Oxford / UK
14:16 14:08
B-0274 Diagnostic accuracy of contrast-enhanced T1 B-0283 Diagnostic value of DW-SSFP and DW-EPI sequences
free-breathing GE sequences in the assessment in differential diagnosis of vertebral osteoporotic
of aortic disease: comparison with standard T1 fractures from the pathological neoplastic fractures
breath-hold GE 3D angiographic sequences J.H. Shin, J. Lim, J. Park; Seoul / KR
C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, D. Fior, M. Colombo, S. Sironi;
Monza / IT 14:16
14:24 B-0284 Assessing the performances of the trabecular bone
score (TBS) on EOS images for the discrimination of
B-0275 3D black-blood T1-weightet turbo spin-echo
osteoporotic fractures
technique for the diagnosis of deep vein thrombosis: A. Feydy, K. Briot, N.-E. Regnard, A. Etcheto, S. Kolta, C. Roux; Paris / FR
a viable alternative to contrast-enhanced MRI
K.M. Treitl1, M. Treitl1, N.N. Kammer1, E. Coppenrath1, H. Kooijman-Kurfuerst2, 14:24
M.F. Reiser1, T. Saam1; 1Munich / DE, 2Hamburg / DE
B-0285 Trabecular bone microstructure assessed by low-dose
14:32 MDCT and iterative reconstruction predicts vertebral
B-0276 Aortic haemodynamics aer valve-sparing aortic root bone strength
T. Baum, F. Kopp, R.A. Nasirudin, E. Grande Garcia, R. Burgkart, E.J. Rummeny,
replacement with a physiologically shaped sinus J.S. Bauer, P.B. Noël; Munich / DE
prosthesis analysed by 4D Flow MRI
T.H. Oechtering1, J. Haegele1, P. Hunold1, C. Schmidtke2, H.-H. Sievers1, 14:32
J. Barkhausen1, A. Frydrychowicz1; 1Lübeck / DE, 2Bad Segeberg / DE
B-0286 Effect of ROI size and positioning on interobserver
14:40 variability, sensitivity and specificity in the
B-0277 New ECG-gated CTA technique coupled with differentiation of acute benign and malignant
computational flow analysis in ascending thoracic vertebral body fractures with quantitative
aortic aneurysm diffusion-weighted MRI
A. Pasta, C. Parisi, S. Maggio, A. Luca; Palermo / IT T. Geith1, B. Margarita1, M. Notohamiprodjo1, A. Biffar1, G. Schmidt1, H. Duerr1,
S. Sourbron2, M.F. Reiser1, A. Baur-Melnyk1; 1Munich / DE, 2Leeds / UK
14:48
14:40
B-0278 Assessment of wall shear stress in patients without
B-0287 ‘The value of DEXA assessment in patients with
aortic disease, with aortic aneurysms and with
a possible osteoporotic vertebral fracture’ - a
penetrating aortic ulcers using velocity encoding 4D
retrospective analysis
MRI O. Azmat1, N. Lee1, C. Groves2; 1Leeds / UK, 2Bradford / UK
M. Rasper, J. Rudolph, B.M. Gramer, C. Maegerlein, C. Reeps, B. Lutz,
H.-H. Eckstein, E.J. Rummeny, A. Huber; Munich / DE
14:48
14:56 B-0288 DECT evaluation of acute bone marrow contusion in
B-0279 Transcranial doppler ultrasonography in the spine with MRI correlation
D. Na1, S.-J. Hong1, C. Kang1, B. Kim2, K.-S. Ahn1, S. Lee2, Y. Jang1; 1Seoul / KR,
Beta-thalassemia major patients without and with 2
Gyeonggi-do / KR
thrombocytosis
A. Shariat, M. Nazeri, A. Abolhasani Foroughi, M. Karimi; Shiraz / IR

256 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:56 14:48
B-0289 MRI following whiplash injury is improved by routine B-0299 Use of MR tractography and T2* perfusion for
imaging of the cranio-cervical junction in addition to differentiating neoplastic and inflammatory cervical
the cervical spine cord lesions
F.W. Smith1, S. Morgan2; 1Aberdeen / UK, 2Bristol / UK M.S. Abdelgawad1, M.S.R. Reda2, N.A.M. Abdelmonsef2; 1Menofyia / EG,
2
Alexandria / EG
15:04
B-0290 Percutaneous vertebroplasty for single or multiple 14:56
thoracolumbar compression fractures B-0300 Natalizumab related PML:
A.R. Shah, A.M. Highland; Sheffield / UK atypical neuroradiological findings
S. Gerevini1, G. Caliendo1, M. Cava1, R. Capra2, N. De Rossi2, A. Falini1,
15:12 M. Cosottini3; 1Milan / IT, 2Brescia / IT, 3Pisa / IT
B-0291 Moiré fringe technique and bi-planar radiography of 15:04

Wednesday
the spine: accuracy to detect vertebral rotation of B-0301 Cortical gray matter localisation of initially
mild scoliotic patients
A. Hocquelet, F. Cornelis, L. Castaings, F. Petitpierre, C. Fournier, O. Hauger; diffusion-positive lesions is associated with no
Bordeaux / FR MRI-visible 8-week scar in a cohort of transitory
cerebral ischemic attack patients
15:20 I. Havsteen, C. Ovesen, J. Damm Nybing, J. Marstrand, A. Christensen,
B-0292 Clinical correlation of a new and practical magnetic H. Christensen; Copenhagen / DK
resonance grading system for cervical foraminal 15:12
stenosis assessment
H.J. Park, C.H. Han; Seoul / KR B-0302 Stress MRI for the assessment of lumbar canal
stenosis in degenerative disc disease:
comparison with routine MRI
14:00–15:30 Room E2 S. Goel; Delhi / IN

Neuro 15:20
B-0303 Dynamic lumbosacral MRI compared to upright
SS 311a Brain trauma, degenerative and spine myelography: comparison in the detection
diseases of segmental dural compression
S. Leschka1, M. Benndorf1, M. Vicari2, S. Meckel1, M. Schumacher1, M. Weigel3,
Moderators: P. Barsi; Budapest/HU, J. Hodel; Lille/FR C. Taschner1; 1Freiburg / DE, 2Bremen / DE, 3Basle / CH
14:00
B-0293 Cerebral perfusion disturbances in traumatic brain 14:00–15:30 Room F1
injury: direct and indirect effects on memory and
psychoemotional outcome Oncologic Imaging
E. Papadaki, S. Demetriou, E. Kavroulakis, S. Papadopoulou, P. Simos,
A. Karantanas; Iraklion / GR
SS 316 Molecular imaging and new agents
14:08 Moderators: A. Pomoni; Lausanne/CH, A.E. Sundin; Stockholm/SE
B-0294 Development of a common MRI protocol for the 14:00
collaborative European neuro trauma effectiveness B-0304 Diagnostic performance of 68Ga-PSMA-PET/MRI
research in TBI study versus 68Ga-PSMA-PET/CT in the evaluation of lymph
P. Pullens , J. Verheyden , W. van Hecke , A. Maas , P.M. Parizel ; Antwerp / BE,
1 2 2 1 1 1
2
Leuven / BE node metastases of metastatic prostate cancer
M.T. Freitag, J. Radtke, B. Hadaschik, H.-P. Schlemmer, U. Haberkorn,
14:16 M.C. Roethke, A. Afshar-Oromieh; Heidelberg / DE
B-0295 Prognostic value of DWI and DTI in severe traumatic 14:08
brain injury: a prospective cohort of 56 patients B-0305 Diagnostic performance of 68Ga PSMA-ligand PET/CT
H. Derbel, S. Haddar, A. Maalej, A. Chaari, H. Chelly, K. Ben Mahfoudh,
M. Bouaziz; Sfax / TN in prostate cancer patients with biochemical relapse
C. Uprimny, A. Kroiss, C. Decristoforo, L. Geraldo Roig, D. Kendler, D. Putzer,
14:24 W. Horninger, W.R. Jaschke, I.J. Virgolini; Innsbruck / AT
B-0296 Prognostic correlation of MRI findings with levels of 14:16
parasitemia in cerebral malaria B-0306 18F-FLT PET in the assessment of chemotherapy in
A.K. Udiya1, A. Jha1, U. Chauhan2, S. Singhal2; 1Lucknow / IN, 2New Delhi / IN
locally advanced breast cancer: a new approach
14:32 B. Malkowski1, E. Chmielowska1, E. Srutek1, P. Szlezak1, T. Gorycki2,
K. Gwozdziewicz2, M. Czarnowska-Cubala2, A. Szymanska-Dubowik2,
B-0297 “Power button sign”: a new typical MR imaging M. Studniarek3; 1Bydgoszcz / PL, 2Gdansk / PL, 3Warsaw / PL
pattern of focal cortical dysplasia in the central region
C. Melleiro, P. Roca, F. Chassoux, J. Meder, C. Oppenheim; Paris / FR 14:24
B-0307 Diagnostic accuracy of 11C-Choline PET/CT in
14:40
hepatocellular carcinoma (HCC)
B-0298 Apparent diffusion coefficient map can help E. Lopci, D. Poretti, A. Palmisano, E. Lanza, L. Rimassa, G. Torzilli, A. Chiti;
the voxel-based morphometric diagnosis Rozzano / IT
of Alzheimer’s disease
H. Takahashi1, K. Ishii2, Y. Watanabe1, H. Tanaka1, T. Murakami2, N. Tomiyama1;
1
Suita / JP, 2Osaka-Sayama / JP

www.myESR.org Final Programme | ECR 2015 257


Scientific Sessions

14:32 14:24
B-0308 Diagnostic value of quantitative perfusion map, with B-0318 Proton-density fat fraction in an ultra-high-field MR
CT-perfusion technique in monitoring of tumour scanner: a feasibility study
response to sorafenib treatment in patients with J.-P. Kühn, B. Mensel, K. Kindermann, S. Hadlich, S. Otto, N. Hosten;
Greifswald / DE
advanced HCC lesions: preliminary results
D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, S. Sironi; Monza / IT 14:32
14:40 B-0319 Simultaneous reconstruction of attenuation and
B-0309 Diagnostic value of first-pass CT-perfusion study in activity distributions in PET/MRI from PET emission
the quantitative vascular assessment of primary and data using MR prior information
T. Heußer1, C. Rank1, T. Beyer2, M. Kachelrieß1; 1Heidelberg / DE, 2Vienna / AT
metastatic liver lesion: preliminary results
O. Minutolo, D. Ippolito, C. Talei Franzesi, M. Mumoli, P.A. Bonaffini, S. Sironi; 14:40
Monza / IT
B-0320 Quality control for quantitative multi-center
14:48 whole-body PET/MRI studies
B-0310 Feasibility of 10-min delayed hepatocyte phase R. Boellaard1, I. Rausch2, T. Beyer2, G. Delso3, S. Ziegler4, M. Yaqub1, H.H. Quick5,
B. Sattler6; 1Amsterdam / NL, 2Vienna / AT, 3Zurich / CH, 4Erlangen / DE,
imaging with 30° flip angle in Gd-EOB-DTPA-enhanced 5
Duisburg-Essen / DE, 6Leipzig / DE
MR imaging for the detection of liver metastases,
compared with 20-min delayed imaging with 14:48
10° flip angle B-0321 Do we need MRI quality assurance: experience from
D. Lee, E.-S. Cho, I. Jeon; Seoul / KR a multi-unit imaging center with 14 MRI systems
L.J. Kuusela, M. Timonen, T. Mäkelä, J. Peltonen, T. Ihalainen, J. Uusi-Simola,
14:56 T. Kaasalainen, S. Savolainen, O. Sipilä; Helsinki / FI
B-0311 Reproducibility of dynamic contrast-enhanced MRI
14:56
in oncology: 2D vs 3D approach
S. Hibat Allah, M. Wagner, S. Raslan, O. Lucidarme; Paris / FR B-0322 Does MRI influence blood coagulation?
P. Seyfer, V. Klingmüller, M. Voelker, A.H. Mahnken, T. Stief; Marburg / DE
15:04
15:04
B-0312 HANP/PTX treatment
L. Zhu, L. Zhang, J. Wang; Xiamen / CN B-0323 Parallel-transmit-accelerated spatially-selective
excitation MRI for reduced-FOV diffusion-weighted
15:12 imaging of the pancreas
B-0313 Theranostic application of a cyanine-based linker K.M. Thierfelder1, W.H. Sommer1, O. Dietrich1, F.G. Meinel1, P.M. Paprottka1,
M.F. Reiser1, K. Nikolaou2; 1Munich / DE, 2Tübingen / DE
functionalised with temozolomide using solid phase
chemistry 15:12
D. Komljenovic, M. Wiessler, R. Pipkorn, W. Waldeck, K. Braun; Heidelberg / DE
B-0324 Method to determine dynamic in vivo material
15:20 properties of the achilles tendon using ultrafast MRI
B-0314 CT perfusion imaging in the evaluation of response to sequence
T.J. Vogl, M. Kardeh, G. Silber; Frankfurt a. Main / DE
treatment of radiofrequency thermal ablation (RFA),
in patients with lung cancer 15:20
A. Infante, A. Contegiacomo, A. del Ciello, A.R. Larici, R. Iezzi, L. Bonomo;
Rome / IT B-0325 Texture analysis of R2 map in the assessment of renal
function: is this a promising tool?
L. Pelliccia, S. Carbone, L. Mazzoni, L. Volterrani; Siena / IT
14:00–15:30 Room F2

Physics in Radiology 14:00–15:30 Room D1

SS 313 Advances in MR technology Chest


Moderators: E. Atalar; Ankara/TR, J. Theysohn; Essen/DE
SS 304 Interventional procedures
14:00 and follow-up
B-0315 Fast field-cycling magnetic resonance imaging: Moderators: I. Vollmer; Barcelona/ES, J.E. Wildberger; Maastricht/NL
a new imaging modality
D.J. Lurie, L.M. Broche, G.R. Davies, N.R. Payne, K.J. Pine, J. Ross, V. Zampetoulas; 14:00
Aberdeen / UK B-0326 Computed tomography characteristics predictive
14:08 for radial EBUS-miniprobe guided diagnosis
of pulmonary lesions
B-0316 Magnetic resonance spectroscopy, dual-phase and W. De Wever, C. Guvenc, J. Yserbyt, D. Testelmans, F. Zanca, C. Dooms;
multi-echo gradient-echo MRI in the quantitative Leuven / BE
assessment of liver steatosis
G. Besutti, L. Nocetti, G. Ligabue, C. Stentarelli, S. Zona, R. Scaglioni, G. Guaraldi, 14:08
P. Torricelli; Modena / IT B-0328 CT-guided FNAB and biopsy of pulmonary nodules:
14:16 predictive factors for diagnosis and pneumothorax
occurrence
B-0317 Hepatic lipid measurement: dual ratio Dixon technique F. Rosella, M. Chiappetta, L.M. Pomes, V. dall’Armi, P. Granone, T. Pirronti,
vs MR spectroscopy at 3T scanner L. Bonomo; Rome / IT
1 1 1 2 3
M. Abd Ellah , B. Henninger , C. Kremser , S. Kannengießer , X. Zhong ,
W.R. Jaschke1; 1Innsbruck / AT, 2Erlangen / DE, 3Malvern, PA / US

258 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:16 14:16
B-0329 Complications of transthoracic CT-guided lung B-0339 Vertebral augmentation in extreme vertebral
biopsies: a systematic review and meta-analysis fractures: comparison between standard and
W.J. Heerink, G. de Jonge, R. Vliegenthart, M. Oudkerk; Groningen / NL augmented vertebroplasty
M. Tsitskari, D.K. Filippiadis, G. Velonakis, L. Reppas, E. Brountzos, N. Kelekis,
14:24 A.D. Kelekis; Athens / GR
B-0330 In CT-guided transthoracic lung biopsy the
contribution of FDG PET/CT in biopsy planning and 14:24
diagnostic accuracy B-0340 Cone-beam computed tomography guided unipedicular
Y. Dadali1, O. Ozmen2, U. Calıkoglu2, &. Bursali2, F. Demirag2; 1Kirsehir / TR, central stentoplasty of the thoracolumbar spine:
2
Ankara / TR early experience and results
K. Huang, U. Pua; Singapore / SG
14:32
B-0331 Radiofrequency ablation of malignant pleural 14:32

Wednesday
mesothelioma plaque B-0341 The use of cone-beam CT in achieving unipedicular
G.G. Taverna, F. Brucculeri, E. Oppezzo, G. Gola, C.M.S.O. Tappero, S. Barbero; spinal cement augmentation
Casale Monferrato / IT T.C. Hui, G. Tan, U. Pua; Singapore / SG
14:40 14:40
B-0332 The diagnostic value of chest MRI in the follow up B-0342 Percutaneous vertebroplasty in malignant spinal
of lung cancer patients treated with radio frequency fractures with posterior vertebral column and/or
ablation epidural involvement. Feasibility and results:
E. Skondras1, A. Fusco2, J. Beeson1, P. Dalal1; 1London / UK, 2Rome / IT
a review of 63 cases
14:48 A. Pellegrin1, G. Gallo1, A. Caudal1, P. Foti1, O. Hauger2, N. Amoretti1; 1Nice / FR,
2
Bordeaux / FR
B-0333 Percutaneous treatment of parapneumonic effusions
and complex empyemas with drainage and fibrinolytic 14:48
therapy B-0343 Preliminary study for analysis of modification of disk
S. Roy-Choudhury, G. Gupta, S. Roy Choudhury, R. Dhar; Kolkata / IN volume and disk fragment in patients with lumbar
14:56 contained disk herniation treated with CT-guided
B-0334 CT assessment of fissure completeness in target lobe ozone-oxygen injection
M. Federici, A. Maira, M. Marconi, I. Iacucci, P. Mancini, M. Polito, C. Simonetti,
selection for endobronchial volume reduction therapy G.R. Ferreri, A. Bellelli; Rome / IT
in COPD
J.B. Seo, S. Shin, S. Lee, S. Lee, S. Oh, N. Kim, Y.-M. Oh; Seoul / KR 14:56
B-0344 Combined microwave ablation and cementoplasty in
15:04 patients with painful bone metastases at high risk of
B-0335 Anatomical and functional lung changes aer fracture
endobronchial lung volume reduction therapy: C. Pusceddu, R. Fele, B. Sotgia, N. Ballicu, L. Melis; Cagliari / IT
evaluation with combined xenon ventilation and
iodine contrast perfusion dual energy CT 15:04
J.B. Seo, S. Shin, S. Lee, S. Oh, N. Kim, S. Lee, Y.-M. Oh; Seoul / KR B-0345 Role of CT guided spinal injections in management
of chronic low back pain
15:12 S.A.Z. Khodair, E. Mashaly, H. Sameer; Qwuesna / EG
B-0336 Metal artifact reduction on chest CT examinations:
comparison of the IMAR (iterative metallic artefact 15:12
reduction) algorithm and monoenergetic approach B-0346 Safety of cervical transforaminal steroid injections
J. Pagniez, L. Legrand, J.-B. Faivre, S. Khung, J. Remy, M. Remy-Jardin; Lille / FR under CT guidance:
a five-year experience in 248 cases
D. Krause, P. Pottecher, P.-Y. Genson, L. Estivalet, S. Favelier, R. Loffroy;
14:00–15:30 Room D2 Dijon / FR

Interventional Radiology 15:20


B-0347 CT-guided (with wide-volume acquisition) cryoablation
SS 309 Musculoskeletal interventions in the management of bone and so tissues lesions
Moderators: J.L. del Cura Rodriguez; Bilbao/ES, T. Lehnert; Frankfurt a. with multiple cryoprobes: the advantage of a 3D and
Main/DE real time planning of treatment
F. Arrigoni, A. La Marra, S. Mariani, L.M. Gregori, F. Smaldone, L. Zugaro,
14:00 A. Barile, C. Masciocchi; L’Aquila / IT
B-0337 MR-guided high intensity focused ultrasound for
non-invasive treatment of osteoid osteoma
G. Cartocci, A. Napoli, G. Brachetti, F. Zaccagna, B. Cavallo Marincola, V. De
Soccio, C. Catalano; Rome / IT

14:08
B-0338 MR guided focused ultrasound surgery (MRgFUS)
vs radiofrequency thermoablation (RFA) in the
imaging-guided treatment of osteoid osteoma:
clinical and imaging results
F. Arrigoni, S. Mariani, A. La Marra, L.M. Gregori, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila / IT

www.myESR.org Final Programme | ECR 2015 259


Scientific Sessions

14:00–15:30 Room G 15:21


B-0357 Pain levels in MR-guided in-bore and MRI/ultrasound
Genitourinary fusion-guided prostate biopsies
F. Dietzel, M. Quentin, L. Schimmöller, D. Blondin, C. Arsov, A. Hiester,
SS 307 Prostate MR imaging R. Rabenalt, P. Albers, G. Antoch; Düsseldorf / DE
Moderators: D. Junker; Innsbruck/AT, J. Rørvik; Bergen/NO

14:00 14:00–15:30 Room K


K-06 Keynote lecture
H.-P. Schlemmer; Heidelberg / DE Radiographers
14:09 SS 314 Quality issues
B-0348 Prostate cancer: assessing the effects of Moderators: J. McNulty; Dublin/IE, J. Wieczorek; Warsaw/PL
androgen-deprivation therapy using quantitative
multi-parametric MRI 14:00
A.M. Hötker, Y. Mazaheri, J. Zheng, C.S. Moskowitz, M.J. Zelefsky, H. Hricak, K-07 Keynote lecture
O. Akin; New York, NY / US J. McNulty; Dublin / IE
14:17 14:09
B-0349 Multiparametric MRI (mpMRI) significantly predicts B-0358 Evaluating the use of oral contrast media for
anterior prostate carcinoma (APC) in patients with abdominopelvic CT for general oncological indications
prior negative biopsy E. Buttigieg, K. Borg Grima, F. Zarb; Msida / MT
A.B. Malik, M. Musch, K.U. Waltering, J.L. Hohenhorst, D. Kröpfl, J.A. Koch;
Essen / DE 14:17
B-0359 Compression in high volume mammography screening:
14:25
comparing applied force measurements with image
B-0350 Agreement between the Roach III equations (RE)
evaluations scores
and multiparametric 3.0T MRI in assessing I.H.R. Hauge, R. Hammond, M. Hauge; Oslo / NO
the T stage of prostate cancer before external
beam radiotherapy (EBR) 14:25
M. Pancot, R. Girometti, M. Signor, C. Zuiani, S. Fongione, B. Massimo; Udine / IT B-0360 Iodinated porphyrins in contrast media agents:
a new approach, first indicators
14:33 R.M.S.C. Pereira1, M.P.M.S. Neves1, P.V. Coelho2, R.M.P. Fernandes2,
B-0351 MR-guided in-bore biopsy: the gold standard of M.F. Faustino1; 1Aveiro / PT, 2Oporto / PT
targeted prostate biopsy procedures?
M. Quentin, L. Schimmöller, D. Blondin, F. Dietzel, T. Ullrich, C. Arsov, 14:33
R. Rabenalt, P. Albers, G. Antoch; Düsseldorf / DE B-0361 Optimisation of image quality of the Codman Hakim
programmable valve, by different phantom positions
14:41 V. Harsaker, M. Berger, A. Holberg, B. Ween; Oslo / NO
B-0352 Diagnostic performance of the ESUR PIRADS scoring
system for multiparametric MRI of the prostate: 14:41
systematic comparison of four parameters vs three B-0362 Frequency and dose levels of paediatric image guide
parameters for detection and grading of prostate fluoroscopy procedures in Portugal
D. Almeida1, N. Carvalho1, B. Esteves1, C. Almeida2, G. Paulo1, J. Santos1;
cancer 1
Coimbra / PT, 2Lisbon / PT
S. Polanec, K. Pinker-Domenig, T.H. Helbich, P. Brader, M. Susani, D. Georg,
P.A.T. Baltzer; Vienna / AT
14:49
14:49 B-0363 Post-mortem evaluation of drowning with whole body
B-0353 Prostate-MRI: experience of the observer and computed tomography
S. Vander Plaetsen, K. Verstraete; Ghent / BE
technical conditions influence the prostate cancer
(PCa) detection rate 14:57
S. Rödel1, S. Blaut1, E. Dürig1, M. Burke2, R. Paulick3, G. Haroske1, F. Steinbach1,
T. Kittner1; 1Dresden / DE, 2Solingen / DE, 3Heidenau / DE B-0364 Facial traits reconstruction with MDCT
C. Dionisi1, E. Fontebasso1, E. Stefani2, S. Barbera3, F. Cavalli4; 1Treviso / IT,
14:57
2
Conegliano / IT, 3Biella / IT, 4Trieste / IT
B-0354 PIRADS analysis of prostate cancer at multiparametric 15:05
MR Imaging: correlation with pathological results B-0365 Lidocaine utilisation in mammography exams
F. Castelli, V. Di Paola, R. Manfredi, R. Pozzi Mucelli; Verona / IT A. Santos1, T. Figueiredo1, L.P. Ribeiro1, A.F.C.L. Abrantes1, S. Rodrigues1,
J.P. Pinheiro1, R.P.P. Almeida1, C.M.L. Abrantes2, O. Lesyuk1; 1Faro / PT,
15:05 2
Pilsen / CZ
B-0355 Transrectal ultrasonography of prostate gland using
elastography in differential diagnostics of hypoechoic 15:13
foci in patients with borderline PSA values B-0366 Comparison between the image quality and the
I. Aboian, E. Usenko, M. Rodzyanko; Rostov-on-Don / RU radiation dose in CT scanning for the detection of
pharyngo-esophageal foreign bodies
15:13 I. Simonetto1, S. Barbera2, G. Addonisio3, C. Dionisi3; 1Spresiano / IT, 2Biella / IT,
B-0356 Mechanical imaging of the prostate by multifrequency
3
Treviso / IT
MR-elastography 15:21
M. Haas, J. Braun, J. Guo, S. Ipek-Ugay, I. Sack, B. Hamm, P. Asbach; Berlin / DE
B-0367 Premature and neonatal chest images’ quality
variations
B. Ween, M. Skoglund, P. Parameswaran, H. Eieland; Oslo / NO

260 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:00–15:30 Room MB 1 14:00–15:30 Room MB 2

Head and Neck Paediatric


SS 308 Temporal bone and temporomandibular SS 312 Bone and so tissue imaging
joint imaging and new MRI techniques Moderators: O.J. Arthurs; London/UK, A. Kanavaki; Athens/GR
Moderators: J. Frühwald-Pallamar; Vienna/AT, S. Petrovic; Nis/RS
14:00
14:00 B-0379 Correlation of fetal MRI with postmortem imaging and
B-0368 Role of CBCT in visualisation of ear anatomy histology in cases of thanatophoric dysplasia
C. Gueldner, R. Weiß, S. Draeger, I. Diogo; Marburg / DE C. Mitter, G.M. Gruber, U. Nemec, P.C. Brugger, G. Kasprian, D. Prayer; Vienna / AT

14:08 14:08
B-0380 Dynamic contrast-enhanced MR imaging for the

Wednesday
B-0369 Recurrent vertigo: is MRI useful for diagnosis of
endolymphatic hydrops in clinical practice? evaluation of so tissue tumours of trunk and limbs in
A. Attye, G. Dumas, I. Tropres, M. Roustit, A. Karkas, E. Banciu, J. Pietras, the children
S. Schmerber, A. Krainik; Grenoble / FR A. Barbashova; Moscow / RU
14:16 14:16
B-0370 CT pre-operative planning of Bonebridge™: B-0381 Simultaneous whole-body PET/MR Imaging in
a new semi-implantable bone conduction paediatric sarcomas and malignant so tissue
hearing device tumours: preliminary results
E.K.C. Law, W.S.S. Tsang, M.C.F. Tong, S. Lin, K.S.S. Bhatia; Shatin / HK J.F. Schäfer, S. Gatidis, I. Tsiflikas, G. Seitz, M. Ebinger, M. Reimold, C. La
Fougère, N. Schwenzer, K. Nikolaou; Tübingen / DE
14:24
B-0371 Auditory brainstem implant: computed tomography 14:32
assessment of electrods dislocation B-0383 When to make a postmortem babygram and when not
F. Spagnolli, N. Cardobi, R. Cerini, M. Barillari, V. Colletti, R. Pozzi Mucelli; K. Kamphuis-van Ulzen, D.H.J.L. Koopmanschap, W.M. Klein; Nijmegen / NL
Verona / IT
14:40
14:32 B-0384 Fetal short femurs: interest of three-dimensional
B-0372 Value of MRI in patients with temporomandibular joint computed tomography in prenatal management
dysfunction: correlation of MRI and clinical findings M. Blouet, F. Belloy, G. Benoist, J.-P. Pelage; Caen / FR
T.J. Vogl1, H.C. Lauer1, T. Lehnert1, N.N.N. Naguib1, H. Soekamto1, N. Fillmann1,
P. Ottl2; 1Frankfurt a. Main / DE, 2Rostock / DE 14:48
B-0385 Dynamic contrast-enhanced MRI of the wrist
14:40
in patients with juvenile idiopathic arthritis:
B-0373 Comparison of a 32-channel head coil and a 2-channel a feasibility study
surface coil for MR imaging of the temporomandibular C.M. Nusman, C. Lavini, R. Hemke, M.W.A. Caan, D. Schonenberg, K.M. Dolman,
joint at 3.0 Tesla J.M. van den Berg, T.W. Kuijpers, M. Maas; Amsterdam / NL
1 1 1 1 1 2 1
A. Manoliu , G. Spinner , M. Wyss , S. Erni , D. Ettlin , D. Nanz , E.J. Ulbrich ,
L.M. Gallo1, G. Andreisek1; 1Zurich / CH 14:56
B-0386 Single radiograph of the pelvis for non traumatic hip
14:48
pathology: what do we miss?
B-0374 MR imaging of the temporomandibular joint at 7.0 S. McGurk, E. Lindell, D. Broomfield; Edinburgh / UK
Tesla: a feasibility study using novel high-permittivity
dielectric pads 15:04
A. Manoliu, G. Spinner, M. Wyss, S. Erni, D. Ettlin, D. Nanz, E.J. Ulbrich, L.M. Gallo, B-0387 Tibial bowing in children:
G. Andreisek; Zurich / CH
what is normal? A radiographic study
I. Zbinden1, E. Rutz1, J.A. Jacobson2, O. Magerkurth1; 1Basle / CH, 2Ann Arbor,
14:56 MI / US
B-0376 Automatic segmentation of head and neck deep
spaces using morphing techniques 15:12
S. Boussouar1, O. Bouhelal1, B. Gilles2, F. Faure2, C. Vaniet1, P. Halimi1, B-0388 Hand bone age determination: quantitative
C.-A. Cuenod1; 1Paris / FR, 2Montpellier / FR
radiographical evaluation method for in 0-59
15:04 months aged children
V. Taravari, I. Özyavuz, E. Yilmaz, O.B. Erol, F. Ertem, R. Sarifov, M. Bulakçi,
B-0377 Volumetric quantification of cervical adiposity: B. Bulakçi, E. Yekeler; Istanbul / TR
a novel anthropometric tool
H.S. Maresky, Z. Sharfman, P. Gottlieb, S. Tal; Zeriffin / IL 15:20
B-0389 Ultrasound evaluation of thyroid gland pathologies
15:12
aer radio- and/or chemotherapy during childhood
B-0378 Does MRI help to distinguish between odontogenic A. Lollert, C. Gies, K. Laudemann, J. Faber, D. Jacob-Heutmann, C. Düber,
cysts and keratocystic odontogenic tumours? G. Staatz; Mainz / DE
U.G. Mueller-Lisse, F.A. Probst, M. Probst, E. Kaltsi, S. Otto, S. Schiel,
M. Troeltzsch, M. Ehrenfeld, P.C. Cornelius; Munich / DE

www.myESR.org Final Programme | ECR 2015 261


Scientific Sessions

14:00–15:30 Room MB 3 15:12


B-0399 Magnetic resonance imaging-based diagnosis of
Cardiac pulmonary hypertension: 4D flow versus standard
SS 303b Cardiac function and flow functional indices
G. Reiter, U. Reiter, G. Kovacs, C. Janig, H. Olschewski, M.H. Fuchsjäger; Graz / AT
Moderators: P. Croisille; Saint-Etienne/FR, P. Donato; Coimbra/PT
15:20
14:00 B-0400 Cardiovascular magnetic resonance myocardial
B-0390 Accuracy of cardiac MRI single - and non-breath-hold feature tracking assessment of myocardial mechanics:
compressed sensing data for right ventricular inter-vendor agreement and considerations on
volumetry reproducibility
H. Haubenreisser, S. Sudarski, S.O. Schönberg, T. Henzler, T. Papavassiliu; V. Stahnke1, C. Unterberg-Buchwald1, J. Kowallick1, P. Lamata2, S. Kutty3,
Mannheim / DE G. Hasenfuß1, P. Beerbaum4, J. Lotz1, A. Schuster1; 1Göttingen / DE, 2London / UK,
3
Omaha, NE / US, 4Hannover / DE
14:08
B-0391 Influence of late-Gadolinium enhancement on
accuracy of quantitative le ventricular assessment 14:00–15:30 Room MB 4
in cardiac MRI single breath-hold undersampled input
data Emergency Radiology
S. Sudarski, H. Haubenreisser, C. Dösch, S. Haneder, T. Henzler, S.O. Schönberg,
T. Pappavassiliu; Mannheim / DE SS 317 Update on imaging approach
14:16 in trauma patients
Moderators: J.B. Dormagen; Oslo/NO, L.M. Lenghel; Cluj-Napoca/RO
B-0392 Feasibility of real-time magnetic resonance imaging
in assessment of ventricular volumes and function in 14:00
paediatric patients with congenital heart disease B-0401 One-shot volume wrist CT aer trauma:
T. Zitzelsberger, A. Hornung, P. Krumm, B. Klumpp, J.F. Schäfer, L. Sieverding,
U. Kramer, K. Nikolaou, F. Bamberg; Tübingen / DE fracture detection and therapeutic consequences
in a prospective cohort study
14:24 A.C.L.F. Steenbakkers, M. Holla, J. de Rooy, J. Hermans, M.J.M. Ploegmakers,
M. Edwards, M. Prokop, M. Brink; Nijmegen / NL
B-0393 Regional myocardial contractility in thalassemia major
by magnetic resonance tagging 14:08
C. Tudisca1, A. Meloni2, E. Grassedonio1, G. Valeri3, M. Missere4, C. Cirotto5,
S. Renne6, M. Midiri1, A. Pepe2; 1Palermo / IT, 2Pisa / IT, 3Ancona / IT, B-0402 Improvement of evaluation time in detection
4
Campobasso / IT, 5Sassari / IT, 6Lamezia Terme / IT of acute rib fractures by generating rotatable
“unfolded rib” images
14:32 G. Homann, C. Kloth, M.N. Bongers, C. Schabel, K. Nikolaou, M. Notohamiprodjo;
B-0394 Time dependent analysis of le ventricular shear Tübingen / DE
wave amplitudes in diastolic dysfunction measured by
14:16
MR elastography
T. Elgeti, I.G. Steffen, B. Hamm, J. Braun, I. Sack; Berlin / DE B-0403 Traumatic thoracolumbar fractures: assessment
by MDCT using Denis’ classification and TLICS scale
14:40 L.E. Dinu, A. Vela, M. Marin, E. Garces, A. Garcia, J. Artigas; Zaragoza / ES
B-0395 CMR evaluation of diastolic function impairment
14:24
in Cushing’s syndrome and its normalisation with
treatment B-0404 Validation of the NEXUS-criteria for CT
R.S. Smit, J.B. Egbers, A.F. Hoogerwaard, J.J. van Netten, D. van der Velde,
C. Roux, N. Kachenoura, P. Kamenicky, E. Bollache, E. Mousseaux, P. Chanson, M. Kraai, J.W. op den Akker; Almelo / NL
A. Redheuil; Paris / FR

14:48 14:32
B-0396 Quality improvement using educational intervention: B-0405 Whole body computed tomography for trauma
improving accuracy of cardiac CT function reporting in patients in the Nordic countries 2014. Survey shows
triple-rule-out patients with acute chest pain significant differences and a need for guidelines
H. Eklöf1, E. Wiklund1, F. Linder1, S. Koskinen2; 1Uppsala / SE, 2Stockholm / SE
P. Suranyi, L. Hewett; Charleston, SC / US

14:56 14:40
B-0397 Evaluation of aortic strain with MR imaging in B-0406 Patients subject to high energy trauma without signs
different pathologic conditions: a retrospective study of injury do not benefit from whole-body CT imaging
F. Linder, H. Eklöf; Uppsala / SE
F. Secchi, M. Scarabello, F. Damiani, M. Petrini, G. Di Leo, F. Sardanelli; Milan / IT

15:04 14:48
B-0398 Intra- and interobserver agreement of noninvasive B-0407 Watch and wait or irradiate
M. Kakollu, N. Jones, L.-G. Baca, S. Pillai, S. Kumar; Cardiff / UK
pressure difference measurements derived from 4D
flow MRI in patients with repaired aortic coarctation 14:56
and healthy volunteers B-0408 Scanning and war: utility of FAST and CT in the
F. Rengier1, M. Delles2, J. Eichhorn1, Y.-J. Azad2, H. von Tengg-Kobligk3, assessment of battlefield abdominal trauma
R. Unterhinninghofen2, H.-U. Kauczor1, R. Dillmann2, S. Ley1; 1Heidelberg / DE, I.M. Smith, D.N. Naumann, M.E.R. Marsden, M. Ballard, D.M. Bowley;
2
Karlsruhe / DE, 3Berne / CH Birmingham / UK

262 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

15:04 14:56
B-0409 CT in trauma patients: automatic dose monitoring for B-0420 To compare post contrast 3D T2 FLAIR, T1-SPACE and
demonstrating the effect of iterative reconstructions MP-RAGE sequences to select the ideal sequence for
K. Higashigaito, A. Becker, K. Sprengel, G. Wanner, H. Alkadhi; Zurich / CH leptomeningeal abnormalities at 3 T MRI
B. Jeevanandham; Coimbatore / IN
15:12
B-0410 Is whole-body CT accurate in management of 15:04
brain-dead patients before organ harvesting? B-0421 Impact of image denoising on image quality,
C. Ridereau-Zins, E. Berthier, L. Dube, C. Nedelcu, C. Aube; Angers / FR quantitative parameters, and sensitivity of
15:20 ultra-low-dose volume perfusion CT imaging
A. Othman1, C. Brockmann1, Z. Yang2, M.A. Brockmann1, M. Wiesmann1, J. Kim2;
B-0411 Comparisons of liver CT perfusion of blunt liver 1
Aachen / DE, 2Seoul / KR
injuries between patients treated with intervention
15:12

Wednesday
and conservative management
Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan, Taiwan / TW B-0422 Quantitative comparison of Gadoterate and Gadobutrol
for the MR-angiographic (MRA) evaluation of
neurovascular disease
14:00–15:30 Room MB 5 M. Dietzel1, P. Hölter1, S. Lang1, T. Struffert1, M. Essig2, A. Dörfler1;
1
Erlangen / DE, 2Winnipeg, MB / CA
Neuro
SS 311b Hypertension and stenosis
Moderators: T.A.. Yousry; London/UK, D. Gürbüz; Istanbul/TR

14:00
B-0412 Endovascular treatment in idiopathic intracranial
hypertension, clinical result and long-term follow-up
M. Aguilar Pérez1, W. Kurre1, D. Horvath-Rizea1, R. Unsöld2, H. Bäzner1,
H. Henkes1; 1Stuttgart / DE, 2Düsseldorf / DE

14:08
B-0413 Leptomeningeal collateral vessels are a major risk
factor for intracranial hemorrhage aer carotid
stenting in patients with carotid atherosclerotic
plaque
K. Lee, H. Kwak, G. Chung, J. Song; Jeonju / KR

14:16
B-0415 Phase contrast and arterial spin labelling magnetic
resonance imaging shows improved cerebral blood
flow aer cardioversion of atrial fibrillation
M. Gardarsdottir1, S. Sigurdsson2, T. Aspelund2, V.A. Gardarsdottir1,
V. Gudnason2, D.O. Arnar1; 1Reykjavik / IS, 2Kopavogur / IS

14:24
B-0416 Contribution of susceptibility weighted imaging in
differentiating acute from chronic internal carotid
occlusion
I. Yoon1, Y. Kim1, Y. Kim1, Y. Won1, H. Song2; 1Uijeongbu / KR, 2Jeju / KR

14:32
B-0417 Intracranial arterial calcifications as a prognostic
factor for the subsequent occurrence of mixed
adverse cardiovascular events (MACE)
F.F. Strobl, B. Kuhlin, F. Bamberg, M.F. Reiser, T. Saam; Munich / DE

14:40
B-0418 Normal ranges and test-retest repeatability of velocity
parameters in intracranial arteries measured with
phase contrast magnetic resonance imaging (PC-MRI)
M. Correia de Verdier, J. Wikström; Uppsala / SE

14:48
B-0419 Endovascular reconstruction of extra- and intracranial
vessels aer subacute or chronic occlusion:
indications, techniques, merits and failures
M. Aguilar Pérez, W. Kurre, E. Henkes, A. Lindner, O. Ganslandt, H. Bäzner,
H. Henkes; Stuttgart / DE

www.myESR.org Final Programme | ECR 2015 263


Scientific Sessions

10:30–12:00 Room B 11:42


B-0432 Gd-EOB-DTPA-enhanced MRI: diagnostic application
Abdominal Viscera of the evaluation of the enhancement kinetic curve
SS 601a Focal liver lesions obtained with MRI of liver tumours
B. Medvedeva, A. Lukyanchenko; Moscow / RU
Moderators: M. Krokidis; Cambridge/UK, B. Marincek; Cleveland, OH/US

10:30 10:30–12:00 Room C


B-0423 Differentiation of intrahepatic mass-forming
cholangiocarcinoma from hepatocellular carcinoma on Breast
Gadoxetic acid-enhanced liver MR
R. Kim1, J. Lee1, C.-I. Shin1, E. Lee2, I. Joo1, I. Hwang1, S. Kim1, J. Han1, B. Choi1;
1
Seoul / KR, 2Goyang-si / KR
SS 602 Imaging techniques and interventions
Moderators: F. Engelken; Berlin/DE, F. Pediconi; Rome/IT
10:38
10:30
B-0424 Discrimination of Hepatic Alveolar Echinococcosis
B-0434 The value of BIRADS classification in paediatric
from Intrahepatic Cholangiocarcinoma using CT and
population and radiologic management of lesions
MR Imaging Ö.S. Okcu1, F. Can2, I. Bilgen1, A. Oktay1; 1Izmir / TR, 2Kutahya / TR
J. Mueller, M. Stojkovic, K.D. Rosenberger, A.K. Berger, C.L. Schlett,
T. Junghanss, H.-U. Kauczor, T.F. Weber; Heidelberg / DE 10:38
10:46 B-0435 Review of invasive cancers not initially identified
B-0425 MRI features of inflammatory hepatocellular by automated whole-breast ultrasound screening:
adenomas on hepatocyte phase imaging with an analysis of the rate of tumour growth
K.M. Kelly; Pasadena, CA / US
liver-specific contrast agents
M.G. Thomeer, F. Willemssen, K. Biermann, R. de Man, J. IJzermans, 10:46
R.S. Dwarkasing; Rotterdam / NL
B-0436 Detection of malignant and benign breast lesions
10:54 in contrast-enhanced spectral mammography (CESM)
B-0426 Gd-EOB-enhanced MRI: findings of hepatocellular compared to ultrasound (US): initial results
adenomas and subgroup differentiation C.M. Perez-Fernandez, F. Schmitzberger, H. Amer, T. Denecke, E.M. Fallenberg;
C. Grieser, I.G. Steffen, D. Seehofer, I.-B. Kilic, E. Schott, A. Huppertz, B. Hamm, Berlin / DE
T. Denecke; Berlin / DE
10:54
11:02 B-0437 Contrast-enhanced spectral mammography
B-0427 Frequency, CT findings, and fate of multiple infarcted in treatment monitoring: an initial comparison
regenerative nodules in liver cirrhosis aer variceal to breast MRI
bleeding or septic shock S. Ravaioli1, R. Sghedoni1, A. Nitrosi1, V. Iotti1, C. Coriani1, R. Vacondio1, C. Mori1,
S. Lee; Seoul / KR V. Ginocchi2, P. Pattacini1; 1Reggio Emilia / IT, 2Guastalla / IT

11:10 11:02
B-0428 Impact of observer experience on diagnostic B-0438 Background parenchymal enhancement (BPE) in
performance in reporting CT and MRI examinations contrast-enhanced spectral mammography (CESM):
of histopathologically proven non-colorectal liver classification and evaluation of impact on diagnostic
metastases performance
M.H. Albrecht, L. Umutyan, M. Hart, C. Polkowski, J.L. Wichmann, T. Lehnert, M. Sklair-Levy, A. Shalmon, Y. Servadio, A. Rundstein, O. Halshtok, M. Gotlieb,
R.W. Bauer, H. Ackermann, T.J. Vogl; Frankfurt a. Main / DE Y. Yagil; Ramat Gan / IL

11:18 11:10
B-0429 Application of dual-energy CT in hypervascular B-0439 Comparison of the accuracy of US-guided biopsy of
neoplstic lesions of liver: subjective and objective breast masses performed with 18-gauge, 16-gauge
analysis in 64 lesions and 14-gauge automated cutting needle biopsy
M.D. Mahajan1, R. Kakkar2, S. Soneji3, S.B. Desai2; 1Bangalore / IN, 2Mumbai / IN, devices
3
Montreal, QC / CA M.L. Huang, K. Hess, R.P. Candelaria, M. Eghtedari, B.E. Adrada, N. Sneige,
B.D. Fornage; Houston, TX / US
11:26
B-0430 Intermediate-stage HCC treated with TACE: 11:18
proposal for a new scoring system B-0440 Modern management of acute breast abscesses:
B. Ginanni, A. Scionti, F. Calcagni, P. Scalise, I. Bargellini, C. Bartolozzi; Pisa / IT radiological interventions replacing surgical incisions?
N.A. Healy, P. Hughes, M. Stenson, S. Harte; Dublin / IE
11:34
B-0431 Significance of gadoxetic acid-enhanced MR imaging 11:26
signal intensity for predicting the efficacy of hepatic B-0441 Clinical and sonographic predictors of complete
arterial infusion chemotherapy in hepatocellular resection for percutaneous excision of benign
carcinoma symptomatic breast lesions using US-guided
N. Fujita, A. Nishie, Y. Asayama, K. Ishigami, Y. Ushijima, Y. Takayama, vacuum-assisted breast biopsy system
D. Okamoto, K. Morita, H. Honda; Fukuoka / JP J.P. Salazar, I. Miranda, Y.K. Ng Wong, C. Avella-García, I. Rubio, R. Salvador;
Barcelona / ES

264 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:26
B-0442 Papillary lesions of the breast: B-0452 CAD soware for assessment of pulmonary nodules
is ultrasound-guided VAB useful in their management? with 100kV/Tin-filtered input data comparing iterative
V. Bertani1, P. Clauser1, A. De Nicolò1, M. Pizzamiglio2, C. Zuiani1, M. Bazzocchi1, to filtered back projection reconstructions:
E. Cassano2; 1Udine / IT, 2Milan / IT
a third-generation dual-source CT phantom study
11:42 S. Sudarski1, V. Steck1, M. Meyer1, H. Haubenreisser1, S.O. Schönberg1,
R. Vliegenthart2, T. Henzler1; 1Mannheim / DE, 2Groningen / NL
B-0443 Non-surgical complete excision of small suspicious
breast lesions using the breast lesion excision biopsy 11:34
system (BLES) B-0453 The visibility of lesions around hip prosthesis in
N.M. Abdel Razek; Giza / EG gemstone spectral imaging dual energy CT:
11:50 with or without metal artifact reduction soware
J. Jeong1, H.-J. Kim1, J. Cha2, H. Lim1, S. Hong1, J. Hwang1; 1Seoul / KR,
B-0444 Can the breast lesion excision system (BLES) under 2
Bucheon / KR
stereotactic guidance be used as a therapeutic tool in
the assessment of small areas of microcalcifications 11:42
of the breast? B-0454 Adaptive statistical iterative reconstruction technique
R.-I. Milos, M. Bernathova, P.A.T. Baltzer, K. Pinker-Domenig, P. Kapetas, to reduce radiation dose of brain CT in children
M. Rudas, T.H. Helbich; Vienna / AT P. Lupo1, F.A. Lupo2, G. De Matteis1, G. Sticchi1; 1Foggia / IT, 2Lecce / IT

11:50
10:30–12:00 Room Z B-0455 Use of dose tracking soware for assessment of
patient positioning in CT
Computer Applications M. Twomey, K. Murphy, K. Carey, P. Nicholson, M. Sheehy, O. O’ Connor,
M.M. Maher; Cork / IE

Thursday
SS 605 Dose tracking:
assessment and reduction of artefacts 10:30–12:00 Room M
Moderators: N. Kachenoura; Paris/FR, J. Thrall; Boston, MA/US

10:30 GI Tract
B-0445 Impact of automated attenuation-based tube voltage SS 601b Inflammatory bowel disease
selection on radiation dose at CT: Moderators: R. Del Vescovo; Rome/IT, C. Hohl; Siegen/DE
an observational big data analysis on a global scale
J.V. Spearman1, J.L. Wichmann1, F.G. Meinel1, I. Driesser2, C. Canstein2, 10:30
R.R. Bayer1, S. Mangold1, C.N. De Cecco1, U.J. Schoepf1; 1Charleston, SC / US,
2
Forchheim / DE K-08 Keynote lecture
S. Romano; Naples / IT
10:38
10:39
B-0446 Lessons learned from developing and establishing a
national web-based MDCT DRL survey program B-0456 The impact of Gadolinium-based contrast agent
A.B. Wallace, A. Hayton; Yallambie / AU in the assessment of Crohn’s disease activity:
Is it contrast agent injection necessary?
10:46 E. Quaia, M. Pontello, R. Angileri, M. Cova; Trieste / IT
B-0447 Adult CT dose monitoring using web based radiation
10:47
dose tracking soware
M. Twomey, J. Ryan, K. Murphy, M. Sheehy, M.M. Maher, O.J. O’ Connor; Cork / IE B-0457 Diagnostic value of CEUS to detect acute phase of
Crohn’s disease: systematic review and meta-analysis
10:54 M. Białecki, A. Białecka, Z. Serafin; Bydgoszcz / PL
B-0448 Accuracy of SSDE calculation using radiation dose
10:55
tracking soware (RDTS)
M. Twomey, K. Murphy, C. Sullivan, K. Carey, N. Moore, O.J. O’Connor, B-0458 Comparison of the impact of MRI and colonoscopy
M.M. Maher; Cork / IE on management of Crohn’s disease
J. Rimola, S. Rodríguez, I. Ordás, A. Lopez, E. Ricart, J. Panes; Barcelona / ES
11:02
B-0449 Automatic cloud-based monitoring and analysis of 11:03
computed tomography (CT) dose exposure using B-0459 Diffusion-weighted MRI for prediction of long-term
DICOM-structured report (DICOM-SR) outcomes in patients with perianal fistulas in Crohn’s
J. Boos, A. Meineke, R.S. Lanzman, C. Schleich, O.T. Bethge, G. Antoch, P. Kröpil; disease treated with anti-tumour necrosis factor
Düsseldorf / DE
antibodies
K. Katulska, M. Wykrętowicz, P. Eder, P. Stajgis, K. Linke, M. Stajgis; Poznan / PL
11:10
B-0450 Simulation study about the accuracy of advanced 11:11
airway geometry determination on MDCT using a B-0460 Multicentre prospective evaluation of soware
computer-generated phantom quantified small bowel motility as a biomarker of
O. Weinheimer, C.P. Heußel, H.-U. Kauczor, M.O. Wielpütz; Heidelberg / DE
inflammatory activity in Crohn’s disease
E.F.W. Gryspeerdt1, A. Menys1, D. Atkinson1, J. Makanyanga1, G. Bhatnagar1,
11:18 C. Tuteinnolthenius2, S.A. Taylor1; 1London / UK, 2Amsterdam / NL
B-0451 Lobewise registration of the lungs in computed
tomography improves anatomically correct
voxel-to-voxel mapping of inspiration and expiration
data
T. Kaireit, S. Dettmer, O. Solyanik, W. Frank, H.-o. Shin; Hannover / DE

www.myESR.org Final Programme | ECR 2015 265


Scientific Sessions

11:19 11:03
B-0461 Is plain MRI feasible to evaluate inflammation and B-0469 Serial native T1- and T2-mapping to quantitatively
bowel damage in IBD? A prospective comparison with monitor resorption of myocardial edema following
conventional MR enterography acute myocardial infarction
K. Nielsen1, V. Løgager1, B. Rezanavaz-Gheshlagh1, P. Munkholm2, E. Tahir, M. Sinn, U. Radunski, D. Saering, K. Muellerleile, C. Stehning, G. Adam,
H.S. Thomsen1; 1Herlev / DK, 2Rungsted Kyst / DK L. Gunnar; Hamburg / DE

11:27 11:11
B-0462 MR enterography including diffusion weighted imaging B-0470 Assessment of intramyocardial haemorrhage
compared to capsule endoscopy in patients with in acute reperfused myocardial infarction using
suscpected or known inflammatory bowel disease 7.oT CMR T2 mapping
S. Kinner, S. Sirin, S. Kathemann, T.C. Lauenstein, M.L. Hahnemann; Essen / DE W. Chen1, B. Zhang1, F. Gao1, J. Zheng2, C. Wang1; 1Chengdu / CN, 2St. Louis,
MO / US
11:35
B-0463 Monitoring response to infliximab monotherapy in 11:19
Crohn’s disease with interval ultrasound: B-0471 Incidence and role of intramyocardial haemorrage
a safe and objective option (IMH) in the assessment of STEMI pts through
A. Wadhwani, P. Patel, K. Novak, R. Wilkens, S. Wilson; Calgary, AB / CA the use of T2 STAR (T2*) and T2 STIR sequences
G. Benedetti, F. De Cobelli, A. Damascelli, M. Cava, A. Esposito, A. Del Maschio;
11:43 Milan / IT
B-0464 CT-enterography: diagnostic value of 4th generation 11:27
iterative reconstruction algorithm in low-dose B-0472 Infarct evolution patterns following a revascularised
protocol in comparison with standard dose CT protocol acute myocardial infarction:
for clinical follow-up of patients with Crohn’s disease
S. Lombardi, D. Ippolito, A. Casiraghi, C. Talei Franzesi, P. Bonaffini, S. Sironi; a multilayer model for LGE analysis
Monza / IT L. Zhang, F. Odille, O. Huttin, N. Girerd, J. Felblinger, P.-Y. Marie, C. De Chillou,
D. Mandry; Nancy / FR
11:51 11:35
B-0465 MR features of anoperineal involvement B-0473 Delayed dual-energy CT (DECT) and conventional
in hidradenitis suppurativa: cardiac CT angiography (CCTA) in detection
comparison with Crohn’s disease
L. Monnier1, A. Dohan2, N. Amara1, L. Vandromme1, A.-M. Zagdanski2, C. Hoeffel1; of chronic myocardial scar tissue:
1
Reims / FR, 2Paris / FR do we need delayed acquisition? Comparison with MRI
E. Pershina, V. Sinitsyn, E.A. Mershina; Moscow / RU

10:30–12:00 Room N 11:43


B-0474 CT evaluation of small-diameter coronary artery
Cardiac stents: impact of an integrated circuit detector
with iterative reconstruction using 3rd generation
SS 603a Myocardial infarction and coronary dual-source CT
intervention P.M. Cannaò, G. Muscogiuri, C.N. De Cecco, J. Wichmann, A. Varga-Szemes,
C. Canstein, U.J. Schoepf; Charleston, SC / US
Moderators: M. Francone; Rome/IT, M. Gutberlet; Leipzig/DE
11:51
10:30
B-0475 Diagnostic accuracy of dual-source computed
K-09 Keynote lecture
M. Gutberlet; Leipzig / DE tomography in evaluation of coronary in-stent
restenosis: a meta-analysis
10:39 L.-Y. Wen, Z.-G. Yang, H.-Y. Xu; Chengdu / CN
B-0466 An investigation into the underlying rate of silent
myocardial infarction in a low-intermediate risk
10:30–12:00 Room L 1
asymptomatic cohort
K. Fitzgerald, J. Weir-McCall, C. Papagiorcopulo, M.A. Lambert, F.M. Sullivan,
S.J. Gandy, J.J.F. Belch, A.D. Struthers, J.G. Houston; Dundee / UK Vascular
10:47 SS 615 Vascular imaging in systemic diseases
B-0467 Long-term prognostic value of dipyridamole stress Moderators: D. Karnabatidis; Patras/GR, D. Tomais; Athens/GR
cardiovascular magnetic resonance in patients with
known or suspected coronary artery disease 10:30
E. Bertella, D. Andreini, S. Mushtaq, M. Petullà, M. Loguercio, A. Baggiano, B-0476 Systemic venous anomalies in patients with
V. Beltrama, P. Gripari, G. Pontone; Milan / IT pulmonary atresia: a CT angiographic study
R. Aslani Menareh Bazari, S. Sabouri, M. Karimi, H. Mahdavirad; Tehran / IR
10:55
B-0468 A preliminary study about the use of 10:38
diffusion-weighted images (DWI) in the evaluation of B-0477 CT angiographic features of large and medium size
ST-segment elevation myocardial infarction (STEMI): arterial vasculopathy of the upper limbs in systemic
our experience sclerosis using 320 mutidetector row scanners
G. Benedetti, A. Esposito, A. Damascelli, M. Cava, A. Del Maschio, F. DeCobelli; Y. Ragab, Y. Emad; Cairo / EG
Milan / IT

266 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:46 10:30–12:00 Room E1


B-0478 Characterisation of aortic distensibility in a rat model
of atherosclerosis using high-resolution black blood Musculoskeletal
cine sequences at 9.4 T SS 610a Shoulder, brachial plexus
P. Fries, J. Stroeder, A. Müller, F. Mahfoud, M. Hohl, D. Linz, A. Massmann,
G.K. Schneider, A. Buecker; Homburg / DE Moderators: K.-F. Kreitner; Mainz/DE, D. Maric; Banja Luka/BA

10:54 10:30
B-0479 Follow-up of atheroma burden with sequential whole B-0487 Biceps pulley and rotator interval of the shoulder in
body contrast enhanced MR angiography: athletes: MR-arthrography dynamic evaluation
a longitudinal cohort study S. Mariani, A. La Marra, F. Arrigoni, L.M. Gregori, L. Patriarca, A. Barile,
J.R. Weir-McCall1, R.D. White2, P. Gutur Ramkumar1, J.J.F. Belch1, A.D. Struthers1, C. Masciocchi; L’Aquila / IT
G. Houston1; 1Dundee / UK, 2Cardiff / UK
10:38
11:02 B-0488 Evaluation of rotator cuff tears by MR arthrography
B-0480 Prediction of recurrent adverse events and organ using the Snyder’s arthroscopic classification and
specific risk in diabetic patients by contrast-enhanced arthroscopy as reference standard
whole body MRI C. Mattiuz, A. Aliprandi, N. Verardi; San Donato Milanese / IT
R.C. Bertheau1, C.L. Schlett1, F. Bamberg2, K. Parhofer3, H. Findeisen4,
H.-U. Kauczor1, S.O. Schönberg5, M.F. Reiser3, S. Weckbach1; 1Heidelberg / DE, 10:46
2
Tübingen / DE, 3Munich / DE, 4Aachen / DE, 5Mannheim / DE B-0489 High-frequency ultrasonography in penetrating tendon
11:10 and nerve injuries of the upper extremity
M. Haroon, I. Ahmad, I. Ahmad, M. Azfar Siddiqui, S. Narayanasamy; Aligarh / IN
B-0481 Screening for asymptomatic cardiovascular disease
with contrast enhanced MRI: association of le 10:54

Thursday
ventricular mass with whole body atheroma burden, B-0491 Quantitative shear wave ultrasound elastography
cardiovascular risk and B type natriuretic peptide of the supraspinatus muscle in relation to tendon
M.A. Lambert1, J.J.F. Belch1, J. Weir-McCall1, S.J. Gandy1, R. Littleford1, integrity and muscle quality
A.D. Struthers1, F. Sullivan2, G. Houston1; 1Dundee / UK, 2Toronto, ON / CA A.B. Rosskopf, C. Ehrmann, F.M. Buck, C. Gerber, C.W.A. Pfirrmann; Zurich / CH
11:18 11:02
B-0482 Reproducibility of manual measurement of B-0492 The effect of percutaneous ultrasound-guided
intima-media thickness at distal common carotid subacromial bursography using microbubbles in
artery under a strict measurement protocol by carotid assessment of subacromial impingement syndrome:
ultrasound in 242 subjects initial experience
J. Plasencia Martínez, J. García Santos; Murcia / ES M. Lu; Chengdu / CN
11:26 11:10
B-0483 Classification of coronary and carotid atherosclerotic B-0493 Evaluation of recurrent rotator cuff tendon tears:
plaque by grating-based phase-contrast computed comparison of MRI, MR arthrography and ultrasound
tomography B. He1, Q. Dong2; 1Kunming / CN, 2Ann Arbor, MI / US
H. Hetterich1, N. Webber1, M. Willner2, J. Herzen2, L. Birnbacher2, A. Hipp2,
F. Bamberg1, F. Pfeiffer2, T. Saam1; 1Munich / DE, 2Garching / DE 11:18
B-0494 Quantification of early fatty infiltration of the rotator
11:34
cuff muscles: comparison of multi-echo Dixon with
B-0484 Simultaneous PET-MR imaging with FDG for the single-voxel MR spectroscopy
evaluation of symptomatic patients with non-stenotic C.A. Agten, A.B. Rosskopf, C. Gerber, C.W.A. Pfirrmann; Zurich / CH
carotid atherosclerotic plaques
A. Schindler, F. Hyafil, D. Sepp, T. Obenhuber, A. Bayer-Karpinska, M. Schwaiger, 11:26
H. Poppert, S. Tobias; Munich / DE
B-0495 MR imaging aer supraspinatus tendon repair with
11:42 good clinical outcomes: morphology and signal
B-0485 Super micro-vascular imaging: a new technique alterations of the supraspinatus tendon
C.A. Agten, F.M. Buck, C.W.A. Pfirrmann; Zurich / CH
detecting neovascularisation in carotid plaque
Q. Yong, L. Zhang, J. Yuan, J. Mu; Beijing / CN 11:34
11:50 B-0496 Usefulness of IDEAL T2 imaging for homogeneous fat
B-0486 3D-black-blood 3T-MRI of the vessel wall and beyond: suppression and reducing susceptibility artifacts in
a clinical perspective brachial plexus MRI at 3T
T. Saam1, K.M. Treitl1, N.N. Kammer1, H. Kooijman2, M.F. Reiser1, E. Coppenrath1; B. Bignotti, S. Airaldi, F. Zaottini, G. Tagliafico, C. Martinoli, A. Tagliafico;
1
Munich / DE, 2Hamburg / DE Genoa / IT

11:42
B-0497 Comparison of 3T MR elastography and shear wave
US elastography measuring normal skeletal muscle
stiffness: a pilot study
D. Na1, S.-J. Hong1, C. Kang1, B. Kim2, K.-S. Ahn1, S. Lee2; 1Seoul / KR,
2
Gyeonggi-do / KR

www.myESR.org Final Programme | ECR 2015 267


Scientific Sessions

11:50 11:35
B-0498 Three-dimensional glenohumeral relationship of B-0507 Peritumoural perfusion and proton spectroscopic MR
different surgical glenoid planes: a three-dimensional imaging in the differentiation of gliomas and solitary
CT-scan study metastases
T.R.G.M. Verstraeten, L.F. De Wilde; Gent / BE G. Sparacia1, A. Iaia2, J. Gadde2, M. Midiri1; 1Palermo / IT, 2Newark, DE / US

11:58 11:43
B-0499 Preoperative guiding for the reconstruction of the B-0508 DWI and dynamic susceptibility contrast
native glenoid plane: an anatomical three-dimensional perfusion-weighted imaging of ganglioglioma in
CT-scan reconstruction study adults: comparision study with oligodendroglioma
T.R.G.M. Verstraeten, L.F. De Wilde; Gent / BE S. Lee, S. Choi; Seoul / KR

11:51
10:30–12:00 Room E2 B-0509 Recurrence of high-grade glioma and post-treatment
effects: differentiation by using perfusion and proton
Neuro spectroscopic MR imaging
C. Ho; Singapore / SG
SS 611 Brain tumour (1)
Moderators: N. Bargalló; Barcelona/ES, Y. Özsunar; Aydin/TR
10:30–12:00 Room F1
10:30
K-10 Keynote lecture Oncologic Imaging
I.M. Björkman-Burtscher; Lund / SE

10:39
SS 616 Whole-body imaging of systemic
B-0500 Perfusion and permeability MRI biomarkers for
tumour spreading
Moderators: K.N. De Paepe; Leuven/BE, C.J. Johnston; Dublin/IE
enhancing and nonenhancing components predict
patient survival in newly diagnosed glioblastoma 10:30
O. Solà1, J. Puig1, G. Blasco1, J. Daunis-i-Estadella1, M. Essig2, R. Jain3,
M. Puigdemont1, S. Pedraza1, J. Cambronero1; 1Girona / ES, 2Winnipeg, MB / CA, K-11 Keynote lecture
X. Montet; Geneva / CH
3
New York, NY / US

10:47 10:39
B-0501 Prognosis prediction of measurable enhancing lesion B-0510 Whole-body MRI with T1, STIR and DWI:
aer completion of standard CCRT and adjuvant first non-invasive step to rule out bone marrow
temozolomide in glioblastoma patients: application of involvement in aggressive lymphoma -
dynamic susceptibility contrast perfusion and DWI feasibility study
A. Balbo-Mussetto, A. Fornari, C. Lario, M. Petracchini, C. Saviolo, R. Bruna,
J. Kim, S. Choi, T. Yun, J.-H. Kim, C.-H. Sohn; Seoul / KR C. Tarella, S. Cirillo; Turin / IT
10:55 10:47
B-0502 The functional language connectome in frontal and B-0511 Whole-body DW-MRI in staging of indolent
temporal gliomas lymphomas: comparison with FDG-PET/CT
K.-H. Nenning, A. Müller, D. Prayer, G. Langs, G. Kasprian; Vienna / AT F. Buemi1, A. Stecco1, M. Quagliozzi1, M. Perchinunno1, A. Biacca1,
A. Santagostino2, M. Lombardi1, A. Carriero1; 1Novara / IT, 2Vercelli / IT
11:03
B-0503 Prognostic value of dynamic contrast-enhanced MRI 10:55
for therapeutic evaluation of brain metastases from B-0512 Surveillance of aggressive lymphoma recurrence aer
lung cancer therapy with whole body-MR-DWI:
G. Kuchcinski, C. Delmaire, E. Le Rhun, R. Duhal, M. Lalisse, R. Lópes, J.-P. Pruvo,
A. Cortot, X. Leclerc; Lille / FR report of a single-centre experience
A. Balbo-Mussetto, A. Fornari, C. Lario, M. Petracchini, C. Saviolo, A. Gueli, A. De
Crescenzo, C. Tarella, S. Cirillo; Turin / IT
11:11
B-0504 Tumour permeability pattern: a potential for new 11:03
prognostic factor in immunocompetent patients with B-0513 Diffusion-weighted MR at 3T for therapy response
primary CNS lymphoma assessment in Hodgkin`s lymphoma:
S. Chung, H. Kim, C. Choi, S. Kim; Seoul / KR
comparison with FDG PET
I. Platzek, B. Beuthien-Baumann, K. Zoephel, T. Brauer, J. Maus, R. Ordemann,
11:19 M. Laniado, J. Kotzerke, J. van den Hoff; Dresden / DE
B-0505 The value of serial MR imaging in the assessment of
brain metastases volume control during stereotactic 11:11
radiosurgery B-0514 Incremental value of diffusion-weighted whole-body
G. Sparacia1, A. Banco1, F. Bencivinni1, G. La Tona1, V. Robusto2, M. Midiri1; imaging with background body signal suppression
1
Palermo / IT, 2Messina / IT
coupled with multiparametric MR imaging for the
11:27 detection of skeletal metastasis in prostate cancer
C.J. Das, P. Chakraborty, A.K. Gupta, C.S. Bal; Dehli / IN
B-0506 Intracranial multi-echo MR perfusion measurements:
reproducibility and differential diagnostic value for
intra- and extraaxial tumours
A. Abramyuk, V. Hietschold, K. Sitoci-Ficici, R. von Kummer; Dresden / DE

268 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:19 11:02
B-0515 Comparison between whole-body MRI and PET/CT B-0524 Fractional anisotropy of the fetal midbrain is
in staging newly diagnosed FDG-avid lymphomas: specifically elevated in Chiari II malformations
our experience R. Woitek, M. Weber, R. Seidl, D. Bettelheim, V. Schöpf, G. Amann, P.C. Brugger,
D. Albano, F. Agnello, C. Patti, A. Mulè, L. La Grutta, F. Midiri, G. Franco, M. Midiri, D. Prayer, G. Kasprian; Vienna / AT
M. Galia; Palermo / IT
11:10
11:27 B-0525 Selected regional changes in brain diffusivity in fetal
B-0516 Comparison of diagnostic certainty for abdominal isolated mild ventriculomegaly
incidentalomas in 18F-FDG PET/MRI and R. Bercovitz1, G. Yaniv1, E. Katorza1, D. Bergman2, C. Hoffmann1, A. Biegon3;
1
Ramat Gan / IL, 2Jerusalem / IL, 3New York, NY / US
18F-FDG PET/CT
B.M. Schaarschmidt1, J. Grueneisen2, P. Heusch1, L. Umutlu2, V. Ruhlmann2, 11:18
S. Rosenbaum-Krumme2, G. Antoch1, C. Buchbender1; 1Düsseldorf / DE,
2
Essen / DE B-0526 Automatic white matter tract segmentation in the
neonatal brain
11:35 C.V. Pul1, L. Fonseca2, N. Lori3, J. Buijs1, P. Andriessen1, A. Vilanova4;
B-0517 ADC of normal abdominal organs and bone marrow
1
Veldhoven / NL, 2Eindhoven / NL, 3Coimbra / NL, 4Del / NL
from whole body DW-MRI at 1.5T: 11:26
the effect of sex and age B-0527 Association between retinoblastoma tumour size and
F. Castelli1, I. Lavdas2, A.G. Rockall2, R.S. Sandhu2, A. Papadaki2, L. Honeyfield2,
A.D. Waldman2, E.O. Aboagye2; 1Verona / IT, 2London / UK tumour extent
M.C. de Jong1, F. van der Meer1, S. Göricke2, H.J. Brisse3, P. Galluzzi4, P. Maeder5,
11:43 A. Moll1, J. Castelijns1, P. de Graaf1; 1Amsterdam / NL, 2Essen / DE, 3Paris / FR,
4
Siena / IT, 5Lausanne / CH
B-0518 Achieving lower radiation dose in follow-up of
oncologic patients: comparison of whole-body CT with 11:34

Thursday
4th generation iterative reconstruction algorithm and B-0528 DTI and MR spectroscopy study in the auditory neural
standard dose examination pathway of paediatric congenital sensorineural
A. Casiraghi, D. Ippolito, P. Bonaffini, C. Talei Franzesi, D. Fior, S. Sironi;
Monza / IT hearing loss patients
C.X. Wu, W.B. Zheng; Shantou / CN
11:51 11:42
B-0519 Image based body surface area evaluation: B-0529 Neonatal lumbar puncture: are traditional clinical
quantitative radiology vs anthropomorphic evaluation landmarks of lumbar anatomy accurate when
A. Iannessi , H. Beaumont , C. Bastiani ; Nice / FR, Valbonne / FR
1 2 1 1 2

compared with ultrasound assessment?


B. Baxter, J. Evans, R. Morris, U. Ghafoor, M.P. Nana, T. Weldon, T. Hildebrandt,
G. Tudor; Bridgend / UK
10:30–12:00 Room F2
11:50
Paediatric B-0530 Comparison of 3T MRI, PET and Ictal SPECT
in presurgical localization of the seizure-onset
SS 612 Foetal and paediatric neuroimaging zone in paediatric patients with refractory temporal
Moderators: I. Boric; Zabok/HR, P.C. Maly Sundgren; Lund/SE
lobe epilepsy
H.M. Kassem1, A. Wafaie2, N. Al Adwani1, N. Al Khuraish1, Z. Azmat1, S. Al Jubran1,
10:30 H. Farghaly3, L. Affifi2, M. El Mahdy1; 1Riyadh / SA, 2Cairo / EG, 3Assiut / EG
B-0520 Correlation between fetal and postmortem MRI and
conventional autopsy in the detection of major fetal
abnormalities 10:30–12:00 Room D1
M. Saldari, S. Bernardo, V. Vinci, A. Giancotti, L. Manganaro, C. Catalano;
Rome / IT Chest
10:38
B-0521 Biometric and diffusional changes in apparently
SS 604 Pulmonary nodule
Moderators: C. Mueller-Mang; Vienna/AT, M. Sánchez; Barcelona/ES
normal fetal head MRI scans of fetuses with
congenital heart disease 10:30
R. Bercovitz1, G. Yaniv1, V. Tchekmeister Abitbol1, C. Hoffmann1, A. Furer2,
E. Katorza1, D. Bergman3, A. Biegon4; 1Ramat Gan / IL, 2Tel Aviv / IL, K-12 Keynote lecture
3
Jerusalem / IL, 4New York, NY / US A. Devaraj; London / UK

10:46 10:39
B-0522 Disrupted developmental organisation of brain B-0531 Ultralow-dose CT with tin-filtration for detection of
connectivity in fetuses with corpus callosum agenesis: solid and sub-solid pulmonary nodules:
an in utero study a phantom study
A. Jakab1, G. Kasprian1, E. Schwartz1, G.M. Gruber1, D. Prayer1, G. Langs1, K. Martini, K. Higashigaito, B.K. Barth, S. Baumüller, T. Frauenfelder; Zurich / CH
V. Schöpf2; 1Vienna / AT, 2Graz / AT
10:47
10:54 B-0532 Comparison of model-based iterative reconstruction
B-0523 Fetal MRI in the evaluation of facial anomalies: with iDose4 and filtered back projection
is there a role? for the analysis of ground-glass opacity nodule
M. Saldari, S. Bernardo, V. Vinci, A. Giancotti, L. Manganaro, C. Catalano; in the chest phantom
Rome / IT J. Nam, S. Choi, S. Shim, J. Lee, K. Bae, J. Park, W. Kwon; Ulsan / KR

www.myESR.org Final Programme | ECR 2015 269


Scientific Sessions

10:55 10:38
B-0533 Agreement of pulmonary nodule management based B-0542 Radiation dose reduction in CT fluoroscopy-guided
on diameter- and volume measurements in CT lung cervical transforaminal epidural steroid injection by
cancer screening minimising preliminary planning step
M.A. Heuvelmans1, R. Vliegenthart1, P.M.A. Van Ooijen1, W.P.T.M. Mali2, H.J. De N. Paik; Ulsan / KR
Koning3, M. Oudkerk1; 1Groningen / NL, 2Utrecht / NL, 3Rotterdam / NL
10:46
11:03 B-0543 Reducing the dose in CT-fluroscopy-guided epidural/
B-0534 CT screening for lung cancer: part-solid nodules in perineural injections-how low remains safe?
baseline and annual repeat rounds on behalf of the S.M. Niehues, M. Haas, J. Vahldiek, K. Erb-Eigner, B. Hamm; Berlin / DE
I-ELCAP investigators
C.I. Henschke, R. Yip, A. Wolf, R. Flores, M. Salvatore, D. Yankelevitz; New York, 10:54
NY, NY / US B-0544 Preoperative embolisation of meningiomas:
11:11 analysis of a single-centre experience
A. Pedicelli, L. Danieli, M. Iacobucci, E. Visconti, F. D’ Argento, C. Colosimo;
B-0535 ACR lung-RADS guidelines for pure ground-glass Rome / IT
nodules: is a threshold of 20mm adequate?
S.J. van Riel1, K. Chung1, E.T. Scholten1, P.A. de Jong2, C.M. Schaefer-Prokop3, 11:02
B. van Ginneken1; 1Nijmegen / NL, 2Utrecht / NL, 3Amersfoort / NL B-0545 New single-layer WEBs intrasaccular flow
11:19 disrupters for intracranial aneurysm treatment:
preliminary results of a European multicenter study
B-0536 Automated CT densitometry in characterizing solitary J. Caroff1, C. Strasilla2, A. Berlis3, T. Patankar4, D. Behme5, E. Jacobsen6, T. Liebig7,
pulmonary nodule enhancement S. Prothmann8, L. Spelle1; 1Clichy / FR, 2Erfurt / DE, 3Augsburg / DE, 4Leeds / UK,
Y. Choi, M. Chung, H. Kim; Bucheon / KR 5
Bochum / DE, 6Oslo / NO, 7Cologne / DE, 8Munich / DE

11:27 11:10
B-0537 Differentiation of persistent and transient subsolid B-0546 Endovascular treatment of ruptured blister-like
nodules: does morphology help? aneursyms with special reference to
K. Chung1, E.T. Scholten1, S.J. van Riel1, F. Ciompi1, P.A. de Jong2, M.M. Wille3, the flow-diverting strategies
M. Prokop1, B. van Ginneken1, C.M. Schaefer-Prokop1; 1Nijmegen / NL, M. Gök1, C. Çinar2, H. Bozkaya2, I. Oran2; 1Kars / TR, 2Izmir / TR
2
Utrecht / NL, 3Hellerup / DK
11:18
11:35
B-0548 Complete recanalization aer mechanical
B-0538 Differentiating pre- and minimally invasive from
thrombectomy with stent retrievers:
invasive adenocarcinoma using CT features in
comparison between balloon guide catheter (BCG) and
persistent pulmonary part-solid nodules
J.G. Cohen1, E. Reymond1, M. Lederlin2, M. Medici1, S. Lantuejoul1, F. Laurent2, distal access catheter (DAC) in acute ischemic stroke
F. Arbib1, A. Jankowski1, G.R. Ferretti1; 1Grenoble / FR, 2Bordeaux / FR A. Velasco1, T. Zoubi1, W. Kurre2, M. Aguilar Perez2, S. Berkemeyer1,
T. Niederstadt1, H. Henkes2, R. Chapot3, W. Heindel4; 1Muenster / DE,
11:43
2
Stuttgart / DE, 3Essen / DE, 4Münster / DE
B-0539 Pulmonary nodules: a comparative evaluation of 11:26
unenhanced CAIPIRINHA- volumetric interpolated B-0549 Detection of residual clots aer endovascular stroke
breath-hold examination (VIBE)- 3-TMRI and multislice therapy with dual energy CT
computed tomography A.E. Grams, M. Knoflach, J. Willeit, M. Sojer, E.R. Gizewski, B. Glodny;
P. Dewes, C. Frellesen, F. Al-Butmeh, J.L. Wichmann, M. Albrecht, T.J. Vogl; Innsbruck / AT
Frankfurt / DE
11:34
11:51 B-0550 Does the therapist’s attitude affect the clinical
B-0540 Detection and quantification of the solid component outcome of lumbar facet joint intra-articular
in pulmonary subsolid nodules by semiautomatic injections?
segmentation A. Maataoui1, K. Kollias2, A. Splettstößer3, T.J. Vogl1, M. Khan1, M. Middendorp1;
E. Scholten1, C. Jacobs2, B. van Ginneken2, S. van Riel2, R. Vliegenthart3, 1
Frankfurt / DE, 2Düsseldorf / DE, 3Hilden / DE
M. Oudkerk3, M. Prokop2, H.A. Gietema1, P.A. de Jong1; 1Utrecht / NL,
2
Nijmegen / NL, 3Groningen / NL
10:30–12:00 Room G
10:30–12:00 Room D2 Genitourinary
Interventional Radiology SS 607a DWI in prostate cancer
Moderators: T. Durmus; Berlin/DE, G. Villeirs; Gent/BE
SS 609 Neuro interventions
Moderators: N. Amoretti; Nice/FR, A. Ringelstein; Essen/DE 10:30
10:30 B-0552 The role of ultra-high b-value diffusion-weighted MRI
for detection of the index tumour in patients with
B-0541 Novel x-ray shielding device for reducing the lens
prostate cancer
exposure during endovascular treatment for brain E. Rud, E. Baco, H.B. Eggesbø; Oslo / NO
diseases
1 2 3 4 5 1
L. Sun , T. Totsuka , K. Akahane , M. Hayakawa , Y. Matsumaru , K. Tsuboi ,
T. Moritake6; 1Tsukuba / JP, 2Higashi Ibaraki Chiou / JP, 3Chiba / JP, 4Osaka / JP,
5
Tokyo / JP, 6Kitakyushu / JP

270 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:38 10:30–12:00 Room K


B-0553 Role of DWI at prostatic lesions at 3T-MRI
in the discrimination of grading: Musculoskeletal
correlation of imaging, quantitative analysis and SS 610b Lower extremity (1)
pathology at 189 MR-guided prostate biopsies Moderators: K. Kapuscinska; Krakow/PL, M. Tzalonikou; Athens/GR
A. Malich; Nordhausen / DE

10:46 10:30
B-0554 Small field-of-view single-shot EPI-DWI of B-0565 MRI of muscle strains of the thigh in professional
the prostate: evaluation of spatially-tailored soccer players:
two-dimensional radiofrequency excitation pulses correlation of imaging findings with the duration of
D. Hausmann1, N. Rathmann1, M. Sertdemir1, P. Riffel1, A. Weidner1, convalescence and presentation at return to play
S. Kannengiesser2, J.N. Morelli3, S.O. Schönberg1, U.I. Attenberger1; M. Regier, C. Behzadi, F.O.O. Henes, G. Adam, P. Catala-Lehnen; Hamburg / DE
1
Mannheim / DE, 2Erlangen / DE, 3Tulsa, OK / US
10:38
10:54 B-0563 Delayed gadolinium enhanced MRI of cartilage
B-0555 Assessment of prostate cancer aggressiveness using of the hip at 7 Tesla
the combination of quantitative diffusion-weighted A. Lazik, J.M. Theysohn, S. Orzada, H.H. Quick, O. Kraff; Essen / DE
and dynamic contrast-enhanced MRI
A.M. Hötker, Y. Mazaheri, Ö. Aras, J. Zheng, C.S. Moskowitz, T. Gondo, 10:46
K. Matsumoto, H. Hricak, O. Akin; New York, NY / US B-0564 Analysis of remodeling processes in patients
11:02 with avascular necrosis of the femoral head aer
advanced core decompression using 3T MRI
B-0556 Advantages of zoomed EPI with A. Lazik, O. Kraff, T. Claßen, S. Landgraeber, T.C. Lauenstein, J.M. Theysohn;
Essen / DE

Thursday
parallel-transmit-accelerated 2D-selective excitation
imaging in diffusion-weighted MRI of the prostate
K.M. Thierfelder1, M. Notohamiprodjo2, J. Weiß2, O. Dietrich1, U.G. Mueller-Lisse1, 10:54
M.F. Reiser1, K. Nikolaou2, D. Theisen1; 1Munich / DE, 2Tübingen / DE B-0566 T2- and T2*-mapping of hip cartilage at 7 Tesla:
11:10 initial results in healthy volunteers
A. Lazik, J.M. Theysohn, S. Orzada, H.H. Quick, O. Kraff; Essen / DE
B-0557 Comparison of field-of-view (FOV) optimised and
constrained undistorted single-shot (FOCUS) with 11:02
conventional DWI for the evaluation of prostate B-0567 CT-imaging of a hip prosthesis using model-based
cancer iterative reconstruction and its influence on metal
Z. Feng; Wuhan / CN artefact reduction: a quantitative analysis
R.H.H. Wellenberg1, M.F. Boomsma1, J.A.C. van Osch1, A. Vlassenbroek2, J. Milles3,
11:18 D. Mueller4, M. Maas5; 1Zwolle / NL, 2Best / NL, 3Eindhoven / NL, 4Hamburg / DE,
B-0559 Diffusion-weighted imaging of the prostate:
5
Amsterdam / NL
comparison of readout-segmented DWI and 11:10
parallel-transmit-accelerated selective excitation DWI B-0568 Various factors contribute to gra extrusion in lateral
regarding image quality and distortion meniscus allogra transplantation:
B.K. Barth , A. Cornelius , D. Nanz , D. Eberli , O.F. Donati ; Zurich / CH,
1 2 1 1 1 1
2
Aarau / CH MRI evaluation of 87 knees
J. Yoon, S. Lee, Y. Cho, R. Son, S. Kim, S. Ahn, H.-K. Lee; Sungnam / KR
11:26
B-0560 Added value of multiparametric MRI to clinical 11:18
parameters for characterising prostate cancer: B-0569 Oedema of the cartilage in the lateral facet of the
a histology validated study patella: does it predict patellar instability?
A. Falkowski1, C. Camathias1, J.A. Jacobson2, O. Magerkurth1; 1Basle / CH, 2Ann
P. Pricolo, S. Alessi, O. De Cobelli, G. Renne, B. Jereczek-Fossa, S. Raimondi, Arbor, MI / US
P. Summers, G. Petralia; Milan / IT

11:34 11:26
B-0561 MR-guided biopsy for prostate cancer: B-0570 Characterisation of achilles tendons in familial
the role of DWI at 3 Tesla in the decision making hypercholesterolemia patients using ultrasound
of index lesion imaging and shear wave elastography: a pilot study
L. Zhang, J. Lin, S. Zhang, Q. Yong; Beijing / CN
V. Panebianco, F. Vasselli, V. Forte, G. Manenti, G. Simonetti, C. Catalano;
Rome / IT
11:34
11:42 B-0571 Neurogenic myositis ossificans of the hip:
B-0562 Diffusion parameters (DTI and DWI) are superior correlation between enhanced CT and surgical findings
C. Hangard, R. Carlier; Garches / FR
to DCE-MRI in differentiation of BPH nodule from
prostate cancer: quantitative comparison 11:42
M. Kekelidze, G. Müller, M. Weigel, T. Haas, M. Pradella, G. Bongartz; Basle / CH
B-0572 Navicular bone position determined by weight bearing
11:50 MRI: interobserver and between day reliability
P. Hansen, S. Hangaard, F.E. Johannsen, S. Stallknecht, M. Henriksen, R. Bouert,
B-0558 Intravoxel incoherent motion (IVIM) MRI J.D. Nybing, B.B. Hansen, M. Boesen; Copenhagen / DK
for the interpretation of pelvic lymph nodes
in prostate cancer:
can we discriminate benign from malignant nodes?
M. Regier, C. Schmitt, C. Seiwerts, C. Behzadi, F.O.O. Henes, M. Kaul, G. Adam,
L. Budaeus; Hamburg / DE

www.myESR.org Final Programme | ECR 2015 271


Scientific Sessions

11:50 11:35
B-0573 Role of the weight-bearing MRI in the evaluation of B-0581 The evaluation of residual bone marrow signal
traumatic and overload pathologies of the midtalar changes in nasopharyngeal carcinoma patients
and subtalar joints treated with radiation therapy
S. Mariani, A. La Marra, F. Arrigoni, L.M. Gregori, L. Patriarca, A. Barile, S. Parlak, B. Ozgen Mocan, G. Yazici, A. Dolgun Barak; Ankara / TR
C. Masciocchi; L’Aquila / IT
11:43
B-0582 CT scan in preservation protocols of laryngeal
10:30–12:00 Room MB 1 carcinomas: choice of response criterions and impact
of on disease free survival
Head and Neck J. Valcke; Marseille / FR

SS 608 Oncologic imaging: CT, MRI and PET 11:51


Moderators: S. Bisdas; Tübingen/DE, C. Czerny; Vienna/AT B-0583 Diagnostic confidence for differentiating benign
from malignant orbital masses - added value of
10:30 multiparametric magnetic resonance imaging
K-13 Keynote lecture P. Asbach, S.-R. Ro, B. Hamm, K. Erb-Eigner; Berlin / DE
C. Czerny; Vienna / AT

10:39
10:30–12:00 Room MB 2
B-0574 Detection of locoregional tumour recurrence
in post treatment head and neck malignancies: Genitourinary
a comparative evaluation of dynamic perfusion CT
with F-18 FDG PET/CT SS 607b Benign gynaecological pathology
N.M. Mulimani, N. Khandelwal, P. Ssingh, V. Gupta, S. Ghoshal, B.R. Mittal; Moderators: J. Arnáiz; Doha/QA, R.N. Lucas; Lisbon/PT
Chandigargh / IN
10:30
10:47
B-0586 Uterine fibroids treatment selection using MRI:
B-0575 FDG PET/CT and DWI of head and neck squamous cell
MR-guided high-intensity focused ultrasound
carcinoma: prognostic value of standardised uptake
(MRgFUS), uterine artery embolisation (UAE)
value and apparent diffusion coefficient
G. Conte, F. Ruju, M. Moscatelli, L. Bonello, L.L. Travaini, S. Raimondi, M. Ansarin, and surgery: a per group analysis of outcomes
L. Preda; Milan / IT F. Ciolina, C. Palla, F. Zaccagna, F. Sandolo, A. Napoli, C. Catalano; Rome / IT

10:55 10:38
B-0576 Combined PET/CT and DWI by rigid image B-0587 Transvaginal sonography vs uro-colon-CT
coregistration increases diagnostic accuracy in the diagnosis of deep infiltrating endometriosis
in head and neck tumours of the anterior and posterior compartment
A. Stecco, M. Perchinunno, S. Ciolfi, I. Divenuto, M. Lombardi, A. Carriero; D. Papadopoulos, F. Coppola, D. Valerio, C. Balacchi, L. Zannoni, S. Del Forno,
Novara / IT R. Seracchioli, R. Golfieri; Bologna / IT

11:03 10:46
B-0577 Oropharyngeal squamous cell carcinoma: B-0589 Role of virtual hysterosalpingography
morphological and functional MRI differences between in the diagnosis the causes of infertility
A. Dmitriev, A. Karpenko, E. Bogdanova; St. Petersburg / RU
human papilloma virus positive and negative tumours.
Preliminary results 10:54
S. Sdao, G. Calareso, L. Bonello, H. Kule, E. Orlandi, N.A. Iacovelli, E. Casiraghi,
P. Panizza; Milan / IT B-0590 The diagnostic accuracy of multidetector CT
in the evaluation of ovarian torsion:
11:11 compared with mis-read cases
B-0578 Evaluation of the feasibility of MRI volumetry J. Kim1, Y.-M. Ku2, S.-L. Lee2; 1Seoul / KR, 2Uijeongbu / KR
in staging of oral carcinoma 11:02
R.S.S. Al Umairi, J. Hallinan, K. Al-Macki, E. Ting, T. Loh, N. Leehy, S. Liang;
Singapore / SG B-0591 Diagnostic performance of diffusion-weighted MRI
in the diagnosis of ovarian torsion: comparison with
11:19 conventional MRI and surgical findings
B-0579 DWI and T2-W MRI for the evaluation of residual T. Bekci, A.V. Polat, K. Aslan, M. Ceyhan Bilgici, M. Danaci; Samsun / TR
lymph nodes in patients affected by squamous
cell carcinoma of the head and neck, treated with 11:10
chemo-radiotherapy B-0592 Ultrasound guided therapeutic aspiration of simple
E. Gangemi, F. Piludu, V. Manciocco, A. Guerrisi, R. Covello, S. Marzi, A. Vidiri; ovarian cysts with tetracycline sclerotherapy
Rome / IT V. Patre, V. Dutt, S.B. Netam, R. Gahine, A. Singh, T. Nagaria; Raipur / IN

11:27 11:18
B-0580 MDCT and MRI evaluation of mandibular invasion by B-0593 Benign enhancing solid component of mature ovarian
squamous cell carcinoma of the oral cavity teratoma: MR imaging features
S. Agarwal; Guwahati / IN H. Shin, K. Kim, C. Lee, J. Choi, J. Lee, Y. Park, C. Park; Seoul / KR

11:26
B-0594 Clinical utility of pelvic magnetic resonance imaging
(MRI) in patients with suspected ectopic pregnancy
Y. Ragab1, M. Edris2; 1Cairo / EG, 2Jeddal / SA

272 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:30–12:00 Room MB 3 11:51


B-0604 Percutaneous pulmonary valve implantation (PPVI):
Cardiac four years follow-up by cardiac magnetic resonance
E. Resta, F. Secchi, G. Di Leo, M. Carminati, F. Sardanelli; San Donato
SS 603b Valvular disease Milanese / IT
Moderators: G. Feuchtner; Innsbruck/AT, M. Gardarsdottir; Reykjavik/IS

10:30 14:00–15:30 Room B


K-14 Keynote lecture
F. De Cobelli; Milan / IT Abdominal Viscera
10:39 SS 701a Liver steatosis and fibrosis
B-0595 Phase contrast 4D flow in bicuspid aortic valves in a Moderators: K.J. Beiderwellen; Essen/DE, L. Martí-Bonmatí; Valencia/ES
porcine model
1 1 1 1 2 1
M. Grothoff , C. Etz , B. Brenneis , F. Reinhold , B. Preim , M. Gutberlet ; 14:00
1
Leipzig / DE, 2Magdeburg / DE
K-15 Keynote lecture
L. Martí-Bonmatí; Valencia / ES
10:47
B-0596 Intraindividual validation of 4D flow measurement 14:09
against 2D flow measurements in aortas with bicuspid B-0605 Semi-automated quantification of abdominal fat
or tricuspid valves by cardiovascular magnetic in non-alcoholic fatty liver disease:
resonance (CMR) a non-invasive assessment in general population
A.E. Kharabish1, K. Belker2, C. Meierhofer2, P. Ewert2, S. Fratz2, S. Fratz2; A. Radmard, A. Abrishami, M. Rahmanian, S. Kooraki, A. Hashemi Taheri,
1
Cairo / EG, 2Munich / DE M. Gerami Seresht, H. Poustchi, R. Malekzadeh, S. Merat; Tehran / IR

Thursday
10:55 14:17
B-0597 Assessment of the regurgitant orifice area in aortic B-0606 Use of dual-energy virtual non-contrast CT for
regurgitation with dual-source CT: comparison with quantitative assessment of hepatic steatosis with
cardiovascular MR dual-source CT scanner: a preliminary study
T. Kim, S. Ko, J. Park, J. Shin, J. Kim; Seoul / KR X. Wang, S.-t. Wang, H.-d. Xue, Z.-Y. Jin; Beijng / CN
11:03 14:25
B-0598 CT planning of aortic valve replacement: B-0607 Heritability of abdominal adipose tissue
evaluation of virtually reconstructed ultra low keV compartments and hepatic lipid accumulation:
monoenergetic reconstructions based a classical twin study
on 3rd generation dual-energy CT Z.D. Drobni1, A.L. Jermendy1, T. Horvath1, A. Bartykowszki1, A.D. Tarnoki1,
H. Haubenreisser, M. Meyer, S.O. Schönberg, T. Henzler; Mannheim / DE S. Voros2, B. Merkely1, P. Maurovich-Horvat1, G. Jermendy1; 1Budapest / HU,
2
Richmond, VA / US
11:11
B-0599 Multimodality imaging evaluation before TAVI: 14:33
incidence of CI-AKI in relation to known risk factors B-0608 The role of MR in the diagnosis of non-alcoholic
C. Schneider, A. Brumberg, F.C. Roller, J. Rixe, P. Roth, G.A. Krombach; fatty liver disease:
Giessen / DE correlation with liver biopsy and insulin resistance
C. Berzovini, R. Faletti, C. Arese, F. Barisone, D. Righi, P. Fonio, G. Gandini;
11:19 Turin / IT
B-0600 Pre-TAVI evaluation: dynamic assessment
of circumference-derived diameter and its influence 14:41
on prosthesis selection B-0609 Association between T2, T2* and indicators of hepatic
J. Turek, M. Kok, C. Mihl, B.L.J.H. Kietselaer, V.V.A. van Ommen, E.C. Nijssen, inflammation as an early sign of non-alcoholic fatty
J.E. Wildberger, M. Das; Maastricht / NL liver disease in asymptomatic high-risk subjects
M.N. Bongers, C. Schabel, F. Bamberg, A. Fritsche, H.-U. Häring, K. Nikolaou,
11:27 F. Schick, J. Machann; Tübingen / DE
B-0601 Valve-in-valve transcatheter implantation work-up:
CT can accurately determine the implanted 14:49
bioprosthesis size B-0610 Grading of steatosis and liver-fibrosis using phase
D. Suchá1, C.G. Daans1, P. Symersky2, R.N. Planken2, W.P.T.M. Mali1, L.A. van contrast imaging
Herwerden1, R.P.J. Budde3; 1Utrecht / NL, 2Amsterdam / NL, 3Rotterdam / NL M. Armbruster1, B. Zupanc1, E. Brun2, A. Bravin2, W.H. Sommer1, R. Reimar1,
W. Thasler1, M.F. Reiser1, P. Coan2; 1Munich / DE, 2Grenoble / FR
11:35
B-0602 Medium-term biventricular heart remodeling 14:57
aer percutaneous and surgical pulmonary valve B-0611 Diagnostic accuracy of real-time ShearWave
implantation evaluated with cardiac magnetic elastography for the noninvasive assessment of liver
resonance fibrosis
F. Secchi, F. Pluchinotta, E. Resta, P. Cannaò, M. Carminati, F. Sardanelli; N. Huet, I. Bricault, A. Martino, M. Medici, E. Chipon, N. Sturm, J.-P. Zarski,
Milan / IT A. Moreau-Gaudry, V. Leroy; Grenoble / FR

11:43 15:05
B-0603 Assessment of pulmonary insufficiency by cardiac B-0612 Diagnostic value of Real-Time elastography (RTE)
magnetic resonance using regurgitation fraction or compared to biopsy in the assessment of liver
absolute value of reverse volume stiffness in patients with chronic viral hepatitis
M. Petrini, F. Secchi, F.R. Pluchinotta, M. Carminati, M. Chessa, F. Sardanelli; San M. Schiavone, D. Ippolito, P.A. Bonaffini, C.R.G.L. Talei Franzesi, D. Fior, S. Sironi;
Donato Milanese / IT Monza / IT

www.myESR.org Final Programme | ECR 2015 273


Scientific Sessions

15:13 15:04
B-0613 Estimation of extracellular volume fraction using B-0623 Unenhanced breast magnetic resonance imaging:
routine four-phase liver CT for grading hepatic fibrosis detection of breast cancer
J.-H. Yoon1, J. Lee1, E. Klotz2, J. Han1, B. Choi1; 1Seoul / KR, 2Forchheim / DE A. Bonatesta, P. Belli, E. Bufi, M. Tumino, C. Buccheri, L. Bonomo; Rome / IT

15:21 15:12
B-0614 Assessment of fibrotic tissue and microvascular B-0624 Breast lesion differentiation by 3-parameter
architecture by in-line phase-contrast imaging in IVIM analysis
mouse model of liver fibrosis H. Dijkstra, M.D. Dorrius, M. Wielema, M. Oudkerk, P.E. Sijens; Groningen / NL
Y. Fu, W.-j. Peng, X. Zhang; Shanghai / CN
15:20
B-0625 Correlation of intravoxel incoherent motion
14:00–15:30 Room C diffusion-weighted imaging with immunohistochemical
index in breast ductal carcinoma
Breast L. Cai, Y. Chen, X. Liu, Y. Chen, Y. Xiao; Fujian / CN

SS 702 Breast:
diffusion-weighted MR imaging (DWI) 14:00–15:30 Room Z
Moderators: G. Forrai; Budapest/HU, C. Iacconi; Carrara/IT
Vascular
14:00
B-0615 Is there a systematic bias of apparent diffusion SS 715 Arteries and veins
Moderators: A. Capelastegui; Galdakao/ES, L. Mailli; London/UK
coefficient (ADC) measurements of the breast if
measured on different workstations? An inter- and 14:00
intra-reader agreement study B-0626 Overall evaluability of 80-kV multi-detector CTA of the
P. Clauser1, M. Maieron1, M. Marcon1, C. Zuiani1, M. Bazzocchi1, P.A.T. Baltzer2;
1
Udine / IT, 2Vienna / AT thoracic aorta using a not-tailored injection protocol
with low concentration iso-osmolar iodinated contrast
14:08 medium
B-0616 Diffusion-weighted imaging with background body A.D. Annoni, A. Formenti, G. Pontone, S. Mushtaq, M. Petullà, E. Bertella,
E. Nobili, M. Pepi, D. Andreini; Milan / IT
signal suppression (DWIBS) imaging of breast lesions
before and aer gadolinium injection 14:08
M. Telegrafo, M. Moschetta, A. Stabile Ianora, G. Angelelli; Bari / IT
B-0627 CTA of the aorta using 80kVp in combination
14:16 with iterative reconstruction:
B-0617 The influence of size and position of the region of evaluation of image quality and dose reduction
J. Boos, J. Aissa, R.S. Lanzman, P. Heusch, L. Schimmöller, G. Antoch, P. Kröpil;
interest on the apparent diffusion coefficient values in Düsseldorf / DE
discriminating between benign and malignant breast
lesions in diffusion weighted imaging 14:16
M. Wielema, M.D. Dorrius, H. Dijkstra, M. Oudkerk, P.E. Sijens; Groningen / NL B-0628 CT dose reduction using sequential or fast pitch spiral
14:24 technique employed in CTA of the aorta:
B-0618 Sensitivity of dynamic contrast-enhanced and results from the CT dose study
A.M. Bucher1, M. Renker2, F.G. Meinel3, T.J. Vogl1, K.M. Chinnaiyan4, G.L. Raff4,
diffusion-weighted MRI in the detection of ductal U.J. Schoepf5; 1Frankfurt a. Main / DE, 2Giessen / DE, 3Munich / DE, 4Royal Oak,
carcinoma in situ and correlation with nuclear grade MI / US, 5Charleston, SC / US
C. Borelli, G.K. Parapatt, R. Fubelli, C. Buccheri, M. Giuliani, P. Rinaldi, P. Belli,
L. Bonomo; Rome / IT 14:24
B-0629 Lower limbs low voltage (80kV) CTA:
14:32 lower radiation dose delivered and less contrast
B-0619 Traffic light labelling of the apparent diffusion medium with preservation of image quality
coefficient improves specificity of breast MRI M. Belgrano, C. Cercato, W. Toscano, A. Rossi, M.A. Cova, M. Cazzagon;
M. Dietzel1, A. Baltzer2, P.A.T. Baltzer2; 1Erlangen / DE, 2Vienna / AT Trieste / IT

14:40 14:32
B-0620 Are morphologic descriptors of MR BIRADS lexicon B-0630 Low-dose runoff CTA in overweight and obese
applicable to breast DWI? patients: effect of hybrid iterative reconstruction
V. Piccione, L. Martincich, S. Carabalona, M. Eandi, S. Osano, F. Astegiano,
D. Regge; Candiolo / IT technique on image quality
V. Aznaurov, E.V. Kondratyev, V. Shirokov, P. Davydenko, G.G. Karmazanovsky;
Moscow / RU
14:48
B-0621 Diffusion-weighted imaging at 3T: 14:40
correlation of the apparent diffusion coefficient B-0631 Location and severity of aortic valve calcium in
value with breast cancer biomarkers patients undergoing transcatheter aortic valve
M. Telesca, F. Pediconi, S. Ursu, M. Luciani, C. De Felice, V. Cipolla, C. Catalano;
Rome / IT implantation
P. Apfaltrer1, T. Henzler1, S. Wolke1, H. Schroefel2, S. Schoenberg1, G. Schymik2;
1
Mannheim / DE, 2Karlsruhe / DE
14:56
B-0622 Role of unenhanced breast MRI for detecting and
differentiating breast lesions
M. Moschetta, M. Telegrafo, E. Tricarico, L. Rella, A. Stabile Ianora, G. Angelelli;
Bari / IT

274 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:48 14:40
B-0632 Accuracy and time-efficiency of multi-path curved B-0642 Ultrasound versus magnetic resonance imaging
planar reformations in the evaluation of low-dose CT for Morton neuroma: systematic review and
angiography of the peripheral arteries meta-analysis
M.M. Schreiner, C. Loewe, S. Unterhumer, M. Weber, G. Mistelbauer, M. Sramek, B. Bignotti, A. Signori, M. Sormani, L. Molfetta, S. Airaldi, F. Zaottini,
E. Gröller, R.E. Schernthaner; Vienna / AT G. Tagliafico, C. Martinoli, A. Tagliafico; Genoa / IT

14:56 14:48
B-0633 3D DCE-MRA in evaluation of blood-flow in diabetic B-0643 Fascicular involvement in common peroneal
foot neuropathy: evaluation with ultrasound
M. Zamyshevskaya, V. Zavadovskaya, M. Zorkaltsev, V. Udodov, E. Grigoriev; S. Airaldi, B. Bignotti, F. Zaottini, G. Tagliafico, A. Tagliafico, C. Martinoli;
Tomsk / RU Genoa / IT

15:04 14:56
B-0634 Differential diagnosis of chronic total occlusive and B-0644 Ultrasound versus magnetic resonance imaging
subtotal occlusive disease of the lower extremity in common peroneal neuropathy
arteries using reverse attenuation gradient sign on S. Airaldi, B. Bignotti, F. Zaottini, G. Tagliafico, A. Tagliafico, C. Martinoli;
Genoa / IT
CTA
H.J. Park; Seoul / KR 15:04
15:12 B-0645 The quantitative MRI evaluation of repair tissue aer
B-0635 Dynamic assessment of deep vein thrombosis: microfracture treatment for ankle osteochondritis
CE MR venography with a bloodpool agent vs duplex dissecans (OCD)
H. Tao, Y. Qiao, S. Chen; Shanghai / CN
ultrasound and contrast venography

Thursday
C.W.K.P. Arnoldussen1, R. Strijkers2, R. de Graaf2, C.H.A. Wittens3, 15:12
J.E. Wildberger2; 1Maastricht / NL, Venlo / NL, 2Maastricht / NL, 3Aachen / DE,
Maastricht / NL B-0646 Knee joint subchondral bone structure is altered in
active athletes
15:20 F.W. Roemer1, M. Jarraya2, J. Niu2, J. Duryea2, J. Lynch3, A. Guermazi1; 1Doha / QA,
B-0636 Thrombus dissolution using contrast enhanced
2
Boston, MA / US, 3San Francisco, CA / US
ultrasound in an in-vitro model of acute deep vein 15:20
thrombosis B-0647 Efficacy of computed tomography (CT) guided
1 1 2 2 1 1
B. Dharmarajah , T. McKinnon , C. Keravnou , M. Averkiou , A. Davies , E. Leen ;
1
London / UK, 2Nicosia / CY radiofrequency ablation (RFA) for osteoid osteomas in
31 patients
J. Kim, E. Lee; Seongnam-si / KR
14:00–15:30 Room E1

Musculoskeletal 14:00–15:30 Room E2

SS 710 Lower extremity (2) Neuro


Moderators: A.M. Ierardi; Varese/IT, M. Reijnierse; Leiden/NL
SS 711 Brain tumour (2)
14:00 Moderators: J.S. Bauer; Munich/DE, P. Due-Tonnessen; Oslo/NO
B-0637 Quantitative MRI evaluation of subchondral sclerosis
at the tibial plateau 14:00
J.W. MacKay, P. Murray, B. Kasmai, S. Donell, A.P. Toms; Norwich / UK B-0648 The diagnostic benefit of T1-DCE MRI for navigated
glioma biopsies
14:08 V.C. Keil, A.M. Vogelgesang, B. Pintea, G. Gielen, J. Gieseke, M. Simon,
B-0638 Quality validation in posterior cruciate ligament H.H. Schild, D.R. Hadizadeh; Bonn / DE
reconstruction: fluoroscopy, radiography and 14:08
computed tomography B-0649 Brain tumours: contribution of diffusion MRI, perfusion
A. Krawinkel, M. Osti, K. Benedetto, M. Cejna; Feldkirch / AT
MRI and spectroscopy in grading primary cerebral
14:16 gliomas and the differentiation of high-grade gliomas
B-0639 Femoral and tibial torsion measurements in children: from solitary metastasis
comparison of MR imaging and 3D models based on K. Drevelegas, D. Chourmouzi, M. Potsi, A. Moumtzouoglou, A. Drevelegas;
Thessaloniki / GR
low-dose biplanar radiographs
A.B. Rosskopf, L.E. Ramseier, C.W.A. Pfirrmann, F.M. Buck; Zurich / CH 14:16
14:24 B-0650 Comparing gadolinium-based DSC perfusion MRI
B-0640 Prevalence of bone marrow oedema and its in malignant brain tumours with and without
association with structural damage in patients with leakage correction
J. Prola Netto, B. Hamilton, C. Varallyay, E. Neuwelt; Portland, OR / US
femoroacetabular impingement syndrome using MRI
Y. Ragab, Y. Emad, A. Anbar; Cairo / EG 14:24
14:32 B-0651 Pseudoprogression or true progression in high-grade
B-0641 Muscle and tendon damage aer gliomas post radiation and chemotherapy:
total hip arthroplasty: incremental value of functional imaging
MRI evaluation of different surgical approaches over conventional MRI
C.A. Agten, R. Sutter, C. Dora, C.W.A. Pfirrmann; Zurich / CH D. Das, S. Arya; New Delhi / IN

www.myESR.org Final Programme | ECR 2015 275


Scientific Sessions

14:40 14:40
B-0653 Dynamic T1 contrast-enhanced MRI of peritumoural B-0664 Accuracy of retrospective PET and MRI-DWI (PET/
white matter in differentiation between glioblastoma MRI-DWI) image fusion in detection of cervical and
multiforme and metastatic tumour endometrial cancer lymph node metastases:
R. Tupý, J. Ferda, J. Kastner, O. Hes, V. Přibáň; Plzen / CZ comparison with PET/CT and MRI-DWI
F. Buemi, A. Stecco, A. Cassarà, G. Sacchetti, R. Matheoud, M. Brambilla,
14:56 A. Arnulfo, A. Carriero; Novara / IT
B-0655 DWI and histological parameters in meningioma
A. Surov1, S. Gottschling2, A. Wienke2, C. Mawrin3, R. Spielmann2, J. Prell2, 14:48
E. Fiedler2; 1Leipzig / DE, 2Halle / DE, 3Magdeburg / DE B-0665 Role of DWI in cervical cancer for prediction and
15:04 monitoring of chemoradiotherapy response
P. Kala, V. BharGavi, R. Avantsa, G. Narayan; Bangalore / IN
B-0656 MRS in differentiating low-grade from high-grade
astrocytoma in children 14:56
M. Dziubinska-Basiak, M. Konopka, M. Basiak, M. Wicher, B-0666 CT performance for the pre-operative quantification
M. Machnikowska-Sokolowska, J. Walecki; Katowice / PL
of peritoneal carcinomatosis in ovarian cancer
15:12 S. Bennani, A.-S. Bats, F. Chamming’s, C. Bensaid, C. Bourillon, C. Couvidat,
F. Lecuru, L. Fournier; Paris / FR
B-0657 fMRI signal changes in the central nervous system
aer 3D based radiotherapy 15:04
A. Kovacs1, M. Emri2, C. Vandulek1, C. Glavak1, Z. Szalai1, G. Biro1, G. Bajzik1, B-0667 Accuracy of MDCT in preoperative definition of
I. Repa1; 1Kaposvár / HU, 2Debrecen / HU
peritoneal carcinomatosis of bowel loops in patients
15:20 with advanced ovarian cancer who underwent
B-0658 Diffusion Kurtosis imaging in diagnosis of malignancy peritonectomy and hyperthermic intraperitoneal
and proliferative activity of brain gliomas chemotherapy
A.S. Tonoyan1, I. Pronin1, F. Grinberg2, E. Farrher2, D. Pitskhelauri1, L. Fadeeva1, S. Guerrini, M.A. Mazzei, A. Cirigliano, N. Cioffi Squitieri, G. Bettini, F.G. Mazzei,
E. Pogosbekyan1, A. Potapov1, V. Kornienko1; 1Moscow / RU, 2Juelich / DE D. Marrelli, L. Volterrani; Siena / IT

15:12
14:00–15:30 Room F1 B-0668 Agreement in identification of tumour recurrence,
peritoneal deposits or distant metastasis in patients
Oncologic Imaging treated with ovarian cancer using MRI
K. Skrobisz-Balandowska, L. Klasa, M. Liro, D. Wydra, M. Studniarek,
SS 716 Urogenital oncology A. Bianek-Bodzak; Gdansk / PL
Moderators: R.A. Kubik-Huch; Baden/CH, I. Thomassin-Naggara; Paris/FR 15:20
14:00 B-0669 Prediction of 5-year survival with texture analysis in
B-0659 Prediction of response of primary tumours patients with ovarian cancer
I. Radlgruber, M.E. Mayerhoefer, S. Aust, S. Polterauer, M. Weber, S. Polterauer,
to neoadjuvant sunitinib using perfusion (DCE) CT T. Knogler; Vienna / AT
in metastatic renal cell carcinoma (mRCC) patients
(PREINSUT trial)
M. Bouaboula, Y. Vano, L. Mauge, H. Pereira, D. Helley, A. Mejean, C.-A. Cuenod, 14:00–15:30 Room F2
S. Oudard, L. Fournier; Paris / FR

14:16 Physics in Radiology


B-0661 Characterising adrenal 18F-FDG uptake SS 713 Innovations in CT technology
in oncologic patients by dynamic MDCT Moderators: P.E. Colombo; Milan/IT, I. Sechopoulos; Atlanta, GA/US
in combined PET/CT scanner
A. Regnaud, V. Soubeyran, H. Lang, M. Christodoulou, C. Constantin, 14:00
M.-E. Kamel; Sion / CH
B-0670 Reconstructing interventional C-arm CT rawdata from
14:08 non-conventional scan trajectories
J. Kuntz1, L. Ritschl2, C. Fleischmann2, M. Knaup1, M. Kachelrieß1;
B-0660 DWI of the renal cell carcinoma: applicability and 1
Heidelberg / DE, 2Nürnberg / DE
limitations of the apparent diffusion coefficient in
differential diagnostics of the malignant renal lesions 14:08
Y. Mytsyk, Y. Borys, I. Dutka, I. Komnatska, I. Datz, I. Shatynska-Mytsyk; Lviv / UA B-0671 Imaging blood vessel boundaries in photon counting
14:24 spectral CT with the nonlinear partial volume effect
M. Persson, H. Bornefalk, F. Grönberg, B. Huber, S. Karlsson, X. Liu, M. Sjölin,
B-0662 Pretreatment DCE-MRI estimates of extravascular M. Danielsson; Stockholm / SE
extracellular volume (ve) predict for survival following
therapy for muscle invasive bladder transitional cell 14:16
carcinoma (TCC) B-0672 Evaluation of a low iodine concentration contrast
T.D. Westwood, L.E. Kershaw, S.B. Donaldson, B.M. Carrington, R. Cowan, media in abdominal multiphasic CT using spectral
J. Lyons, T. Elliot, A. Choudhury, S. Bonington; Manchester / UK imaging: a prospective study on 210 patients
C. Roy, F. Severac, M. Ohana, A. Labani, N. Chakfe; Strasbourg / FR
14:32
B-0663 A MRI scoring system for predicting endometrial vs 14:24
cervical origin in patients with bulky uterine masses B-0674 Does dual energy dual source CT with energy-selective
of indeterminate histology photon counting detectors make sense?
C. Bourgioti, K. Chatoupis, E. Panourgias, C. Tzavara, L. Moulopoulos; S. Faby1, S. Kuchenbecker1, D. Simons1, H.-P. Schlemmer1, M. Lell2,
Athens / GR M. Kachelrieß1; 1Heidelberg / DE, 2Erlangen / DE

276 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:32 14:41
B-0675 Empirical dual-energy beam hardening correction in B-0686 Comparison of diagnostic capability for N-stage in
dual-energy CT non-small cell lung cancer patients with DWI using EPI
S. Schüller1, S. Sawall1, M. Lell2, M. Kachelrieß1; 1Heidelberg / DE, 2Erlangen / DE sequence at 3T and FDG-PET/CT
Y. Ohno1, S. Seki1, H. Koyama1, Y. Kassai2, M. Yui2, T. Yoshikawa1, S. Matsumoto1,
14:40 K. Sugimura1; 1Kobe / JP, 2Otawara / JP
B-0676 Dual source dual energy CT for kidney stones:
impact of patient motion 14:49
B. Krauss, B. Schmidt, T. Allmendinger, T. Flohr; Forchheim / DE B-0687 Multifunctional assessment of NSCLC using
whole-body MRI with DWI and 18F-FDG-PET/CT:
14:48 correlation between ADC and metabolic volumetric
B-0677 A comparison of image quality between fine focal spot and non-volumetric parameters
and standard focal spot CT of the abdomen and pelvis L. Calandriello, A. Larici, M. Ciliberto, A. del Ciello, L. Leccisotti, A. Giordano,
Y.P. Goh, K.K. Lau, K.Y. Low, C.W. Oh, M. Huynh, K. Buchan, A. Kuganesan; L. Bonomo; Rome / IT
Melbourne / AU
14:57
14:56 B-0688 Sequential dynamic PET and dynamic MR imaging
B-0678 Alpha-image reconstruction: a novel iterative image in N-staging of lung cancer patients
reconstruction algorithm with well-defined image P. Flechsig, H. Zabeck, C.-P. Heußel, H.-U. Kauczor, U. Haberkorn, F. Giesel;
quality metrics applied to clinical CT data Heidelberg / DE
S. Lebedev, S. Sawall, M. Knaup, M. Kachelrieß; Heidelberg / DE
15:05
15:04 B-0689 Dynamic contrast-enhanced perfusion area-detector
B-0679 Iterative model reconstruction and hybrid iterative CT in non-small cell lung cancer patients with
reconstruction techniques in liver CT for evaluation

Thursday
chemoradiotherapy: influence of mathematical model
of hepatocellular carcinoma: to early prediction of recurrence
comparison of image quality in the detection of Y. Ohno1, S. Seki1, H. Koyama1, T. Yoshikawa1, S. Matsumoto1, Y. Fujisawa2,
N. Sugihara2, K. Sugimura1; 1Kobe / JP, 2Otawara / JP
hypervascular hepatocellular carcinoma
H. Park, J. Lee, S. Park, J. Lee, Y.-K. Jeong; Seoul / KR
15:13
15:12 B-0690 Value of computerised 3D shape analysis in
B-0680 The influence of the orbital bone density differentiating encapsulated from invasive thymomas
J. Lee, C. Park, S. Park, J. Bae, S. Lee, J. Goo; Seoul / KR
on the eye-lens dose in dental CBCT
A. Stratis, G. Zhang, R. Jacobs, R. Bogaerts, H. Bosmans; Leuven / BE

14:00–15:30 Room D2
14:00–15:30 Room D1
Interventional Radiology
Chest SS 709a TIPS and portal vein intervention
SS 704 Lung cancer: screening and staging Moderators: A. Krajina; Hradec Králové/CZ, A. Massmann; Homburg/DE
Moderators: F. Gleeson; Oxford/UK, T. Henzler; Mannheim/DE
14:00
14:00 B-0691 Comparison of hepatic venous pressure gradient and
K-16 Keynote lecture endoscopic grading of oesophageal varix
P.A. Grenier; Paris / FR E. Lee1, Y. Kim1, S. Yang2, D. Goo1, J. Hwang1, S. Hong1, J. Hwang1, H.-J. Kim1;
1
Seoul / KR, 2Gumi / KR
14:09
14:08
B-0681 Diagnostic performance of ultra-low-dose computed
B-0692 Towards a turning point in gastric varices treatment:
tomography for detecting asbestos-related
modified balloon-occluded retrograde transvenous
pleuropulmonary diseases:
obliteration
prospective study in a screening setting M.-Y. Chang, M. Kim, S. Lee, G. Kim, J. Won, S. Park, D. Lee; Seoul / KR
M. Schaal, F. Severac, A. Labani, M.-Y. Jeung, C. Roy, M. Ohana; Strasbourg / FR
14:16
14:17
B-0693 Fast balloon-occluded retrograde transvenous
B-0682 Pleural abnormalities in lung cancer screening trial:
obliteration using n- butyl cyanoacrylate aer foam
prevalence, features, and relation with cancer
M. Silva1, N. Sverzellati1, D. Colombi1, C. La Vecchia2, C. Galeone2, A. Marchiano2, sclerosants for gastric varices
U. Pastorino2; 1Parma / IT, 2Milan / IT J. Koizumi, C. Itou, T. Hara, T. Sekiguchi, N. Mori, S. Ono, T. Ichikawa, C. Tanaka,
Y. Imai; Isehara / JP
14:25
14:24
B-0683 Parametric response mapping in lung cancer screening
B-0695 Long-term outcome of expandable-polytetraethylene
subjects with and without COPD
E. Pompe1, E.M. van Rikxoort2, L. Gallardo Estrella2, M. Oudkerk3, H.J. de (e-PTFE) covered stents for transjugular intrahepatic
Koning4, J.-W.J. Lammers1, B. van Ginneken2, P.A. de Jong1, F.A.A. Mohamed portosystemic shunts (TIPS)
Hoesein1; 1Utrecht / NL, 2Nijmegen / NL, 3Groningen / NL, 4Rotterdam / NL B. Geeroms, W. Laleman, S. Heye, C. Verslype, F. Nevens, G. Maleux; Leuven / BE

14:33
B-0685 Screening for lung cancer using ultra-low dose
computed tomography with Iterative model
reconstruction algorithm
M. Zhang, Y. Sun, W. Qi, Y. Jiang, Y. Liu, N. Hong; Beijing / CN

www.myESR.org Final Programme | ECR 2015 277


Scientific Sessions

14:32 14:32
B-0696 Digital subtraction angiography during TIPS creation or B-0706 Feasibility of a pneumatically actuated MR-compatible
revision: data on radiation exposure and image quality second generation robot for transrectal prostate
obtained using a standard and a low-dose acquisition biopsy guidance by using the PIRADS classification
protocol in a flat-panel detector-based system D. Yakar, J. Bomers, D. Bosboom, J.J. Fütterer; Nijmegen / NL
M. D’Amico, R. Miraglia, L. Maruzzelli, C. Tafaro, R. Gerasia, A. Luca; Palermo / IT
14:40
14:40 B-0707 Angio-uro dynamic functional MRI: difference between
B-0697 A real-time three-dimensional ultrasound user this new technique and the traditional investigations
interface for TIPS: preliminary results in patients with pathology of the urinary tract (work
C. Klink1, C.F. Cuijpers2, E. Varga2, J. Banerjee1, P. Stappers2, A. Moelker1, T. van in progress)
Walsum1, A. Freudenthal2; 1Rotterdam / NL, 2Del / NL A. Viviani, L. Moreschi, E. Ricci, C. Guerra; Pescia / IT
14:48 14:48
B-0698 Clinical outcomes of selective variceal coil B-0708 Reproducibility and agreement in quantification of
embolisation during PTFE-covered transjugular renal function using 1.5-T DCE-MRI
intrahepatic portosystemic shunt (TIPS) placement for E. Eike ord, E. Andersen, A. Lundervold, E. Hodneland, J. Monssen, E. Hanson,
variceal hemorrhage J. Rørvik; Bergen / NO
C.N. Weber, B.H. Ge, T.W.I. Clark, M.C. Soulen, G.J. Nadolski; Philadelphia, PA / US
14:56
14:56 B-0709 Arterial spin labeling and T1-mapping allow
B-0700 Benefit and safety of combined partial splenic detection of acute kidney injury in patients aer lung
artery embolisation to transjugular intrahepatic transplantation
portosystemic shunt for the treatment of portal M.J. Peperhove, D. Hartung, S. Tewes, M.-S. Jang, B. Jüttner, R. Lichtinghagen,
G. Warnecke, F. Gueler, K. Hueper; Hannover / DE
hypertension: a pilot study
A. Geffray, J. Pucheux, L. d’Alteroche, M. Sainz Barriga, D. Alison, J.-M. Perarnau; 15:04
Chambray-Lès-Tours / FR
B-0710 Distribution profile of gadolinium (Gd) in gadolinium
15:04 chelate-treated renally impaired rats:
B-0701 Portal vein embolisation with histoacryl via an role of pharmaceutical formulation
ipsilateral approach is safe and effective N. Fretellier1, M. Salhi1, J. Schroeder2, T. Chevalier1, G. Jestin-Mayer1, J.-F. Mayer1,
C. Loberg, M. Schmeding, C.K. Kuhl, P. Bruners; Aachen / DE B. Bonnemain1, J.-M. Idée1, C. Corot1; 1Roissy / FR, 2Regensburg / DE

15:12
14:00–15:30 Room G B-0711 Nonionic iodinated contrast medium (CM) and
risk of nephrotoxicity: results of a prospective study
Genitourinary G.M. Giuseppetti, G. Polonara, S. Galassi, G.M. Frascà, F.P. Gentile, L. Ferrante,
E. Skrami, S. Amoroso; Ancona / IT
SS 707 New frontiers and contrast agents in 15:20
GU imaging B-0712 NSsaFe study: determining the incidence
Moderators: S. Dudea; Cluj-Napoca/RO, M. Onur; Elazig/TR of nephrogenic systemic fibrosis aer administration
of Dotarem in patients with renal impairment
14:00 R.G. McWilliams; Liverpool / UK
B-0702 Magnetisation transfer MR imaging of normal and
abnormal testis: initial experience
A. Tsili, A. Ntorkou, D. Baltogiannis, S. Stavrou, V. Maliakas, N. Sofikitis, 14:00–15:30 Room K
M. Argyropoulou; Ioannina / GR

14:08 Interventional Radiology


B-0703 Added value of multi-parametric ultrasound (mpUS) in SS 709b Biopsy techniques and solid tumour
magnetic resonance imaging (MRI)/US fusion-guided
biopsy of the prostate in patients with suspicion for
ablation
Moderators: O. Akhan; Ankara/TR, M. Reiter; Vienna/AT
prostate cancer
T. Fischer, C. Stephan, A. Maxeiner; Berlin / DE 14:00
14:16 B-0713 Clinical application of robotic system for CT-guided
B-0704 Cognitive target MRI-TRUS fusion biopsies of MRI biopsy of lung lesions in comparison to the manual
detected PIRADS 4 and 5 lesions technique
P.P. van Westerveld, J.L.J. Vriesema, J.H.W. van den Hout, E.B. Cornel, J. Veltman; R. Argirò, M. Anzidei, A. Porfiri, M. Bezzi, M. Anile, F. Venuta, C. Catalano;
Almelo / NL Rome / IT

14:24 14:08
B-0705 Computer-assistant histoscanning-targeted prostate B-0714 Robot-assisted navigation system for CT-guided
biopsies in diagnosis of PCa: a pilot study percutaneous lung lesions procedures:
A. Fedorova, S. Salnikova, A. Pavlovichev, N. Sokolova, G. Varlamov, A. Zubarev; our experience in Hong Kong
Moscow / RU C. Chu, S.C. Yu; Shatin / HK

14:16
B-0715 Value of contrast-enhanced ultrasound guided
percutaneous biopsy in peripheral pulmonary lesions
Y. Dong, W.-P. Wang, F. Mao, B. Huang; Shanghai / CN

278 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:24 14:08
B-0716 CT-fluoroscopy guidance for lung biopsies performed B-0725 Diagnostic performance of cone beam computed
by clinical fellows without prior training: tomography and MDCT in diagnostic imaging of the
radiation dose and workflow midface: a comparative study on phantoms and
A. Ghali, P. Rogalla, S. Kandel; Toronto, ON / CA cadaver head scans
S. Veldhoen1, M. Schöllchen2, H. Hanken2, C. Precht1, F.O.O. Henes2, G. Schön2,
14:32 M. Heiland2, G. Adam2, M. Regier2; 1Würzburg / DE, 2Hamburg / DE
B-0717 Cone-beam CT vs CT in lung ablation procedure:
which is faster? 14:16
R. Cazzato1, J. Battistuzzi2, R. Grasso1, X. Buy2, J. Palussiere2; 1Rome / IT, B-0726 Pre- and postoperative head radiography and MSCT
2
Bordeaux / FR imaging in patients with zygomatico-orbital trauma
O.Y. Pavlova, N.S. Serova; Moscow / RU
14:40
B-0718 Percutaneous thermal ablation of breast cancer 14:24
metastases in oligometastatic patients: B-0727 Clinical aspects of imaging quality in visualisation
local control and disease-free survival of anterior and lateral skull base
M. Barral1, A. Auperin1, A. Hakime1, S. Delaloge1, V. Cartier1, V. Tacher1, C. Gueldner, J. Voigt, R. Leppek, J. Werner; Marburg / DE
Y. Otmezguine2, T. de Baere1, F. Deschamps1; 1Villejuif / FR, 2Boulogne
Billancourt / FR 14:32
14:48 B-0728 Reducing the dose of CT of paranasal sinuses:
possibilities using an iteractive reconstruction
B-0719 Pancreatic lesions core biopsy -
algorithm
analysis of efficacy and complications S.M. Niehues, L.-A. Schaafs, B. Hamm; Berlin / DE
M. Studniarek1, K. Gwozdziewicz1, M. Czarnowska-Cubala1, T. Gorycki1,
P. Szlezak2; 1Gdansk / PL, 2Bydgoszcz / PL
14:40

Thursday
14:56 B-0729 80-kVp neck computed tomography in patients
B-0720 Percutaneous microwave ablation (MWA) of renal with suspected peritonsillar abscess:
tumours: intermediate-term results and usefulness evaluation of objective and subjective image quality,
of R.E.N.A.L. scoring for predicting outcomes and and reduction of radiation exposure
J.-E. Scholtz, K. Hüsers, M.H. Albrecht, M. Beeres, M. Kaup, B. Schulz,
complications R.W. Bauer, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main / DE
C. Floridi, L. Nocchi, F. Fontana, A. Ierardi, G. De Marchi, C. Fugazzola,
G. Carrafiello; Varese (VA) / IT
14:48
15:04 B-0730 Assessment of an advanced monoenergetic
B-0721 Retrospective comparison between renal reconstruction technique in dual-energy computed
tumours treated with RFA and laparoscopic tomography of head and neck cancer
M.H. Albrecht, J.-E. Scholtz, R.W. Bauer, M. Kaup, I. Burck, J. Wagenblast,
partial nephrectomy T. Lehnert, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main / DE
V. Acosta Ruiz, P. Dahlman, E. Brekkan, A. Magnusson, M. Häggman,
S. Ladjevardi, M. Lönnemark; Uppsala / SE
14:56
15:12 B-0731 Non-linear image blending for dual energy
B-0722 Radiofrequency ablation of prevertebral sympathetic CT improves visualisation of head and neck
ganglia in patients with essential arterial primary squamous cell carcinoma compared
hypertension for lowering blood pressure to linear blending technique
G. Knyshov, B. Batsak; Kiev / UA J.-E. Scholtz, K. Hüsers, M. Kaup, M. Albrecht, C. Frellesen, R.W. Bauer, J.M. Kerl,
T.J. Vogl, J.L. Wichmann; Frankfurt / DE
15:20
15:04
B-0723 Laser and radiofrequency ablation in the treatment of
B-0732 Direct and indirect organ dose distribution
benign thyroid nodules
G. Mauri, L. Cova, T. Ierace, A. Baroli, L. Solbiati; Busto Arsizio / IT measurements in fluoroscopic swallow examinations
with a modern flat detector system and dose
reduction techniques -a phantom study
14:00–15:30 Room MB 1 A. Pomschar1, J. Weiß2, K. Neumaier1, M. Li1, W. Flatz1, B. Ertl-Wagner1,
M. Peller1, M.F. Reiser1, M. Notohamiprodjo2; 1Munich / DE, 2Tübingen / DE
Head and Neck 15:12
SS 708 CT including cone beam CT: B-0733 Quantitative analyses of 3-D volumetry and histogram
image quality, dosimetry and of thyroid gland on CT: can thyroid CT reflect thyroid
function in the patients with hypothyroidism?
clinical applications K. Lee, J. Ryu; Busan / KR
Moderators: B. Gómez-Ansón; Barcelona/ES,
D.-A. Varoquaux; Marseille/FR 15:20
B-0734 Comparison of incidental findings between normal and
14:00
obstructive sleep apnea patients using cone beam
B-0724 A dentalscan or a multi-layer digital
computed tomography scans
ortopantomography in the study of the jaws? K. Orhan1, U. Oz2, M. Misirli3, S. Aksoy3, F. Rasmussen3; 1Ankara / TR, 2Lefkosa,
A dosimetric evaluation on a CBCT device Mersin 10 / TR, 3Lefkosa, Mersin 10, / TR
F. Testa1, E. Fumero1, E. Roberto2, S. Chauvie2, R. Olivero1, M. Lo Bello1,
D. Fraire1; 1Bra / IT, 2Cuneo / IT

www.myESR.org Final Programme | ECR 2015 279


Scientific Sessions

14:00–15:30 Room MB 2 15:20


B-0745 Non-traumatic colorectal perforation:
GI Tract assessment with MDCT
P.P. Saturnino; Naples / IT
SS 701b Colonic imaging
Moderators: P. Lefere; Roeselare/BE, T. Mang; Vienna/AT
14:00–15:30 Room MB 3
14:00
B-0735 Selection of colon cancer patients for neoadjuvant Cardiac
chemotherapy based on optimised preoperative MDCT
A prospective multi-observer radiologic-pathologic SS 703 Work-up of coronary artery disease
agreement study Moderators: M. Das; Maastricht/NL, S. Mirsadraee; Edinburgh/UK
E. Rosado, A. Germano, A. Costa, R. Theias, A. Gomes, C. Leichsenring,
I. Santiago; Amadora / PT 14:00
B-0746 Characterisation of human coronary atherosclerotic
14:08
plaques with phase-contrast imaging
B-0736 Computer tomography colonography participation and S. Winklhofer1, S. Peter2, V. Tischler1, F. Morsbach1, P. Modregger2,
yield in patients under surveillance for 6-9 mm polyps M. Stampanoni2, M. Thali1, H. Alkadhi1, P. Stolzmann1; 1Zurich / CH, 2Villigen / CH
in a population-based screening trial
C.J. Tutein Nolthenius1, T.N. Boellaard1, Y. Nio1, M.G. Thomeer2, M. de Haan3, 14:08
S. Bipat1, A. Montauban van Swijndregt1, J. Stoker1; 1Amsterdam / NL, B-0747 Double acquisition of CCTA with and without
2
Rotterdam / NL, 3Amersfoort / NL
intravenous vasodilator injection for the diagnosis
14:16 of vasospastic angina: pilot study
E.-J. Kang, K.-N. Lee, J.-H. Lee, H. Kwon, M. Kim; Busan / KR
B-0737 Diagnostic value of computed tomography for staging
colon cancer: a meta-analysis 14:16
E. Nerad1, M.J. Lahaye2, M. Maas2, G.L. Beets2, P. Nelemans2, R.G.H. Beets-Tan2;
1
Eindhoven / NL, 2Maastricht / NL B-0748 Diagnostic yield and accuracy of coronary CT
angiography aer abnormal nuclear myocardial
14:24 perfusion imaging
B-0738 Impact of virtual colonoscopy in the management F.G. Meinel1, U.J. Schoepf2, L.L. Geyer1, A.M. Khan2, V.L. Fernandes2, T.X. O’Brien2;
1
Munich / DE, 2Charleston, SC / US
of patients referred to a tertiary hospital aer an
incomplete colonoscopy 14:24
R. Ferrari1, L. Bertana2, D. Bellini2, T. Biondi2, D. Caruso2, A. Laghi2; 1Rome / IT,
2
Latina / IT B-0749 Comparison fractional flow reserve (FFR),
instantaneous wave-free ratio (iFR) and
14:32 quantitative assessment SPECT-CT in evaluation
B-0739 Virtual colonoscopy under 2 mSv with iterative of intermediate stenosis
reconstruction - are we ready? V. Solomyanyy; Moscow / RU
R. Ferrari, L. Bertana, T. Biondi, D. Bellini, D. Caruso, A. Laghi; Rome / IT
14:32
14:40 B-0750 Impact of coronary CTA use for acute chest pain
B-0740 Does model-based iterative reconstruction technique patients on overall ED performance:
provide advantage in ultra-low dose submilisievert CT system dynamics model analysis
colonography? A. Goehler1, S. Huber1, F. Nautsch1, J. Nagurney2, G. Gazelle2, U. Hoffmann2,
L. Lambert , J. Danes , L. Simakova , J. Jahoda , P. Ourednicek ; Prague / CZ,
1 1 1 1 2 1 H. Wong3; 1New Haven, CT / US, 2Boston, MA / US, 3Toronto, ON / CA
2
Brno / CZ
14:40
14:48 B-0751 ED triage strategies for acute chest pain -
B-0741 Accuracy of ultra-low-dose CTC with iterative longterm clinical and economic outcomes:
reconstructions in the detection of intermediate and going beyond the ROMICAT II trial
diminutive polyps A. Goehler1, T. Mayrhofer2, A. Pursani2, H. Lumish2, J. Nagurney2, Q. Truong2,
F. Pancrazi, P. Scalise, A. Mantarro, E. Guidi, D. Gambaccini, M. Bertini, E. Neri, B. Chow3, G. Gazelle2, U. Hoffmann2; 1New Haven, CT / US, 2Boston, MA / US,
C. Bartolozzi; Pisa / IT
3
Ottawa, BC / CA

14:56 14:48
B-0742 Image quality assessment of ultra low-dose CT B-0752 Evaluation of diagnostic value of a novel non-invasive
colonography using sinogram-affirmed iterative coronary computed tomography angiography
reconstruction algorithm versus standard coronary angiography for
A. Delli Pizzi, R. Cianci, A. Filippone, M. Timpani, A. Tavoletta, G. Esposito, assessing fractional flow reserve
P. Pulsone, A.R. Cotroneo; Chieti / IT S. Mangold, M. Renker, S. Baumann, R. Wang, F.G. Meinel, J.L. Wichmann,
R.R. Bayer, D.H. Steinberg, U.J. Schoepf; Charleston, SC / US
15:04
B-0743 Anatomic variability of the colon: 14:56
a study with CT-colonography B-0753 The effect of coronary calcium deposits and
M. Pancot, R. Girometti, C. Zuiani, M. Bazzocchi; Udine / IT CT acquisition artifacts on coronary CT
angiography derived fractional flow reserve,
15:12 validated by invasive FFR
B-0744 Treatment of perityphlitic abscess: comparison A. Coenen, M.M. Lubbers, A. Kurata, A. Kono, A. Dedic, R.G. Chelu,
of interventional and surgical management M.L. Dijkshoorn, R.-J. van Geuns, K. Nieman; Rotterdam / NL
B. Mensel, L.I. Partecke, J.-P. Kühn, W. Keßler, M. Patrzyk; Greifswald / DE

280 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

15:04
B-0754 Dynamic first pass CT perfusion imaging
of the myocardium vs. intracoronary transluminal
attenuation gradient in coronary CT angiography
for the assessment of coronary artery stenosis
B.M. Gramer1, I. Baur1, M. Rasper1, V. Leber1, A. Leber1, M. Vembar2,
E.J. Rummeny1, A.M. Huber1; 1Munich / DE, 2Cleveland, OH / US

15:12
B-0755 Incremental diagnostic value of functional CT
for the assessment of hemodynamically significant
coronary artery disease: a meta-analysis
R.A.P. Takx1, T. Leiner2, U. Hoffmann1; 1Boston, MA / US, 2Utrecht / NL

15:20
B-0756 Regadenoson-stress dynamic myocardial
perfusion with computed tomography -
diagnostic performance and contribution
in patients prior major vascular surgery
J. Baxa, J. Ferda, M. Hromadka, J. Sedivy, T. Matouskova, B. Kreuzberg; Pilsen / CZ

Thursday

www.myESR.org Final Programme | ECR 2015 281


Scientific Sessions

10:30–12:00 Room C 11:50


B-0767 MR-guided vacuum-assisted breast biopsy:
Breast influence of biopsy device, lesion type and size on
SS 1002 Breast MRI indications and false negative results and underestimation rates
C. Spick, T.H. Helbich, K. Pinker-Domenig, H. Bickel, S.H. Polanec, G. Wengert,
MR-guided biopsy H. Magometschnigg, P.A.T. Baltzer; Vienna / AT
Moderators: G. Esen; Istanbul/TR, S. Schrading; Aachen/DE

10:30 10:30–12:00 Room Z


B-0757 Worldwide practice of breast MRI: insights from the
MIPA study applications - the MIPA study group Vascular
G. Di Leo1, R.M. Trimboli1, I. Ioan2, L.A. Carbonaro1, T.H. Helbich3, F.J. Gilbert4,
N. Houssami5, F. Sardanelli1; 1San Donato Milanese / IT, 2Milan / IT, 3Vienna / AT, SS 1015 Low dose and low contrast
4
Rotterdam / NL, 5Sydney / AU
in vascular imaging
10:38 Moderators: K. Nikolaou; Tübingen/DE, G. Tsoumakidou; Strasbourg/FR
B-0758 Is late-phase information necessary for dynamic 10:30
evaluation of breast cancer?
M.U. Dalmis, A. Gubern Mérida, S. Vreemann, B. Platel, R.M. Mann, B-0768 How does patient breathing influence contrast
N. Karssemeijer; Nijmegen / NL enhancement in central arteries?
A. Gutzeit1, C. Reischauer1, J.E. Roos2, J.M. Froehlich1; 1Lucerne / CH, 2Durham,
10:46 NC / US
B-0759 MRI for diagnosis of malignancy in mammographic 10:38
microcalcifications: a systematic review and
B-0769 Factors influencing contrast bolus geometry during
meta-analysis
B. Bennani-Baiti, P.A.T. Baltzer; Vienna / AT dynamic CTA: in-vitro evaluation using a pulsatile
flow model and in-vivo application
10:54 J. Lee, J. Kwon; Daegu / KR
B-0760 Breast MRI adds high negative predictive value in 10:46
a large cohort of patients with microcalcifications
B-0770 Advanced model-based monoenergetic dual-energy
BI-RADS 3 to 5
A. Cervera Araez, J. Camps Herrero, E. Garcia Oliver, V. Ricart Selma, M. Forment CTA of the abdomen: optimisation of keV settings
Navarro, C. Martinez Rubio, J. Cano Gimeno, I. Martinez Gómez; Valencia / ES M.H. Albrecht, J.-E. Scholtz, K. Hüsers, M. Kaup, A.M. Bucher, R.W. Bauer,
T. Lehnert, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main / DE
11:02
10:54
B-0761 Evaluation of T1/T2 ratios in a pilot study as a
B-0772 Comparison of the diagnostic efficacy of three
potential biomarker of biopsy - proven benign
iodinated contrast media with different ioine
and malignant breast lesions in correlation with
concentrations for coronary CTA:
histopathological disease stage
M. Malikova1, J.N. Tkacz1, P.J. Slanetz1, A. Aakil1, C.-Y. Guo2, H. Jara1; 1Boston, a randomised European multicenter trial
MA / US, 2Taipei City / TW B. Cabeza1, J.-F. Paul2, H.-C. Becker3, A. Laghi4, S. Achenbach5, S. Leschka6;
1
Madrid / ES, 2Paris / FR, 3Munich / DE, 4Latina / IT, 5Erlangen / DE, 6St. Gallen / CH
11:10
11:02
B-0762 Magnetic resonance imaging: evaluation of edema
B-0773 Is automated kV selection for radiation dose reduction
of the breast and the role of T2 STIR sequence in the
independent from contrast media concentration in CT
characterisation of malignant and benign lesions M. Kok1, C. Mihl1, A. Seehofnerova1, J. Turek1, G. Jost2, U. Haberland3,
R. Di Miscio, V. Casali, D. Cannata, E. Miglio, M. Telesca, M. Luciani, F. Pediconi; J.E. Wildberger1, M. Das1; 1Maastricht / NL, 2Berlin / DE, 3Forchheim / DE
Rome / IT
11:10
11:18
B-0774 Low-kV CTA with low contrast medium volume using
B-0763 Can morphological analysis of phyllodes tumour
256-slice and 16-slice CT scans: comparison of
predict the likelihood of malignancy in breast MRI?
G. Choi1, O. Woo1, H. Shin1, E. Hong1, K. Cho1, B. Seo2; 1Seoul / KR, 2Ansan / KR diagnostic accuracy and radiation dose exposure
C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, D. Fior, O. Minutolo, S. Sironi;
Monza / IT
11:26
B-0764 Diagnostic accuracy of breast MRI in the evaluation 11:18
of patients with suspecious nipple discharge B-0775 Contrast media reduction in CTA using low kV settings
V. Casali, M. Telesca, M. Luciani, S. Liberali, F. Pediconi, E. Miglio, R. Di Miscio; M. Kok, C. Mihl, A. Seehofnerova, S. Altintas, B.L.J.H. Kietselaer, J. Turek,
Rome / IT J.E. Wildberger, M. Das; Maastricht / NL
11:34 11:26
B-0765 Mammographic architectural distorsions: B-0776 Low-dose 256-MDCT coronary angiography:
taking advantage of the NPV due to MRI effect of hybrid iterative reconstruction technique
E. Garcia Oliver, J. Camps Herrero, A. Cervera Araez, V. Ricart Selma, C. Martínez
Rubio, J. Cano Gimeno, M. Forment Navarro, I. Martínez Gómez; Alzira / ES on image quality and diagnostic accuracy
in comparison with DSA
11:42 E.V. Kondratyev, V. Shirokov, P. Davydenko, G.G. Karmazanovsky; Moscow / RU
B-0766 Breast MR biopsy: 11:32
pathological and radiological correlation
1 2 2
C. Dratwa , A. Jalaguier-Coudray , J. Thomassin-Piana , J. Chopier , 1 B-0777 Evaluability of low dose CTA for carotid arteries using
I. Thomassin-Naggara1; 1Paris / FR, 2Marseille / FR new model-based iterative reconstruction
A.D. Annoni, A. Formenti, G. Pontone, M. Petullà, E. Nobili, S. Mushtaq,
P. Montorsi, M. Pepi, D. Andreini; Milan / IT

282 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:30–12:00 Room M 10:30–12:00 Room N

Physics in Radiology Cardiac


SS 1013 Optimisation of patient dose in CT SS 1003a Myocardial perfusion imaging
Moderators: A. Del Guerra; Pisa/IT, A. Kowalik; Poznan/PL Moderators: R.W. Bauer; Frankfurt/DE, G.I. Kirova-Nedialkova; Sofia/BG

10:30 10:30
K-17 Keynote lecture B-0789 The pattern of myocardial perfusion in patients with
A. Del Guerra; Pisa / IT intermediate and significant coronary artery stenosis
K.W. Zavadovsky, M.O. Gulya, Y.B. Lishmanov, L.N. Maslov, V.V. Saushkin;
10:39 Tomsk / RU
B-0779 Virtual unenhanced images of the abdomen with
third-generation dual-source dual-energy CT and 10:38
advanced modeled iterative reconstruction: B-0790 Usefulness of resting myocardial perfusion imaging
image quality, attenuation and radiation dose of coronary CT angiography in patients with acute
C.N. De Cecco, A.D. Hardie, G. Muscogiuri, J.L. Wichmann, C. Canstein, symptom in the emergency department:
P. Costello, U.J. Schoepf; Charleston, SC / US perfusion analysis of color-coded three-dimensional
10:47 volume rendering
S. Kim, D. Cha, Y. Choe; Seoul / KR
B-0780 Diagnostic ultra-low dose CT with a novel ultrafast
compressed sensing algorithm 10:46
S. Hashemi Amroabadi, S. Homampour, N.S. Paul; Toronto, ON / CA B-0791 Four-dimensional whole-heart computed tomography
10:55 perfusion of the myocardium with visual analysis
B-0781 Size-specific dose estimate can be used to calculate using temporal averaging of three-dimensional
patient-specific blood dose from paediatric CT datasets: feasibility study
C. Kendziorra, A. Shaban, M. Rief, P.D. Bady, S. Feger, M. Dewey; Berlin / DE
examinations
C. Franck, C. Vandevoorde, P. Smeets, R. Achten, K. Verstraete, H. Thierens, 10:54
K. Bacher; Ghent / BE
B-0792 Quantitative analysis of myocardial perfusion using
11:03 a Langendorff pig heart model: concept and results
G. Pelgrim1, M. Das2, U. Haberland3, S. Van Tuijl4, M. Stijnen4, E. Klotz3,
B-0782 Assessment of high cumulative patient doses of M. Oudkerk1, J.E. Wildberger2, R. Vliegenthart1; 1Groningen / NL, 2Maastricht / NL,
repetitive CT examinations 3
Forchheim / DE, 4Eindhoven / NL
M. Das, C.R.L.P. Jeukens, R.S. Schnerr, S. Niesen, J.E. Wildberger; Maastricht / NL
11:02

Friday
11:11 B-0793 Semi-automated global quantification of le
B-0783 Data distributions and the impact of iterative ventricular myocardial perfusion at stress dynamic CT:
reconstruction algorithms from the first three years diagnostic performance for detection of territorial
of the Australian MDCT DRL project (2011-2014) perfusion deficits
A.B. Wallace, P. Thomas, A. Hayton; Yallambie / AU J.L. Wichmann1, F.G. Meinel1, C.N. De Cecco1, A. Varga-Szemes1, G. Muscogiuri1,
P.M. Cannaò1, Y.H. Choe2, Y. Wang3, U.J. Schoepf1; 1Charleston, SC / US,
11:19 2
Seoul / KR, 3Beijing / CN
B-0784 Patient doses in standard CT examinations:
results of a nationwide survey in Germany 11:10
A.A. Schegerer1, H.-D. Nagel2, G. Stamm3, G. Brix1; 1Neuherberg / DE, B-0794 Le ventricular myocardial perfusion at stress
2
Buchholz / DE, 3Hannover / DE dynamic CT: multi-center evaluation of relative and
11:27 absolute territorial myocardial blood flow in patients
B-0785 Intra-institution CT dose surveys in adults: with coronary artery stenosis
J.L. Wichmann1, C.N. De Cecco1, F.G. Meinel1, A. Varga-Szemes1, G. Muscogiuri1,
what sample size for what precision? P.M. Cannaò1, Y.H. Choe2, Y. Wang3, U.J. Schoepf1; 1Charleston, SC / US,
S. Taylor1, A. Van Muylem2, P.A. Gevenois2, D. Tack3; 1Mons / BE, 2Brussels / BE, 2
Seoul / KR, 3Beijing / CN
3
Baudour / BE
11:18
11:35
B-0795 Cardiac dual-energy computed tomography reduces
B-0786 How much is the effective dose varying between beam-hardening artefacts in a phantom study
follow-up examinations performed on the same CT J. Choe, J. Kang, D.H. Yang, T.-H. Lim; Seoul / KR
scanner, when using the same imaging protocol?
S. Suntharalingam, F.F. Stecker, N. Guberina, M. Forsting, J.M. Theysohn, 11:26
A. Ringelstein, T. Schlosser, K. Nassenstein; Essen / DE B-0796 Quantitative myocardial perfusion with dual-energy
11:43 CT: iodine concentration differences between normal
B-0787 Estimation of organ dose from tube current modulated and ischemic myocardium
R. Oca Pernas, C. Delgado, C. Trinidad, D. Mera, A. Bustos, M. Vázquez; Vigo / ES
CT of the torso: SSDE vs MC simulation
X. Lopez Rendon1, G. Zhang1, H. Bosmans1, R.H. Oyen1, F. Zanca2; 1Leuven / BE, 11:34
2
Diegem / BE
B-0797 Myocardium: dynamic CT perfusion imaging:
11:51 a comparison to coronary angiography/FFR and
B-0788 Quantitative comparison of single-acquisition to MR first pass perfusion imaging
dual-energy iodine maps as a reduced dose A.M. Huber1, B.M. Gramer1, V. Leber1, M. Rasper1, D. Münzel1, A. Leber1,
E. Hoffmann1, M. Vembar2, E.J. Rummeny1; 1Munich / DE, 2Cleveland, OH / US
alternative to abdominal CT-perfusion measurements
S. Skornitzke, F. Fritz, M. Klauß, J. Hansen, G. Pahn, L. Grenacher, H.-U. Kauczor,
W. Stiller; Heidelberg / DE

www.myESR.org Final Programme | ECR 2015 283


Scientific Sessions

11:42 11:34
B-0798 Impact of iterative reconstruction on objective and B-0808 Useful tool in virtopsy: postmortal 31P magnetic
subjective image quality parameters in 256-slice resonance spectroscopy of the skeletal muscle:
MDCT dynamic myocardial perfusion imaging α-ATP/Pi ratio
B.M. Gramer, M. Rasper, V. Leber, A. Leber, E.J. Rummeny, A.M. Huber; J. Yamamura1, T. Schmidt1, S. Keller1, J. Wang2, G. Adam1, R. Fischer1;
Munich / DE 1
Hamburg / DE, 2Hamburg, TX / US

11:50 11:42
B-0799 Relationship among stenosis severity and CT-derived B-0809 Multiparamentric MRI at 7 T for the non invasive
myocardial blood flow in patients with coronary artery assessment of acute ischemic and non-ischemic
disease muscle damage
A. Rossi1, A. Wragg1, E. Klotz2, F. Pugliese1; 1London / UK, 2Forchheim / DE A. Palmisano, A. Esposito, T. Canu, F. Lo Russo, F. De Cobelli, A. Del Maschio;
Milan / IT

10:30–12:00 Room E1 11:50


B-0810 Gadolinium retention in musculoskeletal so tissue
Musculoskeletal with normal renal function; macrocyclic Gd contrast
agent versus linear chelate Gd contrast agent
SS 1010a Tumours, systemic diseases and H. Goto, T. Maeda, H. Hara, T. Akisue, K. Sugimura; Kobe city / JP
muscles
Moderators: M.C. de Jonge; Amsterdam/NL, A. Yakimov; Moscow/RU
10:30–12:00 Room E2
10:30
B-0800 Routinely performed multiparametric MRI helps to
Neuro
differentiate subtypes of myxoid tumours SS 1011 Ischaemic stroke (1)
N. Alberti, X. Buy, M. Kind; Bordeaux / FR
Moderators: E. Avdagic; Sarajevo/BA, A. Bonafe; Montpellier/FR
10:38
B-0801 Whole-body screening of mastocytosis: intraindividual 10:30
comparison of whole-body MRI vs bone scintigraphy B-0811 Can DWI-FLAIR mismatch pattern on MRI be replaced
M.M. Ong, K.A. Buesing, A. Reiter, S.O. Schoenberg, S. Haneder; Mannheim / DE by b1000-b0 mismatch for the prediction of time
from symptom onset in acute ischemic stroke?
10:46 A. Geraldo, L. Berner, J. Haesebaert, T. Cho, A. Chabrol, T. Ritzenthaler,
B-0802 Volume k-trans on dynamic contrast-enhanced MR N. Nighoghossian, Y. Berthèzene; Lyon / FR
imaging in musculoskeletal tumours: correlation with 10:38
intravoxel incoherent motion-derived parameters and B-0812 CT angiography and CT perfusion for outcome
volume apparent diffusion coefficients at 3.0 T prediction in patients with suspected acute
Y. Kim, W.-H. Jee, J.-Y. Jung, Y. Son, Y.-G. Chung; Seoul / KR
ischemic stroke
10:54 T. van Seeters, B.K. Velthuis; Utrecht / NL
B-0803 Myxoid so tissue tumours: 10:46
are MRI signsreliable? A 95-case retrospective study B-0813 Patterns of altered susceptibility during seizures:
N. Alberti, X. Buy, M. Kind; Bordeaux / FR
the value of susceptibility weighted imaging (SWI)
11:02 in detecting ictal events
B-0804 Functional MRI(DW-MRI)in the characterisation of R.K. Verma, F. Wagner, E. Abela, E. Springer, A. Huber, K. Schindler,
C. Weisstanner, J. Gralla, R. Wiest; Berne / CH
Ewing sarcoma: its role in characterising bone marrow
and so tissue involvement and tumour necrosis 10:54
S.L. Juvekar, S.M. Desai, A. Gulia; Mumbai / IN
B-0814 Detection of small-vessel occlusions using
11:10 high-resolution wavelet-based CT angiography
B-0805 High-resolution ultrasound of peripheral nerves in derived from whole-brain CT perfusion data
systemic sclerosis: a pilot study of computer-aided in acute ischaemic stroke
W.G. Kunz, L. Havla, W.H. Sommer, O. Dietrich, B. Ertl-Wagner, M.F. Reiser,
quantitative assessment of nerve density K.M. Thierfelder; Munich / DE
1 1 1 2 1 1
B. Bignotti , G. Tagliafico , G. Massimo , N. Panico , F. Zaottini , S. Airaldi ,
C. Martinoli1, A. Tagliafico1; 1Genoa / IT, 2Lavagna / IT 11:02
11:18 B-0815 Findings associated with space-occupying cerebral
B-0806 Simultaneous [18F]-FDG PET/MRI vs. PET/CT for local edema in patients with large middle cerebral artery
staging of so tissue sarcoma infarcts on follow-up:
M.C. Herbrik1, T.D. Poeppel1, J. Grueneisen1, K. Beiderwellen1, L. Podleska1, a CT angiography and CT perfusion study
P. Heusch2, T.C. Lauenstein1, L. Umutlu1; 1Essen / DE, 2Düsseldorf / DE A.D. Horsch1, J.W. Dankbaar1, T.A. Stemerdink1, E. Bennink1, J.L. Kappelle1,
J. Hofmeijer2, H.W. De Jong1, Y. Van der Graaf1, B.K. Velthuis1; 1Utrecht / NL,
11:26 2
Arnhem / NL
B-0807 Diagnostic performance of real-time elastography in 11:10
miscellaneous limb so tissue masses B-0816 Arterial spin labelling in identifying tissue salvage:
P. Pelotti, G. Facchini, P. Spinnato, G. Filonzi, A. Bazzocchi, A. Moio, G. Filonzi,
U. Albisinni; Bologna / IT is the technique a useful predictor of good recovery
aer acute ischaemic stroke?
F. Bozzetti, S. Piccinini, G. Crisi; Parma / IT

284 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:18 11:11
B-0817 Is Alberta stroke program early CT score B-0826 Impact of the patient age on flip-flop phenomenon in
(ASPECTS) a useful tool in the assessment lung metastasis from thyroid cancer
of acute stroke patients? T. Isoda, S. Baba, Y. Maruoka, Y. Kitamura, M. Sasaki, H. Honda; Fukuoka / JP
J.E.T. Alves, T. Rodrigues, A.L. Sousa, Â. Carneiro, R. Felgueiras, J. Xavier;
Porto / PT 11:19
B-0827 Accuracy of [18F]-FDG PET/MRI for the detection of
11:26 liver metastases
B-0818 Imaging related predictors of favorable outcome K. Beiderwellen1, L. Geraldo2, V. Ruhlmann1, P. Heusch3, B. Gomez1, F. Nensa1,
in acute ischemic stroke treated by thrombectomy L. Umutlu1, T.C. Lauenstein1; 1Essen / DE, 2Barcelona / ES, 3Düsseldorf / DE
A. Balodis, M. Radzina, K. Kupcs, E. Miglāne, J. Savlovskis; Riga / LV
11:27
11:34 B-0828 Diagnostic accuracy of imaging methods
B-0819 Effects of radiation dose reduction in volume for the diagnosis of skeletal malignancies:
perfusion CT imaging of acute ischaemic stroke retrospective analysis against
A. Othman1, C. Brockmann1, M.A. Brockmann1, Z. Yang2, J. Kim2, M. Wiesmann1; pathology-proven reference
1
Aachen / DE, 2Seoul / KR B. Lange1, M. Nielsen2, J. Andersen2, H. Lilholt2, M. Vyberg2, L. Petersen2;
1
Hilleroed / DK, 2Aalborg / DK
11:42
B-0820 Improved prediction of ischaemic stroke outcome 11:35
using combined ASPECTS and the NIHSS B-0829 Dynamic contrast-enhanced magnetic
K.W. Wanambiro1, J. Jowi2, S.W. Ponda1; 1Nairobi / KE, 2Kisumu / KE resonance imaging in benign and malignant
11:50 sclerotic bone lesions
P. Kosucu, S. Süleyman, H. Kavgaci, A. Karacin, A. Küpeli; Trabzon / TR
B-0821 Leptomeningeal score (LMs) on computed tomography
angiography can predict clinical outcome in patients 11:43
with acute ischaemic stroke (AIS) B-0830 Detection of distant metastases in patients
E. Puglielli1, R. Lattanzi1, M. Fuschi1, V. Di Mizio1, V. Di Egidio2; 1Teramo / IT, with primary breast cancer: is 18FDG-PET/CT
2
Pescrara / IT
better than conventional imaging?
A.G.V. Bitencourt, R.R. Cunha, J.F.A. Conrado, W.P. Andrade, E.N.P. Lima,
R. Chojniak; Sao Paulo / BR
10:30–12:00 Room F1
11:51
Oncologic Imaging B-0831 Palliation of painful bone metastases:
the “Rizzoli” experience
SS 1016 Advances in imaging A. Bazzocchi1, G. Facchini1, P. Spinnato1, E. Rimondi1, M. Battaglia1,

Friday
metastatic disease S. Donatiello2, G. Filonzi1, U. Albisinni1; 1Bologna / IT, 2Modena / IT
Moderators: D. Filippiadis; Athens/GR,
M. Müller-Schimpfle; Frankfurt a. Main/DE
10:30–12:00 Room F2
10:30
K-18 Keynote lecture GI Tract
M. Müller-Schimpfle; Frankfurt a. Main /DE
SS 1001 Rectal cancer and anorectal imaging
10:39 Moderators: L. Curvo-Semedo; Coimbra/PT, F. Maccioni; Rome/IT
B-0822 Whole brain 3D T1w-VISTA for the diagnosis
of small brain metastases at 3.0 Tesla 10:30
N.N. Kammer1, E. Coppenrath1, K.M. Treitl1, H. Kooijman2, M.F. Reiser1, T. Saam1; K-19 Keynote lecture
1
Munich / DE, 2Hamburg / DE L. Blomqvist; Stockholm / SE
10:47 10:39
B-0823 Differentiation of primary brain tumours B-0832 Magnetisation transfer (MT) Imaging as a tool to
from metastases: quantitative evaluation of quantify post-chemoradiation fibrosis in rectal cancer:
multi-parameters from diffusion and DCE-MR perfusion does it help in the assessment of tumour response?
in tumour parenchyma and peritumoural area M.H. Martens1, D.M. Lambregts1, N. Papanikolaou2, S. Alefantinou2, M. Maas1,
J. Zhao, J. Chu, J. Yang, Z. Yang, B. Luo; Guangzhou / CN G.C. Manikis2, K. Marias2, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht / NL,
2
Iraklion / GR
10:55
B-0824 Volumetric dynamic contrast enhanced computed 10:47
tomography (DCE-CT) for preoperative assessment of B-0833 Performance of texture analysis, diffusion-weighted
the vascularity of spinal metastases imaging and perfusion imaging in predicting tumoural
C. Lauridsen1, C. Clausen2, M. Lundsgaard2, B. Dahl1, M. Bachman1, S. Frevert1, response to neoadjuvant chemoradiotherapy in rectal
L. Lonn1; 1Copenhagen / DK, 2Herlev / DK cancer patients studied with 3-T MR
M. Ciolina1, C. De Cecco2, B. Ganeshan3, M. Rengo2, D. Bellini2, A. Laghi1;
11:03 1
Rome / IT, 2Latina / IT, 3London / UK
B-0825 Superb microvascular imaging (SMI): applying a new
contrast-free ultrasound technique for the analysis of 10:55
the microvascular structure in suspect lymph nodes B-0834 Follow-up with MRI of rectal cancer treated by TEM:
T. Diekhoff, T. Fischer; Berlin / DE recurrence detection and inter-observer
reproducibility
M. Maas1, M. Martens1, C. van Berlo1, W. Deserno2, J. Leijtens2, G.L. Beets1,
R.G.H. Beets-Tan1; 1Maastricht / NL, 2Roermond / NL

www.myESR.org Final Programme | ECR 2015 285


Scientific Sessions

11:03 10:46
B-0835 Added value of diffusion-weighted MRI for early B-0845 Does accuracy of MSCT signs of right ventricular
detection of tumour response to preoperative dysfunction depend on the time since the onset
chemoradiation therapy, in locally advanced rectal of symptoms in patients with acute pulmonary
cancer: correlation with histopathologic analysis embolism?
M. Mumoli, D. Ippolito, C. Talei Franzesi, O. Minutolo, P.A. Bonaffini, S. Sironi; G. Staskiewicz, E. Czekajska-Chehab, S. Uhlig, E. Siek, A. Tomaszewski,
Monza / IT J. Przegalinski, A. Drop; Lublin / PL

11:11 10:54
B-0836 Reproducibility of evaluation of invasion depth B-0846 Can coronary artery calcifications on CT pulmonary
of rectal cancer into the mesorectal fat: angiography predict right heart strain?
can we reliably discern T3ab from T3cd tumours? M.C. Williams1, N. Morley1, K. Muir1, E.J.R. van Beek1, J.H. Reid2, J. Murchison1;
M. Maas1, G.L. Beets1, M. Ageitos Casais2, X. Li3, S.-X. Rao4, M.M. van Heeswijk1,
1
Edinburgh / UK, 2Melrose / UK
R. Beckers1, R.G.H. Beets-Tan1; 1Maastricht / NL, 2Santiago de Compostela / ES,
3
Beijing / CN, 4Shanghai / CN 11:02
B-0847 Dual-energy CT pulmonary perfusion maps improve
11:19 the detection of small pulmonary embolism:
B-0837 DWI for assessment of rectal cancer nodes aer a multi-rater study
chemoradiotherapy: does the absence of nodes S. Fischer, N. Schultheis, C. Frellesen, M. Kaup, W. Kromen, P. Dewes,
on DWI predict a ypN0 status? J.E. Scholtz, T.J. Vogl, R.W. Bauer; Frankfurt a. Main / DE
M.M. van Heeswijk, D.M. Lambregts, W.M. Palm, B.M.F. Hendriks, G.L. Beets,
R.G.H. Beets-Tan; Maastricht / NL 11:10
B-0848 Evaluation of multi-phase post-mortem
11:27 CT-angiography for the investigation
B-0838 Comparison between MRI and water soluble contrast of pulmonary embolism
enema in evaluating complications aer colorectal A. Perini1, J. Grimm2, C. Egger2, C. Bruguier2, E. Silingardi1, S. Grabherr2;
anastomosis and protective ileostomy in patient with
1
Modena / IT, 2Lausanne / CH
rectal cancer 11:18
E. Raimondi, M. Bassi, V. Pollastri, R. Rizzati, M. Giganti, G. Benea; Ferrara / IT
B-0849 A nomogram based on CT pulmonary angiography
11:35 for prediction of pulmonary hypertension
B-0839 Primary cystic lesions of the retrorectal space: in patients without pulmonary embolism
MRI evaluation, histopathology confirmation and A. Bendet, H. Shmueli, S.Z. Adam, T. Ziv-Baran, S. Berliner, Y. Topilsky,
G. Aviram; Tel Aviv / IL
clinical assessment
R.S. Dwarkasing, S. Verschuuren, G. van Leenders, L. Braun, W. Schouten, 11:26
G. Krestin; Rotterdam / NL
B-0850 Angio-CT in the evaluation of patients with
11:43 chronic thromboembolic pulmonary hypertension
B-0840 Rectal MRI of fistula-in-ano: diagnostic values undergoing pulmonary endarterectomy:
of diffusion-weighted imaging (DWI) radiological and hemodynamic assessment
S. Ahn, J. Park, S. Moon, D. Lee, S. Park, J. Lim; Seoul / KR S. Porelli, M. Giannotta, M.B. Leone, M. Cefarelli, S. Martin Suarez, N. Galié,
M. Zompatori; Bologna / IT
11:51
B-0841 Local staging of rectal cancer: 11:34
performance comparison between 3D transrectal B-0851 Comparison of diagnostic performance of pulmonary
ultrasound and 3-Tesla magnetic resonance imaging MRA and CTA in patients with chronic thromboembolic
E. Guidi1, L. Faggioni1, R. Scandiffio1, R. Balestri1, G. D’Ippolito2, E. Neri1, pulmonary hypertension
P. Buccianti1, C. Bartolozzi1; 1PISA / IT, 2São Paulo / BR E.A. Mershina, V. Sinitsyn, M. Komarova, K. Mershin, N. Danilov; Moscow / RU

11:42
10:30–12:00 Room D1 B-0852 Lung perfusion characteristics in pulmonary arterial
hypertension and peripheral forms of chronic
Chest thromboembolic pulmonary hypertension:
dual-energy CT
SS 1004 Pulmonary hypertension and J. Giordano, N. Tacelli, C. Hossein-Foucher, A. Duhamel, J. Remy, M. Remy-Jardin;
thromboembolic disease Lille / FR
Moderators: E.E.J.G. Coche; Brussels/BE, B. Graca; Coimbra/PT

10:30
B-0842 Are we overcalling pulmonary embolism and why?
Discordance in interpretation of CTPA between general
and chest radiologists
B. Hutchinson1, P. Navin1, E. Marom2, M. Truong2, J. Bruzzi1; 1Galway / IE,
2
Houston, TX / US

10:38
B-0844 Pulmonary infarction in CT pulmonary angiography:
correlation with thrombus distribution and signs of
right heart strain for risk stratification
L.F.M. Beenen, C.M. Schaefer-Prokop, J. Stoker, P. Gerrits, H.R. Buller,
S. Middeldorp; Amsterdam / NL

286 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:30–12:00 Room D2 11:43


B-0861 Assessment of various types of US findings aer
Interventional Radiology irreversible electroporation in porcine liver:
SS 1009 Percutaneous ablation in liver tumours comparison with radiofrequency ablation
K. Sugimoto, Y. Kobayashi, F. Moriyasu; Tokyo / JP
Moderators: T. Denecke; Berlin/DE, F. Orsi; Milan/IT
11:51
10:30 B-0862 Ablation of colorectal liver metastases
K-20 Keynote lecture by irreversible electroporation: results
A. Adam; London / UK
of the COLDFIRE-I ablate-and-resect study
10:39 H.J. Scheffer, K. Nielsen, A.A.J.M. van Tilborg, J.M. Vieveen, G. Kazemier,
H.W.M. Niessen, S. Meijer, P. van den Tol, M.R. Meijerink; Amsterdam / NL
B-0853 MRI-monitored ablation using size adjustable
coaxial electrochemical ablation:
initial experience with a novel technique 10:30–12:00 Room K
B.H. Ge, C.N. Weber, G.J. Nadolski, T.P. Gade, S.J. Hunt, M.C. Soulen, M. Itkin;
Philadelphia, PA / US Radiographers
10:47
B-0854 In vitro artefact assessment of a prototype SS 1014 Radiation dose optimisation
Moderators: D.R. Kool; Nijmegen/NL, D. Pekarovic; Ljubljana/SI
MR-compatible microwave antenna for MR-guided
tumour ablation and comparison with a standard 10:30
MR-compatible radiofrequency ablation device B-0863 Incorrectly placed gonad shields:
R. Hoffmann, F. Eibofner, E. Kessler, H. Rempp, J. Weiß, K. Nikolaou, S. Clasen;
Tübingen / DE influence on radiation dose in abdominal CT
with automatic exposure correction
10:55 M.W. Kusk; Esbjerg / DK
B-0855 Co-registration of inspiratory and expiratory datasets 10:38
for treatment planning for robotic-assisted liver
B-0864 Maintaining image quality in paediatric chest
thermal ablation
B.J. Abdullah1, C. Yeong1, P. Dumpuri2, D. Yamini2, A. Tirumalai2, A. Kulkarni2; CT while lowering dose using sinogram affirmed
1
Kuala Lumpur / MY, 2Florence, OR / US iterative reconstruction
A. Sanderud1, A. Gomes2, A. Vallinga3, A. Vouillamoz4, A.M. Raszkowski1,
11:03 J.W. Rook3, N. Campbell5, S. Borge1, C. Buissink3; 1Oslo / NO, 2Lisbon / PT,
3
Groningen / NL, 4Lausanne / CH, 5Salford / UK
B-0856 Real-time respiratory motion compensation of the
liver using 4D ultrasound and GPU 10:46

Friday
J. Banerjee, C. Klink, E.D. Peters, W.J. Niessen, A. Moelker, T.v. Walsum;
Rotterdam / NL B-0865 The influence of isocenter gantry patient positioning
for paediatric head CT examinations in eye lens dose,
11:11 using in-plane vinyl bismuth and barium shielding
B-0857 Comparison between radiofrequency ablation and F. Pereira, F. Carvalho, M. Malva, G. Paulo, J. Santos; Coimbra / PT
surgical resection by using propensity score matching 10:54
for hepatocellular carcinoma within Milan criteria
A. Hocquelet, N. Frulio, C. Salut, C. Cassinotto, m. Bouzgarrou, H. Trillaud, B-0866 Phantom study: the impact of obesity on abdominal
P. Balageas; Bordeaux / FR CT radiation dose and image quality
A.A. Qurashi, L.A. Rainford, S. Foley; Dublin / IE
11:19
B-0858 Microwave ablation (MWA) in malignant liver tumours: 11:02
comparative evaluation of local tumour control B-0867 Cardiac computed tomography dose levels:
and survival rates using two different microwave a national approach and comparison with other
generator systems cardiac radiation procedures
T.J. Vogl, A. Hagar, N.N.N. Naguib, N.-E.A. Nour Eldin, W.O. Bechstein, S. Zeuzem; D. Vicente1, V. Dessandier1, A. Pimenta2, C. Almeida3, D. Silva4, R. Gaspar1,
Frankfurt a. Main / DE G. Paulo1, J. Santos1; 1Coimbra / PT, 2Porto / PT, 3Lisbon / PT, 4Algarve / PT

11:27 11:10
B-0859 New concept in microwave ablation (MWA) B-0868 Is iterative reconstruction for CT worth the
of liver and lung malignancies: investment? A retrospective study of dose
does MWA with thermosphere technology reproduce reduction and image quality
L.V. Magee, P. Ball; Dundonald / UK
a predictable spheric ablation zone?
T.J. Vogl, L. Basten, B. Panahi, N.-E.A. Nour-Eldin, N.N.N. Naguib; 11:18
Frankfurt a. Main / DE
B-0869 Radioprotection in CT scans: use of bismuth, barium
11:35 and lead shields
B-0860 Local ablation of unresectable liver malignancies R. Pescada, P. Sousa, A.F.C.L. Abrantes, L.P. Ribeiro, R.P.P. Almeida,
S. Rodrigues, K.B. Azevedo, J.P. Pinheiro; Faro / PT
using CT-guided high-dose rate brachytherapy or
CT-guided radiofrequency ablation: a cost comparison 11:26
D. Schnapauff1, F. Collettin1, B. Gebauer1, B. Hamm1, M.H. Maurer2; 1Berlin / DE,
2
Berne / CH B-0871 Development of a soware application
for the registration and monitoring of diagnostic
reference levels
A.F.C.L. Abrantes, B. Braga, L.P. Ribeiro, P. Sousa, R.P.P. Almeida, S. Rodrigues,
S. Rodrigues, J.P. Pinheiro, N.F. Pinto; Faro / PT

www.myESR.org Final Programme | ECR 2015 287


Scientific Sessions

11:34 11:42
B-0872 Design of an ultra-low dose non-contrast kidney stone B-0884 The role of MR in the preoperative management
CT protocol with a radiation dose ≤ 1mSv of primary hyperparathyroidism in clinical practice:
S. Moerup1, D. Skov- Hansen2, O. Graumann3; 1Odense / DK, 2Kolding / DK, single-center experience with a 3T MR
3
Aarhus / DK B. Sacconi, R. Argirò, A. Iannarelli, C. Cipriani, S. Minisola, C. Catalano, M. Bezzi,
D. Diacinti; Rome / IT
11:42
B-0873 CT dose optimisation soware synergy:
a clinical perspective 10:30–12:00 Room MB 2
L.R. O’Hora; Dublin / IE
Paediatric
10:30–12:00 Room MB 1 SS 1012 Abdominal imaging
Moderators: M. Haliloglu; Ankara/TR, A.S. Littooij; Leiden/NL
Head and Neck
10:30
SS 1008 Thyroid and parathyroid imaging B-0885 Re-appraising ultrasonography as the first line
Moderators: A. Lévai; Budapest/HU, J. Olliff; Birmingham/UK diagnostic modality in surgical causes of paediatric
10:30 acute abdomen
I. Goel, R. Anand, M. Narula, S. Choudhury; New Delhi / IN
B-0874 Role of quantitative diffusion-weighted MRI and 1H
MR spectroscopy in distinguishing between benign 10:38
and malignant thyroid nodules B-0886 Comparison of axial T2-weighted BLADE and
R.A. Elshafey, A. Elattar, M. Melees, N. Esheba; Tanta / EG respiratory triggering turbo spin-echo sequences in
10:38 the paediatric abdomen
J. Lee, Y. Choi, J.-E. Cheon, S. Lee, H.-H. Cho, S.-M. Shin, W. Kim, I.-O. Kim;
B-0875 The role of magnetic resonance spectroscopyas a Seoul / KR
pre-surgical diagnostic modality in thyroid nodules
L. Aghaghazvini, P. Pirouzi, H. Sharifian, N. Yazdani, S. Kooraki, A. Ghadiri; 10:46
Tehran / IR B-0887 Fibrosing liver diseases in paediatric age:
10:46 MRI investigation by diagnostic maps of slow diffusion
B-0876 Comparison between two thyroid ultrasound and fast diffusion generated from a multiple b values
classification systems for characterisation of thyroid DWI sequence through IVIM model
P. Gulino, A. Ciccarone, D. Cozzi, D. Salpietro, C. Defilippi; Florence / IT
nodules
G.A. Ashamallah, M.A. El-Adalany; Mansoura / EG 10:54
10:54 B-0888 Quantification of liver steatosis in paediatric
B-0877 Role of ARFI in risk stratification of thyroid nodules by population: comparison of ¹H MRS and Triple-echo GRE
TIRADS sequence with liver biopsy as reference standard
M. Di Martino, L. Pacifico, M. Bezzi, F. Zaccagna, B. Sacconi, C. Chiesa,
B. Raghavan, D. Sundaram; Chennai / IN C. Catalano; Rome / IT
11:02 11:02
B-0879 Preoperative ultrasound of papillary thyroid B-0889 Imaging approach in infantile cholestasis evaluation:
carcinoma (PTC): evaluation of predictive factors for utility and efficacy of US signs in biliary atresia
extrathyroidal extension L. Monti, M. Salsano, G. Soglia, M. Colella Bisogno, A. Simonetti, G. Torre,
H.-S. Ahn, S. Park, S. Kim, M. Seo, B. Chung; Seoul / KR P. Rossi, L. Bonomo, P. Tomà; Rome / IT

11:10 11:10
B-0880 Comparison of clinical and sonographic characteristics B-0890 Impact of hepatic arterial haemodynamics in
for distinguishing follicular adenoma and carcinoma predicting early hepatic arterial thrombosis
and the predictive factors of malignancy in thyroid in paediatric recipients aer living donor liver
follicular neoplasm transplantation
S. Park, S. Kim, H.-S. Ahn, M. Seo, J. Yoo, J. Choi; Seoul / KR L..-H. Gu, H. Fang, F. Li, S. Zhang, C. Shen, L. Han; Shanghai / CN

11:18 11:18
B-0881 Evaluation of underlying lymphocytic thyroiditis with B-0891 The role of magnetic resonance enterography in the
histogram analysis using gray scale ultrasound images evaluation of activity of paediatric Crohn‘s disease
J. Seo, G. Kim, E.-K. Kim, J. Kwak; Seoul / KR F. Al Bunni, M. Zuliani, F. Pomerri; Padua / IT

11:26 11:26
B-0882 Can ARFI elastography be used to differentiate B-0892 Radiation reduction in the follow-up of abdominal
parathyroid from thyroid lesions? trauma imaging using contrast-enhanced ultrasound
A. Chandramohan, D. Abraham, M.T. Manipadam, T.V. Paul; Vellore / IN A.-M. Deganello, E. Konstantatou, O. Romanos, M. Sellars, P. Sidhu; London / UK

11:34 11:34
B-0883 MR appearance of parathyroid adenomas at 3T in B-0893 High-resolution MRI for preoperative workup of
patients with primary hyperparathyroidism: neonates with an anorectal malformation:
the value of imaging for pre-operative localisation a direct comparison with rectofistulography using
A. Iannarelli, B. Sacconi, R. Argirò, C. Cipriani, S. Minisola, C. Catalano, M. Bezzi, surgical findings as reference standard
D. Diacinti; Rome / IT M.G. Thomeer, A. Devos, M. Lequin, N. De Graaf, M. Meradji, I. De Blaauw,
C. Sloots; Rotterdam / NL

288 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:42 11:26
B-0894 The role of functional MR urography (fMRU) in the B-0903 Cardiac diffusion-weighted MR imaging in acute
evaluation of unilateral hydronephrosis in children myocarditis: initial experience
A. Ntoulia, L. LeCompte, M. Adeb, D. Khrichenko, S. Lambert, P. Casale, J.-P. Laissy, V. Gaxotte, A. BenDriss, J.-M. Serfaty; Paris / FR
K. Darge; Philadelphia, PA / US
11:34
11:50 B-0904 Prognostic value of different cardiac magnetic
B-0895 Contrast-enhanced voiding urosonography with resonance (CMR) patterns in patients with acute
a second-generation ultrasound contrast agent myocarditis
for diagnosis of vesicoureteric reflux in 1350 children: M. Cava, G. Benedetti, D. Palumbo, G. Fragasso, A. Esposito, A. Del Maschio,
the experience of a single center F. De Cobelli; Milan / IT
F. Papadopoulou1, A. Ntoulia2, K. Darge2; 1Thessaloniki / GR, 2Philadelphia,
PA / US 11:42
B-0905 Multi-parametric myocardial mapping of patients
with Anderson Fabry disease: regional distribution of
10:30–12:00 Room MB 3 changes in T1, T2 relaxation and ECV
T.C. Walter1, G. Knobloch1, A. Sandek1, V. Ding-Reinelt1, P. Freyhardt1, A. Krebs2,
Cardiac T. Denecke1, B. Hamm1, M. Makowski1; 1Berlin / DE, 2Prague / CZ

SS 1003b Non-ischaemic myocardial disease


Moderators: I. Carbone; Rome/IT, S.D. Rud; St. Petersburg/RU 10:30–12:00 Room MB 4

10:30 Musculoskeletal
B-0896 Late gadolinium enhancement in MRI
for cardiomyopathies: SS 1010b Hand, upper extremity
a quantitative comparison of 2D and 3D acquisition Moderators: I. Beggs; Edinburgh/UK, E. Drakonaki; Iraklion/GR
F. Morsbach, S. Gordic, M. Niemann, H. Alkadhi, R. Goetti, R. Manka; Zurich / CH
10:30
10:38 B-0907 Diagnostic work-up of scapholunate dissociation:
B-0897 Prognostic value of late enhancement in cardiac cine-MR imaging as a new approach
magnetic resonance in patients with dilated E. Rathmann, I. Langner, K. Rebecca, S. Langner, N. Hosten; Greifswald / DE
cardiomyopathy: systematic review and meta-analysis 10:38
F. Secchi, E. Resta, P. Cannaò, M. Petrini, G. Di Leo, F. Sardanelli; Milan / IT
B-0908 Ultra-high field MR-microscopy of fetal forearm -
10:46 ex vivo assessment of the ossification patterns
P.-C. Krüger1, I. Langner1, T. Stahnke2, O. Stachs2, S. Langner1, N. Hosten1;

Friday
B-0898 Extent of myocardial fibrosis by LGE, pre- and 1
Greifswald / DE, 2Rostock / DE
post-contrast T1 and ECV in patients with hypertrophic
cardiomyopathy referenced to normal appearing 10:46
myocardium or healthy volunteers B-0909 Accelerated diffusion tensor imaging of the median
M. Avanesov, D. Säring, M. Patten, U.K. Radunski, K. Muellerleile, C. Stehning,
E. Tahir, G. Adam, G. Lund; Hamburg / DE nerve using simultaneous multi-slice echo planar
imaging with blipped CAIPIRINHA
10:54 L. Filli, M. Piccirelli, D. Kenkel, A. Boss, G. Andreisek, V.M. Runge,
R. Guggenberger; Zurich / CH
B-0899 Prognostic CMR parameters for heart failure
and arrhythmias in large cohort of well treated 10:54
thalassemia major patients B-0910 Evaluation of lesions of the internal ligaments of the
C. Tudisca1, A. Meloni2, E. Grassedonio1, M. Restaino3, F. Terrazzino1,
C. Argento4, N. Vallone5, M. Midiri1, A. Pepe2; 1Palermo / IT, 2Pisa / IT, 3Taranto / IT, wrist: conventional magnetic resonance imaging vs
4
Agrigento / IT, 5Catania / IT MR arthrography
H.A. Kamal; Cairo / EG
11:02
B-0900 Isolated le ventricular non-compaction (LVNC) 11:02
in patients with b-thalassemia: B-0911 Development of a statistical 3D modell of the intact
41 months follow-up with cardiac magnetic resonance distal radius: preliminary results
M. Gatti, R. Faletti, A. Veltri, A. Piga, F. Longo, G. Gandini, R. Bonamini; Turin / IT J. Binder1, S.F. Baumbach1, F. Mück1, A. Synek1, Y. Chevalier1, G. Langs2,
L. Fischer2; 1Munich / DE, 2Vienna / AT
11:10 11:10
B-0901 Isolated non-compaction of the le ventricle: B-0912 Can ultrasound replace MRI in assessment
correlation between clinical and genetic of nerve entrapment in osteofibrous tunnels in the
manifestations of the disease and cardiac upper extremity
MR parameters A.M. Abdel Magied, Y.M. Tohamy, T. Taymour, L. Adel; Cairo / EG
E.A. Mershina, O. Larina, V. Sinitsyn, R. Myasnikov, M. Kharlap, O. Kulikova,
S. Boytsov; Moscow / RU 11:18
11:18 B-0913 Possibilities of magnetic resonance imaging
B-0902 Semiquantitative assessment of low and in diagnosis of shoulder joint instability
A. Filimonova, I. Lisachenko, I. Znamenskiy, A. Uchevatkin; Moscow / RU
high b value DWI for detecting myocardial edema
in acute myocarditis
J. Broncano1, A. Luna2, T. Martin Noguerol2, J. Sanchez-Gonzalez3; 1Córdoba / ES,
2
Jaen / ES, 3Madrid / ES

www.myESR.org Final Programme | ECR 2015 289


Scientific Sessions

11:26
B-0914 High resolution ultrasound in evaluation
of bifid median nerve in carpal tunnel syndrome
in Indian population
S. Sripathi, D. Bansal, A. Ayachit, R. Kadavigere; Manipal / IN

11:34
B-0915 Prospective comparative analysis of ultrasound vs
arthroscopy in evaluation of impingement syndrome
and supraspinatus tear
N. Shetty1, P.E. Chandy1, M.D. Mahajan1, G. K2, N.P. Hegde2, M. Shetty1,
A. Shetty1, V. Ruprela1; 1Bangalore / IN, 2Mangalore / IN

11:42
B-0916 A radiographic union score to assess healing in
surgically treated long bone fractures:
a feasibility study
V. Perlepe1, P. Omoumi2, A. Larbi1, D. Putineanu1, J.-E. Dubuc1, T. Schubert1,
B. Vande Berg1; 1Brussels / BE, 2Lausanne / CH

11:50
B-0917 Novel features of metabolic bone diseases
in high-resolution imaging: reproducibility and
validity of radiologic reading
S. Fussenegger, L. Fischer, M. Weber, F. Kainberger, M. DiFranco, G. Langs,
J.M. Patsch; Vienna / AT

290 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

Friday

www.myESR.org Final Programme | ECR 2015 291


Scientific Sessions

10:30–12:00 Room C 11:51


B-0927 Whole breast ultrasound aer breast tomosynthesis
Breast in a screening population
V.N. Aguillar, A.C. Moura, V.S. Ferreira, C.B. Dequi; Sao Paulo / BR
SS 1402 Digital breast tomosynthesis:
the new mammography
Moderators: A.M.J. Bluekens; Breda/NL, R. Schulz-Wendtland; Erlangen/DE 10:30–12:00 Room Z

10:30 Molecular Imaging


K-21 Keynote lecture
R. Schulz-Wendtland; Erlangen / DE SS 1406 Experimental molecular imaging and
10:39 exploratory clinical studies
Moderators: N. Lassau; Villeiuif/FR, M. Wildgruber; Munich/DE
B-0918 2D mammography dose vs digital breast
tomosynthesis: comparison on a large dataset 10:30
A. Nitrosi, M. Bertolini, A. Corazza, C. Campari, P. Pattacini, G. Tondelli,
V. Ginocchi, L. Ghiddi, M. Iori; Reggio Emilia / IT B-0930 Making use of the intrinsic Gadolinium quenching
effect for cellular imaging
10:47 J. Guenoun, G. Koning, G. Kotek, G.P. Krestin, M. Bernsen; Rotterdam / NL
B-0919 Impact on the recall rate of digital breast 10:38
tomosynthesis (DBT) as an adjunct to digital
B-0931 Optical in vivo imaging of tumour-associated
mammography (DM) in the screening setting
1 1 1 1 2
L.A. Carbonaro , G. Di Leo , N. Verardi , R. Trimboli , G. Saguatti , C. Zuiani , 3 macrophages for evaluation of metastatic capability
M. Bazzocchi3, F. Sardanelli1; 1San Donato Milanese / IT, 2Bologna / IT, 3Udine / IT N. Grosse Hokamp1, K. Barczyk-Kahlert1, A. Becker1, T.J. Vogl1, W. Heindel1,
C. Bremer1, C. Geyer1, M. Eisenblatter2; 1Münster / DE, 2London / UK
10:55
10:46
B-0920 Comparison of digital breast tomosynthesis vs full
B-0932 MRI of antigen-loaded dendritic cell migration
field digital mammography for the detection and
in a pancreatic carcinoma model
characterisation of calcifications in the breast L. Zheng, A.C. Larson, Z. Zhang; Chicago, IL / US
P. Clauser1, M. Bernathova2, G. Nagl3, K. Pinker-Domenig2, P.A.T. Baltzer2,
P. Kapetas1, T.H. Helbich1; 1Udine / IT , 2Vienna / AT, 3Horn / AT 10:54
11:03 B-0933 MRI-monitored percutaneous injection of iron-oxided
B-0921 False positives (FP) in breast cancer screening with labelled Clostridium novyi-NT for bacteriolytic
breast tomosynthesis (BT) vs digital mammography therapy: preclinical studies in xenogra model
(DM) of pancreatic cancer
K. Lang1, M. Nergården1, I. Andersson1, A. Rosso2, S. Zackrisson1; 1Malmö / SE, L. Zheng1, Z. Zhang1, K. Khazaie2, S. Saha3, R.J. Lewandowski1, G. Zhang4,
2
Lund / SE A.C. Larson1; 1Chicago, IL / US, 2Rochester, MN / US, 3Kansas City, MO / US,
4
Shanghai / CN
11:11
11:02
B-0922 Value of breast tomosynthesis combined
B-0934 Using 59Fe labelled triglyceride-rich lipoproteins
with reconstructed synthetic 2D views versus
for visualisation and quantification of brown adipose
tomosynthesis alone in a diagnostic set-up
V. Iotti, A. Nitrosi, S. Ravaioli, G. Levrini, C. Coriani, R. Vacondio, C. Mori, tissue activity at 7T MRI
R. Sghedoni, P. Pattacini; Reggio Emilia / IT C.S.L. Jung, M. Heine, M. Kaul, G. Adam, L. Heeren; Hamburg / DE

11:19 11:10
B-0923 Is synthetised Digital Mammography (3D-DM) superior B-0935 Treatment response and hypoxia monitoring assessed
to conventional Digital Mammography (2D-DM)? A by molecular imaging of tumour microenvironment
retrospective study of 210 patients using multiparametric 3T-MRI and 18F-FMISO
P. Martinez-Miravete1, P. Garcia Barquin2, M. Millor2, J. Etxano2, A. Elizalde2, P. Georg1, P. Andrzejewski2, W. Wadsak2, A. Sturdza2, G. Karanikas2, R. Pötter2,
L. Pina2, R. Zalazar2; 1Zaragoza / ES, 2Pamplona / ES T.H. Helbich2, D. Georg2, K. Pinker-Domenig2; 1Wiener Neustadt / AT, 2Vienna / AT

11:27 11:18
B-0924 Can digital breast tomosynthesis predict the benignity B-0936 Glycosaminoglycan chemical exchange saturation
or malignancy of circumscribed masses? transfer magnetic resonance imaging of knee joint
J. Morel, R. Wasan, A. Iqbal, D.R. Evans, C. Peacock, R. Rahim, J. Goligher, cartilage at 3 Tesla: baseline values in asymptomatic
K. Satchithananda, M.J. Michell; London / UK young adult volunteers
C. Schleich1, F. Miese1, C. Zilkens1, B. Schmitt2, A. Müller-Lutz1, M. Sondern1,
11:35 G. Antoch1, R. Krauspe1, B. Bittersohl1; 1Düsseldorf / DE, 2Macquarie Park
B-0925 Invasive Breast Carcinomas (IBCs) that do not look NSW / AU
suspicious on Digital Breast Tomosynthesis (DBT): 11:26
important considerations when integrating DBT
B-0937 Chemical exchange saturation transfer imaging:
into clinical practice
O. Abeyakoon, R. Rahim, J. Morel, R. Wasan, D. Evans, K. Satchithananda, preliminary experience for characterisation
J. Goligher, C. Peacock, M.J. Michell; London / UK of thoracic nodule and mass based on MR-based
molecular information
11:43 Y. Ohno1, M. Yui2, C. Ouyang3, M. Miyazaki3, S. Seki1, H. Koyama1, T. Yoshikawa1,
B-0926 Additional US or DBT aer digital mammography: S. Matsumoto1, K. Sugimura1; 1Kobe / JP, 2Otawara / JP, 3Vernon Hills, IL / US
which one is the best combination?
A. Elizalde, P. Garcia Barquin, M. Millor, J. Etxano, P. Martinez-Miravete, L. Pina,
M. Páramo; Pamplona / ES

292 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:35
B-0938 Apoptosis-targeted optical fluorescence imaging B-0946 Differences between supine and orthostatic positions
for characterisation of regorafenib effects on in facet joint (FJ) fluid and spondylolisthesis
experimental colon carcinomas validated by perfusion at lumbar-spine MRI
MRI and multiparametric immunohistochemistry C. Ottonello1, A. Giardino1, P. Giuliani1, C. Messina2, G. Di Leo3, F. Sardanelli3;
P.M. Kazmierczak, E. Burian, R. Eschbach, M. Moser, L. Havla, H. Hirner,
1
Rome / IT, 2Milan / IT, 3San Donato Milanese / IT
M.F. Reiser, K. Nikolaou, C.C. Cyran; Munich / DE
11:43
B-0947 Feasibility and reproducibility of T2 mapping
10:30–12:00 Room E1 of the sacroiliac joints at 3T
G. Lefebvre, A. Bergère, E. Dodré, V. Pansini, X. Demondion, A. Cotten; Lille / FR
Musculoskeletal 11:51
SS 1410 Spine B-0948 The effect of low back pain on positional changes
Moderators: M.A. Cova; Trieste/IT, C. Giraudo; Vienna/AT in the lumbar lordosis:
a cross-sectional comparison with healthy controls
10:30 B. Hansen, T. Bendix, J. Grindsted, H. Bliddal, P. Hansen, R. Christensen, R. Riis,
M. Boesen; Copenhagen / DK
K-22 Keynote lecture
I.W. McCall; Devon / UK

10:39 10:30–12:00 Room E2


B-0939 Metal artefacts reduction for spinal fusion implants
in computer tomography: usage of gemstone spectral Neuro
imaging and iterative reconstruction
F. Wang, H. Xue, W. Han, Z. Wu, S. Ma, Y. Zhang, Z. Jin; Beijing / CN SS 1411 Ischaemic stroke (2)
Moderators: A. Biondi; Besancon/FR, W. van Hecke; Antwerp/BE
10:47
B-0940 Diffusion-weighted MRI of the spine: 10:30
is it helpful to discriminate between B-0950 CT angiography and CT perfusion improve prediction
Modic type 1 verterbral endplate changes of infarct occurrence and infarct volume at follow-up
T. van Seeters, L. Kappelle, G. Biessels, Y. van der Graaf, B.K. Velthuis;
and infectious spondylodiscitis? Utrecht / NL
D. Rotzinger, P. Rau, M. Roux, C. Federau, J.-B. Zerlauth, J.-B. Ledoux,
P. Omoumi, F. Becce; Lausanne / CH 10:38
10:55 B-0951 Multicenter experience and outcomes
B-0941 Prevalence of a lumbosacral transitional vertebra and of acute ischemic stroke (AIS) treated with the
concomitant edema in the sacral bone in the SPACE intra-arterial multimodal thrombectomy using
(SPondyloArthritis Caught Early) cohort CTP/CTA for patient selection
F. de Bruin1, S. ter Horst1, J.L. Bloem1, R. Landewé2, K.M. Fagerli3, M. van E. Puglielli1, R. Lattanzi1, M. Fuschi1, V. Di Mizio1, V. Di Egidio2; 1Teramo / IT,
Oosterhout4, D. van der Heijde1, M. Reijnierse1; 1Leiden / NL, 2Amsterdam / NL,
2
Pescara / IT
3
Oslo / NO, 4Gouda / NL
10:46
11:03 B-0952 Application of multi b-values DWI and ASL
B-0942 T2 mapping of the lumbar intervertebral disc in acute ischemia stroke: the relationship between
at 3.0 Tesla: does the nucleus pulposus T2 relaxation fast-ADC and ASL-CBF

Saturday
time predict future low back pain? L. Hu, N. Hong; Beijing / CN
M. Raudner, D. Stelzeneder, C. Kronnerwetter, R. Windhager, S. Trattnig;
Vienna / AT 10:54
B-0953 Diagnostic improvement from average intensity
11:11 projection in acute ischemic stroke
B-0943 Fat suppression in MRI of the spine at 3T using a fast N. Magne, B. Dubourg, E. Tollard, O. Ozkul Wermester, V. Macaigne, J.-N. Dacher,
T2-weighted two-point mDixon TSE technique: E. Gerardin; Rouen / FR
initial clinical experience 11:02
P.A. Kupczyk, M. Marinova, J. Gieseke, H.H. Schild, G.M. Kukuk, D.R. Hadizadeh;
Bonn / DE B-0954 Dual-energy CT brain in the evaluation
of cerebral infarction
11:19 H.S. Teh, M.M.L. Tan, S. Srinivasan, T.W. Choy, K.K. Yeow; Singapore / SG
B-0944 Evaluation of artifacts reducing effect of orthopedic
metal artifact reduction technique in patients aer 11:10
pedicle screw placement B-0955 Endovascular treatment of acute ischemic
Y. Wang, Y. Xiao, Y. Jiang, H. Li, S. Liu; Shanghai / CN stroke. Evolution among 100 consecutive patients
in the last 10 years
11:27 E. Fandiño, J.C. Méndez, D. Lourido, J. García Poza, J. Sanmillán; Madrid / ES
B-0945 Impact of patient positioning during MRI of the
Lumbar Spine in patients with stenosis: 11:18
changes in lordosis and canal dimensions B-0956 Perfusion CT (pCT) in acute stroke:
N. Martins, R.G. Nunes, H. Ferreira, J.P. Figueiredo, L. Barroso, J.D. Mineiro; value of automatically generated colour map
Lisbon / PT in the evaluation of patients with acute stroke
M. Ukmar, R. Pozzi Mucelli, F. Degrassi, F. Neri, F. Pozzi Mucelli, M. Cova;
Trieste / IT

www.myESR.org Final Programme | ECR 2015 293


Scientific Sessions

11:26 11:26
B-0957 False penumbra on CT perfusion studies in acute B-0967 MRI findings in men on active surveillance for prostate
ischaemic stroke (AIS) cancer: does dutasteride make MRI visible lesions
E. Puglielli1, R. Lattanzi1, M. Fuschi1, V. Di Mizio1, V. Di Egidio2; 1Teramo / IT, less conspicuous? Results from a pilot randomised
2
Pescara / IT
controlled trial
11:34 F. Giganti1, C.M. Moore1, N.L. Robertson1, A. Freeman1, F. De Cobelli2,
M. Emberton1, C. Allen1, A. Kirkham1; 1London / UK, 2Milan / IT
B-0958 Clinical predictors of diffusion-weighted MR-imaging
(DWI) abnormalities in transient ischaemic attack 11:34
(TIA) B-0968 Prostate cancer staging with extracapsular
M. Mahmoud, A.F. Christensen, I. Havsteen, H. Christensen; Copenhagen / DK extension risk scoring using multiparametric MRI:
11:42 a correlation with histopathology
L. Boesen, E. Chabanova, V. Loegager, I. Balslev, K. Mikines, H.S. Thomsen;
B-0959 Benefits and harms of endovascular devices for acute Herlev / DK
ischaemic stroke in accordance with the cochrane
collaboration recommendations 11:42
J. Kristensen, C. Gluud, A.F. Christensen, H. Christensen; Copenhagen / DK B-0969 MR-guided prostatic biopsy at 3T: the role of
PI-RADS-score: a histopahologic-radiologic correlation
A. Malich; Nordhausen / DE
10:30–12:00 Room F1
11:50
Oncologic Imaging B-0970 Role of 3T MRI in radiotherapy planning
for stereotactic treatment of the prostate
SS 1416 Prostate cancer imaging with helical tomotherapy
Moderators: E.C. Pereira Mendes Serrao; Cambridge/UK, G. Petralia; Milan/ G. Timon, S. Agostinelli, G. Blandino, G. Vidano, S. Barra, R. Corvò; Genoa / IT
IT

10:30 10:30–12:00 Room F2


B-0960 Apparent diffusion coefficient ratio correlates
significantly with prostate cancer Gleason score at GI Tract
final pathology
L. Boesen, E. Chabanova, V. Loegager, I. Balslev, H.S. Thomsen; Herlev / DK SS 1401 Abdominal and vascular imaging
Moderators: M.M. Maher; Cork/IE, M. Ronot; Clichy/FR
10:38
B-0961 The influence of 3.0T multiparametric prostate 10:38
magnetic resonance for the identification and B-0972 Assessment of bowel wall enhancement for the
localisation of prostatic cancer diagnosis of intestinal ischemia in patients with small
D. Cenzi, L. Zantedeschi, A. Borsato, M. Motton, G. Schenal, S. Montemezzi; bowel obstruction: value of adding unenhanced CT to
Verona / IT
enhanced CT
10:46 A.-M. Chuong, L. Corno, H. Beaussier, G. Chatellier, M. Zins; Paris / FR
B-0962 Multiparametric MRI of prostate: 10:46
can it serve as a screening tool for cancer detection? B-0973 Computed tomography as a diagnostic tool for
A tertiary care cancer hospital experience disseminated histoplasmosis
from South India V.V. Maller, M.O. Afzal, S. Shankar; Memphis, TN / US
A. Prahladan, K. Kalidos, S. Koshy, R. Krishnankutty Nair;
Thiruvananthapuram / IN 10:54
10:54 B-0974 MDCT angiography for suspected acute mesenteric
ischemia: diagnostic yield for ischemic and
B-0963 T2 star relaxation time in the detection and
alternative conditions
assessment of aggressiveness of peripheral zone F.O. Henes1, A. Herzyk1, G. Adam1, M. Regier1, T. Derlin1, A. Laqmani1, M. Lubner2,
cancer in comparison with diffusion-weighted imaging P. Pickhardt2, P. Bannas2; 1Hamburg / DE, 2Madison, WI / US
L.-M. Wu, X.-X. Chen, J.-R. Xu; Shanghai / CN
11:10
11:02 B-0976 Active severe gastrointestinal bleeding (GIB):
B-0964 High resolution computed DWI with high b-value diagnostic performance of the expanded criteria
for prostate cancer: a preliminary study for positive findings on multi-detector CT
Y. Ueno1, S. Takahashi1, Y. Ohno1, M. Yui2, Y. Kassai2, Y. Ueda1, K. Kyotani1,
K. Sugimura1; 1Kobe / JP, 2Ohtawara / JP angiography (MDCTA)
G. Zhang, H. Sun, X. Li, Z. Jin; Beijing / CN
11:10
11:18
B-0965 Diffusion tensor imaging in diagnosing prostate
B-0977 Significance of mesenteric volvulus in patients
cancer: an innovative application of a proven
with bowel obstructive symptom and history
technique
R. Balaji; Chennai / IN of gastric surgery on multidetector CT
J. Nam, J. Lee, Y. Jeong, M. Bang, S. Shin, S. Choi; Ulsan / KR
11:18
11:26
B-0966 1.5 Tesla MRI of the prostate with 32-channel phase
B-0978 Comparison between CT and anatomopathologhical
array cardiac coil: is it better than endorectal coil?
A. Discalzi, R. Faletti, C. Guarnaccia, A. Dominguez, D. Righi, P. Fonio, G. Gandini; findings in gastrointestinal tumours (GIST)
Turin / IT F. Carbonetti, E. Berardi, G. Federici, M. Di Pietropaolo, C. Fantini, S. Caterino,
E. Iannicelli, V. David; Rome / IT

294 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:26
B-0979 CT in peritoneal tuberculosis revisited: B-0989 MR diagnosis of diaphragmatic endometriosis
mystery, myth and reality P. Rousset1, C. Bordonne2, C. Rousset-Jablonski1, F. Golfier1, J. Hugon-Rodin2,
M. Khanna, S. Ramanathan, A.M. Abualruz, D. Kumar, S.R. Buddhavarapu, M. Alifano2, M.-P. Revel2; 1Pierre Bénite / FR, 2Paris / FR
A. Darweesh, J. Khanna; Doha / QA
11:34
11:42 B-0990 Magnetic resonance imaging versus chest radiography
B-0980 Fast MRI-based quantification of visceral adipose in the study of lung parenchyma: preliminary results
tissue in morbidly obese I. Merli, C. Messina, M. Petrini, F. Secchi, L.M. Sconfienza, F. Sardanelli; San
N. Linder, A. Schaudinn, N. Garnov, M. Blüher, T. Schütz, T. Karlas, A. Dietrich, Donato Milanese / IT
T. Kahn, H. Busse; Leipzig / DE
11:42
11:50 B-0991 T2 relaxation and proton density characterisation
B-0981 Real-time splenic elastography as a tool for detection of pathologically proved nonspecific interstitial
and grading of oesophago-gastric varices pneumonia and usual interstitial pneumonia
V. Venugopal, S.K. Arjun; New Delhi / IN M.T.A. Buzan1, M. Eichinger2, C. Heussel2, H.-U. Kauczor2, M. Kreuter2,
U. Oltmanns2, A. Warth2, C.M. Pop1, J. Dinkel2; 1Cluj-Napoca / RO, 2Heidelberg / DE

10:30–12:00 Room D1 11:50


B-0992 Usefulness of diffusion-weighted (DWI) magnetic
Chest resonance for distinguishing different types of
thoracic wall sarcoma
SS 1404 CT dose reduction and MR indications T. Milosavljevic, A. Ivkovic; Nis / RS
Moderators: J. Broncano; Cordoba/ES, E.J. Stern; Seattle, WA/US

10:30 10:30–12:00 Room D2


B-0982 Pulmonary thin-section MRI with ultra-short TE:
Comparison of capability for lung and mediastinal Interventional Radiology
radiological finding assessments with thin-section
MDCT in patients with various pulmonary diseases
SS 1409 Radioembolisation and
1 1 1 2 3 2
Y. Ohno , S. Seki , H. Koyama , A. Lu , M. Yui , M. Miyazaki , T. Yoshikawa , 1 chemoembolisation in liver tumours
S. Matsumoto1, K. Sugimura1; 1Kobe / JP, 2Vernon Hills, IL / US, 3Otawara / JP Moderators: R.F. Dondelinger; Liège/BE, T.A. Heusner; Hamm/DE

10:38 10:30
B-0983 Ultra-low dose CT pulmonary angiography for imaging K-23 Keynote lecture
pregnant women: can dose reduction be achieved P. Haage; Wuppertal / DE
without affecting image quality? 10:39
D. Halpenny, B. Park, J. Alpert, L. Latson, J. Babb, J. Ko; New York, NY / US
B-0993 Post-SIRT survival in a tertiary referall centre for HCC
10:46 P. Lucatelli, G. Vallati, G. Pizzi, F. Portieri, F. Rosella, F. Paradiso; Rome / IT
B-0984 Reducing the radiation dose of CT scans to exclude 10:47
pulmonary embolism by using protocols adapted to
B-0994 Transarterial chemoembolisation (TACE) in primary
patient weight
T. De Bondt, R. Salgado, M. Geldof, F. Deferme, P.M. Parizel; Antwerp / BE liver malignancies: Intraprocedural blood volume
measurement using fast C-arm-CT for monitoring
10:54

Saturday
response
B-0985 Low-kilovoltage and low-mAs MDCT chest T.J. Vogl, S. Tietz, S. Zangos, S. Zeuzem; Frankfurt a. Main / DE
examinations in adults: assessment in terms of 10:55
feasibility, image quality and radiation dose
A.A. Patil; Kochi / IN B-0996 Utility of intra-procedural cone-beam CT in predicting
treatment outcome for drug-eluting bead (DEB)
11:02 transarterial chemoembolisation (TACE)
B-0986 Quantitative measurements in low-dose chest CT with B.H. Ge, C.N. Weber, M.M. Watts; Philadelphia, PA / US
hybrid iterative reconstruction technique 11:03
S. Kawanami, T. Kamitani, T. Yamanouchi, Y. Yamasaki, M. Jinnouchi,
M. Yonezawa, M. Nagao, H. Yabuuchi, H. Honda; Fukuoka / JP B-0997 Conventional transarterial chemoembolisation versus
drug-eluting bead transarterial chemoembolisation for
11:10 the treatment of hepatocellular carcinoma
B-0987 Chest CT radiation dose optimisation: comparison of R. Kloeckner, F. Prinz, C. Ruckes, A. Weinmann, C. Dueber, M.B. Pitton;
automatic exposure control strength curves Mainz / DE
E. Gyssels1, P. Bohy2, A. Cornil3, A. Van Muylen4, P.A.A. Gevenois4, D. Tack2;
1
Sirault / BE, 2Baudour / BE, 3Ath / BE, 4Brussels / BE 11:11
B-0999 Parametric response mapping of dynamic CT for
11:18 longitudinal quantitative assessment of regional
B-0988 Ultra-reduced dose chest CT: comparison between tumour vascularisation in TACE treatment for
iterative model reconstruction, iDose4 and hepatocellular carcinoma
filtered-back projection T. Rodt, D. Kaercher, D.B. Hasdemir, T. Kaireit, C. Lutat, A. Vogel, B. Meyer,
C. de Margerie-Mellon1, C. de Bazelaire1, J. Lambert1, C. Montlahuc1, F. Wacker, H.-O. Shin; Hannover / DE
A. Martineau1, E. de Kerviler1, C. Beigelman2; 1Paris / FR, 2Lausanne / CH

www.myESR.org Final Programme | ECR 2015 295


Scientific Sessions

11:19 11:34
B-1000 Can cone-beam CT-assisted chemoembolisation B-1012 X-ray phase-contrast CT:
improve survival of patients with single nodular a novel method for differentiation of low-fat
hepatocellular carcinoma? angiomyolipomas from renal cell carcinomas
J. Lee, J. Choi, H.-C. Kim; Seoul / KR M. Braunagel1, L. Birnbacher2, M. Willner2, J. Herzen2, S. Notohamiprodjo1,
T. Saam1, F. Pfeiffer2, M.F. Reiser1, M. Notohamiprodjo3; 1Munich / DE,
11:27 2
Garching / DE, 3Tübingen / DE
B-1001 Evaluation of quality of life aer initial TACE for 11:42
treatment of HCC B-1013 CT perfusion parameters to determine
D.B. Hasdemir, M. Nordlohne, K.J. Hartrumpf, N. Schweitzer, A. Vogel, F. Wacker,
B.C. Meyer, T. Rodt; Hannover / DE split renal function
M. El-Diasty, G. Gaballa, H. Gad, M.A. Borg, M. Abou El-Ghar, K. Sheir,
T.A.E. El-Diasty; Mansoura / EG
10:30–12:00 Room G

Genitourinary 10:30–12:00 Room K

SS 1407 Adrenal and kidney imaging Radiographers


Moderators: C.D. Alt; Hamburg/DE, O. Nikolic; Novi Sad/RS
SS 1414 Dose management in medical imaging
10:30 Moderators: H.H. Hjemly; Oslo/NO, C. Loewe; Vienna/AT
B-1003 Volumetry of adrenal glands: 10:30
normative data and influence of various parameters
A. Carsin, N. Oubaya, A. Janvier, S. Mulé, B. Delemer, C. Hoeffel; Reims / FR B-1014 Evaluation of beam collimation in paediatric chest
radiographs
10:38 K. Borg, F. Zarb; Msida / MT
B-1004 Contrast-enhanced computed tomography (CT) in 10:38
intensive care unit patients: B-1015 Using BMI-based exposure tables to reduce dose creep
impact of hyperattenuating adrenal glands
J. Boos, J. Schek, P. Kröpil, P. Heusch, N. Heinzler, G. Antoch, R.S. Lanzman; and improve image quality in lateral hip radiographs
Düsseldorf / DE M.W. Kusk; Esbjerg / DK

10:46 10:46
B-1005 Acute pyelonephritis in kidney transplant patients: B-1016 Paediatric chest digital radiography optimisation
P. Freitas, F. Lopes, D. Costa, J. Santos, G. Paulo; Coimbra / PT
role of diffusion-weighted MR imaging
J. Giglio, R. Faletti, C. Guarnaccia, M. Messina, P. Fonio, G. Gandini; Turin / IT 10:54
10:54 B-1017 An investigation into cardiologists’ opinion/awareness
B-1006 Evaluation of chronic kidney disease using blood of radiation risk as part of routine patient consent for
oxygenation-level dependent magnetic resonance cardiac interventional procedures
I. Banerjee1, J. McNulty1, D. Catania2, D. Maccagni2, L. Masterson1, J.L. Portelli3,
imaging at 3T L.A. Rainford1; 1Dublin / IE, 2Milan / IT, 3Malta / MT
J. Bae, C. Kim, J. Park, B. Park, S. Park; Seoul / KR
11:02
11:02
B-1018 Dose evaluation releted image quality on paediatric
B-1007 Assessment of intravoxel incoherent motion MR chest examination with dedicated flat-panel
imaging for the differentiation of renal benign tumour C. Dionisi1, E. Stefani1, S. Barbera2; 1Treviso / IT, 2Biella / IT
and renal malignant tumour
L. Li, H. Ye, H. Wang, Y. Tang, D. Zheng; Beijing / CN 11:10
B-1019 AP vs PA positioning in lumbar spine computed
11:10
radiography: image quality and individual organ doses
B-1009 Clear cell renal cell carcinoma: associations between E. Davey, A.E. England; Manchester / UK
CT imaging features and patient survival
A.M. Hötker, C.A. Karlo, J. Zheng, C.S. Moskowitz, P. Russo, H. Hricak, O. Akin; 11:18
New York, NY / US
B-1021 Uniformisation of the anode heel effect and
11:18 image quality
A.F.C.L. Abrantes, J. Aleixo, L.P. Ribeiro, S. Rodrigues, P. Sousa, J.P. Pinheiro,
B-1010 Differentiation of clear cell renal cell carcinoma from R.P.P. Almeida, O. Lesyuk; Faro / PT
other renal cortical tumours using a quantitative
multi-parametric MRI Approach 11:26
A.M. Hötker, Y. Mazaheri, A. Wibmer, C.A. Karlo, J. Zheng, C.S. Moskowitz, B-1022 The effect of lead shielding in pelvis radiography
P. Russo, H. Hricak, O. Akin; New York, NY / US N. Mekiš, J. Zibert, D. Zontar; Ljubljana / SI

11:26 11:34
B-1011 Tubulocystic renal cell carcinomas: B-1023 Optimising pelvis images of a paediatric phantom by
a new radiological entity using additional filtration and different combinations
F. Cornelis1, O. Hélénon2, J.-M. Correas2, L. Lemaitre3, M. André4, J.-Y. Meuwly5,
C. Sengel6, L.E. Derchi7, N. Grenier1; 1Bordeaux / FR, 2Paris / FR, 3Lille / FR, of kVp and mAs
4
Marseille / FR, 5Lausanne / CH, 6Grenoble / FR, 7Genoa / IT V. Harsaker1, W. Schaake2, R. Visser2, C. Bloomfield3, F. Boavida4, D. Chabloz5,
E. Crausaz5, E. Huizinga2, H. Hustveit1, H. Knight3, A. Pereira4, P.H. Hogg3;
1
Oslo / NO, 2Groningen / NL, 3Salford / UK, 4Lisbon / PT, 5Lausanne / CH

296 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:42
B-1024 A European collaborative research study investigating
paediatric cardiac interventional radiation dose levels
L.A. Rainford1, D. Catania2, M. Pasquato2, L. Masterson1, C. McLaren3, S. Foley1;
1
Dublin / IE, 2Milan / IT, 3London / UK

Saturday

www.myESR.org Final Programme | ECR 2015 297


Scientific Sessions

10:30–12:00 Room C 11:43


B-1033 Use of computer aided detection in breast cancer
Breast screening programmes
E. Tosi1, S. Teggi1, G. Dell’Oste1, M. Zorzi1, C. Armocida2, A. Armocida3, G. Raso4;
SS 1802 Population-based screening 1
Padova / IT, 2Modena / IT, 3Ferrara / IT, 4Palermo / IT
Moderators: E.J. Cornford; Nottingham/UK, K. Pinker-Domenig; Vienna/AT
11:51
10:30 B-1034 Performance of 3 commercially available
K-24 Keynote lecture CAD-systems applied to ML-views of screening- and
E.M. Fallenberg; Berlin / DE nonscreening-selected cases for stereotactic biopsy:
10:39 comparison to histopathology
R.L. Chelaru, A. Malich; Nordhausen / DE
B-1025 Performance of grid-less digital mammography
acquisition technique for breast screening:
analysis of 22,117 examinations 10:30–12:00 Room Z
L.B. Larsen1, A. Fieselmann2, H. Pfaff2, T. Mertelmeier2; 1Odense / DK,
2
Erlangen / DE Computer Applications
10:47
B-1026 A six-year study of mammographic compression force: SS 1805 Data sharing and content-based
practitioner variability within and between data retrieval
Moderators: P. Sögner; Feldkirch/AT, C.G. Trumm; Munich/DE
screening sites
C.E. Mercer1, K. Szczepura1, J. Kelly2, S. Millington2, E. Denton3, R. Borgen4,
B. Hilton4, P.H. Hogg1; 1Manchester / UK, 2Chester / UK, 3Norwich / UK, 4Lancs / UK 10:30
B-1035 DICOM and DICOM security worldwide:
10:55 adoption maps and country ratings
B-1027 Characteristics of BI-RADS 0 lesions at blinded O. Pianykh; Newton Highlands, MA / US
or non-blinded double reading of screening
10:38
mammograms and impact of arbitration of discrepant
BI-RADS 0 recalls by a third reader B-1036 The RSNA Image Share and the evolving
E.G. Klompenhouwer1, R.J.P. Weber1, A.C. Voogd2, G.J. Den Heeten3, IHE XDS-I environment
L.J.A. Strobbe4, M.J.M. Broeders4, L.E.M. Duijm4; 1Eindhoven / NL, 2Maastricht / NL, D.S. Mendelson1, C.D. Carr2, B.J. Erickson3, E. Siegel4, D. Avrin5, R. Arenson1; 1New
3
Amsterdam / NL, 4Nijmegen / NL York, NY, NY / US, 2Chicago, IL / US, 3Rochester, MN / US, 4Baltimore, MD / US,
5
San Francisco, CA / US
11:03
10:46
B-1028 Effect of volumetric mammographic density on
performance of a breast cancer screening program B-1037 User centered evaluation of the KHRESMOI
using full-field digital mammography image search system for radiologists
M. Holzer1, D. Markonis2, H. Müller2, R. Donner1, G. Langs1; 1Vienna / AT,
J.O.P. Wanders1, K. Holland2, W.B. Veldhuis1, R.M. Mann2, P.H.M. Peeters1, 2
Sierre / CH
C.H. van Gils1, N. Karssemeijer2; 1Utrecht / NL, 2Nijmegen / NL

11:11 10:54
B-1029 Well-defined mass lesions in mammographic B-1038 Development of a shared multisite virtual PACS
P. Rowlands, S. Dyce, N. Pfirsch, S. Lomax; Liverpool / UK
screening: determining the rate of cysts and
solid lesions 11:02
F. Kilburn-Toppin, M. Wallis; Cambridge / UK B-1039 VISCERAL - visual concept extraction challenge
11:19 in radiology: segmentation challenge -
B-1030 Comparison of the diagnostic workup of women overview, insights and preliminary results
K.M. Grünberg1, M.-A. Weber1, O.A. Jimenez del Toro2, O. Goksel3, H. Müller2,
referred at non-blinded or blinded double reading G. Langs4, M. Krenn4, M. Winterstein1, A. Hanbury4; 1Heidelberg / DE, 2Sierre / CH,
in a population-based screening mammography
3
Zurich / CH, 4Vienna / AT
programme in the south of the Netherlands 11:10
E.G. Klompenhouwer1, R.J.P. Weber1, A.C. Voogd1, L.J.A. Strobbe2,
M.J.M. Broeders1, L.E.M. Duijm2; 1Eindhoven / NL, 2Nijmegen / NL B-1040 Automated liver lesions classification using dictionary
Bag-of-Visual-Words (BoVW) model
11:27 N. Rozendorn1, M.M. Amitai2, E. Klang2, E. Konen2, A. Ben Cohen1, I. Diamant1,
B-1031 Characteristics and survival of interval breast cancer H. Greenspan1; 1Tel Aviv / IL, 2Ramat Gan / IL
subtypes at biennial screen-film and full-field digital 11:18
screening mammography B-1041 Evaluation of a computer algorithm for automated
R.J.P. Weber1, E.G. Klompenhouwer1, J. Nederend1, M.W. Louwman1, A.C. Voogd2,
L.J.A. Strobbe3, F.H. Jansen1, L.E.M. Duijm3; 1Eindhoven / NL, 2Maastricht / NL, detection and measurement of liver metastases
3
Nijmegen / NL E. Klang1, A. Ben Cohen2, I. Diamant2, N. Rozendorn2, E. Konen1, H. Greenspan2,
M.M. Amitai1; 1Ramat Gan / IL, 2Tel Aviv / IL
11:35
B-1032 Screening outcome and surgical treatment during 11:26
and aer the transition from screen-film to digital B-1042 A breast cancer digital repository for assessing CADx
screening mammography in the south of the methods on mammography
M. Guevara Lopez1, N. Gonzalez de Posada2, D. Cardoso Moura2, P. Cunha2,
Netherlands I. Ramos2, J. Pinheiro Loureiro2, I. C. Moreira2, B. Ferreira de Araújo2; 1Aveiro / PT,
R.J.P. Weber1, E.G. Klompenhouwer1, J. Nederend1, A.C. Voogd2, L.J.A. Strobbe3, 2
Porto / PT
L.E.M. Duijm3; 1Eindhoven / NL, 2Maastricht / NL, 3Nijmegen / NL

298 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:34 11:27
B-1043 Real world application of new technologies enhancing B-1053 Added value of functional dynamic CT-perfusion
teleradiology services in the Waldviertel healthcare in assessment of neoangiogenesis tumour-related
region, Austria phenomenon in diagnosis and treatment evaluation of
A. Bernegger; Horn / AT HCC patients
D. Ippolito, D. Fior, P.A. Bonaffini, C. Talei Franzesi, R. Corso, S. Sironi; Monza / IT
11:42
B-1044 Teleradiology in Italy: results of an online survey 11:35
F. Coppola1, E. Neri2, D. Regge3; 1Bologna / IT, 2Pisa / IT, 3Turin / IT B-1054 Radiological response of hepatocellular carcinoma
11:50 (HCC) treated with transarterial chemoembolisation
B-1045 French and Italian residents’ expectations concerning (TACE) before liver transplant (LT): correlation with
teleradiology: a comparative study histopathology and recurrence free survival
A. Agostini, D. Nicolini, C. Mincarelli, G. Svegliati Baroni, A. Mandolesi,
N. Pyatigorskaya1, F. Coppola2, D. Regge3, E. Neri4; 1Paris / FR, 2Bologna / IT, A. Lorenzoni, R. Candelari, M. Vivarelli, A. Giovagnoni; Ancona / IT
3
Turin / IT, 4Pisa / IT
11:43
10:30–12:00 Room M
B-1055 The impact of transarterial chemoembolisation (TACE)
on uninvolved liver parenchymal perfusion in patients
Abdominal Viscera with hepatocellular carcinoma undergoing TACE
M. Horger, K. Nikolaou, S. Kaufmann; Tübingen / DE
SS 1801 HCC diagnosis and treatment
Moderators: C. Ayuso Colella; Barcelona/ES, A. Furlan; Pittsburgh, PA/US
10:30–12:00 Studio 2015
10:30
K-25 Keynote lecture
Cardiac
C. Ayuso Colella; Barcelona / ES
SS 1803 Biomarkers in cardiac imaging
10:39 Moderators: A. Kallifatidis; Thessaloniki/GR, T. Leiner; Utrecht/NL
B-1046 Reporting of hepatocellular carcinoma:
comparison of interreader agreement between 10:30
LI-RADS and standard LIKERT-scale in patients B-1056 MRI-proven cardiac pathologies in female carriers of
at risk for hepatocellular carcinoma Duchenne muscular dystrophy
J. Schelhorn, A. Schoenecker, U. Neudorf, K. Nassenstein, U. Schara,
B.K. Barth, O.F. Donati, M.A. Fischer, E.J. Ulbrich, K.A. Christoph, C.S. Reiner; T. Schlosser; Essen / DE
Zurich / CH

10:47 10:38
B-1048 Clinical application of LI-RADS: B-1057 Correlation of thoracic aortic distensibility with aortic
preliminary evaluation with Gd-BOPTA MR Imaging and coronary atherosclerotic plaques
M.A. Karimi, A. Arjmand Shabestari, M. Shahnazi, T. Faghihi Langroudi,
M. Di Martino, M. Bezzi, C. Catalano; Rome / IT H. Pouraliakbar, M. Tehrai; Tehran / IR
10:55 10:46
B-1049 A prospective study to compare the diagnostic B-1058 Cardiac computed tomography is an accurate method
performance of gadoxetic acid-enhanced MRI and US to differentiate le atrial appendage thrombi from
for surveillance of HCC in high risk patients with liver spontaneous echo contrast in acute stroke patients
cirrhosis M. Taina, R. Vanninen, P. Sipola, A. Muuronen, P. Jäkälä, M. Hedman; Kuopio / FI
S. Kim, Y.-S. Lim, J. Byun, H. Won, S. Lee, S. Han, J. An, H. Lee, Y. Lee; Seoul / KR
10:54
11:03 B-1059 Impact of implementing cardiac CT in evaluating
B-1050 Hypointense nodules on hepatobiliary phase Gadoxetic patients suspected of cardioembolic stroke
acid-enhanced MR images: imaging features, evolution A.M. Ajlan, R.R. Bagdadi; Jeddah / SA
and the role of diffusion-weighted imaging
C. Briani, M. Di Pietropaolo, G.F. Federici, F. Carbonetti, M. Marignani, P. Begini, 11:02
E. Iannicelli; Rome / IT B-1060 Geometrical differences of the coronary arteries
11:11 during the cardiac cycle on 4D CT angiography
J.K. van Zandwijk1, V. Tuncay1, C.H. Slump2, M. Oudkerk1, R. Vliegenthart1,
Sunday

B-1051 Non-hypervascular hepatobiliary phase hypointense P.M.A. van Ooijen1; 1Groningen / NL, 2Enschede / NL
nodules on gadoxetic acid-enhanced MRI:
risk of HCC recurrence aer radiofrequency ablation 11:10
D. Lee, J. Lee; Seoul / KR B-1061 Heritability of coronary geometry: initial experience
M. Kolossváry1, Z.D. Drobni1, G. Závodszky1, I. Kolossváry1, P. Kitslaar2,
11:19 B. Merkely1, P. Maurovich-Horvat1; 1Budapest / HU, 2Leiden / NL
B-1052 Role of DWI, ADC and correlation with hepatobiliary 11:18
phase (DPI, delayed phase imaging) findings in the
B-1062 Heritability of coronary calcification and plaque
differentiation of hepatocellular carcinoma (HCC) from
burden: a classical twin study
dysplastic nodules (DNs) in liver cirrhosis P. Maurovich-Horvat1, Z.D. Drobni1, T. Horvath1, A.L. Jermendy1, M. Karoly1,
D. Curione, R. Inchingolo, A. De Gaetano, M. Ciresa, L. Bonomo; Rome / IT M. Kolossvary1, A.D. Tarnoki1, S. Voros2, B. Merkely1; 1Budapest / HU, 2Richmond,
VA / US

www.myESR.org Final Programme | ECR 2015 299


Scientific Sessions

11:26 11:19
B-1063 Measuring athlete’s risk of cardiovascular events B-1072 Use MRI T1rho monitor the curative effective
(MARC) study: the role of coronary CT in the treatment of epimedium on early osteoarthritis
cardiovascular evaluation of middle-aged sportsmen S. Liu, J. Zhang, S. Shen, F. Wang, L. Qiu, M. Chen, C. Zhang; Guangzhou / CN
T. Braber, B.K. Velthuis; Utrecht / NL
11:27
11:34 B-1073 Is it worth to include MRI of the spine in the ASAS
B-1064 Athletes’ normal le ventricular magnetic resonance classification criteria for axial spondyloarthritis:
parameters modified by trabeculae measurement data from the DESIR-cohort
H. Vago, A. Toth, C. Czimbalmos, F. Suhai, I. Csecs, K. Kecskes, B. Merkely; M. de Hooge, J.-B. Pialat, A. Feydy, M. Reijnierse, M. Dougados, D. van der
Budapest / HU Heijde; Paris / FR

11:42 11:35
B-1065 Cardiac MRI in athletes can be a final step in the B-1074 Gouty arthritis: effect of dual-energy CT on diagnostic
eligibility for competitive sport aer suspicious thinking and therapeutic decision making
ultrasonography or stress ECG? T. Finkenstaedt, A. Manoliou, M. Toniolo, T. Frauenfelder, G. Andreisek,
L. Patriarca, F. Bruno, A. Mancini, F. Smaldone, E. Di Cesare, C. Masciocchi; B. Michel, R. Guggenberger, H. Alkadhi; Zurich / CH
L’Aquila / IT
11:43
11:50 B-1075 Prevalence of MRI spinal lesions typical
B-1066 Can pericardial fat volume be a marker of metabolic for axial Spondyloarthritis in patients
syndrome in adult patients? A preliminary study with inflammatory back pain
H. Chen1, J. Yu1, X. Zhang2; 1Chengdu / CN, 2Shanghai / CN M. De Hooge1, J.-B. Pialat2, A. Feydy3, M. Reijnierse1, P. Claudepierre4,
A. Saraux5, M. Dougados3, D. van der Heijde1; 1Leiden / NL, 2Lyon / FR, 3Paris / FR,
4
Créteil / FR, 5Brest / FR
10:30–12:00 Room E1 11:51
Musculoskeletal B-1076 Scoring of spinal lesions compatible with axial
spondyloarthritis on MRI in clinical practice
SS 1810 Arthritis by local radiologist or rheumatologist in DESIR:
Moderators: A. Cotten; Lille/FR, S. Weckbach; Heidelberg/DE comparison with central reading
M. de Hooge1, J.-B. Pialat2, M. Reijnierse1, D. van der Heijde1, M. Dougados3,
10:30 A. Feydy3; 1Leiden / NL, 2Lyon / FR, 3Paris / FR
K-26 Keynote lecture
I. Boric; Zabok / HR
10:30–12:00 Room E2
10:39
B-1067 A comparison between x-ray, CT and DECT in detection Neuro
of tophi in gouty arthritis: first clinical experience with
single source DECT in volume scan mode
SS 1811 Brain epilepsy and inflammation
T. Diekhoff, T. Kiefer, K.-G.A. Hermann; Berlin / DE Moderators: T. Kau; Klagenfurt/AT, M. Mantatzis; Alexandroupolis/GR

10:47 10:30
B-1068 Evaluation of a simplified version of the rheumatoid B-1077 Widespread white matter maldevelopment in children
arthritis magnetic resonance imaging score (RAMRIS) with specific language impairment
I.L. Štepán-Buksakowska1, N. Szabó2, R. Vydrová1, T.Z. Kincses2, J. Šanda1,
comprising 5 joints (RAMRIS5) M. Kynčl1, D. Hořínek2, M. Roček1, V. Komárek1; 1Prague / CZ, 2Brno / CZ
C. Schleich, C. Buchbender, P. Sewerin, B. Ostendorf, C. Rubbert, G. Antoch,
F. Miese; Düsseldorf / DE
10:38
10:55 B-1078 Acute necrotising encephalopathy of childhood:
B-1069 Increased risk for incident radiographic osteoarthritis correlation of MRI findings and clinical outcome
M.D. Mahajan, V. Ruprela, B. Banerjee, P.E. Chandy, R. Ananthasivan, U. Patil,
and cartilage loss in knees undergoing meniscal S. Kumar GG, N. Shetty, P. Reddy; Bangalore / IN
surgery in the previous year
F.W. Roemer1, C. Kwoh2, M. Hannon3, J. Grago3, D.J. Hunter4, F. Eckstein5, 10:46
A. Guermazi6; 1Erlangen / DE, 2Tucson, AZ / US, 3Pittsburgh, PA / US, 4Sydney / AU,
5
Salzburg / AT, 6Boston, MA / US B-1079 Abnormal brain development in neonates with
congenital heart disease: evaluation with quantitative
11:03 magnetic resonance spectroscopy
B-1070 Comparison of optimised high-resolution MR imaging R.A. Elshafey, M. Awny, A. Elmashad, M. Nassar; Tanta / EG
of the temporomandibular joint at 1.5T and 3.0T using 10:54
an optimised high-resolution protocol
A. Manoliu, G. Spinner, M. Wyss, S. Erni, D. Ettlin, D. Nanz, E.J. Ulbrich, L.M. Gallo, B-1080 The value of resting-state fMRI for detecting
G. Andreisek; Zurich / CH epileptogenic zone in patients with focal epilepsy
J. Yin1, B. Zhao1, P. Zuo2, H. Ni1, W. Shen1; 1Tianjin / CN, 2Beijing / CN
11:11
B-1071 Increased risk for radiographic osteoarthritis 11:02
features in young active athletes: B-1081 fMRI resting-state in temporal lobe epilepsy
N. Ananyeva, L. Shmeleva, R. Ezhova; St. Petersburg / RU
a cross-sectional matched case-control study
F.W. Roemer1, M. Jarraya2, J. Niu2, J.-R. Silva Jr.2, R. Frobell3, A. Guermazi1;
1
Doha / QA, 2Boston, MA / US, 3Lund / SE

300 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

11:10 11:03
B-1082 Relative contributory role of Interictal/Ictal SPECT, B-1091 Prognostic value of dynamic contrast-enhanced CT
interictal PET, MR spectroscopy and T2 relaxometry with perfusion imaging in assessing the response to
in localisation of seizure focus in temporal lobe anti-angiogenic therapy in patients with advanced
epilepsies: a metaanalysis and systematic review hepatocellular carcinoma: preliminary results
V. Venugopal, I. Afshan, S.K. Arjun; New Delhi / IN G. Querques, D. Ippolito, P.A. Bonaffini, C. Talei Franzesi, A. Nasatti, S. Sironi;
Monza / IT
11:18
B-1083 Application of “Zero” Time-of-Echo (ZTE) MRI 11:11
sequence for “Silent” T1-weighted imaging B-1092 Prediction of tumouru response to neoadjuvant
at 7.0 Tesla concurrent chemoradiotherapy for borderline
M. Costagli1, M.R. Symms1, L. Angeli1, D.A.C. Kelley2, L. Biagi1, C.H.S. Rua1, resectable pancreatic cancer by diffusion-weighted
G. Tiberi1, M. Tosetti1, M. Cosottini1; 1Pisa / IT, 2San Francisco, CA / US MRI and 18F-FDG PET/CT
I. Joo, J. Lee, J. Han, B. Choi; Seoul / KR
11:26
B-1084 Globe flattening: conventional two-dimensional vs 11:19
three-dimensional T2-weighted imaging B-1093 DCE-MRI-derived parameters as predictors of response
J. Ann, E. Kim; Incheon / KR to neo-adjuvant chemoradiation treatment of rectal
11:34 carcinoma
S. Phongkitkarun, U. Tohmad, N. Larbcharoensub, K. Sumbunnanondha,
B-1085 Decreased auditory GABA+ concentrations in T. Sawangsilpa, E. Sirachainan; Bangkok / TH
presbycusis demonstrated by edited magnetic
resonance spectroscopy 11:27
F. Gao1, B. Zhao1, G. Wang1, F. Ren1, R.A.E. Edden2; 1Jinan / CN, 2Baltimore, B-1094 Automated and semi-automated diffusion-weighted
MD / US MRI volumetry to assess response aer neoadjuvant
11:42 therapy in rectal cancer
M.M. van Heeswijk1, D.M. Lambregts1, S. Oei1, N. Papanikolaou2, S.-X. Rao1,
B-1086 Diffusion tensor imaging of cervical spine in subjects G.L. Beets1, R.F.A. Vliegen3, R.G.H. Beets-Tan1; 1Maastricht / NL, 2Iraklion,
presenting successful aging: preliminary report Crete / GR, 3Heerlen / NL
J. Ciescinski, E. Zawada, B. Augustynska, K. Porzych, Z. Serafin; Bydgoszcz / PL
11:35
11:50 B-1095 Early monitoring of tumour response to photothermal/
B-1087 Multiple sclerosis deep grey matter: photodynamic therapy delivered by nano-graphene
the relation between demyelination, oxide using diffusion-weighted and BOLD-contrast MRI
neurodegeneration, inflammation and iron F. Zhang, J. Cao, G. Fu, G. Fu; Xiamen / CN
L. Haider1, C. Simeonidou2, G. Steinberger1, S. Hametner1, N. Grigoriadis2,
H. Lassmann1, J. Frischer1; 1Vienna / AT, 2Thessaloniki / GR 11:43
B-1096 Tumour volume as a quantitative imaging biomarker
on computed tomography: toward adaptive criteria
10:30–12:00 Room F1 H. Beaumont1, S. Egels2, S. Zaim1, A. Iannessi3, O. Lucidarme2; 1Valbonne / FR,
2
Paris / FR, 3Nice / FR
Oncologic Imaging 11:51
SS 1816 Response assessment: new concepts B-1097 Does DWI improve therapy response evaluation
Moderators: B. Banko; Belgrade/RS, A. Sohaib; London/UK by Gd-EOB-DTPA MRI in patients with HCC aer
radioembolisation?
10:30 J. Schelhorn1, J. Best1, M.P. Reinboldt1, G. Gerken1, M. Ruhlmann1,
T.C. Lauenstein1, G. Antoch2, S. Kinner1; 1Essen / DE, 2Düsseldorf / DE
K-27 Keynote lecture
H. Hricak; New York, NY / US

10:39 10:30–12:00 Room F2


B-1088 Predicting non-response to NAC in patients with
breast cancer using 3D texture analysis Physics in Radiology
N. Michoux1, L. Bollondi2, A. Depeursinge3, A. Geissbühler2, L. Fellah1, H. Müller3,
I. Leconte1; 1Brussels / BE, 2Geneva / CH, 3Sierre / CH SS 1813 Novel digital imaging techniques
Moderators: M. Brink; Nijmegen/NL, N. Kalyvas; Athens/GR
10:47
Sunday

B-1089 Tumour heterogeneity quantified by texture analysis 10:30


on contrast-enhanced CT predicts prognosis B-1098 Dual spectrum single pass digital breast
in patients affected by colorectal cancer liver tomosynthesis imaging
metastases treated with bevacizumab-containing I. Sechopoulos, S.S.J. Feng, L. Merchan, J.G. Nagy; Atlanta, GA / US
chemotherapy 10:38
M. Ravanelli, D. Ngo Ikeng, A. Rossi, A. Berruti, R. Maroldi; Brescia / IT
B-1099 A new anthropomorphic, physical phantom for DBT
10:55 performance evaluation
B-1090 Tumoural response assessment aer N. Oberhofer1, L. Ikejimba2, Y. Chen3, J. Lo2, E. Samei2; 1Bolzano / IT, 2Durham,
NC / US, 3Beijing / CN
chemoembolisation of hypervascular liver lesions
M.-A. Jegonday, A. Fohlen, V. Le Pennec, K. Bouhier-Leporrier,
I. Ollivier-Hourmand, J.-J. Parienti, J.-P. Pelage; Caen / FR

www.myESR.org Final Programme | ECR 2015 301


Scientific Sessions

10:46 10:38
B-1100 A structured phantom for comparative detectability B-1110 The pulmonary vascular alteration in COPD as
evaluation in 2D digital mammography and breast determined by quantitative CT measurement:
tomosynthesis a two-year longitudinal study
L. Cockmartin, N.W. Marshall, G. Zhang, E. Shaheen, H. Bosmans; Leuven / BE N. Yu, C. Jin, Y. Li, J. Ma, Y. Guo; Xi‘an / CN

10:54 10:54
B-1101 In vivo proof of principle: x-ray dark-field radiography B-1112 Correlation study of emphysema based on each lobe
for diagnosis of lung fibrosis and small airway remodeling by using CT quantitative
K. Hellbach1, A. Yaroshenko2, O. Eickelberg3, F.G. Meinel1, M. Bech4, analysis in patients with chronic obstructive
T. Conlon3, M.F. Reiser1, A. Yildirim3, F. Pfeiffer2; 1Munich / DE, 2Garching / DE,
3
Neuherberg / DE, 4Lund / SE pulmonary disease
Y. Guan, Y. Xia, L. Fan, Y. Jiang, S. Liu; Shanghai / CN
11:02
10:46
B-1102 Improved imaging performance with Cs-halide needle
B-1111 Quantitative regional analysis of functional lung
phosphor based detectors over powder phosphor CR
imaging in chronic obstructive pulmonary disease
detectors: application in neonatal imaging
N. Marshall, M. Hofmans, M. Smet, H. Pauwels, H. Bosmans; Leuven / BE (COPD)
T.N.H. Matin, X. Xu, T. Doel, V. Grau, N. Rahman, A. Nickol, F.V. Gleeson;
11:10 Oxford / UK
B-1103 RIS-integrated dose monitoring systems: dose quality 11:02
ratio optimisation by iterative acquisition settings B-1113 Impact of HIV infection lenght on CT assessed
standardisation. First results for a large breast emphysema and respiratory bronchiolitis prevalence
screening programme and pattern
A. Nitrosi, M. Bertolini, A. Corazza, R. Sghedoni, C. Campari, P. Pattacini, C. Mori, R. Scaglioni1, G. Besutti1, G. Ligabue1, A. Santoro1, S. Zona1, J. Leipsic2,
P. Notari, M. Iori; Reggio Emilia / IT G. Guaraldi1, P. Torricelli1; 1Modena / IT, 2Vancouver, BC / CA
11:18 11:10
B-1104 Comparison of mDIXON and proton density liver fat B-1114 Incidentally detected lymphangioleiomyomatosis like
fraction maps in patients suspected of NAFLD/NASH lesions in male patients on thoracic MDCT
with ¹H-MRS as reference S. Malekzadeh, M. Christodoulou, T. Christoforidis, V. Soubeyran, C. Constantin,
J.H. Runge, A.J. Nederveen, J. Verheij, U.H. Beuers, J. Stoker; Amsterdam / NL M.-E. Kamel; Sion / CH

11:26 11:18
B-1106 In vivo study of microcirculation in a murine model of B-1115 CT airway morphology related to obesity:
pseudomyxoma peritonei using the IVIM method for evaluation pre- and post bariatric surgery
the assessment of antiangiogenic drugs with functional correlation
A. Dohan1, C. Eveno1, C. Pimpie1, F. Duchat2, P. Bonnin1, M. Pocard1, P. Soyer1; A.C. Carlton Jones1, N. Soneji1, J. Cousins1, A. Ahmed1, A. Edey2, A. Wells1,
1
Paris / FR, 2Dijon / FR S. Copley1; 1London / UK, 2Bristol / UK

11:34 11:26
B-1107 Improved receiver coil arrays for real-time B-1116 Correlation of radiological findings and
contrast-enhanced MRA of the peripheral vasculature immunological parameters in patients with allergic
S. Riederer, P.T. Weavers; Rochester, MN / US bronchopulmonary aspergillosis (ABPA) based on
11:42 high-attenuation mucus (HAM) impaction and
B-1108 Anatomical noise and impact on lung nodule mean CT density
S. Phuyal; Kathmandu / NP
conspicuity: comparing digital radiography,
dual-energy x-ray, and digital angular tomosynthesis 11:34
S. Richard1, S. Sajja2, X. Wang1, L. Vogelsang1, N.S. Paul2; 1Rochester, NY / US, B-1117 Automated quantification of bronchiectasis, airway
2
Toronto, ON / CA
wall thickening and lumen tapering in chest CT
A. Perez-Rovira1, W. Kuo1, J. Petersen2, H.A.W.M. Tiddens1, M. de Bruijne1;
1
Rotterdam / NL, 2Copenhagen / DK
10:30–12:00 Room D1
11:42
Chest B-1118 Feasibility study of low dose CT with a hybrid iterative
reconstruction technique for evaluation of airway
SS 1804 Obstructive pulmonary diseases and stents in patients with malignant tracheal stenosis
reduced lung function T. Li1, Y. Zhang1, J. Gao1, Y. Jiang2; 1Zhenzhou of Henan province / CN,
Moderators: G.R. Ferretti; Grenoble/FR, A.P. Parkar; Bergen/NO
2
Shanghai / CN

10:30 11:50
B-1109 Predictive value of CT-quantified emphysema and B-1119 Regional image-derived lung function and structure
airway wall thickness on all-cause mortality in in chronic obstructive pulmonary disease (COPD) and
current and former smokers with and without COPD non-small cell lung cancer (NSCLC)
F.A.A. Mohamed Hoesein1, E. Pompe1, M. Schmidt2, R. Vliegenthart3, E.M. Van T.N.H. Matin, X. Xu, D.R. McGowan, T. Doel, N. Rahman, V. Grau, A. Nickol,
Rikxoort4, H.J. De Koning5, J.-W.J. Lammers1, P.A. De Jong1; 1Utrecht / NL, F.V. Gleeson; Oxford / UK
2
Bremen / DE, 3Groningen / NL, 4Nijmegen / NL, 5Rotterdam / NL

302 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

10:30–12:00 Room D2 10:30–12:00 Room G

Interventional Radiology Genitourinary


SS 1809 GI and abdominal interventions SS 1807 GU special topics
Moderators: A.D. Karaosmanoglu; Ankara/TR, A. Veltri; Turin/IT Moderators: A. Tsili; Ioannina/GR, A. Wibmer; Vienna/AT

10:30 10:30
B-1120 Fluoroscopic gastroduodenal stent placement vs B-1131 Scrotal ultrasonography in adult patients with cystic
surgical gastrojejunostomy: fibrosis
palliation for patients with gastric obstructions M. Buscaglia, L.E. Derchi, R. Casciaro, F. Cresta, L. Minicucci; Genoa / IT
due to unresectable gastric cancer 10:38
H.-Y. Song, J.-H. Park, J. Kim, M.-H. Ryu, M.-W. Yoo, J. Lee; Seoul / KR
B-1132 Can we investigate the patient with more than 70%
10:38 dose reduction CT urography without affecting the
B-1121 Efficacy of gastric balloon dilatation and/or diagnostic value?
retrievable stent insertion for pyloric spasm aer M. Al-Amin, I. Diakov; Sofia / BG
pylorus-preserving distal gastrectomy 10:46
J. Bae, S. Kim, C.-I. Shin, I. Joo, J. Yoon, J. Baek, J. Han, B. Choi; Seoul / KR
B-1133 Efficacy of bosentan, an endothelin receptor
10:46 antagonist, in preventing contrast-induced
B-1122 Incidence and management of esophageal perforation nephropathy
aer fluoroscopic balloon dilation in 820 adult A. Nawaz, H. Elzeawy, M. Salama, I. Mamoun, I. Junaid; Jeddah / SA
patients with esophageal strictures 10:54
H.-Y. Song1, W.-Z. Zhou2, J.-H. Park1, H.-Y. Jung1, Y. Kim1; 1Seoul / KR,
2
Nanjing / CN B-1134 Dynamic contrast-enhanced computed tomography:
a new diagnostic tool to assess renal perfusion aer
10:54 ischemia-reperfusion injury in mice
B-1123 Management of benign biliary strictures by M. Braunagel1, A. Helck1, M. Notohamiprodjo2, N. Schupp1, A. Wagner1,
percutaneous interventional techniques M.F. Reiser1, A. Habicht1; 1Munich / DE, 2Tübingen / DE
C.B. Kulkarni, S. Moorthy, S. Karumathil Pullara, N. Prabhu, R. Kannan, N. P.K;
Cochin / IN 11:02
B-1135 Arterial spin labeling and T1-mapping for assessment
11:02 of acute renal allogra rejection in mice
B-1124 Treatment of benign biliary strictures with K. Hueper1, B. Hensen1, S. Rong1, M. Gutberlet1, M. Meier1, M. Mengel2,
bioabsorbable biliary stent: F. Wacker1, D. Hartung1, F. Gueler1; 1Hannover / DE, 2Edmonton, AB / CA
preliminary results of a multicentric study 11:10
G. Mauri1, C. Michelozzi1, F. Melchiorre1, D. Poretti1, V. Pedicini2, G. Paone1,
M. Salvetti1, E. Criado3, J. Fages3, M. De Gregorio4, L. Monfardini1, M. Gimenez5; B-1136 Dual-phase triple-split-bolus protocol for
1
Milan / IT, 2Rozzano / IT, 3Sabadell / ES, 4Zaragoza / ES, 5Buenos Aires / AR pre-operative CT evaluation of laparoscopic donor
11:10 kidney anatomy: a way for dose reduction
A. Posa, R. Iezzi, M. Nestola, A. Contegiacomo, F. Citterio, L. Bonomo; Rome / IT
B-1125 Balloon dilatation biopsy of the Biliary stricture
through the PTBD tract: 11:18
feasibility and diagnostic accuracy B-1138 MR imaging in patients with stress urinary
H. Ryeom, J. Hong; Daegu / KR incontinenсe
A. Solopova, M. Barinova, N. Tupikina, S.K. Ternovoy; Moscow / RU
11:18
B-1126 Endoluminal radiofrequency ablation of malignant 11:26
biliary stenoses B-1139 Estimates of glomerular filtration rate by cystatin
T. Andrasina, J. Panek, J. Hlavsa, V. Bernard, V. Valek; Brno / CZ C formula by Larson to assess renal function in
11:26 outpatients undergoing injection of iodinated contrast
for CT
B-1127 Long-term outcomes of intraductal photodynamic J.I.F. Melo, R. Chojniak, A.G.V. Bitencourt, D.H.C. Silva, J.J. Oliveira, D.H. Silva; São
therapy in Klatskin tumour patients Paulo / BR
O.N. Sergeeva, A. Kukushkin, V. Panov, B. Dolgishin; Moscow / RU
Sunday

11:34
11:34 B-1140 MR-guided focal laser ablation for prostate cancer
B-1128 Percutaneous endoluminal RFA in biliary, Wirsung duct followed by radical prostatectomy:
and PV inoperable malignant block recanalisation validation of MR predicted ablation volume
M. Mizandari, N. Habib, A. Mtvaradze, T. Azrumelashvili; Tbilisi / GE J.G.R. Bomers1, E.B. Cornel2, S.F.M. Jenniskens1, C.A. Hulsbergen-van de Kaa1,
J.A. Witjes1, J.P.M. Sedelaar1, J.J. Fütterer1; 1Nijmegen / NL, 2Hengelo / NL
11:42
B-1130 In vitro effectiveness of vasodilators used in 11:42
intra-arterial infusion therapy of non-occlusive B-1141 Evaluation of periprostatic nerve fibers using diffusion
mesenteric ischemia tensor imaging tractography at 3T:
C. Mahlke, J.-P. Kühn, B. Mensel, A. Glitsch, A. Schreiber, N. Hosten, O. Grisk; correlation with radical prostatectomy specimens
Greiswald / DE C. Kim, B. Jeong, G. Kwon, J. Park, B. Park, S. Park; Seoul / KR

www.myESR.org Final Programme | ECR 2015 303


Scientific Sessions

10:30–12:00 Room K 14:00–15:30 Room A

Radiographers Breast
SS 1814 Professional challenges for SS 1902a Multiparametric MRI and PET
radiographers Moderators: E.M. Fallenberg; Berlin/DE, V. Girardi; Brescia/IT
Moderators: S. Geers-van Gemeren; Utrecht/NL, C. Roche; Galway/IE
14:00
10:30 B-1153 Implementation of multiparametric MRI with
B-1142 An eye-tracking study investigating radiographers’ high-resolution DCE and DWI MRI at 7T of breast
visual search patterns whilst reviewing x-ray tumours: a feasibility study
K. Pinker-Domenig, P.A.T. Baltzer, W. Bogner, D. Leithner, S. Trattnig, O. Zaric,
examination request forms P. Dubsky, Z. Bago-Horvath, T.H. Helbich; Vienna / AT
E. Hendy, J. Grehan, T. Herlihy, L.A. Rainford; Dublin / IE

10:38 14:08
B-1143 Chest x-ray agreement: comparative analysis between B-1154 Quantitative assessment of primary breast cancer at
consultant radiologists, reporting radiographers and 3.0T MRI
R. Bedair, A.J. Patterson, M.A. McLean, R. Manavaki, S. Reid, M. Graves,
expert chest radiologists F.J. Gilbert; Cambridge / UK
N.H. Woznitza1, K. Piper2, S. Burke1, S. Ellis1, G. Bothamley1; 1London / UK,
2
Kent / UK 14:16
10:46 B-1155 Application of total choline compound integral in
B-1144 A self-test for screening radiographers in the diferentiating benign and malignant breast disease
R. Chen, W.-G. Zhang; Chongqing / CN
Netherlands, in signalling apparent abnormalities
C. van Landsveld-Verhoeven, J.M.H. Timmers, P. van de Looi, G.J. den Heeten, 14:24
M.J.M. Broeders; Nijmegen / NL
B-1156 Value of 1H spectroscopy 3T MR imaging in breast
10:54 lesions in addition to BIRADS MR findings and DWI:
B-1145 Comparative study of diagnostic accuracy between CT a preliminary report
R. Asadov, M.E. Aribal, A. Ramazan, M.U. Ugurlu, H. Kaya; Istanbul / TR
colonography and optical colonoscopy
N.F. Pinto, A.F.C.L. Abrantes, L.P. Ribeiro, S. Rodrigues, R.P.P. Almeida,
K.B. Azevedo, B. Tomás, J.P. Pinheiro; Faro / PT 14:32
B-1157 The role of high-field MR spectroscopy in the
11:02 multiparametric evaluation of breast lesions
B-1146 An investigation into the accuracy of computed C. Cavedon, I. Baglio, L. Camera, G. Meliadò, F. Caumo, S. Montemezzi;
Verona / IT
radiography in detecting ferromagnetic intra-ocular
foreign bodies 14:40
H. Momoniat, A. England; Manchester / UK
B-1158 Intraindividual assessment of tumour neovascularity,
11:10 microenvironment, glucose metabolism and hypoxia
B-1148 What is the minimum amount of simulated breast in breast cancer patients by multiparametric 18F-FDG/
movement required for visual detection of blurring? 18F-FMISO PET/MRI at 3T: a feasibility study
P.H. Hogg1, W. Ma1, R. Aspin1, D. Brettle2, S. Millington3, J. Kelly3; K. Pinker-Domenig, P. Andrzejewski, H. Magometschnigg, T.H. Helbich,
1
Manchester / UK, 2Leeds / UK, 3Chester / UK D. Georg, G. Karanikas, W. Wadsak, P. Kapetas, P.A.T. Baltzer; Vienna / AT

11:18 14:48
B-1149 An investigation into preliminary clinical evaluation in B-1159 Value of simultaneous PET MR mammography in
an Irish x-ray departmental setting patients with breast cancer undergoing neoadjuvant
R. Murphy, L.A. Rainford, T. Herlihy, J. Grehan, M. Lotter; Dublin / IE chemotherapy: preliminary results
S. Kinner, J. Nagarajah, J. Grüneisen, L. Umutlu, O. Hoffmann, A.-K. Bittner,
11:26 K. Nassenstein, T. Pöppel; Essen / DE
B-1150 Evaluation of the performance and efficiency of
technology and radiographer: the Italian model 14:56
D. Di Feo1, C. Dionisi2, S. Barbera3; 1Florence / IT, 2Treviso / IT, 3Biella / IT B-1160 Diagnostic accuracy of 18F-FDG PET/CT of the breast:
comparison to DCE MRI imaging at 3 Tesla
11:34 H. Magometschnigg, P.A.T. Baltzer, B. Fueger, T.H. Helbich, G. Karanikas,
B-1151 Adverse event reporting P. Dubsky, M. Rudas, M. Weber, K. Pinker-Domenig; Vienna / AT
S. Browne, L.A. Rainford, J. Grehan, T. Herlihy; Dublin / IE
15:04
11:42 B-1161 18F-FDG PET/CT for initial staging
B-1152 Endovascular treatment of ruptered abdominal aortic in breast cancer patients:
aneurysm (rAAA) is there a relevant impact on treatment planning
J. Jensen, H. Mogensen; Odense / DK compared to conventional staging modalities?
J. Krammer, C.G. Kaiser, A. Schnitzer, K.A. Buesing, S.O. Schoenberg, E. Sperk,
M. Suetterlin, K. Wasser; Mannheim / DE

15:12
B-1162 Feasibility of [F-18]FDG-PET/CT for clinicopathological
evaluation in patients with Ductal Carcinoma In-Situ
(DCIS) of the breast
T. Fujioka, K. Kubota, A. Toriihara, Y. Saida, U. Tateishi; Tokyo / JP

304 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:00–15:30 Room B 15:12


B-1173 Added value of diffusion-weighted imaging for
Abdominal Viscera detecting acute pancreatitis in clinically suspected
SS 1901a Pancreas: tumours, pancreatitis patients
I. Nam, S. Kim, S.-J. Kim, Y.-j. Lim; Busan / KR
Moderators: V. Maniatis; Aabenraa/DK, P. Rodríguez; Madrid/ES
15:20
14:00 B-1174 Secretin-enhanced MRCP features of Santorinicele
B-1164 Frequency and morphological features of incidental before and aer minor papilla sphincterotomy
pancreatic cystic lesions seen on 256 detector row CT: E. Boninsegna, R. Manfredi, A. Ventriglia, R. Negrelli, B. Pedrinolla, A.J. Cybulski,
a large population series S. Mehrabi, R. Pozzi Mucelli; Verona / IT
P. Allegranza, D. Ippolito, P. Bonaffini, F. Leone, D. Fior, A. Casiraghi, S. Sironi;
Monza / IT
14:00–15:30 Room C
14:08
B-1165 Clinical and MDCT features of pancreas metastasis Breast
from various primary malignancies
T. Choi, S. Kim, C.-I. Shin, J. Han, B. Choi; Seoul / KR SS 1902b Preoperative imaging
Moderators: P. Panizza; Milan/IT, S. Perez Rodrigo; Madrid/ES
14:16
B-1166 Diagnostic value of 256 MDCT scan in defining imaging 14:00
features of incidentally detected hypervascular B-1175 Indications and prescriptions
pancreatic lesions: prevalence and characterisation for preoperative breast MRI:
in large cohort of patients first data from the MIPA study. The MIPA study group
P. Allegranza, D. Ippolito, P.A. Bonaffini, F. Leone, D. Fior, A. Casiraghi, S. Sironi; R.M. Trimboli1, G. Di Leo1, A. Benedek1, T.H. Helbich2, F.J. Gilbert3, N. Houssami4,
Monza / IT F. Sardanelli1; 1San Donato Milanese / IT, 2Vienna / AT, 3Rotterdam / NL,
4
Sydney / AU
14:24
B-1167 Enhancement pattern, clinical features and 14:08
perfusional characteristics of symptomatic pancreatic B-1176 Gadobutrol-enhanced breast MRI in the preoperative
endocrine tumours setting: results on 390 patients from an international
L. Zhu, H.-d. Xue, X. Wang, Y.-l. He, H. Sun, Z.-y. Jin; Beijing / CN multicenter study with European blinded readers
R.M. Trimboli1, L.A. Carbonaro1, F.M. Vogt2, K. Siegmann3, K. Partanen4,
14:32 M.L. Rosenberg5, F. Sardanelli1; 1San Donato Milanese / IT, 2Lübeck / DE,
B-1168 Survival outcomes of patients with pancreas
3
Tübingen / DE, 4Helsinki / FI, 5Clion, NJ / US
neuroendocrine neoplasms who 14:16
receive surgical resection: B-1177 Gadobutrol-enhanced breast MRI in the preoperative
association with dynamic contrast-enhanced CT setting: results on 397 patients from an international
D. Kim, H. Kim, K. Kim; Seoul / KR
multicenter study with United States blinded readers
14:40 H. Abe1, E. Wenkel2, S. Malgorzata3, V. Martin4, M. Rosenberg5, G. Newstead1;
1
Chicago, IL / US, 2Erlangen / DE, 3Bydgoszczy / PL, 4Barcelona / ES, 5Berlin / DE
B-1169 Comparison of MDCT and Gadobutrol-enhanced MRI
for detection and characterisation of small (< 3cm) 14:24
pancreatic solid lesions B-1179 Evaluation of microcalcifications extent on
T. Choi, J. Lee, M. Yu, J. Kim, J. Han, B. Choi; Seoul / KR
mammograms in patients with ductal carcinoma in
14:48 situ (DCIS) predicts the value of MRI for DCIS staging
C. Borelli, P. Rinaldi, R. Fubelli, C. Buccheri, M. Giuliani, P. Belli, L. Bonomo;
B-1170 Efficacy of contrast-enhanced magnetic resonance Rome / IT
imaging in the differentiation between malignant and
benign pancreatic cystic neoplasms 14:32
C. Spick, S. Polanec, D. Tamandl, D. Javor, M. Schindl, M. Weber, A. Ba-Ssalamah; B-1180 Breast MR imaging for the assessment of residual
Vienna / AT
disease following initial surgery for breast cancer with
14:56 positive margins
J. Krammer1, E.R. Price2, E. Watson3, M. Jochelson3, M.P. Murray3,
B-1171 MRI features in differential diagnosis between S.O. Schoenberg1, E.A. Morris3; 1Mannheim / DE, 2San Fransisco, CA / US, 3New
mucinous cystoadenomas and mucinous York, NY / US
Sunday

cystoadenocarcinomas of the pancreas


V. Di Paola, S. Mehrabi, R. Manfredi, R. Pozzi Mucelli; Verona / IT 14:40
B-1181 Feasibility and diagnostic accuracy of dynamic breast
15:04 MR in supine compared to prone position
B-1172 Magnetic resonance imaging (MRI) to detect early C. Forte, A. Fausto, A. Carboni, P. Maccari, L. Volterrani; Siena / IT
pancreatic alterations and monitor volume variations
14:48
of abdominal fat stores in a transgenic mouse
model of pancreatic adenocarcinoma, during disease B-1182 Breast mapping of lesion displacement from prone
development MRI to supine MRI-focused US:
P. Marra, A. Esposito, E. Dugnani, T. Canu, V. Pasquale, D. Liberati, L. Piemonti, what the radiologist should know?
F. De Cobelli, A. Del Maschio; Milan / IT M. Telegrafo, M. Moschetta, A. Stabile Ianora, G. Angelelli; Bari / IT

www.myESR.org Final Programme | ECR 2015 305


Scientific Sessions

14:56 15:05
B-1183 PET/MR mammography for local tumour staging of B-1193 Development of a publicly accessible Bayesian CADx
patients with primary breast cancer: algorithm for mammographic mass lesions based
a comparison with PET/CT and MRI alone on the breast imaging:
J. Grueneisen1, J. Nagarajah1, C. Buchbender2, O. Hoffmann1, M. Forsting1, reporting and data system (BI-RADS) lexicon
L. Umutlu1, S. Kinner1; 1Essen / DE, 2Düsseldorf / DE M. Benndorf1, E. Kotter1, M. Langer1, C. Herda2, Y. Wu3, E. Burnside3;
1
Freiburg / DE, 2Graubünden / CH, 3Madison, WI / US
15:04
B-1184 Digital breast tomosynthesis for preoperative local 15:13
staging of breast cancer in dense breasts B-1194 Is PI-RADs-score more accurate versus DWI+T2w
J. Krammer, K. Stepniewski, C.G. Kaiser, A. Schnitzer, S.O. Schoenberg, at 3T MRI of the prostatic gland:
K. Wasser; Mannheim / DE
analysis according to 189 MR-guided prostate biopsies
A. Malich; Nordhausen / DE
14:00–15:30 Room Z 15:21
B-1195 The impact of peer-review introduction on the
Computer Applications subsequent publication rate and impact factor of
SS 1905 Methods for image interpretation and presentations at national radiology meetings
A.M. Cahalane, Y. Purcell, D.E. Malone, E.J. Heffernan; Dublin / IE
reporting
Moderators: M. Fatehi; Tehran/IR, W.J. Niessen; Rotterdam/NL
14:00–15:30 Room M
14:00
K-28 Keynote lecture
W.J. Niessen; Rotterdam / NL
Abdominal Viscera
14:09 SS 1901b Liver CT and ultrasound:
B-1186 IHE-compliant templates for structured reporting: new techniques
Moderators: M. Laniado; Dresden/DE, V. Vandecaveye; Leuven/BE
first implementations
D. Pinto dos Santos, G. Klos, P. Mildenberger; Mainz / DE
14:00
14:17 B-1196 Preoperative CT texture analysis predicts outcome
B-1187 Free text reporting vs structured reporting of MRI in patients with colorectal liver metastases post
of the pelvis in patients with rectal cancer: liver resection
A. Schulz1, K. Skogen1, A. Bethke1, K.J. Labori1, B. Ganeshan2, N.-E. Kløw1,
potential effects for surgical planning J.B. Dormagen1; 1Oslo / NO, 2London / UK
M. Armbruster, J. D‘Haese, M.F. Reiser, W.H. Sommer; Munich / DE

14:25 14:08
B-1188 Development of eye movement adaptation during B-1197 The optimal body size index for determining
the interpretation of CT studies from resident the iodine dose for hepatic dynamic CT:
to specialist radiologists: a potential new tool to a prospective multicenter study using hierarchical
measure resident training progress multivariate linear regression analysis
K. Awai1, M. Kanematsu2, K. Tonsok3, T. Ichikawa4, K. Yoshioka5, T. Mochizuki6,
F.V. Bensch1, J.K. Kaakinen2, R. Bertram2, L. Helle2, N. Lundbom1; 1Helsinki / FI, N. Matsunaga7, Y. Yamashita8; 1Hiroshima / JP, 2Gifu / JP, 3Osaka / JP, 4Chuo / JP,
2
Turku / FI 5
Morioka / JP, 6Matsuyama / JP, 7Ube / JP, 8Kumamoto / JP
14:33 14:16
B-1189 Difference in attitudes towards radiology video B-1198 Reproducibility and variability of very low-dose
reporting between inpatient/emergency medicine hepatic perfusion CT in metastatic liver disease
and subspecialty providers O. Topcuoglu, M. Ozmen, E. Topcuoglu, M. Karcaaltincaba, D. Akata; Ankara / TR
J.D. Balkman, T.L. Cooke, E.S. Cooke; Lebanon, NH / US
14:24
14:41 B-1199 Small-size low-contrast liver lesion detectability:
B-1190 Comparison of consumer grade, tablet and dual energy CT (DECT) versus conventional CT
6MP-displays: observer performance in detection G. Van Gompel, N. Buls, P. Covens, J. de Mey; Brussels / BE
of anatomical and pathological structures
in panoramic radiographs 14:32
S. Kallio-Pulkkinen1, M. Haapea1, E. Liukkonen1, S. Huumonen2, O. Tervonen1, B-1200 Performance of ultrasonic transient elastography for
M. Nieminen1; 1Oulu / FI, 2Turku / FI the noninvasive assessment of liver steatosis
M. Lupsor-Platon, D. Feier, H. Stefanescu, A. Tamas, E. Botan, R. Badea; Cluj
14:49 Napoca / RO
B-1191 Patient lifetime graphs as an aid to subsequent
image interpretations 14:40
D.J. Vining1, A. Pitici2, A. Prisacariu2, C. Popovici2; 1Houston, TX / US, 2Chapel Hill, B-1201 Acoustic radiation force impulse (ARFI) imaging in
NC / US the pre-operative liver function evaluation in patients
14:57 candidate to liver resection
S. Crosara, M. D’Onofrio, A. Ruzzenente, S. Valcanover, R. Pozzi Mucelli;
B-1192 Comparing the utility and usability of the Microso Verona / IT
Kinect and Leap Motion sensor devices in the
context of their application for gesture control 14:48
of biomedical images B-1202 Differential diagnosis of polypoid lesions of the
P. Hughes, N. Nestorov, N.A. Healy, N. Sheehy, N. O’Hare; Dublin / IE gallbladder using contrast-enhanced ultrasonography
X.-S. Liu, L.-H. Gu, J. Du, J.-G. Xia, F.-H. Li; Shanghai / CN

306 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:56 14:49
B-1203 Colour-coded perfusion imaging with CEUS for B-1212 Role of MDCT for evaluating prosthetic malrotation
evaluation of the post-interventional success in patients with painful knee prosthesis
following trans-arterial chemoembolisation (TACE) G. De Franco, G. Martino, C. Campagna, V. Favia, A. Spinarelli, G. Angelelli;
Bari / IT
and ablative techniques of liver lesions: first results
J. Rennert, C. Niessen, C. Stroszczynski, E.M. Jung; Regenbsurg / DE 14:57
15:04 B-1213 Anterolateral ligament of the knee:
B-1204 Liver stiffness evaluation aer radioembolisation correlation of MR imaging with anatomical findings
E. Tahir, C. Berliner, S. Yarar, G. Lüers, M. Karul, G. Adam, J. Yamamura;
by real-time Shear-wave elastography Hamburg / DE
A. Bas, C. Samanci, F. Gulsen, F. Ustabasioglu, M. Cantasdemir, L. Kabasakal,
F. Kantarci, F. Numan; Istanbul / TR 15:05
15:12 B-1214 Effects of extremity positioning on femoral tunnel
B-1205 Future liver remnant volume estimation aer portal localisation aer anatomic single bundle anterior
vein embolisation and contralateral application cruciate ligament reconstruction - evaluation by
of stem cells digitally reconstructed radiographs
J. Ludvík, J. Ferda, P. Duras, V. Třeka, J. Brůha, D. Lysák; Plzeň / CZ P.S. Mahajan, P. Chandra, N. Ahamad, S.A. Hussein; Doha / QA

15:20 15:13
B-1206 An experimental study on the relationship between B-1215 3-dimensional isotropic high spatial resolution
the haemodynamic changes and liver regeneration proton-density-weighted fat-suppressed and
based on a rat model of different degrees of portal T1-weighted imaging of the knee at 3.0 Tesla
R. Homsi1, G.M. Kukuk1, J. Gieseke2, H.H. Schild1, W.A. Willinek1, D.R. Hadizadeh1;
vein stenosis following 70% partial hepatectomy 1
Bonn / DE, 2Best / NL
L. Yang, Y. Luo; Chengdu / CN
15:21
B-1216 Clinical significance of dark cartilage lesions identified
14:00–15:30 Room E1 on MRI
R. Kijowski, B.K. Markhardt; Madison, WI / US
Musculoskeletal
SS 1910 Knee 14:00–15:30 Room E2
Moderators: L. Cerezal; Santander/ES,
L.M. Sconfienza; San Donato Milanese/IT Neuro
K-29 Keynote lecture
M. Mechl; Brno / CZ SS 1911 Advanced imaging
Moderators: M.T. Fernández Taranilla; Toledo/ES,
14:09 L. Pierot; Reims/FR
B-1207 Smaller volume of anterior cruciate ligament
increases the risk of anterior cruciate ligament injury: 14:00
a MRI based case-control study B-1218 Diagnostic performance of diffusion tensor imaging
P.S. Mahajan1, N.M. Al Moosawi2, Y.S. Al Nahedh2; 1Doha / QA, 2Kuwait City / KW in visual pathways of primary open angle glaucoma
patients
14:17 B. Özkul1, F. Yenihayat1, N. Yüksel1, A. Akça2, A. Arslan1; 1Kocaeli / TR,
B-1208 Lateral patellar tilt: the best measurement to unmask 2
İstanbul / TR
patellar maltracking with weight-bearing MRI 14:08
S. Mariani, F. Arrigoni, A. La Marra, L.M. Gregori, A. Barile, C. Masciocchi;
L’Aquila / IT B-1219 A first insight in regional brain changes aer parabolic
flight: a voxel-based morphometry study
14:25 A. Van Ombergen1, B. Jeurissen1, F. Vanhevel2, D. Loeckx3, V. Dousset4,
B-1209 Diagnostic value of the meniscal stability of the knee: S. Laureys5, P.H. Van de Heyning1, P.M. Parizel2, F.L. Wuyts1; 1Antwerp / BE,
2
Edegem / BE, 3Leuven / BE, 4Bordeaux / FR, 5Liege / BE
weight-bearing MRI vs arthroscopy
A. La Marra, S. Mariani, F. Arrigoni, L.M. Gregori, F. Smaldone, A. Barile,
C. Masciocchi; L’Aquila / IT 14:16
B-1220 Evaluating the intracranial perforating branches by
14:33 new x-ray system using a cerium anode
Sunday

B-1210 Association of MRI features with development C. Tanaka; Isehara-City / JP


of radiographic knee osteoarthritis in early knee 14:24
osteoarthritis patients
K. van Oudenaarde1, B. Jobke2, M. Kloppenburg1, A. Oostveen3, B-1221 Diffusion tensor imaging in cord compression:
A.-K. Marijnissen4, J. Wesseling4, S. Bierma-Zeinstra5, H. Bloem1, M. Reijnierse1; the future functional biomarker?
1
Leiden / NL, 2Heidelberg / DE, 3Almelo / NL, 4Utrecht / NL, 5Rotterdam / NL S. Sivasubramanian; Tamil Nadu / IN

14:41 14:32
B-1211 Postero-lateral instability of the knee in young B-1222 Usefulness of diffusion-weighted (DWI) magnetic
patients: association between postero-lateral corner resonance for distinguishing neuroborreliosis from
involvment and anterior cruciate ligament injury and acute disseminated encephalomyelitis
the role of the weight-bearing MRI A. Ivkovic, T. Milosavljevic; Niš / RS
S. Mariani, F. Arrigoni, A. La Marra, L.M. Gregori, A. Barile, C. Masciocchi;
L’Aquila / IT

www.myESR.org Final Programme | ECR 2015 307


Scientific Sessions

14:40 14:48
B-1223 3D time-resolved vessel-selective angiography based B-1234 The possibility of MR dynamic contrast enhancement
on pseudo-continuous arterial spin labelling to separate groups of potentially good and bad
T. Lindner1, U. Jensen-Kondering1, M.J.P. van Osch2, M. Helle3, O. Jansen1; response aer preoperative chemoradiotherapy in
1
Kiel / DE, 2Leiden / NL, 3Hamburg / DE
patients with rectal cancer
14:48 K.B. Puzakov, N. Rubtsova, D. Sidorov, O. Mainovskaya, I. Droshneva;
Moscow / RU
B-1224 Dynamic CT angiography for the evaluation of
shunting vascular malformation of brain and spine 14:56
F. D’orazio, L.M. Gregori, A.V. Giordano, S. Carducci, A. Splendiani, M. Gallucci; B-1235 Modification in abdominal fat distribution in mCRC
L’Aquila / IT
patients aer Cetuximab
14:56 S. Battisti, F. Greco, A. Pallottino, B. Beomonte Zobel; Rome / IT
B-1225 The typical and atypical MR imaging appearances 15:04
of tuberculosis of the central nervous system. An B-1236 3.0-T magnetic resonance imaging in predicting
imaging based experience of 100 cases subtypes of IPMN and invasive IPMN
A. Banerjee; Ludhiana / IN R. Graziani, G. Lo Bue, L. Monti, C. Bonifacio, A. Zerbi, L. Balzarini; Rozzano / IT
15:04 15:12
B-1226 The additional value of neuroimaging combined B-1237 Gastrointestinal stromal tumours of the stomach:
with visual rating scales to the clinical diagnosis of CT percentage of tumour necrosis and prediction of
dementia malignancy
M.V. Verhagen, G.L. Guit, G.J. Hafkamp, C.J. Kalisvaart; Haarlem / NL N. Cioffi Squitieri, M.A. Mazzei, C. Vindigni, G. Sadotti, P. Mercuri, L. Righi,
S. Guerrini, F.G. Mazzei, L. Volterrani; Siena / IT
15:12
B-1227 Multimodal imaging of disorders of consciousness 15:20
L. Hermoye1, L. Tshibanda2, C. Di Perri2, V. Katsaros3, S. Laureys2; 1Brussels / BE, B-1238 Gastrointestinal stromal tumour xenogras:
2
Liège / BE, 3Athens / GR
therapeutic repose to treatment
with imatinib assessed by intravoxel incoherent
14:00–15:30 Room F1 motion diffusion-weighted MR imaging
with histopathological correlation
Oncologic Imaging F. Pan1, J. Deng2, Y. Wang1, H. Wang3, J. Cheng1, W. Wu1; 1Beijing / CN, 2Chicago,
IL / US, 3Shanghai / CN
SS 1916 Oncologic imaging of the GI tract
Moderators: G. Conte; Milan/IT, J. Sosna; Jerusalem/IL
14:00–15:30 Room F2
14:00
B-1228 Value of FDG PET/CT in the assessment of patients
Physics in Radiology
with colon cancer comparing to CT alone SS 1913 Patient and staff dose studies
K. Akbari; Linz / AT
Moderators: H. de las Heras Gala; Madrid/ES, G. Paulo; Coimbra/PT
14:08
B-1229 MR imaging for dedicated staging of colon cancer 14:00
patients: preliminary results K-30 Keynote lecture
C. Leidecker; Forchheim / DE
M.J. Lahaye1, D.M. Lambregts1, E. Nerad2, G.L. Beets1, R.G.H. Beets-Tan1;
1
Maastricht / NL, 2Eindhoven / NL
14:09
14:16 B-1239 Comparing CT dose performance to regional and
B-1230 Modified, high resolution pelvic MRI in rectal cancer: national benchmarks:
a comparison of field strengths - 7T vs. 1.5 T multicenter experience in Belgium
K. Beiderwellen, O. Kraff, A. Laader, S. Johst, S. Maderwald, M. Forsting, L. Pyfferoen1, T.H. Mulkens2, T. De Bondt3, J.W. Casselman1, P.M. Parizel3,
T.C. Lauenstein, L. Umutlu; Essen / DE F. Zanca4; 1Bruges / BE, 2Lier / BE, 3Antwerp / BE, 4Leuven / BE, Brussels / BE

14:24 14:17
B-1231 A novel T3 subgroup system based on MRI for B-1240 Effective dose in cardiac CT - evaluation
stratifying T3 rectal cancer into favorable and of a new dose monitoring soware (radimetrics™)
S. Suntharalingam, N. Guberina, F.F. Stecker, J.M. Theysohn, K. Nassenstein,
unfavorable subgroups M. Forsting, A. Ringelstein, T. Schlosser; Essen / DE
S. Moon, S. Cho, K.-M. Shin, H. Kim, G. Kim, Y.-J. Jang, H. Ryeom; Daegu / KR

14:32 14:25
B-1232 Does multiparametric MRI allow for response B-1241 Limits and strengths of novel dose monitoring
prediction of neoadjuvant chemoradiation in patients programme eXposure
N. Guberina, F.F. Stecker, S. Suntharalingam, M. Schlamann, M. Forsting,
with advanced rectal cancer? J.M. Theysohn, B. Mukherjee, U. Lechel, A. Ringelstein; Essen / DE
D. Hausmann, N. Rathmann, U.I. Attenberger, S.O. Schönberg, F. Doyon,
P. Kienle, R.D. Hofheinz; Mannheim / DE 14:33
14:40 B-1242 Implementation of a dose monitoring soware
B-1233 Evaluation of rectal cancer response to therapy: in clinical routine: first experiences
C. Heilmaier, N. Zuber, D. Weishaupt; Zurich / CH
role of MR tumour regression grade to predict
pathological complete response
M. Rengo, M. Ciolina, C.N. de Cecco, D. Caruso, C. Forina, S. Marzi, A. Laghi;
Rome / IT

308 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:41 14:32
B-1243 Comparison of iterative reconstruction techniques for B-1253 Comparison of chest-CT findings of influenza
reduced-dose liver computed tomography following virus-associated pneumonia in immunocompetent
transarterial chemoembolisation for hepatocellular vs. immunocompromised patients: patterns of
carcinoma involvement and interchangeability at time
W. Lee1, W. Jeong1, M. Cha1, Y. Kim1, S. Lim2, S.-Y. Choi2, D. Choi1; 1Seoul / KR, C. Kloth, K. Nikolaou, M. Horger; Tübingen / DE
2
Gyeonggi-do / KR
14:40
14:49 B-1254 Restrictive allogra syndrome aer lung
B-1244 Detection of midfacial and orbital fractures using transplantation: new radiological insights
ultralow dose CT and iterative reconstructions A. Dubbeldam, J. Coolen, J. Verschakelen, W. De Wever; Leuven / BE
G. Widmann, D. Dalla Torre, R. Hoermann, P. Schullian, E.-M. Gassner, R. Bale,
W. Puelacher; Innsbruck / AT 14:48
14:57 B-1255 Diagnostic accuracy of ultra-low-dose chest CT with
model-based iterative reconstruction (MBIR) in the
B-1245 CTPA bolus timing techniques in pregnancy:
detection of early pulmonary complications within the
an underappreciated contributor
first six months following lung transplantation
to breast radiation dose M.-P. Debray1, G. Dauriat1, A. Khalil1, S. Leygnac1, A. Grandjean2,
D.P. Mitchell, M. Rowan, M. Crockett, F. Ni Ainle, P. Mac Mahon; Dublin / IE E. Schouman-Claeys1, P. Ou1; 1Paris / FR, 2Buc / FR
15:05 14:56
B-1246 Clinical indications and radiation doses to the B-1256 Non-infectious panbronchiolitis in the setting
conceptus associated with CT scanning in pregnancy: of allogeneic stem cell transplantation:
a retrospective study a potential mimic of lower respiratory tract infection
S.E. Woussen, F. Zanca, H. Bosmans, D. Vanbeckevoort, R.H. Oyen; Leuven / BE C. Kloth, U. Grosse, S. Wirths, S. Gatidis, W. Bethge, K. Nikolaou, M. Horger;
Tübingen / DE
15:13
B-1247 Pregnant employee in the cardiac catheterisation lab: 15:04
data for estimation of conceptus dose B-1257 Does the use of a checklist help medical students in
K. Perisinakis, J. Stratakis, G. Solomou, J. Damilakis; Iraklion / GR the detection of abnormalities on a chest radiograph?
A. Abed, E.M. Kok, S.G.F. Robben; Maastricht / NL
15:21
B-1248 Personnel dose reduction for Y90 microspheres 15:12
liver-directed radioembolisation: B-1258 Using comparison films in education
from angiogram suite to patient ward E.M. Kok, A.B.H. de Bruin, J. Leppink, J.J.G. van Merriënboer, S.G.F. Robben;
M. Law, K. Wong, W. Tso, V. Lee, M. Luk; Hong Kong / HK Maastricht / NL

15:20
14:00–15:30 Room D1 B-1259 Clinical impact of double reading of thoracic CT
P.M. Lauritzen1, J. Andersen2, M. Stokke3, A. Tennstrand4, G. Bjerke1, K. Stavem1,
P. Hurlen1, G. Sandbæk2, P. Gulbrandsen5; 1Lørenskog / NO, 2Oslo / NO,
Chest 3
Drammen / NO, 4Bærum / NO, 5Nordbyhagen / NO

SS 1904 Infection, transplantation


and quality issues 14:00–15:30 Room D2
Moderators: C.J. Herold; Vienna/AT, N.J. Screaton; Cambridge/UK
Interventional Radiology
14:00
B-1249 Prevalence and diagnostic value of the vessel SS 1909a Embolotherapy
occlusion sign in CT pulmonary angiography of Moderators: A. Bharadwaz; Aahrus/DK, O. Pellerin; Paris/FR
patients with invasive pulmonary aspergillosis: 14:00
comparison with other characteristic
K-31 Keynote lecture
radiomorphological patterns R.W. Günther; Berlin / DE
C. Hagelstein, M. Reinwald, D. Buchheidt, K.W. Neff, S.O. Schoenberg,
T. Henzler; Mannheim / DE 14:09
14:08 B-1260 A promising non-adhesive cyanoacrylate preclinical
Sunday

B-1250 Pulmonary MRI at 3T in immunocompromised patients study on animal model


J. Izaaryene, V. Vincent; Marseille / FR
with invasive fungal infections
S.N. Nagel, Y. Löschmann, S. Schwartz, B. Hamm, T. Elgeti; Berlin / DE 14:17
14:16 B-1261 Radial versus femoral artery access in patients
B-1251 Incidence of the reversed halo sign and the evolution undergoing peripheral artery embolisation
E. Khayrutdinov1, A. Arablinskiy1, V. Tsurkan1, I. Vorontsov2; 1Moscow / RU,
of the radiologic findings in 20 patients with proven 2
Omsk / RU
pulmonary mucormycosis
J. Choe, M.Y. Kim, S.-H. Kim; Seoul / KR 14:25
B-1262 Endovascular management of postpancreatectomy
14:24
hemorrhage
B-1252 Computed tomography features of pulmonary M. Ronot, E. Pottier, S. Gaujoux, M. Abdel-Rehim, M. Lagadec, A. Sibert,
nocardiosis A. Sauvanet, V. Vilgrain; Clichy / FR
R. Aslani Menareh Bazari, P. Mehrian, M. Karimi, E. Esfandiari; Tehran / IR

www.myESR.org Final Programme | ECR 2015 309


Scientific Sessions

14:33 14:16
B-1263 Prostatic artery embolisation using B-1272 Dual energy CT classification of renal calculi using
the PerFectED technique in the treatment single energy scanners
of prostatic benign hyperplasia: V. Hietschold, F. Schaab, M. Laniado; Dresden / DE
results of a single-centre prospective study 14:24
G. Amouyal, O. Pellerin, N. Thiounn, M. Sapoval; Paris / FR
B-1273 Diagnostic value of B-TFE MR Urography and the
14:41 effect of additional factors on the diagnosis of urinary
B-1264 Functional and technical outcomes of patients stones
treated with selective microcoil embolisation due E. Cifci, G. Coban, T. Cicek, U. Gonulalan; Konya / TR
to pseaudoaneurysms or arteriovenous fistulas 14:32
aer partial nephrectomy B-1274 Renal stone composition in Vivo Determination:
F.F. Strobl, M. D’Anastasi, T. Waggershauser, C.G. Trumm, A. Graser, M.F. Reiser,
P.M. Paprottka; Munich / DE comparison between 100/140 kV Dual-energy CT
and 120 kV Single-energy CT
14:49 M. Bonatti, F. Ferro, P. Pernter, M. Senoner, G. Bonatti; Bolzano / IT
B-1265 Bariatric embolisation using non-spherical Polyvinyl
alcohol (PVA) for suppression of the ghrelin in swine 14:40
models B-1275 Effective z accuracy to determine stone composition
J. Kim, M.-D. Kim; Seoul / KR by single-source dual-energy computed tomography:
an in vivo study
14:57 A. Fekir, C. Werquin, R. Levy, C. Sanavi, V. Macaigne, G. Hue, M. Bubenheim,
B-1266 Selective arterial embolisation for hemangiomas A. Safsaf, J.-N. Dacher; Rouen / FR
G. Facchini, G. Rossi, E. Rimondi, P. Spinnato, G. Filonzi, T. Bartalena, C. Errani,
A. Bazzocchi; Bologna / IT 14:48
B-1276 Visceral obesity and urolithiasis - impact on disease
15:05 incidence, stone size and radiation dose
B-1267 Pre-delivery uterine arteries embolisation preventing J. Hansmann, S.O. Schönberg, A. Tran, T. Henzler, H. Haubenreisser;
peri-post-partum haemorrhage (PPH) in placenta Mannheim / DE
implant anomalies 14:56
R. Niola1, F. Giurazza2, M. Silvestre1, G. Nasti1, M. Di Pasquale1, F. Maglione1;
1
Naples / IT, 2Rome / IT B-1277 The role of multi-parametric MRI and the
supplemental worth of diffusion-weighted MRI on
15:13 bladder cancer before surgical operation
B-1268 Endovascular management of massive post-partum E. Hocaoglu, S. Aksoy, C. Colak, O. Kilickesmez, E. Inci; Istanbul / TR
hemorrhage in abnormal placental implantation
deliveries 15:04
A. Rebonato, S. Mosca, M. Fischer, D. Maiettini, L. Bellantonio, C. Fusco, B-1278 Role of diffusion-weighted (DW) MRI to evaluate upper
C. D’Elia, G. Crinò, M. Scialpi; Perugia / IT excreto urinary wall thickening
C. Roy, A. Labani, M. Ohana, G. Bierry, G. Aleman, H. Lang; Strasbourg / FR
15:21
B-1269 Fetal radiation dose during prophylactic balloon 15:12
occlusion for morbidly adherent placenta - a single B-1279 The value of diffusion-weighted MRI in the diagnosis
centre experience of muscle-invasive bladder cancer
V. Semeraro1, A. Susac1, A. Morasca2, F. D’Antonio1, A.-M. Belli1; 1London / UK, W. Xia, X. Chen, L. Wang, H. Li; Zhengzhou / CN
2
Rome / IT
15:20
B-1280 The dynamic MRI compared to conventional cystogram
14:00–15:30 Room G in evaluation of vesico-urethral anastomosis aer
laparoscopic radical prostatectomy
Genitourinary M. Danti, F. Forte, S. Sbarbati, G. Pagliarella, P. Nardis, S. Della Sala; Rome / IT

SS 1907 Urinary stones, ureters and bladder


pathology 14:00–15:30 Room K
Moderators: M. Bertolotto; Trieste/IT, L. Ponhold; St. Pölten/AT
Interventional Radiology
14:00
B-1270 Additional spectral shaping by a tin filter (150 kV Sn) SS 1909b Aortic interventions
improves image quality and reduces dose in low-dose Moderators: M. Köcher; Olomouc/CZ, B. Peynircioglu; Ankara/TR
abdominal CT for urolithiasis 14:00
P. Dewes, C. Frellesen, J.E. Scholtz, S. Fischer, B. Schulz, T.J. Vogl, R.W. Bauer;
Frankfurt / DE K-32 Keynote lecture
M. Szczerbo-Trojanowska; Lublin / PL
14:08
B-1271 Diagnostic efficiency of split-bolus dual-energy 14:09
computed tomography for patients with suspected B-1281 Two-stage implantation in thoracic endovascular
urinary stones aortic repair
T. Lee, S. Kim; Daegu / KR M. Peng; Beijing / CN

310 ECR 2015 | Final Programme www.myESR.org


Scientific Sessions

14:17
B-1282 Re-expansion of thoraco-abdominal and infrarenal
true lumen collapse by bare-metal stents in
complicated acute aortic dissection type B
A. Massmann, P. Fries, R. Seidel, G.K. Schneider, A. Buecker, H.-J. Schäfers;
Homburg a.d. Saar / DE

14:25
B-1283 Application of color-coded DSA technique in
intra-procedural assessment of thoracic endovascular
aortic repair combined with chimney stenting for le
subclavian artery
X. Guo, P. Li, W. Qiu, L. Ye, L.J. Huang; Beijing / CN

14:33
B-1284 Sandwich-technique for hypogastric artery
preservation by bilateral transfemoral access
A. Massmann1, A. Buecker1, N.J. Mosquera2; 1Homburg a.d. Saar / DE,
2
Ourense / ES

14:41
B-1285 Evaluation of aneurysm neck angle change aer
endovascular aortic aneurysm repair
Y.S. Jeon, T.B. Le, M.H. Moon, K.C. Hong, S.G. Cho, K.M. Park; Incheon / KR

14:49
B-1286 Non-invasive 4-dimensional wireless aneurysm
sac pressure monitoring aer endovascular aortic
aneurysm repair (EVAR): conceptional design of an
integrated stent-gra and first in vitro results
C. Spink1, B. John1, W. Krautschneider1, D. Schröder1, R. Fischbach2,
M. Braunschweig2, J.-H. Buhk1, G. Adam1, A. Koops1; 1Hamburg / DE,
2
Dresden / DE

14:57
B-1287 Ultra low profile polymer-filled stent gra for
abdominal aortic aneurysm treatment:
two-years follow up
E. Macchi, G. De Marchi, A. Ierardi, E. Duka, N. Lucchina, L. Nocchi Cardim,
F. Fontana, G. Carrafiello; Varese / IT

15:05
B-1288 First experience with a novel bioabsorbable and
non-synthetic vascular closure device:
FISHing in the angio-suite
M. Treitl, M.F. Reiser, K. Treitl; Munich / DE

15:13
B-1289 Treatment by embolisation
of type 1 endoleak aer EVAR
C. Marcelin, Y. Lebras, N. Grenier, A. Lasserre; Bordeaux / FR

15:21
B-1290 Hematrix® Active Patch for post-interventional
hemostasis in femoral artery access:
a study on efficacy and safety
Sunday

A. Sauer, A. Dierks, F. Wolfschmidt, N. Hassold, T. Bley, R. Kickuth;


Wuerzburg / DE

www.myESR.org Final Programme | ECR 2015 311


Scientific Sessions

312 ECR 2015 | Final Programme www.myESR.org


Late-Breaking Clinical Trials

12:30–13:30 Room D2

Late-Breaking Clinical Trials (LBCT)


Moderators: M.. Dewey; Berlin / DE,
N.R. Dunnick; Ann Arbor, MI / US

12:30
Image-based structural and functional phenotyping of
the German COPD cohort (COSYCONET) using MRI and
CT
B. Jobst1, J. Biederer1, I. Fellhauer1, S. Triphan1, K. Burmester1, J. Schliebus1,
A. Karch2, C.-P. Heußel1, H.-U. Kauczor1; 1Heidelberg / DE, 2Hannover / DE

12:40

Wednesday
Presentation by discussant:
J.B. Seo; Seoul / KR

12:45
A pragmatic randomised controlled trial of the
comparative effectiveness of computed tomography
versus invasive coronary angiography for the
management of stable chest pain patients: Methods
of the multicentre DISCHARGE trial
R. Haase, M. Dewey, on behalf of the DISCHARGE Consortium (www.
dischargetrial.eu); Berlin / DE

12:55
Presentation by discussant:
K. Kitagawa; Mie / JP

13:00
Economic evaluation of gadoxetic acid-enhanced
magnetic resonance imaging (Gd-EOB-DTPA-MRI) in
the diagnosis of colorectal-cancer metastasis in the
liver: results from the VALUE trial
C.J. Zech1, N. Justo2, A. Lang2, A. Ba-Ssalamah3, M.-J. Kim4, H. Rinde5, E. Jonas2;
1
Basle / CH, 2Stockholm / SE, 3Vienna / AT, 4Seoul / KR, 5Binningen / CH

13:10
Presentation by discussant:
V. Vilgrain; Clichy / FR

13:15
Proteus trial: comparing neoplasia yield and
attendance of sigmoidoscopy and CT colonography in
a colorectal cancer screening setting
D. Regge1, C. Senore2, G. Iussich1, L. Correale2, C. Hassan3, S. Montemezzi4,
N. Segnan2; 1Candiolo / IT, 2Turin / IT, 3Rome / IT, 4Verona / IT

13:25
Presentation by discussant:
A. Laghi; Latina / IT

www.myESR.org Final Programme | ECR 2015 313


Late-Breaking Clinical Trials

314 ECR 2015 | Final Programme www.myESR.org


List of Authors &
Co-Authors

315
List of Authors & Co-Authors

A Aguilar Pérez M.: B-0196, B-0197, B-0412, B-0419, Almeida R.P.P.: B-0365, B-0869, B-0871, B-1021,
Aakil A.: B-0761 B-0548 B-1145
Aamodt R.: B-0037 Aguillar V.L.N.: B-0927 Aloisio P.: B-0062
Aarsnes A.: B-B-0167 Aguillella L.: B-0073 Alomaim W.: B-0208
Abd Ellah M.: B-0002, B-0071, B-0317 Ahamad N.: B-1214 Alpert J.: B-0983
Abd Ellah M.M.H.: B-0076 Åhlström Riklund K.: A-714 Altabella L.: B-0050
Abdel Magied A.M.: B-0912 Ahmad I.: B-0160, B-0489 Althoff C.E.: B-0063
Abdel Razek N.M.: B-0443 Ahmed A.: B-1115 Altintas S.: B-0775
Abdelgawad M.S.: B-0299 Ahmed H.U.: A-330 Alvarez-Linera J.: A-235
Abdelmonsef N.A.M.: B-0299 Ahn H.-S.: B-0879, B-0880 Alves J.E.T.: B-0817
Abdel-Rehim M.: B-1262 Ahn K.-J.: B-0201 Amann G.: B-0524
Abdolell M.: B-0236, B-0237 Ahn K.-S.: B-0288, B-0497 Amara N.: B-0465
Abdraboh N.: B-0215 Ahn S.E.: B-0840 Amaral A.P.: B-0151
Abdullah B.J.: B-0855 Ahn S.H.: B-0568 Ambrosi A.: B-0043
Abe H.: B-1177 Aime S.: A-468 Amer H.: B-0436
Abed A.: B-1257 Airaldi S.: B-0496, B-0642, B-0643, B-0644, B-0805 Amitai M.M.: B-1040, B-1041
Abela E.: B-0813 Aissa J.: B-0627 Ammari S.: A-270
Ajlan A.M.: B-1059 Amoretti N.: B-0342
Abeyakoon O.: B-0925
Akahane K.: B-0541 Amoroso S.: B-0711
Aboagye E.O.: B-0517
Akata D.: A-070, B-1198 Amouyal G.: B-1263
Aboian I.: B-0355
Akbari K.: B-0089, B-1228 Amzallag-Bellenger E.: A-085
Abolhasani Foroughi A.: B-0279
Akça A.: B-1218 An J.: B-1049
Abou El-Ghar M.: B-1013
Akhan O.: A-728 Anand R.: B-0885
Abraham D.: B-0882
Akhtar I.: B-0143 Ananthasivan R.: B-1078
Abrahamsson P.-A.: A-416, A-417
Akin O.: B-0348, B-0555, B-1009, B-1010 Ananyeva N.: B-1081
Abramyuk A.: B-0506
Akisue T.: B-0810 Anbar A.: B-0640
Abrantes A.F.C.L.: B-0365, B-0869, B-0871, B-1021,
Andersen E.: B-0708
B-1145 Aksoy S.: B-0734, B-1277
Andersen E.N.: B-0146
Abrantes C.M.L.: B-0365 Al Adwani N.: B-0530
Andersen J.D.: B-0828
Abrishami A.: B-0605 Al Ansari N.: B-0041
Andersen J.G.: B-0037, B-1259
Abualruz A.M.: B-0979 Al Bunni F.: B-0891
Andersen M.K.: A-524
Abujudeh H.H.: B-0281 Al Jubran S.: B-0530
Andersson I.: B-0921
Abusamaan S.: B-0190 Al Khuraish N.: B-0530
Andong A.-L.: B-0047
Accardi R.: B-0120 Al Moosawi N.M.: B-1207
Andrade W.P.: B-0830
Achenbach S.: B-0772 Al Nahedh Y.S.: B-1207
Andrasina T.: B-1126
Achten R.: B-0781 Al Umairi R.S.S.: B-0578
André M.: B-1011
Ackermann H.: B-0428 Al-Amin M.: B-1132
Andreini D.: B-0179, B-0467, B-0626, B-0777
Acosta Ruiz V.: B-0721 Albano D.: B-0515
Andreisek G.: A-440, B-0373, B-0374, B-0909,
Adam A.: K-20 Albarello L.: B-0251 B-1070, B-1074
Adam E.J.: A-156, A-426, A-638 Albers P.: B-0351, B-0357 Andriessen P.: B-0526
Adam G.: B-0188, B-0223, B-0225, B-0469, B-0558, Alberti N.: B-0800, B-0803 Andrzejewski P.: B-0132, B-0935, B-1158
B-0565, B-0725, B-0808, B-0898, B-0934, B-0974, Albisinni U.: B-0807, B-0831 Angelelli G.: B-0043, B-0189, B-0616, B-0622,
B-1213, B-1286 Albrecht M.: B-0186, B-0539, B-0731 B-1182, B-1212
Adam S.Z.: B-0849 Albrecht M.H.: B-0428, B-0729, B-0730, B-0770 Angeli L.: B-1083
Adamsbaum C.: A-064 Albrecht T.: B-0035 Angileri R.: B-0456
Addonisio G.: B-0366 Al-Butmeh F.: B-0539 Anile M.: B-0713
Adeb M.: B-0894 Alefantinou S.: B-0832 Anker C.: B-0077
Adel L.: B-0912 Aleixo J.: B-1021 Ann J.H.: B-1084
Adelsmayr G.: B-0052 Aleman G.: B-1278 Annoni A.D.: B-0626, B-0777
Adrada B.E.: B-0439 Alessi S.: B-0560 Ansarin M.: B-0575
Affifi L.: B-0530 Alexopoulou E.: A-063 Antoch G.: A-178, A-393, B-0092, B-0351, B-0357,
Afshan I.: B-1082 Alifano M.: B-0989 B-0449, B-0516, B-0627, B-0936, B-1004, B-1068,
Afshar-Oromieh A.: B-0304 Aliprandi A.: B-0488 B-1097
Afzal M.O.: B-0973 Alison D.: B-0700 Antonuccio E.G.M.: B-0121
Agadakos E.: A-603 Alison M.: A-359 Antunes S.: B-0180
Agarwal S.: B-0580 Alkadhi H.: A-123, A-652, B-0107, B-0268, B-0409, Anzidei M.: B-0713
Ageitos Casais M.: B-0836 B-0746, B-0896, B-1074 Aoyagi Y.: B-0184
Aghaghazvini L.: B-0875 Allegranza P.: B-1164, B-1166 Aparina O.: B-0181
Agnello F.: B-0515 Allen C.: B-0967 Apfaltrer P.: B-0631
Agostinelli S.: B-0970 Allen G.M.: B-0067, B-0282 Arablinskiy A.: B-1261
Agostini A.: B-1054 Allmendinger T.: B-0676 Arai Y.: B-0139
Agrawal S.R.: B-0257 Al-Macki K.: B-0578 Aras Ö.: B-0555
Agten C.A.: B-0494, B-0495, B-0641 Almeida C.: B-0362, B-0867 Arbib F.: B-0538
Aguiar P.: A-709 Almeida D.: B-0362 Arcuri P.P.: B-0224

316 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Arenson R.: B-1036 Azfar Siddiqui M.: B-0489 Banerjee I.: B-1017
Arese C.: B-0608 Azmat O.: B-0287 Banerjee J.: B-0697, B-0856
Arfi-Rouche J.: A-389 Azmat Z.: B-0530 Bang M.S.: B-0977
Argento C.: B-0899 Aznaurov V.: B-0630 Bankier A.A.: A-037, A-450
Argento G.: B-0062 Azrumelashvili T.: B-1128 Bannas P.: B-0974
Argibay-Vazquez S.: A-709 Azzeroni R.: B-0170 Bansal D.: B-0914
Argirò R.: B-0713, B-0883, B-0884 Baranes L.: B-0108
Argyropoulou M.I.: A-046, A-686, B-0702 B Barbashova A.: B-0380
Aribal M.E.: B-1156 Baba S.: B-0826 Barbera S.: B-0364, B-0366, B-1018, B-1150
Arjmand Shabestari A.: B-1057 Babb J.: B-0983 Barbero S.: B-0331
Arjun S.K.: B-0981, B-1082 Baca L.-G.: B-0407 Barchetti G.: B-0054
Arkar R.: B-0159 Baccialone J.: B-0128 Barczyk-Kahlert K.: B-0931
Armbruster M.: B-0610, B-1187 Bacher K.: B-0781 Barentsz J.O.: A-437
Armocida A.: B-1033 Bachert P.: B-0103 Bargellini I.: A-198, B-0430
Armocida C.: B-1033 Bachman M.: B-0824 Barile A.: B-0066, B-0068, B-0072, B-0075, B-0338,
Arnar D.O.: B-0415 Bachmann K.: B-0188 B-0347, B-0487, B-0573, B-1208, B-1209, B-1211
Arnaud E.: A-685 Baco E.: B-0552 Barillari M.: B-0371
Arnoldussen C.W.K.P.: B-0635 Badea R.: B-1200 Barinova M.: B-1138
Arnulfo A.: B-0664 Bady P.D.: B-0791 Barisone F.: B-0608
Arora A.: B-0219 Bae J.: B-0133, B-1006, B-1121 Barker A.: B-0064
Arrigoni F.: B-0066, B-0068, B-0072, B-0075, B-0338, Bae J.S.: B-0690 Barkhausen J.: B-0276
B-0347, B-0487, B-0573, B-1208, B-1209, B-1211 Bae K.K.: B-0532 Barkhof F.: A-234, A-609, B-0244
Arslan A.S.: B-1218 Baek J.H.: B-0156, B-1121 Barnett G.: B-0084
Arsov C.: B-0351, B-0357 Bagdadi R.R.: B-1059 Baroli A.: B-0723
Artigas J.M.: B-0403 Baggiano A.: B-0179, B-0467 Baron R.L.: A-132
Artioli D.: B-0191 Baglio I.: B-0216, B-1157 Barone D.: B-0087, B-0246
Arya S.: B-0651 Bago-Horvath Z.: B-1153 Barra S.: B-0970
Asadov R.: B-1156 Baiocco S.: B-0087 Barral M.: B-0718
Asayama Y.: B-0252, B-0431 Bajzik G.: B-0657 Barron D.A.: A-343
Asbach P.: B-0356, B-0583 Bakir B.: B-0221 Barroso L.: B-0945
Aschoff A.: A-375 Bal C.S.: B-0514 Barry J.: B-0020
Ashamallah G.A.: B-0876 Balacchi C.: B-0587 Bartalena T.: B-1266
Aslan K.: B-0591 Balageas P.: B-0857 Bartenstein P.: A-612
Aslani Menareh Bazari R.: B-0476, B-1252 Balagurunathan Y.: B-0094 Barter S.: A-631, A-681
Aspelin P.: B-0100 Balaji R.: B-0965 Barth B.K.: B-0004, B-0531, B-0559, B-1046
Aspelund T.: B-0415 Balas I.: B-0077 Bartolomé P.: B-0211
Aspin R.: B-1148 Balbo-Mussetto A.: B-0510, B-0512 Bartolozzi C.: B-0010, B-0269, B-0430, B-0741,
Assante R.: A-465 Bale R.: A-057, A-364, B-1244 B-0841
Astegiano F.: B-0620 Balenovic A.: A-739 Bartykowszki A.: B-0607
Atalay C.R.: B-0138 Balestri R.: B-0841 Barwick T.: A-030
Atkinson D.: B-0460 Bali M.A.: A-005 Bas A.: B-1204
Attenberger U.I.: B-0554, B-1232 Balkman J.D.: B-0214, B-1189 Basiak M.: B-0656
Attye A.: B-0369 Ball P.: B-0868 Basilico R.: A-368
Aubé C.: B-0195, B-0410 Ballard M.: B-0408 Ba-Ssalamah A.: A-140, A-619, B-0250, B-1170, LBCT
Augustynska B.: B-1086 Ballati F.: B-0015 Bassi M.: B-0838
Auperin A.: B-0718 Ballesio L.: B-0013 Bastarrika G.: A-594
Aust S.: B-0669 Balleyguier C.S.: A-032, A-149, A-270, A-369, A-389 Basten L.: B-0859
Autiero Walleser S.: B-0084 Ballicu N.: B-0344 Bastiani C.: B-0519
Auvinen P.: B-0210 Ballinger J.R.: A-110 Bastos-Leite A.J.: B-0244
Auweter S.: B-0102 Balodis A.: B-0818 Batool M.: B-0097
Avanesov M.: B-0188, B-0898 Balslev I.: B-0960, B-0968 Batool S.: B-0034
Avantsa R.: B-0665 Baltogiannis D.: B-0702 Bats A.-S.: B-0666
Avella-García C.B.: B-0441 Baltzer A.: B-0619 Batsak B.: B-0722
Averkiou M.: B-0636 Baltzer P.A.T.: A-272, A-599, B-0242, B-0352, B-0444, Battaglia M.: B-0831
Aviram G.: B-0849 B-0615, B-0619, B-0759, B-0767, B-0920, B-1153, Battisti S.: B-1235
Avogliero F.: B-0178 B-1158, B-1160 Battistuzzi J.B.: B-0717
Avrin D.: B-1036 Balvay D.: B-0131 Bauer J.S.: A-713, B-0249, B-0285
Awai K.: B-1197 Balzarini L.: B-1236 Bauer R.W.: B-0088, B-0193, B-0428, B-0729,
Awny M.: B-1079 Bamberg F.: A-115, A-252, A-324, B-0001, B-0392, B-0730, B-0731, B-0770, B-0847, B-1270
Ayachit A.: B-0914 B-0417, B-0480, B-0483, B-0609 Bäuerle T.: A-280, A-724
Aydin F.A.: B-0221 Banciu E.: B-0369 Baum T.: B-0285
Ayuso Colella C.: K-25 Banco A.: B-0505 Baumann S.: B-0752
Azad Y.-J.: B-0398 Banerjee A.: B-1225 Baumbach S.F.: B-0911
Azevedo K.B.: B-0869, B-1145 Banerjee B.: B-1078 Baumüller S.: B-0531

www.myESR.org Final Programme | ECR 2015 317


List of Authors & Co-Authors

Baur I.: B-0754 Bendix T.: B-0948 Bezzina P.: A-344


Baur-Melnyk A.: B-0286 BenDriss A.: B-0903 Bezzon E.: B-0018
Baxa J.: B-0756 Benea G.: B-0838 BharGavi V.: B-0665
Baxter B.: B-0529 Benedek A.: B-1175 Bhatia A.: B-0164
Bayat A.R.: B-0203 Benedek T.: A-698 Bhatia K.S.S.: B-0370
Bayer R.R.: B-0445, B-0752 Benedetti G.: B-0468, B-0471, B-0904 Bhatnagar G.: B-0460
Bayer-Karpinska A.: B-0484 Benedetto K.P.: B-0638 Bhayana D.: B-0194
Bayerl C.: B-0001 Benegas M.: B-0090 Biacca A.: B-0511
Bäzner H.: B-0197, B-0412, B-0419 Bengel F.: A-292 Biagi L.: B-0082, B-1083
Bazot M.: A-526, B-0131 Bennani S.: B-0666 Białecka A.: B-0457
Bazzocchi A.: A-711, B-0807, B-0831, B-1266 Bennani-Baiti B.: B-0759 Białecki M.: B-0457
Bazzocchi M.: B-0116, B-0230, B-0442, B-0615, Benndorf M.: B-0235, B-0303, B-1193 Bianchi M.: B-0269
B-0743, B-0919 Bennink E.: B-0815 Bianek-Bodzak A.: B-0668
Beale T.: A-173, A-373 Benoist G.: B-0384 Bick U.: A-476, A-597, B-0209
Beaumont H.: B-0245, B-0519, B-1096 Benoudiba F.: A-560 Bickel H.: B-0767
Beaussier H.: B-0972 Bensaid C.: B-0666 Bidault F.: A-270
Becce F.: B-0940 Bensch F.V.: B-1188 Biederer J.: A-602, LBCT
Bech M.: B-0102, B-1101 Beomonte Zobel B.: B-1235 Biegon A.: B-0521, B-0525
Bechstein W.O.: B-0858 Berardi E.: B-0978 Biermann K.: B-0425
Becker A.: B-0409, B-0931 Bercovitz R.: B-0521, B-0525 Bierma-Zeinstra S.: B-1210
Becker C.D.: A-671 Bérczi V.: A-054, B-0070 Bierry G.: B-1278
Becker H.-C.: B-0772 Berger A.K.: B-0424 Biessels G.J.: B-0950
Becker M.: A-039, A-308, A-667 Berger F.H.: A-060 Biffar A.: B-0286
Beckers R.: B-0836 Berger M.L.: B-0361 Bignotti B.: B-0496, B-0642, B-0643, B-0644, B-0805
Beckmann M.W.: B-0206 Bergère A.: B-0947 Bijan B.: B-0192
Bedair R.: B-0019, B-1154 Bergman D.: B-0521, B-0525 Bilbao J.I.: A-147, A-296, A-425, A-625
Bedlington N.: A-552, A-737 Berkemeyer S.: B-0548 Bilgen I.: B-0434
Beeckman D.: B-0144 Berliner C.: B-1213 Binder J.: B-0911
Beenen L.F.M.: B-0844 Berliner S.: B-0849 Binder T.: A-184
Beerbaum P.: B-0400 Berlis A.: B-0545 Bingul I.: B-0221
Beeres M.: B-0729 Bernard V.: B-1126 Biondi T.: B-0738, B-0739
Beeson J.: B-0332 Bernardi D.: A-707 Bipat S.: B-0736
Beets G.L.: A-337, B-0737, B-0832, B-0834, B-0836, Bernardo S.: B-0140, B-0520, B-0523 Birnbacher L.: B-0101, B-0483, B-1012
B-0837, B-1094, B-1229 Bernathova M.: B-0444, B-0920 Biro G.: B-0657
Beets-Tan R.G.H.: A-336, A-339, A-548, A-566, Bernegger A.: B-1043 Biscaldi E.: A-617
B-0091, B-0113, B-0115, B-0118, B-0737, B-0832, Berner L.P.: B-0811 Bisdas S.: A-311
B-0834, B-0836, B-0837, B-1094, B-1229 Bernsen M.: B-0930 Bitencourt A.G.V.: B-0830, B-1139
Begini P.: B-1050 Berruti A.: B-1089 Bittersohl B.: B-0936
Behme D.: B-0545 Bertana L.: B-0738, B-0739 Bittner A.-K.: B-1159
Behzadi C.: B-0558, B-0565 Bertani V.: B-0116, B-0442 Bjerke G.: B-1259
Beiderwellen K.: B-0255, B-0806, B-0827, B-1230 Bertella E.: B-0179, B-0467, B-0626 Björkman-Burtscher I.M.: K-10
Beigelman C.: B-0988 Bertheau R.C.: B-0480 Blandino G.: B-0970
Beitzke D.: B-0177 Berthèzene Y.: B-0811 Blasco G.: B-0500
Bekci T.: B-0591 Berthier E.: B-0410 Blaut S.: B-0353
Bekkers S.C.A.M.: A-367 Bertini M.: B-0741 Bley T.: B-1290
Belch J.J.F.: B-0466, B-0479, B-0481 Bertolini M.: B-0918, B-1103 Bliddal H.: B-0948
Belgrano M.: B-0629 Bertolotto M.: A-390 Blobel J.: B-0261, B-0262
Belkebir M.: B-0259 Bertram R.: B-1188 Bloem B.R.: B-0085
Belker K.: B-0596 Berzovini C.M.: B-0608 Bloem H.: B-1210
Bellantonio L.: B-1268 Best J.: B-1097 Bloem J.L.: A-334, B-0941
Bellelli A.: B-0343 Besutti G.: B-0316, B-1113 Blomqvist L.: A-567, K-19
Belli A.-M.: A-361, B-1269 Bethge O.T.: B-0449 Blondin D.: B-0351, B-0357
Belli P.: B-0012, B-0117, B-0618, B-0623, B-1179 Bethge W.: B-1256 Bloomfield C.: B-1023
Bellin M.-F.: A-206 Bethke A.: B-1196 Bloomgarden D.C.: B-0281
Bellini D.: B-0738, B-0739, B-0833 Bethune D.: B-0097 Blouet M.: B-0384
Bello L.: B-0027 Bettelheim D.: B-0524 Blüher M.: B-0980
Belloch E.: B-0073 Bettini G.: B-0667 Boavida F.: B-1023
Belloy F.: B-0384 Beuers U.H.: B-1104 Bock M.: A-467
Beltrama V.: B-0179, B-0467 Beuthien-Baumann B.: B-0513 Bockisch A.: B-0255
Ben Cohen A.: B-1040, B-1041 Bevilacqua A.: B-0087, B-0246 Bodossa P.: B-0220
Ben Mahfoudh K.: B-0295 Beyer T.: A-108, A-142, B-0319, B-0320 Boellaard R.: A-265, B-0320
Benaissa A.: A-720 Bezrukov I.: B-0028 Boellaard T.N.: B-0736
Bencivinni F.: B-0505 Bezzi M.: A-144, A-320, B-0713, B-0883, B-0884, Boesen L.: B-0960, B-0968
Bendet A.: B-0849 B-0888, B-1048 Boesen M.: B-0572, B-0948

318 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Bogaerts R.: B-0680 Boulet C.: A-509 Brun E.: B-0610


Bogdanova E.: B-0589 Bourgioti C.: B-0663 Bruna R.: B-0510
Bogetti C.: B-0022 Bourillon C.: B-0666 Bruners P.: B-0701
Bogner W.: B-1153 Bourrier P.: B-0187 Bruno F.: B-1065
Bogue C.: B-0171 Bousquet A.: B-0128 Brussaard C.C.: B-0106
Bohatyrewicz R.: B-0202 Boussouar S.: B-0376 Bruzzi J.: B-0842
Bohndorf K.: A-210 Boutry N.: A-085 Bubenheim M.: B-1275
Bohy P.: B-0987 Bouzad C.: B-0128 Buccheri C.: B-0117, B-0618, B-0623, B-1179
Bollache E.: B-0395 Bouzgarrou M.: B-0857 Buccianti P.: B-0841
Bollondi L.: B-1088 Bowley D.M.: B-0408 Buchan K.: B-0280, B-0677
Bomers J.: B-0706 Boytsov S.: B-0901 Buchbender C.: B-0092, B-0516, B-1068, B-1183
Bomers J.G.R.: B-1140 Bozkaya H.: B-0546 Bucher A.M.: B-0628, B-0770
Bonaffini P.A.: B-0274, B-0308, B-0309, B-0464, Bozzetti F.: B-0816 Buchheidt D.: B-1249
B-0518, B-0612, B-0774, B-0835, B-1053, B-1091, Braber T.: B-1063 Buck A.: A-353
B-1164, B-1166 Brachetti G.: A-435, B-0337 Buck F.M.: B-0491, B-0495, B-0639
Bonamini R.: B-0900 Brader P.: B-0352 Bücker A.: A-287
Bonanni B.: B-0230 Brady A.: A-753 Budaeus L.: B-0558
Bonatesta A.: B-0012, B-0117, B-0623 Braga B.: B-0871 Budde R.P.J.: B-0270, B-0601
Bonatti G.: B-1274 Brambilla M.: B-0664 Buddhavarapu S.R.: B-0979
Bonatti M.: B-1274 Brancatelli G.: A-131, B-0220 Buecker A.: B-0478, B-1282, B-1284
Bonello L.: B-0229, B-0575, B-0577 Brandão S.: A-660 Buemi F.: B-0511, B-0664
Bongartz G.: B-0562 Brans B.: B-0118 Buesing K.A.: B-0801, B-1161
Bongers M.N.: B-0402, B-0609 Brauer T.: B-0513 Bufi E.: B-0012, B-0117, B-0623
Bonifacio C.: B-1236 Braun J.: B-0356, B-0394 Buhk J.-H.: B-1286
Bonington S.: B-0662 Braun K.: B-0313 Buijs J.: B-0526
Boninsegna E.: B-1174 Braun L.M.: B-0839 Buissink C.: B-0864
Bonnemain B.: B-0710 Braunagel M.: B-0101, B-1012, B-1134 Bulakçi B.: B-0388
Bonnin P.: B-1106 Braunschweig M.: B-1286 Bulakçi M.: B-0388
Bonomo L.: A-218, A-623, B-0012, B-0059, B-0117, Bravin A.: B-0610 Buller H.R.: B-0844
B-0121, B-0314, B-0328, B-0618, B-0623, B-0687, Breen D.J.: A-120 Bullock S.: B-0282
B-0889, B-1052, B-1136, B-1179 Brehm B.: B-0206 Buls N.: A-626, B-1199
Booij R.: A-606 Brehmer K.: B-0100 Bult P.: B-0228
Boomsma M.F.: B-0567 Brekkan E.: B-0721 Buonocore V.: B-0041
Boos J.: B-0449, B-0627, B-1004 Bremer C.: B-0931 Burck I.: B-0730
Boraschi P.: B-0010 Bremerich J.: A-700 Burgkart R.: B-0285
Bordonne C.: B-0989 Brenneis B.: B-0595 Burian E.: B-0938
Borelli C.: B-0618, B-1179 Brenner W.: B-0003 Burke M.: B-0353
Borg Grima K.: B-0358 Brettle D.: B-1148 Burke S.: B-1143
Borg K.A.: B-1014 Briani C.: B-1050 Burmester K.: LBCT
Borg M.A.: B-1013 Bricault I.: B-0611 Burnside E.: B-0235, B-1193
Borge S.: B-0864 Briers E.: A-429, A-554 Burrel M.: A-294
Borgen R.: B-1026 Brink J.A.: A-208, A-216, A-756 Bursali İ.: B-0330
Borghesi A.: B-0174 Brink M.: A-202, A-204, B-0401 Buscaglia M.: B-1131
Borgmann T.: B-0060 Briot K.: B-0284 Busse H.: B-0980
Borgmeier A.: B-0095 Brismar T.B.: B-0044, B-0100 Bustos A.: B-0796
Boric I.: K-26 Brisse H.J.: B-0527 Buttari F.: B-0030
Bornefalk H.: B-0671 Brix G.: B-0169, B-0784 Buttigieg E.: B-0358
Borrazzo C.: B-0050 Brkljacic B.: A-454, A-737, A-752 Buy X.: B-0717, B-0800, B-0803
Borro M.: A-164 Broche L.M.: B-0315 Buzan M.T.A.: B-0991
Borsato A.: B-0961 Brockmann C.: B-0421, B-0819 Byrne D.: B-0017
Borys Y.: B-0660 Brockmann M.A.: B-0421, B-0819 Byun J.H.: B-1049
Bosboom D.: B-0203, B-0706 Broeders M.J.M.: B-1027, B-1030, B-1144
Bosmans H.: A-014, B-0680, B-0787, B-1100, B-1102, Bron E.E.: B-0244 C
B-1246 Broncano J.: B-0902 C. Moreira I.: B-1042
Bosmans J.M.L.: A-079 Brookes J.: A-113 Caan M.W.A.: B-0385
Boss A.: B-0909 Broomfield D.: B-0386 Cabeza B.: B-0772
Botan E.: B-1200 Brountzos E.: B-0339, K-01 Cáceres J.: A-458
Bothamley G.: B-1143 Brouwer O.R.: B-0033 Cadioli M.: B-0224
Bouaboula M.: B-0659 Browne S.: B-1151 Cahalane A.M.: B-1195
Bouaziz M.: B-0295 Brucculeri F.: B-0331 Cai L.: B-0625
Bouda D.: B-0187 Brugger P.C.: B-0379, B-0524 Caines J.: B-0236, B-0237
Bouert R.: B-0572 Bruguier C.: B-0848 Calandriello L.: B-0687
Bouhelal O.: B-0376 Brůha J.: B-1205 Calareso G.: B-0577
Bouhier-Leporrier K.: B-1090 Brumberg A.: B-0599 Calcagni F.: B-0430

www.myESR.org Final Programme | ECR 2015 319


List of Authors & Co-Authors

Caliendo G.: B-0300 Casini T.: B-0226 Chatellier G.: B-0972


Calıkoglu U.: B-0330 Casiraghi A.: B-0464, B-0518, B-1164, B-1166 Chatoupis K.: B-0663
Calli C.: A-730 Casiraghi E.: B-0577 Chauhan U.: B-0296
Calvo-Temprano D.: B-0090 Cassano E.: B-0230, B-0442 Chauvie S.: B-0724
Camathias C.: B-0569 Cassarà A.: B-0664 Chelaru R.L.: B-1034
Cambronero J.: B-0500 Cassar-Pullicino V.N.: A-395 Chelly H.: B-0295
Camera L.: B-0038, B-0216, B-1157 Cassart M.: A-126 Chelu R.G.: B-0753
Campagna C.: B-1212 Casselman J.W.: A-644, B-1239 Chen H.: B-1066
Campanino P.P.: B-0022 Cassinotto C.: B-0857 Chen M.: B-1072
Campari C.: B-0918, B-1103 Castaings L.: B-0291 Chen R.: B-1155
Campbell N.: B-0864 Castelijns J.: B-0527 Chen S.: B-0645
Camps Herrero J.: A-065, A-095, B-0760, B-0765 Castellano I.: A-641 Chen W.: B-0470
Can F.: B-0434 Castelli F.: B-0354, B-0517 Chen X.: B-1279
Canale S.: A-149, A-369 Castiglione F.: B-0038 Chen X.-X.: B-0963
Candelari R.: B-1054 Catala-Lehnen P.: B-0565 Chen Y.: B-0048, B-0168, B-0625, B-1099
Candelaria R.P.: B-0439 Catalano C.: B-0013, B-0041, B-0050, B-0054, Cheng J.: B-1238
Cannaò P.M.: B-0051, B-0265, B-0272, B-0474, B-0337, B-0520, B-0523, B-0561, B-0586, B-0621, Cheon J.-E.: B-0886
B-0602, B-0793, B-0794, B-0897 B-0713, B-0883, B-0884, B-0888, B-1048 Cherian M.: B-0159
Cannata D.: B-0762 Catania D.: B-1017, B-1024 Chessa M.: B-0603
Cannavale A.: A-427, B-0125, B-0127 Caterino S.: B-0978 Chevalier T.: B-0710
Cano Gimeno J.: B-0760, B-0765 Cattan P.: B-0187 Chevalier Y.: B-0911
Canstein C.: B-0445, B-0474, B-0779 Caudal A.: B-0342 Chiappetta M.: B-0328
Cantasdemir M.: B-1204 Caumo F.: B-0216, B-1157 Chiappino D.: B-0178
Canu T.: B-0809, B-1172 Cava M.: B-0300, B-0468, B-0471, B-0904 Chiara O.: B-0191
Cao J.: B-1095 Cavalli F.: B-0364 Chiaradia M.: B-0108
Caobelli F.: A-292 Cavallo Marincola B.: B-0337 Chiesa C.: B-0888
Capotondi C.: B-0062 Cavanagh P.: A-552, A-555, A-639, A-754 Chillemi G.: A-164
Capra R.: B-0300 Cavedon C.: B-0216, B-1157 Chinali M.: B-0166
Carabalona S.: B-0620 Cavusoglu M.: B-0138 Chinnaiyan K.M.: B-0628
Caramella D.: A-721 Cay N.: B-0162 Chipon E.: B-0611
Carbonaro L.A.: B-0757, B-0919, B-1176 Cazzagon M.: B-0629 Chirica M.: B-0187
Carbone I.: B-0050, B-0054 Cazzato R.L.: B-0717 Chirico G.: B-0191
Carbone S.F.: B-0325 Cecchi P.: B-0082 Chiti A.: B-0027, B-0307
Carbonetti F.: B-0062, B-0978, B-1050 Cefarelli M.: B-0850 Chmielowska E.: B-0306
Carboni A.: B-1181 Cejna M.: B-0638 Cho E.-S.: B-0310
Cardobi N.: B-0371 Cenzi D.: B-0961 Cho H.-H.: B-0886
Cardoen L.: A-359 Ceravolo R.: B-0082 Cho K.J.: B-0156
Cardoso Moura D.: B-1042 Cercato C.: B-0629 Cho K.R.: B-0763
Carducci S.: B-1224 Cerini R.: B-0371 Cho S.G.: B-0153, B-1285
Carette M.-F.: A-526 Cervera Araez A.: B-0760, B-0765 Cho S.H.: B-1231
Carey K.: B-0448, B-0455 Ceyhan Bilgici M.: B-0591 Cho T.H.: B-0811
Carlier R.: B-0571 Cha D.I.: B-0790 Cho Y.S.: B-0568
Carlton Jones A.L.C.: B-1115 Cha J.G.: B-0453 Choe J.: B-0795, B-1251
Carminati M.: B-0602, B-0603, B-0604 Cha M.J.: B-1243 Choe Y.H.: B-0790, B-0793, B-0794
Carmona-Bayonas A.: B-0090 Chaari A.: B-0295 Choi B.I.: B-0008, B-0009, B-0423, B-0613, B-1092,
Carneiro Â.: B-0817 Chabanova E.: B-0960, B-0968 B-1121, B-1165, B-1169
Carnevale F.C.: A-331 Chabloz D.: B-1023 Choi C.G.: B-0504
Caroff J.: B-0545 Chabrol A.: B-0811 Choi D.: B-1243
Carr C.D.: B-1036 Chai W.: B-0217 Choi G.: B-0763
Carrafiello G.: A-446, B-0720, B-1287 Chakfe N.: B-0672 Choi H.S.: B-0201
Carriero A.: B-0035, B-0086, B-0511, B-0576, B-0664 Chakraborty P.: B-0514 Choi J.I.: B-0880
Carrington B.M.: B-0662 Chala L.F.: B-0111 Choi J.W.: B-0007, B-0593, B-1000
Carsin A.: B-1003 Chalabi N.A.M.: B-0215 Choi K.: B-0009
Cartia F.: B-0229 Chami L.: B-0158 Choi S.H.: B-0501, B-0508, B-0532, B-0977
Cartier V.: B-0718 Chamming’s F.: B-0666 Choi S.-Y.: B-1243
Cartocci G.: B-0337 Chandra P.: B-1214 Choi T.W.: B-1165, B-1169
Caruso D.: B-0738, B-0739, B-1233 Chandramohan A.: B-0882 Choi Y.: B-0536
Carvalho F.: B-0865 Chandy P.E.: B-0915, B-1078 Choi Y.H.: B-0886
Carvalho N.: B-0362 Chang M.-Y.: B-0692 Choi Y.J.: B-0156
Casale P.: B-0894 Chang W.: B-0008 Chojniak R.: B-0830, B-1139
Casali V.: B-0762, B-0764 Chanson P.: B-0395 Chopier J.: B-0766
Cascarano M.: B-0043 Chapot R.: B-0548 Choudhury A.: B-0662
Casciaro R.: B-1131 Charlotte F.: B-0158 Choudhury S.R.: B-0885
Caseiro-Alves F.: A-007, A-438 Chassoux F.: B-0297 Chourmouzi D.: B-0649

320 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Chow B.: B-0751 Colombo N.: A-665 Csecs I.: B-1064


Choy T.W.: B-0954 Colosimo C.: B-0544 Cuenod C.-A.: B-0131, B-0376, B-0659
Choyke P.L.: A-463, A-513 Conlon T.: B-1101 Cuijpers C.F.: B-0697
Christensen A.: B-0301 Conrado J.L.F.A.: B-0830 Cunha P.: B-1042
Christensen A.F.: B-0958, B-0959 Constantin C.: B-0661, B-1114 Cunha R.R.: B-0830
Christensen H.: B-0301, B-0958, B-0959 Conte G.: B-0575 Cunha T.M.: B-0137
Christensen R.: B-0948 Contegiacomo A.: B-0059, B-0314, B-1136 Cunningham D.: B-0112
Christodoulou M.: B-0661, B-1114 Cook G.: A-283, A-515 Cuocolo A.: A-325, A-465
Christoforidis T.: B-1114 Cooke E.S.: B-1189 Curione D.: B-1052
Christoph K.A.: B-1046 Cooke T.L.: B-1189 Curvo-Semedo L.: A-491, A-565
Chu C.M.: B-0714 Coolen J.: B-1254 Cybulski A.J.: B-1174
Chu J.: B-0823 Copley S.: B-1115 Cyran C.C.: B-0938
Chung B.M.: B-0879 Copley S.J.: A-520 Czajkowski Z.: B-0202
Chung G.: B-0413 Coppenrath E.: B-0273, B-0275, B-0486, B-0822 Czarnowska-Cubala M.: B-0306, B-0719
Chung K.: B-0535, B-0537 Coppola F.: B-0587, B-1044, B-1045 Czekajska-Chehab E.: B-0845
Chung M.H.: B-0536 Coppola G.: B-0059 Czerny C.: K-13
Chung S.R.: B-0504 Corazza A.: B-0918, B-1103 Czimbalmos C.: B-1064
Chung Y.-G.: B-0802 Coriani C.: B-0437, B-0922
Chuong A.-M.: B-0972 Cornalba G.: B-0170 D
Cianci R.: B-0742 Cornel E.B.: B-0704, B-1140 D’ Argento F.: B-0544
Ciatti S.: B-0238 Cornelis F.: B-0291, B-1011 Daans C.G.: B-0601
Ciccarone A.: B-0887 Cornelius A.: B-0559 Dacher J.-N.: B-0953, B-1275
Cicek T.: B-1273 Cornelius P.C.: B-0378 Dadali Y.: B-0330
Ciescinski J.: B-1086 Cornil A.: B-0987 Dahl B.: B-0824
Cifci E.: B-1273 Corno L.: B-0972 Dahlman P.: B-0721
Ciliberto M.: B-0687 Cornud F.: A-106, A-329 Dalal P.: B-0332
Çinar C.: B-0546 Corot C.: B-0710 Dall B.: B-0014
Cioffi Squitieri N.: B-0667, B-1237 Correale L.: LBCT Dalla Torre D.: B-1244
Ciolfi S.: B-0576 Correas J.-M.: A-137, B-1011 dall’Armi V.: B-0328
Ciolina F.: B-0586 Correia de Verdier M.: B-0418 Dalmis M.U.: B-0758
Ciolina M.: B-0833, B-1233 Corso R.: B-1053 d’Alteroche L.: B-0700
Ciompi F.: B-0537 Cortot A.: B-0503 Damascelli A.: B-0468, B-0471
Cipolla V.: B-0621 Corvò R.: B-0970 Damiani F.: B-0397
Cipriani A.: B-0012 Cosgrove D.: B-0112 D’Amico M.: B-0163, B-0696
Cipriani C.: B-0883, B-0884 Cosgrove S.: B-0231 Damilakis J.: A-386, A-412, A-584, B-0241, B-1247
Ciresa M.: B-1052 Coşkun A.: A-727 Damm Nybing J.: B-0301
Cirigliano A.: B-0667 Cosottini M.: B-0082, B-0300, B-1083 Dana B.: B-0186
Cirillo S.: B-0510, B-0512 Costa A.: B-0735 Danaci M.: B-0591
Cirotto C.: B-0393 Costa D.: B-1016 D’Anastasi M.: B-1264
Citterio F.: B-1136 Costagli M.: B-0082, B-1083 Danes J.: B-0740
Clark T.W.I.: B-0698 Costantini M.: B-0012 Danieli L.: B-0544
Clasen S.: B-0854 Costello P.: B-0779 Danielsson M.: B-0671
Claßen T.: B-0564 Cotroneo A.R.: B-0742 Danilov N.: B-0851
Claudepierre P.: B-1075 Cotten A.: A-695, B-0947 Dankbaar J.W.: B-0815
Claudon M.: A-194 Cottier Y.: B-0146 Danse E.: A-072
Clausen C.: B-0824 Cousins C.: B-0125 Danti M.: B-1280
Clauser P.: B-0116, B-0230, B-0442, B-0615, B-0920 Cousins J.: B-1115 D’Antonio F.: B-1269
Claussen C.D.: A-379, A-553 Couvidat C.: B-0666 d’Archambeau O.: A-183, A-719
Clément O.: A-267 Cova L.: B-0723 Darge K.: B-0894, B-0895
Clemente A.: B-0178 Cova M.A.: A-301, B-0456, B-0629, B-0956 Darweesh A.: B-0979
Coan P.: B-0610 Covello R.: B-0579 Das C.J.: B-0514
Coban G.: B-1273 Covens P.: B-1199 Das D.: B-0651
Cockmartin L.: B-1100 Cowan N.C.: A-042, A-300 Das M.: A-274, B-0600, B-0773, B-0775, B-0782,
Coelho P.V.: B-0360 Cowan R.: B-0662 B-0792
Coenen A.: B-0753 Cozzi D.: B-0887 Datz I.: B-0660
Cohen J.G.: B-0538 Crausaz E.: B-1023 Daunis-i-Estadella J.: B-0500
Colak C.: B-1277 Cremona A.: B-0062 Dauriat G.: B-1255
Colantoni C.: B-0180, B-0182 Cresta F.: B-1131 Davey E.: B-1019
Colella Bisogno M.: B-0889 Criado E.: B-1124 Dávid G.: B-0200
Colletti V.: B-0371 Crinò G.A.: B-1268 Dávid S.: B-0200
Collettin F.: B-0860 Crisi G.: B-0816 David V.: B-0062, B-0978
Collins J.: B-0064 Cristel G.: B-0015 Davies A.: B-0636
Colombi D.: B-0682 Crockett M.: B-1245 Davies G.R.: B-0315
Colombo M.: B-0274 Crosara S.: B-1201 Davydenko P.: B-0630, B-0776

www.myESR.org Final Programme | ECR 2015 321


List of Authors & Co-Authors

de Baère T.: A-117, A-248, B-0718 Degrassi F.: B-0956 Di Paola V.: B-0354, B-1171
de Barros N.: B-0111 Deguelte S.: B-0259 Di Pasquale M.A.: B-1267
de Bazelaire C.: B-0988 Deiva K.: A-064 Di Pastena F.: B-0013
De Belder F.: A-177, A-183, A-512, A-719 del Ciello A.: B-0314, B-0687 Di Perri C.: B-1227
De Blaauw I.: B-0893 Del Forno S.: B-0587 Di Pietropaolo M.: B-0978, B-1050
De Bondt T.: A-580, B-0984, B-1239 Del Guerra A.: K-17 Di Rocco F.: A-685
de Bruijne M.: B-0168, B-1117 Del Maschio A.: B-0015, B-0180, B-0182, B-0251, Diacinti D.: B-0883, B-0884
de Bruin A.B.H.: B-1258 B-0468, B-0471, B-0809, B-0904, B-1172 Diakov I.: B-1132
de Bruin F.: B-0941 Delaloge S.: A-389, B-0718 Diamant I.: B-1040, B-1041
De Cecco C.N.: A-388, B-0051, B-0265, B-0272, Delemer B.: B-1003 Diamantopoulos A.: B-0124
B-0445, B-0474, B-0779, B-0793, B-0794, B-0833, Delgado C.: B-0796 Diao P.: B-0212
B-1233 D’Elia C.: B-1268 Diehl S.J.: A-405
De Chillou C.: B-0472 Della Bella P.: B-0180, B-0182 Diehl V.: A-401
De Cobelli F.: B-0015, B-0180, B-0182, B-0251, Della Latta D.: B-0178 Diehm T.: B-0169, B-0172
B-0471, B-0809, B-0904, B-0967, B-1172, K-14 Della Sala S.W.: B-1280 Diekhoff T.: B-0825, B-1067
De Cobelli O.: B-0560 Delles M.: B-0398 Diepstraten S.C.E.: A-033
De Crescenzo A.: B-0512 Delli Pizzi A.: B-0742 Dierks A.: B-1290
De Felice C.: B-0621 Dell’Oste G.: B-1033 Dietrich A.: B-0980
De Foer B.: A-644 Delmaire C.: B-0503 Dietrich O.: B-0323, B-0556, B-0814
De Franco G.: B-0043, B-1212 Delongchamps N.B.: A-106, A-329 Dietzel F.: B-0351, B-0357
De Fronzo S.: B-0038 Delso G.: B-0320 Dietzel M.: B-0239, B-0242, B-0422, B-0619
De Gaetano A.M.: B-1052 Demetriou S.: B-0293 DiFranco M.: B-0249, B-0917
De Graaf N.: B-0893 Demirag F.: B-0330 Dijkshoorn M.L.: B-0753
de Graaf P.: B-0527 Demondion X.: B-0947 Dijkstra H.: B-0617, B-0624
de Graaf R.: B-0635 den Harder A.M.: B-0270 Dillmann R.: B-0398
De Gregorio M.A.: B-1124 Den Heeten G.J.: B-1027, B-1144 Ding-Reinelt V.: B-0905
de Haan M.: B-0736 Denecke T.: B-0003, B-0011, B-0426, B-0436, B-0905 Dinkel J.: B-0096, B-0991
de Haan S.: B-0143 Deng J.: B-1238 Dinu L.E.: B-0403
de Hooge M.: B-1073, B-1075, B-1076 Deng W.: B-0080 Diogo I.: B-0368
De Jong H.W.: B-0815 Denjoy N.: A-455 Diogo M.C.: B-0199
de Jong M.C.: B-0527 Denton E.: A-748, A-756, B-1026 Dionisi C.: B-0364, B-0366, B-1018, B-1150
de Jong P.A.: B-0270, B-0535, B-0537, B-0540, Denys A.: A-146, B-0256 D’Ippolito G.: B-0841
B-0683, B-1109 Depeursinge A.: B-1088 Discalzi A.: B-0966
de Jonge G.: B-0329 Dequi C.B.: B-0927 Divenuto I.: B-0086, B-0576
De Kerviler E.: B-0187, B-0988 Derbel H.: B-0295 Dixon A.K.: A-314
De Koning H.J.: B-0533, B-0683, B-1109 Derchi L.E.: A-738, B-1011, B-1131 Dmitriev A.: B-0589
de Lange C.: B-0167 Derlin T.: B-0188, B-0974 Dodré E.: B-0947
de las Heras Gala H.: B-0103 Desai S.B.: B-0429 Dodwell D.: B-0014
de Linde D.: B-0143 Desai S.M.: B-0804 Doel T.: B-1111, B-1119
De Maeseneer M.: A-509 Desai S.R.: A-034 Dogan-Ekici I.: B-0221
de Man R.: B-0425 Desbiolles L.: B-0107 Dohan A.: B-0465, B-1106
De Marchi G.: B-0720, B-1287 Deschamps F.: A-248, B-0718 Dolgishin B.: B-1127
De Margerie C.: B-0187 Deserno W.: B-0834 Dolgun Barak A.: B-0581
de Margerie-Mellon C.: B-0988 deSouza N.M.: A-268, A-494 Dolgushin B.: B-0005
De Matteis G.: B-0454 Dessandier V.: B-0867 Dolman K.M.: B-0385
de Mey J.: A-626, B-0106, B-1199 Dettmer S.: B-0451 Dominguez A.: B-0966
De Nicolò A.: B-0230, B-0442 Deux J.-F.: B-0108 Dominguez A.D.: B-0141
De Ridder M.: A-626 Devaraj A.: A-170, K-12 Dominguez-Prado I.: A-709
de Rooy J.: B-0401 Devos A.: B-0893 Donaldson S.B.: B-0662
De Rossi N.: B-0300 Dewes P.: B-0193, B-0539, B-0847, B-1270 Donatelli G.: B-0082
de Ruiter Q.M.B.: B-0270 Dewey M.: A-651, B-0173, B-0176, B-0243, B-0791, Donati F.: B-0010
De Soccio V.: B-0337 LBCT Donati O.F.: B-0559, B-1046
de Vries B.: B-0115 D’Haese J.: B-1187 Donatiello S.: B-0831
De Wever W.: B-0326, B-1254 Dhar R.: B-0333 Donato G.: B-0022
De Wilde L.F.: B-0498, B-0499 Dharmarajah B.: B-0636 Donell S.: B-0637
Debray M.-P.: B-1255 Di Castro E.: B-0050 Dong Q.: B-0493
DeCobelli F.: B-0468 Di Cesare E.: B-1065 Dong Y.: B-0715
Decristoforo C.: B-0305 Di Egidio V.: B-0821, B-0951, B-0957 Donner R.: B-1037
Dedic A.: B-0753 Di Feo D.: B-1150 D’Onofrio M.: A-134, B-1201
Deepalam S.: B-0198 Di Leo G.: B-0397, B-0604, B-0757, B-0897, B-0919, Donoso L.: A-077, A-217, A-344, A-452
Deferme F.: A-580, B-0984 B-0946, B-1175 Dooms C.: B-0326
Defilippi C.: B-0887 Di Martino M.: B-0888, B-1048 Dora C.: B-0641
DeFriend D.: A-138 Di Miscio R.: B-0762, B-0764 D’orazio F.: B-1224
Deganello A.-M.: B-0892 Di Mizio V.: B-0821, B-0951, B-0957 Dörfler A.: A-175, B-0239, B-0422

322 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Dormagen J.B.: B-1196 Edey A.: B-1115 Etxano J.: B-0211, B-0923, B-0926
Dornia C.: B-0060 Edris M.: B-0594 Etz C.: B-0595
Dorrius M.D.: B-0617, B-0624 Edwards M.: B-0401 Euringer W.: B-0064
dos Santos Silva I.: A-224 Egbers J.B.: B-0404 Evangelista L.: B-0018
Dösch C.: B-0391 Egels S.: B-1096 Evanoff M.: B-0208
Dougados M.: B-1073, B-1075, B-1076 Egger C.: B-0848 Evans A.: A-226, A-598
Dousset V.: B-1219 Eggesbø H.B.: B-0552 Evans D.: B-0925
Doyon F.: B-1232 Eghtedari M.: B-0439 Evans D.R.: B-0924
Draeger S.: B-0368 Ehrenfeld M.: B-0378 Evans J.: B-0529
Dratwa C.: B-0766 Ehrmann C.: B-0491 Eveno C.: B-1106
Drelich-Zbroja A.: B-0057 Eibofner F.: B-0854 Ewert P.: B-0596
Drevelegas A.: B-0649 Eichhorn J.: B-0398 Ewertsen C.: A-056
Drevelegas K.: B-0649 Eichinger M.: B-0991 Ezhova R.: B-1081
Dreyer K.J.: A-214, A-750 Eickelberg O.: B-1101
Driesser I.: B-0445 Eieland H.: B-0367 F
Drobni Z.D.: B-0607, B-1061, B-1062 Eikeord E.: B-0708 Faber J.: B-0389
Dromain C.: A-149, A-270, A-389 Eisenblatter M.: B-0931 Faby S.: B-0674
Drop A.: B-0845 Eklöf H.: B-0405, B-0406 Facchini G.: B-0807, B-0831, B-1266
Droshneva I.: B-1234 El Mahdy M.: B-0530 Fadeeva L.: B-0658
Du J.: B-1202 El-Adalany M.A.: B-0876 Fagan A.J.: B-0017
Dubbeldam A.: B-1254 Elattar A.: B-0874 Fagerli K.M.: B-0941
Dube L.: B-0410 El-Diasty M.: B-1013 Fages J.F.: B-1124
Düber C.: B-0389 El-Diasty T.A.E.: A-302, B-1013 Faggioni L.: A-749, B-0269, B-0841
Dubourg B.: B-0953 Elgeti T.: B-0394, B-1250 Faghihi Langroudi T.: B-1057
Dubrulle F.: A-560 Elizalde A.: B-0211, B-0923, B-0926 Faivre J.-B.: B-0336
Dubsky P.: B-1153, B-1160 Elliot T.: B-0662 Falaschi F.: B-0010
Dubuc J.-E.: B-0916 Ellis S.: B-1143 Faletti R.: B-0608, B-0900, B-0966, B-1005
Duchat F.: B-1106 Elmashad A.: B-1079 Falini A.: B-0300
Duddy L.: B-0020 Els H.: B-0194 Falkowski A.: B-0569
Dueber C.: B-0997 Elshafey R.A.: B-0874, B-1079 Fallenberg E.M.: B-0436, K-24
Duerr H.R.: B-0286 Elverici E.: B-0138 Fan L.: B-1112
Duffy S.W.: A-516, B-0069 Elzeawy H.: B-1133 Fandiño E.: B-0955
Dugnani E.: B-1172 Emad Y.: B-0477, B-0640 Fanelli F.: A-427
Duhal R.: B-0503 Emberton M.: B-0967 Fang H.: B-0890
Duhamel A.: B-0852 Emri M.: B-0657 Fanti S.: A-161, A-529
Duijm L.E.M.: B-1027, B-1030, B-1031, B-1032 Engelen T.: B-0025 Fantini C.: B-0978
Duka E.: B-1287 Engelhorn T.: A-175 Farghaly H.: B-0530
Dumas G.: B-0369 Engelken F.: B-0209 Fargun B.: B-0248
Dumpuri P.: B-0855 England A.E.: B-0141, B-0146, B-0149, B-1019, Farina D.: A-040, A-559, B-0174
Dunet V.: B-0185 B-1146 Farrher E.: B-0658
Duran S.: B-0138 Engler A.: B-0088 Farrugia Wismayer E.: B-0142
Durando M.: B-0022 Eom H.-J.: B-0156 Fasching P.A.: B-0206
Duras P.: B-1205 Erb-Eigner K.: B-0543, B-0583 Fasen B.A.C.M.: B-0085
Dürig E.: B-0353 Erickson B.J.: B-1036 Fatehi M.: A-756
Duron S.: B-0128 Erni S.: B-0373, B-0374, B-1070 Faure F.: B-0376
Duryea J.: B-0646 Erol O.B.: B-0388 Faustino M.D.A.F.: B-0360
Dutka I.: B-0660 Errani C.: B-1266 Fausto A.: B-1181
Dutt V.: B-0592 Ertem F.: B-0388 Favelier S.: B-0346
Dwarkasing R.S.: B-0425, B-0839 Ertl-Wagner B.: A-045, A-092, A-220, A-456, A-733, Favia V.: B-1212
Dweck M.R.: A-531 B-0001, B-0036, B-0732, B-0814 Federau C.: B-0940
Dyce S.: B-1038 Ertürk S.M.: A-732 Federici G.F.: B-0978, B-1050
Dziubinska-Basiak M.: B-0656 Eschbach R.: B-0938 Federici M.: B-0343
Eschrich S.: B-0094 Fedorova A.: B-0705
E Escourrou C.: A-106, A-329 Feger S.: B-0176, B-0791
Eandi M.C.: B-0620 Esfandiari E.: B-1252 Feier D.: B-1200
Earl H.: B-0019 Esheba N.: B-0874 Feignoux J.: B-0175
Ebadi J.: B-0148 Esposito A.: B-0180, B-0182, B-0468, B-0471, Fekir A.: B-1275
Ebdon-Jackson S.: A-642 B-0809, B-0904, B-1172 Felblinger J.: B-0472
Eberli D.: B-0559 Esposito G.: B-0742 Fele R.: B-0344
Ebinger M.: B-0381 Essig M.: B-0239, B-0422, B-0500 Felgueiras R.: B-0817
Eckstein F.: B-1069 Esteves B.: B-0362 Fellah L.: B-1088
Eckstein H.-H.: B-0278 Estivalet L.: B-0346 Fellhauer I.: LBCT
Edden R.A.E.: B-1085 Etcheto A.: B-0284 Fellner C.: B-0218
Eder P.: B-0459 Ettlin D.: B-0373, B-0374, B-1070 Feng S.S.J.: B-1098

www.myESR.org Final Programme | ECR 2015 323


List of Authors & Co-Authors

Feng Z.: B-0557 Fornage B.D.: B-0439 Furlan T.: B-0155


Ferda J.: B-0653, B-0756, B-1205 Fornari A.: B-0510, B-0512 Fuschi M.: B-0821, B-0951, B-0957
Fernandes R.M.P.: B-0360 Forrai G.: A-151, A-557 Fusco A.: B-0332
Fernandes V.L.: B-0748 Forsting M.: A-735, B-0026, B-0029, B-0031, B-0786, Fusco C.: B-1268
Fernandez-Bayó J.: A-016 B-1183, B-1230, B-1240, B-1241 Fussenegger S.: B-0917
Ferrante L.: B-0711 Forstner R.: A-370, A-528 Fütterer J.J.: A-027, A-328, B-0706, B-1140
Ferrari R.: B-0738, B-0739 Forte C.: B-1181
Ferreira de Araújo B.M.: B-1042 Forte F.: B-1280 G
Ferreira H.: B-0945 Forte V.: B-0561 Gaballa G.: B-1013
Ferreira R.: B-0147 Foti P.: B-0342 Gabarre J.: B-0158
Ferreira T.A.: A-102 Fournier C.: B-0291 Gabata T.: B-0105
Ferreira V.C.S.: B-0927 Fournier L.: B-0659, B-0666 Gabelloni M.: B-0269
Ferreri G.R.: B-0343 Fragasso G.: B-0904 Gad H.: B-1013
Ferretti G.R.: A-304, B-0538 Fragata I.: B-0199 Gadde J.: B-0507
Ferro F.: B-1274 Fraioli F.: A-262 Gade T.P.: B-0853
Feuchtner G.: A-186, A-670, B-0071, B-0076 Fraire D.: B-0724 Gahine R.: B-0592
Feydy A.: B-0284, B-1073, B-1075, B-1076 Franceschini G.: B-0012 Galassi S.: B-0711
Fiedler E.: B-0655 Franchi-Abella S.: A-483 Galati E.: B-0269
Fieselmann A.: B-1025 Francisco J.: B-0147 Galati M.C.: B-0224
Figueiredo J.P.: B-0945 Franck C.: B-0781 Galea N.: B-0050, B-0054
Figueiredo T.: B-0365 Franco G.: B-0515 Galeone C.: B-0682
Filassi J.R.: B-0111 Franco L.: B-0143 Galia M.: B-0515
Filimonova A.: B-0913 Francone M.: A-185, A-653, B-0050, B-0054 Galié N.: B-0850
Filippiadis D.: A-190 Frank W.: B-0451 Gallardo Estrella L.: B-0683
Filippiadis D.K.: B-0339 Franquet T.: A-303 Gallo G.: B-0163, B-0342
Filippone A.: A-071, B-0742 Franzius C.: A-401 Gallo L.M.: B-0373, B-0374, B-1070
Filli L.: B-0909 Frascà G.M.: B-0711 Gallucci M.: A-510, B-1224
Fillmann N.: B-0372 Fratz S.: B-0596 Galluzzi P.: B-0527
Filonzi G.: B-0807, B-0831, B-1266 Frauenfelder T.: A-098, B-0531, B-1074 Gamarra F.: B-0095
Findeisen H.: B-0480 Freeman A.: B-0967 Gambaccini D.: B-0741
Finkenstaedt T.: B-1074 Freeman S.: A-139 Gandini G.: B-0022, B-0608, B-0900, B-0966, B-1005
Fior D.: B-0274, B-0518, B-0612, B-0774, B-1053, Freitag M.T.: B-0304 Gandy S.J.: B-0466, B-0481
B-1164, B-1166 Freitas P.: B-1016 Ganeshan B.: B-0093, B-0833, B-1196
Fiorelli A.: B-0054 Frellesen C.: B-0193, B-0539, B-0731, B-0847, Gangemi E.: B-0579
Fischbach R.: B-1286 B-1270 Gangi A.: A-187, A-249
Fischer L.: B-0249, B-0911, B-0917 Fretellier N.: B-0710 Ganslandt O.: B-0196, B-0197, B-0419
Fischer M.: B-1268 Freudenthal A.: B-0697 Gantner L.: B-0107
Fischer M.A.: B-0004, B-0100, B-1046 Frevert S.: B-0824 Gao F.: B-0470, B-1085
Fischer R.: B-0225, B-0808 Freyhardt P.: B-0011, B-0905 Gao J.B.: B-0253, B-1118
Fischer S.: B-0847, B-1270 Friedrich K.M.: A-650 Garbay J.-R.: A-389
Fischer T.: A-133, B-0703, B-0825 Fries P.: B-0478, B-1282 Garces E.: B-0403
Fisher M.: B-0044 Frigerio A.: A-240 Garcia A.: B-0403
Fitzgerald K.: B-0466 Frija G.: A-163, A-213, A-263, A-408, A-409, A-453 Garcia Barquin P.: B-0923, B-0926
Flatabo S.: B-0167 Frijns J.H.M.: A-022 Garcia J.: B-0143
Flatz W.: B-0036, B-0732 Frischer J.: B-1087 Garcia Oliver E.: B-0760, B-0765
Flechsig P.: B-0688 Fritsche A.: B-0609 García Poza J.: B-0955
Fleischmann C.: B-0670 Fritz F.: B-0788 García Santos J.M.: B-0482
Flohr T.: B-0676 Frobell R.: B-1071 García-Barquín P.: B-0211
Flor N.: B-0035 Froehlich J.M.: B-0768 Gardarsdottir M.: B-0415
Flores R.: B-0534 Frosini D.: B-0082 Gardarsdottir V.A.: B-0415
Floridi C.: B-0720 Frulio N.: B-0857 Gardavaud F.: B-0108
Flors L.: A-521 Frydrychowicz A.: B-0276 Garel C.: A-127
Floyd A.: B-0258 Fu G.: B-1095 Garnov N.: B-0980
Fodero G.: B-0224 Fu Y.: B-0614 Garske C.: A-397
Fohlen A.: B-1090 Fubelli R.: B-0117, B-0618, B-1179 Garzón Moll G.: B-0061
Foley S.: B-0208, B-0866, B-1024 Fuchsjäger M.H.: A-066, A-155, B-0052, B-0399 Gąsiorowski J.: B-0227
Fongione S.: B-0350 Fueger B.: B-0250, B-1160 Gaspar R.: B-0867
Fonio P.: B-0022, B-0608, B-0966, B-1005 Fugazzola C.: B-0720 Gassner E.-M.: B-1244
Fonseca L.: B-0526 Fujioka T.: B-1162 Gatidis S.: B-0028, B-0381, B-1256
Fontana F.: B-0720, B-1287 Fujisawa Y.: B-0689 Gatti M.: B-0900
Fontebasso E.: B-0364 Fujita N.: B-0431 Gaujoux S.: B-1262
Forina C.: B-1233 Fumero E.: B-0724 Gavazzi E.: B-0174
Forment Navarro M.: B-0760, B-0765 Funovics M.A.: A-288 Gavelli G.: B-0087, B-0246
Formenti A.: B-0626, B-0777 Furer A.: B-0521 Gaxotte V.: B-0903

324 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Gazelle G.S.: B-0750, B-0751 Ginocchi V.: B-0437, B-0918 Grandjean A.: B-1255
Gazhonova V.E.: B-0134 Gioppo A.: B-0170 Granone P.: B-0328
Ge B.H.: B-0698, B-0853, B-0996 Giordano A.: B-0687 Graser A.: A-492, A-677, B-1264
Gebauer B.: A-145, B-0860 Giordano A.V.: B-1224 Grass M.: A-013
Geeroms B.: B-0695 Giordano J.: B-0852 Grassedonio E.: B-0393, B-0899
Geers-van Gemeren S.: A-640 Giovagnoni A.: B-1054 Grasso R.F.: A-247, B-0717
Geffray A.: B-0700 Girardi V.: A-031 Gratama J.W.C.: B-0263
Geissbühler A.: B-1088 Girerd N.: B-0472 Grau V.: B-1111, B-1119
Geith T.: B-0286 Giri S.: B-0272 Graumann O.: B-0872
Geldof M.: A-580, B-0984 Girometti R.: B-0350, B-0743 Graves M.: B-1154
Gellert M.: A-524 Giuliani M.: B-0618, B-1179 Graves M.J.: B-0019
Gemmel P.: B-0144 Giuliani P.: B-0946 Gray C.: B-0055
Gennaro G.: B-0018, B-0238 Giunta N.: B-0046 Graziani R.: B-1236
Genson P.-Y.: B-0346 Giurazza F.: B-1267 Greco F.: B-1235
Gentile F.P.: B-0711 Giuseppetti G.M.: B-0711 Greenspan H.: B-1040, B-1041
Gentiluomo M.: B-0191 Gizewski E.R.: B-0549 Gregori L.M.: B-0066, B-0068, B-0072, B-0075,
Georg D.: A-285, B-0132, B-0352, B-0935, B-1158 Glavak C.: B-0657 B-0338, B-0347, B-0487, B-0573, B-1208, B-1209,
Georg P.: B-0132, B-0935 Gleeson F.: A-689 B-1211, B-1224
Geraldo A.F.: B-0811 Gleeson F.V.: B-1111, B-1119 Grehan J.: B-1142, B-1149, B-1151
Geraldo L.: B-0827 Glitsch A.: B-1130 Greiser A.: B-0052
Geraldo Roig L.: B-0305 Glodny B.: B-0549 Grenacher L.: B-0099, B-0788
Gerami Seresht M.: B-0605 Glüer C.-C.: A-589 Grenier N.: A-139, A-316, A-461, B-1011, B-1289
Gerardin E.: B-0953 Gluud C.: B-0959 Grenier P.A.: A-168, K-16
Gerasia R.: B-0696 Gned D.: B-0030 Greuter M.J.W.: B-0263, B-0264
Gerber C.: B-0491, B-0494 Goehler A.: B-0750, B-0751 Griebel J.: A-581
Gerevini S.: B-0300 Goel I.: B-0885 Grieser C.: B-0003, B-0011, B-0426
Gerken G.: B-1097 Goel S.: B-0302 Grigoriadis N.: B-1087
Germano A.: B-0735 Goetti R.: B-0896 Grigoriev E.: B-0633
Germonpré S.: B-0144 Goh V.J.: A-514, A-624 Grimm J.: A-591, B-0848
Gerrits P.: B-0844 Goh Y.P.: B-0677 Grinberg F.: B-0658
Gevenois P.A.A.: B-0785, B-0987 Gök M.: B-0546 Grindsted J.: B-0948
Geyer C.: B-0931 Goksel O.: B-1039 Gripari P.: B-0467
Geyer L.L.: B-0748 Gola G.: B-0331 Grisk O.: B-1130
Ghadiri A.: B-0875 Goldberg S.N.: A-326 Gritzmann N.: A-276
Ghafoor U.: B-0529 Golfier F.: B-0989 Gröller E.: B-0632
Ghali A.: B-0716 Golfieri R.: B-0587 Grönberg F.: B-0671
Ghaye B.: A-129 Goligher J.: B-0924, B-0925 Grosse Hokamp N.: B-0931
Gherarducci G.: B-0010 Golitsyn S.P.: B-0181 Grosse R.: B-0225
Ghiddi L.: B-0918 Gomes A.: B-0735, B-0864 Grosse U.: B-1256
Ghoshal S.: B-0574 Gomez B.: B-0255, B-0827 Grothoff M.: B-0595
Giancotti A.: B-0520, B-0523 Gómez-Ansón B.: A-199 Grove O.: B-0094
Giannotta M.: B-0850 Gondo T.: B-0555 Groves A.: B-0093
Giardino A.: B-0946 Gong Q.: B-0080 Groves C.: B-0287
Gibaud B.: A-167 Gonulalan U.: B-1273 Gruber G.M.: B-0379, B-0522
Gielen G.: B-0648 Gonzalez de Posada N.: B-1042 Gruber-rouh T.: B-0186
Gielen J.L.M.A.: A-256 Goo D.E.: B-0691 Grueneisen J.: B-0029, B-0031, B-0516, B-0806,
Giepmans W.: B-0106, B-0266 Goo J.M.: A-539, B-0690 B-1183
Gies C.: B-0389 Goraj B.: B-0085 Grünberg K.M.: B-1039
Gieseke J.: B-0648, B-0943, B-1215 Gordic S.: B-0107, B-0268, B-0896 Grüneisen J.: B-1159
Giesel F.: A-466, B-0688 Göricke S.: B-0527 Gryspeerdt E.F.W.: B-0460
Gietema H.A.: B-0540 Gorycki T.: B-0306, B-0719 Gschwendtner A.: A-636
Giganti F.: B-0251, B-0967 Gotlieb M.: B-0119, B-0438 Gu L.-H.: B-0890, B-1202
Giganti M.: B-0838 Goto H.: B-0810 Guan Y.: B-1112
Gigli S.: B-0013 Gottlieb P.: B-0377 Guaraldi G.: B-0316, B-1113
Giglio J.: B-1005 Gottschling S.: B-0655 Guarnaccia C.: B-0966, B-1005
Gigoni R.: B-0010 Gourtsoyianni S.: A-543, A-564 Guarnieri G.: A-718
Gil B.-M.: B-0201 Gourtsoyiannis N.: A-219 Guberina N.: B-0786, B-1240, B-1241
Gilbert F.J.: A-093, A-148, B-0019, B-0757, B-1154, Grabherr S.: B-0848 Gubern Mérida A.: B-0232, B-0233, B-0758
B-1175 Grago J.: B-1069 Gubskiy I.L.: B-0005
Gilles B.: B-0376 Grainger A.J.: A-023 Gudnason V.: B-0415
Gillies R.: B-0094 Gralla J.: B-0813 Gueldner C.: B-0368, B-0727
Gilligan P.: A-430 Gramer B.M.: B-0278, B-0754, B-0797, B-0798 Gueler F.: B-0709, B-1135
Gimenez M.: B-1124 Grams A.E.: B-0549 Gueli A.: B-0512
Ginanni B.: B-0430 Grande Garcia E.: B-0285 Guenoun J.: B-0930

www.myESR.org Final Programme | ECR 2015 325


List of Authors & Co-Authors

Guerini H.: A-587 Hahnemann M.L.: B-0462 Hayakawa M.: B-0541


Guermazi A.: B-0646, B-1069, B-1071 Haider L.: B-1087 Hayton A.: B-0446, B-0783
Guerra C.: B-0707 Haimerl M.: B-0218 He B.: B-0493
Guerreiro J.: B-0146 Hakime A.: B-0718 He Y.-L.: B-1167
Guerrini S.: B-0667, B-1237 Haliloglu M.: A-703 Healy N.A.: B-0231, B-0440, B-1192
Guerrisi A.: B-0579 Halimi P.: B-0376 Hedman M.: B-1058
Guevara Lopez M.A.: B-1042 Halligan S.: A-422 Heeren L.: B-0934
Guggenberger R.: B-0909, B-1074 Hallinan J.: B-0578 Heerink W.J.: B-0329
Guglielmi G.: A-710 Halpenny D.: B-0983 Heffernan E.J.: B-1195
Guidi E.: B-0741, B-0841 Halshtok O.: B-0438 Hegde N.P.: B-0915
Guit G.L.: B-1226 Hametner S.: B-1087 Hegenscheid K.: A-377
Gulati G.: B-0129 Hamilton B.: B-0650 Heggelund T.: B-0037
Gulbrandsen P.: B-0037, B-1259 Hamm B.: A-416, B-0003, B-0063, B-0262, B-0356, Heiberg L.: B-0167
Gulia A.: B-0804 B-0394, B-0426, B-0543, B-0583, B-0728, B-0860, Heiland M.: B-0725
Gulino P.: B-0887 B-0905, B-1250 Heilmaier C.: B-1242
Gulsen F.: B-1204 Hammond R.L.: B-0359 Heindel W.: B-0548, B-0931
Gulya M.O.: B-0789 Han C.H.: B-0292 Heine J.: B-0094
Gumus M.: B-0162 Han J.K.: B-0008, B-0009, B-0423, B-0613, B-1092, Heine M.: B-0934
Gunnar L.: B-0469 B-1121, B-1165, B-1169 Heinzler N.: B-1004
Gunnarsson C.: B-0084 Han L.: B-0890 Heinz-Peer G.: A-207, A-279
Günther R.W.: B-0063, K-31 Han S.: B-1049 Helbich T.H.: A-223, A-496, A-708, B-0132, B-0352,
Guo C.-Y.: B-0761 Han W.: B-0939 B-0444, B-0757, B-0767, B-0920, B-0935, B-1153,
Guo J.: B-0356 Hanbury A.: B-1039 B-1158, B-1160, B-1175
Guo L.: B-0194 Haneder S.: B-0391, B-0801 Helck A.: B-1134
Guo X.: B-1283 Hangaard S.: B-0572 Hélénon O.: B-1011
Guo Y.: B-1110 Hangard C.: B-0571 Hellbach K.: B-0102, B-1101
Gupta A.K.: B-0514 Hanken H.: B-0725 Helle L.: B-1188
Gupta G.: B-0333 Hannon M.: B-1069 Helle M.: B-1223
Gupta S.K.: B-0205 Hansen B.B.: B-0572, B-0948 Helley D.: B-0659
Gupta V.: B-0205, B-0574 Hansen J.: B-0099, B-0788 Helmberger T.K.: A-293, A-321, A-672
Gupta Y.: B-0124 Hansen P.: B-0572, B-0948 Helshtok O.: B-0119
Gutberlet M.: A-289, B-0595, B-1135, K-09 Hansmann J.: B-1276 Hemke R.: B-0385
Gutur Ramkumar P.: B-0479 Hanson E.: B-0708 Hena H.: B-0190
Gutzeit A.: B-0768 Hara H.: B-0810 Henderson I.: A-522
Guvenc C.: B-0326 Hara T.: B-0693 Hendriks B.M.F.: B-0837
Guziński M.: B-0202 Harden S.: A-641 Hendrikse J.: A-237
Gwozdziewicz K.: B-0306, B-0719 Hardie A.D.: B-0779 Hendy E.: B-1142
Gyssels E.: B-0987 Harej M.: B-0155 Henes F.O.O.: B-0558, B-0565, B-0725, B-0974
Häring H.-U.: B-0609 Henkes E.: B-0197, B-0419
H Haroon M.: B-0489 Henkes H.: B-0196, B-0197, B-0412, B-0419, B-0548
Haage P.: A-694, K-23 Haroske G.: B-0353 Henner A.: B-0145
Haapea M.: B-1190 Harsaker V.: B-0361, B-1023 Henninger B.: B-0002, B-0317
Haas M.: B-0356, B-0543 Hart G.: B-0146 Henriksen M.: B-0572
Haas T.: B-0562 Hart M.: B-0428 Henschke C.I.: B-0534
Haase R.: LBCT Harte S.: B-0440 Hensen B.: B-1135
Haberkorn U.: B-0304, B-0688 Hartmann A.: B-0206 Henzler T.: B-0264, B-0390, B-0391, B-0452, B-0598,
Haberland U.: B-0098, B-0773, B-0792 Hartrumpf K.J.: B-1001 B-0631, B-1249, B-1276
Habib N.: B-1128 Hartung D.: B-0709, B-1135 Herbrik M.C.: B-0806
Habicht A.: B-1134 Harz M.: A-225 Herda C.: B-1193
Hacker M.: A-052, A-109 Hasdemir D.B.: B-0999, B-1001 Hérin E.: B-0108
Hadaschik B.: B-0304 Hasenfuß G.: B-0400 Herlihy T.: B-1142, B-1149, B-1151
Haddar S.: B-0295 Hashemi Amroabadi S.M.: B-0780 Herlin G.: B-0044
Hadizadeh D.R.: B-0648, B-0943, B-1215 Hashemi Taheri A.P.: B-0605 Hermann K.-G.A.: A-579, B-1067
Hadlich S.: B-0318 Hassan C.: LBCT Hermans J.: B-0401
Haeberle L.: B-0206 Hassold N.: B-1290 Hermans R.: A-309
Haegele J.: B-0276 Haubenreisser H.: B-0390, B-0391, B-0452, B-0598, Hermoye L.: B-1227
Haesebaert J.: B-0811 B-1276 Hernandez S.: B-0090
Hafkamp G.J.: B-1226 Haug A.: B-0250 Herold C.J.: A-688
Hafslund B.: A-659 Hauge I.H.R.: B-0359 Herranz M.: A-709
Hagar A.: B-0858 Hauge M.: B-0359 Herth F.J.F.: A-635, A-690
Hägele K.: A-400 Hauger O.: B-0291, B-0342 Herzen J.: B-0101, B-0483, B-1012
Hagelstein C.: B-0172, B-1249 Hausmann D.: B-0554, B-1232 Herzyk A.: B-0974
Häggman M.: B-0721 Havla L.: B-0814, B-0938 Hes O.: B-0653
Hahn H.K.: A-225 Havsteen I.: B-0301, B-0958 Hess K.: B-0439

326 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Hetterich H.: B-0001, B-0483 Hong N.: B-0685, B-0952 Hutchinson B.: B-0842
Heubner M.: B-0029, B-0031 Hong S.-J.: B-0288, B-0497 Huttin O.: B-0472
Heusch P.: B-0026, B-0045, B-0092, B-0255, B-0516, Hong S.S.: B-0453, B-0691 Huumonen S.: B-1190
B-0627, B-0806, B-0827, B-1004 Hoogerbrugge N.: B-0228 Huynh M.: B-0677
Heussel C.P.: A-128, A-637, B-0096, B-0450, B-0991 Hoogerwaard A.F.: B-0404 Huyskens J.: A-177
Heußel C.-P.: B-0688, LBCT Hopf N.J.: B-0196 Hwang I.: B-0423
Heußer T.: B-0103, B-0319 Hoppe H.: A-111 Hwang J.H.: B-0453, B-0691
Heuts E.: B-0115 Horenblas S.: B-0033 Hwang J.Y.: B-0691
Heuvelmans M.A.: B-0533 Horgan K.: B-0014 Hyafil F.: B-0484
Hewett L.: B-0396 Horger M.: B-1055, B-1253, B-1256 Hyun S.J.: B-0114
Heye S.: B-0058, B-0695 Hořínek D.: B-1077
Heywang-Köbrunner S.H.: A-517 Horninger W.: B-0305 I
Hibat Allah S.: B-0311 Hornung A.: B-0392 Iacobucci M.: B-0544
Hickmann A.-K.: B-0196 Horsch A.D.: B-0815 Iacovelli N.A.: B-0577
Hiester A.: B-0357 Horsthuis K.: A-421 Iacucci I.: B-0343
Hietschold V.: B-0506, B-1272 Horváth T.: B-0266, B-0607, B-1062 Iaia A.: B-0507
Higashigaito K.: B-0409, B-0531 Horvath-Rizea D.: B-0412 Iannarelli A.: B-0883, B-0884
Highland A.M.: B-0290 Hossein-Foucher C.: B-0852 Iannessi A.: B-0245, B-0519, B-1096
Higueras V.: B-0073 Hosten N.: A-101, A-250, A-374, B-0318, B-0907, Iannicelli E.: B-0978, B-1050
Hild F.: B-0092 B-0908, B-1130 Ichikawa K.: B-0105
Hildebrandt T.: B-0529 Hötker A.M.: B-0348, B-0555, B-1009, B-1010 Ichikawa T.: B-0693, B-1197
Hilton B.: B-1026 Houari F.: B-0158 Idée J.-M.: B-0710
Hinnenthal J.: B-0084 Houssami N.: A-242, A-656, B-0757, B-1175 Ierace T.: B-0723
Hinrichs J.: B-0222 Houston G.: B-0479, B-0481 Ierardi A.M.: B-0720, B-1287
Hipp A.: B-0483 Houston J.G.: B-0466 Iezzi R.: B-0059, B-0121, B-0314, B-1136
Hirner H.: B-0938 Houthoofd S.: B-0058 Igel C.: B-0077, B-0212
Hlavsa J.: B-1126 Howarth N.: A-503 Ihalainen T.: B-0321
Ho C.L.: B-0509 Hricak H.: B-0348, B-0555, B-1009, B-1010, K-27 IJzermans J.: B-0425
Hocaoglu E.: B-0221, B-1277 Hromadka M.: B-0756 Ikeda S.: B-0139
Hocquelet A.: B-0291, B-0857 Hu L.: B-0952 Ikejimba L.: B-1099
Hodler J.: A-312, A-317 Huang B.: B-0715 Iles S.: B-0236, B-0237
Hodneland E.: B-0708 Huang K.H.: B-0340 Ilic D.: B-0126
Hoe J.: A-596 Huang L.J.: B-1283 Ilic V.: B-0185
Hoeffel C.: A-676, B-0259, B-0465, B-1003 Huang M.L.: B-0439 Illarioshkin S.: B-0083
Hoermann R.: B-1244 Huber A.: B-0278, B-0813 Ilsen B.: B-0106
Hoffmann A.L.: B-0091 Huber A.M.: B-0754, B-0797, B-0798 Ilyas S.: B-0125
Hoffmann C.: B-0521, B-0525 Huber B.: B-0671 Imai Y.: B-0693
Hoffmann E.: B-0797 Huber R.M.: B-0095 Imbriaco M.: B-0038
Hoffmann O.: B-1159, B-1183 Huber S.: B-0750 Inchingolo R.: B-1052
Hoffmann R.: B-0854 Hue G.: B-1275 Inci E.: B-0221, B-1277
Hoffmann U.: B-0750, B-0751, B-0755 Hueper K.: B-0709, B-1135 Infante A.: B-0314
Hofheinz R.D.: B-1232 Huet N.: B-0611 Inglot M.: B-0227
Hofmans M.: B-1102 Hughes P.: B-0440, B-1192 Ingold-Heppner B.: A-096
Hofmeijer J.: B-0815 Hugli O.: B-0185 Innocenti E.: B-0179
Hogg P.H.: A-715, B-0141, B-0143, B-1023, B-1026, Hugon-Rodin J.: B-0989 Ioan I.: B-0757
B-1148 Hui T.C.H.: B-0341 Iori M.: B-0918, B-1103
Hohenhorst J.L.: B-0349 Huijsse S.E.M.: B-0263, B-0264 Iotti V.: B-0437, B-0922
Hohl M.: B-0478 Huis in t Veld R.: B-0074 Ipek-Ugay S.: B-0356
Holberg A.: B-0361 Huisman T.A.G.M.: A-239 Ippolito D.: B-0274, B-0308, B-0309, B-0464, B-0518,
Holla M.: B-0401 Huizinga E.: B-1023 B-0612, B-0774, B-0835, B-1053, B-1091, B-1164,
Holland K.: B-0212, B-1028 Hujairi N.P.: B-0069 B-1166
Holohan K.: B-0231 Hulsbergen-van de Kaa C.A.: B-1140 Iqbal A.: B-0924
Hołownia D.: B-0227 Hunink M.G.M.: A-215, A-522 Iranzo V.: A-683
Hölter P.: B-0422 Hunold P.: A-613, B-0276 Ishigami K.: B-0431
Holzer M.: B-1037 Hunt S.J.: B-0853 Ishii K.: B-0298
Homampour S.: B-0780 Hunter D.J.: B-1069 Ishikawa M.: B-0139
Homann G.: B-0402 Huppertz A.: B-0426 Isoda T.: B-0826
Homsi R.: B-1215 Hur J.: A-538, A-540 Itkin M.: B-0853
Honda H.: B-0252, B-0431, B-0826, B-0986 Hurlen P.: B-0037, B-1259 Itou C.: B-0693
Honeyfield L.: B-0517 Husarik D.B.: B-0107, B-0268 Ittrich H.: B-0223
Hong E.A.: B-0763 Hüsers K.: B-0729, B-0731, B-0770 Iudicello M.: B-0030
Hong G.: B-0152 Hussein S.A.: B-1214 Iussich G.: LBCT
Hong J.: B-1125 Husson B.: A-064 Ivkovic A.: B-0992, B-1222
Hong K.C.: B-1285 Hustveit H.: B-1023 Iwata T.: B-0184

www.myESR.org Final Programme | ECR 2015 327


List of Authors & Co-Authors

Izaaryene J.: B-0049, B-1260 Jha A.: B-0296 Kalidos K.: B-0962
Jha P.: B-0192 Kalina I.: B-0070
J Ji Q.: B-0136 Kalisvaart C.J.: B-1226
Jaakkola M.: B-0145 Jiang Y.: B-0685, B-0944, B-1112, B-1118 Kallenberg M.G.: B-0212
Jackson A.: A-166 Jimenez del Toro O.A.: B-1039 Kallio-Pulkkinen S.: B-1190
Jackson S.A.: A-488 Jiménez-Fonseca P.: B-0090 Kaltsi E.: B-0378
Jacob-Heutmann D.: B-0389 Jin C.: B-1110 Kamal H.A.: B-0910
Jacobi V.: B-0186 Jin H.: B-0048 Kamel M.-E.: B-0661, B-1114
Jacobs A.H.: A-048 Jin Y.: B-0021 Kamenicky P.: B-0395
Jacobs C.: B-0540 Jin Z.: B-0939, B-0976 Kamitani T.: B-0986
Jacobs R.: B-0680 Jin Z.-Y.: B-0606, B-1167 Kammer N.N.: B-0273, B-0275, B-0486, B-0822
Jacobsen E.: B-0545 Jinnouchi M.: B-0986 Kamphuis-Van Ulzen K.: B-0203, B-0383
Jacobson J.A.: B-0387, B-0569 Jobke B.: B-1210 Kandel S.: B-0716
Jacquier A.: A-614, B-0049 Jobst B.: LBCT Kanematsu M.: B-1197
Jäger H.R.: A-176, A-259, A-403 Jochelson M.: B-1180 Kang C.H.: B-0288, B-0497
Jagia P.: B-0129 Johannsen F.E.: B-0572 Kang E.-J.: B-0747
Jahoda J.: B-0740 John B.: B-1286 Kang J.: B-0795
Jain R.: B-0500 Johnson K.J.: A-086 Kang Y.H.: B-0153
Jakab A.: B-0522 Johst S.: B-1230 Kannan R.: B-1123
Jäkälä P.: B-1058 Jonas E.: LBCT Kannengießer S.: B-0002, B-0317, B-0554
Jakobs T.F.: A-055 Jones N.: B-0407 Kantarci F.: B-1204
Jakobsen J.Å.: A-756 Joo I.: B-0009, B-0423, B-1092, B-1121 Kantarci M.: A-704
Jalaguier-Coudray A.: B-0766 Jordan E.: A-679 Kapetas P.: B-0444, B-0920, B-1158
James K.: B-0020 Jorge J.: B-0146 Kaposi P.N.: B-0070
James S.L.J.: A-578 Jørgensen D.R.: B-0212 Kappelle J.L.: B-0815
Jang J.: B-0201 Joseph S.: B-0198 Kappelle L.J.: B-0950
Jang M.-S.: B-0709 Jost G.: B-0773 Karacin A.: B-0829
Jang Y.: B-0288 Jowi J.: B-0820 Karani J.B.: A-197
Jang Y.-J.: B-1231 Joyce E.A.: B-0017 Karanikas G.: B-0132, B-0935, B-1158, B-1160
Janig C.M.: B-0399 Jud S.M.: B-0206 Karantanas A.: B-0293
Jankowski A.: B-0538 Junaid I.: B-1133 Karcaaltincaba M.: A-130, B-1198
Jans L.B.O.: A-087 Jung C.S.L.: B-0934 Karch A.: LBCT
Jansen F.H.: B-1031 Jung E.M.: B-1203 Kardeh M.: B-0324
Jansen N.: A-612 Jung H.-Y.: B-1122 Karelskaya N.A.: B-0006
Jansen O.: B-1223 Jung J.-Y.: B-0802 Karimi M.: B-0279, B-0476, B-1252
Janvier A.: B-1003 Jung S.L.: B-0201 Karimi M.A.: B-1057
Jara H.: B-0761 Junghanss T.: B-0424 Karkas A.: B-0369
Jargiello T.: A-549, B-0057 Juras V.: A-650 Karlas T.: B-0980
Jarraya M.: B-0646, B-1071 Justo N.: LBCT Karlinger K.: B-0070
Jaschke W.R.: B-0002, B-0071, B-0076, B-0305, Jüttner B.: B-0709 Karlo C.A.: B-1009, B-1010
B-0317 Juvekar S.L.: B-0804 Karlsson S.: B-0671
Javor D.: B-1170 Karmazanovsky G.G.: B-0006, B-0630, B-0776
Jee W.-H.: B-0802 K Karoly M.: B-1062
Jeevanandham B.: B-0420 K G.: B-0915 Károlyi M.: B-0266
Jegonday M.-A.: B-1090 Kaakinen J.K.: B-1188 Karpenko A.: B-0589
Jenniskens S.F.M.: B-1140 Kaasalainen T.: B-0321 Karssemeijer N.: B-0212, B-0228, B-0232, B-0233,
Jensen C.J.: B-0045 Kabasakal L.: B-1204 B-0758, B-1028
Jensen J.S.: B-1152 Kachelrieß M.: A-141, A-349, A-643, B-0103, B-0319, Karul M.: B-0188, B-1213
Jensen-Kondering U.: B-1223 B-0670, B-0674, B-0675, B-0678 Karumathil Pullara S.: B-1123
Jeon I.: B-0310 Kachenoura N.: B-0395 Kasakura S.: B-0184
Jeon Y.S.: B-1285 Kaczorowski K.: B-0227 Kasi Arunachalam V.: B-0159
Jeong B.C.: B-1141 Kadavigere R.: B-0914 Kasmai B.: B-0637
Jeong J.: B-0453 Kaercher D.: B-0999 Kasprian G.: B-0379, B-0502, B-0522, B-0524
Jeong W.K.: B-1243 Kahn C.E.: A-080, A-756 Kassai Y.: B-0686, B-0964
Jeong Y.K.: B-0135, B-0977 Kahn T.: B-0980 Kassem H.M.: B-0530
Jeong Y.-K.: B-0679 Kaijzel E.L.: A-590 Kastner J.: B-0653
Jereczek-Fossa B.: B-0560 Kainberger F.: B-0249, B-0917 Kathemann S.: B-0462
Jermendy A.L.: B-0607, B-1062 Kaireit T.: B-0039, B-0222, B-0451, B-0999 Kato T.: B-0139
Jermendy G.: B-0607 Kaiser C.G.: B-1161, B-1184 Katorza E.: B-0521, B-0525
Jessop S.A.: B-0146 Kajander S.: A-114, A-654 Katsanos K.: B-0124
Jestin-Mayer G.: B-0710 Kakkar R.: B-0429 Katsari K.: A-585
Jeukens C.R.L.P.: B-0782 Kakollu M.: B-0407 Katsaros V.: B-1227
Jeung M.-Y.: B-0681 Kala P.: B-0665 Katsifarakis D.: A-157
Jeurissen B.: B-1219 Kalender W.A.: A-271, A-744 Katulska K.: A-124, B-0459

328 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Kauczor H.-U.: A-165, A-266, A-634, B-0096, B-0099, Kim D.W.: B-1168 Klingmüller V.: B-0322
B-0398, B-0424, B-0450, B-0480, B-0688, B-0788, Kim E.-K.: B-0114, B-0157, B-0234, B-0881 Klink C.: B-0697, B-0856
B-0991, LBCT Kim E.Y.: B-1084 Kloeckner R.: B-0997
Kaufmann S.: B-1055 Kim G.C.: B-1231 Klompenhouwer E.G.: B-1027, B-1030, B-1031,
Kaul M.: B-0558, B-0934 Kim G.M.: B-0692 B-1032
Kaup M.: B-0088, B-0729, B-0730, B-0731, B-0770, Kim G.R.: B-0881 Klop W.M.C.: B-0025
B-0847 Kim H.-C.: B-1000 Kloppenburg M.: B-1210
Kavgaci H.: B-0829 Kim H.J.: B-0536, B-1168, B-1231 Klos G.: B-1186
Kavroulakis E.: B-0293 Kim H.-J.: B-0453, B-0691 Kloska S.: B-0239
Kawanami S.: B-0252, B-0986 Kim H.S.: B-0504 Kloth C.: B-0402, B-1253, B-1256
Kawashima H.: B-0105 Kim I.: B-0081 Klotz E.: B-0098, B-0613, B-0792, B-0799
Kaya H.: B-1156 Kim I.-O.: B-0886 Kløw N.-E.: B-1196
Kazemier G.: B-0862 Kim J.: B-0647 Klumpp B.: B-0392
Kazmierczak P.M.: B-0938 Kim J.H.: B-0421, B-0501, B-0819, B-1120, B-1169 Knaup M.: B-0670, B-0678
Kecskes K.: B-1064 Kim J.-H.: B-0501 Knebel J.-F.: B-0256
Keil V.C.: B-0648 Kim J.M.: B-0590, B-1265 Knight H.: B-1023
Kekelidze M.: B-0562 Kim J.S.: B-0597 Knobloch G.: B-0905
Kelekis A.D.: A-189, A-246, B-0339 Kim K.A.: B-0007, B-0593 Knoflach M.: B-0549
Kelekis N.: B-0339 Kim K.W.: B-1168 Knogler T.: B-0669
Keller S.: B-0223, B-0225, B-0808 Kim M.D.: B-0692 Knutsson L.: A-402
Kelley D.A.C.: B-1083 Kim M.-D.: B-1265 Knyshov G.: B-0722
Kelly J.: B-1026, B-1148 Kim M.H.: B-0747 Ko J.: B-0983
Kelly K.M.: B-0435 Kim M.J.: B-0114, B-0234 Ko M.-S.: B-0156
Kendler D.: B-0305 Kim M.-J.: LBCT Ko S.M.: B-0597
Kendziorra C.: B-0173, B-0243, B-0791 Kim M.Y.: B-1251 Kobayashi Y.: B-0861
Kenkel D.: B-0909 Kim N.: B-0334, B-0335 Kocer N.: A-182
Kennedy M.J.: B-0017 Kim N.H.: B-0153 Koch J.A.: B-0349
Keravnou C.: B-0636 Kim R.: B-0423 Koelemay M.: A-244
Kerbaol A.: B-0220 Kim S.H.: A-195, B-0423, B-1121, B-1165, B-1173, Koff D.: A-755
Kerl J.M.: B-0731 B-1271 Koh D.-M.: A-674
Kerl M.: B-0088 Kim S.-H.: B-1251 Koizumi J.: B-0693
Kerl M.J.: B-0193 Kim S.J.: B-0504, B-0879, B-0880 Kok E.M.: B-1257, B-1258
Kershaw L.E.: B-0662 Kim S.-J.: B-1173 Kok M.: B-0600, B-0773, B-0775
Kessler E.: B-0854 Kim S.K.: B-0568 Kokovic T.: B-0126
Keßler W.: B-0744 Kim S.M.: B-0790 Kollias K.: B-0550
Keymeulen K.: B-0115, B-0118 Kim S.Y.: B-1049 Kolossváry I.: B-1061
Khaledian L.: B-0148 Kim T.H.: B-0597 Kolossváry M.: B-0266, B-1061, B-1062
Khalil A.: B-1255 Kim W.S.: B-0886 Kolta S.: B-0284
Khalmukhamedova A.E.: B-0134 Kim Y.: B-0416, B-0802 Komárek V.: B-1077
Khan A.M.: B-0748 Kim Y.H.: B-1122 Komarova M.: B-0183, B-0851
Khan M.F.: B-0550 Kim Y.J.: B-0691 Komljenovic D.: B-0313
Khandelwal N.: B-0164, B-0205, B-0574 Kim Y.K.: B-1243 Komnatska I.: B-0660
Khanna J.: B-0979 Kincses T.Z.: B-1077 Kondratyev E.V.: B-0630, B-0776
Khanna M.: B-0190, B-0979 Kind M.: B-0800, B-0803 Konen E.: B-1040, B-1041
Kharabish A.E.: B-0596 Kindermann K.: B-0318 Koning G.: B-0930
Kharlap M.: B-0901 Kinkel K.: A-394, K-03 Kono A.: B-0753
Khayrutdinov E.: B-1261 Kinner S.: B-0031, B-0165, B-0255, B-0462, B-1097, Konopka M.: B-0656
Khazaie K.: B-0933 B-1159, B-1183 Konovalov R.: B-0083
Khodair S.A.Z.: B-0345 Kirchin M.A.: B-0281 Konstantatou E.: B-0892
Khouri Chalouhi C.: B-0170 Kirkham A.: B-0967 Kooijman H.: B-0273, B-0486, B-0822
Khrichenko D.: B-0894 Kiss J.: B-0070 Kooijman-Kurfuerst H.: B-0275
Khung S.: B-0336 Kitagawa K.: A-471, A-595 Kool D.R.: A-477
Kickuth R.: B-1290 Kitamura Y.: B-0826 Koopmanschap D.H.J.L.: B-0203, B-0383
Kiefer T.: B-1067 Kitslaar P.: B-0266, B-1061 Koops A.: B-1286
Kienle P.: B-1232 Kittner T.: B-0353 Kooraki S.: B-0605, B-0875
Kiessling F.M.A.: A-561 Kivistö S.H.: B-0145 Kopp F.: B-0285
Kietselaer B.L.J.H.: B-0600, B-0775 Klang E.: B-0119, B-1040, B-1041 Koprivsek K.: A-663
Kijowski R.: B-1216 Klasa L.: B-0668 Kornienko V.: B-0658
Kilburn-Toppin F.: B-1029 Klauser A.: A-341, A-697, B-0071, B-0076 Koshida K.: B-0105
Kilic I.-B.: B-0426 Klauß M.: B-0788 Koshy S.M.: B-0962
Kilickesmez O.: B-1277 Klein S.: B-0244 Koskinen S.: B-0405
Kim B.H.: B-0288, B-0497 Klein W.M.: B-0203, B-0383 Kosucu P.: B-0829
Kim B.-S.: B-0201 KleinJan G.H.: B-0025, B-0033 Kotek G.: B-0930
Kim C.K.: B-0133, B-1006, B-1141 Klemenčič T.: B-0150 Kotiaho A.: B-0145

www.myESR.org Final Programme | ECR 2015 329


List of Authors & Co-Authors

Kotter E.: B-1193 Kulkarni A.: B-0855 Landgraeber S.: B-0564


Kotzerke J.: B-0513 Kulkarni C.B.: B-1123 Lang A.: LBCT
Kovacs A.: B-0657 Kumar A.: B-0205 Lang E.: B-0194
Kovács B.: B-0070 Kumar D.: B-0979 Lang H.: B-0661, B-1278
Kovacs G.: B-0052, B-0399 Kumar GG S.: B-1078 Lang K.: B-0921
Kowallick J.T.: B-0400 Kumar S.: B-0407 Lang S.: B-0422
Kowalska B.: B-0154 Kuntz J.: A-012, B-0670 Lange B.: B-0828
Koyama H.: B-0686, B-0689, B-0937, B-0982 Kunz W.G.: B-0814 Langer M.: A-473, B-0064, B-1193
Kozák L.R.: B-0200 Kuo W.: B-0168, B-1117 Langner I.: B-0907, B-0908
Kozics D.: B-0070 Kupcs K.: B-0818 Langner S.: A-254, A-414, B-0907, B-0908
Kozma P.: B-0173 Kupczyk P.A.: B-0943 Langs G.: B-0249, B-0502, B-0522, B-0911, B-0917,
Kraai M.: B-0404 Küpeli A.: B-0829 B-1037, B-1039
Kraff O.: B-0563, B-0564, B-0566, B-1230 Kurata A.: B-0753 Laniado M.: B-0513, B-1272
Krainik A.: B-0369 Kurre W.: B-0196, B-0197, B-0412, B-0419, B-0548 Lantuejoul S.: B-0538
Kramer G.: A-044 Kurucz P.: B-0196 Lanza E.: B-0307
Kramer H.: B-0001 Kusk M.W.: B-0863, B-1015 Lanzman R.S.: B-0449, B-0627, B-1004
Kramer J.: A-506 Kutty S.: B-0400 Laqmani A.: B-0974
Kramer U.: B-0392 Kuusela L.J.: B-0321 Larbcharoensub N.: B-1093
Krammer J.: B-1161, B-1180, B-1184 Kwa T.: B-0231 Larbi A.: B-0916
Kratochwil C.: A-466 Kwak H.: B-0413 Lardenoije S.: B-0232, B-0233
Kraus T.: B-0188 Kwak J.Y.: B-0157, B-0881 Larici A.R.: A-273, A-475, A-571, B-0314, B-0687
Krause D.: B-0346 Kwoh C.K.: B-1069 Larina O.: B-0901
Krauspe R.: B-0936 Kwon G.Y.: B-1141 Lario C.V.: B-0510, B-0512
Krauss B.: B-0676 Kwon H.J.: B-0747 Larsen L.B.: B-1025
Krautschneider W.: B-1286 Kwon J.H.: B-0081 Larson A.C.: B-0932, B-0933
Krawinkel A.: B-0638 Kwon J.Y.: B-0769 Lassau N.: A-135
Krebs A.: B-0905 Kwon W.J.: B-0532 Lasserre A.S.: B-1289
Kremser C.: B-0002, B-0317 Kynčl M.: B-1077 Lassmann H.: B-1087
Krenn M.: B-1039 Kyotani K.: B-0964 Latson L.: B-0983
Krestan C.R.: A-333 Lattanzi R.: B-0821, B-0951, B-0957
Krestin G.P.: A-158, A-251, B-0839, B-0930 L Lau K.K.P.: B-0280, B-0677
Kreuter M.: B-0991 La Fougère C.: B-0024, B-0028, B-0381 Lau T.: B-0280
Kreuzberg B.: B-0756 La Grutta L.: B-0515 Laudemann K.: B-0389
Krishnankutty Nair R.: B-0962 La Marra A.: B-0066, B-0068, B-0072, B-0075, Lauenstein T.C.: B-0026, B-0029, B-0031, B-0255,
Kristensen J.: B-0959 B-0338, B-0347, B-0487, B-0573, B-1208, B-1209, B-0462, B-0564, B-0806, B-0827, B-1097, B-1230
Kroencke T.J.: A-357, A-692 B-1211 Lauer H.C.: B-0372
Kroiss A.: B-0305 La Tona G.: B-0505 Laule M.: B-0176
Krokidis M.: A-433, A-693, B-0125, B-0127 La Vecchia C.: B-0682 Laurent F.: B-0538
Krombach G.A.: B-0053, B-0599 Laader A.: B-1230 Laureys S.: B-1219, B-1227
Kromen W.: B-0847 Labani A.: B-0672, B-0681, B-1278 Lauridsen C.: B-0824
Kronnerwetter C.: B-0942 Labori K.J.: B-1196 Lauritzen P.M.: B-0037, B-1259
Kröpfl D.: B-0349 Labriffe M.: B-0195 Lavdas I.: B-0517
Kröpil P.: B-0449, B-0627, B-1004 Ladjevardi S.: B-0721 Lavini C.: B-0385
Krotenkova M.: B-0083 Laffranchi F.: B-0174 Law E.K.C.: B-0370
Krüger P.-C.: A-101, B-0908 Lagadec M.: B-1262 Law M.: B-1248
Krumm P.: B-0392 Laghi A.: B-0738, B-0739, B-0772, B-0833, B-1233 Lazik A.: B-0563, B-0564, B-0566
Ku Y.-M.: B-0590 Lahaye M.J.: B-0737, B-1229 Le Pennec V.: B-1090
Kubik-Huch R.A.: A-391 Laissy J.-P.: B-0903 Le Rhun E.: B-0503
Kubota K.: B-1162 Lalam R.: A-257 Le T.B.: B-1285
Kuchcinski G.: B-0503 Laleman W.: B-0695 Lebedev S.: B-0678
Kuchenbecker S.: B-0674 Lalisse M.: B-0503 Leber A.: B-0754, B-0797, B-0798
Kucukgergin C.: B-0221 Lamata P.: B-0400 Leber V.: B-0754, B-0797, B-0798
Kuganesan A.: B-0280, B-0677 Lambert J.: B-0988 Lebras Y.: B-1289
Kuhl C.K.: A-094, A-153, B-0701 Lambert L.: B-0740 Leccisotti L.: B-0687
Kuhlin B.: B-0417 Lambert M.A.: B-0466, B-0481 Lechel U.: B-0169, B-1241
Kühn J.-P.: B-0318, B-0744, B-1130 Lambert S.: B-0894 Leclerc X.: B-0503
Kuijpers T.W.: B-0385 Lambregts D.M.J.: A-618, B-0832, B-0837, B-1094, LeCompte L.: B-0894
Kuijs V.: B-0113 B-1229 Leconte I.: B-1088
Kuismin U.: B-0145 Lamki S.: B-0124 Lecuru F.: B-0666
Kukuk G.M.: B-0943, B-1215 Lammer J.: A-362 Lederlin M.: B-0538
Kukushkin A.: B-1127 Lammers J.-W.J.: B-0683, B-1109 Ledoux J.-B.: B-0940
Kule H.: B-0577 Lamot U.: B-0155 Lee C.H.: B-0007, B-0593
Kulikova O.: B-0901 Lança C.: B-0143 Lee D.: B-0310
Kulitzscher B.: A-398 Landewé R.: B-0941 Lee D.H.: B-0840, B-1051

330 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Lee D.Y.: B-0692 Lesyuk O.: B-0365, B-1021 Liukkonen E.: B-1190
Lee E.: B-0647, B-0691 Levrini G.: B-0922 Liuzzi R.: B-0038
Lee E.S.: B-0423 Levy R.: B-1275 Ljubisavljevic S.: B-0079
Lee H.: B-0109 Lewandowski R.J.: B-0933 Llopis E.: A-588, B-0073
Lee H.C.: B-1049 Lewerich B.: A-378, A-399 Lo Bello M.: B-0724
Lee H.-K.: B-0568 Ley S.: B-0398 Lo Bue G.: B-1236
Lee H.Y.: B-0153 Leygnac S.: B-1255 Lo J.: B-1099
Lee J.: B-0007, B-0593, B-0769 Li F.: B-0080, B-0890 Lo Russo F.: B-0809
Lee J.B.: B-0679 Li F.-H.: B-1202 Lobbes M.: A-269, B-0113, B-0115, B-0118
Lee J.H.: B-0135, B-0156, B-0157, B-0532, B-0690, Li H.: B-0944, B-1279 Loberg C.: B-0701
B-0886, B-0977, B-1000, B-1120 Li L.: B-1007 Loeckx D.: B-1219
Lee J.-H.: B-0747 Li M.: B-0036, B-0732 Loegager V.: B-0960, B-0968
Lee J.M.: B-0008, B-0009, B-0423, B-0613, B-0679, Li P.: B-1283 Loewe C.: A-699, B-0177, B-0632
B-1051, B-1092, B-1169 Li T.: B-1118 Loffroy R.: B-0346
Lee K.: B-0413 Li X.: B-0836, B-0976 Logager V.: A-107, B-0461
Lee K.H.: B-0161, B-0733 Li Y.: B-1110 Loguercio M.: B-0467
Lee K.-N.: B-0747 Liang S.: B-0578 Loh T.: B-0578
Lee K.S.: A-537 Liao W.: B-0080 Lollert A.: B-0389
Lee M.J.: A-445 Liberali S.: B-0764 Lomax S.: B-1038
Lee N.: B-0287 Liberati D.: B-1172 Lombardi M.: B-0511, B-0576
Lee S.: B-0427, B-0508 Liccardo I.: B-0038 Lombardi S.: B-0464
Lee S.A.: B-0288, B-0497 Lichtinghagen R.: B-0709 Lomovtseva K.K.: B-0006
Lee S.J.: B-0692, B-1049 Liebergall M.: B-0248 Loney E.: A-021
Lee S.-L.: B-0590 Liebig T.: B-0545 Longo D.L.: A-406
Lee S.M.: B-0334, B-0335, B-0690, B-0886 Ligabue G.: B-0316, B-1113 Longo F.: B-0900
Lee S.W.: B-0334, B-0335 Lightfoot C.B.: B-0236, B-0237 Lonn L.: B-0824
Lee S.Y.: B-0568 Liguori T.L.: B-0178 Lönnemark M.: B-0721
Lee T.Y.: B-1271 Lilholm M.: B-0212 Loose R.W.R.: A-376
Lee V.: B-1248 Lilholt H.J.: B-0828 Lopci E.: B-0027, B-0307
Lee W.J.: B-1243 Lillholm M.: B-0077 Lopes Dias J.: A-196, B-0137
Lee Y.S.: B-1049 Lim A.: B-0112 Lopes F.: B-1016
Leehy N.: B-0578 Lim A.K.P.: A-136 Lopes N.: B-0147
Leen E.: B-0636 Lim H.K.: B-0453 Lópes R.: B-0503
Lefebvre G.: B-0947 Lim J.: B-0283 Lopez A.: B-0458
Lefort M.: B-0158 Lim J.W.: B-0840 Lopez Rendon X.: B-0787
Legou F.: B-0108 Lim J.Y.: B-0153 Lorenzoni A.: B-1054
Legrand L.: B-0336 Lim M.K.: B-0153 Lori N.: B-0526
Lehmann H.: B-0044 Lim S.H.: B-1243 Lorusso F.: B-0043
Lehnert T.: B-0372, B-0428, B-0730, B-0770 Lim T.-H.: A-536, B-0795 Löschmann Y.: B-1250
Leichsenring C.: B-0735 Lim Y.-J.: B-1173 Losio C.: B-0015
Leichter I.: B-0104, B-0248 Lim Y.-S.: B-1049 Lotter M.: B-1149
Leidecker C.: K-30 Lima E.N.P.: B-0830 Lotz J.: B-0400
Leidner B.: B-0100 Limbu H.H.: B-0253 Lourido D.: B-0955
Leijtens J.: B-0834 Lin J.: B-0570 Louwman M.W.: B-1031
Leiner T.: A-291, B-0270, B-0755 Lin S.: B-0370 Lovblad K.-O.: A-181
Leipsic J.: B-1113 Linda A.: A-741, B-0116 Low K.Y.: B-0677
Leitgeb N.: A-432 Lindell E.: B-0386 Löwik C.W.G.M.: A-590
Leithner D.: B-1153 Linder F.: B-0405, B-0406 Lu A.: B-0982
Lell M.: A-372, B-0242, B-0674, B-0675 Linder N.: B-0980 Lu J.: B-0065
Lemaitre L.: B-1011 Lindner A.: B-0419 Lu M.: B-0492
Lembcke A.: B-0262 Lindner T.: B-1223 Lubbers M.M.: B-0753
Lencioni R.: A-295, A-569 Linke K.: B-0459 Lubner M.: B-0974
Lentschig M.: A-401 Linsenmaier U.: A-061, A-297 Luca A.: B-0163, B-0277, B-0696
Lenzen H.: B-0222 Linz D.: B-0478 Lucas R.N.: B-0137
Leonardi B.: B-0166 Lipschuetz T.: B-0104 Lucatelli P.: B-0993
Leone F.: B-1164, B-1166 Liro M.: B-0668 Lucchina N.: B-1287
Leone M.B.: B-0850 Lisachenko I.: B-0913 Luciani A.: B-0108
Leong L.: B-0207 Lishmanov Y.B.: B-0789 Luciani M.L.: B-0621, B-0762, B-0764
Leppek R.: B-0727 Littleford R.: B-0481 Lucic M.A.: A-082, A-261
Leppink J.: B-1258 Liu Q.: B-0065 Lucidarme O.: B-0158, B-0311, B-1096
Lequin M.: B-0893 Liu S.: B-0944, B-1072, B-1112 Lücke C.: A-470
Leroy V.: B-0611 Liu X.: B-0625, B-0671 Ludvík J.: B-1205
Leschka S.: A-706, B-0107, B-0268, B-0772 Liu X.-S.: B-1202 Ludvik M.: A-428
Leschka S.C.: B-0303 Liu Y.: A-493, B-0094, B-0685 Lüers G.: B-1213

www.myESR.org Final Programme | ECR 2015 331


List of Authors & Co-Authors

Luhur R.: B-0262 Mahdavirad H.: B-0476 Marcon M.: B-0116, B-0615
Lui S.: B-0080 Maher M.M.: A-489, B-0171, B-0447, B-0448, B-0455 Marconi M.: B-0343
Luk M.Y.: B-1248 Mahesh M.: A-746 Maresky H.S.: B-0377
Lukyanchenko A.: B-0432 Mahfoud F.: B-0478 Margarita B.: B-0286
Lumish H.: B-0751 Mahlke C.: B-1130 Mariani A.: B-0191
Luna A.: B-0902 Mahmoud M.: B-0958 Mariani S.: B-0066, B-0068, B-0072, B-0075, B-0338,
Lund G.: B-0898 Mahnken A.H.: B-0322 B-0347, B-0487, B-0573, B-1208, B-1209, B-1211
Lundbom N.: B-1188 Maier A.: A-615 Marias K.: B-0832
Lundell L.: B-0044 Maier J.: B-0258 Marie P.-Y.: B-0472
Lundervold A.: B-0708 Maieron M.: B-0615 Marignani M.: B-1050
Lundsgaard M.: B-0824 Maiettini D.: B-1268 Marijnissen A.-K.: B-1210
Luo B.: B-0823 Mainovskaya O.: B-1234 Marin M.A.: B-0403
Luo X.: B-0217 Maira A.: B-0343 Marinova M.: B-0943
Luo Y.: B-1206 Makanyanga J.: B-0460 Mariscotti G.: B-0022
Lupo F.A.: B-0454 Mäkelä T.: B-0321 Markali B.: B-0146
Lupo P.: B-0454 Makowski M.: B-0905 Markhardt B.K.: B-1216
Lupsor-Platon M.: B-1200 Maksimovic R.: B-0016 Markiet K.: B-0154
Lurie D.J.: A-627, B-0315 Malamateniou C.: A-661 Markl M.: B-0064
Lutat C.: B-0039, B-0999 Malavasi S.: B-0246 Markonis D.: B-1037
Lutz B.: B-0278 Malekzadeh R.: B-0605 Maroldi R.: A-278, A-645, B-0174, B-1089
Lv F.: B-0254 Malekzadeh S.: B-1114 Marom E.: B-0842
Lynch J.: B-0646 Maleux G.: B-0058, B-0695 Marra P.: B-1172
Lyons J.: B-0662 Malgorzata S.: B-1177 Marraccini P.: B-0269
Lysák D.: B-1205 Mali W.P.T.M.: B-0533, B-0601 Marrelli D.: B-0667
Maliakas V.: B-0702 Marsden M.E.R.: B-0408
M Malich A.: B-0553, B-0969, B-1034, B-1194 Marshall N.: B-0020, B-1102
Ma J.: B-1110 Malik A.B.: B-0349 Marshall N.W.: B-1100
Ma S.: B-0939 Malikova M.: B-0761 Marstrand J.: B-0301
Ma W.: B-1148 Malkowski B.: B-0306 Marten-Engelke K.: A-519
Ma Y.B.: B-0021 Maller V.V.: B-0973 Martens M.: B-0834
Maalej A.: B-0295 Malone D.E.: B-1195 Martens M.H.: B-0832
Maas A.: B-0294 Maltzeff N.: B-0062 Martí de Gracia M.: B-0061
Maas M.: A-222, A-544, A-577, A-659, B-0385, Malva M.: B-0865 Martí R.: B-0232
B-0567, B-0737, B-0832, B-0834, B-0836 Maly Sundgren P.C.: A-084, A-366, A-687 Martí-Bonmatí L.: A-583, K-15
Maataoui A.: B-0550 Mamoun I.: B-1133 Martin Noguerol T.: B-0902
Mac Mahon P.: B-1245 Manabe T.: B-0139 Martin Suarez S.: B-0850
Macaigne V.: B-0953, B-1275 Manavaki R.: B-1154 Martin V.: B-1177
Maccabelli G.: B-0180, B-0182 Mancini A.: B-0068, B-1065 Martincich L.: B-0620
Maccagni D.: B-1017 Mancini P.: B-0343 Martin-Duverneuil N.: A-560
Maccari P.: B-1181 Manciocco V.: B-0579 Martineau A.: B-0988
Macchi E.: B-1287 Mandolesi A.: B-1054 Martinez de la Haza D.: B-0090
Maccioni F.: A-423, B-0041 Mandry D.: B-0472 Martinez Gómez I.: B-0760, B-0765
MacGillivray T.: B-0055 Manenti G.: B-0561 Martinez Rubio C.: B-0760, B-0765
Machann J.: B-0609 Manfredi R.: A-004, A-074, A-322, B-0354, B-1171, Martínez-Miravete P.: B-0211, B-0923, B-0926
Machnikowska-Sokolowska M.: B-0656 B-1174 Martini K.: B-0531
Mack M.G.: A-038, A-375 Manganaro L.: B-0140, B-0520, B-0523 Martino A.: B-0611
MacKay J.W.: B-0637 Mangold S.: B-0051, B-0272, B-0445, B-0752 Martino G.: B-1212
MacRae A.: B-0194 Manikis G.C.: B-0832 Martinoli C.: B-0071, B-0076, B-0496, B-0642,
Macron L.: B-0175 Manipadam M.T.: B-0882 B-0643, B-0644, B-0805
Maderwald S.: B-1230 Manka R.: A-116, A-472, B-0896 Martins N.: B-0945
Maeda T.: B-0810 Mann P.: B-0103 Maruoka Y.: B-0826
Maeder P.: B-0527 Mann R.M.: A-227, A-633, B-0228, B-0232, B-0233, Maruzzelli L.: B-0163, B-0696
Maegerlein C.: B-0278 B-0758, B-1028 Marzi S.: B-0579, B-1233
Magee L.V.: B-0868 Manoliou A.: B-1074 Masarwah A.N.J.: B-0210
Magerkurth O.: B-0387, B-0569 Manoliu A.: B-0373, B-0374, B-1070 Masciocchi C.: B-0066, B-0068, B-0072, B-0075,
Maggio S.: B-0277 Manos D.: B-0097 B-0338, B-0347, B-0487, B-0573, B-1065, B-1208,
Maglione F.: B-1267 Mansour R.: B-0069 B-1209, B-1211
Magne N.: B-0953 Mantarro A.: B-0741 Mashaly E.: B-0345
Magnusson A.: A-041, B-0721 Mao F.: B-0715 Maslov L.N.: B-0789
Magometschnigg H.: B-0767, B-1158, B-1160 Mao Y.: B-0254 Massimo B.: B-0350
Magyar P.: B-0070 Marano R.: A-542, A-669 Massimo G.: B-0805
Mahajan A.: B-0205 Marcelin C.: B-1289 Massmann A.: B-0478, B-1282, B-1284
Mahajan M.D.: B-0429, B-0915, B-1078 Marchiano A.: B-0682 Masterson L.: B-1017, B-1024
Mahajan P.S.: B-1207, B-1214 Marckmann G.: A-553 Matheoud R.: B-0664

332 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Mathers S.: A-523 Meijer F.J.A.: B-0085 Mihl C.: B-0600, B-0773, B-0775
Mathieu M.-C.: A-270 Meijer S.: B-0862 Mikaszewski B.: B-0154
Mathuriya S.N.: B-0205 Meijerink M.R.: B-0862 Mikines K.: B-0968
Matin T.N.H.: B-1111, B-1119 Meineke A.: B-0449 Mildenberger P.: A-078, A-457, A-747, B-1186
Matos C.: A-073, A-487 Meinel F.G.: B-0102, B-0265, B-0323, B-0445, Miller A.B.: A-241
Matouskova T.: B-0756 B-0628, B-0748, B-0752, B-0793, B-0794, B-1101 Milles J.: B-0106, B-0567
Matsubara K.: B-0105 Meisinger C.: B-0001 Millican-Slater R.: B-0014
Matsumaru Y.: B-0541 Mejean A.: B-0659 Millington S.: B-1026, B-1148
Matsumoto K.: B-0555 Mekiš N.: B-0150, B-1022 Millor M.: B-0923, B-0926
Matsumoto S.: B-0686, B-0689, B-0937, B-0982 Melchiorre F.: B-0170, B-1124 Millor Muruzábal M.: B-0211
Matsunaga N.: B-1197 Melees M.: B-0874 Milne H.: B-0149
Matthew W.G.: B-0019 Melendez J.: B-0232 Milos R.-I.: B-0444
Mattiuz C.: B-0488 Melendres G.: B-0192 Milosavljevic T.: B-0992, B-1222
Mauge L.: B-0659 Meliadò G.: B-0216, B-1157 Milosevic Z.: B-0016
Maurer M.H.: B-0860 Melis L.: B-0344 Mincarelli C.: B-1054
Mauri G.: B-0723, B-1124 Melleiro C.: B-0297 Mineiro J.D.: B-0945
Maurovich-Horvat P.: B-0266, B-0607, B-1061, Mellerio C.: B-0023 Minicucci L.: B-1131
B-1062 Melo J.I.F.D.: B-1139 Minisola S.: B-0883, B-0884
Maurus S.: B-0273 Meloni A.: B-0046, B-0226, B-0393, B-0899 Minutolo O.: B-0309, B-0774, B-0835
Maus J.: B-0513 Mendelson D.S.: B-1036 Miraglia R.: B-0163, B-0696
Mawrin C.: B-0655 Mendelson R.M.: A-620 Miranda I.: B-0441
Maxeiner A.: B-0703 Méndez J.C.: B-0955 Mironova N.: B-0181
Mayer F.: A-375 Mengel M.: B-1135 Mirsadraee S.: B-0055
Mayer J.-F.: B-0710 Mensel B.: B-0318, B-0744, B-1130 Misirli M.: B-0734
Mayerhoefer M.E.: B-0669 Menu Y.: A-546, A-679, A-683 Missere M.: B-0393
Mayo-Smith W.W.: A-282 Menys A.: B-0460 Mistelbauer G.: B-0632
Mayrhofer T.: B-0751 Mera D.: B-0796 Mitchell D.P.: B-1245
Mazaheri Y.: B-0348, B-0555, B-1010 Meradji M.: B-0893 Mittal B.R.: B-0574
Mazonakis M.: B-0241 Merat S.: B-0605 Mitter C.: B-0379
Mazza E.: B-0251 Mercer C.E.: B-1026 Miyamoto H.: B-0071
Mazzamurro F.: B-0041 Merchan L.: B-1098 Miyasaka M.: B-0252
Mazzei F.G.: B-0667, B-1237 Mercuri P.: B-1237 Miyazaki M.: B-0937, B-0982
Mazzei M.A.: B-0667, B-1237 Merkely B.: B-0266, B-0607, B-1061, B-1062, B-1064 Mizandari M.: B-1128
Mazzoni L.: B-0325 Merli I.: B-0990 Mochizuki T.: B-1197
Mc Fadden S.: A-345 Mershin K.: B-0851 Modregger P.: B-0746
McCall I.W.: A-068, K-22 Mershina E.A.: B-0183, B-0473, B-0851, B-0901 Moelker A.: B-0697, B-0856
McDougall E.E.: B-0236 Mertelmeier T.: B-1025 Moerup S.: B-0872
McGowan D.R.: B-1119 Messana D.: B-0046, B-0226 Mogensen H.: B-1152
McGrath C.: A-628 Messina C.: B-0946, B-0990 Mohamed Hoesein F.A.A.: B-0683, B-1109
McGurk S.: B-0386 Messina M.: B-1005 Moio A.: B-0807
McHugo J.: A-392 Messmer-Wullen M.: A-740 Molfetta L.: B-0642
McKean D.: B-0069 Metaxa L.: B-0207 Molinari F.: A-099
McKinnon T.: B-0636 Metens T.: A-745 Moll A.: B-0527
McKnight L.: A-682 Meuli R.: B-0185, B-0256 Møller-Madsen B.: B-0247
McLaren C.: B-1024 Meuwly J.-Y.: B-1011 Moloney F.: B-0171
McLean M.A.: B-0019, B-1154 Mews J.: B-0261, B-0262 Momoniat H.: B-1146
McMahon M.: B-0014 Meyer B.: B-0999 Monfardini L.: B-1124
McMorrow J.P.: B-0017 Meyer B.C.: B-1001 Monnier L.: B-0465
McNulty J.: A-573, B-1017, K-07 Meyer H.: B-0243 Monssen J.A.: B-0708
McQuiston A.: B-0265 Meyer M.: B-0264, B-0452, B-0598 Montauban van Swijndregt A.: B-0736
McWilliams R.G.: B-0712 Mezzanotte L.: A-590 Monteleone A.: B-0178
Meaney J.F.: B-0017 Michel B.: B-1074 Montemezzi S.: B-0216, B-0961, B-1157, LBCT
Mechl M.: K-29 Michell M.J.: B-0924, B-0925 Montet X.: K-11
Meckel S.: B-0303 Michelozzi C.: B-1124 Monti L.: B-0889, B-1236
Meder J.F.: B-0297 Michoux N.: B-1088 Montlahuc C.: B-0988
Meder J.-F.: B-0023 Middeldorp S.: B-0844 Montorsi P.: B-0777
Medici M.: B-0538, B-0611 Middendorp M.: B-0550 Moon H.J.: B-0114
Medvedeva B.: B-0432 Midiri F.: B-0515 Moon M.H.: B-1285
Mehndiratta A.: A-466 Midiri M.: B-0393, B-0505, B-0507, B-0515, B-0899 Moon S.J.: B-1231
Mehrabi S.: B-1171, B-1174 Miele V.: A-122 Moon S.K.: B-0840
Mehrian P.: B-1252 Miese F.: B-0936, B-1068 Moore C.M.: B-0967
Meier M.: B-1135 Migazzo E.: B-0086 Moore N.: B-0448
Meierhofer C.: B-0596 Miglāne E.: B-0818 Moorthy S.: B-1123
Meier-Meitinger M.: B-0206 Miglio E.: B-0762, B-0764 Moosdorff M.: B-0113

www.myESR.org Final Programme | ECR 2015 333


List of Authors & Co-Authors

Morales Vargas A.M.: B-0061 Murphy J.: B-0020 Nelemans P.J.: B-0091
Morasca A.: B-1269 Murphy K.: B-0447, B-0448, B-0455 Nemec U.: B-0379
Moreau-Gaudry A.: B-0611 Murphy R.: B-1149 Nenning K.-H.: B-0502
Morel J.: B-0924, B-0925 Murray M.P.: B-1180 Nensa F.: B-0045, B-0827
Morelli J.N.: B-0554 Murray P.: B-0637 Nerad E.: B-0737, B-1229
Moreschi L.: B-0707 Murtaza A.: B-0213 Nergården M.: B-0921
Morgan D.: B-0281 Mus R.D.M.: B-0228 Neri E.: A-015, A-163, A-749, B-0269, B-0741,
Morgan S.: B-0289 Musch M.: B-0349 B-0841, B-1044, B-1045
Mori C.A.: B-0437, B-0922, B-1103 Muscogiuri G.: B-0051, B-0265, B-0272, B-0474, Neri F.: B-0956
Mori N.: B-0693 B-0779, B-0793, B-0794 Neriman D.: B-0093
Mori T.: B-0184 Mushtaq S.: B-0179, B-0467, B-0626, B-0777 Nestle U.: A-668
Morita K.: B-0431 Muto M.: A-718 Nestola M.: B-0059, B-1136
Moritake T.: B-0541 Muuronen A.: B-1058 Nestorov N.: B-1192
Moriyasu F.: B-0861 Myasnikov R.: B-0901 Netam S.B.: B-0592
Morley N.: B-0846 Mytsyk Y.: B-0660 Neudorf U.: B-1056
Morozov S.: A-751 Neumaier K.: B-0036, B-0732
Morris E.A.: B-1180 N Neuwelt E.: B-0650
Morris R.: B-0529 N’Guyen S.: B-0195 Nevens F.: B-0695
Morsbach F.: B-0746, B-0896 Na D.: B-0288, B-0497 Neves M.D.G.P.M.S.: B-0360
Mosca S.: B-1268 Nadolski G.J.: B-0698, B-0853 Newby D.E.: B-0055
Moscatelli M.: B-0575 Nadrljanski M.: B-0016 Newstead G.: B-1177
Moschetta M.: B-0189, B-0616, B-0622, B-1182 Nagao M.: B-0986 Ng Wong Y.K.: B-0441
Moser M.: B-0938 Nagarajah J.: B-1159, B-1183 Ngo Ikeng D.: B-1089
Moskowitz C.S.: B-0348, B-0555, B-1009, B-1010 Nagaria T.: B-0592 Ni Ainle F.: B-1245
Mosquera N.J.: B-1284 Nagel H.-D.: B-0784 Ni H.: B-1080
Mostbeck G.: A-305 Nagel S.N.: B-1250 Niazi I.K.: B-0213
Motton M.: B-0961 Nagl G.: B-0920 Nicholson A.: A-449
Moulin G.: A-560 Naguib N.N.N.: B-0186, B-0372, B-0858, B-0859 Nicholson P.: B-0020, B-0455
Moulopoulos L.A.: B-0663 Nagurney J.T.: B-0750, B-0751 Nickol A.: B-1111, B-1119
Moumtzouoglou A.: B-0649 Nagy J.G.: B-1098 Nicolini D.: B-1054
Moura A.P.C.: B-0927 Nam I.C.: B-1173 Niederstadt T.: B-0548
Mousseaux E.: B-0395 Nam J.G.: B-0532, B-0977 Niehues S.M.: B-0543, B-0728
Mraity H.A.A.B.: B-0141 Nam S.Y.: B-0156 Nielsen K.: B-0862
Mtvaradze A.: B-1128 Nana M.P.: B-0529 Nielsen K.J.: B-0461
Mu J.: B-0485 Nannini G.: B-0238 Nielsen M.: B-0077, B-0212
Mück F.: B-0911 Nanz D.: B-0373, B-0374, B-0559, B-1070 Nielsen M.L.: B-0828
Mueller D.: B-0567 Napoli A.: A-435, B-0337, B-0586 Nieman K.: B-0753
Mueller J.: B-0424 Napolitano C.: B-0166 Niemann M.: B-0896
Muellerleile K.: B-0469, B-0898 Nappi C.: A-325, A-465 Nieminen M.: B-1190
Mueller-Lisse U.G.: B-0095, B-0378, B-0556 Narayan G.: B-0665 Niesen S.: B-0782
Muir K.: B-0846 Narayanasamy S.: B-0160, B-0489 Niessen C.: B-1203
Mukherjee B.: B-1241 Nardis P.: B-1280 Niessen H.W.M.: B-0862
Mulè A.: B-0515 Narula M.: B-0885 Niessen W.J.: K-28, B-0244, B-0856
Mulé S.: B-1003 Nasatti A.: B-1091 Nievelstein R.A.J.: A-572
Muley T.: B-0096 Nasirudin R.A.: B-0285 Nighoghossian N.: B-0811
Mulimani N.: B-0198 Nassar M.: B-1079 Nijssen E.C.: B-0600
Mulimani N.M.: B-0574 Nassenstein K.: B-0045, B-0786, B-1056, B-1159, Nikitovic M.: B-0016
Mulkens T.H.: B-1239 B-1240 Nikolaou K.: B-0024, B-0028, B-0323, B-0381,
Müller A.: B-0478, B-0502 Nasserinejad K.: B-0168 B-0392, B-0402, B-0556, B-0609, B-0854, B-0938,
Müller G.: B-0562 Nasti G.: B-1267 B-1055, B-1253, B-1256
Müller H.: B-1037, B-1039, B-1088 Naumann D.N.: B-0408 Nilsson A.: A-121, A-436
Müller O.: B-0026 Nautsch F.: B-0750 Nio Y.: B-0736
Müller-Forell W.S.: A-103 Navas Canete A.: A-586 Niola R.: B-1267
Müller-Hübenthal J.: B-0078 Navin P.: B-0842 Nishie A.: B-0252, B-0431
Müller-Lutz A.: B-0936 Nawaz A.: B-1133 Nishimuta Y.: B-0252
Müller-Schimpfle M.: A-632, K-18 Nazeri M.: B-0279 Nitrosi A.: B-0437, B-0918, B-0922, B-1103
Müller-Wille R.: B-0060 Ndlovu J.: B-0143 Niu J.: B-0646, B-1071
Mumoli M.C.: B-0309, B-0835 Nedelcu C.: B-0410 Nobili E.: B-0626, B-0777
Mungai V.: B-0238 Nederend J.: B-1031, B-1032 Nocchi Cardim L.: B-1287
Munkholm P.: B-0461 Nederveen A.J.: B-1104 Nocchi L.: B-0720
Münzel D.: B-0797 Neff K.W.: B-0169, B-0172, B-1249 Nocetti L.: B-0316
Murakami T.: B-0298 Negrelli R.: B-1174 Noebauer-Huhmann I.-M.: A-258
Murchison J.: B-0846 Nekolla S.G.: A-051, A-354 Noël P.B.: B-0285
Murphy D.: A-499 Nelemans P.: B-0115, B-0118, B-0737 Nordlohne M.: B-1001

334 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Notari P.: B-1103 Orhan K.: B-0734 Panahi B.: B-0859


Notohamiprodjo M.: A-281, B-0036, B-0101, B-0286, Orlandi E.: B-0577 Pancot M.: B-0350, B-0743
B-0402, B-0556, B-0732, B-1012, B-1134 Orsenigo E.: B-0251 Pancrazi F.: B-0741
Notohamiprodjo S.: B-0101, B-1012 Orsi F.: A-434 Panebianco V.: B-0561
Nour-Eldin N.-E.A.: B-0186, B-0858, B-0859 Ortiz-Perez J.T.: A-290 Panek J.: B-1126
Novak K.: B-0034, B-0463 Orzada S.: B-0563, B-0566 Panes J.: B-0458
Ntorkou A.: B-0702 Osano S.: B-0620 Panico N.: B-0805
Ntoulia A.: B-0894, B-0895 Osborn A.G.: A-556 Panizza P.: B-0229, B-0577
Ntziachristos V.: A-592 Osman N.: B-0215 Panourgias E.: B-0663
Numan F.: B-1204 Ostendorf B.: B-1068 Panov V.: B-0005, B-1127
Nunes J.: B-0199 Osti M.: B-0638 Pansini V.: B-0947
Nunes R.G.: B-0945 Ostlere S.J.: A-696 Panwar D.: B-0190
Nunez D.: A-299 Othman A.: B-0421, B-0819 Panzeri M.M.: B-0015
Nusman C.M.: B-0385 Otmezguine Y.: B-0718 Paone G.: B-1124
Nyberg L.: A-610 Ottl P.: B-0372 Papadaki A.: B-0517
Nybing J.D.: B-0572 Otto S.: B-0318, B-0378 Papadaki E.: B-0293
Ottonello C.: B-0946 Papadopoulos D.: B-0587
O Ou P.: B-1255 Papadopoulou F.: B-0895
O’ Connor O.J.: B-0171, B-0447, B-0455 Oubaya N.: B-1003 Papadopoulou S.: B-0293
O’ Driscoll F.: B-0231 Oubel E.: B-0245 Papagiorcopulo C.: B-0466
O’Leary D.: B-0208 Oudard S.: B-0659 Papanikolaou N.: B-0832, B-1094
Obenhuber T.: B-0484 Oudelaar B.W.: B-0074 Papavassiliu T.: B-0390
Oberhofer N.: B-1099 Oudkerk M.: B-0263, B-0264, B-0329, B-0533, Pappavassiliu T.: B-0391
O’Brien T.X.: B-0748 B-0540, B-0617, B-0624, B-0683, B-0792, B-1060 Paprottka P.M.: B-0323, B-1264
Oca Pernas R.: B-0796 Ourednicek P.: B-0740 Paradiso F.: B-0993
O’Connor O.J.: B-0448 Ouyang C.: B-0937 Parameswaran P.: B-0367
Odille F.: B-0472 Overlaet W.: B-0261 Páramo M.: B-0926
Oechtering T.H.: B-0276 Ovesen C.: B-0301 Parapatt G.K.: B-0618
Oei E.H.G.: A-648 Owens C.: K-04 Parhofer K.: B-0480
Oei S.: B-1094 Oyen R.H.: A-480, B-0787, B-1246 Pariente D.: A-483
Offiah G.: B-0231 Oz U.: B-0734 Parienti J.-J.: B-1090
Oh C.W.: B-0677 Ozgen Mocan B.: A-020, B-0581 Parisi C.: B-0277
Oh S.Y.: B-0334, B-0335 Özkul B.: B-1218 Parizel P.M.: A-177, A-183, A-512, A-580, A-719,
Oh Y.-M.: B-0334, B-0335 Ozkul Wermester O.: B-0953 B-0294, B-0984, B-1219, B-1239
Ohana M.: B-0672, B-0681, B-1278 Ozmen M.: B-1198 Park B.: B-0983
O’Hare N.: B-1192 Ozmen O.: B-0330 Park B.K.: B-0133, B-1006, B-1141
Ohmstede A.: A-396 Özsoy A.: B-0138 Park C.M.: B-0007, B-0593, B-0690
Ohno Y.: B-0686, B-0689, B-0937, B-0964, B-0982 Özsunar Y.: A-083 Park H.J.: B-0201, B-0292, B-0634, B-0679
O’Hora L.R.: B-0873 Ozturk H.: B-0168 Park J.: B-0283
Oikari S.: B-0210 Özyavuz I.: B-0388 Park J.H.: B-0532, B-0597
Okamoto D.: B-0431 Park J.-H.: B-1120, B-1122
Okcu Ö.S.: B-0434 P Park J.J.: B-0133, B-1006, B-1141
O’Keeffe S.A.: B-0017, B-0231 P.K N.: B-1123 Park J.S.: B-0840
Oktay A.: B-0434 Pacciardi F.: B-0010 Park K.M.: B-1285
Olerud H.: B-0167 Pacifico L.: B-0888 Park S.B.: B-0679
Olivari L.: B-0027 Padhani A.R.: A-233, A-327, A-404, A-420 Park S.H.: B-0879, B-0880
Oliveira J.C.J.: B-1139 Padovano F.: B-0117 Park S.I.: B-0692
Olivero R.: B-0724 Padrón M.: A-340 Park S.J.: B-0690, B-0840
Ollivier-Hourmand I.: B-1090 Pagliarella G.: B-1280 Park S.Y.: B-0133, B-1006, B-1141
Olschewski H.: B-0052, B-0399 Pagniez J.: B-0336 Park Y.S.: B-0007, B-0593
Oltmanns U.: B-0991 Pahn G.: B-0099, B-0788 Parkhomenko D.: B-0181
Omoumi P.: B-0916, B-0940 Pai A.: B-0077 Parlak S.: B-0581
Ong M.M.: B-0801 Paik N.: B-0542 Partanen K.: B-1176
Ono S.: B-0693 Paireder M.: B-0250 Partecke L.I.: B-0744
Ooms E.M.: B-0074 Palkó A.: A-091, A-191, A-193 Parthipun A.: B-0124
Oostveen A.: B-1210 Palla C.: B-0586 Paschetta C.: B-0030
Op de Beeck B.J.: A-307 Pallottino A.: B-1235 Pasco-Papon A.: B-0195
op den Akker J.W.: B-0404 Palm W.M.: B-0837 Pasquale V.: B-1172
Oppenheim C.: B-0023, B-0297 Palmisano A.: B-0180, B-0182, B-0307, B-0809 Pasquato M.: B-1024
Oppezzo E.: B-0331 Palumbo D.: B-0904 Pasta A.: B-0277
Oran I.: B-0546 Palussiere J.: B-0717 Pastorino U.: B-0682
Ordás I.: B-0458 Pameijer F.A.: A-172 Patak M.A.: A-478, A-532
Ordemann R.: B-0513 Pamplona J.: B-0199 Patankar T.: B-0545
Ording Müller L.-S.: A-062 Pan F.: B-1238 Patel P.: B-0463

www.myESR.org Final Programme | ECR 2015 335


List of Authors & Co-Authors

Patel U.: A-043 Perini A.: B-0848 Pirouzi P.: B-0875


Pathak S.S.: B-0056 Perisinakis K.: B-1247 Pirovano G.: B-0281
Patil A.A.: B-0985 Perlepe V.: B-0916 Pirronti T.: B-0328
Patil U.: B-1078 Pernter P.: B-1274 Pitici A.: B-1191
Patre V.: B-0592 Perrot N.: A-526 Pitskhelauri D.: B-0658
Patriarca L.: B-0487, B-0573, B-1065 Pershina E.: B-0473 Pitton M.B.: B-0997
Patrolecco F.: B-0117 Persson A.: A-351 Pixberg M.: B-0078
Patrzyk M.: B-0744 Persson M.: B-0671 Pizzamiglio M.: B-0442
Patsch J.M.: B-0249, B-0917 Pesaresi I.: B-0082 Pizzi G.: B-0993
Pattacini P.: B-0437, B-0918, B-0922, B-1103 Pescada R.: B-0869 Plank F.: A-670, B-0071, B-0076
Patten M.: B-0898 Pescarini L.: B-0018 Planken R.N.: B-0601
Patterson A.J.: B-0019, B-1154 Peter S.: B-0746 Plasencia J.: B-0090
Patti C.: B-0515 Peters A.: B-0001 Plasencia Martínez J.M.: B-0482
Paul J.F.: B-0772 Peters B.: A-485 Platel B.: B-0232, B-0233, B-0758
Paul N.S.: B-0780, B-1108 Peters E.D.: B-0856 Platzek I.: B-0513
Paul T.V.: B-0882 Petersen J.: B-1117 Plesinac-Karapandzic V.: B-0016
Paulick R.: B-0353 Petersen K.: B-0212 Ploegmakers M.J.M.: B-0401
Paulo G.: A-155, A-411, A-523, B-0147, B-0362, Petersen L.J.: B-0828 Pluchinotta F.R.: B-0602, B-0603
B-0865, B-0867, B-1016 Petersen S.: A-253 Pocard M.: B-1106
Pauwels H.: B-1102 Petitpierre F.: B-0291 Podio V.: B-0030
Pavel M.E.: A-160 Petracchini M.: B-0510, B-0512 Podleska L.: B-0806
Pavlova O.Y.: B-0726 Petralia G.: B-0560 Poeppel T.D.: B-0045, B-0806
Pavlovichev A.: B-0705 Petriglia C.: B-0013 Poetter R.: B-0132
Pawluś A.: B-0227 Petrini M.: B-0397, B-0603, B-0897, B-0990 Pogosbekyan E.: B-0658
Payne J.: B-0237 Petullà M.: B-0179, B-0467, B-0626, B-0777 Polanec S.: B-0352, B-1170
Payne N.R.: B-0315 Pfaff H.: B-1025 Polanec S.H.: B-0767
Peacock C.: B-0924, B-0925 Pfannenberg C.: B-0024, B-0028 Polat A.V.: B-0591
Peck D.: A-497 Pfeifer C.: B-0225 Polico I.: B-0018
Pedicelli A.: B-0544 Pfeiffer F.: B-0101, B-0102, B-0483, B-1012, B-1101 Polito M.: B-0343
Pedicini V.: B-1124 Pfirrmann C.W.A.: A-026, A-342, B-0491, B-0494, Polkowski C.: B-0428
Pediconi F.: A-630, B-0621, B-0762, B-0764 B-0495, B-0639, B-0641 Pollastri V.: B-0838
Pedraza S.: B-0500 Pfirsch N.: B-1038 Polonara G.: B-0711
Pedrinolla B.: B-1174 Phan C.M.: A-712 Polterauer S.: B-0669
Peerlings J.: B-0091 Phongkitkarun S.: B-1093 Pomerri F.: B-0891
Peeters P.H.M.: B-1028 Phuyal S.: B-1116 Pomes L.M.: B-0328
Peeters R.: A-431 Pialat J.-B.: B-1073, B-1075, B-1076 Pompe E.: B-0683, B-1109
Pekarovic D.: A-604, A-714 Pianykh O.: B-1035 Pomschar A.: B-0036, B-0732
Pelage J.-P.: A-355, B-0384, B-1090 Piccini D.: B-0272 Ponda S.W.: B-0820
Peled N.: A-691 Piccinini S.: B-0816 Pontello M.: B-0456
Pelgrim G.J.: B-0263, B-0264, B-0792 Piccione V.: B-0620 Pontone G.: B-0179, B-0467, B-0626, B-0777
Pellegrin A.: B-0342 Piccirelli M.: B-0909 Ponzini L.: B-0191
Peller M.: B-0732 Pickhardt P.J.: B-0974 Poorteman L.: B-0058
Pellerin O.: B-1263 Piemonti L.: B-1172 Pop C.M.: B-0991
Pelliccia L.: B-0325 Pierot L.: A-720 Popovič P.: B-0155
Pellone F.: B-0120 Pietras J.: B-0369 Popovici C.: B-1191
Pellot-Barakat C.: B-0158 Piga A.: B-0900 Pöppel T.: B-0026, B-1159
Pelotti P.: B-0807 Pignatelli A.: B-0189 Poppert H.: B-0484
Peltonen J.: B-0321 Pijnappel R.M.: A-154, A-209, A-657 Porelli S.: B-0850
Peng L.Y.: B-0021 Pillai S.: B-0407 Poretti D.: B-0307, B-1124
Peng M.: B-1281 Piludu F.: B-0579 Porfiri A.: B-0713
Peng W.-J.: B-0614 Pimenta A.: B-0867 Portelli J.L.: A-574, B-1017
Pepe A.: B-0046, B-0226, B-0393, B-0899 Pimpie C.: B-1106 Portieri F.: B-0993
Peperhove M.J.: B-0039, B-0709 Pina L.: B-0211, B-0923, B-0926 Porzych K.: B-1086
Pepi M.: B-0626, B-0777 Pine K.J.: B-0315 Posa A.: B-0121, B-1136
Perarnau J.-M.: B-0700 Pinheiro J.P.: B-0365, B-0869, B-0871, B-1021, Potapov A.: B-0658
Perchinunno M.: B-0086, B-0511, B-0576 B-1145 Potet J.: B-0128
Pereira A.: B-1023 Pinheiro Loureiro J.: B-1042 Potsi M.: B-0649
Pereira F.: B-0865 Pinker-Domenig K.: A-658, B-0132, B-0352, B-0444, Pottecher P.: B-0346
Pereira H.: B-0659 B-0767, B-0920, B-0935, B-1153, B-1158, B-1160 Pötter R.: B-0935
Pereira P.L.: A-119, A-318 Pintea B.: B-0648 Pöttgen C.: B-0026
Pereira R.M.S.C.: B-0360 Pinto dos Santos D.: B-1186 Pottier E.: B-1262
Perez R.: B-0073 Pinto N.F.: B-0871, B-1145 Pouraliakbar H.: B-1057
Perez-Fernandez C.M.: B-0436 Piper K.: B-1143 Poustchi H.: B-0605
Perez-Rovira A.: B-0168, B-1117 Pipkorn R.: B-0313 Pozzi Mucelli F.: B-0956

336 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Pozzi Mucelli R.: B-0354, B-0371, B-0956, B-1171, R Rehwald W.G.: B-0051
B-1174, B-1201 Raaijmakers R.: B-0266 Reid J.H.: B-0846
Pozzi-Mucelli R.: A-003 Rabenalt R.: B-0351, B-0357 Reid S.: B-1154
Prabhu N.K.: B-1123 Radlgruber I.: B-0669 Reider L.: B-0177
Pradella M.: B-0562 Radmard A.R.: B-0605 Reijnierse M.: B-0941, B-1073, B-1075, B-1076,
Prahladan A.: B-0962 Radtke J.: B-0304 B-1210
Prayer D.: B-0379, B-0502, B-0522, B-0524 Radunski U.K.: B-0469, B-0898 Reimar R.: B-0610
Precht C.: B-0725 Radzina M.: B-0818 Reimold M.: B-0381
Preda L.: B-0575 Raff G.L.: B-0628 Reinboldt M.P.: B-1097
Preim B.: B-0595 Ragab Y.: B-0477, B-0594, B-0640 Reiner C.S.: B-0004, B-1046
Raghavan B.: B-0877 Reiners C.: B-0095
Prell J.: B-0655
Rahim R.: B-0924, B-0925 Reinhold F.: B-0595
Přibáň V.: B-0653
Rahman N.: B-1111, B-1119 Reinwald M.: B-1249
Price E.R.: B-1180
Rahmanian M.S.: B-0605 Reis C.S.D.: B-0143
Pricolo P.: B-0560 Reis J.: B-0199
Rahmouni A.: B-0108
Prinz F.: B-0997 Reischauer C.: B-0768
Raimondi E.: B-0838
Prisacariu A.: B-1191 Reischl G.: B-0024
Raimondi S.: B-0560, B-0575
Probst F.A.: B-0378 Rainford L.A.: B-0208, B-0866, B-1017, B-1024, Reiser M.F.: A-439, B-0001, B-0095, B-0101, B-0102,
Probst M.: B-0378 B-1142, B-1149, B-1151 B-0123, B-0273, B-0275, B-0286, B-0323, B-0417,
Prokop M.: A-603, A-725, B-0035, B-0401, B-0537, Raiola G.: B-0224 B-0480, B-0486, B-0556, B-0610, B-0732, B-0814,
B-0540 Raissaki M.: A-360 B-0822, B-0938, B-1012, B-1101, B-1134, B-1187,
Prokop W.M.: B-0203 Rajesh S.: B-0219 B-1264, B-1288
Prola Netto J.: B-0650 Ramanathan S.: B-0190, B-0979 Reiter A.: B-0801
Pronin I.: B-0658 Ramazan A.: B-1156 Reiter G.: B-0052, B-0399
Prosch H.: A-097, A-502 Ramirez-GarciaLuna J.L.: B-0247 Reiter U.: B-0052, B-0399
Prothmann S.: B-0545 Ramon F.: A-512 Rella L.: B-0622
Protin-Catteau L.: B-0259 Ramos I.: B-1042 Remedios D.: A-347
Provenzano E.: B-0019 Rampoldi A.: A-112 Rempp H.: B-0024, B-0854
Pruvo J.-P.: B-0503 Ramseier L.E.: B-0639 Remy J.: B-0336, B-0852
Przegalinski J.: B-0845 Raneri F.: B-0027 Rémy-Jardin M.: A-702, B-0336, B-0852
Pua U.: B-0340, B-0341 Rank C.: B-0319 Ren F.: B-1085
Ranschaert E.R.: A-018 Renganathan R.: B-0159
Pucheux J.: B-0700
Rao B.S.: B-0190 Rengier F.: B-0398
Puech P.A.: A-105
Rao S.-X.: B-0836, B-1094 Rengo M.: A-001, B-0833, B-1233
Puelacher W.: B-1244
Raslan S.: B-0311 Renker M.: B-0272, B-0628, B-0752
Puglielli E.: B-0821, B-0951, B-0957
Rasmussen F.: B-0734 Renne G.: B-0560
Pugliese F.: B-0799 Renne S.: B-0393
Raso G.: B-1033
Puig J.: B-0500 Rennert J.: B-1203
Rasper M.: B-0278, B-0754, B-0797, B-0798
Puigdemont M.: B-0500 Raszkowski A.M.: B-0864 Rentsch M.: A-479
Pul C.V.: B-0526 Rathmann E.: B-0907 Repa I.: B-0657
Pullens P.: B-0294 Rathmann N.: B-0554, B-1232 Reppas L.: B-0339
Pulsone P.: B-0742 Ratib O.: A-017, A-081, A-180 Repussard J.: A-413
Purcell Y.: B-1195 Rau P.: B-0940 Resta E.C.: B-0602, B-0604, B-0897
Pursani A.: B-0751 Raudner M.: B-0942 Restaino G.: B-0226
Pusceddu C.: B-0344 Rausch I.: B-0320 Restaino M.C.: B-0899
Putineanu D.: B-0916 Rautou P.-E.: B-0220 Reu S.: B-0095
Putzer D.: B-0305 Ravaioli S.: B-0437, B-0922 Revel M.-P.: A-601, B-0989
Puzakov K.B.: B-1234 Ravanelli M.: B-0174, B-1089 Reymond E.: B-0538
Pyatigorskaya N.: B-1045 Rebecca K.: B-0907 Reyre A.: A-560
Pyfferoen L.: B-1239 Rebellato C.: B-0018 Rezanavaz-Gheshlagh B.: B-0461
Rebonato A.: B-1268 Reznek R.H.: K-18
Reda M.S.R.: B-0299 Ribeiro L.P.: B-0365, B-0869, B-0871, B-1021, B-1145
Q Reddy P.: B-1078 Ricart E.: B-0458
Qi W.: B-0685
Redheuil A.: B-0395 Ricart Selma V.: B-0760, B-0765
Qiao Y.: B-0645 Ricchi P.: B-0046
Reekers J.A.: A-088, A-090, A-243
Qiu L.: B-1072 Reeps C.: B-0278 Ricci E.: B-0707
Qiu W.: B-1283 Rega A.: A-359 Richard P.: B-0108
Quagliozzi M.: B-0511 Regge D.: A-723, B-0620, B-1044, B-1045, LBCT Richard S.: B-1108
Quaia E.: B-0456 Regier M.: B-0558, B-0565, B-0725, B-0974 Richter F.: B-0173
Quentin M.: B-0351, B-0357 Regini E.: B-0022 Riddell A.M.: A-621
Querques G.: B-0308, B-1091 Regnard N.-E.: B-0284 Ridereau-Zins C.: B-0410
Quick H.H.: A-053, A-143, B-0092, B-0320, B-0563, Regnaud A.: B-0661 Riederer S.: B-1107
B-0566 Rehman I.: B-0213 Rief M.: B-0063, B-0176, B-0791
Qurashi A.A.: B-0866 Rehnitz C.: A-649 Riffel P.: B-0554

www.myESR.org Final Programme | ECR 2015 337


List of Authors & Co-Authors

Righi D.: B-0608, B-0966 Rosenbaum-Krumme S.: B-0516 Ryu M.-H.: B-1120
Righi L.: B-1237 Rosenberg M.: B-1177
Riis R.: B-0948 Rosenberg M.L.: B-1176 S
Rimassa L.: B-0307 Rosenberger K.D.: B-0424 Saam T.: B-0101, B-0273, B-0275, B-0417, B-0483,
Rimola J.: A-002, A-534, B-0458 Ross J.: B-0315 B-0486, B-0822, B-1012
Rimondi E.: B-0831, B-1266 Rossi A.: A-047, A-125, A-236, A-734, B-0629, Sabatier F.: B-0187
Rinaldi P.: B-0618, B-1179 B-0799, B-1089 Sablayrolles J.-L.: B-0175
Rinde H.: LBCT Rossi G.: B-1266 Sabouri S.: B-0476
Rinelli G.: B-0166 Rossi P.: B-0889 Sabri A.: B-0097
Ringe K.I.: B-0039, B-0222 Rosskopf A.B.: B-0491, B-0494, B-0639 Sacarea I.: B-0078
Ringelstein A.: B-0786, B-1240, B-1241 Rosso A.: B-0921 Sacchetti G.M.: B-0664
Rinne J.O.: A-611 Roth P.: B-0599 Sacconi B.: B-0883, B-0884, B-0888
Rio J.: A-717 Rothe J.H.: B-0003 Sack I.: B-0356, B-0394
Rio Tinto H.: A-356 Rotili A.: B-0230 Sadotti G.: B-1237
Rispo A.: B-0038 Rotzinger D.: B-0940 Saering D.: B-0469
Ritschl L.: B-0670 Rousseau H.: B-0058 Safran O.: B-0248
Ritzenthaler T.: B-0811 Rousset P.: B-0989 Safriel Y.: B-0084
Riva M.: B-0027 Rousset-Jablonski C.: B-0989 Safsaf A.: B-1275
Rixe J.: B-0599 Roustit M.: B-0369 Saghatchian M.: A-270
Rizzati R.: B-0838 Rouvelas I.: B-0044 Saguatti G.: B-0919
Rizzo G.: B-0180 Roux C.: B-0284, B-0395 Saha S.: B-0933
Ro S.-R.: B-0583 Roux M.: B-0940 Saida Y.: B-1162
Robben S.G.F.: A-482, B-1257, B-1258 Rovira-Cañellas A.: A-608 Saint-Lèbes B.: B-0058
Roberto E.: B-0724 Rowan M.: B-1245 Sainz Barriga M.: B-0700
Robertson N.L.: B-0967 Rowbotham E.L.: A-025 Sajja S.: B-1108
Robinson S.: A-277 Rowiński O.: B-0202 Sakman B.: B-0138
Robusto V.: B-0505 Rowlands P.: B-1038 Sakuda K.: B-0105
Roca P.: B-0297 Rowley H.A.: A-228, A-230 Salama M.: B-1133
Roccia S.: B-0224 Roy C.: B-0672, B-0681, B-1278 Salazar J.P.: B-0441
Roček M.: B-1077 Roy Choudhury S.: B-0333 Saldari M.: B-0140, B-0520, B-0523
Rocher L.: A-206 Roy-Choudhury S.: B-0333 Salem R.: B-0064
Rockall A.G.: A-138, A-462, A-527, B-0517 Rozendorn N.: B-1040, B-1041 Salgado R.: A-593, A-719, B-0984
Rödel S.: B-0353 Rozengarten O.: B-0248 Salhi M.: B-0710
Roden Y.: B-0231 Rua C.H.S.: B-1083 Salnikova S.: B-0705
Rodighiero M.: B-0015 Rubbert C.: B-0092, B-1068 Salpietro D.: B-0887
Rodrigues S.: B-0365, B-0869, B-0871, B-1021, Rubio I.: B-0441 Salsano M.: B-0889
B-1145 Rubtsova N.: B-1234 Salut C.: B-0857
Rodrigues T.: B-0817 Ruckes C.: B-0997 Salvador R.: B-0441
Rodríguez P.: A-313 Rud E.: B-0552 Salvatore M.: B-0038, B-0534
Rodríguez S.: B-0458 Rudas G.: B-0200 Salvetti M.: B-1124
Rodt T.: B-0999, B-1001 Rudas M.: B-0444, B-1160 Samanci C.: B-1204
Rodzyanko M.: B-0355 Rudolph J.: B-0278 Sameer H.: B-0345
Roebuck D.J.: A-481 Ruhlmann M.: B-1097 Samei E.: B-1099
Roemer F.W.: B-0646, B-1069, B-1071 Ruhlmann V.: B-0029, B-0031, B-0092, B-0516, Sanavi C.: B-1275
Roessle M.: B-0064 B-0827 Sanchez M.: B-0090
Roethke M.C.: A-205, A-530, B-0304 Ruibal A.: A-709 Sanchez-Gonzalez J.: B-0902
Rofsky N.M.: B-0281 Ruju F.: B-0575 Šanda J.: B-1077
Rogalla P.: B-0716 Rummeny E.J.: B-0278, B-0285, B-0754, B-0797, Sandbæk G.: B-0037, B-1259
Rohit M.K.: B-0164 B-0798 Sandek A.: B-0905
Roller F.C.: B-0053, B-0599 Rundstein A.: B-0119, B-0438 Sanderud A.: B-0864
Romano F.: B-0038 Runge J.H.: B-1104 Sandhu R.S.: B-0517
Romano L.: B-0035 Runge V.M.: B-0909 Sandolo F.: B-0586
Romano S.: A-010, K-08 Ruprela V.: B-0915, B-1078 Sanmillán J.: B-0955
Romanos O.: B-0892 Russo E.: B-0179 Santagostino A.: B-0511
Romman Z.: B-0104 Russo P.: B-1009, B-1010 Santangelo T.: B-0166
Rong S.: B-1135 Ruszniewski P.: A-162 Santiago A.R.: B-0146
Ronot M.: A-162, A-562, B-0220, B-1262 Rutten M.J.C.M.: B-0228 Santiago I.: B-0735
Rook J.W.: B-0864 Rutz E.: B-0387 Santoni M.: A-427
Roos J.E.: B-0768 Ruzzenente A.: B-1201 Santoro A.: B-1113
Rørvik J.: B-0708 Ryan J.: B-0208, B-0447 Santoro M.: B-0121
Ros P.R.: A-221, A-563, A-666 Ryan M.: B-0084 Santos A.: B-0365
Rosado E.: B-0735 Ryan M.F.: B-0020 Santos J.: A-346, B-0147, B-0362, B-0865, B-0867,
Rosato E.: B-0054 Ryeom H.: B-1125, B-1231 B-1016
Rosella F.: B-0328, B-0993 Ryu J.: B-0161, B-0733 Santos R.: B-0151

338 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Sapoval M.: B-1263 Schima W.: A-028, A-547, A-622, A-680 Schuijf J.D.: B-0261
Saraux A.: B-1075 Schimmöller L.: B-0351, B-0357, B-0627 Schuknecht B.F.: A-174
Sardanelli F.: A-150, A-242, A-518, A-655, B-0397, Schindl M.: B-1170 Schüller S.: B-0675
B-0602, B-0603, B-0604, B-0757, B-0897, B-0919, Schindler A.: B-0484 Schullian P.: B-1244
B-0946, B-0990, B-1175, B-1176 Schindler K.: B-0813 Schultheis N.: B-0847
Sardo E.: B-0022 Schipper R.J.: B-0113, B-0115, B-0118 Schultheiss M.: B-0064
Sarifov R.: B-0388 Schlamann M.: B-0026, B-1241 Schulz A.: B-1196
Sarin S.K.: B-0219 Schlattmann P.: B-0176 Schulz B.: B-0193, B-0729, B-1270
Säring D.: B-0898 Schleich C.: B-0449, B-0936, B-1068 Schulz V.: A-049
Sasaki M.: B-0826 Schlemmer H.-P.: A-104, B-0096, B-0304, B-0674, Schulz-Wendtland R.: B-0206, K-21
Satchithananda K.: B-0112, B-0924, B-0925 K-06 Schumacher M.: B-0303
Sathiadoss P.A.R.P.: B-0160 Schlett C.L.: B-0424, B-0480 Schupp N.: B-1134
Sattler B.: B-0320 Schliebus J.: LBCT Schuster A.: B-0400
Saturnino P.P.: B-0745 Schlosser T.: B-0045, B-0786, B-1056, B-1240 Schütz T.: B-0980
Saude E.: B-0194 Schmachtenberg C.: B-0209 Schwaiger M.: B-0484
Sauer A.: B-1290 Schmeding M.: B-0701 Schwartz E.: B-0522
Saushkin V.V.: B-0789 Schmerber S.: B-0369 Schwartz S.: B-1250
Sauvanet A.: B-1262 Schmidt B.: B-0098, B-0676 Schweiger B.: B-0165
Saviolo C.: B-0510, B-0512 Schmidt G.: B-0286 Schweitzer N.: B-1001
Savlovskis J.: B-0818 Schmidt H.: B-0028 Schwenck J.: B-0024
Savolainen S.: B-0321 Schmidt M.: B-0239, B-1109 Schwenzer N.: A-352, A-379, B-0028, B-0381
Sawall S.: B-0675, B-0678 Schmidt S.: B-0185, B-0256 Schymik G.: B-0631
Sawangsilpa T.: B-1093 Schmidt T.: B-0808 Scialpi M.: B-1268
Sawicki M.: B-0202 Schmidtke C.: B-0276 Scionti A.: B-0430
Saxena A.K.: B-0164 Schmitt B.: B-0936 Sconfienza L.M.: B-0990
Sbarbati S.: B-1280 Schmitt C.: B-0558 Screaton N.J.: A-600
Scaglione M.: A-059 Schmitzberger F.: B-0436 Sdao S.: B-0577
Scaglioni R.: B-0316, B-1113 Schmücker R.: A-255 Seaton T.: B-0112
Scalise P.: B-0430, B-0741 Schnabel P.: B-0096 Sebag G.: A-359
Scandiffio R.: B-0841 Schnapauff D.: B-0860 Seboui S.: B-0231
Scaperotta G.: B-0229 Schneider C.: B-0053, B-0599 Secchi F.: B-0397, B-0602, B-0603, B-0604, B-0897,
Scarabello M.: B-0397 Schneider G.K.: B-0478, B-1282 B-0990
Scardapane A.: B-0043 Schneider J.F.: A-238, A-358 Sechopoulos I.: B-1098
Scarsbrook A.: A-179, A-722 Schnerr R.S.: B-0782 Secinaro A.: B-0166
Schaab F.: B-1272 Schnitzer A.: B-1161, B-1184 Seddon B.: A-675
Schaafs L.-A.: B-0728 Schoenberg S.O.: B-0169, B-0172, B-0631, B-0801, Sedelaar J.P.M.: B-1140
Schaake W.: B-1023 B-1161, B-1180, B-1184, B-1249 Sedivy J.: B-0756
Schaal M.: B-0681 Schoenecker A.: B-1056 Sedlaczek O.L.: A-275
Schaarschmidt B.M.: B-0029, B-0031, B-0092, B-0516 Schoepf U.J.: B-0051, B-0265, B-0272, B-0445, Seehofer D.: B-0011, B-0426
Schabel C.: B-0402, B-0609 B-0474, B-0628, B-0748, B-0752, B-0779, B-0793, Seehofnerova A.: B-0773, B-0775
Schad L.R.: A-407 B-0794 Segnan N.: LBCT
Schaefer- Prokop C.M.: A-204 Schoepf V.: B-0177 Seidel R.: B-1282
Schaefer-Prokop C.M.: A-036, A-203, A-448, A-550, Schöllchen M.: B-0725 Seidl R.: B-0524
A-568, B-0535, B-0537, B-0844 Scholten E.T.: B-0535, B-0537, B-0540 Seith F.: B-0028
Schaeffeler C.: A-442 Scholtz J.-E.: B-0088, B-0193, B-0729, B-0730, Seitz G.: B-0381
Schäfer J.F.: B-0381, B-0392 B-0731, B-0770, B-0847, B-1270 Seiwerts C.: B-0558
Schäfers H.-J.: B-1282 Schön G.: B-0725 Seki S.: B-0686, B-0689, B-0937, B-0982
Schaper N.C.: A-245 Schönberg S.O.: B-0390, B-0391, B-0452, B-0480, Sekiguchi T.: B-0693
Schara U.: B-1056 B-0554, B-0598, B-1232, B-1276 Seliverstov Y.: B-0083
Schaudinn A.: B-0980 Schonenberg D.: B-0385 Seliverstova E.: B-0083
Scheffer H.J.: B-0862 Schönnagel B.: B-0225 Sellars M.: B-0892
Schegerer A.A.: B-0169, B-0784 Schöpf V.: B-0522, B-0524 Semeraro V.: B-1269
Schek J.: B-1004 Schoppmann S.: B-0250 Senan S.: A-570
Schelhorn J.: B-0165, B-1056, B-1097 Schott E.: B-0426 Sengel C.: B-1011
Schemuth H.P.: B-0165 Schouman-Claeys E.: B-1255 Senol U.: A-756
Schenal G.: B-0961 Schouten W.R.: B-0839 Senoner M.: B-1274
Schepers-Bok R.: B-0074 Schramm C.: B-0223 Senore C.: LBCT
Schernthaner R.E.: B-0632 Schreiber A.: B-1130 Seo B.K.: B-0763
Schiani E.: B-0015 Schreiner M.M.: B-0632 Seo J.B.: A-541, B-0334, B-0335
Schiavone M.V.: B-0612 Schröder D.: B-1286 Seo J.W.: B-0881
Schick F.: B-0609 Schroeder J.: B-0710 Seo M.: B-0879, B-0880
Schiel S.: B-0378 Schroefel H.: B-0631 Sepp D.: B-0484
Schild H.H.: B-0648, B-0943, B-1215 Schubert T.: B-0916 Seracchioli R.: B-0587
Schilham A.M.R.: B-0270 Schueller-Weidekamm C.: A-508 Serafin Z.: B-0457, B-1086

www.myESR.org Final Programme | ECR 2015 339


List of Authors & Co-Authors

Serfaty J.-M.: B-0903 Sigurdsson S.: B-0415 Snider F.: B-0059, B-0121
Sergeeva O.N.: B-0005, B-1127 Sijens P.E.: B-0617, B-0624 Sodhi K.S.: B-0164
Serova N.S.: B-0726 Silber G.: B-0324 Soekamto H.: B-0372
Serrenho C.: B-0143 Silingardi E.: B-0848 Sofikitis N.: B-0702
Sertdemir M.: B-0554 Silva D.: B-0867 Soglia G.: B-0889
Servadio Y.: B-0119, B-0438 Silva D.H.: B-1139 Sohn C.-H.: B-0204, B-0501
Severac F.: B-0672, B-0681 Silva D.H.C.: B-1139 Sohn Y.-M.: B-0109
Sewerin P.: B-1068 Silva Jr. J.-R.: B-1071 Soize S.: A-720
Seyfer P.: B-0322 Silva M.: B-0682 Sojer M.: B-0549
Sghedoni R.: B-0437, B-0922, B-1103 Silvestre M.: B-1267 Sojka M.: B-0057
Shaban A.: B-0791 Simakova L.: B-0740 Sokolova N.: B-0705
Shah A.R.: B-0290 Simeonidou C.: B-1087 Solà O.: B-0500
Shahabpour M.: A-509 Simmaco M.: A-164 Solbiati L.: B-0723
Shaheen E.: B-1100 Simon M.: B-0648 Sołek-Pastuszka J.: B-0202
Shahnazi M.: B-1057 Simonelli M.: B-0027 Solis M.P.: B-0090
Shaida N.: B-0125 Simonetti A.: B-0889 Solomou G.: B-1247
Shalmon A.: B-0119, B-0438 Simonetti C.: B-0343 Solomyanyy V.: B-0749
Shankar S.: B-0973 Simonetti G.: B-0561 Solopova A.: B-1138
Sharfman Z.: B-0377 Simonetto I.: B-0366 Solyanik O.: B-0451
Shariat A.: B-0279 Simons D.: B-0674 Sommer G.: A-335
Sharifian H.: B-0875 Simos P.: B-0293 Sommer W.H.: B-0323, B-0610, B-0814, B-1187
Sharma N.: B-0014 Singh A.: B-0592 Son R.C.: B-0568
Sharma S.: B-0129 Singhal M.: B-0164 Son Y.: B-0802
Sharp P.: A-348 Singhal S.: B-0296 Sondern M.: B-0936
Shatynska-Mytsyk I.: B-0660 Sinitsyn V.: B-0183, B-0473, B-0851, B-0901 Soneji N.: B-1115
Sheehy M.: B-0171, B-0447, B-0455 Sinitsyn V.E.: A-459, A-551 Soneji S.: B-0429
Sheehy N.: B-1192 Sinn M.: B-0469 Song E.: B-0109
Sheir K.: B-1013 Sipilä O.: B-0321 Song H.: B-0416
Shen C.: B-0890 Sipola P.: B-1058 Song H.-Y.: B-1120, B-1122
Shen S.: B-1072 Sirachainan E.: B-1093 Song J.: B-0413
Shen W.: B-1080 Sirin S.: B-0165, B-0462 Sorantin E.: A-575
Shetty A.: B-0915 Sironi S.: B-0191, B-0274, B-0308, B-0309, B-0464, Sørensen L.: B-0077
Shetty M.: B-0915 B-0518, B-0612, B-0774, B-0835, B-1053, B-1091, Sormani M.P.: B-0642
Shetty N.: B-0915, B-1078 B-1164, B-1166 Sosna J.: A-350, B-0104
Shi C.: B-0260 Sitoci-Ficici K.H.: B-0506 Sotgia B.: B-0344
Shiguetomi-Medina J.M.: B-0247 Sivasubramanian S.: B-1221 Souahli N.: B-0131
Shim S.W.: B-0135, B-0532 Sivit C.J.: A-298 Soubeyran V.: B-0661, B-1114
Shimizu C.: B-0111 Sjölin M.: B-0671 Souillard-Scemama R.: B-0023
Shin C.-I.: B-0423, B-1121, B-1165 Skanjeti A.: B-0030 Soulen M.C.: B-0698, B-0853
Shin H.J.: B-0157, B-0593 Skehan S.: A-673 Soulez G.: B-0281
Shin H.-O.: B-0451, B-0999 Sklair-Levy M.: B-0119, B-0438 Sourbron S.: B-0286
Shin H.S.: B-0763 Skogen K.: B-1196 Sousa A.L.: B-0817
Shin J.H.: B-0283 Skoglund M.: B-0367 Sousa P.: B-0869, B-0871, B-1021
Shin J.K.: B-0597 Skondras E.: B-0332 Soyer P.: B-0023, B-0259, B-1106
Shin K.-M.: B-1231 Skornitzke S.: B-0099, B-0788 Sözmen Cılız D.: B-0138
Shin N.-Y.: B-0081 Skov- Hansen D.: B-0872 Spagnolli F.: B-0371
Shin S.H.: B-0977 Skrami E.: B-0711 Sparacia G.: B-0505, B-0507
Shin S.-M.: B-0886 Skripkin D.: B-0042 Spearman J.V.: B-0445
Shin S.Y.: B-0334, B-0335 Skrobisz-Balandowska K.: B-0668 Spelle L.: B-0545
Shin Y.S.: B-0153 Skrzywanek P.: B-0202 Sperk E.: B-1161
Shirokov V.: B-0630, B-0776 Slanetz P.J.: B-0761 Spick C.: B-0767, B-1170
Shmeleva L.: B-1081 Sloots C.: B-0893 Spielmann R.P.: B-0655
Shmueli H.: B-0849 Slump C.H.: B-1060 Spies L.: B-0078
Sibert A.: B-1262 Smaldone F.: B-0347, B-1065, B-1209 Spinarelli A.: B-1212
Sidhu P.: B-0892 Smeets P.: B-0781 Spinazzi A.: B-0281
Sidorov D.: B-1234 Smet M.: B-1102 Spink C.: B-1286
Siedentopf C.M.: B-0076 Smidt M.: B-0113, B-0115, B-0118 Spinnato P.: B-0807, B-0831, B-1266
Siegel E.: B-1036 Smit R.S.: B-0404 Spinner G.: B-0373, B-0374, B-1070
Siegmann K.: B-1176 Smith F.W.: B-0289 Splendiani A.: B-1224
Siek E.: B-0845 Smith I.M.: B-0408 Splettstößer A.: B-0550
Sieverding L.: B-0392 Smith M.: B-0281 Sprengel K.: B-0409
Sievers H.-H.: B-0276 Smits M.: A-050, A-229, A-230, A-260, A-495, B-0244 Springer E.: B-0813
Signor M.A.: B-0350 Smugala A.: B-0154 Sramek M.: B-0632
Signori A.: B-0642 Sneige N.: B-0439 Srinivasan S.: B-0954

340 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Sripathi S.: B-0914 Struffert T.: B-0422 Tagliafico A.: B-0071, B-0496, B-0642, B-0643,
Srutek E.: B-0306 Struthers A.D.: B-0466, B-0479, B-0481 B-0644, B-0805
Ssingh P.: B-0574 Studniarek M.: B-0306, B-0668, B-0719 Tagliafico G.: B-0496, B-0642, B-0643, B-0644,
Staatz G.: B-0389 Stukalova O.: B-0181 B-0805
Stabile Ianora A.A.: B-0189, B-0616, B-0622, B-1182 Sturdza A.: B-0132, B-0935 Tahir E.: B-0469, B-0898, B-1213
Stachs O.: B-0908 Sturm N.: B-0611 Taina M.: B-1058
Stahnke T.: B-0908 Suaris T.: B-0207 Takahashi H.: B-0298
Stahnke V.: B-0400 Suchá D.: B-0601 Takahashi S.: B-0964
Stajgis M.: A-058, A-200, B-0459 Sudah M.: B-0210 Takata T.: B-0105
Stajgis P.: B-0459 Sudarski S.: B-0390, B-0391, B-0452 Takayama Y.: B-0431
Stallknecht S.: B-0572 Suetterlin M.: B-1161 Takx R.A.P.: B-0755
Stamm G.: B-0784 Sugihara N.: B-0689 Tal S.: B-0377
Stampanoni M.: B-0746 Sugimoto K.: B-0861 Talei Franzesi C.R.G.L.: B-0274, B-0308, B-0309,
Stankiewicz C.: B-0154 Sugimura K.: B-0686, B-0689, B-0810, B-0937, B-0464, B-0518, B-0612, B-0774, B-0835, B-1053,
Stankovic Z.: B-0064 B-0964, B-0982 B-1091
Stappers P.J.: B-0697 Suhai F.: B-1064 Tali E.T.: A-415
Staskiewicz G.: B-0845 Süleyman S.: B-0829 Tamandl D.: B-0250, B-1170
Staudacher C.: B-0251 Sullivan C.: B-0448 Tamas A.: B-1200
Stavem K.: B-1259 Sullivan F.: B-0481 Tammi M.: B-0210
Stavrou S.: B-0702 Sullivan F.M.: B-0466 Tan G.: B-0341
Stecco A.: B-0086, B-0511, B-0576, B-0664 Sumbunnanondha K.: B-1093 Tan M.M.L.: B-0954
Steck V.: B-0452 Summers P.: B-0560 Tanaka C.: B-0693, B-1220
Stecker F.F.: B-0786, B-1240, B-1241 Sun H.: B-0976, B-1167 Tanaka H.: B-0298
Steenbakkers A.C.L.F.: B-0401 Sun L.: B-0541 Tanase A.: A-359
Stefanescu H.: B-1200 Sun Y.: B-0685 Tang Y.: B-1007
Stefani E.: B-0364, B-1018 Sundaram D.: B-0877 Tanno Y.: B-0184
Steffen I.G.: B-0003, B-0394, B-0426 Sundin A.E.: A-159 Tao H.: B-0645
Stehning C.: B-0469, B-0898 Suntharalingam S.: B-0786, B-1240, B-1241 Taori K.B.: B-0130
Steinbach F.: B-0353 Sunwoo L.: B-0204 Tappero C.M.S.O.: B-0331
Steinberg D.H.: B-0752 Suppa P.: B-0078 Taravari V.: B-0388
Steinberger G.: B-1087 Suranyi P.: B-0051, B-0396 Tardieu M.: A-064
Steins M.: B-0096 Šurlan Popovič K.: B-0155 Tardivel A.-M.: A-389
Stelter L.: B-0011 Surov A.: B-0655 Tardivon A.: A-067
Stelzeneder D.: B-0942 Susac A.: B-1269 Tarella C.: B-0510, B-0512
Stemerdink T.A.: B-0815 Susani M.: B-0352 Tarnoki A.D.: B-0607, B-1062
Stenson M.: B-0440 Sutela A.: B-0210 Taschner C.: B-0303
Stentarelli C.: B-0316 Sutter R.: B-0641 Tateishi U.: B-1162
Štepán-Buksakowska I.L.: B-1077 Svegliati Baroni G.: B-1054 Taverna G.G.: B-0331
Stephan C.: B-0703 Svensson A.: B-0100 Tavoletta A.: B-0742
Stepniewski K.: B-1184 Sverzellati N.: A-169, A-726, B-0682 Taylor A.M.: A-705
Sticchi G.: B-0454 Sweeney J.: B-0080 Taylor S.A.: A-474, A-535, B-0460, B-0785
Stief T.: B-0322 Swi S.: A-371 Taymour T.: B-0912
Stijnen M.: B-0792 Symersky P.: B-0601 Tchekmeister Abitbol V.: B-0521
Stiller W.: B-0099, B-0788 Symms M.R.: B-1083 Teggi S.: B-1033
Stødkilde-Jørgensen H.: B-0247 Synek A.: B-0911 Teh H.S.: B-0954
Stodulski D.: B-0154 Szabó Á.: B-0200 Teh J.: A-507, B-0069
Stojanov D.: B-0079 Szabó N.: B-1077 Tehrai M.: B-1057
Stojanovic I.: B-0079 Szalai Z.: B-0657 Teichgräber U.K.M.: A-286
Stojanovic S.: B-0126 Szczepura K.: B-1026 Teixeira P.A.C.: B-0111
Stojkovic M.: B-0424 Szczerbo-Trojanowska M.: B-0057, K-32 Telegrafo M.: B-0189, B-0616, B-0622, B-1182
Stoker J.: A-069, A-533, B-0736, B-0844, B-1104 Szendrői M.: B-0070 Telesca M.: B-0621, B-0762, B-0764
Stokke M.V.: B-0037, B-1259 Szilveszter B.: B-0266 Tennstrand A.L.: B-0037, B-1259
Stolzmann P.: B-0107, B-0746 Szlezak P.: B-0306, B-0719 ter Horst S.: B-0941
Stoupis C.: A-006, A-545 Szomolanyi P.: A-650 Ter Minassian A.: B-0195
Strasilla C.: B-0545 Szurowska E.: B-0154 Ternovoj S.K.: B-0181, B-1138
Stratakis J.: B-0241, B-1247 Szymańska K.: B-0227 Terrazzino F.: B-0046, B-0226, B-0899
Stratis A.: A-014, B-0680 Szymanska-Dubowik A.: B-0306 Terribile D.: B-0012
Strickland N.H.: A-089 Szymczak A.: B-0227 Tervonen O.: B-1190
Strijkers R.: B-0635 Testa F.: B-0724
Strobbe L.J.A.: B-1027, B-1030, B-1031, B-1032 T Testelmans D.: B-0326
Strobl F.F.: B-0417, B-1264 Tacelli N.: B-0852 Tewes S.: B-0709
Stroeder J.: B-0478 Tacher V.: B-0718 Thaher F.: B-0196
Strojan P.: B-0155 Tack D.: A-501, B-0785, B-0987 Thali M.: B-0746
Stroszczynski C.: B-0060, B-0218, B-1203 Tafaro C.: B-0696 Thanh N.: B-0239

www.myESR.org Final Programme | ECR 2015 341


List of Authors & Co-Authors

Thasler W.: B-0610 Treitl K.M.: B-0123, B-0273, B-0275, B-0486, B-0822, Umutyan L.: B-0428
Theias R.: B-0735 B-1288 Ünal Ö.: B-0162
Theisen D.: B-0556 Treitl M.: B-0123, B-0273, B-0275, B-1288 Unsöld R.: B-0412
Theysohn J.M.: B-0563, B-0564, B-0566, B-0786, Třeška V.: B-1205 Unterberg-Buchwald C.: B-0400
B-1240, B-1241 Treyvaud M.-O.: B-0256 Unterhinninghofen R.: B-0398
Thiefin G.: B-0259 Triantopoulou C.: A-076, A-616 Unterhumer S.: B-0177, B-0632
Thierens H.: B-0781 Tricarico E.: B-0622 Uprimny C.: B-0305
Thierfelder K.M.: B-0323, B-0556, B-0814 Trillaud H.: B-0857 Ursu S.C.: B-0621
Thiounn N.: B-1263 Trimboli R.M.: B-0757, B-0919, B-1175, B-1176 Usenko E.: B-0355
Thiruchelvam P.: B-0112 Trinidad C.: B-0796 Ushijima Y.: B-0431
Thoeny H.C.: A-029, A-310 Triphan S.: LBCT Ustabasioglu F.: B-1204
Thomas P.: B-0783 Troeltzsch M.: B-0378 Uusi-Simola J.: B-0321
Thomassin-Naggara I.: A-526, B-0131, B-0766 Trojanowska A.: A-019, A-646 Uysal M.: B-0221
Thomassin-Piana J.: B-0766 Troost E.G.C.: B-0091
Thomeer M.G.: B-0425, B-0736, B-0893 Tropres I.: B-0369 V
Thomsen H.S.: B-0461, B-0960, B-0968 Trumm C.G.: B-1264 Vacondio R.: B-0437, B-0922
Thorskog M.: B-0143 Truong M.: B-0842 Vago H.: B-1064
Thurnher M.M.: A-511, A-736 Truong Q.: B-0751 Vahldiek J.: B-0543
Tian B.: B-0065 Trybou J.: B-0144 Valbousquet L.: B-0128
Tiberi G.: B-1083 Tsang W.S.S.: B-0370 Valcanover S.: B-1201
Tiddens H.A.W.M.: B-0168, B-1117 Tselikas L.: A-248 Valcke J.: B-0582
Tietz S.: B-0994 Tsetis D.K.: A-443 Valdés Olmos R.A.: B-0025, B-0033
Till V.: B-0126 Tshibanda L.: B-1227 Valdés Solís P.: A-756
Timmers J.M.H.: B-1144 Tsiflikas I.: B-0381 Válek V.: A-118, A-319, B-1126
Timon G.: B-0970 Tsili A.: B-0702 Valentini V.: A-338
Timonen M.: B-0321 Tsitskari M.: B-0339 Valentinitsch A.: B-0249
Timpani M.: B-0742 Tso W.K.: B-1248 Valeri G.: B-0393
Ting E.: B-0578 Tsougos I.: A-629 Valerio D.: B-0587
Tirumalai A.: B-0855 Tsuboi K.: B-0541 Valla D.: B-0220
Tischler V.: B-0746 Tsurkan V.: B-1261 Vallati G.: B-0993
Tkacz J.N.: B-0761 Tsuruda K.M.: B-0236, B-0237 Vallinga A.: B-0864
Tobias S.: B-0484 Tsurumaru D.: B-0252 Vallone N.: B-0899
Tohamy Y.M.: B-0912 Tudisca C.: B-0393, B-0899 van Beek E.J.R.: A-460, A-701, B-0055, B-0846
Tohmad U.: B-1093 Tudor G.: B-0529 Van Beers B.: A-306
Tolan D.J.M.: A-009, A-490 Tufman A.: B-0095 van Berlo C.: B-0834
Tollard E.: B-0953 Tumino M.: B-0117, B-0623 Van de Heyning P.H.: B-1219
Tomà P.: B-0166, B-0889 Tuncay V.: B-1060 van de Looi P.: B-1144
Tomás B.: B-1145 Tupikina N.: B-1138 van de Vijver K.: B-0115
Tomaszewski A.: B-0845 Tupý R.: B-0653 van Delden O.M.: A-011, A-363
Tomiyama N.: B-0298 Turek J.: B-0600, B-0773, B-0775 van den Berg J.M.: B-0385
Toms A.P.: B-0637 Turkay R.: B-0221 van den Berg N.S.: B-0025, B-0033
Tomson A.: B-0044 Tutein Nolthenius C.J.: B-0736 van den Broek W.J.M.: A-716
Tondelli G.: B-0918 Tuteinnolthenius C.: B-0460 van den Hauwe L.: A-177, A-183, A-512, A-719
Tong M.C.F.: B-0370 Twomey M.: B-0171, B-0447, B-0448, B-0455 van den Hoff J.: B-0513
Toniolo M.: B-1074 Tyrrell P.N.M.: A-211 van den Hout J.H.W.: B-0704
Tonoyan A.S.: B-0658 Tyurin I.E.: A-100, B-0005 van den Tol P.(.: B-0862
Tonsok K.: B-1197 Tzavara C.: B-0663 Van der Graaf Y.: B-0815, B-0950
Topcuoglu E.D.: B-1198 van der Heijde D.: B-0941, B-1073, B-1075, B-1076
Topcuoglu O.: B-1198 U van der Lugt A.: A-323
Topilsky Y.: B-0849 Uberoi R.: A-444 van der Meer F.: B-0527
Toriihara A.: B-1162 Uchevatkin A.: B-0913 van der Poel H.G.: B-0033
Torre G.: B-0889 Uder M.: A-375, B-0206, B-0242 van der Valk S.B.A.: B-0074
Torricelli P.: B-0316, B-1113 Udiya A.K.: B-0296 van der Velde D.: B-0404
Torzilli G.: B-0307 Udodov V.: B-0633 van der Woude H.-J.: A-484
Toscano W.: B-0629 Ueda Y.: B-0964 Van der Zijden T.: A-177, A-183, A-719
Tosetti M.: B-0082, B-1083 Ueno Y.: B-0964 Van Dyck P.: A-256
Tosi E.: B-1033 Ugurlu M.U.: B-1156 van Geuns R.-J.: B-0753
Tot T.: A-152 Uhlig S.: B-0845 van Gils C.H.: B-1028
Toth A.: B-1064 Ukmar M.: B-0956 van Ginneken B.: A-451, B-0535, B-0537, B-0540,
Totsuka T.: B-0541 Ulbrich E.J.: B-0373, B-0374, B-1046, B-1070 B-0683
Tran A.: B-1276 Ullah E.: B-0160 Van Goethem J.: A-177, A-183, A-512, A-719
Trattnig S.: A-264, A-647, A-650, B-0942, B-1153 Ullrich T.: B-0351 Van Gompel G.: B-1199
Travaini L.L.: B-0575 Umutlu L.: A-464, B-0026, B-0029, B-0031, B-0255, van Hecke W.: B-0294
Trecate G.: B-0229 B-0516, B-0806, B-0827, B-1159, B-1183, B-1230 van Heeswijk M.M.: B-0836, B-0837, B-1094

342 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

van Herwerden L.A.: B-0601 Venstermans C.: A-177, A-183, A-512, A-719 Voormolen M.: A-177, A-183, A-719
van Landsveld-Verhoeven C.: B-1144 Ventriglia A.: B-1174 Vorontsov I.: B-1261
van Leenders G.J.: B-0839 Venugopal V.: B-0981, B-1082 Voros S.: B-0607, B-1062
van Leeuwen F.W.B.: B-0025, B-0033 Venuta F.: B-0713 Vouillamoz A.: B-0864
van Merriënboer J.J.G.: B-1258 Verardi N.: B-0488, B-0919 Vreemann S.: B-0232, B-0233, B-0758
Van Muylem A.: B-0785 Verbist B.: A-022 Vriesema J.L.J.: B-0704
Van Muylen A.: B-0987 Verellen D.: A-626 Vucaj-Cirilovic V.: B-0126
van Netten J.J.: B-0404 Verhagen M.V.: B-1226 Vullierme M.-P.: A-162
Van Ombergen A.: B-1219 Verheij J.: B-1104 Vyberg M.: B-0828
van Ommen V.V.A.: B-0600 Verheyden J.: B-0294 Vydrová R.: B-1077
Van Ooijen P.M.A.: B-0533, B-1060 Verloh N.: B-0218
van Oosterhout M.: B-0941 Verma R.K.: B-0813 W
van Osch J.A.C.: B-0567 Verschakelen J.: B-1254 W Duffy S.: B-0207
van Osch M.J.P.: B-1223 Verschuuren S.I.: B-0839 Wacker F.: B-0039, B-0222, B-0999, B-1001, B-1135
van Oudenaarde K.: B-1210 Verslype C.: B-0695 Wadhwani A.: B-0034, B-0194, B-0463
van Riel S.: B-0540 Verstraete K.: A-505, A-558, B-0363, B-0781 Wadsak W.: B-0132, B-0935, B-1158
van Riel S.J.: B-0535, B-0537 Verstraeten T.R.G.M.: B-0498, B-0499 Wafaie A.: B-0530
van Rikxoort E.M.: B-0683, B-1109 Veryser J.: A-256 Wagenblast J.: B-0730
van Roozendaal L.: B-0118 Vicari M.: B-0303 Waggershauser T.: B-1264
van Rumund A.: B-0085 Vicente D.: B-0867 Wagner A.: B-1134
van Seeters T.: B-0812, B-0950 Vichter T.: B-0104 Wagner F.: B-0813
van Swieten J.C.: B-0244 Vidano G.: B-0970 Wagner M.: B-0311
van Tilborg A.A.J.M.: B-0862 Vidiri A.: B-0579 Wahab S.: B-0160
Van Tuijl S.: B-0792 Vieveen J.M.: B-0862 Waldeck W.: B-0313
van Walsum T.: B-0697 Viganò S.: B-0019, B-0229 Waldman A.D.: B-0517
van Westerveld P.P.: B-0704 Vikestad K.G.: A-525 Walecka A.: B-0202
van Zandwijk J.K.: B-1060 Vilanova A.: B-0526 Walecki J.: A-365, B-0202, B-0656
van Zelst J.C.M.: B-0228 Vilar J.: A-035, A-500, A-684 Walker-Samuel S.: A-469
Vanbeckevoort D.: B-1246 Vilela P.: A-201 Wallace A.B.: B-0446, B-0783
Vande Berg B.: A-024, A-742, B-0916 Vilgrain V.: A-162, A-294, B-0220, B-1262 Wallis M.: B-1029
Vandenbroucke F.: A-626 Villeirs G.M.: A-232, A-418 Walsh D.: A-740
Vander Plaetsen S.: B-0363 Villers A.: A-419 Walsum T.V.: B-0856
Vandevoorde C.: B-0781 Vincent V.: B-1260 Walter T.C.: B-0011, B-0905
Vandromme L.: B-0465 Vinci V.: B-0140, B-0520, B-0523 Waltering K.U.: B-0349
Vandulek C.: A-396, A-662, B-0657 Vindigni C.: B-1237 Wanambiro K.W.: B-0820
Vanel D.: A-332 Vining D.J.: B-1191 Wanders J.O.P.: B-1028
Vanhevel F.: B-1219 Virgolini I.J.: B-0305 Wang C.: B-0470
Vanhoenacker F.M.H.M.: A-485, A-576 Visconti E.: B-0544 Wang F.: B-0939, B-1072
Vaniet C.: B-0376 Visser R.: B-1023 Wang G.: B-1085
Vanninen R.: B-0210, B-1058 Vivarelli M.: B-1054 Wang H.: B-0094, B-1007, B-1238
Vano Y.: B-0659 Viviani A.: B-0707 Wang J.: B-0225, B-0312, B-0808
Vanzulli A.: B-0035, B-0191 Vlassenbroek A.: B-0567 Wang L.: B-1279
Varallyay C.: B-0650 Vliegen R.F.A.: B-1094 Wang L.-J.: B-0411
Varga E.: B-0697 Vliegenthart R.: B-0263, B-0264, B-0329, B-0452, Wang M.: B-0065
Varga-Szemes A.: B-0051, B-0265, B-0272, B-0474, B-0533, B-0540, B-0792, B-1060, B-1109, K-05 Wang R.: B-0752
B-0793, B-0794 Vochteloo A.J.H.: B-0074 Wang S.-T.: B-0606
Varlamov G.: B-0705 Vock P.: A-387, A-410, A-743 Wang W.-P.: B-0715
Varoquaux A.D.: A-560 Voelker M.: B-0322 Wang X.: B-0606, B-1108, B-1167
Vasilevska Nikodinovska V.: A-441 Vogel A.: B-0999, B-1001 Wang Y.: B-0793, B-0794, B-0944, B-1238
Vasselli F.: B-0561 Vogelgesang A.M.: B-0648 Wang Z.: B-0254
Vázquez M.: B-0796 Vogelsang L.: B-1108 Wanner G.: B-0409
Veit-Haibach P.: A-284 Vogl T.: B-0931 Warnecke G.: B-0709
Vela A.: B-0403 Vogl T.J.: B-0088, B-0186, B-0193, B-0324, B-0372, Warth A.: B-0096, B-0991
Velasco A.: B-0548 B-0428, B-0539, B-0550, B-0628, B-0729, B-0730, Wasan R.: B-0924, B-0925
Veldhoen S.: B-0725 B-0731, B-0770, B-0847, B-0858, B-0859, B-0994, Wasser K.: B-1161, B-1184
Veldhuis W.B.: B-1028 B-1270 Watanabe Y.: B-0298
Vella A.: B-0229 Vogt F.M.: B-1176 Watson E.: B-1180
Velonakis G.: B-0339 Voigt J.: B-0727 Watts M.M.: B-0996
Velroyen A.: B-0102 Vojinovic S.: B-0079 Weavers P.T.: B-1107
Velthuis B.K.: B-0812, B-0815, B-0950, B-1063 Volterrani L.: B-0325, B-0667, B-1181, B-1237 Webber N.: B-0483
Veltman J.: B-0704 von Kummer R.: B-0506 Weber C.N.: B-0698, B-0853, B-0996
Veltri A.: B-0030, B-0900 von Tengg-Kobligk H.: B-0398 Weber M.: B-0524, B-0632, B-0669, B-0917, B-1160,
Vembar M.: B-0754, B-0797 Vonder M.: B-0263, B-0264 B-1170
Venancio J.: A-231 Voogd A.C.: B-1027, B-1030, B-1031, B-1032 Weber M.-A.: A-649, B-1039

www.myESR.org Final Programme | ECR 2015 343


List of Authors & Co-Authors

Weber R.J.P.: B-1027, B-1030, B-1031, B-1032 Winterstein M.: B-1039 Yang L.: B-1206
Weber T.F.: B-0424 Wirth S.: A-479 Yang S.: B-0048
Weber-Donat G.: B-0128 Wirths S.: B-1256 Yang S.B.: B-0691
Weckbach S.: B-0480 Witjes J.A.: B-1140 Yang Z.: B-0421, B-0819, B-0823
Ween B.: B-0361, B-0367 Wittens C.H.A.: B-0635 Yang Z.-G.: B-0475
Weidner A.: B-0554 Woitek R.: B-0524 Yaniv G.: B-0521, B-0525
Weidner M.: B-0169, B-0172 Woldringh G.H.: B-0228 Yankelevitz D.: B-0534
Weigel M.: B-0303, B-0562 Wolf A.: B-0534 Yao L.: B-0080
Weinheimer O.: B-0450 Wolf F.: B-0177 Yaqub M.: B-0320
Weinmann A.: B-0997 Wolfschmidt F.: B-1290 Yarar S.: B-1213
Weir N.: B-0055 Wolke S.: B-0631 Yaroshenko A.: B-0102, B-1101
Weir-McCall J.: B-0466, B-0481 Won H.J.: B-1049 Yazdani N.: B-0875
Weir-McCall J.R.: B-0479 Won J.Y.: B-0692 Yazici G.: B-0581
Weishaupt D.: A-424, A-582, B-1242 Won Y.: B-0416 Ye H.: B-1007
Weiß J.: B-0036, B-0556, B-0732, B-0854 Wong H.: B-0750 Ye L.: B-1283
Weiß R.: B-0368 Wong K.K.: B-1248 Ye Z.: B-0094
Weissmann T.: B-0003 Wong Y.-C.: B-0411 Yekeler E.: B-0388
Weisstanner C.: B-0813 Woo O.: B-0763 Yenihayat F.: B-1218
Weldon T.: B-0529 Wörner B.: B-0123 Yeong C.H.: B-0855
Wellenberg R.H.H.: B-0567 Woussen S.E.: B-1246 Yeow K.K.: B-0954
Wells A.: B-1115 Woznitza N.H.: B-1143 Yildirim A.Ö.: B-1101
Wen L.-Y.: B-0475 Wragg A.: B-0799 Yilmaz E.: B-0388
Wengert G.: B-0767 Wrede K.: B-0026 Yin J.: B-1080
Wenkel E.: B-1177 Wu C.-H.: B-0411 Yip R.: B-0534
Werner J.: B-0727 Wu C.X.: B-0528 Yonezawa M.: B-0986
Werquin C.: B-1275 Wu L.-M.: B-0047, B-0963 Yong Q.: B-0485, B-0570
Weskott H.-P.: A-140 Wu W.: B-1238 Yoo J.I.: B-0880
Wesseling J.: B-1210 Wu Y.: B-0235, B-1193 Yoo M.-W.: B-1120
Wessling J.: A-075 Wu Z.: B-0939 Yoon I.K.: B-0416
West D.J.: A-447 Wuyts F.L.: B-1219 Yoon J.: B-0568
Westwood T.D.: B-0662 Wydra D.: B-0668 Yoon J.H.: B-0114, B-1121
White R.D.: B-0479 Wykrętowicz M.: B-0459 Yoon J.-H.: B-0613
Wibmer A.: B-1010 Yoon R.G.: B-0156
Wyss M.: B-0373, B-0374, B-1070
Wicher M.: B-0656 Yoong P.: B-0069
Wichmann J.: B-0474 Yoshida H.: B-0139
Wichmann J.L.: B-0051, B-0088, B-0265, B-0428,
X Yoshida M.: B-0139
Xavier J.: B-0817 Yoshikawa T.: B-0686, B-0689, B-0937, B-0982
B-0445, B-0539, B-0729, B-0730, B-0731, B-0752,
Xia J.-G.: B-1202 Yoshioka K.: B-0184, B-1197
B-0770, B-0779, B-0793, B-0794
Xia W.: B-1279 Yousry T.A.: A-607, K-02
Widmann G.: B-1244
Xia Y.: B-1112 Yserbyt J.: B-0326
Wielandner A.: B-0177
Wielema M.: B-0617, B-0624 Xiao Y.: B-0080, B-0625, B-0944 Yu J.: B-1066
Wielpütz M.O.: A-171, B-0099, B-0450 Xing J.: B-0253 Yu M.H.: B-1169
Wienke A.: B-0655 Xu B.: B-0065 Yu N.: B-1110
Wiesmann M.: B-0421, B-0819 Xu H.-Y.: B-0475 Yu S.C.: B-0714
Wiessler M.: B-0313 Xu J.-R.: B-0047, B-0963 Yuan J.: B-0485
Wiest R.: B-0813 Xu X.: B-1111, B-1119 Yui M.: B-0686, B-0937, B-0964, B-0982
Wiggermann P.: B-0218 Xu Z.: B-0097 Yüksel N.: B-1218
Wiklund E.: B-0405 Xue H.: B-0939 Yulek F.: B-0162
Wikström J.: B-0418 Xue H.-D.: B-0606, B-1167 Yun H.: B-0048
Wildberger J.E.: A-367, B-0118, B-0600, B-0635, Yun S.J.: B-0109
B-0773, B-0775, B-0782, B-0792 Y Yun T.J.: B-0501
Wildermuth S.: B-0268 Yabuuchi H.: B-0986
Wilkens R.: B-0463 Yagil Y.: B-0438
Wille M.M.: B-0537 Yakar D.: B-0706 Z
Willeit J.: B-0549 Yamamura J.: B-0188, B-0223, B-0225, B-0808, Zabeck H.: B-0688
Willemink M.J.: B-0270 B-1213 Zaccagna F.: B-0337, B-0586, B-0888
Willemssen F.: B-0425 Yamanouchi T.: B-0986 Zackrisson S.: B-0921
Williams M.C.: B-0055, B-0846 Yamasaki Y.: B-0986 Zagdanski A.-M.: B-0187, B-0465
Willinek W.A.: B-1215 Yamashita Y.: B-1197 Zagoria R.J.: A-192, A-193
Willner M.: B-0101, B-0483, B-1012 Yamini D.: B-0855 Zaim S.: B-1096
Wilson D.J.: A-188, A-315, B-0067, B-0282 Yan F.: B-0217 Zalazar R.: B-0923
Wilson S.: B-0034, B-0463 Yan J.: B-0217, B-0260 Zaleska-Dorobisz U.: B-0227
Windhager R.: B-0942 Yang D.H.: B-0795 Zamora D.: A-498
Winklhofer S.: B-0746 Yang J.: B-0823 Zampella E.: A-325

344 ECR 2015 | Final Programme www.myESR.org


List of Authors & Co-Authors

Zampetoulas V.: B-0315 Zorkaltsev M.: B-0633


Zamyshevskaya M.: B-0633 Zorzi M.: B-1033
Zanca F.: B-0326, B-0787, B-1239, B-1246 Zoubi T.: B-0548
Zanetti M.: A-212, A-504 Zubarev A.: B-0705
Zangos S.: B-0994 Zuber N.: B-1242
Zannoni L.: B-0587 Zugaro L.: B-0066, B-0068, B-0072, B-0075, B-0338,
Zantedeschi L.: B-0961 B-0347
Zaottini F.: B-0496, B-0642, B-0643, B-0644, B-0805 Zuiani C.: B-0116, B-0230, B-0350, B-0442, B-0615,
Zarb F.: A-605, B-0142, B-0358, B-1014 B-0743, B-0919
Zareski E.: A-369 Zuliani M.: B-0891
Zaric O.: B-1153 Zuo P.: B-1080
Zarski J.-P.: B-0611 Zupanc B.: B-0610
Zavadovskaya V.: B-0633
Zavadovsky K.W.: B-0789
Závodszky G.: B-1061
Zawada E.: B-1086
Zbinden I.: B-0387
Zdešar U.: A-604
Zech C.J.: LBCT
Zeilinger M.: B-0242
Zelefsky M.J.: B-0348
Zeng M.: B-0048
Zerbi A.: B-1236
Zerlauth J.-B.: B-0940
Zeuzem S.: B-0858, B-0994
Zhang B.: B-0470
Zhang C.: B-1072
Zhang F.: B-1095
Zhang G.: A-014, B-0680, B-0787, B-0933, B-0976,
B-1100
Zhang H.: B-0217, B-0260
Zhang J.: B-1072
Zhang L.: B-0312, B-0472, B-0485, B-0570
Zhang M.: B-0685
Zhang S.: B-0570, B-0890
Zhang W.: B-0080
Zhang W.-G.: B-1155
Zhang X.: B-0614, B-1066
Zhang Y.: B-0939, B-1118
Zhang Y.-H.: B-0044
Zhang Z.: B-0032, B-0932, B-0933
Zhao B.: B-1080, B-1085
Zhao J.: B-0096, B-0823
Zheng D.: B-1007
Zheng J.: B-0348, B-0470, B-0555, B-1009, B-1010
Zheng L.: B-0032, B-0932, B-0933
Zheng W.B.: B-0528
Zhong X.: B-0002, B-0317
Zhou W.-Z.: B-1122
Zhu L.: B-0312, B-1167
Zibert J.: B-1022
Ziegler S.: B-0320
Zilkens C.: B-0936
Zimmermann E.: B-0176
Zimmermann H.A.: B-0095
Zins M.: A-008, A-486, A-678, B-0972
Zitzelsberger T.: B-0392
Ziv-Baran T.: B-0849
Zlatareva D.: A-664
Znamenskiy I.: B-0913
Zoephel K.: B-0513
Zompatori M.: B-0850
Zona S.: B-0316, B-1113
Zontar D.: B-1022

www.myESR.org Final Programme | ECR 2015 345


List of Authors & Co-Authors

346 ECR 2015 | Final Programme www.myESR.org


List of
Moderators

347
List of Moderators

A Casselman J.W.: RC 1712 Fournier L.: ESR/EORTC


Abrahamsson P.-A.: EM 2 Castañer E.: E³ 826 Francone M.: SS 603a
Ahlström Riklund K.: E³ 1618 Cerezal L.: SS 1910 Franquet T.: ESR/ESTRO 1
Akata D.: SS 301b Cesar R.: RC 1504 Frühwald-Pallamar J.: SS 308
Akhan O.: SS 709b Cevasco L.: SS 301a Furlan A.: SS 1801
Akinci D.: RC 1212 Ciraj-Bjelac O.: RC 1213 Fütterer J.J.: E³ 720
Alberich-Bayarri A.: SS 305 Clément O.: E³ 1226d
Alt C.D.: SS 1407 Coche E.E.J.G.: SS 1004 G
Amoretti N.: SS 609 Colin C.: SS 302a Gallagher F.A.: SS 206
Antoch G.: E³ 418 Colombo P.E.: SS 713 Gardarsdottir M.: SS 603b
Arnáiz J.: SS 607b Conte G.: SS 1916 Geers-van Gemeren S.: SS 1814
Arthurs O.J.: SS 312 Cornford E.J.: SS 1802 Geleijns J.: SS 213
Atalar E.: SS 313 Coskun A.: EM 4 Girardi V.: SS 1902a
Athanasiou A.: SS 202b Cotten A.: SS 1810 Giraudo C.: SS 1410
Avdagic E.: SS 1011 Coulden R.A.: E³ 1218 Gleeson F.: SS 704
Ayaz Ü.: RC 408 Cova M.A.: SS 1410 Golay X.: ESR/ESMRMB
Ayuso Colella C.: SS 1801 Croisille P.: E³ 1226c, SS 303b Golding S.J.: SS 208
Azavedo E.: SS 302b Cunha T.M.: E³ 920 Gómez-Ansón B.: SS 708
Curvo-Semedo L.: SS 1001 Gourtsoyiannis N.: ESOR Session
Czerny C.: SS 608 Graca B.: SS 1004
B
Bali M.A.: SS 301a Grainger A.J.: SS 214
Baltzer P.A.T.: SS 302b D Graser A.: E³ 1322
Banko B.: SS 1816 Damilakis J.: RC 513, EF 2 Grenacher L.: RC 501
Barkhof F.: SS 311b Danza F.M.: E³ 620 Grenier N.: E³ 820
Bargalló N.: SS 611 Das M.: SS 703 Grothoff M.: SS 203b
Barsi P.: SS 311a de Bruijne M.: SS 305 Grzycka - Kowalczyk L.: SS 208
Bartolozzi C.: RC 901 De Jonge M.C.: SS 1010a Guberina N.: SS 211a
Basta-Nikolic M.: TF 1 De Paepe K.N.: SS 616 Gürbüz D.: SS 311b
de las Heras Gala H.: SS 1913 Gutberlet M.: SS 603a
Bauer J.S.: SS 711
Bauer R.W.: SS 1003a del Cura Rodriguez J.L.: SS 309
Beggs I.: SS 1010b Del Guerra A.: SS 1013 H
Beiderwellen K.J.: SS 701a Del Vescovo R.: SS 601b Haliloglu M.: SS 1012
Bertolotto M.: SS 1907 Denecke T.: SS 1009 Hamm B.: EM 1, EM 2, EM 3, EM 4
Bharadwaz A.: SS 1909a Dewey M.: LBCT Helbich T.H.: E³ 918, RC 106
Bickelhaupt S.: SS 301b Dietzel M.: SS 202b Henzler T.: SS 704
Biondi A.: SS 1411 Díez Blanco M.: RC 108 Herold C.J.: SS 1904
Bisdas S.: SS 608 Dinkel J.: RC 1204 Heusner T.A.: SS 1409
Bloem J.L.: RC 810 Donato P.: SS 303b Hjemly H.H.: SS 1414
Blomqvist L.: E³ 1522 Dondelinger R.F.: SS 1409 Hodel J.: SS 311a
Bluekens A.M.J.: SS 1402 Donoghue V.: RC 112 Hodler J.: Res.WG
Bonafe A.: SS 1011 Dormagen J.B.: SS 317 Hohl C.: SS 601b
Bonomo L.: ESOR Session, ESR/ESTRO 2, EM 1, EM 2, Dósa E.: SS 209 Hoppe H.: SS 315
EM 3, EM 4 Drakonaki E.: SS 1010b Horta M.: SS 207
Bor D.: RC 1613 Dudea S.: SS 707 Hosten N.: EM 1
Boric I.: SS 612 Due-Tonnessen P.: SS 711 Houssami N.: PS 827
Bozzao A.: SS 211a Dunnick N.R.: LBCT Huisman T.A.G.: RC 111
Breen D.J.: SS 201b Durmus T.: SS 607a
Brink J.A.: MIR 2 I
Brink M.: SS 1813 E Iacconi C.: SS 702
Brisbois D.: SS 315 Eisenblätter M.: SS 206 Iacucci I.: SS 210
Brkljacic B.: RC 1302 Engelken F.: SS 602 Ierardi A.M.: SS 710
Broncano J.: SS 1404 Esen G.: SS 1002
Brountzos E.: SS 215 J
F Johnston C.J.: SS 616
C Fallenberg E.M.: SS 1902a Junker D.: SS 307
Camps Herrero J.: E³ 25A, E³ 25B, E³ 25C, E³ 25D, Fanelli F.: RC 815
E³ 25E Fatehi M.: SS 1905 K
Capelastegui A.: SS 715 Fernández Taranilla M.T.: SS 1911 Kachenoura N.: SS 605
Carbonaro L.A.: SS 302a Ferretti G.R.: SS 1804 Kallifatidis A.: SS 1803
Carbone I.: SS 1003b Feuchtner G.: RC 103, SS 603b Kalyvas N.: SS 1813
Caseiro Alves F.: E³ 1526 Filippiadis D.: SS 1016 Kanavaki A.: SS 312
Cassar-Pullicino V.: E³ 24A, E³ 24B, E³ 24C, E³ 24D, FitzGerald R.: MIR 2 Kapuscinska K.: SS 610b
E³ 24E Forrai G.: SS 702 Karabulut N.: RC 1304

348 ECR 2015 | Final Programme www.myESR.org


List of Moderators

Karaosmanoglu A.D.: SS 1809 Nikolic O.: SS 1407 Schrading S.: SS 1002


Karnabatidis D.: RC 415, SS 615 Schueller G.: SS 217
Kau T.: SS 1811 O Schuknecht B.F.: RC 411
Kawel-Böhm N.: SS 203a Ohmstede A.: EM 5 Schulz-Wendtland R.: SS 1402
Kinkel K.: RC 102, RC 1307, SS 207 Olliff J.: SS 1008 Schürmann K.: SS 209
Kirova-Nedialkova G.I.: SS 1003a Onur M.R.: SS 707 Sconfienza L.M.: E³ 1726, SS 1910
Köcher M.: SS 1909b Ording Müller L.-S.: SS 212 Screaton N.J.: SS 1904
Kool D.R.: SS 1014 Orsi F.: SS 1009 Sculier J.: ESR/ERS
Kowalik A.: SS 1013 Owens C.: SS 212 Sechopoulos I.: SS 713
Krajina A.: SS 709a Oyen R.H.: E³ 1020 Sharp P.: EF 1
Kreitner K.: SS 610a Özbek S.S.: RC 808 Sidhu P.S.: ESR/EFSUMB
Krokidis M.: SS 601a Özsunar Y.: SS 611
Skaane P.: RC 1702
Kubik-Huch R.A.: SS 716
Kurz K.D.: SS 211b Smits M.: ESR/ESMRMB
P Sögner P.: SS 1805
Palkó A.: MC 528, MC 628, MC 728, MC 828 Sohaib A.: SS 1816
L Panizza P.: SS 1902b
Laniado M.: SS 1901b Sosna J.: SS 1916
Papathanasiou M.A.: RC 1311
Lassau N.: SS 1406 Stern E.J.: SS 1404
Parkar A.P.: SS 1804
Lefere P.: SS 701b Stosic-Opincal T.: E³ 1626c
Paulo G.: SS 1913
Lehnert T.: SS 309 Pediconi F.: SS 602 Stratis A.: SS 213
Leiner T.: SS 1803 Pekarovic D.: SS 1014 Sundin A.E.: SS 316
Lemmerling M.M.: RC 508 Pellerin O.: SS 1909a Syrgiamiotis V.: SS 214
Lenghel L.M.: SS 317 Perea R.J.: SS 203b
Lévai A.: SS 1008 Pereira Mendes Serrao E.C.: SS 1416 T
Lievens Y.: ESR/ESTRO 1 Perez Rodrigo S.: SS 1902b Tali E.T.: RC 1511
Lim T.-H.: EM 3 Persson A.: RC 104 Taylor S.A.: E³ 1422
Littooij A.S.: SS 1012 Petralia G.: SS 1416 Theysohn J.: SS 313
Liu Y.: ESR/EORTC Petrovic S.: SS 308 Thibault F.: SS 202a
Llopis E.: SS 210 Peynircioglu B.: SS 1909b Thoeny H.C.: E³ 1226a
Loewe C.: SS 1414 Pfannenberg C.: E³ 518 Thomassin-Naggara I.: SS 716
Lucas R.N.: SS 607b Phoa S.: SS 201a Thrall J.H.: SS 605
Pierot L.: SS 1911
Tomà P.: E³ 926a
M Pina Insausti L.J.: RC 1502
Tomais D.: SS 615
Maccioni F.: SS 1001 Pinker-Domenig K.: SS 1802
Torresin A.: EF 2
Maher M.M.: SS 1401 Plagou A.: RC 1510
Pomoni A.: SS 316 Trianni A.: RC 1313
Mailli L.: SS 715
Ponhold L.: SS 1907 Trojanowska A.: E³ 1626a
Malago R.: SS 201b
Maly Sundgren P.C.: SS 612 Poortmans P.M.P.: ESR/ESTRO 2 Trumm C.G.: SS 1805
Mang T.: SS 701b Prayer D.: RC 412 Tsapaki V.: EF 1
Maniatis V.: SS 1901a Prokop M.: ESR/ERS Tsili A.: SS 1807
Mantatzis M.: SS 1811 Pugliese F.: RC 503 Tsoumakidou G.: SS 1015
Maric D.: SS 610a Tyurin I.E.: SS 216
Marincek B.: SS 601a R Tzalonikou M.: SS 610b
Martí-Bonmatí L.: SS 701a Regge D.: E³ 1326
Martínez-Miravete P.: SS 202a Regini F.: SS 201a U
Massmann A.: SS 709a Reijnierse M.: SS 710 Urbanczyk-Zawadzka M.: SS 303a
McDermott R.: E³ 818 Reiter M.: SS 709b
McNulty J.: SS 314 Ringelstein A.: SS 609 V
Merhemic Z.: SS 211b Robinson P.: RC 1210
van der Lugt A.: RC 1711
Minoiu C.A.: TF 1 Roche C.: SS 1814
van Hecke W.: SS 1411
Mirsadraee S.: SS 703 Rodríguez P.: SS 1901a
Mollet N.R.: SS 303a Vandecaveye V.: SS 1901b
Ronot M.: SS 1401
Morana G.: RC 1301, E³ 1518 Rørvik J.: SS 307 Vandulek C.: EM 5
Mostbeck G.: ESR/EFSUMB Rosendahl K.: RC 410 Varoquaux D.-A.: SS 708
Mueller-Mang C.: SS 604 Rud S.D.: SS 1003b Vassileva J.: RC 113
Müller-Schimpfle M.: SS 1016 Velthuis B.K.: SS 203a
Muto M.: SS 310 S Veltri A.: SS 1809
Sabharwal T.: E³ 926c Vilaplana A.: SS 216
N Sánchez M.: SS 604 Vilela P.: SS 215
Nicolau C.: E³ 520 Sardanelli F.: PS 827 Villeirs G.M.: SS 607a
Nieboer K.H.: SS 217 Scheurecker G.: SS 310 Virgolini I.: EIBIR 3
Niessen W.J.: SS 1905 Schima W.: E³ 1622 Vollmer I.: SS 304
Nikolaou K.: SS 1015 Schönberg S.O.: EIBIR 3 Votrubová J.: E³ 1318

www.myESR.org Final Programme | ECR 2015 349


List of Moderators

W
Wattjes M.P.: RC 511
Weckbach S.: SS 1810
Weishaupt D.: E³ 1222
Wibmer A.: SS 1807
Wieczorek J.: SS 314
Wildberger J.E.: SS 304
Wildgruber M.: SS 1406
Williams M.: RC 403
Wirth S.: RC 417
Wörtler K.: RC 1310

Y
Yakimov A.: SS 1010a

Z
Zampakis P.: RC 515
Zins M.: E³ 1722

350 ECR 2015 | Final Programme www.myESR.org


Notes

THE ANNUAL MEETING OF

www.myESR.org Final Programme | ECR 2015 351


myESR.org
The ECR is the annual meeting of the European Society of Radiology.

352 ECR 2015 | Final Programme www.myESR.org

You might also like